Report ID,Drug Identification Number,Report Type,Brand name,Company Name,Common or Proper name,Ingredients,Strength(s),Packaging size,Route of administration,Shortage status,Dosage form(s),Anticipated start date,Actual start date,Estimated end date,Actual end date,Reason,Date Created,Date Updated,Tier 3
179915,00828602,Shortage,0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION,BAXTER CORPORATION,0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION,DEXTROSE; LIDOCAINE HYDROCHLORIDE,50MG; 4MG,500mL bag,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION; SOLUTION,2023-01-09,2023-01-09,2023-02-13,2023-02-13,Demand increase for the drug.,2023-01-05,2023-02-14,No
181393,00786160,Shortage,"0.9% SODIUM CHLORIDE IRRIGATION, USP",BAXTER CORPORATION,"0.9% SODIUM CHLORIDE IRRIGATION, USP",SODIUM CHLORIDE,900MG,500 mL,IRRIGATION; IRRIGATION,Resolved,SOLUTION,2023-01-18,2023-01-18,2023-03-30,2023-03-30,Disruption of the manufacture of the drug.,2023-01-18,2023-03-31,No
181191,00786160,Shortage,"0.9% SODIUM CHLORIDE IRRIGATION, USP",BAXTER CORPORATION,"0.9% SODIUM CHLORIDE IRRIGATION, USP",SODIUM CHLORIDE,900MG,1000ML,IRRIGATION; IRRIGATION,Resolved,SOLUTION,2023-01-16,2023-01-16,2023-03-30,2023-03-30,Disruption of the manufacture of the drug.,2023-01-16,2023-03-31,No
200398,00038903,Shortage,5% DEXTROSE AND 0.45% SODIUM CHLORIDE,ICU MEDICAL CANADA INC,Dextrose and Sodium Chloride Injection USP,SODIUM CHLORIDE; DEXTROSE,4.5MG; 50MG,1000 mL,INTRAVENOUS; INTRAVENOUS,Avoided shortage,SOLUTION,2023-09-18,,2023-10-30,2023-09-06,Disruption of the manufacture of the drug.,2023-07-28,2023-09-06,No
197756,00060348,Shortage,"5% DEXTROSE INJECTION, USP",BAXTER CORPORATION,"5% DEXTROSE INJECTION, USP",DEXTROSE,5G,25 mL - JB0080,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2023-07-06,2023-07-06,2023-07-28,2023-07-28,Disruption of the manufacture of the drug.,2023-07-06,2023-07-31,No
189362,00060348,Shortage,"5% DEXTROSE INJECTION, USP",BAXTER CORPORATION,5% DEXTROSE INJECTION,DEXTROSE,5G,250 ML - JB0048,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2023-04-12,2023-04-12,2023-04-28,2023-04-28,Disruption of the manufacture of the drug.,2023-04-12,2023-04-29,No
187084,00060348,Shortage,"5% DEXTROSE INJECTION, USP",BAXTER CORPORATION,"5% DEXTROSE INJECTION, USP",DEXTROSE,5G,25 mL - JB0080,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2023-03-15,2023-03-15,2023-03-30,2023-03-30,Disruption of the manufacture of the drug.,2023-03-15,2023-03-31,No
206816,00060348,Shortage,"5% DEXTROSE INJECTION, USP",BAXTER CORPORATION,"5% Dextrose Injection, USP",DEXTROSE,5G,100 ML - JB0082P,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2023-10-11,2023-10-11,2023-10-23,2023-10-23,Disruption of the manufacture of the drug.,2023-10-11,2023-10-24,No
192068,02470780,Shortage,AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN,AA PHARMA INC,AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN,CLARITHROMYCIN; AMOXICILLIN; LANSOPRAZOLE,500MG; 500MG; 30MG,56BLS,ORAL; ORAL,Resolved,TABLET; CAPSULE; KIT; CAPSULE (DELAYED RELEASE),2023-05-08,,2023-10-19,2023-10-18,Disruption of the manufacture of the drug.,2023-05-08,2023-10-19,No
208027,02272873,Shortage,AA-LEVOCARB CR,AA PHARMA INC,AA-Levocarb CR,CARBIDOPA; LEVODOPA,25MG; 100MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),2023-10-25,,2024-01-19,2024-01-02,Disruption of the manufacture of the drug.,2023-10-25,2024-01-03,No
208870,02245211,Shortage,AA-LEVOCARB CR,AA PHARMA INC,AA-Levocarb CR,CARBIDOPA; LEVODOPA,50MG; 200MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),2023-11-10,,2024-01-19,2024-01-02,Disruption of the manufacture of the drug.,2023-11-01,2024-01-03,No
213143,02493268,Shortage,AA-RISEDRONATE DR,AA PHARMA INC,AA_RISEDRONATE dr,RISEDRONATE SODIUM,35MG,30BTL,ORAL,Resolved,TABLET (DELAYED-RELEASE),2023-12-13,,2024-02-20,2024-02-20,Disruption of the manufacture of the drug.,2023-12-13,2024-02-22,No
206725,02539047,Shortage,ABSORICA LD,SUN PHARMACEUTICAL INDUSTRIES LIMITED,ISOTRETINOIN CAPSULE,ISOTRETINOIN,8MG,30's,ORAL,Resolved,CAPSULE,,2023-09-29,,2023-11-20,Delay in shipping of the drug.,2023-10-10,2023-11-21,No
206728,02539063,Shortage,ABSORICA LD,SUN PHARMACEUTICAL INDUSTRIES LIMITED,ISOTRETINOIN CAPSULES,ISOTRETINOIN,24MG,30's,ORAL,Resolved,CAPSULE,,2023-09-29,,2023-11-20,Delay in shipping of the drug.,2023-10-10,2023-11-21,No
206731,02539055,Shortage,ABSORICA LD,SUN PHARMACEUTICAL INDUSTRIES LIMITED,ISOTRETINOIN CAPSULES,ISOTRETINOIN,16MG,30's,ORAL,Resolved,CAPSULE,,2023-09-29,,2023-11-20,Delay in shipping of the drug.,2023-10-10,2023-11-21,No
206734,02539071,Shortage,ABSORICA LD,SUN PHARMACEUTICAL INDUSTRIES LIMITED,ISOTRETINOIN CAPSULES,ISOTRETINOIN,32MG,30's,ORAL,Resolved,CAPSULE,,2023-09-29,,2023-11-20,Delay in shipping of the drug.,2023-10-10,2023-11-21,No
193986,02479796,Shortage,ACCEL-SILDENAFIL,ACCEL PHARMA INC,Accel-Sildenafil 25 mg,SILDENAFIL,25MG,4,ORAL; ORAL,Resolved,TABLET,2023-06-05,2023-06-02,2023-06-23,2023-06-16,Delay in shipping of the drug.,2023-06-08,2023-06-19,No
181973,02362422,Shortage,ACETAMINOPHEN TABLETS USP 325 MG,APOTEX INC,ACETAMINOPHEN,ACETAMINOPHEN,325MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-01-17,2023-02-24,2023-02-17,Disruption of the manufacture of the drug.,2023-01-20,2023-02-23,No
196000,02362201,Shortage,ACÉTAMINOPHÈNE BLASON SHIELD 500,LABORATOIRE RIVA INC.,Acéta. 500mg 1000blasons,ACETAMINOPHEN,500MG,1000,ORAL; ORAL,Actual shortage,TABLET,,2020-06-20,,,Disruption of the manufacture of the drug.,2023-06-20,2023-06-20,No
195992,02022222,Shortage,ACÉTAMINOPHÈNE COMPRIMÉ TABLET 500,LABORATOIRE RIVA INC.,Acéta. 500mg 1000comp.,ACETAMINOPHEN,500MG,1000,ORAL; ORAL,Actual shortage,TABLET,,2023-06-20,,,Disruption of the manufacture of the drug.,2023-06-20,2023-06-21,No
183593,00545015,Shortage,ACETAZOLAMIDE,AA PHARMA INC,Acetazolamide,ACETAZOLAMIDE,250MG,100BTL,ORAL; ORAL,Resolved,TABLET,2023-02-03,,2023-04-14,2023-04-04,Disruption of the manufacture of the drug.,2023-02-03,2023-04-05,No
185664,02358328,Shortage,"ACETAZOLAMIDE FOR INJECTION, USP",STERIMAX INC,"ACETAZOLAMIDE FOR INJECTION, USP",ACETAZOLAMIDE,500MG,1 vial,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION,,2023-02-28,2023-03-06,2023-03-02,Demand increase for the drug.,2023-02-28,2023-03-03,No
188809,02358328,Shortage,"ACETAZOLAMIDE FOR INJECTION, USP",STERIMAX INC,"ACETAZOLAMIDE FOR INJECTION, USP",ACETAZOLAMIDE,500MG,1 VIAL,INTRAVENOUS; INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,,2023-06-30,,,Demand increase for the drug.,2023-04-05,2024-01-25,No
212999,02243098,Shortage,ACETYLCYSTEINE SOLUTION,SANDOZ CANADA INCORPORATED,ACETYLCYSTEINE,ACETYLCYSTEINE,200MG,30ML,ORAL; INTRAVENOUS; INHALATION; ORAL; INTRAVENOUS; INHALATION,Resolved,SOLUTION,,2023-12-11,2023-12-22,2024-01-03,Disruption of the manufacture of the drug.,2023-12-11,2024-01-04,No
196632,02243098,Shortage,ACETYLCYSTEINE SOLUTION,SANDOZ CANADA INCORPORATED,ACETYLCYSTEINE,ACETYLCYSTEINE,200MG,30 ml 1LIVI,ORAL; INTRAVENOUS; INHALATION; ORAL; INTRAVENOUS; INHALATION,Resolved,SOLUTION,,2023-06-27,2023-07-07,2023-07-10,Disruption of the manufacture of the drug.,2023-06-27,2023-07-11,No
186913,02243098,Shortage,ACETYLCYSTEINE SOLUTION,SANDOZ CANADA INCORPORATED,ACETYLCYSTEINE SOLUTION,ACETYLCYSTEINE,200MG,30ML,ORAL; INTRAVENOUS; INHALATION; ORAL; INTRAVENOUS; INHALATION,Resolved,SOLUTION,,2023-03-13,2023-04-07,2023-03-20,Disruption of the manufacture of the drug.,2023-03-13,2023-03-21,No
204114,02243098,Shortage,ACETYLCYSTEINE SOLUTION,SANDOZ CANADA INCORPORATED,ACETYLCYSTEINE,ACETYLCYSTEINE,200MG,30ML,ORAL; INTRAVENOUS; INHALATION; ORAL; INTRAVENOUS; INHALATION,Resolved,SOLUTION,,2023-09-11,2023-10-27,2023-10-23,Shortage of an active ingredient.,2023-09-11,2023-10-24,No
197911,02381478,Shortage,ACH-ALENDRONATE,ACCORD HEALTHCARE INC,ALENDRONATE SODIUM,ALENDRONIC ACID,5MG,28,ORAL; ORAL,Resolved,TABLET,,2023-07-07,2023-07-26,2023-07-21,Delay in shipping of the drug.,2023-07-07,2023-07-22,No
192856,02381478,Shortage,ACH-ALENDRONATE,ACCORD HEALTHCARE INC,ALENDRONATE SODIUM,ALENDRONIC ACID,5MG,28,ORAL; ORAL,Resolved,TABLET,,2023-05-19,2023-07-10,2023-07-10,Disruption of the manufacture of the drug.,2023-05-19,2023-07-14,No
213617,02381494,Shortage,ACH-ALENDRONATE,ACCORD HEALTHCARE INC,ALENDRONATE,ALENDRONIC ACID,70MG,4,ORAL; ORAL,Resolved,TABLET,,2023-12-12,2023-12-21,2023-12-21,Delay in shipping of the drug.,2023-12-16,2023-12-22,No
214531,02419556,Shortage,ACH-AMLODIPINE,ACCORD HEALTHCARE INC,AMLODIPINE BESYLATE,AMLODIPINE,2.5MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-12-29,2024-05-10,,Disruption of the manufacture of the drug.,2023-12-29,2024-03-22,No
181030,02419556,Shortage,ACH-AMLODIPINE,ACCORD HEALTHCARE INC,AMLODIPINE BESYLATE,AMLODIPINE,2.5MG,100,ORAL; ORAL,Resolved,TABLET,,2023-01-13,,2023-02-24,Disruption of the manufacture of the drug.,2023-01-13,2023-02-25,No
181033,02419564,Shortage,ACH-AMLODIPINE,ACCORD HEALTHCARE INC,AMLODIPINE BESYLATE,AMLODIPINE,5MG,250,ORAL; ORAL,Resolved,TABLET,,2023-01-13,2023-03-31,2023-03-27,Disruption of the manufacture of the drug.,2023-01-13,2023-04-03,No
195262,02419556,Shortage,ACH-AMLODIPINE,ACCORD HEALTHCARE INC,AMLODIPINE BESYLATE,AMLODIPINE,2.5MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-16,,2023-09-15,Requirements related to complying with good manufacturing practices.,2023-06-17,2023-09-16,No
195273,02419564,Shortage,ACH-AMLODIPINE,ACCORD HEALTHCARE INC,AMLODIPINE BESYLATE,AMLODIPINE,5MG,250,ORAL; ORAL,Resolved,TABLET,,2023-06-16,,2023-09-15,Requirements related to complying with good manufacturing practices.,2023-06-17,2023-09-16,No
195276,02419572,Shortage,ACH-AMLODIPINE,ACCORD HEALTHCARE INC,AMLODIPINE BESYLATE,AMLODIPINE,10MG,250,ORAL; ORAL,Resolved,TABLET,,2023-06-16,,2023-09-15,Requirements related to complying with good manufacturing practices.,2023-06-17,2023-09-16,No
213620,02351218,Shortage,ACH-ANASTROZOLE,ACCORD HEALTHCARE INC,ANASTROZOLE,ANASTROZOLE,1MG,30,ORAL; ORAL,Resolved,TABLET,,2023-12-05,2024-01-15,2024-01-17,Demand increase for the drug.,2023-12-16,2024-01-19,No
195183,02487721,Shortage,ACH-APIXABAN,ACCORD HEALTHCARE INC,APIXABAN,APIXABAN,5MG,180,ORAL,Resolved,TABLET,,2023-06-16,2023-06-23,2023-06-23,Delay in shipping of the drug.,2023-06-16,2023-06-24,No
212848,02487721,Shortage,ACH-APIXABAN,ACCORD HEALTHCARE INC,APIXABAN,APIXABAN,5MG,60 180,ORAL,Resolved,TABLET,,2023-12-08,2024-03-14,2024-03-15,Disruption of the manufacture of the drug.,2023-12-08,2024-03-16,No
197908,02457784,Shortage,ACH-ATORVASTATIN CALCIUM,ACCORD HEALTHCARE INC,ATORVASTATIN,ATORVASTATIN,80MG,90,ORAL; ORAL,Resolved,TABLET,,2023-07-07,2023-08-17,2023-08-18,Delay in shipping of the drug.,2023-07-07,2023-08-19,No
181039,02457776,Shortage,ACH-ATORVASTATIN CALCIUM,ACCORD HEALTHCARE INC,ATORVASTATIN,ATORVASTATIN,40MG,500,ORAL; ORAL,Resolved,TABLET,,2023-01-09,,2023-03-06,Demand increase for the drug.,2023-01-13,2023-03-07,No
201598,02457768,Shortage,ACH-ATORVASTATIN CALCIUM,ACCORD HEALTHCARE INC,ATORVASTATIN,ATORVASTATIN,20MG,90,ORAL; ORAL,Resolved,TABLET,,2023-08-11,2023-09-01,2023-09-01,Delay in shipping of the drug.,2023-08-11,2023-09-02,No
201601,02457768,Shortage,ACH-ATORVASTATIN CALCIUM,ACCORD HEALTHCARE INC,ATORVASTATIN,ATORVASTATIN,20MG,500,ORAL; ORAL,Resolved,TABLET,,2023-08-11,2023-08-17,2023-08-18,Delay in shipping of the drug.,2023-08-11,2023-08-19,No
203456,02457784,Shortage,ACH-ATORVASTATIN CALCIUM,ACCORD HEALTHCARE INC,ATORVASTATIN,ATORVASTATIN,80MG,90,ORAL; ORAL,Resolved,TABLET,,2023-09-01,2023-10-25,2023-10-26,Delay in shipping of the drug.,2023-09-01,2023-10-27,No
203975,02457768,Shortage,ACH-ATORVASTATIN CALCIUM,ACCORD HEALTHCARE INC,ATORVASTATIN,ATORVASTATIN,20MG,90,ORAL; ORAL,Resolved,TABLET,,2023-09-07,2023-09-21,2023-10-02,Delay in shipping of the drug.,2023-09-08,2023-10-03,No
203978,02457776,Shortage,ACH-ATORVASTATIN CALCIUM,ACCORD HEALTHCARE INC,ATORVASTATIN,ATORVASTATIN,40MG,90,ORAL; ORAL,Resolved,TABLET,,2023-09-07,2023-10-25,2023-10-24,Delay in shipping of the drug.,2023-09-08,2023-10-25,No
199633,02457741,Shortage,ACH-ATORVASTATIN CALCIUM,ACCORD HEALTHCARE INC,ATORVASTATIN,ATORVASTATIN,10MG,90,ORAL; ORAL,Resolved,TABLET,,2023-07-21,2023-08-04,2023-08-03,Delay in shipping of the drug.,2023-07-21,2023-08-04,No
212187,02457776,Shortage,ACH-ATORVASTATIN CALCIUM,ACCORD HEALTHCARE INC,ATORVASTATIN,ATORVASTATIN,40MG,90,ORAL; ORAL,Resolved,TABLET,,2023-12-01,2023-12-08,2023-12-08,Delay in shipping of the drug.,2023-12-01,2023-12-09,No
212199,02457776,Shortage,ACH-ATORVASTATIN CALCIUM,ACCORD HEALTHCARE INC,ATORVASTATIN,ATORVASTATIN,40MG,500,ORAL; ORAL,Resolved,TABLET,,2023-12-01,2024-01-05,2024-01-05,Delay in shipping of the drug.,2023-12-01,2024-01-06,No
212210,02457768,Shortage,ACH-ATORVASTATIN CALCIUM,ACCORD HEALTHCARE INC,ATORVASTATIN,ATORVASTATIN,20MG,500,ORAL; ORAL,Resolved,TABLET,,2023-12-01,2024-01-19,2024-01-17,Demand increase for the drug.,2023-12-01,2024-01-19,No
212190,02325985,Shortage,ACH-BICALUTAMIDE,ACCORD HEALTHCARE INC,Bicalutamide,BICALUTAMIDE,50MG,30,ORAL; ORAL,Resolved,TABLET,,2023-11-01,2023-12-13,2023-12-14,Demand increase for the drug.,2023-12-01,2023-12-15,No
191757,02379295,Shortage,ACH-CANDESARTAN,ACCORD HEALTHCARE INC,CANDESARTAN CILEXETIL,CANDESARTAN CILEXETIL,32MG,100,ORAL; ORAL,Resolved,TABLET,,2023-05-05,2023-06-16,2023-06-16,Demand increase for the drug.,2023-05-05,2023-06-17,No
199644,02379295,Shortage,ACH-CANDESARTAN,ACCORD HEALTHCARE INC,CANDESARTAN CILEXETIL,CANDESARTAN CILEXETIL,32MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-21,2023-11-01,2023-11-02,Demand increase for the drug.,2023-07-21,2023-11-03,No
185595,02379287,Shortage,ACH-CANDESARTAN,ACCORD HEALTHCARE INC,CANDESARTAN CILEXETIL,CANDESARTAN CILEXETIL,16MG,100,ORAL; ORAL,Resolved,TABLET,,2023-02-24,,2023-04-27,Demand increase for the drug.,2023-02-24,2023-04-28,No
195279,02434652,Shortage,ACH-ESCITALOPRAM,ACCORD HEALTHCARE INC,ESCITALOPRAM,ESCITALOPRAM,10MG,30,ORAL; ORAL,Resolved,TABLET,,2023-06-16,,2023-10-05,Requirements related to complying with good manufacturing practices.,2023-06-17,2023-10-06,No
195282,02434652,Shortage,ACH-ESCITALOPRAM,ACCORD HEALTHCARE INC,Escitalopram,ESCITALOPRAM,10MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-16,,2023-10-05,Requirements related to complying with good manufacturing practices.,2023-06-17,2023-10-06,No
195285,02434660,Shortage,ACH-ESCITALOPRAM,ACCORD HEALTHCARE INC,Escitalopram,ESCITALOPRAM,20MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-16,,2023-09-15,Requirements related to complying with good manufacturing practices.,2023-06-17,2023-09-16,No
207014,02425610,Shortage,ACH-EZETIMIBE,ACCORD HEALTHCARE INC,EZETIMIBE,EZETIMIBE,10MG,100,ORAL; ORAL,Resolved,TABLET,,2023-10-12,2023-10-25,2023-10-30,Demand increase for the drug.,2023-10-13,2023-10-31,No
211396,02425610,Shortage,ACH-EZETIMIBE,ACCORD HEALTHCARE INC,EZETIMIBE,EZETIMIBE,10MG,100,ORAL; ORAL,Resolved,TABLET,,2023-11-22,2023-12-12,2023-12-13,Demand increase for the drug.,2023-11-24,2023-12-15,No
201604,02393441,Shortage,ACH-FLUOXETINE,ACCORD HEALTHCARE INC,FLUOXETINE HYDROCHLORIDE,FLUOXETINE,10MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-08-11,2023-09-09,2023-09-08,Delay in shipping of the drug.,2023-08-11,2023-09-09,No
195288,02490986,Shortage,ACH-IMATINIB,ACCORD HEALTHCARE INC,IMATINIB MESYLATE,IMATINIB,100MG,120,ORAL,Resolved,TABLET,,2023-06-16,,2023-09-15,Requirements related to complying with good manufacturing practices.,2023-06-17,2023-09-16,No
195292,02490994,Shortage,ACH-IMATINIB,ACCORD HEALTHCARE INC,IMATINIB MESYLATE,IMATINIB,400MG,30,ORAL,Resolved,TABLET,,2023-06-16,,2023-09-15,Requirements related to complying with good manufacturing practices.,2023-06-17,2023-09-16,No
187460,02399776,Shortage,ACH-LEVETIRACETAM,ACCORD HEALTHCARE INC,ACH Levetiracetam,LEVETIRACETAM,250MG,120,ORAL; ORAL,Resolved,TABLET,,2023-03-17,,2023-04-13,Delay in shipping of the drug.,2023-03-20,2023-04-15,No
194724,02399776,Shortage,ACH-LEVETIRACETAM,ACCORD HEALTHCARE INC,Levetiracetam,LEVETIRACETAM,250MG,120,ORAL; ORAL,Resolved,TABLET,,2023-06-12,2023-09-15,2023-09-15,Demand increase for the drug.,2023-06-12,2023-09-16,No
199638,02399784,Shortage,ACH-LEVETIRACETAM,ACCORD HEALTHCARE INC,LEVETIRACETAM,LEVETIRACETAM,500MG,120,ORAL; ORAL,Resolved,TABLET,,2023-07-21,2023-09-07,2023-09-08,Demand increase for the drug.,2023-07-21,2023-09-09,No
196330,02399792,Shortage,ACH-LEVETIRACETAM,ACCORD HEALTHCARE INC,LEVETIRACETAM,LEVETIRACETAM,750MG,120,ORAL; ORAL,Resolved,TABLET,,2023-06-23,2023-09-13,2023-09-15,Disruption of the manufacture of the drug.,2023-06-23,2023-09-16,No
195295,02509067,Shortage,ACH-METHOTREXATE,ACCORD HEALTHCARE INC,METHOTREXATE DISODIUM,METHOTREXATE,2.5MG,100,ORAL,Resolved,TABLET,,2023-06-16,,2023-09-15,Requirements related to complying with good manufacturing practices.,2023-06-17,2023-09-16,No
209750,02379236,Shortage,ACH-MONTELUKAST,ACCORD HEALTHCARE INC,MONTELUKAST,MONTELUKAST,10MG,30,ORAL; ORAL,Resolved,TABLET,,2023-11-06,2023-11-20,2023-11-21,Delay in shipping of the drug.,2023-11-10,2023-11-22,No
208987,02379236,Shortage,ACH-MONTELUKAST,ACCORD HEALTHCARE INC,MONTELUKAST,MONTELUKAST,10MG,30,ORAL; ORAL,Resolved,TABLET,,2023-11-01,2023-11-20,2023-11-21,Delay in shipping of the drug.,2023-11-03,2023-11-22,No
192862,02383780,Shortage,ACH-MYCOPHENOLATE,ACCORD HEALTHCARE INC,MYCOPHENOLATE MOFETIL,MYCOPHENOLATE MOFETIL,250MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-05-19,2023-05-26,2023-05-26,Delay in shipping of the drug.,2023-05-19,2023-05-29,No
194727,02378574,Shortage,ACH-MYCOPHENOLATE,ACCORD HEALTHCARE INC,MYCOPHENOLATE MOFETIL,MYCOPHENOLATE MOFETIL,500MG,50,ORAL; ORAL,Resolved,TABLET,,2023-06-12,2023-11-02,2023-11-02,Demand increase for the drug.,2023-06-12,2023-11-03,No
185586,02456338,Shortage,ACH-OLMESARTAN,ACCORD HEALTHCARE INC,OLMESARTAN MEDOXOMIL,OLMESARTAN MEDOXOMIL,40MG,90,ORAL,Resolved,TABLET,,2023-02-21,,2023-03-06,Demand increase for the drug.,2023-02-24,2023-03-07,No
212213,02456311,Shortage,ACH-OLMESARTAN,ACCORD HEALTHCARE INC,OLMESARTAN MEDOXOMIL,OLMESARTAN MEDOXOMIL,20MG,30 90,ORAL,Actual shortage,TABLET,,2023-12-01,,,Demand increase for the drug.,2023-12-01,2024-01-19,No
196333,02468964,Shortage,ACH-OLMESARTAN HCTZ,ACCORD HEALTHCARE INC,OLMESARTAN HCTZ,OLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE,40MG; 25MG,30,ORAL; ORAL,Avoided shortage,TABLET,,2023-06-23,2023-07-07,2023-06-07,Delay in shipping of the drug.,2023-06-23,2023-07-07,No
214525,02468964,Shortage,ACH-OLMESARTAN HCTZ,ACCORD HEALTHCARE INC,OLMESARTAN MEDOXOMIL HCTZ,OLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE,40MG; 25MG,30,ORAL; ORAL,Resolved,TABLET,,2023-12-29,2024-03-15,2024-03-15,Disruption of the manufacture of the drug.,2023-12-29,2024-03-16,No
208456,02391600,Shortage,ACH-PIOGLITAZONE,ACCORD HEALTHCARE INC,PIOGLITAZONE HYDROCHLORIDE,PIOGLITAZONE,15MG,90,ORAL; ORAL,Actual shortage,TABLET,,2023-10-27,,,Disruption of the manufacture of the drug.,2023-10-27,2024-01-19,No
187454,02440644,Shortage,ACH-PRAVASTATIN,ACCORD HEALTHCARE INC,PRAVASTATIN,PRAVASTATIN SODIUM,10MG,100,ORAL; ORAL,Resolved,TABLET,,2023-03-20,2023-06-28,2023-06-29,Disruption of the manufacture of the drug.,2023-03-20,2023-06-30,No
185589,02440644,Shortage,ACH-PRAVASTATIN,ACCORD HEALTHCARE INC,PRAVASTATIN,PRAVASTATIN SODIUM,10MG,100,ORAL; ORAL,Resolved,TABLET,,2023-02-21,,2023-03-17,Disruption of the manufacture of the drug.,2023-02-24,2023-03-18,No
214071,02449846,Shortage,ACH-PREGABALIN,ACCORD HEALTHCARE INC,PREGABALIN,PREGABALIN,50MG,100,ORAL,Resolved,CAPSULE,,2023-12-19,2024-01-10,2024-01-05,Demand increase for the drug.,2023-12-22,2024-01-06,No
208984,02449846,Shortage,ACH-PREGABALIN,ACCORD HEALTHCARE INC,PREGABALIN,PREGABALIN,50MG,100,ORAL,Resolved,CAPSULE,,2023-11-01,2023-11-24,2023-11-24,Delay in shipping of the drug.,2023-11-03,2023-11-25,No
209753,02449870,Shortage,ACH-PREGABALIN,ACCORD HEALTHCARE INC,PREGABALIN,PREGABALIN,150MG,100,ORAL,Resolved,CAPSULE,,2023-11-10,2023-12-22,2023-12-01,Delay in shipping of the drug.,2023-11-10,2023-12-02,No
192859,02449900,Shortage,ACH-PREGABALIN,ACCORD HEALTHCARE INC,PREGABALIN,PREGABALIN,300MG,100,ORAL,Resolved,CAPSULE,,2023-05-19,2023-11-23,2023-11-24,Disruption of the manufacture of the drug.,2023-05-19,2023-11-25,No
209756,02449900,Shortage,ACH-PREGABALIN,ACCORD HEALTHCARE INC,PREGABALIN,PREGABALIN,300MG,100,ORAL,Resolved,CAPSULE,,2023-11-06,2023-11-23,2023-11-24,Delay in shipping of the drug.,2023-11-10,2023-11-25,No
196327,02449838,Shortage,ACH-PREGABALIN,ACCORD HEALTHCARE INC,PREGABALIN,PREGABALIN,25MG,100,ORAL,Resolved,CAPSULE,,2023-06-23,2023-11-01,2023-11-02,Disruption of the manufacture of the drug.,2023-06-23,2023-11-03,No
213623,02450860,Shortage,ACH-QUETIAPINE FUMARATE XR,ACCORD HEALTHCARE INC,QUETIAPINE FUMARATE,QUETIAPINE,50MG,60,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),,2023-12-15,,,Disruption of the manufacture of the drug.,2023-12-16,2024-01-19,No
214534,02438925,Shortage,ACH-ROSUVASTATIN,ACCORD HEALTHCARE INC,ROSUVASTATIN,ROSUVASTATIN,10MG,500,ORAL; ORAL,Actual shortage,TABLET,,2023-12-29,2024-05-10,,Disruption of the manufacture of the drug.,2023-12-29,2024-03-22,No
192853,02438917,Shortage,ACH-ROSUVASTATIN,ACCORD HEALTHCARE INC,ROSUVASTATIN,ROSUVASTATIN,5MG,500,ORAL; ORAL,Resolved,TABLET,,2023-05-15,,2023-10-06,Requirements related to complying with good manufacturing practices.,2023-05-19,2023-10-07,No
209765,02438941,Shortage,ACH-ROSUVASTATIN,ACCORD HEALTHCARE INC,ROSUVASTATIN,ROSUVASTATIN,40MG,90,ORAL; ORAL,Actual shortage,TABLET,,2023-11-06,2024-05-10,,Disruption of the manufacture of the drug.,2023-11-10,2024-03-22,No
182631,02438925,Shortage,ACH-ROSUVASTATIN,ACCORD HEALTHCARE INC,ROSUVASTATIN,ROSUVASTATIN,10MG,"90, 500",ORAL; ORAL,Resolved,TABLET,,2023-01-23,,2023-03-09,Disruption of the manufacture of the drug.,2023-01-27,2023-03-10,No
194730,02438925,Shortage,ACH-ROSUVASTATIN,ACCORD HEALTHCARE INC,ROSUVASTATIN,ROSUVASTATIN,10MG,90,ORAL; ORAL,Resolved,TABLET,,2023-06-12,,2023-10-05,Requirements related to complying with good manufacturing practices.,2023-06-12,2023-10-06,No
194733,02438933,Shortage,ACH-ROSUVASTATIN,ACCORD HEALTHCARE INC,ROSUVASTATIN,ROSUVASTATIN,20MG,90,ORAL; ORAL,Actual shortage,TABLET,,2023-06-12,2024-05-10,,Requirements related to complying with good manufacturing practices.,2023-06-12,2024-03-22,No
195298,02438917,Shortage,ACH-ROSUVASTATIN,ACCORD HEALTHCARE INC,ROSUVASTATIN,ROSUVASTATIN,5MG,90,ORAL; ORAL,Resolved,TABLET,,2023-06-16,,2023-09-15,Requirements related to complying with good manufacturing practices.,2023-06-17,2023-09-16,No
195301,02438941,Shortage,ACH-ROSUVASTATIN,ACCORD HEALTHCARE INC,ROSUVASTATIN,ROSUVASTATIN,40MG,90,ORAL; ORAL,Resolved,TABLET,,2023-06-16,,2023-09-15,Requirements related to complying with good manufacturing practices.,2023-06-17,2023-09-16,No
195304,02438925,Shortage,ACH-ROSUVASTATIN,ACCORD HEALTHCARE INC,ROSUVASTATIN,ROSUVASTATIN,10MG,500,ORAL; ORAL,Resolved,TABLET,,2023-06-16,,2023-10-06,Requirements related to complying with good manufacturing practices.,2023-06-17,2023-10-07,No
195307,02438933,Shortage,ACH-ROSUVASTATIN,ACCORD HEALTHCARE INC,ROSUVASTATIN,ROSUVASTATIN,20MG,500,ORAL; ORAL,Resolved,TABLET,,2023-06-16,,2023-09-15,Requirements related to complying with good manufacturing practices.,2023-06-17,2023-09-16,No
185581,02438933,Shortage,ACH-ROSUVASTATIN,ACCORD HEALTHCARE INC,ROSUVASTATIN,ROSUVASTATIN,20MG,500,ORAL; ORAL,Resolved,TABLET,,2023-02-24,,2023-03-09,Delay in shipping of the drug.,2023-02-24,2023-03-10,No
195310,02438941,Shortage,ACH-ROSUVASTATIN,ACCORD HEALTHCARE INC,ROSUVASTATIN,ROSUVASTATIN,40MG,500,ORAL; ORAL,Resolved,TABLET,,2023-06-16,,2023-09-15,Requirements related to complying with good manufacturing practices.,2023-06-17,2023-09-16,No
208981,02439352,Shortage,ACH-SOLIFENACIN SUCCINATE,ACCORD HEALTHCARE INC,SOLIFENACIN SUCCINATE,SOLIFENACIN SUCCINATE,10MG,30,ORAL,Resolved,TABLET,,2023-11-02,2024-01-10,2024-01-10,Demand increase for the drug.,2023-11-03,2024-01-12,No
209762,02439352,Shortage,ACH-SOLIFENACIN SUCCINATE,ACCORD HEALTHCARE INC,SOLIFENACIN SUCCINATE,SOLIFENACIN SUCCINATE,10MG,30,ORAL,Resolved,TABLET,,2023-11-10,2024-01-10,2024-01-10,Demand increase for the drug.,2023-11-10,2024-01-12,No
201094,02439344,Shortage,ACH-SOLIFENACIN SUCCINATE,ACCORD HEALTHCARE INC,SOLIFENACIN SUCCINATE,SOLIFENACIN SUCCINATE,5MG,30,ORAL,Resolved,TABLET,,2023-07-31,2023-08-25,2023-08-25,Demand increase for the drug.,2023-08-04,2023-09-01,No
203969,02439352,Shortage,ACH-SOLIFENACIN SUCCINATE,ACCORD HEALTHCARE INC,SOLIFENACIN SUCCINATE,SOLIFENACIN SUCCINATE,10MG,30,ORAL,Resolved,TABLET,,2023-09-07,2023-10-20,2023-10-20,Demand increase for the drug.,2023-09-08,2023-10-23,No
203972,02439344,Shortage,ACH-SOLIFENACIN SUCCINATE,ACCORD HEALTHCARE INC,SOLIFENACIN SUCCINATE,SOLIFENACIN SUCCINATE,5MG,30,ORAL,Resolved,TABLET,,2023-09-07,2024-01-10,2024-01-10,Demand increase for the drug.,2023-09-08,2024-01-12,No
213250,02454068,Shortage,ACH-TACROLIMUS,ACCORD HEALTHCARE INC,TACROLIMUS MONOHYDRATE,TACROLIMUS,0.5MG,100,ORAL,Actual shortage,CAPSULE (IMMEDIATE RELEASE),,2023-12-01,,,Disruption of the manufacture of the drug.,2023-12-13,2024-01-19,No
195313,02515989,Shortage,ACH-TADALAFIL,ACCORD HEALTHCARE INC,Tadalafil,TADALAFIL,5MG,28,ORAL,Resolved,TABLET,,2023-06-16,,2023-09-15,Requirements related to complying with good manufacturing practices.,2023-06-17,2023-09-16,No
195316,02515997,Shortage,ACH-TADALAFIL,ACCORD HEALTHCARE INC,TADALAFIL,TADALAFIL,10MG,4,ORAL,Resolved,TABLET,,2023-06-16,,2023-09-15,Requirements related to complying with good manufacturing practices.,2023-06-17,2023-09-16,No
195319,02516004,Shortage,ACH-TADALAFIL,ACCORD HEALTHCARE INC,Tadalafil,TADALAFIL,20MG,4,ORAL,Resolved,TABLET,,2023-06-16,,2023-09-15,Requirements related to complying with good manufacturing practices.,2023-06-17,2023-09-16,No
211391,02407493,Shortage,ACH-TELMISARTAN,ACCORD HEALTHCARE INC,TELMISARTAN,TELMISARTAN,80MG,100,ORAL; ORAL,Resolved,TABLET,,2023-11-23,2024-01-03,2023-12-28,Delay in shipping of the drug.,2023-11-24,2023-12-29,No
212184,02407493,Shortage,ACH-TELMISARTAN,ACCORD HEALTHCARE INC,TELMISARTAN,TELMISARTAN,80MG,100,ORAL; ORAL,Resolved,TABLET,,2023-12-01,2024-01-03,2023-12-28,Delay in shipping of the drug.,2023-12-01,2023-12-29,No
181042,02419122,Shortage,ACH-TELMISARTAN HCTZ,ACCORD HEALTHCARE INC,TELMISARTAN HYDROCHLORIDE,HYDROCHLOROTHIAZIDE; TELMISARTAN,25MG; 80MG,100,ORAL; ORAL,Resolved,TABLET,,2023-01-09,,2023-03-06,Demand increase for the drug.,2023-01-13,2023-03-07,No
182634,02419114,Shortage,ACH-TELMISARTAN HCTZ,ACCORD HEALTHCARE INC,TELMISARTAN HYDROCHLORIDE,HYDROCHLOROTHIAZIDE; TELMISARTAN,12.5MG; 80MG,100,ORAL; ORAL,Resolved,TABLET,,2023-01-23,2023-03-24,2023-03-30,Disruption of the manufacture of the drug.,2023-01-27,2023-04-03,No
195322,02419114,Shortage,ACH-TELMISARTAN HCTZ,ACCORD HEALTHCARE INC,TELMISARTAN HYDROCHLOROTHIAZIDE,HYDROCHLOROTHIAZIDE; TELMISARTAN,12.5MG; 80MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-16,,2023-09-15,Requirements related to complying with good manufacturing practices.,2023-06-17,2023-09-16,No
195325,02419122,Shortage,ACH-TELMISARTAN HCTZ,ACCORD HEALTHCARE INC,TELMISARTAN HYDROCHLORIDE,HYDROCHLOROTHIAZIDE; TELMISARTAN,25MG; 80MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-16,,2023-09-15,Requirements related to complying with good manufacturing practices.,2023-06-17,2023-09-16,No
198405,02389819,Shortage,ACH-TEMOZOLOMIDE,ACCORD HEALTHCARE INC,TEMOZOLOMIDE,TEMOZOLOMIDE,20MG,5 sachet,ORAL; ORAL,Resolved,CAPSULE,,2023-07-12,2024-03-29,2024-04-01,Delay in shipping of the drug.,2023-07-12,2024-04-02,No
214522,02395738,Shortage,ACH-TOPIRAMATE,ACCORD HEALTHCARE INC,TOPIRAMATE,TOPIRAMATE,25MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-12-27,,,Disruption of the manufacture of the drug.,2023-12-29,2023-12-29,No
185598,02395746,Shortage,ACH-TOPIRAMATE,ACCORD HEALTHCARE INC,TOPIRAMATE,TOPIRAMATE,100MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-02-24,,,Disruption of the manufacture of the drug.,2023-02-24,2023-10-20,No
189213,02269198,Shortage,ACLASTA,SANDOZ CANADA INCORPORATED,ACLASTA,ZOLEDRONIC ACID,5MG,100ML 1LIVI,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-04-11,2023-05-12,2023-05-15,Disruption of the manufacture of the drug.,2023-04-11,2023-05-16,No
184204,02297485,Shortage,ACT AMLODIPINE,TEVA CANADA LIMITED,AMLODIPINE 5MG TAB,AMLODIPINE,5MG,100,ORAL; ORAL,Resolved,TABLET,,2023-02-07,2023-03-20,2023-04-27,Disruption of the manufacture of the drug.,2023-02-09,2023-04-28,No
195585,02247339,Shortage,ACT CIPROFLOXACIN,TEVA CANADA LIMITED,ACT CIPROFLOXACIN,CIPROFLOXACIN,250MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-09-30,2023-07-04,Disruption of the manufacture of the drug.,2023-06-19,2023-07-05,No
190731,02448319,Shortage,ACT DEXTROAMPHETAMINE SR,TEVA CANADA LIMITED,ACT-DEXTROAMPHETAMINE SRCAP 10MG 100,DEXTROAMPHETAMINE SULFATE,10MG,100,ORAL; ORAL,Resolved,CAPSULE (SUSTAINED-RELEASE),,2023-04-27,2023-05-30,2023-06-08,Disruption of the manufacture of the drug.,2023-04-27,2023-06-09,No
184225,02448327,Shortage,ACT DEXTROAMPHETAMINE SR,TEVA CANADA LIMITED,DEXTROAMPHETAMINE SRCAP 15MG,DEXTROAMPHETAMINE SULFATE,15MG,100,ORAL; ORAL,Resolved,CAPSULE (SUSTAINED-RELEASE),,2023-02-07,2023-05-20,2023-06-08,Disruption of the manufacture of the drug.,2023-02-09,2023-06-09,No
190776,02291878,Shortage,ACT ENALAPRIL,TEVA CANADA LIMITED,ACT-ENALAPRIL 2.5MG TABLETS 100,ENALAPRIL SODIUM,2MG,100,ORAL; ORAL,Resolved,TABLET,,2023-04-27,2023-07-10,2023-07-13,Disruption of the manufacture of the drug.,2023-04-27,2023-07-14,No
195646,02291908,Shortage,ACT ENALAPRIL,TEVA CANADA LIMITED,ACT ENALAPRIL,ENALAPRIL SODIUM,16MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-06-30,2023-07-05,Disruption of the manufacture of the drug.,2023-06-19,2023-07-06,No
194113,02291894,Shortage,ACT ENALAPRIL,TEVA CANADA LIMITED,ACT ENALAPRIL,ENALAPRIL SODIUM,8MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-08,2023-07-30,2023-07-27,Disruption of the manufacture of the drug.,2023-06-08,2023-07-28,No
183395,02291908,Shortage,ACT ENALAPRIL,TEVA CANADA LIMITED,ENALAPRIL 20MG  TAB,ENALAPRIL SODIUM,16MG,100,ORAL; ORAL,Resolved,TABLET,,2023-01-30,2023-07-10,2023-07-11,Disruption of the manufacture of the drug.,2023-02-02,2023-07-12,No
195469,02291878,Shortage,ACT ENALAPRIL,TEVA CANADA LIMITED,ACT ENALAPRIL,ENALAPRIL SODIUM,2MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-06-30,2023-07-04,Disruption of the manufacture of the drug.,2023-06-19,2023-07-05,No
195475,02291894,Shortage,ACT ENALAPRIL,TEVA CANADA LIMITED,ACT ENALAPRIL,ENALAPRIL SODIUM,8MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-06-30,2023-07-04,Disruption of the manufacture of the drug.,2023-06-19,2023-07-05,No
183392,02281279,Shortage,ACT FLUCONAZOLE,TEVA CANADA LIMITED,FLUCONAZOLE 100MG TAB,FLUCONAZOLE,100MG,50,ORAL; ORAL,Resolved,TABLET,,2023-01-30,2024-02-10,2023-02-20,Disruption of the manufacture of the drug.,2023-02-02,2023-10-04,No
195530,02281260,Shortage,ACT FLUCONAZOLE,TEVA CANADA LIMITED,ACT FLUCONAZOLE,FLUCONAZOLE,50MG,50,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-07-10,2023-07-04,Disruption of the manufacture of the drug.,2023-06-19,2023-07-05,No
195551,02281279,Shortage,ACT FLUCONAZOLE,TEVA CANADA LIMITED,ACT FLUCONAZOLE,FLUCONAZOLE,100MG,50,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-07-10,2023-07-20,Disruption of the manufacture of the drug.,2023-06-19,2023-07-21,No
206404,02255537,Shortage,ACT FLUVOXAMINE,TEVA CANADA LIMITED,FLUVOXAMINE 100MG TAB,FLUVOXAMINE MALEATE,100MG,100,ORAL; ORAL,Resolved,TABLET,,2023-09-09,2023-11-30,2023-10-18,Disruption of the manufacture of the drug.,2023-10-05,2023-10-19,No
180878,02255529,Shortage,ACT FLUVOXAMINE,TEVA CANADA LIMITED,FLUVOXAMINE 50MG TAB,FLUVOXAMINE MALEATE,50MG,100,ORAL; ORAL,Resolved,TABLET,,2023-01-10,2023-07-30,2023-06-08,Disruption of the manufacture of the drug.,2023-01-12,2023-06-09,No
199092,02255529,Shortage,ACT FLUVOXAMINE,TEVA CANADA LIMITED,ACT FLUVOXAMINE,FLUVOXAMINE MALEATE,50MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-18,2024-03-20,2024-03-06,Disruption of the manufacture of the drug.,2023-07-18,2024-03-18,No
209108,02255537,Shortage,ACT FLUVOXAMINE,TEVA CANADA LIMITED,ACT-FLUVOXAMINE 100MG TAB,FLUVOXAMINE MALEATE,100MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-11-01,2024-04-30,,Disruption of the manufacture of the drug.,2023-11-03,2024-04-11,No
211998,02324067,Shortage,ACT MEMANTINE,TEVA CANADA LIMITED,MEMANTINE 10MG FC TAB,MEMANTINE HYDROCHLORIDE,10MG,100,ORAL; ORAL,Resolved,TABLET,,2023-11-29,2023-12-20,2023-12-21,Disruption of the manufacture of the drug.,2023-11-30,2024-01-08,No
212001,02324067,Shortage,ACT MEMANTINE,TEVA CANADA LIMITED,MEMANTINE 10MG FC TAB,MEMANTINE HYDROCHLORIDE,10MG,30 ud,ORAL; ORAL,Resolved,TABLET,,2023-11-29,2024-01-31,2023-12-06,Disruption of the manufacture of the drug.,2023-11-30,2023-12-07,No
181588,02324067,Shortage,ACT MEMANTINE,TEVA CANADA LIMITED,ACT-MEMANTINE 10MG FC TAB,MEMANTINE HYDROCHLORIDE,10MG,"100, 30UD",ORAL; ORAL,Resolved,TABLET,,2023-01-18,2023-02-20,2023-02-07,Disruption of the manufacture of the drug.,2023-01-19,2023-02-09,No
195180,02324067,Shortage,ACT MEMANTINE,TEVA CANADA LIMITED,ACT MEMANTINE,MEMANTINE HYDROCHLORIDE,10MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-16,2023-07-10,2023-07-06,Disruption of the manufacture of the drug.,2023-06-16,2023-07-07,No
213374,02324067,Shortage,ACT MEMANTINE,TEVA CANADA LIMITED,MEMANTINE 10MG FC TAB,MEMANTINE HYDROCHLORIDE,10MG,30UD,ORAL; ORAL,Resolved,TABLET,,2023-12-13,2024-03-20,2024-03-20,Disruption of the manufacture of the drug.,2023-12-14,2024-03-21,No
190680,02324067,Shortage,ACT MEMANTINE,TEVA CANADA LIMITED,ACT-MEMANTINE 10MG FC TABLETS 100,MEMANTINE HYDROCHLORIDE,10MG,100,ORAL; ORAL,Resolved,TABLET,,2023-04-27,2023-10-31,2023-11-20,Disruption of the manufacture of the drug.,2023-04-27,2023-11-21,No
181594,02257734,Shortage,ACT METFORMIN,TEVA CANADA LIMITED,METFORMIN 850MG FC TAB,METFORMIN HYDROCHLORIDE,850MG,500,ORAL; ORAL,Resolved,TABLET,,2023-01-18,2023-03-31,2023-04-27,Disruption of the manufacture of the drug.,2023-01-19,2023-04-28,No
190722,02297329,Shortage,ACT PRAMIPEXOLE,TEVA CANADA LIMITED,ACT-PRAMIPEXOLE 1MG TABLETS 100,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,1MG,100,ORAL; ORAL,Resolved,TABLET,,2023-04-27,2024-01-31,2024-01-10,Disruption of the manufacture of the drug.,2023-04-27,2024-01-11,No
190725,02297337,Shortage,ACT PRAMIPEXOLE,TEVA CANADA LIMITED,ACT-PRAMIPEXOLE 1.5MG TABLETS 100,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,1.5MG,100,ORAL; ORAL,Resolved,TABLET,,2023-04-27,2024-01-31,2024-01-10,Disruption of the manufacture of the drug.,2023-04-27,2024-01-11,No
195127,02297329,Shortage,ACT PRAMIPEXOLE,TEVA CANADA LIMITED,ACT PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,1MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-16,2023-07-30,2023-07-04,Disruption of the manufacture of the drug.,2023-06-16,2023-07-05,No
208260,02297310,Shortage,ACT PRAMIPEXOLE,TEVA CANADA LIMITED,PRAMIPEXOLE 0.5MG TAB,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.5MG,`100,ORAL; ORAL,Resolved,TABLET,,2023-10-11,2024-01-31,2024-01-10,Disruption of the manufacture of the drug.,2023-10-26,2024-01-11,No
195466,02297337,Shortage,ACT PRAMIPEXOLE,TEVA CANADA LIMITED,ACT PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,1.5MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-07-31,2023-07-04,Disruption of the manufacture of the drug.,2023-06-19,2023-07-05,No
195582,02297302,Shortage,ACT PRAMIPEXOLE,TEVA CANADA LIMITED,ACT PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.25MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-07-30,2023-07-04,Disruption of the manufacture of the drug.,2023-06-19,2023-07-05,No
190719,02297302,Shortage,ACT PRAMIPEXOLE,TEVA CANADA LIMITED,ACT-PRAMIPEXOLE 0.25MG TABLETS 100,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.25MG,100,ORAL; ORAL,Resolved,TABLET,,2023-04-27,2024-01-31,2024-01-10,Disruption of the manufacture of the drug.,2023-04-27,2024-01-11,No
196367,02316080,Shortage,ACT QUETIAPINE,TEVA CANADA LIMITED,ACT QUETIAPINE,QUETIAPINE,25MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-23,2023-07-20,2023-07-11,Disruption of the manufacture of the drug.,2023-06-26,2023-07-12,No
180881,02316080,Shortage,ACT QUETIAPINE,TEVA CANADA LIMITED,QUETIAPINE 25MG FC TAB,QUETIAPINE,25MG,500,ORAL; ORAL,Resolved,TABLET,,2023-01-10,2023-02-10,2023-01-17,Disruption of the manufacture of the drug.,2023-01-12,2023-01-19,No
199106,02316099,Shortage,ACT QUETIAPINE,TEVA CANADA LIMITED,ACT QUETIAPINE,QUETIAPINE,100MG,500,ORAL; ORAL,Resolved,TABLET,,2023-07-18,2023-10-10,2023-10-04,Disruption of the manufacture of the drug.,2023-07-18,2023-10-05,No
199390,02316099,Shortage,ACT QUETIAPINE,TEVA CANADA LIMITED,ACT QUETIAPINE,QUETIAPINE,100MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-20,2023-10-10,2023-10-05,Disruption of the manufacture of the drug.,2023-07-20,2023-10-06,No
190734,02358840,Shortage,ACT RALOXIFENE,TEVA CANADA LIMITED,ACT-RALOXIFENE 60MG FC TABLETS 100,RALOXIFENE HYDROCHLORIDE,60MG,100,ORAL; ORAL,Resolved,TABLET,,2023-04-27,2023-08-20,2023-08-17,Disruption of the manufacture of the drug.,2023-04-27,2023-08-18,No
195781,02358840,Shortage,ACT RALOXIFENE,TEVA CANADA LIMITED,ACT RALOXIFENE,RALOXIFENE HYDROCHLORIDE,60MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-07-20,2023-07-04,Disruption of the manufacture of the drug.,2023-06-20,2023-07-05,No
195629,02254727,Shortage,ACT TERBINAFINE,TEVA CANADA LIMITED,ACT TERBINAFINE,TERBINAFINE,250MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-08-10,2023-07-17,Disruption of the manufacture of the drug.,2023-06-19,2023-08-17,No
184195,02254727,Shortage,ACT TERBINAFINE,TEVA CANADA LIMITED,TERBINAFINE 250MG TAB,TERBINAFINE,250MG,100,ORAL; ORAL,Resolved,TABLET,,2023-02-07,2023-08-30,2023-07-04,Disruption of the manufacture of the drug.,2023-02-09,2023-07-05,No
199936,01959034,Shortage,ACT-HIB,SANOFI PASTEUR LIMITED,Haemophilus b Conjugate Vaccine (Tetanus Protein - Conjugate),TETANUS PROTEIN; HAEMOPHILUS INFLUENZAE TYPE B-PRP,30MCG; 10MCG,5 x 0.5 mL vials,INTRAMUSCULAR; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION; KIT,,2023-07-20,2023-08-11,2023-07-28,Other (Please describe in comments),2023-07-24,2023-07-28,No
207261,01959034,Shortage,ACT-HIB,SANOFI PASTEUR LIMITED,Haemophilus b Conjugate Vaccine (Tetanus Protein – Conjugate),TETANUS PROTEIN; HAEMOPHILUS INFLUENZAE TYPE B-PRP,30MCG; 10MCG,"5 x 0.5 mL vials / 5 fioles de 0,5 mL",INTRAMUSCULAR; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION; KIT,2023-10-30,2023-10-23,2023-11-25,2023-11-21,Other (Please describe in comments),2023-10-18,2023-11-23,No
193833,02248722,Shortage,ACULAR LS,ABBVIE CORPORATION,ACULAR LS,KETOROLAC TROMETHAMINE,0.40%,5mL  white opaque plastic bottle with a controlled dropper tip,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,,2023-06-05,2023-07-07,2023-07-05,Demand increase for the drug.,2023-06-06,2023-07-06,No
203384,02240835,Shortage,ADVAIR 100 DISKUS,GLAXOSMITHKLINE INC,fluticasone propionate and salmeterol inhalation powder,FLUTICASONE PROPIONATE; SALMETEROL,100MCG; 50MCG,60s,INHALATION; INHALATION,Resolved,POWDER,,2023-08-30,2023-10-11,2023-09-14,Disruption of the manufacture of the drug.,2023-08-31,2023-09-15,No
187763,02240837,Shortage,ADVAIR 500 DISKUS,GLAXOSMITHKLINE INC,fluticasone propionate and salmeterol inhalation powder,FLUTICASONE PROPIONATE; SALMETEROL,500MCG; 50MCG,1x60,INHALATION; INHALATION,Resolved,POWDER,,2023-03-20,2023-04-21,2023-04-18,Disruption of the manufacture of the drug.,2023-03-23,2023-04-20,No
211577,02232570,Shortage,AIROMIR,"BAUSCH HEALTH, CANADA INC.",AIROMIR,SALBUTAMOL,100MCG,200 dose,INHALATION; INHALATION,Resolved,METERED-DOSE AEROSOL,,2023-01-31,,2023-11-28,Other (Please describe in comments),2023-11-27,2023-11-29,No
194954,02239505,Shortage,ALDARA P,"BAUSCH HEALTH, CANADA INC.",ALDARA P,IMIQUIMOD,5%,7.5g,TOPICAL; TOPICAL,Resolved,CREAM,,2023-06-12,2023-07-14,2023-07-10,Demand increase for the drug.,2023-06-15,2023-07-11,No
204072,00299979,Shortage,ALLERGENIC EXTRACT NON POLLENS,ALK-ABELLO INC,Pecan Nut (Food),NON POLLEN,100000UNIT,"5mL, 10mL",PERCUTANEOUS; SUBCUTANEOUS; INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS; INTRADERMAL,Actual shortage,LIQUID,2023-09-11,2023-09-11,,,Delay in shipping of the drug.,2023-09-11,2023-09-12,No
201856,00299979,Shortage,ALLERGENIC EXTRACT NON POLLENS,ALK-ABELLO INC,Peanut,NON POLLEN,100000UNIT,"5mL, 10mL",PERCUTANEOUS; SUBCUTANEOUS; INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS; INTRADERMAL,Actual shortage,LIQUID,2023-08-15,2023-08-15,,,Delay in shipping of the drug.,2023-08-15,2023-08-16,No
201801,02248151,Shortage,ALPHAGAN P,ABBVIE CORPORATION,Alphagan P,BRIMONIDINE TARTRATE,0.15%,5 mL,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,,2023-08-14,2023-12-22,2023-12-13,Disruption of the manufacture of the drug.,2023-08-14,2023-12-14,No
201805,02248151,Shortage,ALPHAGAN P,ABBVIE CORPORATION,Alphagan P,BRIMONIDINE TARTRATE,0.15%,10 mL,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,,2023-08-14,2023-12-01,2023-11-27,Disruption of the manufacture of the drug.,2023-08-14,2023-11-28,No
180122,02422956,Shortage,ALPROLIX,SANOFI-AVENTIS CANADA INC,ALPROLIX 3000,"RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN",3000UNIT,3000 IU/vial,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION; KIT,,2023-01-05,2023-01-31,2023-01-30,Demand increase for the drug.,2023-01-06,2023-01-31,No
196825,02422956,Shortage,ALPROLIX,SANOFI-AVENTIS CANADA INC,"Coagulation Factor IX (Recombinant), Fc Fusion Protein","RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN",3000UNIT,3000 IU/vial,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION; KIT,,2023-06-28,2023-07-10,2023-07-07,Demand increase for the drug.,2023-06-29,2023-07-10,No
192507,02422956,Shortage,ALPROLIX,SANOFI-AVENTIS CANADA INC,ALPROLIX,"RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN",3000UNIT,1,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION; KIT,,2023-05-15,2023-06-20,2023-06-20,Other (Please describe in comments),2023-05-15,2023-06-21,No
201872,02486717,Shortage,AMIKACIN SULFATE INJECTION,OMEGA LABORATORIES LIMITED,Amikacin Sulfate Injection,AMIKACIN,250MG,10 x 2 mL vial / fiole,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-08-28,2024-02-28,2024-02-22,Disruption of the manufacture of the drug.,2023-08-15,2024-02-23,No
203649,02242971,Shortage,AMIKACIN SULFATE INJECTION USP,SANDOZ CANADA INCORPORATED,AMIKACIN,AMIKACIN,250MG,2ML,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-09-05,2023-09-29,2023-10-02,Disruption of the manufacture of the drug.,2023-09-05,2023-10-03,No
213095,00582662,Shortage,AMINOPHYLLINE INJ 25MG/ML,OMEGA LABORATORIES LIMITED,Aminophylline Injection USP,AMINOPHYLLINE,25MG,10 x 10mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Actual shortage,SOLUTION,,2023-12-19,2024-07-15,,Disruption of the manufacture of the drug.,2023-12-12,2024-03-25,Yes
205759,00582662,Shortage,AMINOPHYLLINE INJ 25MG/ML,OMEGA LABORATORIES LIMITED,Aminophylline Injection USP,AMINOPHYLLINE,25MG,10 x 10mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-10-02,,2023-11-06,Disruption of the manufacture of the drug.,2023-10-02,2023-11-07,No
210886,00582662,Shortage,AMINOPHYLLINE INJ 25MG/ML,OMEGA LABORATORIES LIMITED,Aminophylline Injection USP,AMINOPHYLLINE,25MG,10 x 10mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-11-20,,2023-12-04,Demand increase for the drug.,2023-11-20,2023-12-05,No
189237,02423227,Shortage,AMIODARONE HYDROCHLORIDE FOR INJECTION,JAMP PHARMA CORPORATION,Amiodarone hydrochloride for injection,AMIODARONE HYDROCHLORIDE,50MG,30,INTRAVENOUS,Actual shortage,SOLUTION,,2023-04-11,2025-01-31,,Disruption of the manufacture of the drug.,2023-04-11,2024-03-12,No
197956,02242325,Shortage,AMIODARONE HYDROCHLORIDE FOR INJECTION,SANDOZ CANADA INCORPORATED,AMIODARONE HCL,AMIODARONE HYDROCHLORIDE,50MG,3ml 10LIVI,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,,2023-07-10,2023-07-14,2023-07-17,Disruption of the manufacture of the drug.,2023-07-10,2023-07-18,No
187811,02242325,Shortage,AMIODARONE HYDROCHLORIDE FOR INJECTION,SANDOZ CANADA INCORPORATED,AMIODARONE HYDROCHLORIDE FOR INJECTION,AMIODARONE HYDROCHLORIDE,50MG,18ML 1LIVI,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,2023-03-24,2023-03-24,2023-05-26,2023-05-01,Disruption of the manufacture of the drug.,2023-03-24,2023-05-03,No
183741,02423227,Shortage,AMIODARONE HYDROCHLORIDE FOR INJECTION,JAMP PHARMA CORPORATION,Amiodarone Hydrochloride,AMIODARONE HYDROCHLORIDE,50MG,10 x 3 mL vials,INTRAVENOUS,Avoided shortage,SOLUTION,2023-05-15,,2023-06-15,2023-03-07,Other (Please describe in comments),2023-02-06,2023-03-11,No
194926,02245248,Shortage,"AMIODARONE HYDROCHLORIDE FOR INJECTION, USP",FRESENIUS KABI CANADA LTD,"AMIODARONE HYDROCHLORIDE FOR INJECTION, USP",AMIODARONE HYDROCHLORIDE,50MG,3 mL,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2023-07-01,2023-07-01,2023-08-28,2023-07-10,Disruption of the manufacture of the drug.,2023-06-14,2023-07-20,No
198913,02352788,Shortage,AMOXICILLIN,SANIS HEALTH INC,AMOXICILLIN,AMOXICILLIN,250MG,250MG/5ML 100 ML,ORAL; ORAL,Resolved,GRANULES FOR SUSPENSION,,2023-07-18,2023-09-01,2023-09-01,Disruption of the manufacture of the drug.,2023-07-18,2023-09-05,No
198944,02352753,Shortage,AMOXICILLIN,SANIS HEALTH INC,AMOXICILLIN,AMOXICILLIN,250MG,250MG/5ML 100 ML,ORAL; ORAL,Resolved,GRANULES FOR SUSPENSION,,2023-07-18,2023-11-03,2023-11-03,Disruption of the manufacture of the drug.,2023-07-18,2023-11-06,No
188048,02495929,Shortage,AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION,SANDOZ CANADA INCORPORATED,AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION,AMOXICILLIN; CLAVULANIC ACID,1000MG; 200MG,10 PSOIJ,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,,2023-03-27,2023-06-16,2023-06-19,Disruption of the manufacture of the drug.,2023-03-27,2023-06-20,No
198613,02332450,Shortage,ANACIN,PALADIN LABS INC.,CAFFEINE ACETYLSALICYLIC ACID,CAFFEINE; ACETYLSALICYLIC ACID,32MG; 325MG,"50, 100 and 200 tabs",ORAL; ORAL,Actual shortage,TABLET,,2023-04-23,,,Disruption of the manufacture of the drug.,2023-07-13,2023-07-13,No
207713,00402591,Shortage,ANAFRANIL,APOTEX INC,CLOMIPRAMINE,CLOMIPRAMINE HYDROCHLORIDE,50MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-10-16,2023-12-22,2023-12-21,Disruption of the manufacture of the drug.,2023-10-20,2023-12-22,No
204346,02221861,Shortage,ANANDRON,CHEPLAPHARM ARZNEIMITTEL GMBH,nilutamide,NILUTAMIDE,50MG,Box of 90 tablets,ORAL; ORAL,Actual shortage,TABLET,2023-09-18,,,,Disruption of the manufacture of the drug.,2023-09-14,2023-11-18,No
189852,02162725,Shortage,ANAPROX,ATNAHS PHARMA UK LIMITED,Naproxen sodium tablets USP,NAPROXEN SODIUM,275MG,100s,ORAL; ORAL,Resolved,TABLET,,2023-04-19,,2023-05-25,Shortage of an active ingredient.,2023-04-19,2023-05-26,No
196763,00704423,Shortage,ANDROCUR DEPOT,BAYER INC,cyproterone acetate solution,CYPROTERONE ACETATE,100MG,3 x 3mL ampoules,INTRAMUSCULAR; INTRAMUSCULAR,Actual shortage,SOLUTION,,2022-10-31,,,Other (Please describe in comments),2023-06-28,2023-06-28,No
204107,02245345,Shortage,ANDROGEL,BGP PHARMA ULC,TESTOSTERONE,TESTOSTERONE,1%,30 UNIT TRADE CA,TRANSDERMAL; TRANSDERMAL,Resolved,GEL,2023-10-04,2023-10-04,2023-10-24,2023-10-25,Disruption of the manufacture of the drug.,2023-09-11,2023-10-30,No
196710,02245345,Shortage,ANDROGEL,BGP PHARMA ULC,TESTOSTERONE,TESTOSTERONE,1%,30 UNIT TRADE CA,TRANSDERMAL; TRANSDERMAL,Resolved,GEL,2023-07-12,2023-07-12,2023-08-15,2023-08-16,Demand increase for the drug.,2023-06-27,2023-08-21,No
192956,02249499,Shortage,ANDROGEL,BGP PHARMA ULC,TESTOSTERONE,TESTOSTERONE,12.5MG,1.25G,TRANSDERMAL; TRANSDERMAL,Resolved,GEL,2023-05-26,,2023-06-06,2023-05-29,Disruption of the manufacture of the drug.,2023-05-24,2023-05-31,No
202909,00505773,Shortage,ANUSOL-HC OINTMENT,CHURCH & DWIGHT CANADA CORP,Hydrocortisone Acetate - Zinc Sulfate monohydrate,ZINC SULFATE; HYDROCORTISONE ACETATE,0.5%; 0.5%,30g,RECTAL; RECTAL,Resolved,OINTMENT,,2023-08-12,2023-09-12,2023-09-13,Demand increase for the drug.,2023-08-24,2023-09-14,No
191394,00505773,Shortage,ANUSOL-HC OINTMENT,CHURCH & DWIGHT CANADA CORP,Hydrocortisone acetate / Zinc Sulfate,ZINC SULFATE; HYDROCORTISONE ACETATE,0.5%; 0.5%,30g,RECTAL; RECTAL,Resolved,OINTMENT,2023-05-01,2023-04-24,2023-07-17,2023-07-13,Disruption of the manufacture of the drug.,2023-05-01,2023-07-14,No
187232,00642894,Shortage,APO PIROXICAM CAP 20MG,APOTEX INC,PIROXICAM,PIROXICAM,20MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE,,2023-03-14,2023-03-24,2023-03-22,Disruption of the manufacture of the drug.,2023-03-16,2023-03-23,No
188418,00550957,Shortage,APO PREDNISONE TAB 50MG,APOTEX INC,PREDNISONE,PREDNISONE,50MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-03-28,2023-06-09,2023-06-08,Disruption of the manufacture of the drug.,2023-03-30,2023-06-09,No
208420,00312770,Shortage,APO PREDNISONE TAB 5MG,APOTEX INC,PREDNISONE,PREDNISONE,5MG,1000 BTL,ORAL; ORAL,Resolved,TABLET,,2023-10-24,2024-01-19,2024-01-11,Disruption of the manufacture of the drug.,2023-10-27,2024-01-12,No
209357,00441775,Shortage,APO TRIAZIDE,APOTEX INC,HYDROCHLOROTHIAZIDE/TRIAMTERENE,HYDROCHLOROTHIAZIDE; TRIAMTERENE,25MG; 50MG,1000 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-01,2023-11-10,2023-11-09,Disruption of the manufacture of the drug.,2023-11-06,2023-11-10,No
198465,02396769,Shortage,APO-ABACAVIR,APOTEX INC,ABACAVIR,ABACAVIR,300MG,60 BTL,ORAL; ORAL,Resolved,TABLET,,2023-07-04,2023-08-11,2023-08-11,Disruption of the manufacture of the drug.,2023-07-13,2023-08-12,No
194574,02491400,Shortage,APO-ABIRATERONE FILM COATED TABLETS,APOTEX INC,ABIRATERONE,ABIRATERONE ACETATE,500MG,60 BLS,ORAL,Resolved,TABLET,,2023-06-06,2023-07-14,2023-07-12,Disruption of the manufacture of the drug.,2023-06-09,2023-07-13,No
194577,02491397,Shortage,APO-ABIRATERONE FILM COATED TABLETS,APOTEX INC,ABIRATERONE,ABIRATERONE ACETATE,250MG,60 BLS,ORAL,Resolved,TABLET,,2023-06-06,2023-07-14,2023-07-12,Disruption of the manufacture of the drug.,2023-06-09,2023-07-13,No
207692,02491397,Shortage,APO-ABIRATERONE FILM COATED TABLETS,APOTEX INC,ABIRATERONE,ABIRATERONE ACETATE,250MG,60 BLS,ORAL,Resolved,TABLET,,2023-10-16,2023-11-17,2023-11-16,Disruption of the manufacture of the drug.,2023-10-20,2023-11-17,No
207701,02491400,Shortage,APO-ABIRATERONE FILM COATED TABLETS,APOTEX INC,ABIRATERONE,ABIRATERONE ACETATE,500MG,60 BLS,ORAL,Resolved,TABLET,,2023-10-16,2023-11-17,2023-11-16,Disruption of the manufacture of the drug.,2023-10-20,2023-11-17,No
200185,02491400,Shortage,APO-ABIRATERONE FILM COATED TABLETS,APOTEX INC,ABIRATERONE,ABIRATERONE ACETATE,500MG,60 BLS,ORAL,Resolved,TABLET,,2023-07-25,2023-08-11,2023-08-01,Disruption of the manufacture of the drug.,2023-07-27,2023-08-04,No
210707,02147610,Shortage,APO-ACEBUTOLOL,APOTEX INC,ACEBUTOLOL,ACEBUTOLOL,200MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-14,2023-12-15,2023-12-14,Disruption of the manufacture of the drug.,2023-11-17,2023-12-15,No
185448,02147610,Shortage,APO-ACEBUTOLOL,APOTEX INC,ACEBUTOLOL,ACEBUTOLOL,200MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-02-21,2023-03-17,2023-03-15,Disruption of the manufacture of the drug.,2023-02-23,2023-03-16,No
207725,02147602,Shortage,APO-ACEBUTOLOL,APOTEX INC,ACEBUTOLOL,ACEBUTOLOL,100MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-10-16,2023-12-15,2023-12-14,Disruption of the manufacture of the drug.,2023-10-20,2023-12-15,No
205492,02229977,Shortage,APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH,APOTEX INC,ACETAMINOPHEN,ACETAMINOPHEN,500MG,1000 BTL,ORAL; ORAL,Resolved,TABLET,,2023-09-26,2023-10-27,2023-10-26,Disruption of the manufacture of the drug.,2023-09-28,2023-10-27,No
203566,02207648,Shortage,APO-ACYCLOVIR,APOTEX INC,ACYCLOVIR,ACYCLOVIR,400MG,100 BTL,ORAL; ORAL,Actual shortage,TABLET,,2023-08-29,,,Disruption of the manufacture of the drug.,2023-09-01,2023-09-01,No
203837,02248730,Shortage,APO-ALENDRONATE,APOTEX INC,ALENDRONATE,ALENDRONIC ACID,70MG,4 BLS,ORAL; ORAL,Resolved,TABLET,,2023-09-05,2023-10-27,2023-10-19,Disruption of the manufacture of the drug.,2023-09-07,2023-10-20,No
191892,02454475,Shortage,APO-ALENDRONATE/VITAMIN D3,APOTEX INC,ALENDRONATE/VITAMIN D3,VITAMIN D3; ALENDRONIC ACID,5600UNIT; 70MG,4 BLS,ORAL; ORAL,Resolved,TABLET,,2023-05-02,2023-06-23,2023-06-15,Disruption of the manufacture of the drug.,2023-05-06,2023-06-16,No
185033,02454475,Shortage,APO-ALENDRONATE/VITAMIN D3,APOTEX INC,ALENDRONATE/VITAMIN D3,VITAMIN D3; ALENDRONIC ACID,5600UNIT; 70MG,4 BLS,ORAL; ORAL,Resolved,TABLET,,2023-02-14,2023-05-14,2023-04-20,Disruption of the manufacture of the drug.,2023-02-16,2023-04-21,No
186572,02454467,Shortage,APO-ALENDRONATE/VITAMIN D3,APOTEX INC,ALENDRONATE/VITAMIN D3,VITAMIN D3; ALENDRONIC ACID,2800UNIT; 70MG,4 BLS,ORAL; ORAL,Resolved,TABLET,,2023-03-07,2023-05-14,2023-04-20,Disruption of the manufacture of the drug.,2023-03-09,2023-04-21,No
202830,02315866,Shortage,APO-ALFUZOSIN,APOTEX INC,ALFUZOSIN,ALFUZOSIN HYDROCHLORIDE,10MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-08-22,2023-09-01,2023-08-31,Disruption of the manufacture of the drug.,2023-08-23,2023-09-01,No
209372,02315866,Shortage,APO-ALFUZOSIN,APOTEX INC,ALFUZOSIN,ALFUZOSIN HYDROCHLORIDE,10MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-11-01,2023-12-22,2023-12-14,Disruption of the manufacture of the drug.,2023-11-06,2023-12-15,No
188424,02402777,Shortage,APO-ALLOPURINOL,APOTEX INC,ALLOPURINOL,ALLOPURINOL,200MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-03-28,2023-05-26,2023-05-25,Disruption of the manufacture of the drug.,2023-03-30,2023-05-26,No
213584,02402777,Shortage,APO-ALLOPURINOL,APOTEX INC,ALLOPURINOL,ALLOPURINOL,200MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-12-12,2024-01-26,2024-01-25,Disruption of the manufacture of the drug.,2023-12-15,2024-01-26,No
185028,02402777,Shortage,APO-ALLOPURINOL,APOTEX INC,ALLOPURINOL,ALLOPURINOL,200MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-02-14,2023-05-26,2023-05-25,Disruption of the manufacture of the drug.,2023-02-16,2023-05-26,No
209369,02402777,Shortage,APO-ALLOPURINOL,APOTEX INC,ALLOPURINOL,ALLOPURINOL,200MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-01,2024-01-26,2024-01-25,Disruption of the manufacture of the drug.,2023-11-06,2024-01-26,No
187727,02246194,Shortage,APO-AMIODARONE TABLETS,APOTEX INC,AMIODARONE,AMIODARONE HYDROCHLORIDE,200MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-03-21,2023-05-05,2023-05-05,Disruption of the manufacture of the drug.,2023-03-23,2023-05-06,No
204408,02246194,Shortage,APO-AMIODARONE TABLETS,APOTEX INC,AMIODARONE,AMIODARONE HYDROCHLORIDE,200MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-09-12,2023-09-29,2023-09-27,Disruption of the manufacture of the drug.,2023-09-15,2023-09-28,No
207698,02403137,Shortage,APO-AMITRIPTYLINE,APOTEX INC,AMITRIPTYLINE,AMITRIPTYLINE HYDROCHLORIDE,10MG,1000 BTL,ORAL; ORAL,Actual shortage,TABLET,,2023-10-16,,,Disruption of the manufacture of the drug.,2023-10-20,2023-10-20,No
183486,02411318,Shortage,APO-AMLODIPINE-ATORVASTATIN,APOTEX INC,AMLODIPINE/ATORVASTATIN,ATORVASTATIN; AMLODIPINE,10MG; 10MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-01-31,2023-02-28,2023-03-01,Disruption of the manufacture of the drug.,2023-02-02,2023-03-02,No
185022,02411261,Shortage,APO-AMLODIPINE-ATORVASTATIN,APOTEX INC,AMLODIPINE/ATORVASTATIN,ATORVASTATIN; AMLODIPINE,20MG; 5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-02-14,2023-02-28,2023-03-01,Disruption of the manufacture of the drug.,2023-02-16,2023-03-02,No
185025,02411342,Shortage,APO-AMLODIPINE-ATORVASTATIN,APOTEX INC,AMLODIPINE/ATORVASTATIN,ATORVASTATIN; AMLODIPINE,80MG; 10MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-02-14,2023-02-28,2023-02-27,Disruption of the manufacture of the drug.,2023-02-16,2023-03-02,No
212940,02411342,Shortage,APO-AMLODIPINE-ATORVASTATIN,APOTEX INC,AMLODIPINE/ATORVASTATIN,ATORVASTATIN; AMLODIPINE,80MG; 10MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-12-05,2024-01-19,2024-01-18,Disruption of the manufacture of the drug.,2023-12-08,2024-01-19,No
197872,02411296,Shortage,APO-AMLODIPINE-ATORVASTATIN,APOTEX INC,APO- AMLO-ATORVASTATIN,ATORVASTATIN; AMLODIPINE,80MG; 5MG,100 btl,ORAL; ORAL,Resolved,TABLET,,2023-07-05,2023-09-01,2023-08-25,Disruption of the manufacture of the drug.,2023-07-07,2023-09-01,No
185483,02243350,Shortage,APO-AMOXI CLAV,APOTEX INC,AMOXICILLIN CLAVULANIC ACID,CLAVULANIC ACID; AMOXICILLIN,125MG; 250MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-02-21,2023-03-24,2023-03-15,Disruption of the manufacture of the drug.,2023-02-23,2023-03-16,No
205483,02243350,Shortage,APO-AMOXI CLAV,APOTEX INC,AMOXICILLIN CLAVULANIC ACID,CLAVULANIC ACID; AMOXICILLIN,125MG; 250MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-09-26,2023-10-13,2023-10-05,Disruption of the manufacture of the drug.,2023-09-28,2023-10-06,No
204990,02245623,Shortage,APO-AMOXI CLAV,APOTEX INC,APO-AMOXICLAV,CLAVULANIC ACID; AMOXICILLIN,125MG; 875MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-09-19,2023-12-08,2023-12-07,Disruption of the manufacture of the drug.,2023-09-22,2023-12-08,No
185039,02245623,Shortage,APO-AMOXI CLAV,APOTEX INC,AMOXICILLIN CLAVULANIC ACID,CLAVULANIC ACID; AMOXICILLIN,125MG; 875MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-02-14,2023-03-24,2023-03-15,Disruption of the manufacture of the drug.,2023-02-16,2023-03-16,No
184103,02445530,Shortage,APO-AMPHETAMINE XR,APOTEX INC,AMPHETAMINE,MIXED SALTS AMPHETAMINE,25MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2023-02-07,2023-04-07,2023-04-05,Disruption of the manufacture of the drug.,2023-02-09,2023-04-06,No
185474,02445506,Shortage,APO-AMPHETAMINE XR,APOTEX INC,AMPHETAMINE,MIXED SALTS AMPHETAMINE,10MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2023-02-21,2023-03-24,2023-03-22,Disruption of the manufacture of the drug.,2023-02-23,2023-03-23,No
204987,02445506,Shortage,APO-AMPHETAMINE XR,APOTEX INC,DEXTROAMPHETAMINE,MIXED SALTS AMPHETAMINE,10MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2023-09-19,2023-11-24,2023-11-16,Disruption of the manufacture of the drug.,2023-09-22,2023-11-17,No
203551,02471116,Shortage,APO-ARIPIPRAZOLE,APOTEX INC,ARIPIPRAZOLE,ARIPIPRAZOLE,15MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-08-29,2023-09-22,2023-09-14,Disruption of the manufacture of the drug.,2023-09-01,2023-09-15,No
203816,02471108,Shortage,APO-ARIPIPRAZOLE,APOTEX INC,ARIPIPRAZOLE,ARIPIPRAZOLE,10MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-09-05,2024-01-19,2024-01-18,Disruption of the manufacture of the drug.,2023-09-07,2024-01-19,No
182370,02471086,Shortage,APO-ARIPIPRAZOLE,APOTEX INC,ARIPIPRAZOLE,ARIPIPRAZOLE,2MG,30 BTL and 100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-01-24,2023-03-31,2023-03-28,Disruption of the manufacture of the drug.,2023-01-26,2023-03-30,No
182373,02471094,Shortage,APO-ARIPIPRAZOLE,APOTEX INC,ARIPIPRAZOLE,ARIPIPRAZOLE,5MG,30 BTL,ORAL; ORAL,Resolved,TABLET,,2023-01-24,2023-04-06,2023-04-04,Disruption of the manufacture of the drug.,2023-01-26,2023-04-06,No
182376,02471116,Shortage,APO-ARIPIPRAZOLE,APOTEX INC,ARIPIPRAZOLE,ARIPIPRAZOLE,15MG,30 BTL and 100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-01-24,2023-03-10,2023-03-07,Disruption of the manufacture of the drug.,2023-01-26,2023-03-09,No
182379,02471124,Shortage,APO-ARIPIPRAZOLE,APOTEX INC,ARIPIPRAZOLE,ARIPIPRAZOLE,20MG,30 BTL and 100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-01-24,2023-03-10,2023-03-07,Disruption of the manufacture of the drug.,2023-01-26,2023-03-09,No
185477,02471108,Shortage,APO-ARIPIPRAZOLE,APOTEX INC,ARIPIPRAZOLE,ARIPIPRAZOLE,10MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-02-21,2023-03-31,2023-03-15,Disruption of the manufacture of the drug.,2023-02-23,2023-03-16,No
214226,02471116,Shortage,APO-ARIPIPRAZOLE,APOTEX INC,ARIPIPRAZOLE,ARIPIPRAZOLE,15MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-12-19,2024-03-01,2024-02-15,Disruption of the manufacture of the drug.,2023-12-22,2024-02-16,No
209889,02471116,Shortage,APO-ARIPIPRAZOLE,APOTEX INC,ARIPIPRAZOLE,ARIPIPRAZOLE,15MG,30 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-06,,2023-11-30,Disruption of the manufacture of the drug.,2023-11-10,2023-12-01,No
209892,02471132,Shortage,APO-ARIPIPRAZOLE,APOTEX INC,ARIPIPRAZOLE,ARIPIPRAZOLE,30MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-06,,2023-11-30,Demand increase for the drug.,2023-11-10,2023-12-01,No
209895,02471116,Shortage,APO-ARIPIPRAZOLE,APOTEX INC,ARIPIPRAZOLE,ARIPIPRAZOLE,15MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-06,,2023-11-30,Disruption of the manufacture of the drug.,2023-11-10,2023-12-01,No
209898,02471124,Shortage,APO-ARIPIPRAZOLE,APOTEX INC,ARIPIPRAZOLE,ARIPIPRAZOLE,20MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-06,,2023-11-30,Disruption of the manufacture of the drug.,2023-11-10,2023-12-01,No
209901,02471086,Shortage,APO-ARIPIPRAZOLE,APOTEX INC,ARIPIPRAZOLE,ARIPIPRAZOLE,2MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-06,,2023-11-30,Disruption of the manufacture of the drug.,2023-11-10,2023-12-01,No
209904,02471086,Shortage,APO-ARIPIPRAZOLE,APOTEX INC,ARIPIPRAZOLE,ARIPIPRAZOLE,2MG,30 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-06,,2023-11-30,Disruption of the manufacture of the drug.,2023-11-10,2023-12-01,No
209907,02471108,Shortage,APO-ARIPIPRAZOLE,APOTEX INC,ARIPIPRAZOLE,ARIPIPRAZOLE,10MG,30 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-06,2024-01-19,2024-01-18,Disruption of the manufacture of the drug.,2023-11-10,2024-01-19,No
209910,02471094,Shortage,APO-ARIPIPRAZOLE,APOTEX INC,ARIPIPRAZOLE,ARIPIPRAZOLE,5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-03,2024-01-19,2024-01-18,Disruption of the manufacture of the drug.,2023-11-10,2024-01-19,No
209913,02471132,Shortage,APO-ARIPIPRAZOLE,APOTEX INC,ARIPIPRAZOLE,ARIPIPRAZOLE,30MG,30 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-06,,2023-11-30,Disruption of the manufacture of the drug.,2023-11-10,2023-12-01,No
209916,02471124,Shortage,APO-ARIPIPRAZOLE,APOTEX INC,ARIPIPRAZOLE,ARIPIPRAZOLE,20MG,30 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-06,,2023-11-30,Disruption of the manufacture of the drug.,2023-11-10,2023-12-01,No
209919,02471094,Shortage,APO-ARIPIPRAZOLE,APOTEX INC,ARIPIPRAZOLE,ARIPIPRAZOLE,5MG,30 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-06,2024-01-19,2024-01-18,Disruption of the manufacture of the drug.,2023-11-10,2024-01-19,No
193203,00773689,Shortage,APO-ATENOL TAB 50MG,APOTEX INC,ATENOLOL,ATENOLOL,50MG,30 BLS,ORAL; ORAL,Resolved,TABLET,,2023-05-23,2023-07-14,2023-07-12,Disruption of the manufacture of the drug.,2023-05-26,2023-07-13,No
193600,02318059,Shortage,APO-ATOMOXETINE,APOTEX INC,ATOMOXETINE,ATOMOXETINE,40MG,30 BLS,ORAL; ORAL,Resolved,CAPSULE,,2023-05-30,2023-07-07,2023-07-04,Disruption of the manufacture of the drug.,2023-06-02,2023-07-07,No
199524,02318075,Shortage,APO-ATOMOXETINE,APOTEX INC,ATOMOXETINE,ATOMOXETINE,80MG,30 BLS,ORAL; ORAL,Resolved,CAPSULE,,2023-07-18,2023-08-25,2023-08-17,Disruption of the manufacture of the drug.,2023-07-21,2023-08-18,No
204411,02318059,Shortage,APO-ATOMOXETINE,APOTEX INC,ATOMOXETINE,ATOMOXETINE,40MG,30 BLS,ORAL; ORAL,Resolved,CAPSULE,,2023-09-12,2023-12-08,2023-11-30,Disruption of the manufacture of the drug.,2023-09-15,2023-12-01,No
206566,02318059,Shortage,APO-ATOMOXETINE,APOTEX INC,ATOM,ATOMOXETINE,40MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE,,2023-10-03,2023-12-15,2023-11-30,Disruption of the manufacture of the drug.,2023-10-06,2023-12-01,No
210695,02295318,Shortage,APO-ATORVASTATIN,APOTEX INC,ATORVASTATIN,ATORVASTATIN,80MG,30 BLS,ORAL; ORAL,Resolved,TABLET,,2023-11-14,2023-12-22,2023-11-30,Disruption of the manufacture of the drug.,2023-11-17,2023-12-01,No
211493,02295318,Shortage,APO-ATORVASTATIN,APOTEX INC,ATORVASTATIN,ATORVASTATIN,80MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-21,2023-12-08,2023-11-30,Disruption of the manufacture of the drug.,2023-11-24,2023-12-01,No
188976,02295318,Shortage,APO-ATORVASTATIN,APOTEX INC,ATORVASTATIN,ATORVASTATIN,80MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-04-04,2023-04-28,2023-04-26,Disruption of the manufacture of the drug.,2023-04-06,2023-04-27,No
213556,02295288,Shortage,APO-ATORVASTATIN,APOTEX INC,ATORVASTATIN,ATORVASTATIN,20MG,30 BLS,ORAL; ORAL,Resolved,TABLET,,2023-12-12,2024-04-05,2024-04-04,Disruption of the manufacture of the drug.,2023-12-15,2024-04-05,No
190002,02415542,Shortage,APO-AZITHROMYCIN Z,APOTEX INC,AZITHROMYCIN,AZITHROMYCIN,250MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-04-18,2023-06-30,2023-06-22,Disruption of the manufacture of the drug.,2023-04-21,2023-06-23,No
213573,02415542,Shortage,APO-AZITHROMYCIN Z,APOTEX INC,AZITHROMYCIN,AZITHROMYCIN,250MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-12-12,2024-01-05,2023-12-21,Disruption of the manufacture of the drug.,2023-12-15,2023-12-22,No
211499,02139332,Shortage,APO-BACLOFEN,APOTEX INC,BACLOFEN,BACLOFEN,10MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-21,2023-12-22,2023-12-15,Disruption of the manufacture of the drug.,2023-11-24,2023-12-22,No
198470,02139332,Shortage,APO-BACLOFEN,APOTEX INC,BACLOFEN,BACLOFEN,10MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-07-04,2023-10-27,2023-10-26,Disruption of the manufacture of the drug.,2023-07-13,2023-10-27,No
196943,02139391,Shortage,APO-BACLOFEN,APOTEX INC,BACLOFEN,BACLOFEN,20MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-06-25,2023-08-04,2023-07-28,Disruption of the manufacture of the drug.,2023-06-29,2023-08-04,No
193620,02139332,Shortage,APO-BACLOFEN,APOTEX INC,BACLOFEN,BACLOFEN,10MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-05-30,2023-08-04,2023-07-28,Disruption of the manufacture of the drug.,2023-06-02,2023-08-04,No
210677,02139391,Shortage,APO-BACLOFEN,APOTEX INC,BACLOFEN,BACLOFEN,20MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-14,2023-12-22,2023-12-21,Disruption of the manufacture of the drug.,2023-11-17,2023-12-22,No
198473,02238796,Shortage,APO-BECLOMETHASONE NASAL SPRAY,APOTEX INC,BECLOMETHASONE,BECLOMETHASONE DIPROPIONATE,50MCG,200 DOSES,NASAL; NASAL,Resolved,SUSPENSION,,2023-07-04,2023-10-20,2023-10-13,Disruption of the manufacture of the drug.,2023-07-13,2023-10-15,No
193611,02238796,Shortage,APO-BECLOMETHASONE NASAL SPRAY,APOTEX INC,BECLOMETHASONE,BECLOMETHASONE DIPROPIONATE,50MCG,200 Metered Sprays,NASAL; NASAL,Resolved,SUSPENSION,,2023-05-30,2023-06-23,2023-06-22,Disruption of the manufacture of the drug.,2023-06-02,2023-06-23,No
212389,02537788,Shortage,APO-BROMFENAC,APOTEX INC,BROMFENAC,BROMFENAC,0.07%,3 mL,OPHTHALMIC,Resolved,SOLUTION,,2023-11-28,2024-01-05,2024-01-04,Disruption of the manufacture of the drug.,2023-12-02,2024-01-05,No
184072,02211076,Shortage,APO-BUSPIRONE,APOTEX INC,BUSPIRONE,BUSPIRONE HYDROCHLORIDE,10MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-02-07,2023-05-19,2023-05-11,Disruption of the manufacture of the drug.,2023-02-09,2023-05-12,No
213587,02455897,Shortage,APO-CABERGOLINE,APOTEX INC,CABERGOLINE,CABERGOLINE,0.5MG,8 BTL,ORAL,Resolved,TABLET,,2023-12-12,2023-12-22,2023-12-15,Disruption of the manufacture of the drug.,2023-12-15,2023-12-22,No
194584,02247935,Shortage,APO-CARVEDILOL,APOTEX INC,CARVEDILOL,CARVEDILOL,12.5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-06-06,2023-07-28,2023-07-26,Disruption of the manufacture of the drug.,2023-06-09,2023-07-27,No
203554,02247935,Shortage,APO-CARVEDILOL,APOTEX INC,CARVEDILOL,CARVEDILOL,12.5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-08-29,2023-11-17,2023-11-16,Disruption of the manufacture of the drug.,2023-09-01,2023-11-17,No
187223,02247935,Shortage,APO-CARVEDILOL,APOTEX INC,CARVEDILOL,CARVEDILOL,12.5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-03-14,2023-04-28,2023-04-26,Disruption of the manufacture of the drug.,2023-03-16,2023-04-27,No
190008,02240774,Shortage,APO-CEFADROXIL,APOTEX INC,CEFADROXIL,CEFADROXIL,500MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE,,2023-04-18,2024-03-15,2024-03-07,Disruption of the manufacture of the drug.,2023-04-21,2024-03-08,No
183495,02244393,Shortage,APO-CEFUROXIME,APOTEX INC,CEFUROXIME,CEFUROXIME,250MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-01-31,2023-02-17,2023-02-08,Disruption of the manufacture of the drug.,2023-02-02,2023-02-09,No
185471,02418940,Shortage,APO-CELECOXIB,APOTEX INC,CELECOXIB,CELECOXIB,200MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE,,2023-02-21,2023-03-03,2023-03-01,Disruption of the manufacture of the drug.,2023-02-23,2023-03-02,No
209930,00768715,Shortage,APO-CEPHALEX,APOTEX INC,CEPHALEXIN,CEPHALEXIN,500MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-06,2024-01-19,2024-01-11,Disruption of the manufacture of the drug.,2023-11-10,2024-01-12,No
185939,00768723,Shortage,APO-CEPHALEX,APOTEX INC,CEPALEXIN,CEPHALEXIN,250MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-02-28,2023-04-14,2023-04-04,Disruption of the manufacture of the drug.,2023-03-02,2023-04-14,No
185480,00768715,Shortage,APO-CEPHALEX,APOTEX INC,CEPHALEXIN,CEPHALEXIN,500MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-02-21,2023-03-03,2023-02-27,Disruption of the manufacture of the drug.,2023-02-23,2023-03-02,No
189656,00768715,Shortage,APO-CEPHALEX,APOTEX INC,CEPHALEXIN,CEPHALEXIN,500MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-04-11,2023-10-20,2023-10-19,Disruption of the manufacture of the drug.,2023-04-14,2023-10-20,No
197876,00768723,Shortage,APO-CEPHALEX,APOTEX INC,APO-CEPHALEX,CEPHALEXIN,250MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-07-05,2024-01-19,2024-01-11,Disruption of the manufacture of the drug.,2023-07-07,2024-01-12,No
211496,02284987,Shortage,APO-CILAZAPRIL/HCTZ,APOTEX INC,CILAZAPRIL/HCTZ,HYDROCHLOROTHIAZIDE; CILAZAPRIL,12.5MG; 5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-21,2023-12-01,2023-11-30,Disruption of the manufacture of the drug.,2023-11-24,2023-12-01,No
203809,02452707,Shortage,APO-CINACALCET,APOTEX INC,CINACALCET,CINACALCET,60MG,30 BTL,ORAL; ORAL,Resolved,TABLET,,2023-09-05,2023-10-20,2023-10-13,Disruption of the manufacture of the drug.,2023-09-07,2023-10-15,No
193606,02452707,Shortage,APO-CINACALCET,APOTEX INC,CINACALCET,CINACALCET,60MG,30 BTL,ORAL; ORAL,Resolved,TABLET,,2023-05-30,2023-06-16,2023-06-15,Disruption of the manufacture of the drug.,2023-06-02,2023-06-16,No
181113,02452693,Shortage,APO-CINACALCET,APOTEX INC,CINACALCET,CINACALCET,30MG,30 BTL,ORAL; ORAL,Resolved,TABLET,,2023-01-09,2023-02-10,2023-01-25,Disruption of the manufacture of the drug.,2023-01-13,2023-01-26,No
187721,02246057,Shortage,APO-CITALOPRAM,APOTEX INC,CITALOPRAM,CITALOPRAM,40MG,30 BLS,ORAL; ORAL,Resolved,TABLET,,2023-03-21,2023-05-05,2023-05-05,Disruption of the manufacture of the drug.,2023-03-23,2023-05-06,No
203828,02274744,Shortage,APO-CLARITHROMYCIN,APOTEX INC,CLARITHROMYCIN,CLARITHROMYCIN,250MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-09-05,2023-09-15,2023-09-14,Disruption of the manufacture of the drug.,2023-09-07,2023-09-15,No
207722,02274752,Shortage,APO-CLARITHROMYCIN,APOTEX INC,CLARITHROMYCIN,CLARITHROMYCIN,500MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-10-16,2023-12-15,2023-12-14,Disruption of the manufacture of the drug.,2023-10-20,2023-12-15,No
212928,02274744,Shortage,APO-CLARITHROMYCIN,APOTEX INC,CLARITHROMYCIN,CLARITHROMYCIN,250MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-12-05,2023-12-15,2023-12-14,Disruption of the manufacture of the drug.,2023-12-08,2023-12-15,No
189994,02252767,Shortage,APO-CLOPIDOGREL,APOTEX INC,CLOPIDOGREL,CLOPIDOGREL,75MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-04-18,2023-05-05,2023-05-05,Disruption of the manufacture of the drug.,2023-04-21,2023-05-06,No
201716,02398591,Shortage,APO-CLOPIDOGREL,APOTEX INC,CLOPIDOGREL,CLOPIDOGREL,300MG,30 BLS,ORAL; ORAL,Resolved,TABLET,,2023-08-08,2023-11-17,2023-11-16,Disruption of the manufacture of the drug.,2023-08-12,2023-11-17,No
190011,02494051,Shortage,APO-COLESEVELAM,APOTEX INC,COLESEVELAM,COLESEVELAM HYDROCHLORIDE,625MG,180 BTL,ORAL,Resolved,TABLET,,2023-04-18,2023-07-28,2023-07-26,Disruption of the manufacture of the drug.,2023-04-21,2023-07-27,No
210674,02494051,Shortage,APO-COLESEVELAM,APOTEX INC,COLESEVELAM,COLESEVELAM HYDROCHLORIDE,625MG,180 BTL,ORAL,Resolved,TABLET,,2023-11-14,2023-12-22,2023-12-21,Disruption of the manufacture of the drug.,2023-11-17,2023-12-22,No
185492,02468913,Shortage,APO-DABIGATRAN,APOTEX INC,DABIGATRAN,DABIGATRAN ETEXILATE,150MG,60 BTL,ORAL; ORAL,Resolved,CAPSULE,,2023-02-21,2023-03-24,2023-03-22,Disruption of the manufacture of the drug.,2023-02-23,2023-03-23,No
189659,02468913,Shortage,APO-DABIGATRAN,APOTEX INC,DABIGATRAN,DABIGATRAN ETEXILATE,150MG,60 BTL,ORAL; ORAL,Resolved,CAPSULE,,2023-04-11,2023-06-09,2023-06-07,Disruption of the manufacture of the drug.,2023-04-14,2023-06-08,No
203563,02527197,Shortage,APO-DAPAGLIFLOZIN,APOTEX INC,DAPAGLIFLOZIN,DAPAGLIFLOZIN,10MG,500 BTL,ORAL,Resolved,TABLET,,2023-08-29,2023-12-29,2024-01-04,Disruption of the manufacture of the drug.,2023-09-01,2024-01-05,No
209333,02527197,Shortage,APO-DAPAGLIFLOZIN,APOTEX INC,DAPAGLIFLOZIN,DAPAGLIFLOZIN,10MG,30 BLS,ORAL,Resolved,TABLET,,2023-11-01,2024-01-05,2024-01-04,Disruption of the manufacture of the drug.,2023-11-06,2024-01-05,No
208370,02527197,Shortage,APO-DAPAGLIFLOZIN,APOTEX INC,DAPAGLIFLOZIN,DAPAGLIFLOZIN,10MG,100 BTL,ORAL,Resolved,TABLET,,2023-10-24,2023-12-29,2024-01-04,Disruption of the manufacture of the drug.,2023-10-27,2024-01-05,No
213547,02452510,Shortage,APO-DARIFENACIN,APOTEX INC,DARIFENACIN,DARIFENACIN,7.5MG,100 BTL,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),,2023-12-12,2024-06-30,,Disruption of the manufacture of the drug.,2023-12-15,2024-02-02,No
212368,02452529,Shortage,APO-DARIFENACIN,APOTEX INC,DARIFENACIN,DARIFENACIN,15MG,30 BTL,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),,2023-11-28,2024-06-30,,Disruption of the manufacture of the drug.,2023-12-01,2024-02-02,No
203819,02461552,Shortage,APO-DEFERASIROX,APOTEX INC,DEFERASIROX,DEFERASIROX,250MG,30 BLS,ORAL; ORAL,Resolved,TABLET FOR SUSPENSION,,2023-09-05,2023-09-22,2023-09-14,Disruption of the manufacture of the drug.,2023-09-07,2023-09-15,No
187238,02467119,Shortage,APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS,APOTEX INC,DESVENLAFAXINE SUCCINATE,DESVENLAFAXINE,50MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-03-14,2023-04-07,2023-04-04,Disruption of the manufacture of the drug.,2023-03-16,2023-04-06,No
190874,02467119,Shortage,APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS,APOTEX INC,DESVENLAFAXINE SUCCINATE,DESVENLAFAXINE,50MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-04-23,2023-06-30,2023-06-23,Disruption of the manufacture of the drug.,2023-04-27,2023-06-29,No
191898,02467127,Shortage,APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS,APOTEX INC,DESVENLAFAXINE SUCCINATE,DESVENLAFAXINE,100MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-05-02,2023-05-12,2023-05-11,Disruption of the manufacture of the drug.,2023-05-06,2023-05-12,No
193218,02467127,Shortage,APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS,APOTEX INC,DESVENLAFAXINE SUCCINATE,DESVENLAFAXINE,100MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-05-23,2023-07-28,2023-07-20,Disruption of the manufacture of the drug.,2023-05-26,2023-07-21,No
182361,00839183,Shortage,APO-DICLO,APOTEX INC,DICLOFENAC,DICLOFENAC SODIUM,50MG,100 BTL,ORAL; ORAL,Resolved,TABLET (ENTERIC-COATED),,2023-01-24,2023-04-21,2023-04-20,Disruption of the manufacture of the drug.,2023-01-26,2023-04-21,No
214238,00839183,Shortage,APO-DICLO,APOTEX INC,DICLOFENAC NA,DICLOFENAC SODIUM,50MG,100 BTL,ORAL; ORAL,Resolved,TABLET (ENTERIC-COATED),,2023-12-19,2024-02-23,2024-02-22,Disruption of the manufacture of the drug.,2023-12-22,2024-02-23,No
201704,00839183,Shortage,APO-DICLO,APOTEX INC,DICLOFENAC,DICLOFENAC SODIUM,50MG,100 BTL,ORAL; ORAL,Resolved,TABLET (ENTERIC-COATED),,2023-08-08,2023-10-06,2023-10-05,Disruption of the manufacture of the drug.,2023-08-12,2023-10-06,No
212392,02091194,Shortage,APO-DICLO SR,APOTEX INC,DICLOFENAC NA,DICLOFENAC SODIUM,100MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-11-28,2024-01-05,2024-01-04,Disruption of the manufacture of the drug.,2023-12-02,2024-01-05,No
198514,02441020,Shortage,APO-DICLOFENAC OPHTHALMIC,APOTEX INC,DICLOFENAC NA,DICLOFENAC SODIUM,0.10%,5 ML,OPHTHALMIC; OPHTHALMIC,Actual shortage,SOLUTION,,2023-07-11,,,Disruption of the manufacture of the drug.,2023-07-13,2023-07-13,No
200197,02230997,Shortage,APO-DILTIAZ CD,APOTEX INC,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,120MG,500 BTL,ORAL; ORAL,Resolved,CAPSULE (CONTROLLED-DELIVERY); CAPSULE (CONTROLLED-DELIVERY),,2023-07-25,2023-08-25,2023-08-22,Shortage of an inactive ingredient or component.,2023-07-27,2023-08-23,No
195097,02239699,Shortage,APO-DIVALPROEX,APOTEX INC,DIVALPROEX,VALPROIC ACID,250MG,100 BTL,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE); TABLET (ENTERIC-COATED),,2023-06-13,2023-07-07,2023-07-04,Disruption of the manufacture of the drug.,2023-06-16,2023-07-07,No
187226,02239700,Shortage,APO-DIVALPROEX,APOTEX INC,DIVALPROEX,VALPROIC ACID,500MG,100 BTL,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE); TABLET (ENTERIC-COATED),,2023-03-14,2023-03-24,2023-03-17,Disruption of the manufacture of the drug.,2023-03-16,2023-03-23,No
198500,02239700,Shortage,APO-DIVALPROEX,APOTEX INC,DIVALPROEX,VALPROIC ACID,500MG,100 BTL,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE); TABLET (ENTERIC-COATED),,2023-07-11,2023-09-22,2023-09-21,Disruption of the manufacture of the drug.,2023-07-13,2023-09-22,No
199530,02239698,Shortage,APO-DIVALPROEX,APOTEX INC,DIVALPROEX,VALPROIC ACID,125MG,100 BTL,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE); TABLET (ENTERIC-COATED),,2023-07-18,2023-09-01,2023-08-31,Disruption of the manufacture of the drug.,2023-07-21,2023-09-01,No
199533,02239699,Shortage,APO-DIVALPROEX,APOTEX INC,DIVALPROEX,VALPROIC ACID,250MG,100 BTL,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE); TABLET (ENTERIC-COATED),,2023-07-18,2023-10-27,2023-10-26,Disruption of the manufacture of the drug.,2023-07-21,2023-10-27,No
180081,02239699,Shortage,APO-DIVALPROEX,APOTEX INC,DIVALPROEX,VALPROIC ACID,250MG,100 BTL,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE); TABLET (ENTERIC-COATED),,2023-01-02,2023-01-20,2023-01-19,Disruption of the manufacture of the drug.,2023-01-06,2023-01-20,No
190846,02239699,Shortage,APO-DIVALPROEX,APOTEX INC,DIVALPROEX,VALPROIC ACID,250MG,100 BTL,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE); TABLET (ENTERIC-COATED),,2023-04-25,2023-05-05,2023-05-05,Disruption of the manufacture of the drug.,2023-04-27,2023-05-06,No
191889,02239700,Shortage,APO-DIVALPROEX,APOTEX INC,DIVALPROEX,VALPROIC ACID,500MG,100 BTL,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE); TABLET (ENTERIC-COATED),,2023-05-02,2023-05-19,2023-05-11,Disruption of the manufacture of the drug.,2023-05-06,2023-05-12,No
196292,02239700,Shortage,APO-DIVALPROEX,APOTEX INC,DIVALPROEX,VALPROIC ACID,500MG,100 BTL,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE); TABLET (ENTERIC-COATED),,2023-06-20,2023-07-07,2023-07-04,Disruption of the manufacture of the drug.,2023-06-23,2023-07-07,No
185036,02299615,Shortage,APO-DORZO-TIMOP,APOTEX INC,DORZOLAMIDE/TIMOLOL,TIMOLOL; DORZOLAMIDE,5MG; 20MG,10 ML,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION; SOLUTION,,2023-02-14,2023-03-03,2023-02-22,Disruption of the manufacture of the drug.,2023-02-16,2023-02-23,No
205015,02299615,Shortage,APO-DORZO-TIMOP,APOTEX INC,DORZOLAMIDE/TIMOLOL,TIMOLOL; DORZOLAMIDE,5MG; 20MG,10 ML,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION; SOLUTION,,2023-09-19,2023-11-30,2023-11-23,Disruption of the manufacture of the drug.,2023-09-22,2023-11-24,No
184077,02240588,Shortage,APO-DOXAZOSIN,APOTEX INC,DOXAZOSIN,DOXAZOSIN,1MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-02-07,2023-03-24,2023-03-17,Disruption of the manufacture of the drug.,2023-02-09,2023-03-23,No
185451,02240589,Shortage,APO-DOXAZOSIN,APOTEX INC,DOXAZOSIN,DOXAZOSIN,2MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-02-21,2023-03-24,2023-03-17,Disruption of the manufacture of the drug.,2023-02-23,2023-03-23,No
212946,02240590,Shortage,APO-DOXAZOSIN,APOTEX INC,DOXAZOSIN,DOXAZOSIN,4MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-12-05,2024-03-22,2024-03-21,Disruption of the manufacture of the drug.,2023-12-08,2024-03-22,No
200194,02512645,Shortage,APO-DOXYCYCLINE MR,APOTEX INC,DOXYCYCLINE,DOXYCYCLINE,40MG,28 BLS,ORAL,Resolved,CAPSULE (IMMEDIATE AND DELAYED RELEASE),,2023-07-25,2023-08-11,2023-08-11,Disruption of the manufacture of the drug.,2023-07-27,2023-08-12,No
212374,02512645,Shortage,APO-DOXYCYCLINE MR,APOTEX INC,DOXYCYCLINE,DOXYCYCLINE,40MG,28 BLS,ORAL,Resolved,CAPSULE (IMMEDIATE AND DELAYED RELEASE),,2023-11-28,2023-12-22,2023-12-21,Disruption of the manufacture of the drug.,2023-12-01,2023-12-22,No
191895,02512645,Shortage,APO-DOXYCYCLINE MR,APOTEX INC,DOXYCYCLINE,DOXYCYCLINE,40MG,28 BLS,ORAL,Resolved,CAPSULE (IMMEDIATE AND DELAYED RELEASE),,2023-05-02,2023-06-09,2023-06-08,Disruption of the manufacture of the drug.,2023-05-06,2023-06-09,No
206573,02512645,Shortage,APO-DOXYCYCLINE MR,APOTEX INC,DOXYCYCLINE,DOXYCYCLINE,40MG,28 BLS,ORAL,Resolved,CAPSULE (IMMEDIATE AND DELAYED RELEASE),,2023-10-03,2023-11-03,2023-11-03,Disruption of the manufacture of the drug.,2023-10-06,2023-11-06,No
212365,02413248,Shortage,APO-DOXYLAMINE/B6,APOTEX INC,DOXYLAMINE/B6,PYRIDOXINE HYDROCHLORIDE; DOXYLAMINE SUCCINATE,10MG; 10MG,100 BTL,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE),,2023-11-28,2024-02-16,2024-02-08,Disruption of the manufacture of the drug.,2023-12-01,2024-02-09,No
209342,02413248,Shortage,APO-DOXYLAMINE/B6,APOTEX INC,DOXYLAMINE/B6,PYRIDOXINE HYDROCHLORIDE; DOXYLAMINE SUCCINATE,10MG; 10MG,500 BTL,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE),,2023-11-01,2024-02-16,2024-02-08,Disruption of the manufacture of the drug.,2023-11-06,2024-02-09,No
211481,02440423,Shortage,APO-DULOXETINE,APOTEX INC,DULOXETINE,DULOXETINE,30MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-11-21,2024-01-05,2024-01-04,Disruption of the manufacture of the drug.,2023-11-24,2024-01-05,No
208417,02440423,Shortage,APO-DULOXETINE,APOTEX INC,DULOXETINE,DULOXETINE,30MG,500 BTL,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-10-23,2024-01-05,2024-01-04,Disruption of the manufacture of the drug.,2023-10-27,2024-01-05,No
209336,02440431,Shortage,APO-DULOXETINE,APOTEX INC,DULOXETINE,DULOXETINE,60MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-11-01,2024-01-05,2024-01-04,Disruption of the manufacture of the drug.,2023-11-06,2024-01-05,No
210639,02440431,Shortage,APO-DULOXETINE,APOTEX INC,DULOXETINE,DULOXETINE,60MG,500 BTL,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-10-30,2024-01-05,2024-01-04,Disruption of the manufacture of the drug.,2023-11-17,2024-01-05,No
212943,02440431,Shortage,APO-DULOXETINE,APOTEX INC,DULOXETINE,DULOXETINE,60MG,30 BLS,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-12-05,2024-01-05,2024-01-04,Disruption of the manufacture of the drug.,2023-12-08,2024-01-05,No
206560,02440423,Shortage,APO-DULOXETINE,APOTEX INC,DULOXETINE,DULOXETINE,30MG,30 BLS,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-10-03,2024-01-05,2024-01-04,Disruption of the manufacture of the drug.,2023-10-06,2024-01-05,No
192806,02404206,Shortage,APO-DUTASTERIDE,APOTEX INC,DUTASTERIDE,DUTASTERIDE,0.5MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE,,2023-05-16,2023-08-04,2023-07-26,Disruption of the manufacture of the drug.,2023-05-19,2023-07-27,No
207719,02404206,Shortage,APO-DUTASTERIDE,APOTEX INC,DUTASTERIDE,DUTASTERIDE,0.5MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE,,2023-10-16,2023-11-18,2023-11-09,Disruption of the manufacture of the drug.,2023-10-20,2023-11-10,No
212937,02404206,Shortage,APO-DUTASTERIDE,APOTEX INC,DUTASTERIDE,DUTASTERIDE,0.5MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE,,2023-12-05,2023-12-22,2023-12-14,Disruption of the manufacture of the drug.,2023-12-08,2023-12-15,No
201696,02404206,Shortage,APO-DUTASTERIDE,APOTEX INC,DUTASTERIDE,DUTASTERIDE,0.5MG,30 BLS,ORAL; ORAL,Resolved,CAPSULE,,2023-08-08,2023-08-25,2023-08-17,Disruption of the manufacture of the drug.,2023-08-12,2023-08-18,No
189653,02468247,Shortage,APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR,APOTEX INC,EMTRICITABINE/TENOFOVIR/EFAVIRENZ,TENOFOVIR DISOPROXIL FUMARATE; EMTRICITABINE; EFAVIRENZ,300MG; 200MG; 600MG,30 BTL,ORAL; ORAL,Resolved,TABLET,,2023-04-11,2023-07-07,2023-07-04,Disruption of the manufacture of the drug.,2023-04-14,2023-07-07,No
189650,02452006,Shortage,APO-EMTRICITABINE-TENOFOVIR,APOTEX INC,EMTRICITABINE/TENOFOVIR,EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE,200MG; 300MG,30 BTL,ORAL; ORAL,Resolved,TABLET,,2023-04-11,2023-05-19,2023-05-16,Disruption of the manufacture of the drug.,2023-04-14,2023-05-19,No
213562,02019906,Shortage,APO-ENALAPRIL,APOTEX INC,ENALAPRIL,ENALAPRIL MALEATE,20MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-12-12,2023-12-22,2023-12-21,Disruption of the manufacture of the drug.,2023-12-15,2023-12-22,No
192815,02396955,Shortage,APO-ENTECAVIR,APOTEX INC,ENTECAVIR,ENTECAVIR,0.5MG,30 BTL,ORAL; ORAL,Resolved,TABLET,,2023-05-16,2023-06-23,2023-06-15,Disruption of the manufacture of the drug.,2023-05-19,2023-06-16,No
194568,02339099,Shortage,APO-ESOMEPRAZOLE,APOTEX INC,ESOMEPRAZOLE,ESOMEPRAZOLE,20MG,30 BLS,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE),,2023-06-06,2023-07-28,2023-07-26,Disruption of the manufacture of the drug.,2023-06-09,2023-07-27,No
188427,02339102,Shortage,APO-ESOMEPRAZOLE,APOTEX INC,ESOMEPRAZOLE,ESOMEPRAZOLE,40MG,30 BLS,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE),,2023-03-28,2023-08-25,2023-08-22,Disruption of the manufacture of the drug.,2023-03-30,2023-08-23,No
209951,02339102,Shortage,APO-ESOMEPRAZOLE,APOTEX INC,ESOMEPRAZOLE,ESOMEPRAZOLE,40MG,100 BTL,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE),,2023-11-07,2023-12-15,2023-12-07,Disruption of the manufacture of the drug.,2023-11-10,2023-12-08,No
212961,02427826,Shortage,APO-EZETIMIBE,APOTEX INC,EZETIMIBE,EZETIMIBE,10MG,30 BLS,ORAL; ORAL,Actual shortage,TABLET,,2023-12-05,,,Disruption of the manufacture of the drug.,2023-12-08,2024-01-19,No
180116,02292041,Shortage,APO-FAMCICLOVIR,APOTEX INC,FAMCICLOVIR,FAMCICLOVIR,250MG,30 BTL,ORAL; ORAL,Resolved,TABLET,,2023-01-02,2023-02-10,2023-02-08,Disruption of the manufacture of the drug.,2023-01-06,2023-02-09,No
212955,02292068,Shortage,APO-FAMCICLOVIR,APOTEX INC,FAMCICLOVIR,FAMCICLOVIR,500MG,30 BTL,ORAL; ORAL,Resolved,TABLET,,2023-12-05,2024-02-16,2024-01-18,Disruption of the manufacture of the drug.,2023-12-08,2024-01-19,No
210689,02452375,Shortage,APO-FELODIPINE,APOTEX INC,FELODIPINE,FELODIPINE,5MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-11-14,2024-02-02,2024-02-01,Disruption of the manufacture of the drug.,2023-11-17,2024-02-02,No
195091,02452367,Shortage,APO-FELODIPINE,APOTEX INC,FELODIPINE,FELODIPINE,2.5MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-06-13,2023-08-04,2023-07-28,Disruption of the manufacture of the drug.,2023-06-16,2023-08-04,No
184086,02452367,Shortage,APO-FELODIPINE,APOTEX INC,FELODIPINE,FELODIPINE,2.5MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-02-07,2023-03-03,2023-03-01,Disruption of the manufacture of the drug.,2023-02-09,2023-03-02,No
211484,02452383,Shortage,APO-FELODIPINE,APOTEX INC,FELODIPINE,FELODIPINE,10MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-11-21,2024-02-09,2024-02-08,Disruption of the manufacture of the drug.,2023-11-24,2024-02-09,No
199527,02452375,Shortage,APO-FELODIPINE,APOTEX INC,FELODIPINE,FELODIPINE,5MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-07-18,2023-08-04,2023-07-28,Disruption of the manufacture of the drug.,2023-07-21,2023-08-04,No
196300,02452383,Shortage,APO-FELODIPINE,APOTEX INC,FELODIPINE,FELODIPINE,10MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-06-20,2023-08-04,2023-07-28,Disruption of the manufacture of the drug.,2023-06-23,2023-08-04,No
203539,02275538,Shortage,APO-FLECAINIDE,APOTEX INC,FLECAINIDE,FLECAINIDE ACETATE,50MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-08-29,2023-09-08,2023-09-06,Disruption of the manufacture of the drug.,2023-09-01,2023-09-07,No
185456,02216353,Shortage,APO-FLUOXETINE,APOTEX INC,FLUOXETINE,FLUOXETINE,10MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE,,2023-02-22,2023-03-03,2023-03-01,Disruption of the manufacture of the drug.,2023-02-23,2023-03-02,No
190850,02231328,Shortage,APO-FLUOXETINE,APOTEX INC,FLUOXETINE,FLUOXETINE,20MG,120 mL,ORAL; ORAL,Resolved,SOLUTION,,2023-04-24,2023-05-12,2023-05-05,Disruption of the manufacture of the drug.,2023-04-27,2023-05-06,No
208406,02526557,Shortage,APO-FLUTICASONE HFA,APOTEX INC,FLUTICASONE,FLUTICASONE PROPIONATE,125MCG,120 MD,ORAL; INHALATION,Resolved,METERED-DOSE AEROSOL,,2023-10-24,2023-11-03,2023-10-27,Disruption of the manufacture of the drug.,2023-10-27,2023-11-06,No
185486,02526557,Shortage,APO-FLUTICASONE HFA,APOTEX INC,FLUTICASONE,FLUTICASONE PROPIONATE,125MCG,120 MD,ORAL; INHALATION,Resolved,METERED-DOSE AEROSOL,,2023-02-21,2023-03-10,2023-03-01,Disruption of the manufacture of the drug.,2023-02-23,2023-03-02,No
188940,02231329,Shortage,APO-FLUVOXAMINE,APOTEX INC,FLUVOXAMINE,FLUVOXAMINE MALEATE,50MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-04-04,2023-07-28,2023-07-26,Disruption of the manufacture of the drug.,2023-04-06,2023-07-27,No
207710,02231330,Shortage,APO-FLUVOXAMINE,APOTEX INC,FLUVOXAMINE,FLUVOXAMINE MALEATE,100MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-10-16,2024-01-26,2024-01-18,Disruption of the manufacture of the drug.,2023-10-20,2024-01-19,No
206582,02266016,Shortage,APO-FOSINOPRIL,APOTEX INC,FOSINOPRIL,FOSINOPRIL SODIUM,20MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-10-03,2024-02-16,2024-02-15,Disruption of the manufacture of the drug.,2023-10-06,2024-02-16,No
198508,02426471,Shortage,APO-FROVATRIPTAN,APOTEX INC,FROVATRIPTAN,FROVATRIPTAN,2.5MG,6 BLS,ORAL,Resolved,TABLET,,2023-07-11,2023-07-21,2023-07-20,Disruption of the manufacture of the drug.,2023-07-13,2023-07-21,No
205486,02327260,Shortage,APO-GATIFLOXACIN,APOTEX INC,GATIFLOXACIN,GATIFLOXACIN,0.30%,5 ML,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,,2023-09-26,2023-11-24,2023-11-23,Disruption of the manufacture of the drug.,2023-09-28,2023-11-24,No
189988,02245247,Shortage,APO-GLICLAZIDE,APOTEX INC,GLICLAZIDE,GLICLAZIDE,80MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-04-18,2023-06-30,2023-06-28,Disruption of the manufacture of the drug.,2023-04-21,2023-06-29,No
194571,02407124,Shortage,APO-GLICLAZIDE MR,APOTEX INC,GLICLAZIDE,GLICLAZIDE,60MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-06-06,2023-09-29,2023-09-21,Disruption of the manufacture of the drug.,2023-06-09,2023-09-22,No
182382,02297795,Shortage,APO-GLICLAZIDE MR,APOTEX INC,GLICLAZIDE,GLICLAZIDE,30MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-01-24,2023-02-24,2023-02-22,Disruption of the manufacture of the drug.,2023-01-26,2023-02-23,No
206563,02297795,Shortage,APO-GLICLAZIDE MR,APOTEX INC,GLICLAZIDE,GLICLAZIDE,30MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-10-03,2024-02-16,2024-02-15,Disruption of the manufacture of the drug.,2023-10-06,2024-02-16,No
213559,02523752,Shortage,APO-GUANFACINE XR,APOTEX INC,GUANFACINE,GUANFACINE,4MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-12-12,2024-01-19,2024-01-11,Disruption of the manufacture of the drug.,2023-12-15,2024-01-12,No
209339,02523728,Shortage,APO-GUANFACINE XR,APOTEX INC,GUANFACINE,GUANFACINE,1MG,30 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-11-01,2024-01-12,2024-01-11,Disruption of the manufacture of the drug.,2023-11-06,2024-01-12,No
214220,02523744,Shortage,APO-GUANFACINE XR,APOTEX INC,GUANFACINE,GUANFACINE,3MG,30 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-12-19,2024-01-19,2024-01-11,Disruption of the manufacture of the drug.,2023-12-22,2024-01-12,No
212949,02523736,Shortage,APO-GUANFACINE XR,APOTEX INC,GUANFACINE,GUANFACINE,2MG,30 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-12-05,2024-01-12,2024-01-11,Disruption of the manufacture of the drug.,2023-12-08,2024-01-12,No
214232,02523736,Shortage,APO-GUANFACINE XR,APOTEX INC,GUANFACINE,GUANFACINE,2MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-12-19,2024-01-12,2024-01-11,Disruption of the manufacture of the drug.,2023-12-22,2024-01-12,No
206579,02523728,Shortage,APO-GUANFACINE XR,APOTEX INC,GUANFACINE,GUANFACINE,1MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-10-03,2024-01-12,2024-01-11,Disruption of the manufacture of the drug.,2023-10-06,2024-01-12,No
204999,00441627,Shortage,APO-HYDRALAZINE,APOTEX INC,HYDRALAZINE,HYDRALAZINE HYDROCHLORIDE,25MG,100 BTL,ORAL; ORAL,Resolved,TABLET; TABLET,,2023-09-19,2023-11-03,2023-11-03,Disruption of the manufacture of the drug.,2023-09-22,2023-11-06,No
209942,02327856,Shortage,APO-HYDROCHLOROTHIAZIDE,APOTEX INC,HYDROCHLOROTHIAZIDE,HYDROCHLOROTHIAZIDE,12.5MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-07,2023-11-17,2023-11-16,Disruption of the manufacture of the drug.,2023-11-10,2023-11-17,No
208397,02364115,Shortage,APO-HYDROMORPHONE,APOTEX INC,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,1MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-10-24,2024-01-05,2023-12-14,Disruption of the manufacture of the drug.,2023-10-27,2023-12-15,No
194587,02364158,Shortage,APO-HYDROMORPHONE,APOTEX INC,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,8MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-06-06,2023-10-20,2023-10-13,Disruption of the manufacture of the drug.,2023-06-09,2023-10-15,No
203548,02364123,Shortage,APO-HYDROMORPHONE,APOTEX INC,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,2MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-08-29,2023-10-13,2023-09-27,Disruption of the manufacture of the drug.,2023-09-01,2023-09-28,No
203852,02364131,Shortage,APO-HYDROMORPHONE,APOTEX INC,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,4MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-09-05,2023-11-03,2023-11-03,Disruption of the manufacture of the drug.,2023-09-07,2023-11-06,No
212383,02364123,Shortage,APO-HYDROMORPHONE,APOTEX INC,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,2MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-28,2024-01-19,2024-01-11,Disruption of the manufacture of the drug.,2023-12-02,2024-01-12,No
202406,02247937,Shortage,APO-HYDROXYUREA,APOTEX INC,HYDROXYUREA,HYDROXYUREA,500MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE; CAPSULE,,2023-08-15,2023-09-22,2023-09-08,Disruption of the manufacture of the drug.,2023-08-18,2023-09-12,No
183489,02247937,Shortage,APO-HYDROXYUREA,APOTEX INC,HYDROXYUREA,HYDROXYUREA,500MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE; CAPSULE,,2023-01-31,2023-02-17,2023-02-08,Disruption of the manufacture of the drug.,2023-02-02,2023-02-09,No
180109,00506052,Shortage,APO-IBUPROFEN,APOTEX INC,IBUPROFEN,IBUPROFEN,400MG,1000 BTL,ORAL; ORAL,Resolved,TABLET,,2023-01-02,2023-02-24,2023-02-08,Disruption of the manufacture of the drug.,2023-01-06,2023-02-09,No
210733,00585114,Shortage,APO-IBUPROFEN TAB 600MG,APOTEX INC,IBUPROFEN,IBUPROFEN,600MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-14,2023-11-30,2023-11-30,Disruption of the manufacture of the drug.,2023-11-17,2023-12-01,No
189638,00585114,Shortage,APO-IBUPROFEN TAB 600MG,APOTEX INC,APO-IBUPROFEN,IBUPROFEN,600MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-04-11,2023-04-21,2023-04-20,Disruption of the manufacture of the drug.,2023-04-14,2023-04-21,No
203846,02245246,Shortage,APO-INDAPAMIDE 1.25 MG TABLETS,APOTEX INC,INDAPAMIDE,INDAPAMIDE,1.25MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-09-05,2023-11-30,2023-11-23,Disruption of the manufacture of the drug.,2023-09-07,2023-11-24,No
192370,02245246,Shortage,APO-INDAPAMIDE 1.25 MG TABLETS,APOTEX INC,INDAPAMIDE,INDAPAMIDE,1.25MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-05-09,2023-05-26,2023-05-25,Disruption of the manufacture of the drug.,2023-05-12,2023-05-26,No
201168,02223678,Shortage,APO-INDAPAMIDE 2.5MG TABLETS,APOTEX INC,INDAPAMIDE,INDAPAMIDE,2.5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-08-01,2023-08-18,2023-08-17,Disruption of the manufacture of the drug.,2023-08-04,2023-08-18,No
209964,02243539,Shortage,APO-LABETALOL,APOTEX INC,LABETALOL,LABETALOL HYDROCHLORIDE,200MG,100 BTL,ORAL,Resolved,TABLET,,2023-11-07,2024-01-05,2024-01-04,Disruption of the manufacture of the drug.,2023-11-10,2024-01-05,No
198511,02243539,Shortage,APO-LABETALOL,APOTEX INC,LABETALOL,LABETALOL HYDROCHLORIDE,200MG,100 BTL,ORAL,Resolved,TABLET,,2023-07-11,2023-07-28,2023-07-20,Disruption of the manufacture of the drug.,2023-07-13,2023-07-21,No
212359,02243538,Shortage,APO-LABETALOL,APOTEX INC,LABETALOL,LABETALOL HYDROCHLORIDE,100MG,100 BTL,ORAL,Resolved,TABLET,,2023-11-28,2024-01-26,2024-01-04,Disruption of the manufacture of the drug.,2023-12-01,2024-01-05,No
185489,02243539,Shortage,APO-LABETALOL,APOTEX INC,LABETALOL,LABETALOL HYDROCHLORIDE,200MG,100 BTL,ORAL,Resolved,TABLET,,2023-02-21,2023-03-03,2023-03-01,Disruption of the manufacture of the drug.,2023-02-23,2023-03-02,No
195069,02243538,Shortage,APO-LABETALOL,APOTEX INC,LABETALOL,LABETALOL HYDROCHLORIDE,100MG,100 BTL,ORAL,Resolved,TABLET,,2023-06-13,2023-07-28,2023-07-20,Disruption of the manufacture of the drug.,2023-06-16,2023-07-21,No
181110,02375540,Shortage,APO-LAMIVUDINE-ZIDOVUDINE,APOTEX INC,LAMIVUDINE ZIDOVUDINE,ZIDOVUDINE; LAMIVUDINE,300MG; 150MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-01-09,2023-01-20,2023-01-19,Disruption of the manufacture of the drug.,2023-01-13,2023-01-20,No
195075,02245210,Shortage,APO-LAMOTRIGINE,APOTEX INC,LAMOTRIGINE,LAMOTRIGINE,150MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-06-13,2023-06-30,2023-06-22,Disruption of the manufacture of the drug.,2023-06-16,2023-06-23,No
203545,02245209,Shortage,APO-LAMOTRIGINE,APOTEX INC,LAMOTRIGINE,LAMOTRIGINE,100MG,100 BTL,ORAL; ORAL,Resolved,TABLET; TABLET,,2023-08-29,2023-09-29,2023-09-28,Disruption of the manufacture of the drug.,2023-09-01,2023-09-29,No
195100,02245209,Shortage,APO-LAMOTRIGINE,APOTEX INC,LAMOTRIGINE,LAMOTRIGINE,100MG,100 BTL,ORAL; ORAL,Resolved,TABLET; TABLET,,2023-06-13,2023-06-30,2023-06-22,Disruption of the manufacture of the drug.,2023-06-16,2023-06-23,No
201693,02245210,Shortage,APO-LAMOTRIGINE,APOTEX INC,LAMOTRIGINE,LAMOTRIGINE,150MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-08-08,2023-10-06,2023-10-05,Disruption of the manufacture of the drug.,2023-08-12,2023-10-06,No
184089,02293838,Shortage,APO-LANSOPRAZOLE,APOTEX INC,LANSOPRAZOLE,LANSOPRAZOLE,30MG,500 BTL,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-02-07,2023-03-24,2023-03-15,Disruption of the manufacture of the drug.,2023-02-09,2023-03-16,No
192796,02293838,Shortage,APO-LANSOPRAZOLE,APOTEX INC,LANSOPRAZOLE,LANSOPRAZOLE,30MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-05-16,2023-06-16,2023-06-08,Disruption of the manufacture of the drug.,2023-05-19,2023-06-09,No
207716,02293811,Shortage,APO-LANSOPRAZOLE,APOTEX INC,LANSOPRAZOLE,LANSOPRAZOLE,15MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-10-16,2023-11-10,2023-11-03,Disruption of the manufacture of the drug.,2023-10-20,2023-11-06,No
198525,02293838,Shortage,APO-LANSOPRAZOLE,APOTEX INC,LANSOPRAZOLE,LANSOPRAZOLE,30MG,500 BTL,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-07-11,2023-11-10,2023-11-03,Disruption of the manufacture of the drug.,2023-07-13,2023-11-06,No
191877,02293838,Shortage,APO-LANSOPRAZOLE,APOTEX INC,LANSOPRAZOLE,LANSOPRAZOLE,30MG,500 BTL,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-05-02,2023-06-02,2023-05-25,Disruption of the manufacture of the drug.,2023-05-06,2023-05-26,No
183480,02293811,Shortage,APO-LANSOPRAZOLE,APOTEX INC,LANSOPRAZOLE,LANSOPRAZOLE,15MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-01-31,2023-03-24,2023-03-15,Disruption of the manufacture of the drug.,2023-02-02,2023-03-16,No
209348,02293838,Shortage,APO-LANSOPRAZOLE,APOTEX INC,LANSOPRAZOLE,LANSOPRAZOLE,30MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-11-01,2023-11-24,2023-11-23,Disruption of the manufacture of the drug.,2023-11-06,2023-11-24,No
214215,02293838,Shortage,APO-LANSOPRAZOLE,APOTEX INC,LANSOPRAZOLE,LANSOPRAZOLE,30MG,500 BTL,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-12-19,2024-02-02,2024-02-01,Disruption of the manufacture of the drug.,2023-12-22,2024-02-02,No
181970,02293838,Shortage,APO-LANSOPRAZOLE,APOTEX INC,LANSOPRAZOLE,LANSOPRAZOLE,30MG,500 BTL,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-01-17,2023-02-02,2023-01-25,Disruption of the manufacture of the drug.,2023-01-20,2023-01-26,No
197879,02293838,Shortage,APO-LANSOPRAZOLE,APOTEX INC,APO-LANSOPRAZOLE,LANSOPRAZOLE,30MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-07-05,2023-09-15,2023-09-14,Disruption of the manufacture of the drug.,2023-07-07,2023-09-15,No
192367,02256509,Shortage,APO-LEFLUNOMIDE,APOTEX INC,LEFLUNOMIDE,LEFLUNOMIDE,20MG,30 BTL,ORAL; ORAL,Resolved,TABLET,,2023-05-09,2023-06-02,2023-06-01,Disruption of the manufacture of the drug.,2023-05-12,2023-06-02,No
205009,02256495,Shortage,APO-LEFLUNOMIDE,APOTEX INC,LEFLUNOMIDE,LEFLUNOMIDE,10MG,30 BTL,ORAL; ORAL,Resolved,TABLET,,2023-09-19,2023-11-10,2023-11-09,Disruption of the manufacture of the drug.,2023-09-22,2023-11-10,No
207695,02507978,Shortage,APO-LENALIDOMIDE,APOTEX INC,LENALIDOMIDE,LENALIDOMIDE,20MG,21 BLS,ORAL,Resolved,CAPSULE,,2023-10-16,2023-12-01,2023-11-30,Disruption of the manufacture of the drug.,2023-10-20,2023-12-01,No
186589,02358514,Shortage,APO-LETROZOLE,APOTEX INC,LETROZOLE,LETROZOLE,2.5MG,30 BLS,ORAL; ORAL,Resolved,TABLET,,2023-03-07,2023-03-24,2023-03-15,Disruption of the manufacture of the drug.,2023-03-09,2023-03-16,No
203840,02285932,Shortage,APO-LEVETIRACETAM,APOTEX INC,LEVETIRACETAM,LEVETIRACETAM,500MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-09-05,2023-10-27,2023-10-26,Disruption of the manufacture of the drug.,2023-09-07,2023-10-27,No
204405,02285940,Shortage,APO-LEVETIRACETAM,APOTEX INC,LEVETIRACETAM,LEVETIRACETAM,750MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-09-12,2023-10-27,2023-10-26,Disruption of the manufacture of the drug.,2023-09-15,2023-10-27,No
183477,02285940,Shortage,APO-LEVETIRACETAM,APOTEX INC,LEVETIRACETAM,LEVETIRACETAM,750MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-01-31,2023-06-23,2023-06-22,Disruption of the manufacture of the drug.,2023-02-02,2023-06-23,No
212931,02285932,Shortage,APO-LEVETIRACETAM,APOTEX INC,LEVETIRACETAM,LEVETIRACETAM,500MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-12-05,2023-12-15,2023-12-14,Disruption of the manufacture of the drug.,2023-12-08,2023-12-15,No
189641,02285924,Shortage,APO-LEVETIRACETAM,APOTEX INC,LEVETIRACETAM,LEVETIRACETAM,250MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-04-11,2023-06-23,2023-06-22,Disruption of the manufacture of the drug.,2023-04-14,2023-06-23,No
210656,02285940,Shortage,APO-LEVETIRACETAM,APOTEX INC,LEVETIRACETAM,LEVETIRACETAM,750MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-14,2023-12-15,2023-12-14,Disruption of the manufacture of the drug.,2023-11-17,2023-12-15,No
187718,02195941,Shortage,APO-LEVOCARB-TAB 25MG/100MG,APOTEX INC,LEVODOPA/CARBIDOPA,LEVODOPA; CARBIDOPA,100MG; 25MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-03-21,2023-04-06,2023-04-04,Disruption of the manufacture of the drug.,2023-03-23,2023-04-06,No
182364,02195941,Shortage,APO-LEVOCARB-TAB 25MG/100MG,APOTEX INC,LEVODOPA CARBIDOPA,LEVODOPA; CARBIDOPA,100MG; 25MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-01-24,2023-03-31,2023-03-28,Disruption of the manufacture of the drug.,2023-01-26,2023-03-30,No
189632,02195941,Shortage,APO-LEVOCARB-TAB 25MG/100MG,APOTEX INC,LEVODOPA/CARBIDOPA,LEVODOPA; CARBIDOPA,100MG; 25MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-04-11,2023-05-05,2023-04-28,Disruption of the manufacture of the drug.,2023-04-14,2023-05-06,No
212569,02325942,Shortage,APO-LEVOFLOXACIN,APOTEX INC,LEVOFLOXACIN,LEVOFLOXACIN,750MG,30 BTL,ORAL; ORAL,Resolved,TABLET,,2023-12-05,2024-03-15,2024-03-07,Disruption of the manufacture of the drug.,2023-12-06,2024-03-08,No
185468,02325942,Shortage,APO-LEVOFLOXACIN,APOTEX INC,LEVOFLOXACIN,LEVOFLOXACIN,750MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-02-21,,2023-05-01,Disruption of the manufacture of the drug.,2023-02-23,2023-05-06,No
185007,02284715,Shortage,APO-LEVOFLOXACIN,APOTEX INC,LEVOFLOXACIN,LEVOFLOXACIN,500MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-02-14,,2023-05-18,Disruption of the manufacture of the drug.,2023-02-16,2023-05-19,No
185010,02284707,Shortage,APO-LEVOFLOXACIN,APOTEX INC,LEVOFLOXACIN,LEVOFLOXACIN,250MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-02-14,,2023-05-01,Disruption of the manufacture of the drug.,2023-02-16,2023-05-06,No
208379,02426552,Shortage,APO-LINEZOLID,APOTEX INC,LINEZOLID,LINEZOLID,600MG,30 BTL,ORAL; ORAL,Resolved,TABLET; TABLET,,2023-10-24,2023-11-03,2023-11-03,Disruption of the manufacture of the drug.,2023-10-27,2023-11-10,No
213581,02217503,Shortage,APO-LISINOPRIL,APOTEX INC,LISINOPRIL,LISINOPRIL,10MG,100 BTL,ORAL; ORAL,Actual shortage,TABLET,,2023-12-12,,,Disruption of the manufacture of the drug.,2023-12-15,2024-04-05,No
198528,02217481,Shortage,APO-LISINOPRIL,APOTEX INC,LISINOPRIL,LISINOPRIL,5MG,100 BTL,ORAL; ORAL,Anticipated shortage,TABLET,2024-12-30,,,,Shortage of an active ingredient.,2023-07-13,2024-04-05,No
198536,02217511,Shortage,APO-LISINOPRIL,APOTEX INC,LISINOPRIL,LISINOPRIL,20MG,100 BTL,ORAL; ORAL,Actual shortage,TABLET,,2024-04-02,,,Shortage of an active ingredient.,2023-07-13,2024-04-05,No
203557,02277298,Shortage,APO-MEDROXY,APOTEX INC,MEDROXYPROGESTERONE,MEDROXYPROGESTERONE ACETATE,10MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-08-29,2023-12-20,2023-12-21,Disruption of the manufacture of the drug.,2023-09-01,2023-12-22,No
181101,02277298,Shortage,APO-MEDROXY,APOTEX INC,MEDROXYPROGESTERONE,MEDROXYPROGESTERONE ACETATE,10MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-01-09,2023-08-18,2023-08-17,Shortage of an active ingredient.,2023-01-13,2024-03-22,No
189671,02267640,Shortage,APO-MEDROXY,APOTEX INC,MEDROXYPROGESTERONE,MEDROXYPROGESTERONE ACETATE,100MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-06-20,2023-10-20,2023-10-13,Shortage of an active ingredient.,2023-04-14,2024-03-22,No
203822,02244726,Shortage,APO-MEDROXY TABLETS,APOTEX INC,MEDROXYPROGESTERONE,MEDROXYPROGESTERONE ACETATE,2.5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-09-05,2023-11-30,2023-11-30,Disruption of the manufacture of the drug.,2023-09-07,2023-12-01,No
204414,02244727,Shortage,APO-MEDROXY TABLETS,APOTEX INC,MEDROXYPROGESTERONE,MEDROXYPROGESTERONE ACETATE,5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-09-12,2023-11-30,2023-11-30,Disruption of the manufacture of the drug.,2023-09-15,2023-12-01,No
189662,02244726,Shortage,APO-MEDROXY TABLETS,APOTEX INC,MEDROXYPROGESTERONE,MEDROXYPROGESTERONE ACETATE,2.5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-06-13,2023-09-01,2023-08-25,Shortage of an active ingredient.,2023-04-14,2024-03-22,No
189665,02244727,Shortage,APO-MEDROXY TABLETS,APOTEX INC,MEDROXYPROGESTERONE,MEDROXYPROGESTERONE ACETATE,5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-04-24,2023-08-18,2023-08-17,Shortage of an active ingredient.,2023-04-14,2024-03-22,No
194564,02396467,Shortage,APO-MELOXICAM,APOTEX INC,MELOXICAM,MELOXICAM,1.5G,10 mL,ORAL; ORAL,Resolved,SUSPENSION,,2023-06-06,2023-07-14,2023-07-07,Disruption of the manufacture of the drug.,2023-06-09,2023-07-13,No
209926,02396467,Shortage,APO-MELOXICAM,APOTEX INC,APO-MELOXICAM,MELOXICAM,1.5G,180 mL,ORAL; ORAL,Resolved,SUSPENSION,,2023-11-06,2023-12-08,2023-12-07,Shortage of an inactive ingredient or component.,2023-11-10,2023-12-08,No
203542,02396467,Shortage,APO-MELOXICAM,APOTEX INC,MELOXICAM,MELOXICAM,1.5G,100 mL,ORAL; ORAL,Resolved,SUSPENSION,,2023-08-29,2024-02-09,2024-02-08,Disruption of the manufacture of the drug.,2023-09-01,2024-02-09,No
188982,02396467,Shortage,APO-MELOXICAM,APOTEX INC,"MELOXICAM,",MELOXICAM,1.5G,180 mL,ORAL; ORAL,Resolved,SUSPENSION,,2023-04-04,2023-07-14,2023-07-07,Disruption of the manufacture of the drug.,2023-04-06,2023-07-13,No
204993,02396467,Shortage,APO-MELOXICAM,APOTEX INC,MELOXICAM,MELOXICAM,1.5G,32 ML,ORAL; ORAL,Resolved,SUSPENSION,,2023-09-19,2023-12-15,2023-12-07,Disruption of the manufacture of the drug.,2023-09-22,2023-12-08,No
193230,02396467,Shortage,APO-MELOXICAM,APOTEX INC,MELOXICAM,MELOXICAM,1.5G,100 mL,ORAL; ORAL,Resolved,SUSPENSION,,2023-05-23,2023-07-14,2023-07-07,Disruption of the manufacture of the drug.,2023-05-26,2023-07-13,No
185042,02396467,Shortage,APO-MELOXICAM,APOTEX INC,MELOXICAM,MELOXICAM,1.5G,32 ML,ORAL; ORAL,Resolved,SUSPENSION,,2023-02-14,2023-05-31,2023-04-03,Disruption of the manufacture of the drug.,2023-02-16,2023-04-04,No
184100,02460653,Shortage,APO-METFORMIN ER,APOTEX INC,METFORMIN,METFORMIN HYDROCHLORIDE,1000MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-02-07,2023-02-24,2023-02-17,Disruption of the manufacture of the drug.,2023-02-09,2023-02-23,No
212362,02305062,Shortage,APO-METFORMIN ER,APOTEX INC,METFORMIN,METFORMIN HYDROCHLORIDE,500MG,500 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-11-28,2024-02-02,2024-01-25,Disruption of the manufacture of the drug.,2023-12-01,2024-01-26,No
186575,02460653,Shortage,APO-METFORMIN ER,APOTEX INC,METFORMIN,METFORMIN HYDROCHLORIDE,1000MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-03-07,2023-04-06,2023-04-04,Disruption of the manufacture of the drug.,2023-03-09,2023-04-06,No
189647,02460653,Shortage,APO-METFORMIN ER,APOTEX INC,METFORMIN,METFORMIN HYDROCHLORIDE,1000MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-04-11,2024-02-02,2024-02-01,Disruption of the manufacture of the drug.,2023-04-14,2024-02-02,No
201719,02305062,Shortage,APO-METFORMIN ER,APOTEX INC,METFORMIN,METFORMIN HYDROCHLORIDE,500MG,500 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-07-24,2023-10-20,2023-10-13,Disruption of the manufacture of the drug.,2023-08-13,2023-10-15,No
192785,02249324,Shortage,APO-METHYLPHENIDATE,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,10MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-05-16,2023-07-07,2023-07-07,Disruption of the manufacture of the drug.,2023-05-19,2023-07-08,No
203812,02249324,Shortage,APO-METHYLPHENIDATE,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,10MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-09-05,2023-10-27,2023-10-19,Disruption of the manufacture of the drug.,2023-09-07,2023-10-20,No
187724,02249324,Shortage,APO-METHYLPHENIDATE,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,10MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-03-21,2023-05-05,2023-04-26,Disruption of the manufacture of the drug.,2023-03-23,2023-04-27,No
209351,02249324,Shortage,APO-METHYLPHENIDATE,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,10MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-01,2023-12-01,2023-11-30,Disruption of the manufacture of the drug.,2023-11-06,2023-12-01,No
208400,02452758,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,27MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-10-24,2023-11-30,2023-11-09,Disruption of the manufacture of the drug.,2023-10-27,2023-11-10,No
203804,02452731,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,18MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-09-05,2023-10-27,2023-10-19,Disruption of the manufacture of the drug.,2023-09-07,2023-10-20,No
185927,02452758,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,27MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-02-28,2023-04-28,2023-04-26,Disruption of the manufacture of the drug.,2023-03-02,2023-04-27,No
203855,02452758,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,27MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-09-05,2023-10-23,2023-09-18,Disruption of the manufacture of the drug.,2023-09-07,2023-09-19,No
181107,02452731,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,18MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-01-09,2023-05-12,2023-04-20,Disruption of the manufacture of the drug.,2023-01-13,2023-04-21,No
191880,02452731,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,18MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-05-02,2023-06-23,2023-06-08,Disruption of the manufacture of the drug.,2023-05-06,2023-06-09,No
209298,02452731,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,18MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-11-03,2024-04-19,2024-04-18,Disruption of the manufacture of the drug.,2023-11-06,2024-04-19,No
212371,02452758,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,27MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-11-30,2024-02-29,2024-01-11,Disruption of the manufacture of the drug.,2023-12-01,2024-01-12,No
185019,02330377,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,54MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-02-14,2023-05-19,2023-05-11,Disruption of the manufacture of the drug.,2023-02-16,2023-05-12,No
196297,02452731,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,18MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-06-20,2023-08-25,2023-08-22,Demand increase for the drug.,2023-06-23,2023-08-23,No
214241,02452766,Shortage,APO-METHYLPHENIDATE ER,APOTEX INC,METHYLPHENIDATE,METHYLPHENIDATE HYDROCHLORIDE,36MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-12-19,2024-01-26,2024-01-25,Disruption of the manufacture of the drug.,2023-12-22,2024-01-26,No
195094,00618632,Shortage,APO-METOPROLOL,APOTEX INC,METOPROLOL,METOPROLOL TARTRATE,50MG,1000 BTL,ORAL; ORAL,Resolved,TABLET,,2023-06-13,2023-07-21,2023-07-14,Disruption of the manufacture of the drug.,2023-06-16,2023-07-21,No
192791,00618640,Shortage,APO-METOPROLOL,APOTEX INC,METOPROLOL,METOPROLOL TARTRATE,100MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-05-16,2023-07-21,2023-07-20,Disruption of the manufacture of the drug.,2023-05-19,2023-07-21,No
207728,02246010,Shortage,APO-METOPROLOL,APOTEX INC,METOPROLOL,METOPROLOL TARTRATE,25MG,1000 BTL,ORAL; ORAL,Resolved,TABLET,,2023-10-16,2023-11-30,2023-11-30,Disruption of the manufacture of the drug.,2023-10-20,2023-12-01,No
200200,02278685,Shortage,APO-MIDODRINE,APOTEX INC,MIDODRINE,MIDODRINE HYDROCHLORIDE,5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-07-25,2023-10-06,2023-09-21,Disruption of the manufacture of the drug.,2023-07-27,2023-09-22,No
210701,02278677,Shortage,APO-MIDODRINE,APOTEX INC,MIDODRINE,MIDODRINE HYDROCHLORIDE,2.5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-14,2023-12-22,2023-12-21,Disruption of the manufacture of the drug.,2023-11-17,2023-12-22,No
209375,02278685,Shortage,APO-MIDODRINE,APOTEX INC,MIDODRINE,MIDODRINE HYDROCHLORIDE,5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-01,2023-12-22,2023-12-21,Disruption of the manufacture of the drug.,2023-11-06,2023-12-22,No
185013,02286610,Shortage,APO-MIRTAZAPINE,APOTEX INC,MIRTAZAPINE,MIRTAZAPINE,15MG,30 BTL,ORAL; ORAL,Resolved,TABLET,,2023-02-14,2023-03-24,2023-03-15,Disruption of the manufacture of the drug.,2023-02-16,2023-03-16,No
212922,02286637,Shortage,APO-MIRTAZAPINE,APOTEX INC,MIRTAZAPINE,MIRTAZAPINE,45MG,30 BTL,ORAL; ORAL,Resolved,TABLET,,2023-12-05,2023-12-15,2023-12-14,Disruption of the manufacture of the drug.,2023-12-08,2023-12-15,No
189644,02286629,Shortage,APO-MIRTAZAPINE,APOTEX INC,MIRTAZAPINE,MIRTAZAPINE,30MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-04-11,2023-08-04,2023-07-28,Disruption of the manufacture of the drug.,2023-04-14,2023-08-04,No
214244,02286629,Shortage,APO-MIRTAZAPINE,APOTEX INC,MIRTAZAPINE,MIRTAZAPINE,30MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-12-19,2024-02-16,2024-02-08,Disruption of the manufacture of the drug.,2023-12-22,2024-02-09,No
210662,02286629,Shortage,APO-MIRTAZAPINE,APOTEX INC,MIRTAZAPINE,MIRTAZAPINE,30MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-14,2023-12-08,2023-11-30,Disruption of the manufacture of the drug.,2023-11-17,2023-12-01,No
201707,02285398,Shortage,APO-MODAFINIL,APOTEX INC,MODAFINIL,MODAFINIL,100MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-08-08,2023-10-27,2023-10-26,Disruption of the manufacture of the drug.,2023-08-12,2023-10-27,No
196946,02403587,Shortage,APO-MOMETASONE,APOTEX INC,MOMETASONE,MOMETASONE FUROATE,50MCG,140 MS,NASAL; NASAL,Resolved,"SPRAY, METERED DOSE",,2023-06-25,2023-07-14,2023-07-07,Disruption of the manufacture of the drug.,2023-06-29,2024-01-19,No
208388,02374609,Shortage,APO-MONTELUKAST,APOTEX INC,MONTELUKAST,MONTELUKAST,10MG,90 BTL,ORAL; ORAL,Resolved,TABLET,,2023-10-24,2023-11-30,2023-11-30,Disruption of the manufacture of the drug.,2023-10-27,2023-12-01,No
209954,02374609,Shortage,APO-MONTELUKAST,APOTEX INC,MONTELUKAST,MONTELUKAST,10MG,30 BLS,ORAL; ORAL,Resolved,TABLET,,2023-11-07,2023-11-30,2023-11-30,Disruption of the manufacture of the drug.,2023-11-10,2023-12-01,No
203825,02377616,Shortage,APO-MONTELUKAST,APOTEX INC,MONTELUKAST,MONTELUKAST,5MG,30 BLS,ORAL; ORAL,Resolved,TABLET (CHEWABLE),,2023-09-05,2023-10-20,2023-10-13,Disruption of the manufacture of the drug.,2023-09-07,2023-10-15,No
196952,02374609,Shortage,APO-MONTELUKAST,APOTEX INC,MONTELUKAST,MONTELUKAST,10MG,30 BLS,ORAL; ORAL,Resolved,TABLET,,2023-06-25,2023-08-04,2023-08-01,Disruption of the manufacture of the drug.,2023-06-29,2023-08-04,No
187241,02374609,Shortage,APO-MONTELUKAST,APOTEX INC,MONTELUKAST,MONTELUKAST,10MG,90 BTL,ORAL; ORAL,Resolved,TABLET,,2023-03-14,2023-03-31,2023-03-24,Disruption of the manufacture of the drug.,2023-03-16,2023-03-30,No
205495,02377608,Shortage,APO-MONTELUKAST,APOTEX INC,MONTELUKAST,MONTELUKAST,4MG,30 BLS,ORAL; ORAL,Resolved,TABLET (CHEWABLE),,2023-09-26,2023-10-20,2023-10-13,Disruption of the manufacture of the drug.,2023-09-28,2023-10-15,No
196315,02374609,Shortage,APO-MONTELUKAST,APOTEX INC,MONTELUKAST,MONTELUKAST,10MG,90 BTL,ORAL; ORAL,Resolved,TABLET,,2023-06-20,2023-08-04,2023-08-01,Disruption of the manufacture of the drug.,2023-06-23,2023-08-04,No
202397,02404923,Shortage,APO-MOXIFLOXACIN,APOTEX INC,MOXIFLOXACIN,MOXIFLOXACIN,400MG,30 BTL,ORAL; ORAL,Resolved,TABLET; TABLET,,2023-08-15,,2023-11-30,Disruption of the manufacture of the drug.,2023-08-18,2023-12-01,No
212958,02352559,Shortage,APO-MYCOPHENOLATE,APOTEX INC,MYCOPHENOLATE,MYCOPHENOLATE MOFETIL,250MG,100 BLS,ORAL; ORAL,Actual shortage,CAPSULE,,2023-12-05,,,Disruption of the manufacture of the drug.,2023-12-08,2024-01-19,No
212965,02352567,Shortage,APO-MYCOPHENOLATE,APOTEX INC,MYCOPHENOLATE,MYCOPHENOLATE MOFETIL,500MG,50 BLS,ORAL; ORAL,Actual shortage,TABLET,,2023-12-05,,,Disruption of the manufacture of the drug.,2023-12-08,2024-01-19,No
210715,00782505,Shortage,APO-NADOLOL,APOTEX INC,NADOLOL,NADOLOL,40MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-14,2024-01-26,2024-01-25,Disruption of the manufacture of the drug.,2023-11-17,2024-01-26,No
212919,00782467,Shortage,APO-NADOLOL,APOTEX INC,NADOLOL,NADOLOL,80MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-12-05,2024-01-26,2024-01-25,Disruption of the manufacture of the drug.,2023-12-08,2024-01-26,No
180119,02444275,Shortage,APO-NALTREXONE,APOTEX INC,NALTREXONE,NALTREXONE HYDROCHLORIDE,50MG,30 BTL,ORAL; ORAL,Resolved,TABLET,,2023-01-02,2023-03-31,2023-03-24,Disruption of the manufacture of the drug.,2023-01-06,2023-03-30,No
193215,01940309,Shortage,APO-NAPRO-NA DS,APOTEX INC,NAPROXEN NA,NAPROXEN SODIUM,550MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-05-23,2023-07-28,2023-07-26,Disruption of the manufacture of the drug.,2023-05-26,2023-07-27,No
203849,00600806,Shortage,APO-NAPROXEN,APOTEX INC,NAPROXEN,NAPROXEN,375MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-09-05,2023-10-13,2023-10-12,Disruption of the manufacture of the drug.,2023-09-07,2023-10-13,No
185942,00592277,Shortage,APO-NAPROXEN,APOTEX INC,NAPROXEN,NAPROXEN,500MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-02-28,2023-04-28,2023-04-28,Disruption of the manufacture of the drug.,2023-03-02,2023-05-06,No
185459,00592277,Shortage,APO-NAPROXEN,APOTEX INC,NAPROXEN,NAPROXEN,500MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-02-21,2023-05-05,2023-04-28,Disruption of the manufacture of the drug.,2023-02-23,2023-05-06,No
205489,00592277,Shortage,APO-NAPROXEN,APOTEX INC,NAPROXEN,NAPROXEN,500MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-09-26,2023-11-17,2023-11-09,Disruption of the manufacture of the drug.,2023-09-28,2023-11-10,No
205498,00592277,Shortage,APO-NAPROXEN,APOTEX INC,NAPROXEN,NAPROXEN,500MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-09-26,2023-11-17,2023-11-09,Disruption of the manufacture of the drug.,2023-09-28,2023-11-10,No
201171,00592277,Shortage,APO-NAPROXEN,APOTEX INC,NAPROXEN,NAPROXEN,500MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-08-01,2023-08-18,2023-08-11,Disruption of the manufacture of the drug.,2023-08-04,2023-08-12,No
195063,00592277,Shortage,APO-NAPROXEN,APOTEX INC,NAPROXEN,NAPROXEN,500MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-06-13,2023-08-25,2023-08-17,Disruption of the manufacture of the drug.,2023-06-16,2023-08-18,No
190859,02246701,Shortage,APO-NAPROXEN EC,APOTEX INC,NAPROXEN,NAPROXEN,500MG,100 BTL,ORAL; ORAL,Resolved,TABLET (ENTERIC-COATED),,2023-04-24,2023-06-23,2023-06-16,Disruption of the manufacture of the drug.,2023-04-27,2023-06-23,No
180113,02246701,Shortage,APO-NAPROXEN EC,APOTEX INC,NAPROXEN,NAPROXEN,500MG,100 BTL,ORAL; ORAL,Resolved,TABLET (ENTERIC-COATED),,2023-01-02,2023-03-03,2023-03-01,Disruption of the manufacture of the drug.,2023-01-06,2023-03-02,No
189991,02246699,Shortage,APO-NAPROXEN EC TABLETS,APOTEX INC,NAPROXEN,NAPROXEN,250MG,100 BTL,ORAL; ORAL,Resolved,TABLET (ENTERIC-COATED),,2023-04-18,2023-06-23,2023-06-16,Disruption of the manufacture of the drug.,2023-04-21,2023-06-23,No
201699,02246699,Shortage,APO-NAPROXEN EC TABLETS,APOTEX INC,NAPROXEN,NAPROXEN,250MG,100 BTL,ORAL; ORAL,Resolved,TABLET (ENTERIC-COATED),,2023-08-08,2023-11-24,2023-11-16,Disruption of the manufacture of the drug.,2023-08-12,2023-11-17,No
184083,02281821,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,10MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-02-07,2023-06-02,2023-06-01,Disruption of the manufacture of the drug.,2023-02-09,2023-06-02,No
184097,02333015,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,20MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-02-07,2023-06-02,2023-06-01,Disruption of the manufacture of the drug.,2023-02-09,2023-06-02,No
182367,02281813,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,7.5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-01-24,2023-02-03,2023-02-01,Disruption of the manufacture of the drug.,2023-01-26,2023-02-02,No
198518,02281821,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,10MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-07-11,2023-09-15,2023-09-14,Disruption of the manufacture of the drug.,2023-07-13,2023-09-15,No
191874,02281813,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,7.5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-05-02,2023-06-02,2023-06-01,Disruption of the manufacture of the drug.,2023-05-06,2023-06-02,No
202403,02281791,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,2.5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-08-15,2023-09-29,2023-09-27,Disruption of the manufacture of the drug.,2023-08-18,2023-09-28,No
209363,02281791,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,2.5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-01,2024-03-08,2024-02-29,Disruption of the manufacture of the drug.,2023-11-06,2024-03-01,No
200180,02281813,Shortage,APO-OLANZAPINE,APOTEX INC,OLANZAPINE,OLANZAPINE,7.5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-07-25,2023-09-29,2023-09-27,Disruption of the manufacture of the drug.,2023-07-27,2023-09-28,No
192788,02360624,Shortage,APO-OLANZAPINE ODT,APOTEX INC,OLANZAPINE,OLANZAPINE,10MG,30 BLS,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-05-16,2023-06-02,2023-05-26,Disruption of the manufacture of the drug.,2023-05-19,2023-06-02,No
188968,02360640,Shortage,APO-OLANZAPINE ODT,APOTEX INC,OLANZAPINE,OLANZAPINE,20MG,30 BLS,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-04-04,2023-06-02,2023-05-26,Disruption of the manufacture of the drug.,2023-04-06,2023-06-02,No
213553,02360640,Shortage,APO-OLANZAPINE ODT,APOTEX INC,OLANZAPINE,OLANZAPINE,20MG,30 BLS,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-12-12,2023-12-29,2024-01-04,Disruption of the manufacture of the drug.,2023-12-15,2024-01-05,No
213576,02360632,Shortage,APO-OLANZAPINE ODT,APOTEX INC,OLANZAPINE,OLANZAPINE,15MG,30 BLS,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-12-12,2023-12-29,2024-01-04,Disruption of the manufacture of the drug.,2023-12-15,2024-01-05,No
185930,02360632,Shortage,APO-OLANZAPINE ODT,APOTEX INC,OLANZAPINE,OLANZAPINE,15MG,30 BLS,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-02-28,2023-05-31,2023-05-26,Disruption of the manufacture of the drug.,2023-03-02,2023-06-02,No
196949,02360616,Shortage,APO-OLANZAPINE ODT,APOTEX INC,OLANZAPINE,OLANZAPINE,5MG,30 BLS,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-06-25,2023-11-03,2023-11-03,Disruption of the manufacture of the drug.,2023-06-29,2023-11-06,No
199515,02360640,Shortage,APO-OLANZAPINE ODT,APOTEX INC,OLANZAPINE,OLANZAPINE,20MG,30 BLS,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-07-18,2023-11-03,2023-11-03,Shortage of an inactive ingredient or component.,2023-07-21,2023-11-06,No
190862,02360616,Shortage,APO-OLANZAPINE ODT,APOTEX INC,OLANZAPINE,OLANZAPINE,5MG,30 BLS,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-04-24,2023-06-02,2023-05-26,Disruption of the manufacture of the drug.,2023-04-27,2023-06-02,No
214223,02360624,Shortage,APO-OLANZAPINE ODT,APOTEX INC,OLANZAPINE,OLANZAPINE,10MG,30 BLS,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-12-19,2024-01-05,2024-01-04,Disruption of the manufacture of the drug.,2023-12-22,2024-01-05,No
202409,02245058,Shortage,APO-OMEPRAZOLE,APOTEX INC,OMEPRAZOLE,OMEPRAZOLE,20MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-08-15,2023-09-15,2023-09-14,Disruption of the manufacture of the drug.,2023-08-18,2023-09-15,No
199536,02288184,Shortage,APO-ONDANSETRON,APOTEX INC,ONDANSETRON,ONDANSETRON,4MG,10 BLS,ORAL; ORAL,Resolved,TABLET,,2023-07-18,2024-03-08,2024-02-29,Disruption of the manufacture of the drug.,2023-07-21,2024-03-01,No
195086,02163543,Shortage,APO-OXYBUTYNIN,APOTEX INC,OXYBUTYNIN,OXYBUTYNIN CHLORIDE,5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-06-13,2023-07-14,2023-07-12,Disruption of the manufacture of the drug.,2023-06-16,2023-07-13,No
187229,02163543,Shortage,APO-OXYBUTYNIN,APOTEX INC,OXYBUTYNIN,OXYBUTYNIN CHLORIDE,5MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-03-14,2023-04-28,2023-04-26,Disruption of the manufacture of the drug.,2023-03-16,2023-04-27,No
183474,02163543,Shortage,APO-OXYBUTYNIN,APOTEX INC,OXYBUTYNIN,OXYBUTYNIN CHLORIDE,5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-01-31,2023-04-28,2023-04-26,Disruption of the manufacture of the drug.,2023-02-02,2023-04-27,No
193614,02306530,Shortage,APO-OXYCODONE CR,APOTEX INC,OXYCODONE,OXYCODONE HYDROCHLORIDE,40MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-05-30,2023-08-11,2023-08-11,Disruption of the manufacture of the drug.,2023-06-02,2023-08-12,No
193224,02366754,Shortage,APO-OXYCODONE CR,APOTEX INC,OXYCODONE,OXYCODONE HYDROCHLORIDE,10MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE); TABLET (EXTENDED-RELEASE),,2023-05-23,2023-08-11,2023-08-11,Disruption of the manufacture of the drug.,2023-05-26,2023-08-12,No
196312,02366789,Shortage,APO-OXYCODONE CR,APOTEX INC,OXYCODONE,OXYCODONE HYDROCHLORIDE,80.0MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-06-20,2023-08-18,2023-08-11,Disruption of the manufacture of the drug.,2023-06-23,2023-08-12,No
208382,02394766,Shortage,APO-OXYCODONE CR,APOTEX INC,OXYCODONE CR,OXYCODONE HYDROCHLORIDE,15MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-10-24,2023-11-03,2023-11-03,Disruption of the manufacture of the drug.,2023-10-27,2023-11-06,No
191883,02324628,Shortage,APO-OXYCODONE/ACET,APOTEX INC,OXYCODONE/ACETAMINOPHEN,ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE,325MG; 5MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-05-02,2023-08-04,2023-08-01,Disruption of the manufacture of the drug.,2023-05-06,2023-08-04,No
184106,02292920,Shortage,APO-PANTOPRAZOLE,APOTEX INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,100 BTL,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE),,2023-02-07,2023-02-22,2023-02-22,Disruption of the manufacture of the drug.,2023-02-09,2023-02-23,No
185936,02292912,Shortage,APO-PANTOPRAZOLE,APOTEX INC,PANTOPRAZOLE,PANTOPRAZOLE,20MG,100 BTL,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE),,2023-02-28,2023-04-28,2023-04-26,Disruption of the manufacture of the drug.,2023-03-02,2023-04-27,No
183492,02292920,Shortage,APO-PANTOPRAZOLE,APOTEX INC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,500 BTL,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE),,2023-01-31,2023-02-22,2023-02-22,Disruption of the manufacture of the drug.,2023-02-02,2023-02-23,No
205006,02240907,Shortage,APO-PAROXETINE,APOTEX INC,PAROXETINE,PAROXETINE,10MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-09-19,2023-10-06,2023-10-05,Disruption of the manufacture of the drug.,2023-09-22,2023-10-06,No
205018,02240909,Shortage,APO-PAROXETINE,APOTEX INC,PAROXETINE,PAROXETINE,30MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-09-19,2023-10-06,2023-10-05,Disruption of the manufacture of the drug.,2023-09-22,2023-10-06,No
211502,02289261,Shortage,APO-PERINDOPRIL,APOTEX INC,PERINDOPRIL ERBUMINE,PERINDOPRIL ERBUMINE,2MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-21,2023-12-15,2023-12-07,Disruption of the manufacture of the drug.,2023-11-24,2023-12-08,No
213550,02289296,Shortage,APO-PERINDOPRIL,APOTEX INC,PERINDOPRIL ERBUMINE,PERINDOPRIL ERBUMINE,8MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-12-12,2023-12-29,2023-12-21,Disruption of the manufacture of the drug.,2023-12-15,2023-12-22,No
190005,02289261,Shortage,APO-PERINDOPRIL,APOTEX INC,PERINDOPRIL,PERINDOPRIL ERBUMINE,2MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-04-18,2023-05-09,2023-05-05,Disruption of the manufacture of the drug.,2023-04-21,2023-05-06,No
208411,02453061,Shortage,APO-PERINDOPRIL-INDAPAMIDE,APOTEX INC,PERINDOPRIL-INDAPAMIDE,PERINDOPRIL ERBUMINE; INDAPAMIDE,8MG; 2.5MG,100 BTL,ORAL,Resolved,TABLET,,2023-10-24,2024-02-09,2024-02-08,Disruption of the manufacture of the drug.,2023-10-27,2024-02-09,No
184092,02297574,Shortage,APO-PERINDOPRIL-INDAPAMIDE,APOTEX INC,PERINDOPRIL-INDAPAMIDE,INDAPAMIDE; PERINDOPRIL ERBUMINE,1.25MG; 4MG,30 BLS,ORAL,Resolved,TABLET,,2023-02-07,2023-09-22,2023-09-15,Disruption of the manufacture of the drug.,2023-02-09,2023-09-22,No
198505,02297574,Shortage,APO-PERINDOPRIL-INDAPAMIDE,APOTEX INC,PERINDOPRIL-INDAPAMIDE,INDAPAMIDE; PERINDOPRIL ERBUMINE,1.25MG; 4MG,100 BTL,ORAL,Resolved,TABLET,,2023-07-11,2023-12-22,2023-12-21,Disruption of the manufacture of the drug.,2023-07-13,2023-12-22,No
186580,02453061,Shortage,APO-PERINDOPRIL-INDAPAMIDE,APOTEX INC,PERIN,PERINDOPRIL ERBUMINE; INDAPAMIDE,8MG; 2.5MG,100 BTL,ORAL,Avoided shortage,TABLET,,2023-03-07,2023-09-22,2022-09-14,Disruption of the manufacture of the drug.,2023-03-09,2023-09-15,No
186583,02453061,Shortage,APO-PERINDOPRIL-INDAPAMIDE,APOTEX INC,PERINDOPRIL-INDAPAMIDE,PERINDOPRIL ERBUMINE; INDAPAMIDE,8MG; 2.5MG,30 BLS,ORAL,Resolved,TABLET,,2023-03-07,2023-09-22,2023-09-15,Disruption of the manufacture of the drug.,2023-03-09,2023-09-22,No
209936,02468581,Shortage,APO-PERINDOPRIL/AMLODIPINE,APOTEX INC,PERINDOPRIL/AMLODIPINE,AMLODIPINE; PERINDOPRIL ARGININE,10MG; 14MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-07,2024-02-09,2024-02-08,Disruption of the manufacture of the drug.,2023-11-10,2024-02-09,No
211490,02468573,Shortage,APO-PERINDOPRIL/AMLODIPINE,APOTEX INC,PERINDOPRIL/AMLODIPINE,AMLODIPINE; PERINDOPRIL ARGININE,5MG; 7MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-21,2023-12-29,2023-12-14,Disruption of the manufacture of the drug.,2023-11-24,2023-12-15,No
193617,02468581,Shortage,APO-PERINDOPRIL/AMLODIPINE,APOTEX INC,PERINDOPRIL/AMLODIPINE,AMLODIPINE; PERINDOPRIL ARGININE,10MG; 14MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-05-30,2023-07-07,2023-06-28,Disruption of the manufacture of the drug.,2023-06-02,2023-06-29,No
207704,02468581,Shortage,APO-PERINDOPRIL/AMLODIPINE,APOTEX INC,PERINDOPRIL-INDAPAMIDE,AMLODIPINE; PERINDOPRIL ARGININE,10MG; 14MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-10-16,2023-12-15,2023-10-26,Disruption of the manufacture of the drug.,2023-10-20,2023-10-27,No
207707,02468573,Shortage,APO-PERINDOPRIL/AMLODIPINE,APOTEX INC,PERINDOPRIL-INDAPAMIDE,AMLODIPINE; PERINDOPRIL ARGININE,5MG; 7MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-10-16,2023-12-15,2023-10-26,Disruption of the manufacture of the drug.,2023-10-20,2023-10-27,No
204424,02468581,Shortage,APO-PERINDOPRIL/AMLODIPINE,APOTEX INC,PERINDOPRIL-INDAPAMIDE,AMLODIPINE; PERINDOPRIL ARGININE,10MG; 14MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-09-12,2023-10-13,2023-09-27,Disruption of the manufacture of the drug.,2023-09-15,2023-09-28,No
212386,02468565,Shortage,APO-PERINDOPRIL/AMLODIPINE,APOTEX INC,PERINDOPRIL/AMLODIPINE,AMLODIPINE; PERINDOPRIL ARGININE,2.5MG; 3.5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-30,2023-12-29,2023-12-14,Disruption of the manufacture of the drug.,2023-12-02,2023-12-15,No
185465,02292386,Shortage,APO-PRAMIPEXOLE,APOTEX INC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-02-21,2023-04-14,2023-04-13,Disruption of the manufacture of the drug.,2023-02-23,2023-04-14,No
183483,02292378,Shortage,APO-PRAMIPEXOLE,APOTEX INC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.25MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-01-31,2023-04-14,2023-04-13,Disruption of the manufacture of the drug.,2023-02-02,2023-04-14,No
210659,02292408,Shortage,APO-PRAMIPEXOLE,APOTEX INC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,1.5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-14,2023-12-08,2023-12-07,Disruption of the manufacture of the drug.,2023-11-17,2023-12-08,No
181967,00882801,Shortage,APO-PRAZO TAB 1MG,APOTEX INC,PRAZOSIN,PRAZOSIN,1MG,100 BTL,ORAL; ORAL,Actual shortage,TABLET,,2023-01-17,2024-09-30,,Disruption of the manufacture of the drug.,2023-01-20,2024-03-27,Yes
188943,00882828,Shortage,APO-PRAZO TAB 2MG,APOTEX INC,PRAZOSIN,PRAZOSIN,2MG,100 BTL,ORAL; ORAL,Actual shortage,TABLET,,2023-04-04,2024-09-30,,Disruption of the manufacture of the drug.,2023-04-06,2024-03-27,Yes
185924,00882836,Shortage,APO-PRAZO TAB 5MG,APOTEX INC,PRAZOSIN,PRAZOSIN,5MG,100 BTL,ORAL; ORAL,Actual shortage,TABLET,,2023-02-28,2024-09-30,,Shortage of an active ingredient.,2023-03-02,2024-03-27,Yes
203560,02394235,Shortage,APO-PREGABALIN,APOTEX INC,PREGABALIN,PREGABALIN,25MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE,,2023-08-29,2023-11-03,2023-10-19,Disruption of the manufacture of the drug.,2023-09-01,2023-10-20,No
191871,02243325,Shortage,APO-PROPAFENONE,APOTEX INC,PROPAFENONE,PROPAFENONE HYDROCHLORIDE,300MG,100 BTL,ORAL; ORAL,Resolved,TABLET; TABLET,,2023-05-02,2023-07-07,2023-07-04,Disruption of the manufacture of the drug.,2023-05-06,2023-07-07,No
190856,02243324,Shortage,APO-PROPAFENONE,APOTEX INC,PROPAFENONE,PROPAFENONE HYDROCHLORIDE,150MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-04-24,2023-07-07,2023-07-04,Disruption of the manufacture of the drug.,2023-04-27,2023-07-07,No
209922,02491605,Shortage,APO-PRUCALOPRIDE,APOTEX INC,APO-PRUCALOPRIDE,PRUCALOPRIDE,2MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-07,2023-12-01,2023-11-30,Disruption of the manufacture of the drug.,2023-11-10,2023-12-01,No
206557,02491591,Shortage,APO-PRUCALOPRIDE,APOTEX INC,PRUCALOPRIDE,PRUCALOPRIDE,1MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-10-03,2023-12-01,2023-11-30,Disruption of the manufacture of the drug.,2023-10-06,2023-12-01,No
186586,02501635,Shortage,APO-QUETIAPINE FUMARATE,APOTEX INC,QUETIAPINE,QUETIAPINE,25MG,100 BTL,ORAL,Resolved,TABLET (IMMEDIATE RELEASE),,2023-03-07,2023-04-14,2023-04-06,Disruption of the manufacture of the drug.,2023-03-09,2023-04-14,No
212969,02457237,Shortage,APO-QUETIAPINE XR,APOTEX INC,QUETIAPINE,QUETIAPINE,150MG,60 BTL,ORAL; ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),,2023-12-05,,,Disruption of the manufacture of the drug.,2023-12-08,2024-01-19,No
181104,02279215,Shortage,APO-RALOXIFENE,APOTEX INC,RALOXIFENE,RALOXIFENE HYDROCHLORIDE,60MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-01-09,2023-04-28,2023-04-20,Disruption of the manufacture of the drug.,2023-01-13,2023-04-21,No
210743,02404699,Shortage,APO-RASAGILINE,APOTEX INC,RASAGILINE,RASAGILINE,1MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-14,2023-12-15,2023-12-07,Disruption of the manufacture of the drug.,2023-11-17,2023-12-08,No
187244,02404699,Shortage,APO-RASAGILINE,APOTEX INC,RASAGILINE,RASAGILINE,1MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-03-14,2023-04-28,2023-04-26,Disruption of the manufacture of the drug.,2023-03-16,2023-04-27,No
192803,02282143,Shortage,APO-RISPERIDONE,APOTEX INC,RISPERIDONE,RISPERIDONE,2.0MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-05-16,2023-08-11,2023-08-01,Disruption of the manufacture of the drug.,2023-05-19,2023-08-04,No
209957,02282127,Shortage,APO-RISPERIDONE,APOTEX INC,RISPERIDONE,RISPERIDONE,0.50MG,500 BTL,ORAL; ORAL,Actual shortage,TABLET,,2023-11-07,2024-05-03,,Disruption of the manufacture of the drug.,2023-11-10,2024-03-22,No
192821,02282143,Shortage,APO-RISPERIDONE,APOTEX INC,RISPERIDONE,RISPERIDONE,2.0MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-05-16,2023-08-11,2023-08-01,Disruption of the manufacture of the drug.,2023-05-19,2023-08-04,No
198480,02282119,Shortage,APO-RISPERIDONE,APOTEX INC,RISPERIDONE,RISPERIDONE,0.25MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-07-04,2023-08-18,2023-08-17,Disruption of the manufacture of the drug.,2023-07-13,2023-08-18,No
198486,02282127,Shortage,APO-RISPERIDONE,APOTEX INC,RISPERIDONE,RISPERIDONE,0.50MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-07-04,2023-08-11,2023-08-01,Disruption of the manufacture of the drug.,2023-07-13,2023-08-04,No
198489,02282135,Shortage,APO-RISPERIDONE,APOTEX INC,RISPERIDONE,RISPERIDONE,1.0MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-07-04,2023-08-11,2023-08-01,Disruption of the manufacture of the drug.,2023-07-13,2023-08-04,No
205002,02282143,Shortage,APO-RISPERIDONE,APOTEX INC,RISPERIDONE,RISPERIDONE,2.0MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-09-19,2023-12-15,2023-11-30,Disruption of the manufacture of the drug.,2023-09-22,2023-12-01,No
214247,02282143,Shortage,APO-RISPERIDONE,APOTEX INC,RISPERIDONE,RISPERIDONE,2.0MG,100 BTL,ORAL; ORAL,Actual shortage,TABLET,,2023-12-19,2024-04-26,,Disruption of the manufacture of the drug.,2023-12-22,2024-03-01,No
199518,02336715,Shortage,APO-RIVASTIGMINE,APOTEX INC,RIVASTIGMINE,RIVASTIGMINE,1.5MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE,,2023-07-18,2024-01-19,2024-01-04,Disruption of the manufacture of the drug.,2023-07-21,2024-01-05,No
205501,02336723,Shortage,APO-RIVASTIGMINE,APOTEX INC,RIVASTIGMINE,RIVASTIGMINE,3MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE,,2023-09-26,2024-01-19,2024-01-04,Disruption of the manufacture of the drug.,2023-09-28,2024-01-05,No
196303,02393468,Shortage,APO-RIZATRIPTAN,APOTEX INC,RIZATRIPTAN,RIZATRIPTAN,5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-06-20,2023-07-07,2023-06-28,Disruption of the manufacture of the drug.,2023-06-23,2023-06-29,No
192812,02338009,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,40MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-05-16,2023-06-23,2023-06-15,Disruption of the manufacture of the drug.,2023-05-19,2023-06-16,No
202827,02338009,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,40MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-08-22,2023-09-08,2023-08-31,Disruption of the manufacture of the drug.,2023-08-23,2023-09-01,No
187730,02338009,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,40MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-03-21,2023-04-28,2023-03-24,Disruption of the manufacture of the drug.,2023-03-23,2023-04-27,No
190865,02338009,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,40MG,30 BLS,ORAL; ORAL,Resolved,TABLET,,2023-04-26,2023-05-05,2023-05-05,Disruption of the manufacture of the drug.,2023-04-27,2023-05-06,No
201710,02337991,Shortage,APO-ROSUVASTATIN,APOTEX INC,ROSUVASTATIN,ROSUVASTATIN,20MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-08-08,2023-09-01,2023-08-22,Disruption of the manufacture of the drug.,2023-08-12,2023-08-23,No
198539,02245669,Shortage,APO-SALBUTAMOL HFA,APOTEX INC,SALBUTAMOL,SALBUTAMOL,100MCG,200 DOSES,INHALATION; INHALATION,Actual shortage,METERED-DOSE AEROSOL,,2023-09-05,2024-05-31,,Disruption of the manufacture of the drug.,2023-07-13,2024-02-09,No
209945,02238280,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,25MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE,,2023-11-07,2024-01-19,2024-01-18,Disruption of the manufacture of the drug.,2023-11-10,2024-01-19,No
204420,02238280,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,25MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE,,2023-09-12,2023-10-06,2023-10-05,Disruption of the manufacture of the drug.,2023-09-15,2023-10-06,No
185004,02238281,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,50MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE,,2023-02-14,2023-03-24,2023-03-22,Disruption of the manufacture of the drug.,2023-02-16,2023-03-23,No
210683,02238282,Shortage,APO-SERTRALINE,APOTEX INC,SERTRALINE,SERTRALINE,100MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE,,2023-11-14,2024-01-19,2024-01-11,Disruption of the manufacture of the drug.,2023-11-17,2024-01-12,No
208414,02248202,Shortage,APO-SILDENAFIL,APOTEX INC,SILDEN,SILDENAFIL,50MG,4 BLS,ORAL; ORAL,Resolved,TABLET,,2023-10-24,2023-12-07,2023-11-30,Disruption of the manufacture of the drug.,2023-10-27,2023-12-01,No
200188,02248202,Shortage,APO-SILDENAFIL,APOTEX INC,SILDENAFIL,SILDENAFIL,50MG,4 BLS,ORAL; ORAL,Resolved,TABLET,,2023-07-25,2023-08-11,2023-08-11,Disruption of the manufacture of the drug.,2023-07-27,2023-08-12,No
184080,02247014,Shortage,APO-SIMVASTATIN,APOTEX INC,SIMVASTATIN,SIMVASTATIN,40MG,30 BLS,ORAL; ORAL,Resolved,TABLET,,2023-02-07,2023-02-17,2023-02-14,Disruption of the manufacture of the drug.,2023-02-09,2023-02-16,No
209939,02247012,Shortage,APO-SIMVASTATIN,APOTEX INC,SIMVASTATIN,SIMVASTATIN,10MG,30 BLS,ORAL; ORAL,Resolved,TABLET,,2023-11-07,2023-11-24,2023-11-23,Disruption of the manufacture of the drug.,2023-11-10,2023-11-24,No
203834,02247014,Shortage,APO-SIMVASTATIN,APOTEX INC,SIMVASTATIN,SIMVASTATIN,40MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-09-05,2024-04-19,2024-02-29,Disruption of the manufacture of the drug.,2023-09-07,2024-03-01,No
196309,02247014,Shortage,APO-SIMVASTATIN,APOTEX INC,SIMVASTATIN,SIMVASTATIN,40MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-06-20,2023-07-21,2023-07-14,Disruption of the manufacture of the drug.,2023-06-23,2023-07-21,No
206576,02247014,Shortage,APO-SIMVASTATIN,APOTEX INC,SIMVASTATIN,SIMVASTATIN,40MG,30 BLS,ORAL; ORAL,Resolved,TABLET,,2023-10-03,2023-12-01,2023-11-30,Disruption of the manufacture of the drug.,2023-10-06,2023-12-01,No
195058,02247015,Shortage,APO-SIMVASTATIN,APOTEX INC,SIMVASTATIN,SIMVASTATIN,80MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-06-13,2023-06-30,2023-06-28,Disruption of the manufacture of the drug.,2023-06-16,2023-06-29,No
184112,02508656,Shortage,APO-SITAGLIPTIN MALATE,APOTEX INC,SITAGLIPTAN MALATE,SITAGLIPTIN,25MG,30 BTL,ORAL,Resolved,TABLET,,2023-02-07,2023-04-11,2023-04-05,Demand increase for the drug.,2023-02-09,2023-04-06,No
188411,02508672,Shortage,APO-SITAGLIPTIN MALATE,APOTEX INC,SITAGLIPTAN MALATE,SITAGLIPTIN,100MG,100 BTL,ORAL,Resolved,TABLET,,2023-03-28,2023-04-15,2023-04-13,Demand increase for the drug.,2023-03-30,2023-04-14,No
188415,02508664,Shortage,APO-SITAGLIPTIN MALATE,APOTEX INC,SITAGLIPTAN MALATE,SITAGLIPTIN,50MG,30 BTL,ORAL,Resolved,TABLET,,2023-03-28,2023-04-12,2023-04-06,Demand increase for the drug.,2023-03-30,2023-05-19,No
207683,02509415,Shortage,APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE,APOTEX INC,SITAGLIPTAN MALATE/METFORMIN,METFORMIN HYDROCHLORIDE; SITAGLIPTIN,500MG; 50MG,60 BTL,ORAL,Resolved,TABLET,,2023-10-16,2023-11-03,2023-11-03,Disruption of the manufacture of the drug.,2023-10-20,2023-11-06,No
207686,02509423,Shortage,APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE,APOTEX INC,SITAGLIPTAN MALATE/METFORMIN,METFORMIN HYDROCHLORIDE; SITAGLIPTIN,850MG; 50MG,60 BTL,ORAL,Resolved,TABLET,,2023-10-16,2023-12-29,2023-12-21,Disruption of the manufacture of the drug.,2023-10-20,2023-12-22,No
207689,02509423,Shortage,APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE,APOTEX INC,SITAGLIPTAN MALATE/METFORMIN,METFORMIN HYDROCHLORIDE; SITAGLIPTIN,850MG; 50MG,100 BTL,ORAL,Resolved,TABLET,,2023-10-16,2023-12-29,2023-12-21,Disruption of the manufacture of the drug.,2023-10-20,2023-12-22,No
185948,02509415,Shortage,APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE,APOTEX INC,SITAGLIPTAN MALATE/METFORMIN,METFORMIN HYDROCHLORIDE; SITAGLIPTIN,500MG; 50MG,100 BTL,ORAL,Resolved,TABLET,,2023-03-03,2023-08-04,2023-07-26,Demand increase for the drug.,2023-03-02,2023-07-27,No
185951,02509423,Shortage,APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE,APOTEX INC,SITAGLIPTAN MALATE/METFORMIN,METFORMIN HYDROCHLORIDE; SITAGLIPTIN,850MG; 50MG,60 BTL,ORAL,Resolved,TABLET,,2023-03-03,2023-10-06,2023-10-05,Demand increase for the drug.,2023-03-02,2023-10-06,No
185954,02509423,Shortage,APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE,APOTEX INC,SITAGLIPTAN MALATE/METFORMIN,METFORMIN HYDROCHLORIDE; SITAGLIPTIN,850MG; 50MG,100 BTL,ORAL,Resolved,TABLET,,2023-03-02,2023-10-06,2023-10-05,Demand increase for the drug.,2023-03-02,2023-10-06,No
185957,02509431,Shortage,APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE,APOTEX INC,SITAGLIPTAN MALATE/METFORMIN,METFORMIN HYDROCHLORIDE; SITAGLIPTIN,1000MG; 50MG,60 BTL,ORAL,Resolved,TABLET,,2023-03-02,2023-08-04,2023-07-26,Demand increase for the drug.,2023-03-02,2023-07-27,No
185961,02509431,Shortage,APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE,APOTEX INC,SITAGLIPTAN MALATE/METFORMIN,METFORMIN HYDROCHLORIDE; SITAGLIPTIN,1000MG; 50MG,100 BTL,ORAL,Resolved,TABLET,,2023-03-02,2023-08-04,2023-07-26,Demand increase for the drug.,2023-03-02,2023-07-27,No
185964,02509431,Shortage,APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE,APOTEX INC,SITAGLIPTAN MALATE/METFORMIN,METFORMIN HYDROCHLORIDE; SITAGLIPTIN,1000MG; 50MG,500 BTL,ORAL,Resolved,TABLET,,2023-03-02,2023-08-04,2023-07-26,Demand increase for the drug.,2023-03-02,2023-07-27,No
180124,02509415,Shortage,APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE,APOTEX INC,SITAGLIPTAN/METFORMIN,METFORMIN HYDROCHLORIDE; SITAGLIPTIN,500MG; 50MG,60 BTL,ORAL,Resolved,TABLET,,2023-01-02,2023-08-04,2023-07-26,Demand increase for the drug.,2023-01-06,2023-07-27,No
185967,02506297,Shortage,APO-SITAGLIPTIN/METFORMIN XR,APOTEX INC,SITAGLIPTAN PHOSPHATE/METFORMIN,METFORMIN HYDROCHLORIDE; SITAGLIPTIN,1000MG; 100MG,30 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-03-02,2024-01-31,2024-02-01,Demand increase for the drug.,2023-03-02,2024-02-02,No
185970,02506270,Shortage,APO-SITAGLIPTIN/METFORMIN XR,APOTEX INC,SITAGLIPTAN PHOSPHATE/METFORMIN,METFORMIN HYDROCHLORIDE; SITAGLIPTIN,500MG; 50MG,60 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-03-02,2024-01-31,2024-02-01,Demand increase for the drug.,2023-03-02,2024-02-02,No
185973,02506289,Shortage,APO-SITAGLIPTIN/METFORMIN XR,APOTEX INC,SITAGLIPTAN PHOSPHATE/METFORMIN,METFORMIN HYDROCHLORIDE; SITAGLIPTIN,1000MG; 50MG,60 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-03-02,2024-01-31,2024-02-01,Demand increase for the drug.,2023-03-02,2024-02-02,No
185976,02506289,Shortage,APO-SITAGLIPTIN/METFORMIN XR,APOTEX INC,SITAGLIPTAN PHOSPHATE/METFORMIN,METFORMIN HYDROCHLORIDE; SITAGLIPTIN,1000MG; 50MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-03-02,2024-01-31,2024-02-01,Demand increase for the drug.,2023-03-02,2024-02-02,No
185982,02506289,Shortage,APO-SITAGLIPTIN/METFORMIN XR,APOTEX INC,SITAGLIPTAN PHOSPHATE/METFORMIN,METFORMIN HYDROCHLORIDE; SITAGLIPTIN,1000MG; 50MG,500 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-03-02,2024-01-31,2024-02-01,Demand increase for the drug.,2023-03-02,2024-02-02,No
185985,02506297,Shortage,APO-SITAGLIPTIN/METFORMIN XR,APOTEX INC,SITAGLIPTAN PHOSPHATE/METFORMIN,METFORMIN HYDROCHLORIDE; SITAGLIPTIN,1000MG; 100MG,100 BTL,ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-03-02,2024-01-31,2024-02-01,Demand increase for the drug.,2023-03-02,2024-02-02,No
180086,02210428,Shortage,APO-SOTALOL,APOTEX INC,SOTALOL,SOTALOL HYDROCHLORIDE,80MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-01-02,2023-02-17,2023-02-14,Disruption of the manufacture of the drug.,2023-01-06,2023-02-16,No
180093,02167794,Shortage,APO-SOTALOL,APOTEX INC,SOTALOL,SOTALOL HYDROCHLORIDE,160MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-01-02,2023-02-17,2023-02-14,Disruption of the manufacture of the drug.,2023-01-06,2023-02-16,No
189635,02210428,Shortage,APO-SOTALOL,APOTEX INC,SOTALOL,SOTALOL HYDROCHLORIDE,80MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-04-11,2023-06-30,2023-06-23,Disruption of the manufacture of the drug.,2023-04-14,2023-06-29,No
186569,02167794,Shortage,APO-SOTALOL,APOTEX INC,SOTALOL,SOTALOL HYDROCHLORIDE,160MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-03-07,2023-06-30,2023-06-23,Disruption of the manufacture of the drug.,2023-03-09,2023-06-29,No
212952,02167794,Shortage,APO-SOTALOL,APOTEX INC,SOTALOL,SOTALOL HYDROCHLORIDE,160MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-12-05,2024-01-19,2024-01-04,Disruption of the manufacture of the drug.,2023-12-08,2024-01-05,No
187235,02268388,Shortage,APO-SUMATRIPTAN,APOTEX INC,SUMATRIPTAN,SUMATRIPTAN,50MG,6 BLS,ORAL; ORAL,Resolved,TABLET,,2023-03-14,2023-03-31,2023-03-28,Disruption of the manufacture of the drug.,2023-03-16,2023-03-30,No
199539,02268388,Shortage,APO-SUMATRIPTAN,APOTEX INC,SUMATRIPTAN,SUMATRIPTAN,50MG,6 BLS,ORAL; ORAL,Resolved,TABLET,,2023-06-18,2023-09-15,2023-09-14,Disruption of the manufacture of the drug.,2023-07-21,2023-09-15,No
212380,02268388,Shortage,APO-SUMATRIPTAN,APOTEX INC,SUMATRIPTAN,SUMATRIPTAN,50MG,6 BLS,ORAL; ORAL,Resolved,TABLET,,2023-11-28,2023-12-15,2023-12-14,Disruption of the manufacture of the drug.,2023-12-02,2023-12-15,No
208403,02422107,Shortage,APO-TADALAFIL,APOTEX INC,TADALAFIL,TADALAFIL,10MG,4 BLS,ORAL; ORAL,Resolved,TABLET,,2023-10-24,2023-11-30,2023-11-23,Disruption of the manufacture of the drug.,2023-10-27,2023-11-24,No
184109,02422093,Shortage,APO-TADALAFIL,APOTEX INC,TADALAFIL,TADALAFIL,5MG,30 BLS,ORAL; ORAL,Resolved,TABLET,,2023-02-07,2023-02-22,2023-02-22,Disruption of the manufacture of the drug.,2023-02-09,2023-02-23,No
201165,02422093,Shortage,APO-TADALAFIL,APOTEX INC,TADALAFIL,TADALAFIL,5MG,30 BLS,ORAL; ORAL,Resolved,TABLET,,2023-08-01,2023-09-08,2023-09-06,Disruption of the manufacture of the drug.,2023-08-04,2023-09-07,No
208373,02422093,Shortage,APO-TADALAFIL,APOTEX INC,TADALAFIL,TADALAFIL,5MG,30 BLS,ORAL; ORAL,Resolved,TABLET,,2023-10-24,2023-11-30,2023-11-23,Disruption of the manufacture of the drug.,2023-10-27,2023-11-24,No
211478,02421933,Shortage,APO-TADALAFIL PAH,APOTEX INC,TADALAFIL,TADALAFIL,20MG,60 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-21,2023-12-22,2023-12-21,Disruption of the manufacture of the drug.,2023-11-24,2023-12-22,No
193209,00812404,Shortage,APO-TAMOX TAB 10MG,APOTEX INC,TAMOXIFEN,TAMOXIFEN,10MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-05-23,2023-06-02,2023-06-01,Disruption of the manufacture of the drug.,2023-05-26,2023-06-02,No
192800,02362406,Shortage,APO-TAMSULOSIN CR,APOTEX INC,TAMSULOSIN,TAMSULOSIN HYDROCHLORIDE,0.4MG,500 BTL and 100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-05-16,2023-07-28,2023-07-20,Disruption of the manufacture of the drug.,2023-05-19,2023-07-21,No
188973,02362406,Shortage,APO-TAMSULOSIN CR,APOTEX INC,TAMSULOSIN,TAMSULOSIN HYDROCHLORIDE,0.4MG,500 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-04-04,2023-04-21,2023-04-20,Disruption of the manufacture of the drug.,2023-04-06,2023-04-21,No
192818,02362406,Shortage,APO-TAMSULOSIN CR,APOTEX INC,TAMSULOSIN,TAMSULOSIN HYDROCHLORIDE,0.4MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-05-16,2023-06-30,2023-06-22,Disruption of the manufacture of the drug.,2023-05-19,2023-06-23,No
202824,02362406,Shortage,APO-TAMSULOSIN CR,APOTEX INC,TAMSULOSIN,TAMSULOSIN HYDROCHLORIDE,0.4MG,500 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-08-22,2023-11-10,2023-11-03,Disruption of the manufacture of the drug.,2023-08-23,2023-11-06,No
209286,02362406,Shortage,APO-TAMSULOSIN CR,APOTEX INC,TAMSULOSIN,TAMSULOSIN HYDROCHLORIDE,0.4MG,500 BTL,ORAL; ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),,2023-11-08,2024-07-26,,Shortage of an active ingredient.,2023-11-06,2024-03-15,Yes
205480,02362406,Shortage,APO-TAMSULOSIN CR,APOTEX INC,TAMSULOSIN,TAMSULOSIN HYDROCHLORIDE,0.4MG,30 BLS,ORAL; ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),,2023-09-26,2024-07-26,,Disruption of the manufacture of the drug.,2023-09-28,2024-03-15,Yes
200177,02362406,Shortage,APO-TAMSULOSIN CR,APOTEX INC,TAMSULOSIN,TAMSULOSIN HYDROCHLORIDE,0.4MG,100 BTL,ORAL; ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),,2023-07-25,2024-07-26,,Disruption of the manufacture of the drug.,2023-07-27,2024-03-15,Yes
195250,02234502,Shortage,APO-TERAZOSIN,APOTEX INC,TERAZOSIN,TERAZOSIN,1MG,100 BTL,ORAL; ORAL,Resolved,TABLET,2024-04-01,,2024-04-30,2024-04-01,Shortage of an active ingredient.,2023-06-16,2024-04-02,No
195253,02234503,Shortage,APO-TERAZOSIN,APOTEX INC,TERAZOSIN,TERAZOSIN,2MG,100 BTL,ORAL; ORAL,Resolved,TABLET,2024-04-01,,2024-04-30,2024-04-01,Shortage of an active ingredient.,2023-06-16,2024-04-02,No
195256,02234504,Shortage,APO-TERAZOSIN,APOTEX INC,TERAZOSIN,TERAZOSIN,5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,2024-04-01,,2024-04-30,2024-04-01,Shortage of an active ingredient.,2023-06-16,2024-04-02,No
195259,02234505,Shortage,APO-TERAZOSIN,APOTEX INC,TERAZOSIN,TERAZOSIN,10MG,100 BTL,ORAL; ORAL,Actual shortage,TABLET,,2023-08-29,2024-05-17,,Shortage of an active ingredient.,2023-06-16,2024-03-08,No
203843,02239893,Shortage,APO-TERBINAFINE,APOTEX INC,TERBINAFINE,TERBINAFINE,250MG,30 BLS,ORAL; ORAL,Resolved,TABLET,,2023-09-05,2023-11-03,2023-11-03,Disruption of the manufacture of the drug.,2023-09-07,2023-12-22,No
204417,02239893,Shortage,APO-TERBINAFINE,APOTEX INC,TERBINAFINE,TERBINAFINE,250MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-09-12,2023-11-03,2023-11-03,Disruption of the manufacture of the drug.,2023-09-15,2023-12-22,No
212377,02239893,Shortage,APO-TERBINAFINE,APOTEX INC,TERBINAFINE,TERBINAFINE,250MG,30 BLS,ORAL; ORAL,Resolved,TABLET,,2023-11-28,2024-01-19,2024-01-04,Disruption of the manufacture of the drug.,2023-12-02,2024-01-05,No
193212,02239893,Shortage,APO-TERBINAFINE,APOTEX INC,TERBINAFINE,TERBINAFINE,250MG,30 BLS,ORAL; ORAL,Resolved,TABLET,,2023-05-23,2023-06-23,2023-06-15,Disruption of the manufacture of the drug.,2023-05-26,2023-06-16,No
208385,02500639,Shortage,APO-TERIFLUNOMIDE,APOTEX INC,TERIFLUNOMIDE,TERIFLUNOMIDE,14MG,28 BLS,ORAL,Resolved,TABLET,,2023-10-24,2024-01-19,2024-01-11,Disruption of the manufacture of the drug.,2023-10-27,2024-01-12,No
202818,02407590,Shortage,APO-TETRABENAZINE,APOTEX INC,TETRABENZINE,TETRABENAZINE,25MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-08-22,2023-10-06,2023-09-30,Disruption of the manufacture of the drug.,2023-08-23,2023-10-06,No
193603,02407590,Shortage,APO-TETRABENAZINE,APOTEX INC,TETRABENZINE,TETRABENAZINE,25MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-05-30,2023-06-30,2023-06-22,Disruption of the manufacture of the drug.,2023-06-02,2023-06-23,No
206569,02482630,Shortage,APO-TICAGRELOR,APOTEX INC,TICRAGELOR,TICAGRELOR,90MG,180 BTL,ORAL,Resolved,TABLET,,2023-10-03,2023-12-08,2023-12-07,Disruption of the manufacture of the drug.,2023-10-06,2023-12-08,No
195049,02482630,Shortage,APO-TICAGRELOR,APOTEX INC,TICRAGELOR,TICAGRELOR,90MG,60 BLS,ORAL,Resolved,TABLET,,2023-06-13,2023-08-25,2023-08-22,Disruption of the manufacture of the drug.,2023-06-16,2023-08-23,No
214250,02482630,Shortage,APO-TICAGRELOR,APOTEX INC,TICRAGELOR,TICAGRELOR,90MG,60 BLS,ORAL,Resolved,TABLET,,2023-12-19,2024-04-12,2024-04-04,Disruption of the manufacture of the drug.,2023-12-22,2024-04-05,No
209948,02279649,Shortage,APO-TOPIRAMATE,APOTEX INC,TOPIRAMATE,TOPIRAMATE,200MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-07,2024-01-05,2024-01-04,Disruption of the manufacture of the drug.,2023-11-10,2024-01-05,No
209345,02279630,Shortage,APO-TOPIRAMATE,APOTEX INC,APO-TOPIRAMATE,TOPIRAMATE,100MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-01,2024-01-05,2024-01-04,Disruption of the manufacture of the drug.,2023-11-06,2024-01-05,No
212925,02426153,Shortage,APO-TRAMADOL,APOTEX INC,TRAMODOL,TRAMADOL HYDROCHLORIDE,50MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-12-05,2024-02-09,2023-12-21,Disruption of the manufacture of the drug.,2023-12-08,2023-12-22,No
197884,02336790,Shortage,APO-TRAMADOL/ACET,APOTEX INC,TRAMADOL ACETAMINOPHEN,TRAMADOL HYDROCHLORIDE; ACETAMINOPHEN,37.5MG; 325MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-07-05,2023-09-08,2023-08-31,Disruption of the manufacture of the drug.,2023-07-07,2023-09-01,No
190871,02415305,Shortage,APO-TRAVOPROST-TIMOP PQ,APOTEX INC,TRAVOPROST / TIMOLOL,TIMOLOL; TRAVOPROST,0.5%; 0.004%,5 ML,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,,2023-04-24,2023-07-21,2023-07-12,Disruption of the manufacture of the drug.,2023-04-27,2023-07-13,No
201162,02415305,Shortage,APO-TRAVOPROST-TIMOP PQ,APOTEX INC,TRAVOPROST / TIMOLOL,TIMOLOL; TRAVOPROST,0.5%; 0.004%,5ML,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,,2023-08-01,2023-08-11,2023-08-11,Disruption of the manufacture of the drug.,2023-08-04,2023-08-12,No
192809,02147653,Shortage,APO-TRAZODONE D TABLETS 150MG,APOTEX INC,TRAZODONE,TRAZODONE HYDROCHLORIDE,150MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-05-16,2023-10-06,2023-10-05,Disruption of the manufacture of the drug.,2023-05-19,2023-10-06,No
202821,02147645,Shortage,APO-TRAZODONE TABLETS 100MG,APOTEX INC,TRAZODONE,TRAZODONE HYDROCHLORIDE,100MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-08-22,2023-10-13,2023-10-05,Disruption of the manufacture of the drug.,2023-08-23,2023-10-06,No
193221,02147645,Shortage,APO-TRAZODONE TABLETS 100MG,APOTEX INC,TRAZODONE,TRAZODONE HYDROCHLORIDE,100MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-05-23,2023-07-28,2023-07-26,Disruption of the manufacture of the drug.,2023-05-26,2023-07-27,No
208376,02147645,Shortage,APO-TRAZODONE TABLETS 100MG,APOTEX INC,TRAZODONE,TRAZODONE HYDROCHLORIDE,100MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-10-24,2024-01-05,2024-01-04,Disruption of the manufacture of the drug.,2023-10-27,2024-01-05,No
199521,02147637,Shortage,APO-TRAZODONE TABLETS 50MG,APOTEX INC,TRAZODONE,TRAZODONE HYDROCHLORIDE,50MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-07-18,2023-10-06,2023-10-05,Disruption of the manufacture of the drug.,2023-07-21,2023-10-06,No
188949,02248538,Shortage,APO-TRYPTOPHAN,APOTEX INC,TRYPTOPHAN,TRYPTOPHAN,500MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-04-04,2023-05-12,2023-05-11,Disruption of the manufacture of the drug.,2023-04-06,2023-05-12,No
210725,02295822,Shortage,APO-VALACYCLOVIR,APOTEX INC,VALACYCLOVIR,VALACYCLOVIR,500MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-14,2024-02-09,2024-02-01,Disruption of the manufacture of the drug.,2023-11-17,2024-02-02,No
209961,02354705,Shortage,APO-VALACYCLOVIR,APOTEX INC,VALACYCLOVIR,VALACYCLOVIR,1000MG,21 BLS,ORAL; ORAL,Resolved,TABLET,,2023-11-07,2024-02-02,2024-02-01,Disruption of the manufacture of the drug.,2023-11-10,2024-02-02,No
200191,02354705,Shortage,APO-VALACYCLOVIR,APOTEX INC,VALACYCLOVIR,VALACYCLOVIR,1000MG,21 BLS,ORAL; ORAL,Resolved,TABLET,,2023-07-25,2023-08-31,2023-08-22,Disruption of the manufacture of the drug.,2023-07-27,2023-08-23,No
194593,02238370,Shortage,APO-VALPROIC ACID ORAL SOLUTION,APOTEX INC,VALPROIC ACID,VALPROIC ACID,250MG,450 mL,ORAL; ORAL,Actual shortage,SOLUTION,2023-09-05,,,,Disruption of the manufacture of the drug.,2023-06-09,2023-09-06,No
182684,02238370,Shortage,APO-VALPROIC ACID ORAL SOLUTION,APOTEX INC,VALPROIC ACID,VALPROIC ACID,250MG,450 mL,ORAL; ORAL,Actual shortage,SOLUTION,2023-07-30,,,,Other (Please describe in comments),2023-01-30,2023-07-31,No
190014,02419890,Shortage,APO-VARENICLINE,APOTEX INC,VARENICLINE,VARENICLINE,1MG,56 BTL,ORAL; ORAL,Resolved,TABLET,,2023-04-18,2023-04-28,2023-04-26,Disruption of the manufacture of the drug.,2023-04-21,2023-04-27,No
192364,02419890,Shortage,APO-VARENICLINE,APOTEX INC,VARENICLINE,VARENICLINE,1MG,56 BTL,ORAL; ORAL,Resolved,TABLET,,2023-05-09,2023-06-02,2023-06-01,Disruption of the manufacture of the drug.,2023-05-12,2023-06-02,No
193227,02419882,Shortage,APO-VARENICLINE,APOTEX INC,VARENICLINE,VARENICLINE,0.5MG,56 BTL,ORAL; ORAL,Resolved,TABLET,,2023-05-23,2023-06-02,2023-06-01,Disruption of the manufacture of the drug.,2023-05-26,2023-06-02,No
209366,02419890,Shortage,APO-VARENICLINE,APOTEX INC,VARENICLINE,VARENICLINE,1MG,56 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-01,2023-12-01,2023-11-30,Disruption of the manufacture of the drug.,2023-11-06,2023-12-01,No
194581,02331691,Shortage,APO-VENLAFAXINE XR,APOTEX INC,VENLAFAXINE,VENLAFAXINE,75MG,500 BTL,ORAL; ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),,2023-06-06,,,Disruption of the manufacture of the drug.,2023-06-09,2023-08-18,No
189999,02331691,Shortage,APO-VENLAFAXINE XR,APOTEX INC,VENLAFAXINE,VENLAFAXINE,75MG,100 BTL,ORAL; ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),,2023-04-18,,,Disruption of the manufacture of the drug.,2023-04-21,2023-09-01,No
192361,02331683,Shortage,APO-VENLAFAXINE XR,APOTEX INC,VENLAFAXINE,VENLAFAXINE,37.5MG,500 BTL,ORAL; ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),,2023-05-09,,,Disruption of the manufacture of the drug.,2023-05-12,2023-09-01,No
196306,02331683,Shortage,APO-VENLAFAXINE XR,APOTEX INC,VENLAFAXINE,VENLAFAXINE,37.5MG,100 BTL,ORAL; ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),,2023-06-20,,,Disruption of the manufacture of the drug.,2023-06-23,2023-09-01,No
185462,00782483,Shortage,APO-VERAP TAB 80MG,APOTEX INC,VERAPAMIL,VERAPAMIL HYDROCHLORIDE,80MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-02-21,2023-03-03,2023-02-27,Disruption of the manufacture of the drug.,2023-02-23,2023-03-02,No
201713,00782483,Shortage,APO-VERAP TAB 80MG,APOTEX INC,VERAPAMIL,VERAPAMIL HYDROCHLORIDE,80MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-08-08,2023-09-29,2023-09-28,Disruption of the manufacture of the drug.,2023-08-12,2023-09-29,No
180106,00782491,Shortage,APO-VERAP TABLET 120MG,APOTEX INC,VERAPAMIL,VERAPAMIL HYDROCHLORIDE,120MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-01-02,2023-03-03,2023-03-01,Disruption of the manufacture of the drug.,2023-01-06,2023-03-02,No
202400,00782491,Shortage,APO-VERAP TABLET 120MG,APOTEX INC,VERAPAMIL,VERAPAMIL HYDROCHLORIDE,120MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-08-15,2023-09-29,2023-09-28,Disruption of the manufacture of the drug.,2023-08-18,2023-09-29,No
210698,02242924,Shortage,APO-WARFARIN,APOTEX INC,WARFARIN,WARFARIN SODIUM,1MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-14,2023-12-22,2023-12-21,Disruption of the manufacture of the drug.,2023-11-17,2023-12-22,No
212934,02436159,Shortage,APO-ZOLPIDEM ODT,APOTEX INC,ZOLPIDEM,ZOLPIDEM TARTRATE,5MG,30 BLS,SUBLINGUAL; SUBLINGUAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-12-05,2024-02-23,2024-02-22,Disruption of the manufacture of the drug.,2023-12-08,2024-02-23,No
214235,02434946,Shortage,APO-ZOLPIDEM ODT,APOTEX INC,ZOLPIDEM,ZOLPIDEM TARTRATE,10MG,30 BLS,SUBLINGUAL; SUBLINGUAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-12-19,2024-02-23,2024-02-22,Disruption of the manufacture of the drug.,2023-12-22,2024-02-23,No
188421,02218313,Shortage,APO-ZOPICLONE,APOTEX INC,ZOPICLONE,ZOPICLONE,7.5MG,500 BTL,ORAL; ORAL,Resolved,TABLET,,2023-03-28,2023-05-26,2023-05-25,Disruption of the manufacture of the drug.,2023-03-30,2023-05-26,No
209933,02218313,Shortage,APO-ZOPICLONE,APOTEX INC,ZOPICLONE,ZOPICLONE,7.5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-11-06,2023-11-24,2023-11-23,Disruption of the manufacture of the drug.,2023-11-10,2023-11-24,No
188946,02218313,Shortage,APO-ZOPICLONE,APOTEX INC,ZOPICLONE,ZOPICLONE,7.5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-04-04,2023-05-26,2023-05-25,Disruption of the manufacture of the drug.,2023-04-06,2023-05-26,No
213565,02245077,Shortage,APO-ZOPICLONE,APOTEX INC,ZOPICLONE,ZOPICLONE,5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-12-12,2024-02-23,2024-02-22,Disruption of the manufacture of the drug.,2023-12-15,2024-02-23,No
214229,02218313,Shortage,APO-ZOPICLONE,APOTEX INC,ZOPICLONE,ZOPICLONE,7.5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,,2023-12-19,2024-02-23,2024-02-22,Disruption of the manufacture of the drug.,2023-12-22,2024-02-23,No
204639,02375885,Shortage,APPRILON,GALDERMA CANADA INC,doxycycline,DOXYCYCLINE,40MG,"40 mg, 28 capsules",ORAL; ORAL,Resolved,CAPSULE (IMMEDIATE AND DELAYED RELEASE),2023-09-28,,2023-10-20,2023-10-17,Delay in shipping of the drug.,2023-09-18,2023-10-18,No
199224,02241888,Shortage,ARAVA,SANOFI-AVENTIS CANADA INC,ARAVA,LEFLUNOMIDE,10MG,30,ORAL; ORAL,Resolved,TABLET,,2023-07-17,2023-11-27,2023-11-23,Demand increase for the drug.,2023-07-19,2023-11-28,No
184712,02241889,Shortage,ARAVA,SANOFI-AVENTIS CANADA INC,ARAVA 20 mg,LEFLUNOMIDE,20MG,Bottle of 30 tablets,ORAL; ORAL,Resolved,TABLET,,2023-02-14,2023-06-30,2023-06-12,Other (Please describe in comments),2023-02-15,2023-06-14,No
192296,02194058,Shortage,ARISTOCORT R,"BAUSCH HEALTH, CANADA INC.",ARISTOCORT R,TRIAMCINOLONE ACETONIDE,0.10%,30g,TOPICAL; TOPICAL,Resolved,CREAM,2023-05-15,,2023-08-10,2023-07-18,Delay in shipping of the drug.,2023-05-11,2023-07-21,No
181211,02194058,Shortage,ARISTOCORT R,"BAUSCH HEALTH, CANADA INC.",ARISTOCORT R,TRIAMCINOLONE ACETONIDE,0.10%,500G,TOPICAL; TOPICAL,Resolved,CREAM,,2022-12-19,,2023-12-01,Other (Please describe in comments),2023-01-16,2023-12-08,No
202716,02194058,Shortage,ARISTOCORT R,"BAUSCH HEALTH, CANADA INC.",ARISTOCORT R,TRIAMCINOLONE ACETONIDE,0.10%,30g,TOPICAL; TOPICAL,Resolved,CREAM,2023-09-15,2023-09-11,2023-09-20,2023-09-19,Other (Please describe in comments),2023-08-23,2023-09-21,No
212815,02446561,Shortage,ARNUITY ELLIPTA,GLAXOSMITHKLINE INC,fluticasone furoate dry powder for oral inhalation,FLUTICASONE FUROATE,100MCG,1x30,ORAL; INHALATION; ORAL; INHALATION,Resolved,POWDER,,2023-12-07,2024-01-31,2024-01-24,Disruption of the manufacture of the drug.,2023-12-08,2024-01-26,No
180648,01917056,Shortage,ARTHROTEC 50,PFIZER CANADA ULC,ARTHROTEC,MISOPROSTOL; DICLOFENAC SODIUM,200MCG; 50MG,250's,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE),,2023-01-10,2023-02-17,2023-02-16,Demand increase for the drug.,2023-01-11,2023-02-17,No
198802,02243596,Shortage,ASMANEX TWISTHALER,ORGANON CANADA INC.,mometasone furoate dry powder inhaler,MOMETASONE FUROATE,400MCG,60,INHALATION; INHALATION,Resolved,POWDER,,2023-07-13,2023-07-20,2023-07-18,Delay in shipping of the drug.,2023-07-17,2023-07-19,No
179906,02438690,Shortage,ASMANEX TWISTHALER,ORGANON CANADA INC.,mometasone furoate dry powder inhaler,MOMETASONE FUROATE,100MCG,30,INHALATION; INHALATION,Resolved,POWDER,,2023-01-05,2023-03-31,2023-03-31,Demand increase for the drug.,2023-01-05,2023-04-01,No
194896,00024694,Shortage,ATARAX,SEARCHLIGHT PHARMA INC,Atarax,HYDROXYZINE HYDROCHLORIDE,10MG,473ml,ORAL; ORAL,Resolved,SYRUP,2023-06-14,2023-06-14,2023-07-21,2023-07-14,Demand increase for the drug.,2023-06-14,2023-07-15,No
188757,02326701,Shortage,ATENOLOL,PRO DOC LIMITEE,ATENOLOL,ATENOLOL,25MG,500,ORAL; ORAL,Avoided shortage,TABLET,2023-07-31,,2023-08-01,2023-06-20,Delay in shipping of the drug.,2023-04-04,2023-06-21,No
188760,00828807,Shortage,ATENOLOL,PRO DOC LIMITEE,ATENOLOL,ATENOLOL,50MG,30-500,ORAL; ORAL,Resolved,TABLET,2023-05-12,2023-05-10,2023-07-01,2023-06-20,Delay in shipping of the drug.,2023-04-04,2023-06-21,No
196720,02466465,Shortage,ATENOLOL,SANIS HEALTH INC,ATENOLOL,ATENOLOL,50MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-27,,2023-10-06,Disruption of the manufacture of the drug.,2023-06-27,2023-10-10,No
187253,00828793,Shortage,ATENOLOL,PRO DOC LIMITEE,ATENOLOL,ATENOLOL,100MG,30-100,ORAL; ORAL,Resolved,TABLET,,2023-03-16,2023-07-01,2023-06-20,Delay in shipping of the drug.,2023-03-16,2023-06-21,No
211134,02238316,Shortage,ATENOLOL,SIVEM PHARMACEUTICALS ULC,Atenolol,ATENOLOL,50MG,30,ORAL; ORAL,Actual shortage,TABLET,,2023-07-17,,,Other (Please describe in comments),2023-11-22,2023-11-22,No
210709,02041413,Shortage,ATIVAN,PFIZER CANADA ULC,Ativan 0.5mg,LORAZEPAM,0.5MG,500's,ORAL; ORAL,Actual shortage,TABLET,,2024-02-06,2024-06-14,,Disruption of the manufacture of the drug.,2023-11-17,2024-03-26,No
210722,02041421,Shortage,ATIVAN,PFIZER CANADA ULC,Ativan 1mg,LORAZEPAM,1MG,1000's,ORAL; ORAL,Anticipated shortage,TABLET,2024-05-17,,2024-06-14,,Disruption of the manufacture of the drug.,2023-11-17,2024-04-08,No
210735,02041448,Shortage,ATIVAN,PFIZER CANADA ULC,Ativan 2mg,LORAZEPAM,2MG,1000's,ORAL; ORAL,Anticipated shortage,TABLET,2024-04-25,,2024-08-30,,Disruption of the manufacture of the drug.,2023-11-17,2024-04-11,No
200453,02467828,Shortage,ATOMOXETINE,SANIS HEALTH INC,ATOMOXETINE,ATOMOXETINE,100MG,30,ORAL; ORAL,Resolved,CAPSULE,,2023-07-31,,2023-08-22,Disruption of the manufacture of the drug.,2023-07-31,2023-08-29,No
198921,02467798,Shortage,ATOMOXETINE,SANIS HEALTH INC,ATOMOXETINE,ATOMOXETINE,60MG,30,ORAL; ORAL,Resolved,CAPSULE,,2023-07-18,2023-09-01,2023-09-05,Disruption of the manufacture of the drug.,2023-07-18,2023-09-06,No
198910,02467747,Shortage,ATOMOXETINE,SANIS HEALTH INC,ATOMOXETINE,ATOMOXETINE,10MG,30,ORAL; ORAL,Resolved,CAPSULE,,2023-07-18,2023-09-01,2023-09-01,Disruption of the manufacture of the drug.,2023-07-18,2023-09-05,No
210691,02432196,Shortage,ATROPINE INJECTION BP,HIKMA CANADA LIMITED,ATROPINE INJECTION BP,ATROPINE SULFATE,0.6MG,1mL,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,2024-01-01,,2024-04-01,2024-04-16,Demand increase for the drug.,2023-11-17,2024-04-17,No
210686,02432188,Shortage,ATROPINE INJECTION BP,HIKMA CANADA LIMITED,ATROPINE INJECTION BP,ATROPINE SULFATE,0.4MG,1mL,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,2024-01-01,,2024-04-01,2024-04-15,Demand increase for the drug.,2023-11-17,2024-04-16,No
213831,00328154,Shortage,ATROPINE SULFATE INJECTION USP,PFIZER CANADA ULC,ATROPINE SULFATE INJECTION USP,ATROPINE SULFATE,1MG,10 x 10mL LifeShield,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Actual shortage,SOLUTION,2024-01-19,,,,Disruption of the manufacture of the drug.,2023-12-19,2024-01-20,No
211587,02443201,Shortage,AURO-ALFUZOSIN,AURO PHARMA INC,AURO-ALFUZOSIN,ALFUZOSIN HYDROCHLORIDE,10MG,100's,ORAL; ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),2023-11-27,2023-11-30,2024-07-31,,Demand increase for the drug.,2023-11-27,2024-03-26,No
214398,02397072,Shortage,AURO-AMLODIPINE,AURO PHARMA INC,AURO-AMLODIPINE,AMLODIPINE,5MG,100's and 500's,ORAL; ORAL,Resolved,TABLET,2023-12-28,2023-12-28,2024-03-31,2024-02-12,Demand increase for the drug.,2023-12-28,2024-02-13,No
199919,02397080,Shortage,AURO-AMLODIPINE,AURO PHARMA INC,AMLODIPINE,AMLODIPINE,10MG,500,ORAL; ORAL,Avoided shortage,TABLET,,2023-07-24,2023-08-31,2023-07-10,Demand increase for the drug.,2023-07-24,2023-08-29,No
203286,02471701,Shortage,AURO-AMOXICLAV,AURO PHARMA INC,AMOXICLAV,CLAVULANIC ACID; AMOXICILLIN,125MG; 875MG,100s,ORAL,Resolved,TABLET,,2023-08-29,2023-11-15,2023-11-10,Demand increase for the drug.,2023-08-29,2023-11-11,No
199557,02471698,Shortage,AURO-AMOXICLAV,AURO PHARMA INC,AMOXICLAV,CLAVULANIC ACID; AMOXICILLIN,125MG; 500MG,100's,ORAL,Resolved,TABLET,,2023-07-21,2024-03-15,2024-03-04,Demand increase for the drug.,2023-07-21,2024-03-05,No
199922,02471671,Shortage,AURO-AMOXICLAV,AURO PHARMA INC,AMOXICLAV,CLAVULANIC ACID; AMOXICILLIN,125MG; 250MG,100,ORAL,Resolved,TABLET,,2023-07-24,,2024-01-01,Demand increase for the drug.,2023-07-24,2024-02-02,No
199925,02471701,Shortage,AURO-AMOXICLAV,AURO PHARMA INC,AMOXICLAV,CLAVULANIC ACID; AMOXICILLIN,125MG; 875MG,100,ORAL,Avoided shortage,TABLET,,2023-07-24,2023-08-31,2023-06-15,Demand increase for the drug.,2023-07-24,2023-08-29,No
207384,02460025,Shortage,AURO-ARIPIPRAZOLE,AURO PHARMA INC,Auro-Aripiprazole 2mg,ARIPIPRAZOLE,2MG,30's,ORAL; ORAL,Resolved,TABLET,2023-10-19,2023-10-23,2024-02-28,2023-11-27,Demand increase for the drug.,2023-10-19,2023-11-28,No
210208,02460025,Shortage,AURO-ARIPIPRAZOLE,AURO PHARMA INC,AURO-ARIPIPRAZOLE,ARIPIPRAZOLE,2MG,100's and 30's,ORAL; ORAL,Actual shortage,TABLET,,2023-11-15,2024-05-01,,Demand increase for the drug.,2023-11-15,2024-04-16,No
214401,02460068,Shortage,AURO-ARIPIPRAZOLE,AURO PHARMA INC,AURO-AMOXICILLIN,ARIPIPRAZOLE,15MG,30's,ORAL; ORAL,Actual shortage,TABLET,,2023-12-28,2024-04-30,,Demand increase for the drug.,2023-12-28,2024-03-26,No
214404,02460076,Shortage,AURO-ARIPIPRAZOLE,AURO PHARMA INC,AURO-ARIPIPRAZOLE,ARIPIPRAZOLE,20MG,100's and 30's,ORAL; ORAL,Actual shortage,TABLET,2023-12-28,2023-12-28,2024-04-30,,Demand increase for the drug.,2023-12-28,2024-03-26,No
214407,02460033,Shortage,AURO-ARIPIPRAZOLE,AURO PHARMA INC,AURO-ARIPIPRAZOLE,ARIPIPRAZOLE,5MG,100's and 30's,ORAL; ORAL,Actual shortage,TABLET,2023-12-28,2023-12-28,2024-05-01,,Demand increase for the drug.,2023-12-28,2024-04-16,No
199562,02460025,Shortage,AURO-ARIPIPRAZOLE,AURO PHARMA INC,ARIPIPRAZOLE,ARIPIPRAZOLE,2MG,100's,ORAL; ORAL,Resolved,TABLET,,2023-07-21,2023-08-15,2023-08-11,Demand increase for the drug.,2023-07-21,2023-08-15,No
214410,02482371,Shortage,AURO-AZITHROMYCIN,AURO PHARMA INC,AURO-AZITHROMYCIN,AZITHROMYCIN,200MG,22.5mL,ORAL; ORAL,Resolved,POWDER FOR SUSPENSION,2023-12-28,2023-12-28,2024-02-15,2024-02-12,Demand increase for the drug.,2023-12-28,2024-02-13,No
211580,02449153,Shortage,AURO-BETAHISTINE,AURO PHARMA INC,AURO-BETAHISTINE,BETAHISTINE HYDROCHLORIDE,16MG,100's,ORAL; ORAL,Actual shortage,TABLET,,2023-11-27,2024-05-15,,Demand increase for the drug.,2023-11-27,2024-03-26,No
199567,02449145,Shortage,AURO-BETAHISTINE,AURO PHARMA INC,BETAHISTINE,BETAHISTINE HYDROCHLORIDE,8MG,100s,ORAL; ORAL,Resolved,TABLET,,2023-07-21,2023-08-31,2023-08-25,Demand increase for the drug.,2023-07-21,2023-08-29,No
199570,02418517,Shortage,AURO-CARVEDILOL,AURO PHARMA INC,CARVEDILOL,CARVEDILOL,12.5MG,100s,ORAL; ORAL,Resolved,TABLET,,2023-07-21,2023-09-15,2023-09-13,Demand increase for the drug.,2023-07-21,2023-09-14,No
199573,02418495,Shortage,AURO-CARVEDILOL,AURO PHARMA INC,CARVEDILOL,CARVEDILOL,3.125MG,100s,ORAL; ORAL,Resolved,TABLET,,2023-07-21,2023-09-15,2023-09-15,Demand increase for the drug.,2023-07-21,2023-09-16,No
211590,02432773,Shortage,AURO-CEFIXIME,AURO PHARMA INC,AURO-CEFIXIME,CEFIXIME,400MG,1x7 Blst and  1x10 Blst,ORAL; ORAL,Resolved,TABLET,,2023-11-27,2024-03-29,2024-03-26,Demand increase for the drug.,2023-11-27,2024-03-27,No
211593,02468689,Shortage,AURO-CEFIXIME,AURO PHARMA INC,AURO-CEFIXIME,CEFIXIME,100MG,50 ml,ORAL; ORAL,Actual shortage,POWDER FOR SUSPENSION,,2023-11-27,,,Demand increase for the drug.,2023-11-27,2023-12-18,No
199576,02347253,Shortage,AURO-CEFPROZIL,AURO PHARMA INC,CEFPROZIL,CEFPROZIL,500MG,100's,ORAL; ORAL,Resolved,TABLET; TABLET,,2023-07-21,2023-08-31,2023-08-14,Demand increase for the drug.,2023-07-21,2023-08-29,No
204515,02347253,Shortage,AURO-CEFPROZIL,AURO PHARMA INC,AURO-CEFPROZIL,CEFPROZIL,500MG,100's,ORAL; ORAL,Resolved,TABLET; TABLET,2023-09-15,,2023-10-14,2023-10-13,Demand increase for the drug.,2023-09-15,2023-10-14,No
204518,02344823,Shortage,AURO-CEFUROXIME,AURO PHARMA INC,AURO-CEFUROXIME,CEFUROXIME,250MG,60's,ORAL; ORAL,Resolved,TABLET,2023-09-15,,2024-01-12,2024-01-12,Demand increase for the drug.,2023-09-15,2024-01-13,No
214537,02445670,Shortage,AURO-CELECOXIB,AURO PHARMA INC,AURO-CELECOXIB,CELECOXIB,100MG,100's and 500's,ORAL; ORAL,Resolved,CAPSULE,,2023-12-29,2024-04-05,2024-03-27,Demand increase for the drug.,2023-12-29,2024-03-28,No
210215,02445689,Shortage,AURO-CELECOXIB,AURO PHARMA INC,AURO-CELECOXIB,CELECOXIB,200MG,100's and 500's,ORAL; ORAL,Actual shortage,CAPSULE,,2022-11-15,2024-05-01,,Demand increase for the drug.,2023-11-15,2024-04-16,No
199579,02445670,Shortage,AURO-CELECOXIB,AURO PHARMA INC,CELECOXIB,CELECOXIB,100MG,500's,ORAL; ORAL,Resolved,CAPSULE,,2023-06-21,2023-08-31,2023-08-14,Demand increase for the drug.,2023-07-21,2023-08-29,No
214540,02470578,Shortage,AURO-CEPHALEXIN,AURO PHARMA INC,AURO-CEPHALEXIN,CEPHALEXIN,250MG,100's,ORAL; ORAL,Resolved,TABLET,,2023-12-29,2024-04-30,2024-04-18,Delay in shipping of the drug.,2023-12-29,2024-04-19,No
207389,02470586,Shortage,AURO-CEPHALEXIN,AURO PHARMA INC,AURO-CEPHALEXIN,CEPHALEXIN,500MG,100's,ORAL; ORAL,Resolved,TABLET,2023-10-19,2023-10-23,2024-02-28,2024-02-26,Demand increase for the drug.,2023-10-19,2024-02-27,No
199582,02470578,Shortage,AURO-CEPHALEXIN,AURO PHARMA INC,CEPHALEXIN,CEPHALEXIN,250MG,100s,ORAL; ORAL,Resolved,TABLET,,2023-07-21,2023-11-30,2023-11-10,Demand increase for the drug.,2023-07-21,2023-11-11,No
199587,02497751,Shortage,AURO-CEPHALEXIN,AURO PHARMA INC,CEPHALEXIN,CEPHALEXIN,250MG,100ML,ORAL,Resolved,POWDER FOR SUSPENSION,,2023-07-21,2023-08-31,2023-10-01,Demand increase for the drug.,2023-07-21,2023-10-02,No
199590,02381907,Shortage,AURO-CIPROFLOXACIN,AURO PHARMA INC,CIPROFLOXACIN,CIPROFLOXACIN,250MG,100s,ORAL; ORAL,Resolved,TABLET,,2023-07-31,2024-01-15,2024-01-09,Demand increase for the drug.,2023-07-21,2024-01-10,No
199593,02381923,Shortage,AURO-CIPROFLOXACIN,AURO PHARMA INC,CIPROFLOXACIN,CIPROFLOXACIN,500MG,500's,ORAL; ORAL,Resolved,TABLET,,2023-06-21,2023-11-15,2023-11-10,Demand increase for the drug.,2023-07-21,2023-11-11,No
199596,02436914,Shortage,AURO-CLINDAMYCIN,AURO PHARMA INC,CLINDAMYCIN,CLINDAMYCIN,300MG,100's,ORAL; ORAL,Avoided shortage,CAPSULE,,2023-07-21,2023-08-31,2023-07-04,Demand increase for the drug.,2023-07-21,2023-08-29,No
214543,02416387,Shortage,AURO-CLOPIDOGREL,AURO PHARMA INC,AURO-CLOPIDOGREL,CLOPIDOGREL,75MG,100's,ORAL; ORAL,Resolved,TABLET,,2023-12-29,2024-02-15,2024-01-15,Demand increase for the drug.,2023-12-29,2024-01-16,No
207394,02400561,Shortage,AURO-DONEPEZIL,AURO PHARMA INC,AURO-DONEPEZIL,DONEPEZIL HYDROCHLORIDE,5MG,100's and 30's,ORAL; ORAL,Resolved,TABLET,,2023-10-11,,2024-03-27,Demand increase for the drug.,2023-10-19,2024-03-28,No
199599,02400588,Shortage,AURO-DONEPEZIL,AURO PHARMA INC,DONEPEZIL,DONEPEZIL HYDROCHLORIDE,10MG,30's,ORAL; ORAL,Resolved,TABLET,,2023-07-21,2023-08-30,2023-08-25,Demand increase for the drug.,2023-07-21,2023-08-29,No
199602,02400561,Shortage,AURO-DONEPEZIL,AURO PHARMA INC,DONEPEZIL,DONEPEZIL HYDROCHLORIDE,5MG,100's,ORAL; ORAL,Resolved,TABLET,,2023-07-21,2023-10-01,2023-09-13,Demand increase for the drug.,2023-07-21,2023-09-14,No
199605,02436655,Shortage,AURO-DULOXETINE,AURO PHARMA INC,DULOXETINE,DULOXETINE,60MG,100's,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-07-21,2024-01-30,2024-02-01,Demand increase for the drug.,2023-07-21,2024-02-02,No
199608,02469308,Shortage,AURO-DUTASTERIDE,AURO PHARMA INC,DUTASTERIDE,DUTASTERIDE,0.5MG,100's,ORAL; ORAL,Resolved,CAPSULE,,2023-07-21,2023-12-28,2023-12-28,Demand increase for the drug.,2023-07-21,2023-12-29,No
199611,02469308,Shortage,AURO-DUTASTERIDE,AURO PHARMA INC,DUTASTERIDE,DUTASTERIDE,0.5MG,3 X 10s Blst,ORAL; ORAL,Resolved,CAPSULE,,2023-07-21,2024-01-30,2023-12-28,Demand increase for the drug.,2023-07-21,2023-12-29,No
204524,02478404,Shortage,AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR,AURO PHARMA INC,AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR,TENOFOVIR DISOPROXIL FUMARATE; EMTRICITABINE; EFAVIRENZ,300MG; 200MG; 600MG,30's,ORAL,Resolved,TABLET,2023-09-15,,2023-11-01,2023-11-01,Demand increase for the drug.,2023-09-15,2023-11-13,No
199928,02479451,Shortage,AURO-ELETRIPTAN,AURO PHARMA INC,ELETRIPTAN,ELETRIPTAN,20MG,1 X 6,ORAL; ORAL,Resolved,TABLET,,2023-07-24,2023-12-15,2023-12-13,Demand increase for the drug.,2023-07-24,2023-12-14,No
210218,02459965,Shortage,AURO-FLECAINIDE,AURO PHARMA INC,AURO-FLECAINIDE,FLECAINIDE ACETATE,100MG,100's,ORAL; ORAL,Actual shortage,TABLET,,2023-11-15,2024-04-30,,Demand increase for the drug.,2023-11-15,2024-03-27,No
199614,02385627,Shortage,AURO-FLUOXETINE,AURO PHARMA INC,FLUOXETINE,FLUOXETINE,10MG,100's,ORAL; ORAL,Resolved,CAPSULE,,2023-07-21,2023-12-30,2023-12-28,Demand increase for the drug.,2023-07-21,2023-12-29,No
199617,02385635,Shortage,AURO-FLUOXETINE,AURO PHARMA INC,FLUOXETINE,FLUOXETINE,20MG,100's,ORAL; ORAL,Resolved,CAPSULE,,2023-07-21,2023-12-30,2023-12-28,Demand increase for the drug.,2023-07-21,2023-12-29,No
214546,02428334,Shortage,AURO-GABAPENTIN TABLETS,AURO PHARMA INC,Auro-Gabapentin,GABAPENTIN,600MG,100's,ORAL; ORAL,Resolved,TABLET,,2023-12-29,2024-04-05,2024-03-27,Demand increase for the drug.,2023-12-29,2024-03-28,No
199630,02428342,Shortage,AURO-GABAPENTIN TABLETS,AURO PHARMA INC,GABAPENTIN,GABAPENTIN,800MG,100's,ORAL; ORAL,Resolved,TABLET,,2023-07-21,2023-08-31,2023-08-23,Demand increase for the drug.,2023-07-21,2023-08-29,No
214549,02425165,Shortage,AURO-GALANTAMINE ER,AURO PHARMA INC,AURO-GALANTAMINE ER,GALANTAMINE,16MG,100's and 30's,ORAL; ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),,2023-12-29,2024-05-01,,Demand increase for the drug.,2023-12-29,2024-04-16,No
199636,02425165,Shortage,AURO-GALANTAMINE ER,AURO PHARMA INC,GALANTAMINE ER,GALANTAMINE,16MG,100's,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2023-07-21,2023-11-01,2023-10-30,Demand increase for the drug.,2023-07-21,2023-10-31,No
199647,02425157,Shortage,AURO-GALANTAMINE ER,AURO PHARMA INC,GALANTAMINE ER,GALANTAMINE,8MG,100s,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2023-07-21,2023-08-30,2023-08-28,Demand increase for the drug.,2023-07-21,2023-08-29,No
199650,02425157,Shortage,AURO-GALANTAMINE ER,AURO PHARMA INC,GALANTAMINE ER,GALANTAMINE,8MG,30's,ORAL; ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),,2023-07-21,2024-07-31,,Demand increase for the drug.,2023-07-21,2024-03-27,No
207399,02524473,Shortage,AURO-HYDROCORTISONE,AURO PHARMA INC,AURO-HYDROCORTISONE,HYDROCORTISONE,20MG,100's,ORAL,Resolved,TABLET,2023-10-19,2023-10-23,2024-04-17,2024-04-16,Demand increase for the drug.,2023-10-19,2024-04-19,No
208748,02524465,Shortage,AURO-HYDROCORTISONE,AURO PHARMA INC,AURO-HYDROCORTISONE,HYDROCORTISONE,10MG,100's,ORAL,Resolved,TABLET,2023-10-31,,2024-01-28,2024-01-29,Demand increase for the drug.,2023-10-31,2024-01-30,No
208751,02475340,Shortage,AURO-LACOSAMIDE,AURO PHARMA INC,AURO-LACOSAMIDE,LACOSAMIDE,100MG,60's,ORAL; ORAL,Resolved,TABLET,2023-10-31,,2024-02-15,2024-02-12,Demand increase for the drug.,2023-10-31,2024-02-13,No
208754,02475332,Shortage,AURO-LACOSAMIDE,AURO PHARMA INC,AURO-LACOSAMIDE,LACOSAMIDE,50MG,60's,ORAL; ORAL,Resolved,TABLET,2023-10-31,,2024-01-12,2024-01-12,Demand increase for the drug.,2023-10-31,2024-01-13,No
211598,02475367,Shortage,AURO-LACOSAMIDE,AURO PHARMA INC,AURO-LACOSAMIDE,LACOSAMIDE,200MG,60's,ORAL; ORAL,Resolved,TABLET,,2023-11-27,2024-02-29,2024-02-27,Demand increase for the drug.,2023-11-27,2024-02-28,No
199653,02381354,Shortage,AURO-LAMOTRIGINE,AURO PHARMA INC,LAMOTRIGINE,LAMOTRIGINE,25MG,100's,ORAL; ORAL,Resolved,TABLET,,2023-07-21,2023-08-30,2023-08-17,Demand increase for the drug.,2023-07-21,2023-08-29,No
207402,02375257,Shortage,AURO-LEVETIRACETAM,AURO PHARMA INC,AURO-LEVETIRACETAM,LEVETIRACETAM,500MG,100's,ORAL; ORAL,Resolved,TABLET,2023-10-19,,2024-01-15,2024-01-09,Demand increase for the drug.,2023-10-19,2024-01-10,No
204527,02394499,Shortage,AURO-LISINOPRIL,AURO PHARMA INC,AURO-LISINOPRIL,LISINOPRIL,20MG,100's,ORAL; ORAL,Actual shortage,TABLET,2023-09-15,,,,Demand increase for the drug.,2023-09-15,2024-02-27,No
211603,02390892,Shortage,AURO-MELOXICAM,AURO PHARMA INC,AURO-MELOXICAM,MELOXICAM,15MG,3x10 Blst,ORAL; ORAL,Actual shortage,TABLET,2023-11-27,,2024-05-15,,Demand increase for the drug.,2023-11-27,2024-04-16,No
214552,02438283,Shortage,AURO-METFORMIN,AURO PHARMA INC,AURO-METFORMIN,METFORMIN HYDROCHLORIDE,850MG,100's and 500's,ORAL; ORAL,Actual shortage,TABLET,,2023-12-29,2024-05-01,,Demand increase for the drug.,2023-12-29,2024-04-16,No
214555,02524023,Shortage,AURO-METHOTREXATE,AURO PHARMA INC,AURO-METHOTREXATE,METHOTREXATE,2.5MG,100's,ORAL,Actual shortage,TABLET,,2023-12-29,,,Demand increase for the drug.,2023-12-29,2024-02-27,No
214558,02411709,Shortage,AURO-MIRTAZAPINE,AURO PHARMA INC,AURO-MIRTAZAPINE,MIRTAZAPINE,30MG,30's and 100's,ORAL; ORAL,Resolved,TABLET,,2023-12-29,2024-03-15,2024-03-13,Demand increase for the drug.,2023-12-29,2024-03-14,No
214561,02299801,Shortage,AURO-MIRTAZAPINE OD,AURO PHARMA INC,AURO-MIRTAZAPINE OD,MIRTAZAPINE,15MG,5x6's,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-12-29,2024-03-15,2024-03-13,Demand increase for the drug.,2023-12-29,2024-03-14,No
208757,02430487,Shortage,AURO-MODAFINIL,AURO PHARMA INC,AURO-MODAFINIL,MODAFINIL,100MG,3x10 Blst,ORAL; ORAL,Actual shortage,TABLET,2023-11-27,,2024-05-01,,Demand increase for the drug.,2023-10-31,2024-04-16,No
199656,02401274,Shortage,AURO-MONTELUKAST,AURO PHARMA INC,MONTELUKAST,MONTELUKAST,10MG,3X10 Blst,ORAL; ORAL,Resolved,TABLET,,2023-07-21,2023-09-30,2023-09-30,Demand increase for the drug.,2023-07-21,2023-10-02,No
199659,02401274,Shortage,AURO-MONTELUKAST,AURO PHARMA INC,MONTELUKAST,MONTELUKAST,10MG,90's,ORAL; ORAL,Resolved,TABLET,,2023-07-21,2023-09-30,2023-09-30,Demand increase for the drug.,2023-07-21,2023-10-02,No
199662,02432242,Shortage,AURO-MOXIFLOXACIN,AURO PHARMA INC,MOXIFLOXACIN,MOXIFLOXACIN,400MG,100's,ORAL; ORAL,Resolved,TABLET,,2023-07-21,2023-08-15,2023-08-03,Demand increase for the drug.,2023-07-21,2023-08-15,No
211613,02318601,Shortage,AURO-NEVIRAPINE,AURO PHARMA INC,AURO-NEVIRAPINE,NEVIRAPINE,200MG,60's,ORAL; ORAL,Resolved,TABLET,2023-11-27,,2024-03-31,2024-02-26,Demand increase for the drug.,2023-11-27,2024-02-27,No
199665,02443864,Shortage,AURO-OLMESARTAN,AURO PHARMA INC,OLMESARTAN,OLMESARTAN MEDOXOMIL,20MG,100's,ORAL; ORAL,Actual shortage,TABLET,,2023-07-21,2024-05-01,,Demand increase for the drug.,2023-07-21,2024-04-16,No
199670,02476495,Shortage,AURO-OLMESARTAN HCTZ,AURO PHARMA INC,OLMESARTAN HCTZ,HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL,12.5MG; 40MG,100's,ORAL; ORAL,Resolved,TABLET,,2023-07-21,2024-04-30,2024-03-27,Demand increase for the drug.,2023-07-21,2024-03-28,No
199673,02511282,Shortage,AURO-ONDANSETRON ODT,AURO PHARMA INC,ONDANSETRON ODT,ONDANSETRON,4MG,1 X 10's,ORAL,Actual shortage,TABLET (ORALLY DISINTEGRATING),,2023-07-21,2024-05-30,,Demand increase for the drug.,2023-07-21,2024-03-27,No
203283,02383292,Shortage,AURO-PAROXETINE,AURO PHARMA INC,PAROXETINE,PAROXETINE,30MG,100s,ORAL; ORAL,Resolved,TABLET,,2023-09-30,2023-11-30,2023-11-28,Demand increase for the drug.,2023-08-29,2023-11-29,No
199676,02383292,Shortage,AURO-PAROXETINE,AURO PHARMA INC,PAROXETINE,PAROXETINE,30MG,100's,ORAL; ORAL,Avoided shortage,TABLET,,2023-07-21,2023-08-31,2023-01-19,Demand increase for the drug.,2023-07-21,2023-08-29,No
199682,02459833,Shortage,AURO-PERINDOPRIL,AURO PHARMA INC,PERINDOPRIL,PERINDOPRIL ERBUMINE,8MG,100's and 3x10 Blst,ORAL; ORAL,Actual shortage,TABLET,,2023-07-21,2024-07-03,,Demand increase for the drug.,2023-07-21,2024-04-18,No
210221,02459825,Shortage,AURO-PERINDOPRIL,AURO PHARMA INC,AURO-PERINDOPRIL,PERINDOPRIL ERBUMINE,4MG,100's and 30's,ORAL; ORAL,Actual shortage,TABLET,,2023-11-15,2024-05-30,,Demand increase for the drug.,2023-11-15,2024-04-16,No
204530,02459817,Shortage,AURO-PERINDOPRIL,AURO PHARMA INC,AURO-PERINDOPRIL,PERINDOPRIL ERBUMINE,2MG,3x10 Blst,ORAL; ORAL,Actual shortage,TABLET,2023-09-15,2023-11-15,2024-07-03,,Demand increase for the drug.,2023-09-15,2024-04-18,No
199679,02459817,Shortage,AURO-PERINDOPRIL,AURO PHARMA INC,PERINDOPRIL,PERINDOPRIL ERBUMINE,2MG,100's and 500's,ORAL; ORAL,Resolved,TABLET,,2023-06-21,2023-09-09,2023-09-13,Demand increase for the drug.,2023-07-21,2023-09-14,No
214564,02424061,Shortage,AURO-PRAMIPEXOLE,AURO PHARMA INC,AURO-PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.25MG,100's,ORAL; ORAL,Resolved,TABLET,,2023-12-29,2024-03-15,2024-03-13,Demand increase for the drug.,2023-12-29,2024-03-14,No
204533,02493578,Shortage,AURO-PROGESTERONE,AURO PHARMA INC,AURO-PROGESTERONE,PROGESTERONE,100MG,3x10 Blst,ORAL,Resolved,CAPSULE,2023-09-15,,,2024-02-27,Demand increase for the drug.,2023-09-15,2024-02-28,No
199685,02390248,Shortage,AURO-QUETIAPINE,AURO PHARMA INC,QUETIAPINE,QUETIAPINE,200MG,500's,ORAL; ORAL,Resolved,TABLET,,2023-07-21,2024-02-28,2023-12-28,Demand increase for the drug.,2023-07-21,2023-12-29,No
210226,02390213,Shortage,AURO-QUETIAPINE,AURO PHARMA INC,AURO-QUETIAPINE,QUETIAPINE,100MG,100's,ORAL; ORAL,Resolved,TABLET,2023-11-15,2023-11-15,2024-01-30,2024-01-15,Demand increase for the drug.,2023-11-15,2024-01-16,No
199690,02387417,Shortage,AURO-RAMIPRIL,AURO PHARMA INC,RAMIPRIL,RAMIPRIL,10MG,3 X 10's,ORAL; ORAL,Resolved,CAPSULE,,2023-07-21,2023-12-15,2023-12-13,Demand increase for the drug.,2023-07-21,2023-12-14,No
199693,02387395,Shortage,AURO-RAMIPRIL,AURO PHARMA INC,RAMIPRIL,RAMIPRIL,2.5MG,500's,ORAL; ORAL,Resolved,CAPSULE,,2023-07-21,2023-12-15,2023-12-13,Demand increase for the drug.,2023-07-21,2023-12-14,No
199696,02424266,Shortage,AURO-REPAGLINIDE,AURO PHARMA INC,REPAGLINIDE,REPAGLINIDE,1MG,100's,ORAL; ORAL,Resolved,TABLET,,2023-07-21,2023-09-30,2023-09-13,Demand increase for the drug.,2023-07-21,2023-09-14,No
211622,02424266,Shortage,AURO-REPAGLINIDE,AURO PHARMA INC,AURO-REPAGLINIDE,REPAGLINIDE,1MG,100's,ORAL; ORAL,Resolved,TABLET,2023-11-27,,2023-12-19,2023-12-05,Demand increase for the drug.,2023-11-27,2023-12-06,No
214569,02442590,Shortage,AURO-ROSUVASTATIN,AURO PHARMA INC,AURO-ROSUVASTATIN,ROSUVASTATIN,20MG,3x10 Blst,ORAL; ORAL,Resolved,TABLET,,2023-12-29,2024-03-29,2024-03-27,Demand increase for the drug.,2023-12-29,2024-03-28,No
207405,02442574,Shortage,AURO-ROSUVASTATIN,AURO PHARMA INC,AURO-ROSUVASTATIN,ROSUVASTATIN,5MG,3x10 Blst,ORAL; ORAL,Resolved,TABLET,2023-10-19,2023-10-23,2023-12-28,2023-12-28,Demand increase for the drug.,2023-10-19,2023-12-29,No
204536,02442604,Shortage,AURO-ROSUVASTATIN,AURO PHARMA INC,AURO-ROSUVASTATIN,ROSUVASTATIN,40MG,90's,ORAL; ORAL,Resolved,TABLET,2023-09-15,,,2023-11-13,Demand increase for the drug.,2023-09-15,2023-11-14,No
203277,02390914,Shortage,AURO-SERTRALINE,AURO PHARMA INC,Sertraline,SERTRALINE,50MG,250s,ORAL; ORAL,Resolved,CAPSULE,,2023-08-29,2023-12-15,2023-12-13,Demand increase for the drug.,2023-08-29,2023-12-14,No
203280,02390906,Shortage,AURO-SERTRALINE,AURO PHARMA INC,SERTRALINE,SERTRALINE,25MG,250s,ORAL; ORAL,Resolved,CAPSULE,,2023-08-29,2023-11-15,2023-11-10,Demand increase for the drug.,2023-08-29,2023-11-11,No
214572,02390922,Shortage,AURO-SERTRALINE,AURO PHARMA INC,AURO-SERTRALINE,SERTRALINE,100MG,100's and 250's,ORAL; ORAL,Resolved,CAPSULE,,2023-12-29,2024-04-17,2024-03-27,Demand increase for the drug.,2023-12-29,2024-03-28,No
214575,02390914,Shortage,AURO-SERTRALINE,AURO PHARMA INC,AURO-SERTRALINE,SERTRALINE,50MG,100's and 250's,ORAL; ORAL,Actual shortage,CAPSULE,,2023-12-29,2024-05-01,,Demand increase for the drug.,2023-12-29,2024-04-19,No
199850,02390922,Shortage,AURO-SERTRALINE,AURO PHARMA INC,SERTRALINE,SERTRALINE,100MG,250's,ORAL; ORAL,Resolved,CAPSULE,,2023-07-24,2023-10-30,2023-10-30,Demand increase for the drug.,2023-07-24,2023-10-31,No
199853,02390906,Shortage,AURO-SERTRALINE,AURO PHARMA INC,SERTRALINE,SERTRALINE,25MG,250's,ORAL; ORAL,Avoided shortage,CAPSULE,,2023-07-24,2023-08-31,2023-04-24,Demand increase for the drug.,2023-07-24,2023-08-29,No
199857,02390914,Shortage,AURO-SERTRALINE,AURO PHARMA INC,SERTRALINE,SERTRALINE,50MG,250's,ORAL; ORAL,Avoided shortage,CAPSULE,,2023-07-24,2023-08-31,2023-02-22,Demand increase for the drug.,2023-07-24,2023-08-29,No
214580,02414368,Shortage,AURO-SILDENAFIL,AURO PHARMA INC,AURO-SILDENAFIL,SILDENAFIL,25MG,1X4'S Blst,ORAL; ORAL,Resolved,TABLET,,2023-12-29,2024-02-28,2024-02-12,Demand increase for the drug.,2023-12-29,2024-02-13,No
207409,02478501,Shortage,AURO-SILODOSIN,AURO PHARMA INC,AURO-SILODOSIN,SILODOSIN,4MG,30's,ORAL,Actual shortage,CAPSULE,2023-10-19,2023-10-23,2024-05-01,,Demand increase for the drug.,2023-10-19,2024-04-16,No
208787,02405156,Shortage,AURO-SIMVASTATIN,AURO PHARMA INC,AURO-SIMVASTATIN,SIMVASTATIN,10MG,100's nad 500's,ORAL; ORAL,Actual shortage,TABLET,2023-10-31,,2024-05-01,,Demand increase for the drug.,2023-10-31,2024-04-16,No
199866,02405156,Shortage,AURO-SIMVASTATIN,AURO PHARMA INC,SIMVASTATIN,SIMVASTATIN,10MG,500's,ORAL; ORAL,Resolved,TABLET,,2023-07-24,2023-10-01,2023-09-13,Demand increase for the drug.,2023-07-24,2023-09-14,No
199871,02405164,Shortage,AURO-SIMVASTATIN,AURO PHARMA INC,SIMVASTATIN,SIMVASTATIN,20MG,500's,ORAL; ORAL,Actual shortage,TABLET,,2023-07-24,2024-05-01,,Demand increase for the drug.,2023-07-24,2024-04-16,No
199874,02405172,Shortage,AURO-SIMVASTATIN,AURO PHARMA INC,SIMVASTATIN,SIMVASTATIN,40MG,500's,ORAL; ORAL,Actual shortage,TABLET,,2023-07-24,2024-05-01,,Demand increase for the drug.,2023-07-24,2024-04-16,No
199877,02405180,Shortage,AURO-SIMVASTATIN,AURO PHARMA INC,SIMVASTATIN,SIMVASTATIN,80MG,30's,ORAL; ORAL,Resolved,TABLET,,2023-07-24,2024-03-15,2024-03-13,Other (Please describe in comments),2023-07-24,2024-03-14,No
214583,02529882,Shortage,AURO-SITAGLIPTIN,AURO PHARMA INC,AURO-SITAGLIPTIN,SITAGLIPTIN,100MG,100's,ORAL,Resolved,TABLET,,2023-12-29,2024-02-29,2024-02-13,Demand increase for the drug.,2023-12-29,2024-02-14,No
199880,02529882,Shortage,AURO-SITAGLIPTIN,AURO PHARMA INC,SITAGLIPTIN,SITAGLIPTIN,100MG,500's,ORAL,Resolved,TABLET,,2023-07-24,2023-09-30,2023-09-13,Demand increase for the drug.,2023-07-24,2023-09-14,No
199883,02529874,Shortage,AURO-SITAGLIPTIN,AURO PHARMA INC,SITAGLIPTIN,SITAGLIPTIN,50MG,30's and 500's,ORAL,Resolved,TABLET,,2023-07-24,2023-08-31,2023-08-22,Demand increase for the drug.,2023-07-24,2023-08-29,No
199888,02529866,Shortage,AURO-SITAGLIPTIN,AURO PHARMA INC,SITAGLIPTIN,SITAGLIPTIN,25MG,30's,ORAL,Resolved,TABLET,,2023-07-24,2023-10-01,2023-10-31,Demand increase for the drug.,2023-07-24,2023-11-01,No
204540,02446375,Shortage,AURO-SOLIFENACIN,AURO PHARMA INC,AURO-SOLIFENACIN,SOLIFENACIN SUCCINATE,5MG,100's and 3x10 Blst,ORAL; ORAL,Resolved,TABLET,2023-09-15,2023-10-01,2024-04-17,2024-04-16,Demand increase for the drug.,2023-09-15,2024-04-17,No
199891,02435934,Shortage,AURO-TADALAFIL,AURO PHARMA INC,TADALAFIL,TADALAFIL,10MG,2 X 2 Blst,ORAL; ORAL,Resolved,TABLET,,2023-07-24,2023-08-06,2023-08-03,Demand increase for the drug.,2023-07-24,2023-08-08,No
199894,02435926,Shortage,AURO-TADALAFIL,AURO PHARMA INC,TADALAFIL,TADALAFIL,5MG,2 X 14,ORAL; ORAL,Actual shortage,TABLET,,2023-07-24,2024-05-01,,Demand increase for the drug.,2023-07-24,2024-04-16,No
199899,02453568,Shortage,AURO-TELMISARTAN,AURO PHARMA INC,TELMISARTAN,TELMISARTAN,40MG,500's,ORAL; ORAL,Resolved,TABLET,,2023-07-24,2023-11-30,2023-11-28,Demand increase for the drug.,2023-07-24,2023-11-29,No
199904,02453576,Shortage,AURO-TELMISARTAN,AURO PHARMA INC,TELMISARTAN,TELMISARTAN,80MG,100's and 500's,ORAL; ORAL,Resolved,TABLET,,2023-07-24,2024-03-15,2024-03-13,Demand increase for the drug.,2023-07-24,2024-03-14,No
207412,02460173,Shortage,AURO-TENOFOVIR,AURO PHARMA INC,Auro-Tenofovir 300mg,TENOFOVIR DISOPROXIL FUMARATE,300MG,30's,ORAL; ORAL,Resolved,TABLET,2023-10-19,2023-10-23,2023-11-15,2023-11-10,Demand increase for the drug.,2023-10-19,2023-11-11,No
214586,02320134,Shortage,AURO-TERBINAFINE,AURO PHARMA INC,AURO-TERBINAFINE,TERBINAFINE,250MG,2x14 Blst,ORAL; ORAL,Resolved,TABLET,,2023-12-29,2024-03-28,2024-03-26,Demand increase for the drug.,2023-12-29,2024-03-27,No
199933,02320134,Shortage,AURO-TERBINAFINE,AURO PHARMA INC,TERBINAFINE,TERBINAFINE,250MG,2 X 14,ORAL; ORAL,Resolved,TABLET,,2023-07-24,2023-11-30,2023-11-10,Demand increase for the drug.,2023-07-24,2023-11-11,No
207419,02345846,Shortage,AURO-TOPIRAMATE,AURO PHARMA INC,Auro-Topiramate 200mg,TOPIRAMATE,200MG,100's,ORAL; ORAL,Actual shortage,TABLET,2023-10-19,2023-10-23,2024-05-01,,Demand increase for the drug.,2023-10-19,2024-04-16,No
207426,02345803,Shortage,AURO-TOPIRAMATE,AURO PHARMA INC,Auro-Topiramate,TOPIRAMATE,25MG,100's,ORAL; ORAL,Resolved,TABLET,2023-10-19,2023-10-23,2024-01-30,2024-01-15,Demand increase for the drug.,2023-10-19,2024-01-16,No
208797,02471884,Shortage,AURO-TRANDOLAPRIL,AURO PHARMA INC,AURO-TRANDOLAPRIL,TRANDOLAPRIL,2MG,100's,ORAL; ORAL,Avoided shortage,CAPSULE,,2023-10-31,2023-11-30,2023-09-10,Demand increase for the drug.,2023-10-31,2023-11-10,No
199907,02405059,Shortage,AURO-VALACYCLOVIR,AURO PHARMA INC,VALACYCLOVIR,VALACYCLOVIR,1000MG,100,ORAL,Resolved,TABLET,,2023-07-24,2024-07-31,2024-04-18,Demand increase for the drug.,2023-07-24,2024-04-19,No
199910,02405040,Shortage,AURO-VALACYCLOVIR,AURO PHARMA INC,VALACYCLOVIR,VALACYCLOVIR,500MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-24,2024-04-17,2024-04-16,Demand increase for the drug.,2023-07-24,2024-04-18,No
199913,02435179,Shortage,AURO-VALGANCICLOVIR,AURO PHARMA INC,VALGANCICLOVIR,VALGANCICLOVIR,450MG,60s,ORAL; ORAL,Resolved,TABLET,,2023-07-24,2024-03-17,2024-03-15,Demand increase for the drug.,2023-07-24,2024-03-16,No
210229,02449544,Shortage,AURO-ZIPRASIDONE,AURO PHARMA INC,AURO-ZIPRASIDONE,ZIPRASIDONE,20MG,60's,ORAL; ORAL,Resolved,CAPSULE,,2023-11-15,2024-02-15,2024-02-13,Demand increase for the drug.,2023-11-15,2024-02-14,No
210257,02449552,Shortage,AURO-ZIPRASIDONE,AURO PHARMA INC,AURO-ZIPRASIDONE,ZIPRASIDONE,40MG,60's,ORAL; ORAL,Actual shortage,CAPSULE,,2023-11-15,2024-04-30,,Demand increase for the drug.,2023-11-15,2024-03-27,No
187479,02449579,Shortage,AURO-ZIPRASIDONE,AURO PHARMA INC,AURO-ZIPRASIDONE,ZIPRASIDONE,80MG,60's,ORAL; ORAL,Resolved,CAPSULE,,2023-03-01,2023-07-10,2023-06-09,Demand increase for the drug.,2023-03-20,2023-07-14,No
199916,02449544,Shortage,AURO-ZIPRASIDONE,AURO PHARMA INC,ZIPRASIDONE,ZIPRASIDONE,20MG,60's,ORAL; ORAL,Resolved,CAPSULE,,2023-07-24,2023-07-31,2023-07-25,Demand increase for the drug.,2023-07-24,2023-08-02,No
193896,02298589,Shortage,AVAMYS,GLAXOSMITHKLINE INC,fluticasone furoate nasal spray,FLUTICASONE FUROATE,27.5MCG,1x120,NASAL; NASAL,Resolved,"SPRAY, METERED DOSE",,2023-06-06,2023-06-23,2023-06-23,Demand increase for the drug.,2023-06-08,2023-06-24,No
196772,02298589,Shortage,AVAMYS,GLAXOSMITHKLINE INC,fluticasone furoate nasal spray,FLUTICASONE FUROATE,27.5MCG,1x120,NASAL; NASAL,Resolved,"SPRAY, METERED DOSE",,2023-06-23,2023-08-02,2023-07-21,Demand increase for the drug.,2023-06-28,2023-07-22,No
200368,02298589,Shortage,AVAMYS,GLAXOSMITHKLINE INC,fluticasone furoate nasal spray,FLUTICASONE FUROATE,27.5MCG,1x120,NASAL; NASAL,Resolved,"SPRAY, METERED DOSE",,2023-07-28,2023-08-31,2023-08-14,Disruption of the manufacture of the drug.,2023-07-28,2023-08-15,No
205521,02298589,Shortage,AVAMYS,GLAXOSMITHKLINE INC,fluticasone furoate nasal spray,FLUTICASONE FUROATE,27.5MCG,1x120,NASAL; NASAL,Resolved,"SPRAY, METERED DOSE",,2023-09-25,2023-12-08,2023-11-24,Disruption of the manufacture of the drug.,2023-09-29,2023-11-25,No
205012,02433532,Shortage,BACKUP PLAN ONESTEP,APOTEX INC,LEVONORGESTREL,LEVONORGESTREL,1.5MG,1 BLS,ORAL; ORAL,Resolved,TABLET,,2023-09-19,2023-10-27,2023-10-19,Disruption of the manufacture of the drug.,2023-09-22,2023-10-20,No
200471,02287021,Shortage,BACLOFEN,SANIS HEALTH INC,BACLOFEN,BACLOFEN,10MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-31,,2023-11-23,Disruption of the manufacture of the drug.,2023-07-31,2023-11-27,No
203125,02287048,Shortage,BACLOFEN,SANIS HEALTH INC,BACLOFEN,BACLOFEN,20MG,100,ORAL; ORAL,Resolved,TABLET,,2023-08-25,,2023-09-22,Disruption of the manufacture of the drug.,2023-08-29,2023-09-25,No
212107,02287021,Shortage,BACLOFEN,SANIS HEALTH INC,BACLOFEN,BACLOFEN,10MG,100,ORAL; ORAL,Avoided shortage,TABLET,2023-12-01,,,2023-11-30,Disruption of the manufacture of the drug.,2023-12-01,2023-12-01,No
193244,02457059,Shortage,BACLOFEN INJECTION,HIKMA CANADA LIMITED,BACLOFEN INJECTION,BACLOFEN,0.05MG,1mL,INTRATHECAL; INTRATHECAL,Actual shortage,SOLUTION,,2023-05-26,,,Delay in shipping of the drug.,2023-05-26,2023-05-27,No
191450,02485516,Shortage,BACLOFEN INTRATHECAL,AVIR PHARMA INC.,Baclofen intrathecal 2mg/ML,BACLOFEN,2MG,20ml,INTRATHECAL,Resolved,SOLUTION,2023-05-02,2023-05-02,,2023-05-25,Delay in shipping of the drug.,2023-05-02,2023-06-01,No
191464,02485494,Shortage,BACLOFEN INTRATHECAL,AVIR PHARMA INC.,Baclofen intrathecal 0.05mg/ml,BACLOFEN,0.05MG,1ml,INTRATHECAL,Resolved,SOLUTION,2023-05-02,2023-05-02,,2023-05-25,Delay in shipping of the drug.,2023-05-02,2023-06-01,No
200893,00037818,Shortage,BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP,PFIZER CANADA ULC,BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP,SODIUM CHLORIDE,9MG,25 x 10ml vial,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Avoided shortage,SOLUTION,2024-04-01,,,2024-03-06,Disruption of the manufacture of the drug.,2023-08-03,2024-03-06,No
181448,00037818,Shortage,BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP,PFIZER CANADA ULC,BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP,SODIUM CHLORIDE,9MG,25 x 20mL vial,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-03-03,,2024-03-21,Disruption of the manufacture of the drug.,2023-01-18,2024-03-22,No
200807,00038202,Shortage,BACTERIOSTATIC WATER FOR INJECTION USP,PFIZER CANADA ULC,BACTERIOSTATIC WATER FOR INJECTION USP,WATER,30ML,25 x 30ml vial,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Anticipated shortage,SOLUTION,2024-05-01,,,,Disruption of the manufacture of the drug.,2023-08-03,2024-02-28,No
195560,01928775,Shortage,BALMINIL DM  (3MG/ML SUCROSE FREE),TEVA CANADA LIMITED,BALMINIL DM  (3MG/ML SUCROSE FREE),DEXTROMETHORPHAN HYDROBROMIDE,15MG,250ML,ORAL; ORAL,Resolved,SYRUP,,2023-06-19,2024-02-28,2023-10-03,Disruption of the manufacture of the drug.,2023-06-19,2023-10-04,No
213253,02370050,Shortage,BENLYSTA,GLAXOSMITHKLINE INC,Belimumab for injection,BELIMUMAB,120MG,1x5ML,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION,,2023-12-13,2024-02-09,2024-02-06,Disruption of the manufacture of the drug.,2023-12-13,2024-02-07,No
203270,02248472,Shortage,BENZACLIN,"BAUSCH HEALTH, CANADA INC.",BENZACLIN,BENZOYL PEROXIDE; CLINDAMYCIN,5%; 1%,50g,TOPICAL; TOPICAL,Resolved,GEL,,2023-08-28,2023-09-28,2023-09-18,Demand increase for the drug.,2023-08-29,2023-09-21,No
207376,02248472,Shortage,BENZACLIN,"BAUSCH HEALTH, CANADA INC.",BENZACLIN,BENZOYL PEROXIDE; CLINDAMYCIN,5%; 1%,50g,TOPICAL; TOPICAL,Resolved,GEL,2023-11-24,2023-11-28,2024-01-22,2024-01-17,Demand increase for the drug.,2023-10-19,2024-01-18,No
205401,02248472,Shortage,BENZACLIN,"BAUSCH HEALTH, CANADA INC.",BENZACLIN,BENZOYL PEROXIDE; CLINDAMYCIN,5%; 1%,50g,TOPICAL; TOPICAL,Resolved,GEL,,2023-09-25,2023-10-04,2023-10-03,Demand increase for the drug.,2023-09-28,2023-10-06,No
193931,02248472,Shortage,BENZACLIN,"BAUSCH HEALTH, CANADA INC.",BENZACLIN,BENZOYL PEROXIDE; CLINDAMYCIN,5%; 1%,50g,TOPICAL; TOPICAL,Resolved,GEL,2023-07-11,,2023-08-02,2023-08-06,Demand increase for the drug.,2023-06-08,2023-08-09,No
204911,02225271,Shortage,BENZAMYCIN,"BAUSCH HEALTH, CANADA INC.",BENZAMYCIN,BENZOYL PEROXIDE; ERYTHROMYCIN,5%; 3%,46.6G,TOPICAL; TOPICAL,Resolved,GEL,2023-10-06,2023-09-26,2023-12-14,2023-12-04,Demand increase for the drug.,2023-09-21,2023-12-06,No
181808,00716626,Shortage,BETADERM CRM 0.1%,TARO PHARMACEUTICALS INC,BETADERM,BETAMETHASONE,0.10%,454,TOPICAL; TOPICAL,Resolved,CREAM,,2023-01-11,2023-04-07,2023-04-06,Disruption of the manufacture of the drug.,2023-01-19,2023-04-07,No
182907,00716634,Shortage,BETADERM LOTION 0.1%,TARO PHARMACEUTICALS INC,BETADERM,BETAMETHASONE,0.10%,75,TOPICAL; TOPICAL,Resolved,LOTION,,2023-01-16,2023-04-07,2023-04-06,Disruption of the manufacture of the drug.,2023-02-01,2023-04-07,No
203635,02326302,Shortage,BI-PEGLYTE,PENDOPHARM DIVISION OF PHARMASCIENCE INC,BI-PEGLYTE,POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM BICARBONATE; SODIUM SULFATE; POLYETHYLENE GLYCOL 3350; BISACODYL,0.76G; 1.46G; 1.69G; 5.74G; 59.55G; 5MG,KIT,ORAL; ORAL,Actual shortage,POWDER FOR SOLUTION; KIT; TABLET (DELAYED-RELEASE),2023-09-05,2023-09-05,2024-05-15,,Disruption of the manufacture of the drug.,2023-09-05,2024-04-12,No
211253,02359685,Shortage,BIACNA TOPICAL GEL,"BAUSCH HEALTH, CANADA INC.",BIACNA TOPICAL GEL,TRETINOIN; CLINDAMYCIN PHOSPHATE,0.025%; 1.2%,60g,TOPICAL; TOPICAL,Resolved,GEL,,2023-11-28,2023-12-15,2023-12-12,Other (Please describe in comments),2023-11-23,2023-12-15,No
187755,02359685,Shortage,BIACNA TOPICAL GEL,"BAUSCH HEALTH, CANADA INC.",BIACNA TOPICAL GEL,TRETINOIN; CLINDAMYCIN PHOSPHATE,0.025%; 1.2%,60g,TOPICAL; TOPICAL,Resolved,GEL,2023-05-29,,2023-06-08,2023-06-06,Delay in shipping of the drug.,2023-03-23,2023-06-08,No
213471,02359685,Shortage,BIACNA TOPICAL GEL,"BAUSCH HEALTH, CANADA INC.",BIACNA TOPICAL GEL,TRETINOIN; CLINDAMYCIN PHOSPHATE,0.025%; 1.2%,60 mg,TOPICAL; TOPICAL,Resolved,GEL,2024-01-26,,2024-02-02,2024-01-30,Other (Please describe in comments),2023-12-15,2024-02-01,No
181319,02146908,Shortage,BIAXIN,BGP PHARMA ULC,CLARITHROMYCIN,CLARITHROMYCIN,125MG,"55ML, 105ML",ORAL; ORAL,Avoided shortage,GRANULES FOR SUSPENSION,2023-04-05,,2023-06-13,2023-02-02,Demand increase for the drug.,2023-01-17,2023-02-06,No
182226,02244641,Shortage,BIAXIN,BGP PHARMA ULC,CLARITHROMYCIN,CLARITHROMYCIN,250MG,105ML,ORAL; ORAL,Resolved,GRANULES FOR SUSPENSION,2023-02-23,2023-02-23,2023-03-31,2023-03-29,Demand increase for the drug.,2023-01-23,2023-04-04,No
195936,02277174,Shortage,BIPHENTIN,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,30MG,100,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),2023-06-20,2023-06-20,2023-07-14,2023-07-11,Delay in shipping of the drug.,2023-06-20,2023-07-12,No
196775,02277166,Shortage,BIPHENTIN,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,10MG,100,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),2023-06-28,2023-06-28,2023-07-11,2023-07-11,Delay in shipping of the drug.,2023-06-28,2023-07-12,No
191144,02277182,Shortage,BIPHENTIN,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,40MG,100,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),2023-04-28,2023-04-28,2023-06-30,2023-06-26,Delay in shipping of the drug.,2023-04-28,2023-06-27,No
191148,02277204,Shortage,BIPHENTIN,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,60MG,50,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),2023-04-28,2023-04-28,2023-05-05,2023-05-01,Delay in shipping of the drug.,2023-04-28,2023-05-03,No
184493,02277166,Shortage,BIPHENTIN,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,10MG,100,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),2023-02-13,2023-02-13,2023-02-17,2023-02-16,Delay in shipping of the drug.,2023-02-13,2023-02-17,No
191409,02277166,Shortage,BIPHENTIN,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,10MG,100,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),2023-05-01,2023-05-01,2023-06-07,2023-06-08,Delay in shipping of the drug.,2023-05-01,2023-06-09,No
197815,02277158,Shortage,BIPHENTIN,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,20MG,100,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),2023-07-06,2023-07-06,2023-07-14,2023-07-14,Delay in shipping of the drug.,2023-07-07,2023-07-15,No
180941,02277174,Shortage,BIPHENTIN,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,30MG,100,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),2023-01-13,2023-01-13,2023-01-27,2023-01-30,Delay in shipping of the drug.,2023-01-13,2023-01-31,No
179939,02277182,Shortage,BIPHENTIN,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,40MG,100,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),2023-01-05,2023-01-05,2023-02-17,2023-02-16,Delay in shipping of the drug.,2023-01-05,2023-02-17,No
183524,02277190,Shortage,BIPHENTIN,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,50MG,50,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),2023-02-02,2023-02-02,2023-04-05,2023-04-04,Delay in shipping of the drug.,2023-02-03,2023-04-05,No
183527,02277204,Shortage,BIPHENTIN,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,60MG,50,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),2023-02-02,2023-02-02,2023-04-05,2023-04-04,Delay in shipping of the drug.,2023-02-03,2023-04-05,No
187628,02277182,Shortage,BIPHENTIN,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,40MG,100,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),2023-03-21,2023-03-21,2023-04-05,2023-04-04,Delay in shipping of the drug.,2023-03-22,2023-04-05,No
201032,02435268,Shortage,BIVALIRUDIN FOR INJECTION,FRESENIUS KABI CANADA LTD,BIVALIRUDIN FOR INJECTION,BIVALIRUDIN,250MG,10mL,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION,,2023-07-21,2023-11-30,2023-11-17,Disruption of the manufacture of the drug.,2023-08-03,2023-11-18,No
212050,02131692,Shortage,BLEOMYCIN FOR INJECTION USP,PFIZER CANADA ULC,BLEOMYCIN FOR INJECTION USP,BLEOMYCIN,15UNIT,15IU vial,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; INTRACAVITARY; INTRA-ARTERIAL; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; INTRACAVITARY; INTRA-ARTERIAL,Resolved,POWDER FOR SOLUTION,,2024-01-18,,2024-04-09,Disruption of the manufacture of the drug.,2023-11-30,2024-04-10,No
179831,02247600,Shortage,BOOSTRIX,GLAXOSMITHKLINE INC,"Combined diphtheria, tetanus, acellular pertussis (adsorbed) vaccine for booster vaccination",PERTACTIN; FILAMENTOUS HAEMAGGLUTININ; PERTUSSIS TOXOID; TETANUS TOXOID; DIPHTHERIA TOXOID,2.5MCG; 8MCG; 8MCG; 20UNIT; 2UNIT,10s,INTRAMUSCULAR; INTRAMUSCULAR,Resolved,SUSPENSION,,2023-01-03,2023-05-16,2023-05-15,Delay in shipping of the drug.,2023-01-04,2023-05-16,No
196056,02312557,Shortage,BOOSTRIX-POLIO,GLAXOSMITHKLINE INC,"Combined diphtheria, tetanus, acellular pertussis (adsorbed) and inactivated poliomyelitis vaccine",INACTIVATED POLIOVIRUS TYPE III; INACTIVATED POLIOVIRUS TYPE II; INACTIVATED POLIOVIRUS TYPE I; PERTACTIN ADSORBED; FILAMENTOUS HAEMAGGLUTININ ADSORBED; PERTUSSIS TOXOID ADSORBED; TETANUS TOXOID ADSORBED; DIPHTHERIA TOXOID ADSORBED,32D; 8D; 40D; 2.5MCG; 8MCG; 8MCG; 5.0LF; 2.5LF,10's,INTRAMUSCULAR; INTRAMUSCULAR,Resolved,SUSPENSION,,2023-06-20,2023-10-18,2023-10-02,Delay in shipping of the drug.,2023-06-21,2023-10-04,No
192906,02309238,Shortage,BREVIBLOC PREMIXED INJECTION,BAXTER CORPORATION,BREVIBLOC PREMIXED INJECTION,ESMOLOL HYDROCHLORIDE,10MG,250mL,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2023-05-19,2023-05-19,2023-06-28,2023-06-28,Demand increase for the drug.,2023-05-23,2023-06-29,No
206521,02187086,Shortage,BREVICON 0.5/35 TABLETS (21-DAY PACK),PFIZER CANADA ULC,Brevicon,NORETHINDRONE; ETHINYL ESTRADIOL,0.5MG; 0.035MG,21's,ORAL; ORAL,Resolved,TABLET,,2023-10-06,2023-10-27,2023-10-25,Demand increase for the drug.,2023-10-06,2023-10-26,No
206524,02187094,Shortage,BREVICON 0.5/35 TABLETS (28-DAY PACK),PFIZER CANADA ULC,Brevicon,NORETHINDRONE; ETHINYL ESTRADIOL,.5MG; .035MG,28's,ORAL; ORAL,Resolved,TABLET,,2023-10-06,2023-10-27,2023-10-27,Demand increase for the drug.,2023-10-06,2023-10-28,No
188193,02189054,Shortage,BREVICON 1/35 TABLETS (21-DAY PACK),PFIZER CANADA ULC,BREVICON,ETHINYL ESTRADIOL; NORETHINDRONE,0.035MG; 1MG,21's,ORAL; ORAL,Resolved,TABLET,2023-03-29,2023-03-29,2023-04-25,2023-04-25,Disruption of the manufacture of the drug.,2023-03-28,2023-04-26,No
195942,02189054,Shortage,BREVICON 1/35 TABLETS (21-DAY PACK),PFIZER CANADA ULC,BREVICON,ETHINYL ESTRADIOL; NORETHINDRONE,0.035MG; 1MG,21's,ORAL; ORAL,Resolved,TABLET,2023-07-05,,2023-10-27,2023-10-25,Disruption of the manufacture of the drug.,2023-06-20,2023-10-26,No
193321,02189062,Shortage,BREVICON 1/35 TABLETS (28-DAY PACK),PFIZER CANADA ULC,BREVICON 1/35,ETHINYL ESTRADIOL; NORETHINDRONE,0.035MG; 1MG,28's,ORAL; ORAL,Resolved,TABLET,2023-06-05,,2023-07-21,2023-07-18,Disruption of the manufacture of the drug.,2023-05-30,2023-07-26,No
213856,02189062,Shortage,BREVICON 1/35 TABLETS (28-DAY PACK),PFIZER CANADA ULC,Brevicon,ETHINYL ESTRADIOL; NORETHINDRONE,0.035MG; 1MG,28's,ORAL; ORAL,Resolved,TABLET,,2024-01-04,2024-03-26,2024-03-15,Demand increase for the drug.,2023-12-19,2024-03-20,No
204196,02189062,Shortage,BREVICON 1/35 TABLETS (28-DAY PACK),PFIZER CANADA ULC,Brevicon,ETHINYL ESTRADIOL; NORETHINDRONE,0.035MG; 1MG,28's,ORAL; ORAL,Resolved,TABLET,2023-09-20,,2023-10-27,2023-10-27,Disruption of the manufacture of the drug.,2023-09-13,2023-10-28,No
198719,02301334,Shortage,BRIMONIDINE P,AA PHARMA INC,Brimonidine P,BRIMONIDINE TARTRATE,0.15%,5ML,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,2023-07-17,,2023-10-13,2023-10-13,Disruption of the manufacture of the drug.,2023-07-14,2023-10-14,No
202748,02301334,Shortage,BRIMONIDINE P,AA PHARMA INC,Brimonidine P,BRIMONIDINE TARTRATE,0.15%,10ML,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,2023-08-24,,2023-10-13,2023-10-13,Disruption of the manufacture of the drug.,2023-08-23,2023-10-14,No
204928,02483874,Shortage,BUDESONIDE,TILLOTTS PHARMA GMBH,Budesonide Controlled Ileal Release Capsules 3 mg,BUDESONIDE,3MG,100,ORAL; ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE); CAPSULE (SUSTAINED-RELEASE),2023-09-06,2023-09-13,,,Disruption of the manufacture of the drug.,2023-09-22,2023-09-22,No
211218,02460645,Shortage,BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP,STERIMAX INC,BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP,BUPIVACAINE HYDROCHLORIDE,7.5MG,10 AMPOULES X 2 ML,INTRASPINAL; INTRASPINAL,Avoided shortage,SOLUTION,2024-03-27,,,2024-03-08,Disruption of the manufacture of the drug.,2023-11-22,2024-03-08,Yes
211742,02512424,Shortage,BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP,OMEGA LABORATORIES LIMITED,Bupivacaine Hydrochloride In Dextrose Injection USP,BUPIVACAINE HYDROCHLORIDE,7.5MG,10 x 2 mL vial / fiole,INTRASPINAL,Resolved,SOLUTION,,2023-12-05,,2023-12-13,Demand increase for the drug.,2023-11-28,2023-12-14,No
194676,02512424,Shortage,BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP,OMEGA LABORATORIES LIMITED,Bupivacaine Hydrochloride In Dextrose Injection USP,BUPIVACAINE HYDROCHLORIDE,7.5MG,10 x 2 mL vial / fiole,INTRASPINAL,Resolved,SOLUTION,,2023-06-09,,2023-09-07,Demand increase for the drug.,2023-06-10,2023-09-08,No
204665,02512424,Shortage,BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP,OMEGA LABORATORIES LIMITED,Bupivacaine Hydrochloride In Dextrose Injection USP,BUPIVACAINE HYDROCHLORIDE,7.5MG,10 x 2 mL vial / fiole,INTRASPINAL,Resolved,SOLUTION,2023-09-25,2023-09-20,2023-11-17,2023-11-10,Demand increase for the drug.,2023-09-18,2023-11-11,No
189687,02512424,Shortage,BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP,OMEGA LABORATORIES LIMITED,Bupivacaine Hydrochloride In Dextrose Injection USP,BUPIVACAINE HYDROCHLORIDE,7.5MG,10 x 2 mL vial / fiole,INTRASPINAL,Resolved,SOLUTION,,2023-04-14,2023-05-26,2023-05-26,Demand increase for the drug.,2023-04-14,2023-05-27,No
210780,02488930,Shortage,"BUPIVACAINE HYDROCHLORIDE INJECTION, USP",BAXTER CORPORATION,Bupivacaine Hydrochloride,BUPIVACAINE HYDROCHLORIDE,7.5MG,AIN03056,RETROBULBAR; EPIDURAL,Avoided shortage,SOLUTION,2024-04-12,,,2024-04-11,Requirements related to complying with good manufacturing practices.,2023-11-17,2024-04-11,Yes
213678,02443686,Shortage,BUPIVACAINE INJECTION BP,STERIMAX INC,BUPIVACAINE INJECTION BP,BUPIVACAINE HYDROCHLORIDE,2.5MG,10 VIALS X 10 ML,EPIDURAL; BLOCK/INFILTRATION; EPIDURAL; BLOCK/INFILTRATION,Anticipated shortage,SOLUTION,2024-05-08,,,,Disruption of the manufacture of the drug.,2023-12-18,2024-04-05,Yes
213681,02443686,Shortage,BUPIVACAINE INJECTION BP,STERIMAX INC,BUPIVACAINE INJECTION BP,BUPIVACAINE HYDROCHLORIDE,2.5MG,10 VIALS X 20 ML,EPIDURAL; BLOCK/INFILTRATION; EPIDURAL; BLOCK/INFILTRATION,Actual shortage,SOLUTION,2024-04-13,,,,Disruption of the manufacture of the drug.,2023-12-18,2024-04-14,Yes
185280,00728276,Shortage,BURINEX,KARO PHARMA AB,BURINEX TAB 5 MG,BUMETANIDE,5MG,30,ORAL; ORAL,Resolved,TABLET,,2022-12-05,,2023-04-23,Delay in shipping of the drug.,2023-02-22,2023-04-24,No
204870,00363812,Shortage,BUSCOPAN,SANOFI CONSUMER HEALTH INC,Buscopan,HYOSCINE BUTYLBROMIDE,10MG,20,ORAL; ORAL,Resolved,TABLET,,2023-09-20,2023-11-24,2023-11-14,Demand increase for the drug.,2023-09-20,2023-11-14,No
206788,00363839,Shortage,BUSCOPAN,SANOFI CONSUMER HEALTH INC,Buscopan,HYOSCINE BUTYLBROMIDE,20MG,12,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,2023-10-11,2023-10-11,2024-03-22,2024-03-25,Delay in shipping of the drug.,2023-10-11,2024-03-26,No
183517,02341220,Shortage,BUTRANS 20,PURDUE PHARMA,Buprenorphine Transdermal System,BUPRENORPHINE,20MCG,4,TRANSDERMAL; TRANSDERMAL,Resolved,PATCH,2023-02-03,2023-02-03,2023-03-10,2023-02-08,Delay in shipping of the drug.,2023-02-03,2023-02-09,No
183519,02341220,Shortage,BUTRANS 20,PURDUE PHARMA,Buprenorphine Transdermal System,BUPRENORPHINE,20MCG,4,TRANSDERMAL; TRANSDERMAL,Resolved,PATCH,2023-02-03,2023-02-03,2023-03-31,2023-02-16,Delay in shipping of the drug.,2023-02-03,2023-02-17,No
192664,02399008,Shortage,BYSTOLIC,ABBVIE CORPORATION,BYSTOLIC 5 mg,NEBIVOLOL,5MG,30 tablets/bottle,ORAL; ORAL,Resolved,TABLET,,2023-05-15,2023-12-08,2023-11-22,Delay in shipping of the drug.,2023-05-17,2024-02-06,No
206797,02398990,Shortage,BYSTOLIC,ABBVIE CORPORATION,BYSTOLIC 2.5 mg,NEBIVOLOL,2.5MG,30 tablets/bottle,ORAL; ORAL,Resolved,TABLET,,2023-10-06,2023-12-01,2023-11-22,Demand increase for the drug.,2023-10-11,2023-11-23,No
187625,02399016,Shortage,BYSTOLIC,ABBVIE CORPORATION,Nebivolol Hydrochloride,NEBIVOLOL,10MG,30 tablets,ORAL; ORAL,Resolved,TABLET,,2023-03-24,2023-08-04,2023-08-02,Delay in shipping of the drug.,2023-03-22,2023-08-04,No
181668,02487497,Shortage,CABAZITAXEL FOR INJECTION,SANDOZ CANADA INCORPORATED,CABAZITAXEL,CABAZITAXEL,45MG,4.5ML,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-01-18,2023-02-03,2023-02-08,Demand increase for the drug.,2023-01-19,2023-02-09,No
203175,02487497,Shortage,CABAZITAXEL FOR INJECTION,SANDOZ CANADA INCORPORATED,CABAZITAXEL,CABAZITAXEL,45MG,4.5ML,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-08-29,2023-11-17,2023-11-20,Requirements related to complying with good manufacturing practices.,2023-08-29,2023-11-21,No
187500,02273292,Shortage,CADUET,UPJOHN CANADA ULC,CADUET,ATORVASTATIN; AMLODIPINE,20MG; 10MG,90,ORAL; ORAL,Resolved,TABLET,,2023-02-23,2023-06-13,2023-06-07,Demand increase for the drug.,2023-03-20,2023-06-13,No
187510,02273314,Shortage,CADUET,UPJOHN CANADA ULC,CADUET,ATORVASTATIN; AMLODIPINE,80MG; 10MG,90,ORAL; ORAL,Actual shortage,TABLET,2023-05-31,2023-06-06,2024-07-09,,Disruption of the manufacture of the drug.,2023-03-20,2024-04-16,No
201947,02273241,Shortage,CADUET,UPJOHN CANADA ULC,CADUET,ATORVASTATIN; AMLODIPINE,20MG; 5MG,90,ORAL; ORAL,Resolved,TABLET,2023-08-22,2023-08-10,2023-09-20,2023-09-19,Disruption of the manufacture of the drug.,2023-08-16,2023-09-26,No
184556,02273284,Shortage,CADUET,UPJOHN CANADA ULC,CADUET,ATORVASTATIN; AMLODIPINE,10MG; 10MG,90,ORAL; ORAL,Resolved,TABLET,2023-03-01,,2023-03-07,2023-03-07,Disruption of the manufacture of the drug.,2023-02-14,2023-03-20,No
203082,02526751,Shortage,CAFFEINE CITRATE ORAL SOLUTION USP,OMEGA LABORATORIES LIMITED,Caffeine Citrate Oral solution,CAFFEINE CITRATE,20MG,10 x 3mL vial / fiole,ORAL,Resolved,SOLUTION,,2023-08-28,,2023-10-25,Demand increase for the drug.,2023-08-28,2023-10-26,No
200770,00821780,Shortage,CALCIJECT INJ 100MG/ML,OMEGA LABORATORIES LIMITED,Calcium Chloride For Injection USP,CALCIUM CHLORIDE,100MG,10 x 10mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,,2023-08-03,2023-10-31,2023-10-30,Demand increase for the drug.,2023-08-02,2023-10-31,Yes
201624,00821780,Shortage,CALCIJECT INJ 100MG/ML,OMEGA LABORATORIES LIMITED,Calcium Chloride For Injection USP,CALCIUM CHLORIDE,100MG,10 x 50mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,,2023-08-14,2023-12-08,2023-11-23,Demand increase for the drug.,2023-08-11,2023-11-24,Yes
180130,00821780,Shortage,CALCIJECT INJ 100MG/ML,OMEGA LABORATORIES LIMITED,Calcium Chloride For Injection USP,CALCIUM CHLORIDE,100MG,10 x 50mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,,2023-01-06,2023-01-18,2023-01-17,Demand increase for the drug.,2023-01-06,2023-01-18,No
192434,00821780,Shortage,CALCIJECT INJ 100MG/ML,OMEGA LABORATORIES LIMITED,Calcium Chloride For Injection USP,CALCIUM CHLORIDE,100MG,10 x 10mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,,2023-06-02,,2023-06-13,Demand increase for the drug.,2023-05-12,2023-06-14,No
190165,00821780,Shortage,CALCIJECT INJ 100MG/ML,OMEGA LABORATORIES LIMITED,Calcium Chloride For Injection USP,CALCIUM CHLORIDE,100MG,10 x 50mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,,2023-06-09,,2023-06-13,Demand increase for the drug.,2023-04-21,2023-06-14,No
189676,00821780,Shortage,CALCIJECT INJ 100MG/ML,OMEGA LABORATORIES LIMITED,Calcium Chloride For Injection USP,CALCIUM CHLORIDE,100MG,10 x 10mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,,2023-04-14,2023-05-05,2023-05-01,Demand increase for the drug.,2023-04-14,2023-05-03,No
200787,00294748,Shortage,CALCIUM CHLORIDE INJECTION USP,PFIZER CANADA ULC,CALCIUM CHLORIDE INJECTION USP,CALCIUM CHLORIDE,100MG,10 x 10ml LifeShield syringe,INTRAVENOUS; INTRAVENOUS,Actual shortage,SOLUTION,,2023-08-03,,,Disruption of the manufacture of the drug.,2023-08-03,2023-09-05,Yes
180888,00535230,Shortage,CALMYLIN,TEVA CANADA LIMITED,CALMYLIN W/CODEINE ORIGINAL SYRUP,AMMONIUM CHLORIDE; DIPHENHYDRAMINE HYDROCHLORIDE; CODEINE PHOSPHATE,125MG; 12.5MG; 3.33MG,100ml,ORAL; ORAL,Resolved,SYRUP,,2023-01-10,2023-09-10,2023-09-10,Disruption of the manufacture of the drug.,2023-01-12,2023-10-03,No
195769,00535230,Shortage,CALMYLIN,TEVA CANADA LIMITED,CALMYLIN,AMMONIUM CHLORIDE; DIPHENHYDRAMINE HYDROCHLORIDE; CODEINE PHOSPHATE,125MG; 12.5MG; 3.33MG,250ML,ORAL; ORAL,Resolved,SYRUP,,2023-06-19,2023-09-10,2023-09-10,Disruption of the manufacture of the drug.,2023-06-20,2023-10-03,No
195792,00535230,Shortage,CALMYLIN,TEVA CANADA LIMITED,CALMYLIN,AMMONIUM CHLORIDE; DIPHENHYDRAMINE HYDROCHLORIDE; CODEINE PHOSPHATE,125MG; 12.5MG; 3.33MG,100ML,ORAL; ORAL,Resolved,SYRUP,,2023-06-19,2023-07-30,2023-07-04,Disruption of the manufacture of the drug.,2023-06-20,2023-07-05,No
195836,00535230,Shortage,CALMYLIN,TEVA CANADA LIMITED,CALMYLIN,AMMONIUM CHLORIDE; DIPHENHYDRAMINE HYDROCHLORIDE; CODEINE PHOSPHATE,125MG; 12.5MG; 3.33MG,350ML,ORAL; ORAL,Resolved,SYRUP,,2023-06-19,2023-09-30,2023-09-30,Disruption of the manufacture of the drug.,2023-06-20,2023-10-03,No
195061,02198630,Shortage,CALMYLIN ACE,TEVA CANADA LIMITED,CALMYLIN ACE,CODEINE PHOSPHATE; PHENIRAMINE MALEATE; GUAIFENESIN,10MG; 7.5MG; 100MG,500ML,ORAL; ORAL,Resolved,SYRUP,,2023-06-16,2023-10-30,2023-10-30,Disruption of the manufacture of the drug.,2023-06-16,2023-10-31,No
195521,02172917,Shortage,CALMYLIN PSE WITH CODEINE,TEVA CANADA LIMITED,CALMYLIN PSE WITH CODEINE,GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE; CODEINE PHOSPHATE,100MG; 30MG; 3.3MG,250ML,ORAL; ORAL,Resolved,SYRUP,,2023-06-19,2023-06-30,2023-07-05,Disruption of the manufacture of the drug.,2023-06-19,2023-07-06,No
195042,02172917,Shortage,CALMYLIN PSE WITH CODEINE,TEVA CANADA LIMITED,CALMYLIN PSE WITH CODEINE,GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE; CODEINE PHOSPHATE,100MG; 30MG; 3.3MG,100ML,ORAL; ORAL,Resolved,SYRUP,,2023-06-16,2023-06-30,2023-07-05,Disruption of the manufacture of the drug.,2023-06-16,2023-07-06,No
189345,02293269,Shortage,CAMPRAL,MYLAN PHARMACEUTICALS ULC,ACCAMPROSATE,ACAMPROSATE CALCIUM,333MG,84BL,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE),2023-04-19,2023-04-14,2023-04-28,2023-04-19,Disruption of the manufacture of the drug.,2023-04-12,2023-05-01,No
206781,02293269,Shortage,CAMPRAL,MYLAN PHARMACEUTICALS ULC,ACAMPROSATE CALCIUM,ACAMPROSATE CALCIUM,333MG,84BL,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE),2023-10-31,2023-11-02,2023-11-22,2023-11-23,Disruption of the manufacture of the drug.,2023-10-11,2023-11-28,No
213971,02293269,Shortage,CAMPRAL,MYLAN PHARMACEUTICALS ULC,ACAMPROSATE CALCIUM,ACAMPROSATE CALCIUM,333MG,84 BL,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE),,2023-12-16,2024-01-03,2024-01-05,Other (Please describe in comments),2023-12-21,2024-01-10,No
203308,02244265,Shortage,CANCIDAS,MERCK CANADA INC,caspofungin for injection,CASPOFUNGIN,50MG,1dose vial,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION,2023-09-29,2023-09-21,2023-11-17,2023-10-31,Demand increase for the drug.,2023-08-30,2023-11-01,No
208711,02244265,Shortage,CANCIDAS,MERCK CANADA INC,caspofungin for injection,CASPOFUNGIN,50MG,1dose vial,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION,2023-11-03,2023-11-01,2023-12-15,2023-12-14,Delay in shipping of the drug.,2023-10-31,2023-12-15,No
207815,02244266,Shortage,CANCIDAS,MERCK CANADA INC,caspofungin for injection,CASPOFUNGIN,70MG,70MG 1DOSE VIAL,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION,2023-11-03,2023-10-26,2023-12-01,2023-11-29,Demand increase for the drug.,2023-10-23,2023-11-30,No
207878,02435845,Shortage,CANDESARTAN,SANIS HEALTH INC,CANDESARTAN,CANDESARTAN CILEXETIL,32MG,100,ORAL; ORAL,Resolved,TABLET,,2023-10-23,2024-03-14,2024-03-11,Disruption of the manufacture of the drug.,2023-10-23,2024-03-11,No
198936,02388901,Shortage,CANDESARTAN,SANIS HEALTH INC,CANDESARTAN,CANDESARTAN CILEXETIL,4MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-18,2023-10-31,2023-10-31,Disruption of the manufacture of the drug.,2023-07-18,2023-11-06,No
198795,02388936,Shortage,CANDESARTAN,SANIS HEALTH INC,CANDESARTAN,CANDESARTAN CILEXETIL,16MG,500,ORAL; ORAL,Resolved,TABLET,,2023-07-17,2023-09-01,2023-09-01,Disruption of the manufacture of the drug.,2023-07-17,2023-09-05,No
211086,02388901,Shortage,CANDESARTAN,SANIS HEALTH INC,CANDESARTAN,CANDESARTAN CILEXETIL,4MG,100,ORAL; ORAL,Resolved,TABLET,,2023-11-17,2023-12-11,2023-12-08,Disruption of the manufacture of the drug.,2023-11-22,2023-12-26,No
211081,02394804,Shortage,CANDESARTAN/HCTZ,SANIS HEALTH INC,CANDESARTAN/HCTZ,HYDROCHLOROTHIAZIDE; CANDESARTAN CILEXETIL,12.5MG; 16MG,100,ORAL; ORAL,Resolved,TABLET,,2023-11-17,2023-12-28,2023-12-28,Disruption of the manufacture of the drug.,2023-11-22,2024-01-17,No
196200,02519879,Shortage,CAPECITABINE,JAMP PHARMA CORPORATION,Capecitabine Tablets,CAPECITABINE,150MG,60,ORAL,Resolved,TABLET,,2023-06-20,,2023-09-19,Disruption of the manufacture of the drug.,2023-06-23,2023-09-20,No
196203,02519879,Shortage,CAPECITABINE,JAMP PHARMA CORPORATION,Capecitabine Tablets,CAPECITABINE,150MG,6x10,ORAL,Resolved,TABLET,,2023-06-20,,2023-09-26,Disruption of the manufacture of the drug.,2023-06-23,2023-09-27,No
196206,02519887,Shortage,CAPECITABINE,JAMP PHARMA CORPORATION,Capecitabine Tablets,CAPECITABINE,500MG,120,ORAL,Resolved,TABLET,,2023-06-20,,2023-09-19,Disruption of the manufacture of the drug.,2023-06-23,2023-09-20,No
196216,02519887,Shortage,CAPECITABINE,JAMP PHARMA CORPORATION,Capecitabine Tablets,CAPECITABINE,500MG,12x10,ORAL,Resolved,TABLET,,2023-06-20,,2023-09-26,Disruption of the manufacture of the drug.,2023-06-23,2023-09-27,No
182714,02378582,Shortage,CAPRELSA,"SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC",CAPRELSA 100 mg,VANDETANIB,100MG,3,ORAL; ORAL,Resolved,TABLET,2023-02-06,,2023-02-17,2023-02-07,Other (Please describe in comments),2023-01-30,2023-02-08,No
206942,02489244,Shortage,CARBETOCIN INJECTION,JUNO PHARMACEUTICALS CORP.,Carbetocin Injection,CARBETOCIN,100MCG,5 pre-filled syringes (1 mL) per carton,INTRAVENOUS; INTRAVENOUS,Actual shortage,SOLUTION,2023-11-01,,2024-05-31,,Demand increase for the drug.,2023-10-13,2024-03-01,No
192969,02241999,Shortage,CARBOCAINE 1%,PFIZER CANADA ULC,CARBOCAINE 1%,MEPIVACAINE HYDROCHLORIDE,10MG,10 x 30mL vial,EPIDURAL; INTRACAUDAL; INTRACAUDAL; EPIDURAL,Resolved,SOLUTION,,2023-05-24,,2023-06-05,Disruption of the manufacture of the drug.,2023-05-24,2023-06-06,No
212587,00236683,Shortage,CARBOLITH,"BAUSCH HEALTH, CANADA INC.",CARBOLITH,LITHIUM CARBONATE,300MG,100's,ORAL; ORAL,Avoided shortage,CAPSULE,2024-01-08,,2024-01-22,2023-12-19,Other (Please describe in comments),2023-12-06,2023-12-20,No
201480,02126680,Shortage,CARBOPLATIN INJECTION BP,PFIZER CANADA ULC,CARBOPLATIN,CARBOPLATIN,10MG,1 x 1 vial,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-08-25,,2023-10-18,Disruption of the manufacture of the drug.,2023-08-09,2023-10-19,No
204867,02126680,Shortage,CARBOPLATIN INJECTION BP,PFIZER CANADA ULC,CARBOPLATIN INJECTION BP,CARBOPLATIN,10MG,60mL vial,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-09-20,,2023-10-04,Disruption of the manufacture of the drug.,2023-09-20,2023-10-05,No
187124,02126680,Shortage,CARBOPLATIN INJECTION BP,PFIZER CANADA ULC,CARBOPLATIN INJECTION BP,CARBOPLATIN,10MG,60mL vial,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-03-29,,2023-05-16,Disruption of the manufacture of the drug.,2023-03-15,2023-05-17,No
212548,02460947,Shortage,CASPOFUNGIN FOR INJECTION,JUNO PHARMACEUTICALS CORP.,CASPOFUNGIN FOR INJECTION,CASPOFUNGIN,50MG,1 X 50 MG,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION,2023-12-06,2023-12-06,2024-01-31,2024-01-17,Demand increase for the drug.,2023-12-06,2024-01-18,No
201029,02486989,Shortage,CASPOFUNGIN FOR INJECTION,FRESENIUS KABI CANADA LTD,CASPOFUNGIN FOR INJECTION,CASPOFUNGIN,50MG,10 mL,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION,,2023-08-01,2024-02-29,2024-02-29,Disruption of the manufacture of the drug.,2023-08-03,2024-03-01,No
212553,02460955,Shortage,CASPOFUNGIN FOR INJECTION,JUNO PHARMACEUTICALS CORP.,CASPOFUNGIN FOR INJECTION,CASPOFUNGIN,70MG,1 X 70 MG,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION,2023-12-06,2023-12-06,2024-01-31,2024-01-17,Demand increase for the drug.,2023-12-06,2024-01-18,No
195853,02108127,Shortage,CEFAZOLIN FOR INJECTION,TEVA CANADA LIMITED,CEFAZOLIN FOR INJECTION,CEFAZOLIN,1G,10,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,,2023-06-19,2023-08-31,2023-07-05,Disruption of the manufacture of the drug.,2023-06-20,2023-07-06,No
190779,02108127,Shortage,CEFAZOLIN FOR INJECTION,TEVA CANADA LIMITED,CEFAZOLIN SODIUM INJ 1 GRAM PK 10,CEFAZOLIN,1G,10,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,,2023-04-27,2023-08-20,2023-08-03,Disruption of the manufacture of the drug.,2023-04-27,2023-08-04,No
182608,02437120,Shortage,CEFAZOLIN FOR INJECTION,STERIMAX INC,CEFAZOLIN FOR INJECTION,CEFAZOLIN,10G,10 VIALS,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION,2023-01-31,,2023-06-30,2023-06-30,Delay in shipping of the drug.,2023-01-27,2023-07-06,No
183209,02437112,Shortage,CEFAZOLIN FOR INJECTION,STERIMAX INC,CEFAZOLIN FOR INJECTION,CEFAZOLIN,1G,25 VIALS,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,2023-02-03,,2023-05-05,2023-05-05,Delay in shipping of the drug.,2023-02-02,2023-05-08,No
191391,02308967,Shortage,CEFAZOLIN FOR INJECTION USP,SANDOZ CANADA INCORPORATED,CEFAZOLIN,CEFAZOLIN,10G,1PSOIJ,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,,2023-05-01,2023-06-30,2023-07-04,Disruption of the manufacture of the drug.,2023-05-01,2023-07-05,No
197055,02308932,Shortage,CEFAZOLIN FOR INJECTION USP,SANDOZ CANADA INCORPORATED,CEFAZOLIN,CEFAZOLIN,500MG,10PSOIJ,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,,2023-07-04,2024-01-19,2024-01-08,Demand increase for the drug.,2023-07-04,2024-01-09,No
188643,02308959,Shortage,CEFAZOLIN FOR INJECTION USP,SANDOZ CANADA INCORPORATED,CEFAZOLIN FOR INJECTION USP,CEFAZOLIN,1G,10PSOIJ,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,,2023-04-04,2023-06-30,2023-07-04,Requirements related to complying with good manufacturing practices.,2023-04-04,2023-07-05,No
182605,02437848,Shortage,CEFTAZIDIME FOR INJECTION BP,STERIMAX INC,CEFTAZIDIME FOR INJECTION BP,CEFTAZIDIME,1G,10 VIALS,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,2023-01-31,,2023-03-31,2023-02-13,Delay in shipping of the drug.,2023-01-27,2023-02-14,No
188239,02250292,Shortage,CEFTRIAXONE SODIUM FOR INJECTION BP,PFIZER CANADA ULC,CEFTRIAXONE SODIUM FOR INJECTION BP,CEFTRIAXONE,1G,10 x 1g vial,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,,2023-04-01,,2023-07-10,Disruption of the manufacture of the drug.,2023-03-29,2023-07-11,No
195408,02292262,Shortage,CEFTRIAXONE SODIUM FOR INJECTION BP,SANDOZ CANADA INCORPORATED,CEFTRIAXONE SODIUM,CEFTRIAXONE,250MG,10PSOIJ,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,,2023-06-19,2023-08-04,2023-07-17,Demand increase for the drug.,2023-06-19,2023-07-18,No
208527,02292262,Shortage,CEFTRIAXONE SODIUM FOR INJECTION BP,SANDOZ CANADA INCORPORATED,CEFTRIAXONE SODIUM,CEFTRIAXONE,250MG,10PSOIJ,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,,2023-10-30,2024-01-12,2024-01-08,Demand increase for the drug.,2023-10-30,2024-01-09,No
188648,02292262,Shortage,CEFTRIAXONE SODIUM FOR INJECTION BP,SANDOZ CANADA INCORPORATED,CEFTRIAXONE SODIUM FOR INJECTION BP,CEFTRIAXONE,250MG,10PSOIJ,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,,2023-04-04,2023-04-21,2023-04-11,Delay in shipping of the drug.,2023-04-04,2023-04-12,No
182289,00028096,Shortage,CELESTONE SOLUSPAN,ORGANON CANADA INC.,BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE SUSPENSION USP GLUCOCORTICOID,BETAMETHASONE; BETAMETHASONE ACETATE,3MG; 3MG,1ML VIAL,INTRAMUSCULAR; INTRADERMAL; INTRABURSAL; INTRA-ARTICULAR; INTRAMUSCULAR; INTRADERMAL; INTRABURSAL; INTRA-ARTICULAR,Resolved,SUSPENSION,2023-03-31,2023-03-15,2023-11-24,2023-11-20,Disruption of the manufacture of the drug.,2023-01-25,2023-11-21,No
182292,00028096,Shortage,CELESTONE SOLUSPAN,ORGANON CANADA INC.,BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE SUSPENSION USP GLUCOCORTICOID,BETAMETHASONE; BETAMETHASONE ACETATE,3MG; 3MG,5ML VIAL,INTRAMUSCULAR; INTRADERMAL; INTRABURSAL; INTRA-ARTICULAR; INTRAMUSCULAR; INTRADERMAL; INTRABURSAL; INTRA-ARTICULAR,Resolved,SUSPENSION,2023-04-21,2023-03-29,2023-11-17,2023-11-15,Disruption of the manufacture of the drug.,2023-01-25,2023-11-16,No
211633,00028096,Shortage,CELESTONE SOLUSPAN,ORGANON CANADA INC.,BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE SUSPENSION USP GLUCOCORTICOID,BETAMETHASONE; BETAMETHASONE ACETATE,3MG; 3MG,1ML VIAL,INTRAMUSCULAR; INTRADERMAL; INTRABURSAL; INTRA-ARTICULAR; INTRAMUSCULAR; INTRADERMAL; INTRABURSAL; INTRA-ARTICULAR,Actual shortage,SUSPENSION,2023-11-27,2023-11-27,2024-05-03,,Delay in shipping of the drug.,2023-11-27,2024-04-09,No
213243,00028096,Shortage,CELESTONE SOLUSPAN,ORGANON CANADA INC.,BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE SUSPENSION USP GLUCOCORTICOID,BETAMETHASONE; BETAMETHASONE ACETATE,3MG; 3MG,5ML,INTRAMUSCULAR; INTRADERMAL; INTRABURSAL; INTRA-ARTICULAR; INTRAMUSCULAR; INTRADERMAL; INTRABURSAL; INTRA-ARTICULAR,Resolved,SUSPENSION,,2023-12-13,2024-02-02,2024-02-01,Demand increase for the drug.,2023-12-13,2024-02-02,No
198742,02521253,Shortage,CEPHALEXIN,SANIS HEALTH INC,CEPHALEXIN,CEPHALEXIN,250MG,100,ORAL,Resolved,TABLET,,2023-07-14,2024-03-09,2024-03-07,Disruption of the manufacture of the drug.,2023-07-14,2024-03-08,No
198745,02521261,Shortage,CEPHALEXIN,SANIS HEALTH INC,CEPHALEXIN,CEPHALEXIN,500MG,100,ORAL,Resolved,TABLET,,2023-07-18,2023-12-13,2023-12-13,Disruption of the manufacture of the drug.,2023-07-14,2023-12-26,No
189469,02230988,Shortage,CEREBYX,SEARCHLIGHT PHARMA INC,Cerebyx 5x2ml,FOSPHENYTOIN SODIUM,75MG,5x2ml,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION; LIQUID,2023-04-21,,2023-12-01,2023-12-01,Disruption of the manufacture of the drug.,2023-04-12,2023-12-02,No
187772,02230988,Shortage,CEREBYX,SEARCHLIGHT PHARMA INC,Cerebyx,FOSPHENYTOIN SODIUM,75MG,10ml,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION; LIQUID,,2023-03-20,2023-04-15,2023-04-13,Delay in shipping of the drug.,2023-03-23,2023-04-14,No
213247,02230988,Shortage,CEREBYX,SEARCHLIGHT PHARMA INC,Cerebyx 10ml,FOSPHENYTOIN SODIUM,75MG,1x10ml,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION; LIQUID,,2023-12-13,2024-01-31,2024-01-30,Demand increase for the drug.,2023-12-13,2024-01-31,No
193088,02312263,Shortage,CESAMET,"BAUSCH HEALTH, CANADA INC.",CESAMET,NABILONE,0.25MG,n/a,ORAL; ORAL,Resolved,CAPSULE,2023-07-04,,2023-07-07,2023-07-09,Other (Please describe in comments),2023-05-25,2023-07-10,No
207328,02517566,Shortage,CETIRIZINE EXTRA STRENGTH,JAMP PHARMA CORPORATION,Cetirizine Hydrochloride Tablets USP,CETIRIZINE HYDROCHLORIDE,10MG,100,ORAL,Resolved,TABLET; CAPSULE,,2023-10-16,2023-12-31,2024-01-03,Disruption of the manufacture of the drug.,2023-10-19,2024-01-04,No
185263,02247621,Shortage,CHLORAL HYDRATE SYRUP ODAN,ODAN LABORATORIES LTD,Chloral Hydrate Oral Solution,CHLORAL HYDRATE,500MG,500 mL,ORAL; ORAL,Resolved,SYRUP,,2023-02-21,2023-03-31,2023-03-24,Disruption of the manufacture of the drug.,2023-02-21,2023-03-27,No
196092,02484374,Shortage,CHLORAPREP,BECTON DICKINSON CANADA INC.,CHLORAPREP,ISOPROPYL ALCOHOL; CHLORHEXIDINE GLUCONATE,70%; 2%,"1mL Applicator: 1 shelf pack = 60EA, 1 case = 240EA, 1.5 mL Applicator: 1 shelf back = 20EA, 1 case = 500EA",TOPICAL; TOPICAL,Resolved,SOLUTION,2023-07-01,,,2024-03-20,Demand increase for the drug.,2023-06-22,2024-03-21,No
196649,02160757,Shortage,CHLORAPREP ONE-STEP,CAREFUSION CANADA ULC,"CHLORAPREP ONE-STEP, SWABSTICK 2%, CHP-SINGLE CANADA",ISOPROPYL ALCOHOL; CHLORHEXIDINE GLUCONATE,70%; 2%,ONE-STEP SINGLE  SWABSTICK,TOPICAL; TOPICAL,Resolved,SOLUTION,2023-07-01,,,2024-03-20,Demand increase for the drug.,2023-06-27,2024-03-21,No
202731,00522996,Shortage,CHLORDIAZEPOXIDE,AA PHARMA INC,Chlordiazepoxide,CHLORDIAZEPOXIDE HYDROCHLORIDE,25MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE,,2023-08-15,,2023-09-13,Shortage of an inactive ingredient or component.,2023-08-23,2023-09-14,No
202738,00522988,Shortage,CHLORDIAZEPOXIDE,AA PHARMA INC,Chlordiazepoxide,CHLORDIAZEPOXIDE HYDROCHLORIDE,10MG,100 BTL,ORAL; ORAL,Actual shortage,CAPSULE,,2023-08-15,,,Disruption of the manufacture of the drug.,2023-08-23,2023-08-23,No
202741,00522724,Shortage,CHLORDIAZEPOXIDE,AA PHARMA INC,Chlordiazepoxide,CHLORDIAZEPOXIDE HYDROCHLORIDE,5MG,100 BTL,ORAL; ORAL,Actual shortage,CAPSULE,,2023-08-15,,,Disruption of the manufacture of the drug.,2023-08-23,2023-08-23,No
204546,02455609,Shortage,CHOLESTYRAMINE-ODAN,ODAN LABORATORIES LTD,"Cholestyramine for Oral Suspension, USP",CHOLESTYRAMINE RESIN,4G,30 sachets,ORAL; ORAL,Actual shortage,POWDER FOR SUSPENSION,,2023-09-18,,,Demand increase for the drug.,2023-09-15,2024-01-30,Yes
180743,02237514,Shortage,CIPRO ORAL SUSPENSION,BAYER INC,Ciprofloxacin Suspension,CIPROFLOXACIN,500MG,100 mL,ORAL; ORAL,Avoided shortage,SUSPENSION,2023-03-06,,2023-03-10,2023-03-03,Other (Please describe in comments),2023-01-12,2023-03-06,No
211200,02353326,Shortage,CIPROFLOXACIN,SANIS HEALTH INC,CIPROFLOXACIN,CIPROFLOXACIN,500MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-02-27,2024-05-01,,Disruption of the manufacture of the drug.,2023-11-22,2024-03-31,No
211197,02353318,Shortage,CIPROFLOXACIN,SANIS HEALTH INC,CIPROFLOXACIN,CIPROFLOXACIN,250MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-10-11,2024-05-01,,Disruption of the manufacture of the drug.,2023-11-22,2024-03-31,No
202569,02408813,Shortage,CISATRACURIUM OMEGA MULTIDOSE,OMEGA LABORATORIES LIMITED,Cisatracurium Besylate Injection,CISATRACURIUM,2MG,10 x 10mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-10-11,2023-12-15,2023-12-07,Disruption of the manufacture of the drug.,2023-08-21,2023-12-08,No
213113,02408813,Shortage,CISATRACURIUM OMEGA MULTIDOSE,OMEGA LABORATORIES LIMITED,Cisatracurium Besylate Injection,CISATRACURIUM,2MG,10 x 10mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-12-12,2024-05-15,2024-04-01,Demand increase for the drug.,2023-12-12,2024-04-02,Yes
195121,02403188,Shortage,CISPLATIN INJECTION,TEVA CANADA LIMITED,CISPLATIN INJECTION,CISPLATIN,1.0MG,50ML,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-06-16,2023-08-10,2023-08-17,Disruption of the manufacture of the drug.,2023-06-16,2023-08-18,No
190671,02403188,Shortage,CISPLATIN INJECTION,TEVA CANADA LIMITED,CISPLATIN INJECTION 1MG/ML 50ML,CISPLATIN,1.0MG,50ml,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-04-27,2023-08-30,2023-06-08,Disruption of the manufacture of the drug.,2023-04-27,2023-06-09,No
183756,02430568,Shortage,CITALOPRAM,JAMP PHARMA CORPORATION,Citalopram hydrobromide,CITALOPRAM,40MG,3x10,ORAL; ORAL,Resolved,TABLET,,2023-02-06,2023-04-10,2023-03-31,Disruption of the manufacture of the drug.,2023-02-06,2023-04-03,No
212507,02319918,Shortage,CLADRIBINE INJECTION,FRESENIUS KABI CANADA LTD,CLADRIBINE INJECTION,CLADRIBINE,1MG,10 mL,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2024-01-01,2024-01-01,2024-04-14,2024-04-05,Disruption of the manufacture of the drug.,2023-12-05,2024-04-06,No
180938,02238829,Shortage,CLAVULIN 875,GLAXOSMITHKLINE INC,amoxicillin / clavulanate potassium tablets,CLAVULANIC ACID; AMOXICILLIN,125MG; 875MG,20s,ORAL; ORAL,Resolved,TABLET,,2023-01-13,2023-03-31,2023-03-10,Demand increase for the drug.,2023-01-13,2023-03-11,No
203402,02247499,Shortage,CLIMARA 25,BAYER INC,ESTRADIOL,ESTRADIOL,25MCG,4's,TRANSDERMAL; TRANSDERMAL,Resolved,PATCH,,2023-08-30,2023-12-13,2023-11-10,Other (Please describe in comments),2023-08-31,2023-11-11,No
188064,02231509,Shortage,CLIMARA 50,BAYER INC,ESTRADIOL,ESTRADIOL,50MCG,4's,TRANSDERMAL; TRANSDERMAL,Resolved,PATCH,2023-05-01,2023-04-18,2023-08-11,2023-08-14,Other (Please describe in comments),2023-03-27,2023-08-15,No
203740,02231509,Shortage,CLIMARA 50,BAYER INC,ESTRADIOL,ESTRADIOL,50MCG,4's,TRANSDERMAL; TRANSDERMAL,Resolved,PATCH,2023-11-15,2023-10-12,2023-12-13,2023-11-10,Other (Please describe in comments),2023-09-06,2023-11-11,No
203406,02247500,Shortage,CLIMARA 75,BAYER INC,ESTRADIOL,ESTRADIOL,75MCG,4's,TRANSDERMAL; TRANSDERMAL,Resolved,PATCH,,2023-08-30,2023-12-13,2023-11-10,Other (Please describe in comments),2023-08-31,2023-11-11,No
183714,02485478,Shortage,CLINDAMYCIN INJECTION IN 5% DEXTROSE,BAXTER CORPORATION,CLINDAMYCIN INJECTION IN 5% DEXTROSE,CLINDAMYCIN,600MG,50mL,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2023-06-10,2023-06-10,2023-10-31,2023-10-31,Shortage of an active ingredient.,2023-02-06,2023-11-01,No
183717,02485486,Shortage,CLINDAMYCIN INJECTION IN 5% DEXTROSE,BAXTER CORPORATION,CLINDAMYCIN INJECTION IN 5% DEXTROSE,CLINDAMYCIN,900MG,50mL,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2023-04-27,2023-04-27,2023-10-31,2023-10-31,Shortage of an active ingredient.,2023-02-06,2023-11-01,No
200512,02230540,Shortage,CLINDAMYCIN INJECTION USP,SANDOZ CANADA INCORPORATED,CLINDAMYCIN,CLINDAMYCIN,150MG,6ML 10LIVI V2,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-07-31,2023-08-18,2023-08-21,Disruption of the manufacture of the drug.,2023-07-31,2023-08-22,No
200525,02230540,Shortage,CLINDAMYCIN INJECTION USP,SANDOZ CANADA INCORPORATED,CLINDAMYCIN,CLINDAMYCIN,150MG,4ML 10LIVI,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-07-31,2023-08-11,2023-08-14,Disruption of the manufacture of the drug.,2023-07-31,2023-08-15,No
186218,02230540,Shortage,CLINDAMYCIN INJECTION USP,SANDOZ CANADA INCORPORATED,CLINDAMYCIN,CLINDAMYCIN,150MG,6ML 10LIVI,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-03-03,2023-05-19,2023-05-01,Disruption of the manufacture of the drug.,2023-03-06,2023-05-03,No
186246,02230535,Shortage,CLINDAMYCIN INJECTION USP,SANDOZ CANADA INCORPORATED,CLINDAMYCIN,CLINDAMYCIN,150MG,60ML,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-03-06,2023-05-19,2023-05-08,Requirements related to complying with good manufacturing practices.,2023-03-06,2023-05-09,No
181671,02230540,Shortage,CLINDAMYCIN INJECTION USP,SANDOZ CANADA INCORPORATED,CLINDAMYCIN,CLINDAMYCIN,150MG,2ML 10LIVI,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-01-18,2023-05-19,2023-05-22,Shortage of an inactive ingredient or component.,2023-01-19,2023-05-25,No
181674,02230540,Shortage,CLINDAMYCIN INJECTION USP,SANDOZ CANADA INCORPORATED,CLINDAMYCIN,CLINDAMYCIN,150MG,6ML,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-01-18,2023-02-10,2023-01-31,Shortage of an inactive ingredient or component.,2023-01-19,2023-02-01,No
205789,02230535,Shortage,CLINDAMYCIN INJECTION USP,SANDOZ CANADA INCORPORATED,Clindamycin,CLINDAMYCIN,150MG,60ml,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-10-02,2024-02-02,2024-01-23,Requirements related to complying with good manufacturing practices.,2023-10-02,2024-01-24,No
182824,02408511,Shortage,CLINDAMYCIN IV INFUSION,SANDOZ CANADA INCORPORATED,CLINDAMYCIN,CLINDAMYCIN,12MG,1ML,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-01-31,,2023-10-26,Requirements related to complying with good manufacturing practices.,2023-01-31,2023-10-27,No
182829,02408538,Shortage,CLINDAMYCIN IV INFUSION,SANDOZ CANADA INCORPORATED,CLINDAMYCIN,CLINDAMYCIN,18MG,1ML 10LIF,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-01-31,2023-09-22,2023-09-25,Requirements related to complying with good manufacturing practices.,2023-01-31,2023-09-26,No
200495,02408511,Shortage,CLINDAMYCIN IV INFUSION,SANDOZ CANADA INCORPORATED,CLINDAMYCIN,CLINDAMYCIN,12MG,10LIIF,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-07-31,2024-01-26,2024-01-31,Disruption of the manufacture of the drug.,2023-07-31,2024-02-01,No
200926,02382822,Shortage,CLINDOXYL ADV GEL,GLAXOSMITHKLINE INC,clindamycin and benzoyl peroxide gel,CLINDAMYCIN; BENZOYL PEROXIDE,1%; 3%,45G,TOPICAL; TOPICAL,Resolved,GEL,,2023-08-02,2024-03-15,2024-02-15,Demand increase for the drug.,2023-08-03,2024-02-16,No
193899,02243158,Shortage,CLINDOXYL GEL,GLAXOSMITHKLINE INC,clindamycin and benzoyl peroxide gel,CLINDAMYCIN; BENZOYL PEROXIDE,1%; 5%,45G,TOPICAL; TOPICAL,Resolved,GEL,,2023-06-05,2023-07-15,2023-06-16,Demand increase for the drug.,2023-06-08,2023-06-17,No
196974,02243158,Shortage,CLINDOXYL GEL,GLAXOSMITHKLINE INC,clindamycin and benzoyl peroxide gel,CLINDAMYCIN; BENZOYL PEROXIDE,1%; 5%,45G,TOPICAL; TOPICAL,Resolved,GEL,,2023-06-28,2023-09-29,2023-08-28,Demand increase for the drug.,2023-06-30,2023-08-30,No
203953,02243158,Shortage,CLINDOXYL GEL,GLAXOSMITHKLINE INC,clindamycin and benzoyl peroxide gel,CLINDAMYCIN; BENZOYL PEROXIDE,1%; 5%,45G,TOPICAL; TOPICAL,Resolved,GEL,,2023-09-06,2024-03-15,2024-03-12,Demand increase for the drug.,2023-09-08,2024-03-13,No
187295,02400553,Shortage,CLOPIDOGREL,SANIS HEALTH INC,CLOPIDOGREL,CLOPIDOGREL,75MG,500,ORAL; ORAL,Resolved,TABLET,2023-05-30,,,2024-03-01,Disruption of the manufacture of the drug.,2023-03-16,2024-03-02,No
205192,00812382,Shortage,CLOTRIMADERM TOPICAL,TARO PHARMACEUTICALS INC,CLOTRIMADERM,CLOTRIMAZOLE,1%,30,TOPICAL; TOPICAL,Resolved,CREAM,,2023-09-22,2023-11-17,2023-09-28,Disruption of the manufacture of the drug.,2023-09-25,2024-01-05,No
180420,00812366,Shortage,CLOTRIMADERM VAGINAL 6,TARO PHARMACEUTICALS INC,CLOTRIMAZOLE,CLOTRIMAZOLE,1%,50,VAGINAL; VAGINAL,Resolved,CREAM,,2022-12-14,2023-02-24,2023-02-22,Disruption of the manufacture of the drug.,2023-01-10,2023-02-28,No
204793,00812366,Shortage,CLOTRIMADERM VAGINAL 6,TARO PHARMACEUTICALS INC,CLOTRIMADERM,CLOTRIMAZOLE,1%,50g,VAGINAL; VAGINAL,Resolved,CREAM,,2023-07-20,2023-11-17,2023-10-30,Disruption of the manufacture of the drug.,2023-09-20,2024-01-05,No
184496,02163748,Shortage,CODEINE CONTIN 100MG CONTROLLED RELEASE TAB,PURDUE PHARMA,Codeine Controlled Release Tablets,CODEINE,100MG,60,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),2023-02-13,2023-02-13,2023-06-16,2023-06-09,Delay in shipping of the drug.,2023-02-13,2023-06-10,No
188181,02163780,Shortage,CODEINE CONTIN 150MG CONTROLLED RELEASE TAB,PURDUE PHARMA,Codeine Controlled Release Tablets,CODEINE,150MG,60,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),2023-03-28,2023-03-28,2023-07-07,2023-06-20,Delay in shipping of the drug.,2023-03-28,2023-06-21,No
200267,02230302,Shortage,CODEINE CONTIN 50MG CONTROLLED RELEASE TAB,PURDUE PHARMA,Codeine Controlled Release Tablets,CODEINE,50MG,60,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),2023-07-27,2023-07-27,2023-09-15,2023-09-08,Delay in shipping of the drug.,2023-07-27,2023-09-09,No
192720,02230302,Shortage,CODEINE CONTIN 50MG CONTROLLED RELEASE TAB,PURDUE PHARMA,Codeine Controlled Release Tablets,CODEINE,50MG,60,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),2023-05-18,2023-05-18,2023-06-16,2023-06-09,Delay in shipping of the drug.,2023-05-18,2023-06-10,No
208850,02230302,Shortage,CODEINE CONTIN 50MG CONTROLLED RELEASE TAB,PURDUE PHARMA,Codeine Controlled Release Tablets,CODEINE,50MG,60,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),2023-11-01,2023-11-01,2024-01-05,2024-01-04,Demand increase for the drug.,2023-11-01,2024-01-05,No
191596,02132680,Shortage,COLESTID TABLETS,PFIZER CANADA ULC,COLESTID 1G,COLESTIPOL HYDROCHLORIDE,1G,120's TAB,ORAL; ORAL,Resolved,TABLET,2023-05-05,2023-05-08,2024-01-10,2024-01-10,Disruption of the manufacture of the drug.,2023-05-03,2024-01-11,No
203963,02417170,Shortage,CONSTELLA,ABBVIE CORPORATION,Constella 290mg,LINACLOTIDE,290MCG,30 capsules bottle,ORAL; ORAL,Resolved,CAPSULE,,2023-09-08,2023-09-29,2023-09-21,Delay in shipping of the drug.,2023-09-08,2023-09-22,No
193091,00280437,Shortage,CORTISONE ACETATE,"BAUSCH HEALTH, CANADA INC.",CORTISONE ACETATE,CORTISONE ACETATE,25MG,100s,ORAL; ORAL,Avoided shortage,TABLET,2023-06-16,,2023-06-19,2023-06-13,Other (Please describe in comments),2023-05-25,2023-06-15,No
205939,02240113,Shortage,COSOPT,ELVIUM LIFE SCIENCES,Dorzolamide and Timolol Ophthalmic Solution,TIMOLOL; DORZOLAMIDE,5MG; 20MG,10ml,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,2023-10-03,2023-10-03,2023-10-27,2023-10-25,Delay in shipping of the drug.,2023-10-03,2023-10-26,No
188222,02258692,Shortage,COSOPT PRESERVATIVE-FREE,ELVIUM LIFE SCIENCES,Dorzolamide and Timolol Ophthalmic Solution,TIMOLOL; DORZOLAMIDE,5MG; 20MG,0.2ml,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,2023-03-29,2023-03-29,2023-04-22,2023-04-18,Delay in shipping of the drug.,2023-03-29,2023-04-19,No
182432,02258692,Shortage,COSOPT PRESERVATIVE-FREE,ELVIUM LIFE SCIENCES,Dorzolamide and Timolol Ophthalmic Solution,TIMOLOL; DORZOLAMIDE,5MG; 20MG,60,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,2023-01-26,2023-01-26,2023-03-17,2023-03-16,Delay in shipping of the drug.,2023-01-26,2023-03-17,No
191137,02258692,Shortage,COSOPT PRESERVATIVE-FREE,ELVIUM LIFE SCIENCES,Dorzolamide and Timolol Ophthalmic Solution. Cosopt UD 2% 0.2mL 60 Pipettes,TIMOLOL; DORZOLAMIDE,5MG; 20MG,.2ml,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,2023-04-28,2023-04-28,2023-05-26,2023-05-25,Delay in shipping of the drug.,2023-04-28,2023-05-26,No
179950,02258692,Shortage,COSOPT PRESERVATIVE-FREE,ELVIUM LIFE SCIENCES,Dorzolamide and Timolol Ophthalmic Solution,TIMOLOL; DORZOLAMIDE,5MG; 20MG,.2ml,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,2023-01-05,2023-01-05,2023-01-27,2023-01-25,Delay in shipping of the drug.,2023-01-05,2023-01-26,No
186649,00263818,Shortage,COTAZYM,ORGANON CANADA INC.,PANCRELIPASE CAPSULES,PROTEASE; AMYLASE; LIPASE,35000UNIT; 40000UNIT; 10000UNIT,100,ORAL; ORAL,Resolved,CAPSULE (IMMEDIATE RELEASE),2023-03-20,2023-03-16,2023-05-05,2023-05-03,Delay in shipping of the drug.,2023-03-10,2023-05-04,No
197801,00263818,Shortage,COTAZYM,ORGANON CANADA INC.,PANCRELIPASE CAPSULES,PROTEASE; AMYLASE; LIPASE,35000UNIT; 40000UNIT; 10000UNIT,100,ORAL; ORAL,Resolved,CAPSULE (IMMEDIATE RELEASE),,2023-07-07,2023-09-08,2023-08-25,Delay in shipping of the drug.,2023-07-07,2023-08-26,No
192694,00263818,Shortage,COTAZYM,ORGANON CANADA INC.,PANCRELIPASE CAPSULES,PROTEASE; AMYLASE; LIPASE,35000UNIT; 40000UNIT; 10000UNIT,100,ORAL; ORAL,Resolved,CAPSULE (IMMEDIATE RELEASE),2023-05-29,2023-05-18,2023-06-16,2023-06-09,Delay in shipping of the drug.,2023-05-18,2023-06-10,No
203960,00263818,Shortage,COTAZYM,ORGANON CANADA INC.,PANCRELIPASE CAPSULES,PROTEASE; AMYLASE; LIPASE,35000UNIT; 40000UNIT; 10000UNIT,100,ORAL; ORAL,Resolved,CAPSULE (IMMEDIATE RELEASE),2023-09-18,2023-09-13,2023-10-30,2023-10-27,Delay in shipping of the drug.,2023-09-08,2023-10-28,No
210882,00263818,Shortage,COTAZYM,ORGANON CANADA INC.,PANCRELIPASE CAPSULES,PROTEASE; AMYLASE; LIPASE,35000UNIT; 40000UNIT; 10000UNIT,100,ORAL; ORAL,Resolved,CAPSULE (IMMEDIATE RELEASE),,2023-11-17,2023-12-01,2023-11-30,Delay in shipping of the drug.,2023-11-20,2023-12-01,No
181463,00263818,Shortage,COTAZYM,ORGANON CANADA INC.,PANCRELIPASE CAPSULES,PROTEASE; AMYLASE; LIPASE,35000UNIT; 40000UNIT; 10000UNIT,100,ORAL; ORAL,Resolved,CAPSULE (IMMEDIATE RELEASE),,2023-01-18,2023-02-17,2023-02-13,Delay in shipping of the drug.,2023-01-18,2023-02-14,No
179772,00821373,Shortage,COTAZYM ECS 20,ORGANON CANADA INC.,PANCRELIPASE DELAYED-RELEASE CAPSULES,PROTEASE; AMYLASE; LIPASE,100000UNIT; 100000UNIT; 25000UNIT,100,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-01-03,2023-03-31,2023-03-31,Delay in shipping of the drug.,2023-01-04,2023-04-01,No
191163,00821373,Shortage,COTAZYM ECS 20,ORGANON CANADA INC.,PANCRELIPASE DELAYED-RELEASE CAPSULES,PROTEASE; AMYLASE; LIPASE,100000UNIT; 100000UNIT; 25000UNIT,100,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-04-26,2023-05-12,2023-05-12,Delay in shipping of the drug.,2023-04-28,2023-05-13,No
192697,00502790,Shortage,COTAZYM ECS 8,ORGANON CANADA INC.,PANCRELIPASE DELAYED-RELEASE CAPSULES,PROTEASE; AMYLASE; LIPASE,45000UNIT; 42000UNIT; 10800UNIT,500,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),2023-06-04,2023-05-25,2023-06-23,2023-06-09,Delay in shipping of the drug.,2023-05-18,2023-06-10,No
182256,00502790,Shortage,COTAZYM ECS 8,ORGANON CANADA INC.,PANCRELIPASE DELAYED-RELEASE CAPSULES,PROTEASE; AMYLASE; LIPASE,45000UNIT; 42000UNIT; 10800UNIT,500,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-01-24,2023-04-21,2023-04-21,Delay in shipping of the drug.,2023-01-24,2023-04-22,No
209503,02246624,Shortage,COVERSYL,SERVIER CANADA INC,Perindopril Erbumine,PERINDOPRIL ERBUMINE,8MG,100's,ORAL; ORAL,Resolved,TABLET,,2023-11-07,2023-11-30,2023-11-21,Delay in shipping of the drug.,2023-11-07,2023-11-22,No
184472,02246624,Shortage,COVERSYL,SERVIER CANADA INC,Perindopril Erbumine,PERINDOPRIL ERBUMINE,8MG,100,ORAL; ORAL,Resolved,TABLET,2023-02-14,,2023-02-24,2023-02-16,Delay in shipping of the drug.,2023-02-13,2023-02-17,No
213729,02246624,Shortage,COVERSYL,SERVIER CANADA INC,Perindopril Erbumine,PERINDOPRIL ERBUMINE,8MG,30's,ORAL; ORAL,Resolved,TABLET,,2023-12-18,2024-01-08,2023-12-30,Delay in shipping of the drug.,2023-12-18,2023-12-31,No
198211,02321653,Shortage,COVERSYL PLUS HD,SERVIER CANADA INC,Perindopril Erbumine+Indapamide,INDAPAMIDE; PERINDOPRIL ERBUMINE,2.5MG; 8MG,30's,ORAL; ORAL,Resolved,TABLET,,2023-07-05,2023-08-23,2023-08-22,Delay in shipping of the drug.,2023-07-11,2023-08-23,No
205207,02321653,Shortage,COVERSYL PLUS HD,SERVIER CANADA INC,Perindopril Erbumine+Indapamide,INDAPAMIDE; PERINDOPRIL ERBUMINE,2.5MG; 8MG,30's,ORAL; ORAL,Resolved,TABLET,,2023-09-13,2023-10-13,2023-09-28,Other (Please describe in comments),2023-09-26,2023-09-29,No
189916,02321653,Shortage,COVERSYL PLUS HD,SERVIER CANADA INC,Perindopril Erbumine+Indapamide,INDAPAMIDE; PERINDOPRIL ERBUMINE,2.5MG; 8MG,30's,ORAL; ORAL,Avoided shortage,TABLET,2023-04-24,,2023-05-10,2023-04-21,Delay in shipping of the drug.,2023-04-20,2023-04-24,No
200377,02182874,Shortage,COZAAR,ORGANON CANADA INC.,losartan potassium tablets,LOSARTAN POTASSIUM,50MG,30,ORAL; ORAL,Resolved,TABLET,,2023-07-26,2023-07-28,2023-07-28,Delay in shipping of the drug.,2023-07-28,2023-07-31,No
205876,01985205,Shortage,CREON MINIMICROSPHERES 25,BGP PHARMA ULC,CREON MINIMICROSPHERES 25,PROTEASE; AMYLASE; LIPASE,1600UNIT; 25500UNIT; 25000UNIT,25,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-09-28,2023-11-21,2023-11-21,Disruption of the manufacture of the drug.,2023-10-03,2023-11-29,No
196713,01985205,Shortage,CREON MINIMICROSPHERES 25,BGP PHARMA ULC,CREON MINIMICROSPHERES 25,PROTEASE; AMYLASE; LIPASE,1600UNIT; 25500UNIT; 25000UNIT,25,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-06-26,2023-07-15,2023-07-14,Other (Please describe in comments),2023-06-27,2023-08-16,No
192959,01985205,Shortage,CREON MINIMICROSPHERES 25,BGP PHARMA ULC,CREON MINIMICROSPHERES MICRO,PROTEASE; AMYLASE; LIPASE,1600UNIT; 25500UNIT; 25000UNIT,25,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-05-23,2023-06-13,2023-06-09,Other (Please describe in comments),2023-05-24,2023-06-13,No
188613,01985205,Shortage,CREON MINIMICROSPHERES 25,BGP PHARMA ULC,CREON MINIMICROSPHERES 25,PROTEASE; AMYLASE; LIPASE,1600UNIT; 25500UNIT; 25000UNIT,100,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-03-31,2023-04-24,2023-04-26,Other (Please describe in comments),2023-04-04,2023-05-01,No
201970,01985205,Shortage,CREON MINIMICROSPHERES 25,BGP PHARMA ULC,PROTEASE AMYLASE LIPASE,PROTEASE; AMYLASE; LIPASE,1600UNIT; 25500UNIT; 25000UNIT,25,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),2023-08-16,2023-08-17,2023-09-25,2023-09-22,Other (Please describe in comments),2023-08-16,2023-09-26,No
213742,02494639,Shortage,CREON MINIMICROSPHERES 35,BGP PHARMA ULC,PROTEASE AMYLASE LIPASE,PROTEASE; AMYLASE; LIPASE,2240UNIT; 35700UNIT; 35000UNIT,100 BT,ORAL,Resolved,CAPSULE (DELAYED RELEASE); CAPSULE,,2023-12-08,2024-01-19,2024-01-15,Demand increase for the drug.,2023-12-19,2024-01-22,No
184582,02445158,Shortage,CREON MINIMICROSPHERES MICRO,BGP PHARMA ULC,CREON MINIMICROSPHERES MICRO,PROTEASE; AMYLASE; LIPASE,320UNIT; 5100UNIT; 5000UNIT,20G,ORAL; ORAL,Resolved,"GRANULES FOR SUSPENSION, DELAYED RELEASE",2023-02-23,2023-02-21,2023-03-14,2023-03-14,Disruption of the manufacture of the drug.,2023-02-14,2023-03-20,No
213745,02445158,Shortage,CREON MINIMICROSPHERES MICRO,BGP PHARMA ULC,PROTEASE AMYLASE LIPASE,PROTEASE; AMYLASE; LIPASE,320UNIT; 5100UNIT; 5000UNIT,20 G,ORAL; ORAL,Resolved,"GRANULES FOR SUSPENSION, DELAYED RELEASE",,2023-12-15,2024-03-05,2024-02-22,Demand increase for the drug.,2023-12-19,2024-04-03,No
206596,00016055,Shortage,CUPRIMINE,"BAUSCH HEALTH, CANADA INC.",CUPRIMINE,PENICILLAMINE,250MG,n/a,ORAL; ORAL,Resolved,CAPSULE,2023-12-01,2023-12-04,2023-12-11,2023-12-11,Other (Please describe in comments),2023-10-06,2023-12-15,No
186886,00016055,Shortage,CUPRIMINE,"BAUSCH HEALTH, CANADA INC.",CUPRIMINE,PENICILLAMINE,250MG,250,ORAL; ORAL,Avoided shortage,CAPSULE,2023-04-03,,2023-04-28,2022-03-21,Other (Please describe in comments),2023-03-13,2023-03-23,No
192293,00016055,Shortage,CUPRIMINE,"BAUSCH HEALTH, CANADA INC.",CUPRIMINE,PENICILLAMINE,250MG,n/a,ORAL; ORAL,Resolved,CAPSULE,2023-06-16,2023-06-13,2023-07-09,2023-07-09,Other (Please describe in comments),2023-05-11,2023-07-10,No
200983,02463393,Shortage,CYANOCOBALAMIN INJECTION USP,HIKMA CANADA LIMITED,CYANOCOBALAMIN INJECTION USP,VITAMIN B12,1000MCG,1mL,SUBCUTANEOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAMUSCULAR,Resolved,SOLUTION; LIQUID,2023-09-01,,2023-11-30,2023-12-14,Disruption of the manufacture of the drug.,2023-08-03,2023-12-15,No
186103,01987003,Shortage,CYANOCOBALAMIN INJECTION USP,STERIMAX INC,CYANOCOBALAMIN INJECTION USP,VITAMIN B12,1000MCG,1 VIAL 10 ML,SUBCUTANEOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-03-03,2023-03-13,2023-03-27,Delay in shipping of the drug.,2023-03-03,2023-03-29,No
212036,02064413,Shortage,CYKLOKAPRON 100 MG/ML,PFIZER CANADA ULC,TRANEXAMIC ACID,TRANEXAMIC ACID,100MG,10 x 10mL amp,INTRAVENOUS; INTRAVENOUS,Actual shortage,SOLUTION,,2023-12-01,2024-05-29,,Disruption of the manufacture of the drug.,2023-11-30,2024-01-19,No
181402,02301490,Shortage,CYMBALTA,ELI LILLY CANADA INC,Duloxetine hydrochloride delayed release capsules,DULOXETINE,60MG,Carton containing 28 capsules in blister packaging,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-01-18,2023-02-22,2023-02-21,Delay in shipping of the drug.,2023-01-18,2023-02-22,No
198134,00397466,Shortage,CYSTO-CONRAY II,LIEBEL-FLARSHEIM COMPANY LLC,Iothalamate Meglumine Injection 17.2% w/v,IOTHALAMATE MEGLUMINE,172MG,250 mL,URETHRAL; URETHRAL,Actual shortage,SOLUTION,2023-08-05,,,,Disruption of the manufacture of the drug.,2023-07-11,2023-08-06,No
185788,02231962,Shortage,CYTOGAM,KI BIOPHARMA LLC,CYTOMEGALOVIRUS IMMUNE GLOBULIN (HUMAN),CYTOMEGALOVIRUS IMMUNOLOBULIN,2500MG,50 ML,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2023-06-15,,2024-01-15,2023-12-07,Other (Please describe in comments),2023-03-01,2023-12-10,No
180924,01919466,Shortage,CYTOMEL,PFIZER CANADA ULC,Cytomel,LIOTHYRONINE,25MCG,100's,ORAL; ORAL,Resolved,TABLET,2023-01-27,2023-01-26,2023-05-31,2023-05-26,Disruption of the manufacture of the drug.,2023-01-12,2023-05-30,No
184528,02162695,Shortage,CYTOVENE,CHEPLAPHARM ARZNEIMITTEL GMBH,ganciclovir for injection,GANCICLOVIR,500MG,500 mg/vial,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION,,2023-02-14,2024-03-31,2024-03-13,Disruption of the manufacture of the drug.,2023-02-14,2024-03-14,No
192273,00260436,Shortage,DALACIN C PHOSPHATE,PFIZER CANADA ULC,Clindamycin solution,CLINDAMYCIN,150MG,1 x 60mL vial,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-05-11,,2023-10-05,Disruption of the manufacture of the drug.,2023-05-11,2023-10-06,No
197701,00260436,Shortage,DALACIN C PHOSPHATE,PFIZER CANADA ULC,Clindamycin,CLINDAMYCIN,150MG,25 x 2mL,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-07-20,,2023-09-15,Disruption of the manufacture of the drug.,2023-07-06,2023-09-18,No
194917,01997572,Shortage,DANTRIUM INTRAVENOUS,"ENDO PAR INNOVATION COMPANY, LLC",DANTROLENE SODIUM,DANTROLENE SODIUM,20MG,6x 20mg,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION,,2023-06-12,2023-07-21,2023-07-24,Delay in shipping of the drug.,2023-06-14,2023-07-28,No
193379,02490838,Shortage,DAPTOMYCIN FOR INJECTION,SANDOZ CANADA INCORPORATED,DAPTOMYCIN,DAPTOMYCIN,500MG,LYVI,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,,2023-05-30,2023-06-23,2023-06-27,Disruption of the manufacture of the drug.,2023-05-30,2023-06-28,No
210841,02490838,Shortage,DAPTOMYCIN FOR INJECTION,SANDOZ CANADA INCORPORATED,DAPTOMYCIN,DAPTOMYCIN,500MG,LYVI,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,,2023-11-20,2023-11-24,2023-11-27,Disruption of the manufacture of the drug.,2023-11-20,2023-11-28,No
207820,02494590,Shortage,DAPTOMYCIN FOR INJECTION,ACCORD HEALTHCARE INC,DAPTOMYCIN,DAPTOMYCIN,500MG,1,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,,2023-10-23,,,Disruption of the manufacture of the drug.,2023-10-23,2023-10-24,No
212030,02247022,Shortage,DEFEROXAMINE MESYLATE FOR INJECTION,PFIZER CANADA ULC,DEFEROXAMINE MESYLATE FOR INJECTION,DEFEROXAMINE MESYLATE,2G,2g vial,SUBCUTANEOUS; INTRAVENOUS; INTRAPERITONEAL; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAPERITONEAL; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,,2024-03-04,,2024-04-17,Disruption of the manufacture of the drug.,2023-11-30,2024-04-18,No
188236,02241600,Shortage,DEFEROXAMINE MESYLATE FOR INJECTION,PFIZER CANADA ULC,DEFEROXAMINE MESYLATE FOR INJECTION,DEFEROXAMINE MESYLATE,500MG,10 x 500mg vial,SUBCUTANEOUS; INTRAVENOUS; INTRAPERITONEAL; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAPERITONEAL; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,,2023-05-24,,2023-08-18,Disruption of the manufacture of the drug.,2023-03-29,2023-08-21,No
205404,00029246,Shortage,DELATESTRYL,"BAUSCH HEALTH, CANADA INC.",DELATESTRYL,TESTOSTERONE ENANTHATE,200MG,200mg,INTRAMUSCULAR; INTRAMUSCULAR,Resolved,SOLUTION,,2023-09-26,2023-10-24,2023-10-23,Delay in shipping of the drug.,2023-09-28,2023-10-26,No
191622,00029246,Shortage,DELATESTRYL,"BAUSCH HEALTH, CANADA INC.",DELATESTRYL,TESTOSTERONE ENANTHATE,200MG,n/a,INTRAMUSCULAR; INTRAMUSCULAR,Resolved,SOLUTION,,2023-05-04,2023-06-07,2023-05-30,Demand increase for the drug.,2023-05-04,2023-05-31,No
181436,00029246,Shortage,DELATESTRYL,"BAUSCH HEALTH, CANADA INC.",DELATESTRYL,TESTOSTERONE ENANTHATE,200MG,5ml,INTRAMUSCULAR; INTRAMUSCULAR,Resolved,SOLUTION,,2023-01-20,2023-04-28,2023-04-21,Demand increase for the drug.,2023-01-18,2023-04-22,No
181316,00443832,Shortage,DEPAKENE,BGP PHARMA ULC,VALPROIC ACID,VALPROIC ACID,250MG,240ML,ORAL; ORAL,Resolved,SOLUTION; SOLUTION,2023-01-24,2023-01-27,2023-03-28,2023-03-28,Disruption of the manufacture of the drug.,2023-01-17,2023-04-04,No
201955,00030767,Shortage,DEPO-MEDROL 80 MG/ML,PFIZER CANADA ULC,DEPO-MEDROL 80 MG/ML,METHYLPREDNISOLONE ACETATE,80MG,5x1ML,INTRASYNOVIAL; INTRAMUSCULAR; INTRALESIONAL; INTRA-ARTICULAR; INTRASYNOVIAL; INTRAMUSCULAR; INTRALESIONAL; INTRA-ARTICULAR,Resolved,SUSPENSION,,2023-08-16,,2023-09-11,Disruption of the manufacture of the drug.,2023-08-16,2023-09-13,No
199303,00030783,Shortage,DEPO-TESTOSTERONE INJ 100MG/ML,PFIZER CANADA ULC,Testosterone,TESTOSTERONE CYPIONATE,100MG,10 mL,INTRAMUSCULAR; INTRAMUSCULAR,Resolved,SOLUTION,2023-08-15,,,2023-08-25,Disruption of the manufacture of the drug.,2023-07-20,2023-08-26,No
191074,01981242,Shortage,DESFERAL 500MG,NOVARTIS PHARMACEUTICALS CANADA INC,DESFERAL 500MG,DEFEROXAMINE MESYLATE,500MG,1 X 10,SUBCUTANEOUS; INTRAVENOUS; INTRAPERITONEAL; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAPERITONEAL; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,2023-05-15,,2023-09-18,2023-09-29,Demand increase for the drug.,2023-04-28,2023-10-04,No
204811,02239065,Shortage,DETROL,BGP PHARMA ULC,TOLTERODINE TARTRATE,TOLTERODINE TARTRATE,2MG,1x60 BTL,ORAL; ORAL,Actual shortage,TABLET,,2023-02-06,2024-05-28,,Disruption of the manufacture of the drug.,2023-09-20,2024-03-25,No
184454,02023865,Shortage,DEXAMETHASONE,PHARMA STULLN INC.,Dexamethasone,DEXAMETHASONE SODIUM PHOSPHATE,0.10%,Dexamethasone 0.1% 5ml bottle,OTIC; OPHTHALMIC; OTIC; OPHTHALMIC,Resolved,SOLUTION; SOLUTION,2023-02-13,2023-02-13,2023-05-30,2023-07-06,Delay in shipping of the drug.,2023-02-13,2023-07-07,No
187964,02387743,Shortage,DEXAMETHASONE OMEGA UNIDOSE,OMEGA LABORATORIES LIMITED,Dexamethasone Sodium Phosphate Injection USP,DEXAMETHASONE PHOSPHATE,10MG,10 x 1 mL vial / fiole,INTRAVENOUS; INTRASYNOVIAL; INTRAMUSCULAR; INTRAVENOUS; INTRASYNOVIAL; INTRAMUSCULAR,Resolved,SOLUTION,,2023-03-29,,2023-03-30,Demand increase for the drug.,2023-03-24,2023-03-31,No
182149,02387743,Shortage,DEXAMETHASONE OMEGA UNIDOSE,OMEGA LABORATORIES LIMITED,"DEXAMETHASONE, 10 MG/ML (10 MG/1 ML), INJ, PRESERVATIVE FREE",DEXAMETHASONE PHOSPHATE,10MG,10 x 1 mL Vial/ Fiole,INTRAVENOUS; INTRASYNOVIAL; INTRAMUSCULAR; INTRAVENOUS; INTRASYNOVIAL; INTRAMUSCULAR,Resolved,SOLUTION,,2023-01-27,2023-02-10,2023-02-10,Demand increase for the drug.,2023-01-20,2023-02-11,No
197961,00874582,Shortage,DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP,SANDOZ CANADA INCORPORATED,DEXAMETHASONE,DEXAMETHASONE,10MG,1ML 10LIVI,INTRAVENOUS; INTRASYNOVIAL; INTRAMUSCULAR; INTRAVENOUS; INTRASYNOVIAL; INTRAMUSCULAR,Resolved,LIQUID,,2023-07-10,2023-08-25,2023-08-07,Demand increase for the drug.,2023-07-10,2023-08-08,No
205147,00874582,Shortage,DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP,SANDOZ CANADA INCORPORATED,DEXAMETHASONE,DEXAMETHASONE,10MG,1ML,INTRAVENOUS; INTRASYNOVIAL; INTRAMUSCULAR; INTRAVENOUS; INTRASYNOVIAL; INTRAMUSCULAR,Resolved,LIQUID,,2023-09-25,2023-10-27,2023-10-30,Disruption of the manufacture of the drug.,2023-09-25,2023-10-31,No
186053,00874582,Shortage,DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP,SANDOZ CANADA INCORPORATED,DEXAMETHASONE,DEXAMETHASONE,10MG,1ML,INTRAVENOUS; INTRASYNOVIAL; INTRAMUSCULAR; INTRAVENOUS; INTRASYNOVIAL; INTRAMUSCULAR,Resolved,LIQUID,,2023-02-17,2023-06-30,2023-05-01,Disruption of the manufacture of the drug.,2023-03-02,2023-05-03,No
191996,00874582,Shortage,DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP,SANDOZ CANADA INCORPORATED,DEXAMETHASONE,DEXAMETHASONE,10MG,1ML,INTRAVENOUS; INTRASYNOVIAL; INTRAMUSCULAR; INTRAVENOUS; INTRASYNOVIAL; INTRAMUSCULAR,Resolved,LIQUID,,2023-05-08,2023-07-07,2023-05-30,Demand increase for the drug.,2023-05-08,2023-05-31,No
184624,00664227,Shortage,DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML,SANDOZ CANADA INCORPORATED,DEXAMETHASONE,DEXAMETHASONE PHOSPHATE,4MG,5ML,INTRAVENOUS; INTRASYNOVIAL; INTRAMUSCULAR; INTRAVENOUS; INTRASYNOVIAL; INTRAMUSCULAR,Resolved,SOLUTION,,2023-02-14,2023-06-02,2023-04-11,Disruption of the manufacture of the drug.,2023-02-14,2023-04-12,No
193383,00664227,Shortage,DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML,SANDOZ CANADA INCORPORATED,DEXAMETHASONE,DEXAMETHASONE PHOSPHATE,4MG,5ML,INTRAVENOUS; INTRASYNOVIAL; INTRAMUSCULAR; INTRAVENOUS; INTRASYNOVIAL; INTRAMUSCULAR,Resolved,SOLUTION,,2023-05-30,2023-07-07,2023-06-27,Disruption of the manufacture of the drug.,2023-05-30,2023-06-28,No
185091,02204266,Shortage,DEXAMETHASONE-OMEGA,OMEGA LABORATORIES LIMITED,Dexamethasone Sodium Phosphate Injection USP,DEXAMETHASONE PHOSPHATE,4MG,10 x 1 mL vial / fiole,SOFT TISSUE INJECTION; INTRAVENOUS; INTRAMUSCULAR; INTRALESIONAL; INTRA-ARTICULAR; SOFT TISSUE INJECTION; INTRAVENOUS; INTRAMUSCULAR; INTRALESIONAL; INTRA-ARTICULAR,Resolved,LIQUID,,2023-03-02,2023-03-18,2023-03-16,Demand increase for the drug.,2023-02-17,2023-03-17,No
185098,02204266,Shortage,DEXAMETHASONE-OMEGA,OMEGA LABORATORIES LIMITED,Dexamethasone Sodium Phosphate Injection USP,DEXAMETHASONE PHOSPHATE,4MG,10 x 25 mL vial / fiole,SOFT TISSUE INJECTION; INTRAVENOUS; INTRAMUSCULAR; INTRALESIONAL; INTRA-ARTICULAR; SOFT TISSUE INJECTION; INTRAVENOUS; INTRAMUSCULAR; INTRALESIONAL; INTRA-ARTICULAR,Resolved,LIQUID,2023-03-03,2023-03-03,2023-03-11,2023-03-07,Demand increase for the drug.,2023-02-17,2023-03-08,No
211728,02204274,Shortage,DEXAMETHASONE-OMEGA,OMEGA LABORATORIES LIMITED,Dexamethasone Sodium Phosphate Injection USP,DEXAMETHASONE PHOSPHATE,10MG,1 x 10mL vial / fiole,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-12-19,2024-01-12,2024-01-05,Disruption of the manufacture of the drug.,2023-11-28,2024-01-06,No
209449,02204266,Shortage,DEXAMETHASONE-OMEGA,OMEGA LABORATORIES LIMITED,Dexamethasone Sodium Phosphate Injection USP,DEXAMETHASONE PHOSPHATE,4MG,10 x 1mL vial/fiole,SOFT TISSUE INJECTION; INTRAVENOUS; INTRAMUSCULAR; INTRALESIONAL; INTRA-ARTICULAR; SOFT TISSUE INJECTION; INTRAVENOUS; INTRAMUSCULAR; INTRALESIONAL; INTRA-ARTICULAR,Resolved,LIQUID,,2023-11-28,,2024-02-27,Disruption of the manufacture of the drug.,2023-11-06,2024-02-28,No
188481,02204274,Shortage,DEXAMETHASONE-OMEGA,OMEGA LABORATORIES LIMITED,Dexamethasone Sodium Phosphate Injection USP,DEXAMETHASONE PHOSPHATE,10MG,1 x 10mL vial / fiole,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-04-11,2023-05-19,2023-05-18,Demand increase for the drug.,2023-03-31,2023-05-19,No
194664,02204266,Shortage,DEXAMETHASONE-OMEGA,OMEGA LABORATORIES LIMITED,Dexamethasone Sodium Phosphate Injection USP,DEXAMETHASONE PHOSPHATE,4MG,10 x 1 mL vial / fiole,SOFT TISSUE INJECTION; INTRAVENOUS; INTRAMUSCULAR; INTRALESIONAL; INTRA-ARTICULAR; SOFT TISSUE INJECTION; INTRAVENOUS; INTRAMUSCULAR; INTRALESIONAL; INTRA-ARTICULAR,Resolved,LIQUID,,2023-06-09,,2023-06-19,Demand increase for the drug.,2023-06-09,2023-06-20,No
190160,02204266,Shortage,DEXAMETHASONE-OMEGA,OMEGA LABORATORIES LIMITED,Dexamethasone Sodium Phosphate Injection USP,DEXAMETHASONE PHOSPHATE,4MG,10 x 1 mL vial / fiole,SOFT TISSUE INJECTION; INTRAVENOUS; INTRAMUSCULAR; INTRALESIONAL; INTRA-ARTICULAR; SOFT TISSUE INJECTION; INTRAVENOUS; INTRAMUSCULAR; INTRALESIONAL; INTRA-ARTICULAR,Resolved,LIQUID,,2023-04-28,2023-05-26,2023-05-18,Demand increase for the drug.,2023-04-21,2023-05-19,No
190168,02204274,Shortage,DEXAMETHASONE-OMEGA,OMEGA LABORATORIES LIMITED,Dexamethasone Sodium Phosphate Injection USP,DEXAMETHASONE PHOSPHATE,10MG,10 x 1 mL vial / fiole,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,2023-04-21,2023-04-28,2023-10-13,2023-10-11,Disruption of the manufacture of the drug.,2023-04-21,2023-10-12,No
181744,01924567,Shortage,DEXEDRINE SPANSULE SRC 15MG,PALADIN LABS INC.,DEXTROAMPHETAMINE SULFATE,DEXTROAMPHETAMINE SULFATE,15MG,100 Capsules,ORAL; ORAL,Resolved,CAPSULE (SUSTAINED-RELEASE),2023-01-19,2023-01-19,2023-03-28,2023-03-24,Demand increase for the drug.,2023-01-19,2023-03-25,No
206945,02487365,Shortage,DEXMEDETOMIDINE HYDROCHLORIDE INJECTION,JUNO PHARMACEUTICALS CORP.,DEXMEDETOMIDINE HYDROCHLORIDE INJECTION,DEXMEDETOMIDINE,200MCG,50 ML (20 SINGLE USE VIALS PER CARTON),INTRAVENOUS,Resolved,SOLUTION,2023-10-16,,2023-10-31,2023-10-31,Delay in shipping of the drug.,2023-10-13,2023-11-01,No
206948,02487373,Shortage,DEXMEDETOMIDINE HYDROCHLORIDE INJECTION,JUNO PHARMACEUTICALS CORP.,DEXMEDETOMIDINE HYDROCHLORIDE INJECTION,DEXMEDETOMIDINE,400MCG,100 ML (10 SINGLE USE VIALS PER CARTON),INTRAVENOUS,Resolved,SOLUTION,2023-10-16,,2023-10-31,2023-10-31,Delay in shipping of the drug.,2023-10-13,2023-11-01,No
201593,02487365,Shortage,DEXMEDETOMIDINE HYDROCHLORIDE INJECTION,JUNO PHARMACEUTICALS CORP.,DEXMEDETOMIDINE HYDROCHLORIDE INJECTION 4 MCG/ML,DEXMEDETOMIDINE,200MCG,50 ML (20 SINGLE USE VIALS PER CARTON),INTRAVENOUS,Resolved,SOLUTION,2023-08-11,2023-08-11,2023-10-31,2023-08-24,Disruption of the manufacture of the drug.,2023-08-11,2023-09-05,No
192661,00060747,Shortage,DEXTROSE 5% AND 0.9% SOD CHLORIDE INJ,BAXTER CORPORATION,% Dextrose and 0.9% Sodium Chloride Injection,SODIUM CHLORIDE; DEXTROSE,900MG; 5G,1000 mL - JB1064,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,2023-05-17,2023-05-17,2023-06-05,2023-05-25,Disruption of the manufacture of the drug.,2023-05-17,2023-05-26,No
184314,00060747,Shortage,DEXTROSE 5% AND 0.9% SOD CHLORIDE INJ,BAXTER CORPORATION,DEXTROSE 5% AND 0.9% SOD CHLORIDE INJ,SODIUM CHLORIDE; DEXTROSE,900MG; 5G,500 ML,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,2023-02-10,2023-02-10,2023-03-15,2023-03-15,Disruption of the manufacture of the drug.,2023-02-10,2023-03-16,No
182591,02517132,Shortage,DEXTROSE INJECTION,OMEGA LABORATORIES LIMITED,Dextrose Injection,DEXTROSE,50%,10 x 50 mL vial / fiole,INTRAVENOUS,Resolved,SOLUTION,,2023-01-30,,2023-04-27,Demand increase for the drug.,2023-01-27,2023-04-28,No
192884,02517132,Shortage,DEXTROSE INJECTION,OMEGA LABORATORIES LIMITED,Dextrose Injection,DEXTROSE,50%,10 x 50 mL vial / fiole,INTRAVENOUS,Resolved,SOLUTION,,2023-05-26,2023-07-25,2023-07-20,Demand increase for the drug.,2023-05-19,2023-07-21,No
201190,02517132,Shortage,DEXTROSE INJECTION,OMEGA LABORATORIES LIMITED,Dextrose Injection,DEXTROSE,50%,10 x 50mL vial / fiole,INTRAVENOUS,Resolved,SOLUTION,,2023-08-07,2024-05-01,2024-03-21,Demand increase for the drug.,2023-08-04,2024-03-22,Yes
193864,00037915,Shortage,DEXTROSE INJECTION USP,ICU MEDICAL CANADA INC,Dextrose Injection USP,DEXTROSE,50MG,500 mL,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-05-30,2023-07-24,2023-07-25,Disruption of the manufacture of the drug.,2023-06-07,2023-08-01,No
200792,02468514,Shortage,DEXTROSE INJECTION USP,PFIZER CANADA ULC,DEXTROSE INJECTION USP,DEXTROSE,500MG,10 x 50ml ANSYR syringe,INTRAVENOUS,Actual shortage,SOLUTION,,2023-08-03,,,Disruption of the manufacture of the drug.,2023-08-03,2023-09-05,Yes
190311,02468514,Shortage,DEXTROSE INJECTION USP,PFIZER CANADA ULC,DEXTROSE INJECTION USP,DEXTROSE,500MG,25 x 50mL vial,INTRAVENOUS,Actual shortage,SOLUTION,,2023-04-26,,,Disruption of the manufacture of the drug.,2023-04-26,2023-09-05,Yes
203374,00037966,Shortage,DEXTROSE INJECTION USP,ICU MEDICAL CANADA INC,Dextrose Injection USP,DEXTROSE,200MG,500 mL in 1000 mL Container,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-06-27,,2023-11-01,Disruption of the manufacture of the drug.,2023-08-31,2023-11-02,No
203389,00037974,Shortage,DEXTROSE INJECTION USP,ICU MEDICAL CANADA INC,Dextrose Injection USP,DEXTROSE,500MG,500 mL,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-08-21,,2023-11-01,Disruption of the manufacture of the drug.,2023-08-31,2023-11-02,No
179912,02468514,Shortage,DEXTROSE INJECTION USP,PFIZER CANADA ULC,DEXTROSE INJECTION USP,DEXTROSE,500MG,25 x 50mL vials,INTRAVENOUS,Resolved,SOLUTION,,2023-01-05,,2023-01-20,Disruption of the manufacture of the drug.,2023-01-05,2023-01-21,No
192972,02468514,Shortage,DEXTROSE INJECTION USP,PFIZER CANADA ULC,DEXTROSE INJECTION USP,DEXTROSE,500MG,10 x 50mL LifeShield syringe,INTRAVENOUS,Actual shortage,SOLUTION,,2023-06-19,,,Disruption of the manufacture of the drug.,2023-05-24,2023-09-05,Yes
201529,02238162,Shortage,DIASTAT,"BAUSCH HEALTH, CANADA INC.",DIASTAT,DIAZEPAM,5MG,2pk,RECTAL; RECTAL,Resolved,GEL,,2023-07-28,2024-01-19,2024-01-17,Other (Please describe in comments),2023-08-09,2024-01-18,No
193094,02519070,Shortage,DIASTAT,"BAUSCH HEALTH, CANADA INC.",DIASTAT,DIAZEPAM,10MG,n/a,RECTAL,Resolved,GEL,2023-06-26,,2024-01-19,2024-01-17,Other (Please describe in comments),2023-05-25,2024-01-18,No
198997,02230684,Shortage,DICETEL,BGP PHARMA ULC,PINAVERIUM BROMIDE,PINAVERIUM BROMIDE,100MG,5x20 CA,ORAL; ORAL,Resolved,TABLET,2023-09-27,2023-09-25,2024-04-02,2024-04-03,Disruption of the manufacture of the drug.,2023-07-18,2024-04-09,No
192637,02475065,Shortage,DICLOFENAC,PHARMA STULLN INC.,Diclofenac Sodium Ophthalmic Solution,DICLOFENAC SODIUM,0.10%,Diclofenac 0.1% Box 50xUD 0.3ml (PF),OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,2023-05-01,2023-05-01,2023-08-30,2023-09-09,Delay in shipping of the drug.,2023-05-17,2023-09-14,No
192243,02361043,Shortage,DIGIFAB,BTG INTERNATIONAL INC,Digoxin Immune Fab (ovine),DIGOXIN IMMUNE FAB,40MG,One vial,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION,,2023-05-10,2024-01-12,2024-01-12,Demand increase for the drug.,2023-05-11,2024-01-16,No
203106,00022772,Shortage,DILANTIN,BGP PHARMA ULC,PHENYTOIN SODIUM,PHENYTOIN SODIUM,30MG,100 CA,ORAL; ORAL,Resolved,CAPSULE,2023-09-27,2023-09-26,,2023-10-20,Disruption of the manufacture of the drug.,2023-08-29,2023-10-25,No
204814,00023698,Shortage,DILANTIN INFATABS,BGP PHARMA ULC,PHENYTOIN,PHENYTOIN,50MG,100BT,ORAL; ORAL,Resolved,TABLET (CHEWABLE); TABLET,,2023-08-30,2023-10-03,2023-10-03,Disruption of the manufacture of the drug.,2023-09-20,2023-10-11,No
181283,00023698,Shortage,DILANTIN INFATABS,UPJOHN CANADA ULC,DILANTIN INFATABS,PHENYTOIN,50MG,100,ORAL; ORAL,Resolved,TABLET,,2023-01-11,2023-05-16,2023-05-09,Demand increase for the drug.,2023-01-17,2023-05-25,No
184549,00023698,Shortage,DILANTIN INFATABS,UPJOHN CANADA ULC,DILANTIN INFATABS,PHENYTOIN,50MG,100,ORAL; ORAL,Resolved,TABLET,,2022-12-22,2023-05-09,2022-12-22,Demand increase for the drug.,2023-02-14,2023-03-20,No
193001,00023698,Shortage,DILANTIN INFATABS,UPJOHN CANADA ULC,DILANTIN INFATABS,PHENYTOIN,50MG,100,ORAL; ORAL,Resolved,TABLET,2023-05-31,2023-05-29,,2023-07-20,Demand increase for the drug.,2023-05-25,2023-08-16,No
184279,00786543,Shortage,DILAUDID,PURDUE PHARMA,Hydromorphone hydrochloride,HYDROMORPHONE HYDROCHLORIDE,8MG,100,ORAL; ORAL,Resolved,TABLET,2023-02-09,2023-02-09,2023-03-24,2023-03-24,Delay in shipping of the drug.,2023-02-09,2023-03-27,No
186152,02244728,Shortage,DILTIAZEM HYDROCHLORIDE INJECTION,SANDOZ CANADA INCORPORATED,DILTIAZEM,DILTIAZEM HYDROCHLORIDE,5MG,10ML,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-02-24,2023-05-05,2023-04-11,Shortage of an inactive ingredient or component.,2023-03-03,2023-04-12,No
187972,02514095,Shortage,DILTIAZEM HYDROCHLORIDE INJECTION,OMEGA LABORATORIES LIMITED,Diltiazem Hydrochloride Injection,DILTIAZEM HYDROCHLORIDE,5MG,10 x 5 mL vial / fiole,INTRAVENOUS,Resolved,SOLUTION,,2023-03-29,2023-04-07,2023-03-31,Demand increase for the drug.,2023-03-24,2023-04-01,No
189684,02514095,Shortage,DILTIAZEM HYDROCHLORIDE INJECTION,OMEGA LABORATORIES LIMITED,Diltiazem Hydrochloride Injection,DILTIAZEM HYDROCHLORIDE,5MG,10 x 10 mL vial / fiole,INTRAVENOUS,Resolved,SOLUTION,,2023-05-26,,2023-09-01,Disruption of the manufacture of the drug.,2023-04-14,2023-09-02,No
212442,00392731,Shortage,DIMENHYDRINATE INJECTION USP,SANDOZ CANADA INCORPORATED,DIMENHYDRINATE,DIMENHYDRINATE,10MG,10LIVI,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION; LIQUID,,2023-12-04,2023-12-22,2023-12-22,Disruption of the manufacture of the drug.,2023-12-04,2024-01-03,No
210671,02428954,Shortage,DIMENHYDRINATE INJECTION USP,HIKMA CANADA LIMITED,DIMENHYDRINATE INJECTION USP,DIMENHYDRINATE,50MG,1mL,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Actual shortage,SOLUTION,2023-12-15,,2024-04-01,,Disruption of the manufacture of the drug.,2023-11-17,2023-12-16,No
188443,02063808,Shortage,DIPENTUM,ATNAHS PHARMA UK LIMITED,Dipentum,OLSALAZINE SODIUM,250MG,100,ORAL; ORAL,Actual shortage,CAPSULE,2022-07-05,,2024-11-30,,Other (Please describe in comments),2023-03-31,2023-11-30,No
199211,02063808,Shortage,DIPENTUM,ATNAHS PHARMA UK LIMITED,Dipentum,OLSALAZINE SODIUM,250MG,100,ORAL; ORAL,Actual shortage,CAPSULE,,2022-11-05,2024-11-30,,Other (Please describe in comments),2023-07-19,2023-11-30,No
193760,02063808,Shortage,DIPENTUM,ATNAHS PHARMA UK LIMITED,Dipentum,OLSALAZINE SODIUM,250MG,100,ORAL; ORAL,Resolved,CAPSULE,2022-08-20,2022-08-20,2024-01-10,2023-11-24,Other (Please describe in comments),2023-06-05,2023-11-25,No
191388,00596612,Shortage,DIPHENHYDRAMINE HYDROCHLORIDE INJECTION USP,SANDOZ CANADA INCORPORATED,DIPHENHYDRAMINE HCL,DIPHENHYDRAMINE HYDROCHLORIDE,50MG,1ML 10LIVI,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-05-01,2023-09-22,2023-09-19,Disruption of the manufacture of the drug.,2023-05-01,2023-09-20,No
181679,00596612,Shortage,DIPHENHYDRAMINE HYDROCHLORIDE INJECTION USP,SANDOZ CANADA INCORPORATED,DIPHENHYDRAMINE,DIPHENHYDRAMINE HYDROCHLORIDE,50MG,1ML,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-01-18,2023-03-17,2023-02-08,Disruption of the manufacture of the drug.,2023-01-19,2023-02-09,No
199745,02219336,Shortage,DIPHENIST 50MG/ML,OMEGA LABORATORIES LIMITED,Diphenhydramine Hydrochloride Injection USP,DIPHENHYDRAMINE HYDROCHLORIDE,50MG,10 x 1 mL vial / fiole,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-07-21,2023-08-31,2023-08-31,Demand increase for the drug.,2023-07-21,2023-09-01,No
183620,02219336,Shortage,DIPHENIST 50MG/ML,OMEGA LABORATORIES LIMITED,Diphenhydramine Hydrochloride Injection USP,DIPHENHYDRAMINE HYDROCHLORIDE,50MG,10 x 1 mL vial / fiole,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-02-03,2023-03-21,2023-03-17,Demand increase for the drug.,2023-02-03,2023-03-18,No
210021,00417246,Shortage,DIPROSONE,ORGANON CANADA INC.,betamethasone dipropionate lotion,BETAMETHASONE,0.05%,75,TOPICAL; TOPICAL,Resolved,LOTION,2023-12-04,2023-11-30,2023-12-15,2023-12-15,Delay in shipping of the drug.,2023-11-13,2023-12-16,No
193649,02244475,Shortage,"DIPYRIDAMOLE INJECTION, USP",FRESENIUS KABI CANADA LTD,"DIPYRIDAMOLE INJECTION, USP",DIPYRIDAMOLE,5MG,10 mL,INTRAVENOUS; INTRAVENOUS,Actual shortage,LIQUID,2023-07-01,2023-08-23,2024-06-30,,Disruption of the manufacture of the drug.,2023-06-02,2024-03-28,Yes
190144,02242010,Shortage,DOBUTAMINE INJECTION USP,SANDOZ CANADA INCORPORATED,DOBUTAMINE INJECTION USP,DOBUTAMINE,12.5MG,20ML,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,,2023-04-21,2023-07-07,2023-07-04,Disruption of the manufacture of the drug.,2023-04-21,2023-07-05,No
200032,02410397,Shortage,DOXORUBICIN,PFIZER CANADA ULC,DOXORUBICIN,DOXORUBICIN HYDROCHLORIDE,2MG,25mL vial,INTRAVESICAL; INTRAVENOUS; INTRAVESICAL; INTRAVENOUS,Resolved,SOLUTION,,2023-09-01,,2023-09-11,Disruption of the manufacture of the drug.,2023-07-26,2023-09-12,No
199246,02194465,Shortage,DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP,PFIZER CANADA ULC,DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP,DOXORUBICIN HYDROCHLORIDE,50MG,25mL vial,INTRAVESICAL; INTRAVENOUS; INTRAVESICAL; INTRAVENOUS,Resolved,POWDER FOR SOLUTION,2023-08-31,,,2023-09-11,Disruption of the manufacture of the drug.,2023-07-20,2023-09-14,No
195219,02409275,Shortage,DOXORUBICIN HYDROCHLORIDE INJECTION,TEVA CANADA LIMITED,DOXORUBICIN HYDROCHLORIDE INJECTION,DOXORUBICIN HYDROCHLORIDE,2MG,5ML,INTRAVESICAL; INTRAVENOUS; INTRAVESICAL; INTRAVENOUS,Resolved,SOLUTION,,2023-06-16,2023-12-20,2023-07-04,Disruption of the manufacture of the drug.,2023-06-16,2023-07-05,No
180891,02409275,Shortage,DOXORUBICIN HYDROCHLORIDE INJECTION,TEVA CANADA LIMITED,DOXORUBICIN INJ 10MG/5ML,DOXORUBICIN HYDROCHLORIDE,2MG,5ml,INTRAVESICAL; INTRAVENOUS; INTRAVESICAL; INTRAVENOUS,Resolved,SOLUTION,,2023-01-10,2023-10-10,2023-10-05,Disruption of the manufacture of the drug.,2023-01-12,2023-10-06,No
195806,02409275,Shortage,DOXORUBICIN HYDROCHLORIDE INJECTION,TEVA CANADA LIMITED,DOXORUBICIN HYDROCHLORIDE INJECTION,DOXORUBICIN HYDROCHLORIDE,2MG,100ML,INTRAVESICAL; INTRAVENOUS; INTRAVESICAL; INTRAVENOUS,Resolved,SOLUTION,,2023-06-19,2023-11-10,2023-10-18,Disruption of the manufacture of the drug.,2023-06-20,2023-10-19,No
182277,02247208,Shortage,DUKORAL,VALNEVA SWEDEN AB,"Oral, Inactivated Cholera and LT-producing ETEC Diarrhea Vaccine","VIBRIO CHOLERAE OGAWA 50 CLASSICAL BIOTYPE, HEAT INACTIVATED; VIBRIO CHOLERAE INABA 48 CLASSICAL BIOTYPE, HEAT INACTIVATED; VIBRIO CHOLERAE INABA 6973 E1 TOR BIOTYPE, FORMALIN INACTIVATED; RECOMBINANT CHOLERA TOXIN B SUBUNIT; VIBRIO CHOLERAE OGAWA 50 CLASSICAL BIOTYPE, FORMALIN INACTIVATED",31250000000CELLS; 31250000000CELLS; 31250000000CELLS; 1MG; 31250000000CELLS,1 Dose and 2 Dose,ORAL; ORAL,Resolved,SUSPENSION,,2023-01-24,2023-05-15,2023-05-11,Demand increase for the drug.,2023-01-25,2023-05-15,No
211052,02490897,Shortage,DULOXETINE,SANIS HEALTH INC,DULOXETINE,DULOXETINE,60MG,100,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-11-17,2024-01-22,2024-01-22,Disruption of the manufacture of the drug.,2023-11-22,2024-01-30,No
202687,02490889,Shortage,DULOXETINE,SANIS HEALTH INC,DULOXETINE,DULOXETINE,30MG,100,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-08-22,2024-01-22,2024-01-22,Disruption of the manufacture of the drug.,2023-08-22,2024-01-30,No
211141,02453649,Shortage,DULOXETINE,SIVEM PHARMACEUTICALS ULC,Duloxetine,DULOXETINE,60MG,30,ORAL; ORAL,Actual shortage,CAPSULE (DELAYED RELEASE),,2023-11-19,,,Disruption of the manufacture of the drug.,2023-11-22,2023-11-22,No
207835,02415534,Shortage,DUREZOL,NOVARTIS PHARMACEUTICALS CANADA INC,DUREZOL 0.05% EMUL 5ML,DIFLUPREDNATE,0.05%,5ML,OPHTHALMIC; OPHTHALMIC,Resolved,EMULSION,2023-10-23,2023-10-23,2024-03-08,2024-03-05,Delay in shipping of the drug.,2023-10-23,2024-03-06,No
200468,02443058,Shortage,DUTASTERIDE,SANIS HEALTH INC,DUTASTERIDE,DUTASTERIDE,0.5MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-07-31,2023-12-01,2023-12-01,Disruption of the manufacture of the drug.,2023-07-31,2023-12-02,No
183173,02429012,Shortage,DUTASTERIDE,SIVEM PHARMACEUTICALS ULC,Dutasteride,DUTASTERIDE,0.5MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-02-02,2023-04-15,2023-04-24,Delay in shipping of the drug.,2023-02-02,2023-04-26,No
201912,02432889,Shortage,DYMISTA,BGP PHARMA ULC,AZELASTINE HYDROCHLORIDE FLUTICASONE PROPIONATE,AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE,137MCG; 50MCG,25 ML,NASAL; NASAL,Resolved,"SPRAY, METERED DOSE",2023-09-01,2023-08-22,,2023-10-30,Disruption of the manufacture of the drug.,2023-08-16,2023-10-31,No
181286,02237282,Shortage,EFFEXOR XR,UPJOHN CANADA ULC,EFFEXOR XR,VENLAFAXINE,150MG,90,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2022-12-02,2023-02-21,2023-03-02,Disruption of the manufacture of the drug.,2023-01-17,2023-03-20,No
213124,02237279,Shortage,EFFEXOR XR,BGP PHARMA ULC,VENLAFAXINE,VENLAFAXINE,37.5MG,90 BT,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2023-11-15,,2023-12-07,Other (Please describe in comments),2023-12-13,2023-12-19,No
207370,00330582,Shortage,EFUDEX,"BAUSCH HEALTH, CANADA INC.",EFUDEX,FLUOROURACIL,5%,40g,TOPICAL; TOPICAL,Resolved,CREAM,2023-10-24,,2023-11-03,2023-11-06,Other (Please describe in comments),2023-10-19,2023-11-09,No
213446,00330582,Shortage,EFUDEX,"BAUSCH HEALTH, CANADA INC.",EFUDEX,FLUOROURACIL,5%,40g,TOPICAL; TOPICAL,Resolved,CREAM,2024-01-26,2024-01-26,2024-05-15,2024-04-16,Other (Please describe in comments),2023-12-15,2024-04-17,No
212824,00335053,Shortage,ELAVIL,AA PHARMA INC,ELAVIL,AMITRIPTYLINE HYDROCHLORIDE,10MG,1000BTL,ORAL; ORAL,Actual shortage,TABLET,2023-12-08,2023-12-08,,,Disruption of the manufacture of the drug.,2023-12-08,2024-04-01,No
211837,00335053,Shortage,ELAVIL,AA PHARMA INC,ELAVIL,AMITRIPTYLINE HYDROCHLORIDE,10MG,100 BTL,ORAL; ORAL,Actual shortage,TABLET,2023-11-29,2023-11-29,,,Disruption of the manufacture of the drug.,2023-11-29,2024-04-01,No
207373,02247238,Shortage,ELIDEL,"BAUSCH HEALTH, CANADA INC.",ELIDEL,PIMECROLIMUS,1%,30g,TOPICAL; TOPICAL,Resolved,CREAM,2023-11-13,2023-11-07,2023-12-05,2023-12-04,Other (Please describe in comments),2023-10-19,2023-12-06,No
204001,02248239,Shortage,ELIGARD,TOLMAR INTERNATIONAL LTD.,Leuprolide acetate for injection,LEUPROLIDE ACETATE,7.5MG,1 Carton / Kit,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,"POWDER FOR SUSPENSION, SUSTAINED-RELEASE",2023-09-08,,,2023-09-27,Delay in shipping of the drug.,2023-09-08,2023-09-28,No
196133,00871095,Shortage,ELOCOM,ORGANON CANADA INC.,Mometasone Furoate Lotion,MOMETASONE FUROATE,0.10%,75,TOPICAL; TOPICAL,Resolved,LOTION,2023-09-15,2023-09-06,2023-10-15,2023-10-09,Delay in shipping of the drug.,2023-06-22,2023-10-10,No
190247,00851744,Shortage,ELOCOM,ORGANON CANADA INC.,mometasone furoate cream,MOMETASONE FUROATE,0.10%,50,TOPICAL; TOPICAL,Resolved,CREAM,2023-05-05,2023-04-27,2023-06-09,2023-05-19,Delay in shipping of the drug.,2023-04-24,2023-05-20,No
179909,00851744,Shortage,ELOCOM,ORGANON CANADA INC.,mometasone furoate cream,MOMETASONE FUROATE,0.10%,15,TOPICAL; TOPICAL,Resolved,CREAM,2023-03-13,2023-03-09,2023-05-26,2023-05-19,Delay in shipping of the drug.,2023-01-05,2023-05-20,No
205536,00851744,Shortage,ELOCOM,ORGANON CANADA INC.,mometasone furoate cream,MOMETASONE FUROATE,0.10%,50,TOPICAL; TOPICAL,Actual shortage,CREAM,2023-10-23,2023-10-20,2024-04-26,,Delay in shipping of the drug.,2023-09-29,2024-03-04,No
183909,02430347,Shortage,ELOCTATE,SANOFI-AVENTIS CANADA INC,ELOCTATE 2000,ANTIHEMOPHILIC FACTOR,2000UNIT,2000 IU/vial,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION; KIT,,2023-02-06,2023-03-15,2023-03-06,Demand increase for the drug.,2023-02-08,2023-03-07,No
192281,02458446,Shortage,EMERADE,"BAUSCH HEALTH, CANADA INC.",EMERADE,EPINEPHRINE,0.3MG,n/a,INTRAMUSCULAR,Actual shortage,SOLUTION,,2023-05-03,,,Other (Please describe in comments),2023-05-11,2023-05-11,No
192284,02458454,Shortage,EMERADE,"BAUSCH HEALTH, CANADA INC.",EMERADE,EPINEPHRINE,0.5MG,n/a,INTRAMUSCULAR,Actual shortage,SOLUTION,,2023-05-03,,,Other (Please describe in comments),2023-05-11,2023-05-11,No
210906,02491087,Shortage,EMGALITY,ELI LILLY CANADA INC,galcanezumab injection,GALCANEZUMAB,120MG,Carton package containing one 120 mg/mL single-use prefilled pen,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION,2023-12-22,2023-12-22,2024-02-08,2024-02-02,Other (Please describe in comments),2023-11-20,2024-02-05,No
203737,00886858,Shortage,EMLA CREAM,ASPEN PHARMACARE CANADA INC.,lidocaine 2.5% and prilocaine 2.5% 5x5g Tube with 10 Tegaderm dressings,LIDOCAINE; PRILOCAINE,2.5%; 2.5%,5 Tube,TOPICAL; TOPICAL,Resolved,CREAM,,2023-09-15,2023-10-05,2023-09-15,Delay in shipping of the drug.,2023-09-06,2023-09-18,No
209402,00886858,Shortage,EMLA CREAM,ASPEN PHARMACARE CANADA INC.,lidocaine 2.5% and prilocaine 2.5% 5g Tube with 2 Tegaderm dressings,LIDOCAINE; PRILOCAINE,2.5%; 2.5%,1 Tube,TOPICAL; TOPICAL,Resolved,CREAM,2023-12-15,2023-12-20,2024-01-15,2024-01-08,Disruption of the manufacture of the drug.,2023-11-06,2024-01-18,No
194461,02273217,Shortage,ENABLEX,SEARCHLIGHT PHARMA INC,Enablex,DARIFENACIN,7.5MG,100 tablets,ORAL; ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),2023-08-01,,2024-07-15,,Shortage of an active ingredient.,2023-06-09,2024-02-02,No
194549,02273225,Shortage,ENABLEX,SEARCHLIGHT PHARMA INC,ENABLEX,DARIFENACIN,15MG,100 Tablets,ORAL; ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),2023-08-01,,2024-07-15,,Shortage of an active ingredient.,2023-06-09,2024-02-02,No
213843,02388499,Shortage,ENALAPRILAT INJECTION USP,HIKMA CANADA LIMITED,ENALAPRILAT INJECTION USP,ENALAPRILAT,1.25MG,2mL,INTRAVENOUS; INTRAVENOUS,Actual shortage,SOLUTION,,2023-12-19,2024-04-30,,Delay in shipping of the drug.,2023-12-19,2024-03-01,No
193425,02334992,Shortage,ENDOMETRIN,FERRING INC,PROGESTIN,PROGESTERONE,100MG,100 mg effervescent vaginal tablets packed individually in a sealed foil pouch with vaginal applicators.,VAGINAL; VAGINAL,Actual shortage,"VAGINAL TABLET, EFFERVESCENT",,2023-05-31,2024-06-02,,Other (Please describe in comments),2023-05-31,2023-12-14,No
186642,02487020,Shortage,ENGERIX-B,GLAXOSMITHKLINE INC,Hepatitis B vaccine (recombinant),HEPATITIS B SURFACE ANTIGEN,10MCG,1s,INTRAMUSCULAR; INTRAMUSCULAR,Resolved,SUSPENSION,,2023-03-06,2023-05-01,2023-04-27,Delay in shipping of the drug.,2023-03-10,2023-04-28,No
207381,02487039,Shortage,ENGERIX-B,GLAXOSMITHKLINE INC,Hepatitis B vaccine (recombinant),HEPATITIS B SURFACE ANTIGEN,20MCG,1s,INTRAMUSCULAR; INTRAMUSCULAR,Resolved,SUSPENSION,,2023-10-16,2023-11-21,2023-11-21,Delay in shipping of the drug.,2023-10-19,2023-11-22,No
187609,02052431,Shortage,ENTOCORT ENEMA,TILLOTTS PHARMA GMBH,Enema,SODIUM CHLORIDE; BUDESONIDE,115ML; 2.3MG,7,RECTAL; RECTAL,Resolved,ENEMA; TABLET; KIT,2023-03-27,2023-03-27,2023-04-15,2023-04-27,Delay in shipping of the drug.,2023-03-21,2023-05-08,No
200978,02435810,Shortage,EPINEPHRINE INJECTION USP,HIKMA CANADA LIMITED,EPINEPHRINE INJECTION USP,EPINEPHRINE,1MG,1mL,SUBCUTANEOUS; INTRAVENOUS; INTRATRACHEAL; INTRAMUSCULAR; INTRACARDIAC; SUBCUTANEOUS; INTRAVENOUS; INTRATRACHEAL; INTRAMUSCULAR; INTRACARDIAC,Resolved,SOLUTION,2023-09-01,,2024-03-25,2024-03-27,Disruption of the manufacture of the drug.,2023-08-03,2024-03-28,No
179966,00578657,Shortage,EPIPEN JR,MYLAN SPECIALTY LP,EPIPEN JR,EPINEPHRINE,0.15MG,1,INTRAMUSCULAR; INTRAMUSCULAR,Resolved,SOLUTION,,2023-01-04,2023-01-27,2023-01-23,Disruption of the manufacture of the drug.,2023-01-06,2023-01-24,No
194144,02324091,Shortage,EPIRUBICIN FOR INJECTION,TEVA CANADA LIMITED,EPIRUBICIN FOR INJECTION,EPIRUBICIN HYDROCHLORIDE,2MG,25ML,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-06-08,2023-09-20,2023-09-30,Disruption of the manufacture of the drug.,2023-06-08,2023-10-03,No
207533,02324091,Shortage,EPIRUBICIN FOR INJECTION,TEVA CANADA LIMITED,EPIRUBICIN INJECTION 2MG/ML,EPIRUBICIN HYDROCHLORIDE,2MG,25ml,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-05-10,2023-12-31,2023-11-29,Disruption of the manufacture of the drug.,2023-10-19,2023-11-30,No
195784,02324091,Shortage,EPIRUBICIN FOR INJECTION,TEVA CANADA LIMITED,EPIRUBICIN FOR INJECTION,EPIRUBICIN HYDROCHLORIDE,2MG,25ML,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-06-19,2023-12-10,2023-07-04,Disruption of the manufacture of the drug.,2023-06-20,2023-07-05,No
185077,02324091,Shortage,EPIRUBICIN FOR INJECTION,TEVA CANADA LIMITED,EPIRUBICIN FOR INJECTION,EPIRUBICIN HYDROCHLORIDE,2MG,25ML,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-02-17,2023-04-10,2023-04-27,Disruption of the manufacture of the drug.,2023-02-17,2023-04-28,No
194978,02326663,Shortage,ERYTHROMYCIN OPHTHALMIC OINTMENT USP,STERI-MED PHARMA INC.,Erythromycin ophthalmic ointment USP 3.5g,ERYTHROMYCIN,5MG,3.5g,OPHTHALMIC; OPHTHALMIC,Resolved,OINTMENT,2023-05-29,2023-05-29,2023-07-17,2023-07-12,Demand increase for the drug.,2023-06-16,2023-07-15,No
180368,02394839,Shortage,ESOMEPRAZOLE,PRO DOC LIMITEE,ESOMEPRAZOLE,ESOMEPRAZOLE,20MG,30,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE),,2022-10-03,2023-03-02,2023-03-02,Delay in shipping of the drug.,2023-01-10,2023-03-03,No
184628,02241835,Shortage,ESTALIS 140/50 MCG,SANDOZ CANADA INCORPORATED,ESTALIS,NORETHINDRONE ACETATE; ESTRADIOL,140MCG; 50MCG,8TTSM,TRANSDERMAL; TRANSDERMAL,Resolved,PATCH,,2023-02-14,2023-03-03,2023-02-24,Delay in shipping of the drug.,2023-02-14,2023-03-03,No
191385,02241835,Shortage,ESTALIS 140/50 MCG,SANDOZ CANADA INCORPORATED,ESTALIS,NORETHINDRONE ACETATE; ESTRADIOL,140MCG; 50MCG,8TTSM,TRANSDERMAL; TRANSDERMAL,Resolved,PATCH,,2023-05-01,2023-05-19,2023-05-08,Disruption of the manufacture of the drug.,2023-05-01,2023-05-09,No
207082,02241835,Shortage,ESTALIS 140/50 MCG,SANDOZ CANADA INCORPORATED,ESTALIS,NORETHINDRONE ACETATE; ESTRADIOL,140MCG; 50MCG,8TTSM,TRANSDERMAL; TRANSDERMAL,Resolved,PATCH,,2023-10-16,2023-11-10,2023-11-06,Disruption of the manufacture of the drug.,2023-10-16,2023-11-07,No
207761,02241837,Shortage,ESTALIS 250/50 MCG,SANDOZ CANADA INCORPORATED,ESTALIS,NORETHINDRONE ACETATE; ESTRADIOL,250MCG; 50MCG,8TTSM,TRANSDERMAL; TRANSDERMAL,Resolved,PATCH,,2023-10-23,2023-11-10,2023-11-06,Disruption of the manufacture of the drug.,2023-10-23,2023-11-07,No
193719,02244002,Shortage,ESTRADOT 100,SANDOZ CANADA INCORPORATED,ESTRADOT,ESTRADIOL,100MCG,8TTS,TRANSDERMAL; TRANSDERMAL,Resolved,PATCH,,2023-06-05,2023-08-18,2023-08-21,Disruption of the manufacture of the drug.,2023-06-05,2023-08-22,No
197971,02245676,Shortage,ESTRADOT 25,SANDOZ CANADA INCORPORATED,ESTRADOT,ESTRADIOL,25MCG,8TTS,TRANSDERMAL; TRANSDERMAL,Resolved,PATCH,,2023-07-10,2023-08-25,2023-08-29,Delay in shipping of the drug.,2023-07-10,2023-08-30,No
205793,02245676,Shortage,ESTRADOT 25,SANDOZ CANADA INCORPORATED,Estradot,ESTRADIOL,25MCG,8TTS,TRANSDERMAL; TRANSDERMAL,Resolved,PATCH,,2023-10-02,2023-11-10,2023-11-13,Disruption of the manufacture of the drug.,2023-10-02,2023-11-14,No
204735,02243999,Shortage,ESTRADOT 37.5,SANDOZ CANADA INCORPORATED,ESTRADOT 37.5,ESTRADIOL,37.5MCG,8TTS,TRANSDERMAL; TRANSDERMAL,Resolved,PATCH,,2023-09-19,2023-11-10,2023-11-13,Disruption of the manufacture of the drug.,2023-09-19,2023-11-14,No
195413,02244000,Shortage,ESTRADOT 50,SANDOZ CANADA INCORPORATED,ESTRADOT,ESTRADIOL,50MCG,8TTS,TRANSDERMAL; TRANSDERMAL,Resolved,PATCH,,2023-06-19,2023-11-03,2023-11-06,Disruption of the manufacture of the drug.,2023-06-19,2023-11-07,No
192563,02244001,Shortage,ESTRADOT 75,SANDOZ CANADA INCORPORATED,ESTRADOT,ESTRADIOL,75MCG,8TTS,TRANSDERMAL; TRANSDERMAL,Resolved,PATCH,,2023-05-15,2023-08-18,2023-08-21,Disruption of the manufacture of the drug.,2023-05-16,2023-08-22,No
210056,02244001,Shortage,ESTRADOT 75,SANDOZ CANADA INCORPORATED,Estradot 75,ESTRADIOL,75MCG,8TTS,TRANSDERMAL; TRANSDERMAL,Resolved,PATCH,,2023-11-13,2023-12-22,2023-12-11,Disruption of the manufacture of the drug.,2023-11-13,2023-12-12,No
196657,02168898,Shortage,ESTRING,PFIZER CANADA ULC,ESTRING,ESTRADIOL,2MG,1 ea,VAGINAL; VAGINAL,Resolved,RING (SLOW-RELEASE),,2023-06-27,2023-07-21,2023-07-21,Disruption of the manufacture of the drug.,2023-06-27,2023-07-22,No
185649,02168898,Shortage,ESTRING,PFIZER CANADA ULC,ESTRING,ESTRADIOL,2MG,1 ea,VAGINAL; VAGINAL,Resolved,RING (SLOW-RELEASE),2023-03-15,2023-03-13,2023-05-02,2023-05-08,Disruption of the manufacture of the drug.,2023-02-27,2023-05-09,No
201581,02168898,Shortage,ESTRING,PFIZER CANADA ULC,Estring,ESTRADIOL,2MG,1ea,VAGINAL; VAGINAL,Actual shortage,RING (SLOW-RELEASE),,2023-08-10,,,Disruption of the manufacture of the drug.,2023-08-10,2024-03-13,No
207367,00247979,Shortage,ETIBI,"BAUSCH HEALTH, CANADA INC.",ETIBI,ETHAMBUTOL HYDROCHLORIDE,400MG,n/a,ORAL; ORAL,Avoided shortage,TABLET,2023-11-06,,2023-11-10,2023-11-04,Other (Please describe in comments),2023-10-19,2023-11-09,No
184937,02080036,Shortage,ETOPOSIDE INJECTION,TEVA CANADA LIMITED,ETOPOSIDE INJECTION 20MG/ML,ETOPOSIDE,20MG,50ml,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,,2023-02-14,2023-06-30,2023-06-08,Disruption of the manufacture of the drug.,2023-02-16,2023-06-09,No
195789,02080036,Shortage,ETOPOSIDE INJECTION,TEVA CANADA LIMITED,ETOPOSIDE INJECTION,ETOPOSIDE,20MG,50ML,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,,2023-06-19,2023-07-30,2023-07-27,Disruption of the manufacture of the drug.,2023-06-20,2023-07-28,No
210801,02302853,Shortage,EXELON PATCH 10,KNIGHT THERAPEUTICS INC.,Rivastigmine Transdermal Patch,RIVASTIGMINE,9.5MG,9.5 mg/24hr,TRANSDERMAL; TRANSDERMAL,Resolved,PATCH,,2023-11-17,,2023-12-21,Delay in shipping of the drug.,2023-11-18,2023-12-22,No
181052,02247745,Shortage,"FAMOTIDINE OMEGA   -(WITH PRESERVATIVE,BENZYL ALCOHOL)",OMEGA LABORATORIES LIMITED,Famotidine Injection,FAMOTIDINE,10MG,1 x 20mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-01-13,2023-04-18,2023-04-11,Demand increase for the drug.,2023-01-13,2023-04-12,No
202613,02247745,Shortage,"FAMOTIDINE OMEGA   -(WITH PRESERVATIVE,BENZYL ALCOHOL)",OMEGA LABORATORIES LIMITED,Famotidine Injection,FAMOTIDINE,10MG,1 x 20 mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-09-18,2024-04-23,2024-04-22,Disruption of the manufacture of the drug.,2023-08-21,2024-04-23,No
200767,02247735,Shortage,FAMOTIDINE OMEGA  -(WITHOUT PRESERVATIVE),OMEGA LABORATORIES LIMITED,Famotidine Injection,FAMOTIDINE,10MG,10 x 2mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-08-03,2023-08-18,2023-08-14,Demand increase for the drug.,2023-08-02,2023-08-15,No
189010,02247735,Shortage,FAMOTIDINE OMEGA  -(WITHOUT PRESERVATIVE),OMEGA LABORATORIES LIMITED,Famotidine Injection,FAMOTIDINE,10MG,10 x 2 mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-04-06,2023-05-12,2023-05-12,Demand increase for the drug.,2023-04-06,2023-05-13,No
184429,02247735,Shortage,FAMOTIDINE OMEGA  -(WITHOUT PRESERVATIVE),OMEGA LABORATORIES LIMITED,Famotidine Injection,FAMOTIDINE,10MG,10 x 2 mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-02-17,2023-03-21,2023-03-21,Demand increase for the drug.,2023-02-10,2023-03-22,No
192878,02247735,Shortage,FAMOTIDINE OMEGA  -(WITHOUT PRESERVATIVE),OMEGA LABORATORIES LIMITED,Famotidine Injection,FAMOTIDINE,10MG,10 x 2 mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-06-09,,2023-06-19,Demand increase for the drug.,2023-05-19,2023-06-20,No
210891,02247735,Shortage,FAMOTIDINE OMEGA  -(WITHOUT PRESERVATIVE),OMEGA LABORATORIES LIMITED,Famotidine Injection,FAMOTIDINE,10MG,10 x 2 mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2023-12-11,2023-12-05,2024-01-26,2024-01-15,Disruption of the manufacture of the drug.,2023-11-20,2024-01-16,No
193234,02248416,Shortage,FASTURTEC,SANOFI-AVENTIS CANADA INC,FASTURTEC,RASBURICASE,1.5MG,3 vials,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION,2023-05-26,2023-05-25,2023-09-29,2023-10-03,Other (Please describe in comments),2023-05-26,2023-10-04,No
205826,02385406,Shortage,FENTANYL CITRATE INJECTION USP,HIKMA CANADA LIMITED,FENTANYL CITRATE INJECTION USP,FENTANYL,50MCG,2mL,EPIDURAL; INTRAVENOUS; INTRAMUSCULAR; EPIDURAL; INTRAVENOUS; INTRAMUSCULAR,Actual shortage,SOLUTION,2023-11-01,,,,Disruption of the manufacture of the drug.,2023-10-02,2023-11-02,No
201035,02501554,Shortage,"FENTANYL CITRATE INJECTION, USP",FRESENIUS KABI CANADA LTD,"FENTANYL CITRATE INJECTION, USP",FENTANYL,50MCG,5 mL,INTRAVENOUS; INTRAMUSCULAR; EPIDURAL,Resolved,SOLUTION,,2023-07-31,2023-08-31,2023-08-30,Disruption of the manufacture of the drug.,2023-08-03,2023-08-31,No
205907,02501554,Shortage,"FENTANYL CITRATE INJECTION, USP",FRESENIUS KABI CANADA LTD,"FENTANYL CITRATE INJECTION, USP",FENTANYL,50MCG,1 mL,INTRAVENOUS; INTRAMUSCULAR; EPIDURAL,Resolved,SOLUTION,2023-10-06,2023-10-06,2023-11-15,2023-11-15,Delay in shipping of the drug.,2023-10-03,2023-11-17,No
211212,02496151,Shortage,FENTANYL INJECTION BP,STERIMAX INC,FENTANYL INJECTION BP,FENTANYL,250MCG,10 VIALS,INTRAVENOUS; INTRAMUSCULAR; EPIDURAL,Resolved,SOLUTION,,2023-11-22,2023-12-29,2023-12-15,Delay in shipping of the drug.,2023-11-22,2023-12-16,No
194172,02408031,Shortage,FENTORA,TEVA CANADA LIMITED,FENTORA,FENTANYL,600MCG,28,SUBLINGUAL; BUCCAL; SUBLINGUAL; BUCCAL,Resolved,TABLET (EFFERVESCENT),,2023-06-08,2023-08-30,2023-08-30,Disruption of the manufacture of the drug.,2023-06-08,2023-10-04,No
195548,02408031,Shortage,FENTORA,TEVA CANADA LIMITED,FENTORA,FENTANYL,600MCG,28,SUBLINGUAL; BUCCAL; SUBLINGUAL; BUCCAL,Resolved,TABLET (EFFERVESCENT),,2023-06-19,2023-07-30,2023-07-04,Disruption of the manufacture of the drug.,2023-06-19,2023-07-05,No
190698,02408023,Shortage,FENTORA,TEVA CANADA LIMITED,FENTORA 400MCG BUCCAL TAB PP 28,FENTANYL,400MCG,28,SUBLINGUAL; BUCCAL; SUBLINGUAL; BUCCAL,Resolved,TABLET (EFFERVESCENT),,2023-04-27,2023-06-30,2023-06-20,Disruption of the manufacture of the drug.,2023-04-27,2023-06-21,No
181813,02243333,Shortage,FERRLECIT,SANOFI-AVENTIS CANADA INC,FERRLECIT,,12.5MG,10,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION; LIQUID,,2023-01-18,2023-03-31,2023-03-02,Other (Please describe in comments),2023-01-19,2023-03-06,No
199542,02441004,Shortage,FETZIMA,ABBVIE CORPORATION,Fetzima ER 120 mg capsules,LEVOMILNACIPRAN,120MG,30 capsules bottle,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),2023-07-24,,2023-08-15,2023-08-15,Disruption of the manufacture of the drug.,2023-07-21,2023-08-16,No
203315,00176192,Shortage,FIORINAL-C 1/4,ARALEZ PHARMACEUTICALS CANADA INC,acetylsalicylic acid-caffeine-codeine-butalbital,CODEINE PHOSPHATE; BUTALBITAL; CAFFEINE; ACETYLSALICYLIC ACID,15MG; 50MG; 40MG; 330MG,bottles of 100,ORAL; ORAL,Resolved,CAPSULE,,2023-08-30,2023-10-06,2023-10-05,Disruption of the manufacture of the drug.,2023-08-30,2023-10-06,No
196995,01926861,Shortage,FLAGYL,SANOFI-AVENTIS CANADA INC,Metronidazole,METRONIDAZOLE,10%,60 g,VAGINAL; VAGINAL,Resolved,CREAM,,2023-06-30,2023-07-31,2023-07-13,Other (Please describe in comments),2023-06-30,2023-07-14,No
208580,01926861,Shortage,FLAGYL,SANOFI-AVENTIS CANADA INC,Metronidazole,METRONIDAZOLE,10%,60g,VAGINAL; VAGINAL,Resolved,CREAM,,2023-10-26,2023-11-17,2023-11-03,Other (Please describe in comments),2023-10-30,2023-11-04,No
186612,01926861,Shortage,FLAGYL,SANOFI-AVENTIS CANADA INC,FLAGYL,METRONIDAZOLE,10%,1,VAGINAL; VAGINAL,Resolved,CREAM,,2023-03-07,2023-04-30,2023-03-30,Other (Please describe in comments),2023-03-09,2023-03-31,No
210443,02270102,Shortage,FLOMAX CR,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,FLOMAX CR,TAMSULOSIN HYDROCHLORIDE,0.4MG,3X10,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),2023-11-24,,2024-02-05,2024-01-23,Demand increase for the drug.,2023-11-16,2024-01-24,No
193859,02086026,Shortage,FLORINEF,PALADIN LABS INC.,Fludrocortisone,FLUDROCORTISONE 21-ACETATE,0.1MG,100 tabs,ORAL; ORAL,Resolved,TABLET,,2023-06-06,2023-06-28,2023-06-26,Delay in shipping of the drug.,2023-06-07,2023-06-27,No
209694,02244293,Shortage,FLOVENT HFA,GLAXOSMITHKLINE INC,fluticasone propionate inhalation aerosol,FLUTICASONE PROPIONATE,250MCG,1x60,ORAL; INHALATION; ORAL; INHALATION,Resolved,METERED-DOSE AEROSOL,,2023-11-07,2023-12-06,2023-12-01,Disruption of the manufacture of the drug.,2023-11-10,2023-12-06,No
209697,02244292,Shortage,FLOVENT HFA,GLAXOSMITHKLINE INC,fluticasone propionate inhalation aerosol,FLUTICASONE PROPIONATE,125MCG,1x60,ORAL; INHALATION; ORAL; INHALATION,Resolved,METERED-DOSE AEROSOL,,2023-11-06,2023-12-15,2023-11-21,Disruption of the manufacture of the drug.,2023-11-10,2023-11-22,No
208284,02244293,Shortage,FLOVENT HFA,GLAXOSMITHKLINE INC,fluticasone propionate inhalation aerosol,FLUTICASONE PROPIONATE,250MCG,1x120,ORAL; INHALATION; ORAL; INHALATION,Resolved,METERED-DOSE AEROSOL,,2023-10-26,2023-12-15,2023-12-08,Disruption of the manufacture of the drug.,2023-10-26,2023-12-09,No
188090,02244292,Shortage,FLOVENT HFA,GLAXOSMITHKLINE INC,fluticasone propionate inhalation aerosol,FLUTICASONE PROPIONATE,125MCG,1x60,ORAL; INHALATION; ORAL; INHALATION,Resolved,METERED-DOSE AEROSOL,,2023-03-22,2023-04-12,2023-04-05,Disruption of the manufacture of the drug.,2023-03-27,2023-04-06,No
182556,02388448,Shortage,FLUCONAZOLE INJECTION SDZ,SANDOZ CANADA INCORPORATED,FLUCONAZOLE,FLUCONAZOLE,2MG,100ML,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-01-25,2023-03-17,2023-03-13,Disruption of the manufacture of the drug.,2023-01-27,2023-03-14,No
187430,02388448,Shortage,FLUCONAZOLE INJECTION SDZ,SANDOZ CANADA INCORPORATED,FLUCONAZOLE INJECTION,FLUCONAZOLE,2MG,100ML,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-03-20,2023-04-21,2023-04-17,Delay in shipping of the drug.,2023-03-20,2023-04-18,No
186428,00505005,Shortage,FLUORESCITE,ALCON CANADA INC,FLUORESCEIN (FLUORESCEIN SODIUM) 10 %,FLUORESCEIN,10%,5 ml,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2023-03-09,,2023-03-31,2023-03-20,Delay in shipping of the drug.,2023-03-07,2023-03-21,No
208867,00405361,Shortage,FLUPHENAZINE,AA PHARMA INC,FLUPHENAZINE,FLUPHENAZINE HYDROCHLORIDE,5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,2023-11-10,,2024-01-31,2024-01-02,Disruption of the manufacture of the drug.,2023-11-01,2024-01-03,No
188320,01912038,Shortage,FLURBIPROFEN,AA PHARMA INC,FLURBIPROFEN,FLURBIPROFEN,100MG,100BTL,ORAL; ORAL,Resolved,TABLET,2023-04-15,,2023-05-22,2023-05-19,Disruption of the manufacture of the drug.,2023-03-30,2023-05-26,No
202758,00426849,Shortage,FOLIC ACID,AA PHARMA INC,Folic Acid,FOLIC ACID,5MG,1000BTL,ORAL; ORAL,Resolved,TABLET,2023-08-23,,2023-11-08,2023-10-30,Disruption of the manufacture of the drug.,2023-08-23,2023-11-01,No
191239,00426849,Shortage,FOLIC ACID,AA PHARMA INC,FOLIC ACID,FOLIC ACID,5MG,1000 BTL,ORAL; ORAL,Resolved,TABLET,2023-05-01,,2023-07-26,2023-07-24,Disruption of the manufacture of the drug.,2023-05-01,2023-07-31,No
209690,00426849,Shortage,FOLIC ACID,AA PHARMA INC,Folic Acid,FOLIC ACID,5MG,1000BTL,ORAL; ORAL,Resolved,TABLET,2023-11-09,,2024-01-05,2023-12-22,Disruption of the manufacture of the drug.,2023-11-09,2023-12-23,No
199441,02470349,Shortage,FOQUEST,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,85MG,60,ORAL; ORAL,Resolved,CAPSULE (CONTROLLED RELEASE),2023-07-21,2023-07-21,2023-08-25,2023-08-25,Delay in shipping of the drug.,2023-07-21,2023-08-28,No
203858,02470349,Shortage,FOQUEST,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,85MG,60,ORAL; ORAL,Resolved,CAPSULE (CONTROLLED RELEASE),2023-09-08,2023-09-08,2023-09-22,2023-09-22,Delay in shipping of the drug.,2023-09-07,2023-09-23,No
195939,02470306,Shortage,FOQUEST,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,35MG,60,ORAL; ORAL,Resolved,CAPSULE (CONTROLLED RELEASE),2023-06-20,2023-06-20,2023-07-07,2023-06-23,Delay in shipping of the drug.,2023-06-20,2023-06-24,No
188286,02470322,Shortage,FOQUEST,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,55MG,60,ORAL; ORAL,Resolved,CAPSULE (CONTROLLED RELEASE),2023-03-30,2023-03-30,2023-04-14,2023-04-11,Delay in shipping of the drug.,2023-03-30,2023-04-12,No
196767,02470349,Shortage,FOQUEST,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,85MG,60,ORAL; ORAL,Avoided shortage,CAPSULE (CONTROLLED RELEASE),2023-07-10,,2023-07-14,2023-06-28,Delay in shipping of the drug.,2023-06-28,2023-06-28,No
201903,02470330,Shortage,FOQUEST,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,70MG,60,ORAL; ORAL,Resolved,CAPSULE (CONTROLLED RELEASE),2023-08-16,2023-08-16,2023-08-25,2023-08-25,Delay in shipping of the drug.,2023-08-16,2023-08-28,No
191152,02470292,Shortage,FOQUEST,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,25MG,60,ORAL; ORAL,Resolved,CAPSULE (CONTROLLED RELEASE),2023-04-28,2023-04-28,2023-05-05,2023-05-01,Delay in shipping of the drug.,2023-04-28,2023-05-03,No
204210,02470322,Shortage,FOQUEST,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,55MG,60,ORAL; ORAL,Resolved,CAPSULE (CONTROLLED RELEASE),2023-09-13,2023-09-13,2023-09-22,2023-09-22,Delay in shipping of the drug.,2023-09-13,2023-09-23,No
191155,02470322,Shortage,FOQUEST,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,55MG,60,ORAL; ORAL,Resolved,CAPSULE (CONTROLLED RELEASE),2023-04-28,2023-04-28,2023-05-05,2023-05-04,Delay in shipping of the drug.,2023-04-28,2023-05-05,No
201413,02470306,Shortage,FOQUEST,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,35MG,60,ORAL; ORAL,Resolved,CAPSULE (CONTROLLED RELEASE),2023-08-09,2023-08-09,2023-08-18,2023-08-17,Delay in shipping of the drug.,2023-08-08,2023-08-18,No
188874,02470314,Shortage,FOQUEST,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,45MG,60,ORAL; ORAL,Resolved,CAPSULE (CONTROLLED RELEASE),2023-04-05,2023-04-05,2023-04-14,2023-04-13,Delay in shipping of the drug.,2023-04-05,2023-04-14,No
188877,02470349,Shortage,FOQUEST,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,85MG,60,ORAL; ORAL,Resolved,CAPSULE (CONTROLLED RELEASE),2023-04-05,2023-04-05,2023-04-21,2023-04-18,Delay in shipping of the drug.,2023-04-05,2023-04-19,No
179942,02470322,Shortage,FOQUEST,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,55MG,60,ORAL; ORAL,Resolved,CAPSULE (CONTROLLED RELEASE),2023-01-05,2023-01-05,2023-02-17,2023-02-16,Delay in shipping of the drug.,2023-01-05,2023-02-17,No
179946,02470330,Shortage,FOQUEST,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,70MG,60,ORAL; ORAL,Resolved,CAPSULE (CONTROLLED RELEASE),2023-01-05,2023-01-05,2023-01-09,2023-01-09,Delay in shipping of the drug.,2023-01-05,2023-01-10,No
183530,02470306,Shortage,FOQUEST,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,35MG,60,ORAL; ORAL,Avoided shortage,CAPSULE (CONTROLLED RELEASE),2023-02-02,2023-02-02,2023-02-17,2022-02-16,Delay in shipping of the drug.,2023-02-03,2023-02-16,No
184298,02470314,Shortage,FOQUEST,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,45MG,60,ORAL; ORAL,Resolved,CAPSULE (CONTROLLED RELEASE),2023-02-09,2023-02-09,2023-02-17,2023-02-16,Delay in shipping of the drug.,2023-02-09,2023-02-17,No
185068,02470322,Shortage,FOQUEST,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,55MG,60,ORAL; ORAL,Resolved,CAPSULE (CONTROLLED RELEASE),2023-02-17,2023-02-17,2023-03-28,2023-03-27,Delay in shipping of the drug.,2023-02-17,2023-03-28,No
183533,02470349,Shortage,FOQUEST,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,85MG,60,ORAL; ORAL,Resolved,CAPSULE (CONTROLLED RELEASE),2023-02-02,2023-02-02,2023-02-17,2023-02-16,Delay in shipping of the drug.,2023-02-03,2023-02-17,No
187631,02470330,Shortage,FOQUEST,ELVIUM LIFE SCIENCES,methylphenidate hydrochloride Controlled Release Capsules,METHYLPHENIDATE HYDROCHLORIDE,70MG,60,ORAL; ORAL,Resolved,CAPSULE (CONTROLLED RELEASE),2023-03-21,2023-03-21,2023-04-14,2023-04-11,Delay in shipping of the drug.,2023-03-22,2023-04-12,No
190331,02314940,Shortage,FOSAVANCE,ORGANON CANADA INC.,alendronate sodium / cholecalciferol tablets,VITAMIN D3; ALENDRONIC ACID,5600UNIT; 70MG,4,ORAL; ORAL,Resolved,TABLET,,2023-04-26,2023-06-23,2023-06-20,Demand increase for the drug.,2023-04-26,2023-06-21,No
196834,02314940,Shortage,FOSAVANCE,ORGANON CANADA INC.,alendronate sodium / cholecalciferol tablets,VITAMIN D3; ALENDRONIC ACID,5600UNIT; 70MG,4,ORAL; ORAL,Resolved,TABLET,,2023-06-26,2023-09-15,2023-09-13,Demand increase for the drug.,2023-06-29,2023-09-14,No
192129,02257084,Shortage,FROVA,ENDO PHARMACEUTICALS INC.,FROVATRIPTAN,FROVATRIPTAN,2.5MG,7 tabs,ORAL; ORAL,Actual shortage,TABLET,,2023-02-13,,,Disruption of the manufacture of the drug.,2023-05-09,2023-05-09,No
213398,02243862,Shortage,FUCITHALMIC,AMDIPHARM LIMITED,Fusidic acid 1% viscous eye drops,FUSIDIC ACID,1%,5g,OPHTHALMIC; OPHTHALMIC,Resolved,DROPS,,2023-12-14,2024-03-31,2024-03-27,Other (Please describe in comments),2023-12-14,2024-03-28,No
187306,02351447,Shortage,FUROSEMIDE,SANIS HEALTH INC,FUROSEMIDE,FUROSEMIDE,80MG,100,ORAL; ORAL,Resolved,TABLET,,2023-02-27,2023-07-05,2023-07-05,Disruption of the manufacture of the drug.,2023-03-16,2023-07-06,No
187311,02351420,Shortage,FUROSEMIDE,SANIS HEALTH INC,FUROSEMIDE,FUROSEMIDE,20MG,100,ORAL; ORAL,Resolved,TABLET,,2023-03-13,2023-06-30,2023-07-05,Disruption of the manufacture of the drug.,2023-03-16,2023-07-06,No
200426,02351420,Shortage,FUROSEMIDE,SANIS HEALTH INC,FUROSEMIDE,FUROSEMIDE,20MG,1000,ORAL; ORAL,Resolved,TABLET,,2023-07-31,2023-10-19,2023-10-19,Disruption of the manufacture of the drug.,2023-07-31,2023-10-23,No
210680,02384094,Shortage,FUROSEMIDE INJECTION USP,HIKMA CANADA LIMITED,FUROSEMIDE INJECTION USP,FUROSEMIDE,20MG,2mL,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,2023-11-17,,2024-03-01,2024-02-13,Delay in shipping of the drug.,2023-11-17,2024-02-14,No
211055,02353253,Shortage,GABAPENTIN,SANIS HEALTH INC,GABAPENTIN,GABAPENTIN,300MG,500,ORAL; ORAL,Resolved,CAPSULE,,2023-11-17,2024-03-08,2024-03-07,Disruption of the manufacture of the drug.,2023-11-22,2024-03-08,No
203128,02353253,Shortage,GABAPENTIN,SANIS HEALTH INC,GABAPENTIN,GABAPENTIN,300MG,500,ORAL; ORAL,Resolved,CAPSULE,,2023-08-25,2023-10-20,2023-10-20,Disruption of the manufacture of the drug.,2023-08-29,2023-10-23,No
207859,02353245,Shortage,GABAPENTIN,SANIS HEALTH INC,GABAPENTIN,GABAPENTIN,100MG,500,ORAL; ORAL,Resolved,CAPSULE,,2023-10-23,,2023-11-13,Disruption of the manufacture of the drug.,2023-10-23,2023-11-14,No
214528,02416859,Shortage,GABAPENTIN CAPSULES USP,ACCORD HEALTHCARE INC,GABAPENTIN,GABAPENTIN,300MG,100,ORAL; ORAL,Actual shortage,CAPSULE,,2023-12-29,,,Disruption of the manufacture of the drug.,2023-12-29,2024-01-19,No
181036,02416867,Shortage,GABAPENTIN CAPSULES USP,ACCORD HEALTHCARE INC,GABAPENTIN,GABAPENTIN,400MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-01-13,2023-03-10,2023-03-13,Disruption of the manufacture of the drug.,2023-01-13,2023-03-14,No
209759,02416840,Shortage,GABAPENTIN CAPSULES USP,ACCORD HEALTHCARE INC,GABAPENTIN,GABAPENTIN,100MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-11-10,2023-12-15,2023-12-18,Disruption of the manufacture of the drug.,2023-11-10,2023-12-19,No
207607,02416840,Shortage,GABAPENTIN CAPSULES USP,ACCORD HEALTHCARE INC,GABAPENTIN,GABAPENTIN,100MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-10-20,2023-11-01,2023-11-02,Delay in shipping of the drug.,2023-10-20,2023-11-03,No
207610,02416859,Shortage,GABAPENTIN CAPSULES USP,ACCORD HEALTHCARE INC,GABAPENTIN,GABAPENTIN,300MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-10-20,2023-10-27,2023-10-27,Delay in shipping of the drug.,2023-10-20,2023-10-28,No
191750,02392526,Shortage,GABAPENTIN TABLETS USP,ACCORD HEALTHCARE INC,GABAPENTIN TABLETS USP,GABAPENTIN,600MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-05-05,,,Disruption of the manufacture of the drug.,2023-05-05,2023-10-04,No
207850,02443023,Shortage,GALANTAMINE ER,SANIS HEALTH INC,GALANTAMINE ER,GALANTAMINE,16MG,100,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2023-10-23,2024-04-05,2024-04-03,Disruption of the manufacture of the drug.,2023-10-23,2024-04-04,No
200443,02443015,Shortage,GALANTAMINE ER,SANIS HEALTH INC,GALANTAMINE ER,GALANTAMINE,8MG,100,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2023-07-31,2024-01-22,2024-01-18,Disruption of the manufacture of the drug.,2023-07-31,2024-01-30,No
202833,02231470,Shortage,GAMMAGARD S/D,TAKEDA CANADA INC,Immunoglobulin Intravenous (Human),IMMUNOGLOBULIN,5G,100 mL Vial,INTRAVENOUS; INTRAVENOUS,Resolved,KIT; SOLUTION; POWDER FOR SOLUTION,2023-08-23,2023-08-23,2023-09-30,2023-09-13,Delay in shipping of the drug.,2023-08-24,2023-09-14,No
207306,02231470,Shortage,GAMMAGARD S/D,TAKEDA CANADA INC,Immunoglobulin Intravenous (Human),IMMUNOGLOBULIN,5G,100 mL Vial,INTRAVENOUS; INTRAVENOUS,Resolved,KIT; SOLUTION; POWDER FOR SOLUTION,2023-12-15,,2024-04-30,2024-01-29,Other (Please describe in comments),2023-10-19,2024-01-31,No
180226,02341689,Shortage,GD-DICLOFENAC/MISOPROSTOL 50,GENMED A DIVISION OF PFIZER CANADA ULC,GD-DICLOFENAC/MISOPROSTOL,MISOPROSTOL; DICLOFENAC SODIUM,200MCG; 50MG,250's,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE),2023-01-10,2023-01-10,2023-02-10,2023-02-10,Demand increase for the drug.,2023-01-10,2023-02-11,No
208030,02341697,Shortage,GD-DICLOFENAC/MISOPROSTOL 75,GENMED A DIVISION OF PFIZER CANADA ULC,GD-DICLOFENAC/MISOPROSTOL 75,MISOPROSTOL; DICLOFENAC SODIUM,200MCG; 75MG,250's,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE),2023-11-03,,2024-01-31,2024-02-21,Demand increase for the drug.,2023-10-25,2024-02-22,No
198120,02341697,Shortage,GD-DICLOFENAC/MISOPROSTOL 75,GENMED A DIVISION OF PFIZER CANADA ULC,GD-DICLOFENAC/MISOPROSTOL 75,MISOPROSTOL; DICLOFENAC SODIUM,200MCG; 75MG,250's,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE),,2023-07-10,2023-08-29,2023-08-16,Demand increase for the drug.,2023-07-11,2023-08-17,No
181289,02373068,Shortage,GD-LATANOPROST/TIMOLOL,UPJOHN CANADA ULC,GD-LATANOPROST/TIMOLOL,LATANOPROST; TIMOLOL,50MCG; 5MG,1,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,,2023-02-21,,2023-05-16,Disruption of the manufacture of the drug.,2023-01-17,2023-05-25,No
213209,02402831,Shortage,GEMCITABINE INJECTION,PFIZER CANADA ULC,GEMCITABINE INJECTION,GEMCITABINE,38MG,1 X 52.6ML,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2024-01-02,,2024-02-15,Disruption of the manufacture of the drug.,2023-12-13,2024-02-16,No
201496,02401703,Shortage,GENOTROPIN,PFIZER CANADA ULC,Genotropin 5.3mg,SOMATROPIN,5.3MG,5 pack,SUBCUTANEOUS; SUBCUTANEOUS,Actual shortage,POWDER FOR SOLUTION,,2023-08-08,2024-12-20,,Demand increase for the drug.,2023-08-09,2024-02-21,No
201499,02401711,Shortage,GENOTROPIN,PFIZER CANADA ULC,Genotropin 12mg,SOMATROPIN,12MG,5 pack,SUBCUTANEOUS; SUBCUTANEOUS,Actual shortage,POWDER FOR SOLUTION,,2023-08-08,2024-12-20,,Demand increase for the drug.,2023-08-09,2024-04-17,No
201502,02401762,Shortage,GENOTROPIN,PFIZER CANADA ULC,Genotropin 0.6mg,SOMATROPIN,0.6MG,7 pack,SUBCUTANEOUS; SUBCUTANEOUS,Actual shortage,POWDER FOR SOLUTION,,2023-08-08,2024-12-20,,Demand increase for the drug.,2023-08-09,2024-02-21,No
201505,02401770,Shortage,GENOTROPIN,PFIZER CANADA ULC,Genotropin 0.8mg,SOMATROPIN,0.8MG,7 pack,SUBCUTANEOUS; SUBCUTANEOUS,Actual shortage,POWDER FOR SOLUTION,,2023-08-08,2024-12-20,,Demand increase for the drug.,2023-08-09,2024-02-21,No
201508,02401797,Shortage,GENOTROPIN,PFIZER CANADA ULC,Genotropin 1.2mg,SOMATROPIN,1.2MG,7 pack,SUBCUTANEOUS; SUBCUTANEOUS,Actual shortage,POWDER FOR SOLUTION,,2023-08-08,2024-12-20,,Demand increase for the drug.,2023-08-09,2024-02-21,No
201511,02401819,Shortage,GENOTROPIN,PFIZER CANADA ULC,Genotropin 1.6mg,SOMATROPIN,1.6MG,7 pack,SUBCUTANEOUS; SUBCUTANEOUS,Actual shortage,POWDER FOR SOLUTION,,2023-08-08,2024-12-20,,Demand increase for the drug.,2023-08-09,2024-02-21,No
201514,02401827,Shortage,GENOTROPIN,PFIZER CANADA ULC,Genotropin 1.8mg,SOMATROPIN,1.8MG,7 pack,SUBCUTANEOUS; SUBCUTANEOUS,Actual shortage,POWDER FOR SOLUTION,,2023-08-08,2024-12-20,,Demand increase for the drug.,2023-08-09,2024-02-21,No
191669,02401819,Shortage,GENOTROPIN,PFIZER CANADA ULC,GENOTROPIN,SOMATROPIN,1.6MG,7 PACK,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,POWDER FOR SOLUTION,2023-05-10,2023-05-10,2023-06-21,2023-06-14,Demand increase for the drug.,2023-05-04,2023-06-15,No
181682,02242652,Shortage,GENTAMICIN INJECTION USP,SANDOZ CANADA INCORPORATED,GENTAMICIN,GENTAMICIN,40MG,2ML,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-01-18,2023-01-27,2023-01-31,Disruption of the manufacture of the drug.,2023-01-19,2023-02-01,No
197061,02268531,Shortage,GENTAMICIN INJECTION USP,SANDOZ CANADA INCORPORATED,GENTAMICIN,GENTAMICIN,10MG,10MG/ML 2ML 10LIVI,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-07-04,2023-07-14,2023-07-10,Disruption of the manufacture of the drug.,2023-07-04,2023-07-11,No
186057,02242652,Shortage,GENTAMICIN INJECTION USP,SANDOZ CANADA INCORPORATED,GENTAMICIN,GENTAMICIN,40MG,20ML,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-02-17,,2023-03-27,Disruption of the manufacture of the drug.,2023-03-02,2023-03-28,No
197760,02082152,Shortage,GENTAMICIN(E),BAXTER CORPORATION,GENTAMICIN (AS SULFATE) IN 0.9% SODIUM CHLORIDE INJECTION,GENTAMICIN,1.6MG,50 mL - JB0852P,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2023-07-06,2023-07-06,2023-07-28,2023-07-28,Disruption of the manufacture of the drug.,2023-07-06,2023-07-31,No
179918,02082152,Shortage,GENTAMICIN(E),BAXTER CORPORATION,GENTAMICIN(E),GENTAMICIN,1.6MG,50mL (JB0852P),INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2023-01-09,2023-01-09,2023-02-06,2023-02-06,Demand increase for the drug.,2023-01-05,2023-02-07,No
185563,02082152,Shortage,GENTAMICIN(E),BAXTER CORPORATION,GENTAMICIN(E),GENTAMICIN,1.6MG,80mg/50mL (JB0852P),INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2023-02-24,2023-02-24,2023-03-27,2023-03-27,Demand increase for the drug.,2023-02-24,2023-03-28,No
191077,02482533,Shortage,GILENYA,NOVARTIS PHARMACEUTICALS CANADA INC,GILENYA,FINGOLIMOD,0.25MG,2 X 14,ORAL; ORAL,Resolved,CAPSULE,2023-04-20,2023-04-13,2023-05-19,2023-06-06,Delay in shipping of the drug.,2023-04-28,2023-06-07,No
189007,02333627,Shortage,GLUCAGEN HYPOKIT,NOVO NORDISK CANADA INC,GLUCAGEN® HYPOKIT 1 MG,GLUCAGON,1MG,EA,INTRAMUSCULAR; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION; KIT,2023-04-10,,2024-02-29,2024-02-29,Other (Please describe in comments),2023-04-06,2024-03-01,Yes
187074,02243297,Shortage,GLUCAGON,ELI LILLY CANADA INC,"Glucagon for Injection, rDNA origin",GLUCAGON,1MG,Kit containing 1 mg glucagon sterile lyophilized powder in a 3 mL vial and 1 mL prefilled diluent syringe,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION; KIT,2023-03-17,2023-03-16,2023-04-10,2023-04-10,Demand increase for the drug.,2023-03-14,2023-04-11,No
180461,02243297,Shortage,GLUCAGON,ELI LILLY CANADA INC,"Glucagon for Injection, rDNA origin",GLUCAGON,1MG,Kit containing 1 mg glucagon sterile lyophilized powder in a 3 mL vial and 1 mL prefilled diluent syringe,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION; KIT,,2023-01-10,2023-02-06,2023-01-27,Demand increase for the drug.,2023-01-10,2023-01-28,No
184615,02099233,Shortage,GLUCOPHAGE,SANOFI-AVENTIS CANADA INC,GLUCOPHAGE 500 mg,METFORMIN HYDROCHLORIDE,500MG,500,ORAL; ORAL,Resolved,TABLET,,2023-02-14,2023-06-30,2023-06-22,Other (Please describe in comments),2023-02-14,2023-06-23,No
199227,02099233,Shortage,GLUCOPHAGE,SANOFI-AVENTIS CANADA INC,GLUCOPHAGE,METFORMIN HYDROCHLORIDE,500MG,500,ORAL; ORAL,Resolved,TABLET,,2023-07-17,2023-08-31,2023-08-31,Other (Please describe in comments),2023-07-19,2023-09-01,No
184642,02099233,Shortage,GLUCOPHAGE,SANOFI-AVENTIS CANADA INC,GLUCOPHAGE 500 mg,METFORMIN HYDROCHLORIDE,500MG,100,ORAL; ORAL,Resolved,TABLET,,2023-02-14,2023-06-30,2023-06-22,Other (Please describe in comments),2023-02-14,2023-06-23,No
207147,02382857,Shortage,GLYCOPYRROLATE INJECTION,OMEGA LABORATORIES LIMITED,Glycopyrrolate Injection,GLYCOPYRROLATE,0.2MG,10 x 1mL vial / fiole,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-10-23,2023-11-03,2023-10-25,Demand increase for the drug.,2023-10-16,2023-10-26,No
186160,02039508,Shortage,GLYCOPYRROLATE INJECTION USP,SANDOZ CANADA INCORPORATED,GLYCOPYRROLATE,GLYCOPYRROLATE,0.2MG,20ML,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-02-24,2023-04-14,2023-04-04,Disruption of the manufacture of the drug.,2023-03-03,2023-04-05,No
204118,02039508,Shortage,GLYCOPYRROLATE INJECTION USP,SANDOZ CANADA INCORPORATED,GLYCOPYRROLATE,GLYCOPYRROLATE,0.2MG,2ML,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-09-11,2023-10-06,2023-10-10,Disruption of the manufacture of the drug.,2023-09-11,2023-10-11,No
181847,02473895,Shortage,GLYCOPYRROLATE INJECTION USP,STERIMAX INC,GLYCOPYRROLATE INJECTION USP,GLYCOPYRROLATE,0.4MG,10 X 2 ML VIALS,INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-01-20,2023-04-14,2023-04-14,Delay in shipping of the drug.,2023-01-19,2023-04-17,No
210061,02039508,Shortage,GLYCOPYRROLATE INJECTION USP,SANDOZ CANADA INCORPORATED,GLYCOPYRROLATE,GLYCOPYRROLATE,0.2MG,20 ML 1 LIVI,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-11-13,2023-12-08,2023-12-04,Disruption of the manufacture of the drug.,2023-11-13,2023-12-05,No
200632,02473879,Shortage,GLYCOPYRROLATE INJECTION USP,STERIMAX INC,GLYCOPYRROLATE INJECTION USP,GLYCOPYRROLATE,0.2MG,10 x 1 mL vials,INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-07-03,2023-09-29,2023-09-29,Disruption of the manufacture of the drug.,2023-08-01,2023-09-30,No
201539,02248154,Shortage,GONAL-F,"EMD SERONO, A DIVISION OF EMD INC., CANADA",follitropin alfa,FOLLITROPIN ALFA,5.5MCG,vial,SUBCUTANEOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,,2023-08-09,2023-09-18,2023-09-11,Disruption of the manufacture of the drug.,2023-08-10,2023-09-12,No
192881,02322765,Shortage,GRANISETRON HYDROCHLORIDE INJECTION,OMEGA LABORATORIES LIMITED,Granisetron Hydrochloride Injection,GRANISETRON,1MG,1 x 4mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,,2023-06-02,,2023-08-01,Demand increase for the drug.,2023-05-19,2023-08-02,No
213110,02322765,Shortage,GRANISETRON HYDROCHLORIDE INJECTION,OMEGA LABORATORIES LIMITED,Granisetron Hydrochloride Injection,GRANISETRON,1MG,10 x 1mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,,2023-12-19,,2024-01-18,Demand increase for the drug.,2023-12-12,2024-01-19,No
204668,02322765,Shortage,GRANISETRON HYDROCHLORIDE INJECTION,OMEGA LABORATORIES LIMITED,Granisetron Hydrochloride Injection,GRANISETRON,1MG,10 x 1 mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,,2023-09-25,,2023-10-18,Demand increase for the drug.,2023-09-18,2023-10-19,No
192440,02322765,Shortage,GRANISETRON HYDROCHLORIDE INJECTION,OMEGA LABORATORIES LIMITED,GRANISETRON HYDROCHLORIDE INJECTION,GRANISETRON,1MG,10 x 1mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,,2023-05-12,,2023-06-13,Demand increase for the drug.,2023-05-12,2023-06-14,No
186163,00808652,Shortage,HALOPERIDOL INJ 5MG/ML USP,SANDOZ CANADA INCORPORATED,HALOPERIDOL,HALOPERIDOL,5MG,1ML,INTRAMUSCULAR; INTRAMUSCULAR,Resolved,LIQUID,,2023-02-24,2023-03-31,2023-03-13,Disruption of the manufacture of the drug.,2023-03-03,2023-03-14,No
213813,02130300,Shortage,HALOPERIDOL LA,SANDOZ CANADA INCORPORATED,HALOPERIDOL LA,HALOPERIDOL,100MG,5ML,INTRAMUSCULAR; INTRAMUSCULAR,Resolved,LIQUID,,2023-12-19,2024-01-12,2024-01-16,Disruption of the manufacture of the drug.,2023-12-19,2024-01-17,No
209700,02187078,Shortage,HAVRIX - SUS IM 1440 ELISA UNITS/ML,GLAXOSMITHKLINE INC,"hepatitis A vaccine, inactivated","HEPATITIS A VACCINE, INACTIVATED",1440UNIT,1's (prefilled syringe / seringue préremplie),INTRAMUSCULAR; INTRAMUSCULAR,Resolved,SUSPENSION,,2023-11-06,2024-02-26,2024-02-21,Delay in shipping of the drug.,2023-11-10,2024-02-22,No
181252,00453811,Shortage,HEPARIN LEO INJ 1000UNIT/ML,LEO PHARMA INC,Sodium Heparin injection,HEPARIN SODIUM,1000UNIT,10 x 10 mL vial,SUBCUTANEOUS; INTRAVENOUS; SUBCUTANEOUS; INTRAVENOUS,Resolved,LIQUID,,2023-01-17,2023-01-27,2023-01-30,Other (Please describe in comments),2023-01-17,2023-01-31,No
189324,00453811,Shortage,HEPARIN LEO INJ 1000UNIT/ML,LEO PHARMA INC,Sodium Heparin injection,HEPARIN SODIUM,1000UNIT,10 x 10 mL vial,SUBCUTANEOUS; INTRAVENOUS; SUBCUTANEOUS; INTRAVENOUS,Resolved,LIQUID,,2023-04-12,2023-05-05,2023-05-04,Demand increase for the drug.,2023-04-12,2023-05-05,No
182837,02303086,Shortage,HEPARIN SODIUM INJECTION USP        (MULTIDOSE VIAL-WITH PRESERVATIVE),SANDOZ CANADA INCORPORATED,HEPARIN SODIUM INJECTION USP,HEPARIN SODIUM,1000UNIT,10ML,SUBCUTANEOUS; INTRAVENOUS; SUBCUTANEOUS; INTRAVENOUS,Actual shortage,SOLUTION,2023-02-27,2023-02-09,2024-05-31,,Disruption of the manufacture of the drug.,2023-01-31,2023-04-21,No
197978,02303086,Shortage,HEPARIN SODIUM INJECTION USP        (MULTIDOSE VIAL-WITH PRESERVATIVE),SANDOZ CANADA INCORPORATED,HEPARIN NA,HEPARIN SODIUM,1000UNIT,30 ML 10LIVI,SUBCUTANEOUS; INTRAVENOUS; SUBCUTANEOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-07-10,2023-08-25,2023-08-21,Demand increase for the drug.,2023-07-10,2023-08-22,No
181686,02303086,Shortage,HEPARIN SODIUM INJECTION USP        (MULTIDOSE VIAL-WITH PRESERVATIVE),SANDOZ CANADA INCORPORATED,HEPARIN,HEPARIN SODIUM,1000UNIT,30ML,SUBCUTANEOUS; INTRAVENOUS; SUBCUTANEOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-01-18,2023-02-10,2023-02-14,Disruption of the manufacture of the drug.,2023-01-19,2023-02-15,No
206707,02303108,Shortage,HEPARIN SODIUM INJECTION USP       (MULTIDOSE VIAL-WITH PRESERVATIVE),SANDOZ CANADA INCORPORATED,HEPARIN NA,HEPARIN SODIUM,10000UNIT,5ML 10 LI VI,SUBCUTANEOUS; INTRAVENOUS; SUBCUTANEOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-10-10,,2023-10-18,Disruption of the manufacture of the drug.,2023-10-10,2023-10-19,No
183002,02502402,Shortage,HULIO,BGP PHARMA ULC,ADALIMUMAB,ADALIMUMAB,40MG,2 x 0.8mL sterile solution subcutaneous injection (PEN) (40mg/0.8mL),SUBCUTANEOUS,Resolved,SOLUTION,,2023-01-18,2023-02-02,2023-02-01,Disruption of the manufacture of the drug.,2023-02-01,2023-02-02,No
198947,00465283,Shortage,HYDREA,CHEPLAPHARM ARZNEIMITTEL GMBH,Hydroxyurea Capsules,HYDROXYUREA,500MG,bottles of 100,ORAL; ORAL,Resolved,CAPSULE,2023-07-19,,2023-09-22,2023-09-21,Disruption of the manufacture of the drug.,2023-07-18,2023-09-22,No
201259,02145928,Shortage,HYDROMORPHONE HP 10,SANDOZ CANADA INCORPORATED,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,10MG,50ML 1LIVI,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-08-07,2023-08-25,2023-08-14,Disruption of the manufacture of the drug.,2023-08-07,2023-08-15,No
186963,02145928,Shortage,HYDROMORPHONE HP 10,SANDOZ CANADA INCORPORATED,HYDROMORPHONE HP 10,HYDROMORPHONE HYDROCHLORIDE,10MG,1ML,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-03-13,2023-04-14,2023-03-27,Disruption of the manufacture of the drug.,2023-03-13,2023-03-28,No
193713,02244797,Shortage,HYDROMORPHONE HP FORTE INJECTION,SANDOZ CANADA INCORPORATED,HYDROMORPHONE INJECTION,HYDROMORPHONE HYDROCHLORIDE,1000MG,10ML 1LIVI,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Actual shortage,SOLUTION,,2023-06-05,,,Disruption of the manufacture of the drug.,2023-06-05,2023-07-04,No
182563,02145901,Shortage,HYDROMORPHONE HYDROCHLORIDE INJECTION USP,SANDOZ CANADA INCORPORATED,HYDROMORPHONE HCL,HYDROMORPHONE HYDROCHLORIDE,2MG,1ML,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-01-25,2023-02-17,2023-02-03,Disruption of the manufacture of the drug.,2023-01-27,2023-03-06,No
187433,02145901,Shortage,HYDROMORPHONE HYDROCHLORIDE INJECTION USP,SANDOZ CANADA INCORPORATED,HYDROMORPHONE HYDROCHLORIDE INJECTION,HYDROMORPHONE HYDROCHLORIDE,2MG,1ML,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-03-20,2023-04-14,2023-04-12,Disruption of the manufacture of the drug.,2023-03-20,2023-04-13,No
203181,02145901,Shortage,HYDROMORPHONE HYDROCHLORIDE INJECTION USP,SANDOZ CANADA INCORPORATED,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,2MG,1ML,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-08-29,2023-08-29,2023-08-29,Disruption of the manufacture of the drug.,2023-08-29,2023-08-30,No
190148,02145901,Shortage,HYDROMORPHONE HYDROCHLORIDE INJECTION USP,SANDOZ CANADA INCORPORATED,HYDROMORPHONE HCL,HYDROMORPHONE HYDROCHLORIDE,2MG,1ML 10LIVI,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-04-21,2023-05-12,2023-05-08,Disruption of the manufacture of the drug.,2023-04-21,2023-05-09,No
181139,02491699,Shortage,"HYDROMORPHONE HYDROCHLORIDE INJECTION, USP",FRESENIUS KABI CANADA LTD,"HYDROMORPHONE HYDROCHLORIDE INJECTION, USP",HYDROMORPHONE HYDROCHLORIDE,2MG,1mL,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-03-15,2023-05-01,2023-05-01,Disruption of the manufacture of the drug.,2023-01-16,2023-05-01,No
181142,02491680,Shortage,"HYDROMORPHONE HYDROCHLORIDE INJECTION, USP",FRESENIUS KABI CANADA LTD,"HYDROMORPHONE HYDROCHLORIDE INJECTION, USP",HYDROMORPHONE HYDROCHLORIDE,10MG,1mL,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-03-15,2023-05-15,2023-05-11,Other (Please describe in comments),2023-01-16,2023-05-12,No
201627,02491680,Shortage,"HYDROMORPHONE HYDROCHLORIDE INJECTION, USP",FRESENIUS KABI CANADA LTD,"HYDROMORPHONE HYDROCHLORIDE INJECTION, USP",HYDROMORPHONE HYDROCHLORIDE,10MG,5 mL,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Actual shortage,SOLUTION,2023-10-01,,2024-06-24,,Disruption of the manufacture of the drug.,2023-08-11,2024-04-05,No
205344,00646059,Shortage,HYDROXYZINE,AA PHARMA INC,Hydroxyzine,HYDROXYZINE HYDROCHLORIDE,10MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE,2023-09-27,,2023-11-20,2023-11-14,Disruption of the manufacture of the drug.,2023-09-27,2023-11-15,No
186480,00646059,Shortage,HYDROXYZINE,AA PHARMA INC,HYDROXYZINE,HYDROXYZINE HYDROCHLORIDE,10MG,100BTL,ORAL; ORAL,Resolved,CAPSULE,2023-02-22,,2023-06-15,2023-06-12,Disruption of the manufacture of the drug.,2023-03-08,2023-06-13,No
196837,00646016,Shortage,HYDROXYZINE,AA PHARMA INC,HYDROXYZINE,HYDROXYZINE HYDROCHLORIDE,50MG,100BTL,ORAL; ORAL,Resolved,CAPSULE,2023-06-29,,2023-08-11,2023-08-08,Disruption of the manufacture of the drug.,2023-06-29,2023-08-14,No
201570,02297841,Shortage,HYZAAR,ORGANON CANADA INC.,losartan potassium and hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM,12.5MG; 100MG,30,ORAL; ORAL,Resolved,TABLET,,2023-08-10,2023-09-22,2023-09-21,Delay in shipping of the drug.,2023-08-10,2023-09-22,No
198083,02230047,Shortage,HYZAAR,ORGANON CANADA INC.,losartan potassium and hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM,12.5MG; 50MG,30,ORAL; ORAL,Resolved,TABLET,,2023-07-10,2023-09-08,2023-09-01,Delay in shipping of the drug.,2023-07-10,2023-09-05,No
212618,02241007,Shortage,HYZAAR DS,ORGANON CANADA INC.,losartan potassium and hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM,25MG; 100MG,30,ORAL; ORAL,Resolved,TABLET,,2023-12-06,2023-12-22,2023-12-21,Delay in shipping of the drug.,2023-12-07,2023-12-22,No
198086,02241007,Shortage,HYZAAR DS,ORGANON CANADA INC.,losartan potassium and hydrochlorothiazide tablets,HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM,25MG; 100MG,30,ORAL; ORAL,Resolved,TABLET,,2023-07-10,2023-09-08,2023-08-21,Delay in shipping of the drug.,2023-07-10,2023-08-22,No
205354,02410028,Shortage,IDARUBICIN,PFIZER CANADA ULC,IDARUBICIN,IDARUBICIN HYDROCHLORIDE,1MG,1 X 10ML,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2023-12-02,,,2024-01-12,Disruption of the manufacture of the drug.,2023-09-27,2024-01-13,No
201980,02410028,Shortage,IDARUBICIN,PFIZER CANADA ULC,IDARUBICIN,IDARUBICIN HYDROCHLORIDE,1MG,1X5ML,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-11-07,,2023-12-18,Disruption of the manufacture of the drug.,2023-08-16,2023-12-19,No
203950,02241357,Shortage,IFEX,BAXTER CORPORATION,Ifosfamide for Injection,IFOSFAMIDE,1G,1 gram (JB0852P),INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION,2023-09-08,2023-09-08,2023-10-09,2023-10-09,Delay in shipping of the drug.,2023-09-08,2023-10-10,No
189506,02411393,Shortage,ILEVRO,NOVARTIS PHARMACEUTICALS CANADA INC,ILEVRO 0.3%,NEPAFENAC,0.30%,3ML,OPHTHALMIC; OPHTHALMIC,Resolved,SUSPENSION,2023-04-15,2023-04-04,2023-05-16,2023-05-17,Disruption of the manufacture of the drug.,2023-04-13,2023-05-19,No
179840,02212188,Shortage,IMITREX,GLAXOSMITHKLINE INC,Sumatriptan succinate injection,SUMATRIPTAN,6MG,2x0.5mL,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION; LIQUID,,2023-01-04,2023-05-01,2023-03-29,Demand increase for the drug.,2023-01-04,2023-03-31,No
213449,02212188,Shortage,IMITREX,GLAXOSMITHKLINE INC,Sumatriptan succinate injection,SUMATRIPTAN,6MG,2x0.5mL (Refill pack / L’emballage de recharge),SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION; LIQUID,,2023-12-11,2024-01-12,2024-01-04,Delay in shipping of the drug.,2023-12-15,2024-01-05,No
185059,02212188,Shortage,IMITREX,GLAXOSMITHKLINE INC,Sumatriptan succinate injection,SUMATRIPTAN,6MG,2x0.5mL (Refill pack / L’emballage de recharge),SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION; LIQUID,,2023-02-16,2023-04-05,2023-04-04,Demand increase for the drug.,2023-02-17,2023-04-05,No
189933,02212188,Shortage,IMITREX,GLAXOSMITHKLINE INC,Sumatriptan succinate injection,SUMATRIPTAN,6MG,2x0.5mL,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION; LIQUID,,2023-04-20,2023-05-24,2023-05-04,Demand increase for the drug.,2023-04-20,2023-05-05,No
185082,02230418,Shortage,IMITREX,GLAXOSMITHKLINE INC,Sumatriptan nasal spray,SUMATRIPTAN,5MG,2s,NASAL; NASAL,Resolved,SPRAY,,2023-02-14,2023-02-24,2023-02-22,Demand increase for the drug.,2023-02-17,2023-02-23,No
214042,02212153,Shortage,IMITREX DF - TAB 50MG,GLAXOSMITHKLINE INC,Sumatriptan succinate tablets,SUMATRIPTAN,50MG,6s,ORAL; ORAL,Actual shortage,TABLET,,2023-12-21,,,Disruption of the manufacture of the drug.,2023-12-22,2024-04-01,No
200704,01908286,Shortage,IMOVAX RABIES RABIES VACCINE INACTIVATED (DCO),SANOFI PASTEUR LIMITED,Rabies Vaccine Inactivated (DCO),RABIES VACCINE INACTIVATED,2.5UNIT,"1.0 mL single dose vial with 1 mL diluent / Fiole de 1,0 mL à dose unique avec 1 mL de diluant",INTRAMUSCULAR; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,,2023-08-01,2023-08-30,2023-08-04,Demand increase for the drug.,2023-08-02,2023-08-05,No
181311,02398869,Shortage,INDAYO,MYLAN PHARMACEUTICALS ULC,ETHINYL ESTRADIOL LEVONORGESTREL,ETHINYL ESTRADIOL; LEVONORGESTREL,0.03MG; 0.15MG,91BL,ORAL; ORAL,Resolved,TABLET,2023-01-17,2023-01-20,,2023-02-01,Other (Please describe in comments),2023-01-17,2023-02-02,No
186110,02329093,Shortage,INDIUM DTPA IN 111,GE HEALTHCARE CANADA INC,Pentetate Indium Disodium In 111 Injection,PENTETATE INDIUM DISODIUM IN 111,37MBq,1.5 mL,INTRATHECAL; INTRATHECAL,Resolved,SOLUTION,,2023-03-03,2023-03-17,2023-03-17,Other (Please describe in comments),2023-03-03,2023-03-18,No
199839,02455455,Shortage,INVOKAMET,JANSSEN INC,INVOKAMET 150/1000MG,METFORMIN HYDROCHLORIDE; CANAGLIFLOZIN,1000MG; 150MG,60,ORAL; ORAL,Avoided shortage,TABLET,2023-12-18,,2024-01-06,2023-10-13,Shortage of an active ingredient.,2023-07-24,2023-10-13,No
199842,02455420,Shortage,INVOKAMET,JANSSEN INC,INVOKAMET 50/1000MG,METFORMIN HYDROCHLORIDE; CANAGLIFLOZIN,1000MG; 50MG,60,ORAL; ORAL,Avoided shortage,TABLET,2023-12-15,,2024-01-06,2023-10-13,Shortage of an active ingredient.,2023-07-24,2023-10-13,No
199845,02455439,Shortage,INVOKAMET,JANSSEN INC,INVOKAMET 150/500MG,METFORMIN HYDROCHLORIDE; CANAGLIFLOZIN,500MG; 150MG,60,ORAL; ORAL,Avoided shortage,TABLET,2023-12-18,,2023-12-18,2023-10-13,Shortage of an active ingredient.,2023-07-24,2023-10-13,No
186512,02246084,Shortage,IPRAVENT,AA PHARMA INC,Ipravent,IPRATROPIUM BROMIDE,42MCG,15ML,NASAL; NASAL,Resolved,SOLUTION,2023-03-23,,2023-04-26,2023-03-30,Disruption of the manufacture of the drug.,2023-03-08,2023-03-31,No
206273,02246084,Shortage,IPRAVENT,AA PHARMA INC,Ipravent,IPRATROPIUM BROMIDE,42MCG,15ML,NASAL; NASAL,Resolved,SOLUTION,2023-10-02,,2023-10-30,2023-10-30,Shortage of an inactive ingredient or component.,2023-10-05,2023-11-01,No
207903,02372398,Shortage,IRBESARTAN,SANIS HEALTH INC,IRBESARTAN,IRBESARTAN,300MG,100,ORAL; ORAL,Resolved,TABLET,,2023-10-23,2024-03-15,2024-02-28,Disruption of the manufacture of the drug.,2023-10-23,2024-02-29,No
196716,02372371,Shortage,IRBESARTAN,SANIS HEALTH INC,IRBESARTAN,IRBESARTAN,150MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-27,2023-11-09,2023-11-09,Disruption of the manufacture of the drug.,2023-06-27,2023-11-13,No
211146,02385287,Shortage,IRBESARTAN,SIVEM PHARMACEUTICALS ULC,Irbesartan,IRBESARTAN,75MG,100,ORAL; ORAL,Resolved,TABLET,,2023-09-04,2024-03-01,2024-03-15,Delay in shipping of the drug.,2023-11-22,2024-04-01,No
212033,02258218,Shortage,IRINOTECAN HYDROCHLORIDE INJECTION USP,PFIZER CANADA ULC,IRINOTECAN HYDROCHLORIDE INJECTION USP,IRINOTECAN HYDROCHLORIDE,20MG,2mL vial,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-12-12,,2024-01-19,Disruption of the manufacture of the drug.,2023-11-30,2024-01-20,No
187760,02258218,Shortage,IRINOTECAN HYDROCHLORIDE INJECTION USP,PFIZER CANADA ULC,IRINOTECAN HYDROCHLORIDE INJECTION USP,IRINOTECAN HYDROCHLORIDE,20MG,5mL vial,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-05-24,,2023-08-30,Disruption of the manufacture of the drug.,2023-03-23,2023-08-31,No
204240,02258218,Shortage,IRINOTECAN HYDROCHLORIDE INJECTION USP,PFIZER CANADA ULC,IRINOTECAN HYDROCHLORIDE INJECTION USP,IRINOTECAN HYDROCHLORIDE,20MG,25mL vial,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-10-19,,2023-12-12,Disruption of the manufacture of the drug.,2023-09-13,2023-12-13,No
179784,00897639,Shortage,ISOPROTERENOL HYDROCHLORIDE INJECTION USP,SANDOZ CANADA INCORPORATED,Isoproterenol,ISOPROTERENOL HYDROCHLORIDE,0.2MG,10 x 1ML Ampoules,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-01-18,2023-03-10,2023-03-06,Shortage of an active ingredient.,2023-01-04,2023-03-07,No
213750,01907123,Shortage,ISOPTIN SR,BGP PHARMA ULC,VERAPAMIL HYDROCHLORIDE,VERAPAMIL HYDROCHLORIDE,120MG,100 BT,ORAL; ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),,2023-12-15,2024-05-28,,Demand increase for the drug.,2023-12-19,2024-04-16,No
210486,02488086,Shortage,IVOZFO,VERITY PHARMACEUTICALS INC.,fosfomycin (supplied as fosfomycin sodium),FOSFOMYCIN,4G,4 g vial,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,2024-01-31,,2024-05-30,,Other (Please describe in comments),2023-11-17,2024-02-01,No
211335,02372010,Shortage,JALYN,GLAXOSMITHKLINE INC,dutasteride/tamsulosin hydrochloride modified release capsules,TAMSULOSIN HYDROCHLORIDE; DUTASTERIDE,0.4MG; 0.5MG,30s,ORAL; ORAL,Actual shortage,CAPSULE (IMMEDIATE AND EXTENDED RELEASE),,2023-11-23,2024-05-09,,Demand increase for the drug.,2023-11-23,2024-04-17,No
180274,02504200,Shortage,JAMP ATORVASTATIN CALCIUM,JAMP PHARMA CORPORATION,Atorvastatin calcium tablets,ATORVASTATIN,20MG,30,ORAL,Resolved,TABLET,,2022-12-09,2023-02-10,2023-02-01,Other (Please describe in comments),2023-01-10,2023-02-03,No
183651,02504219,Shortage,JAMP ATORVASTATIN CALCIUM,JAMP PHARMA CORPORATION,Atorvastatin calcium,ATORVASTATIN,40MG,3x10,ORAL,Resolved,TABLET,,2023-02-06,2023-03-10,2023-03-07,Demand increase for the drug.,2023-02-06,2023-03-11,No
207347,02502631,Shortage,JAMP CALCIUM POLYSTYRENE SULFONATE,JAMP PHARMA CORPORATION,Calcium Polystyrene Sulfonate Powder,CALCIUM POLYSTYRENE SULFONATE,999MG,300 g,RECTAL; ORAL,Actual shortage,POWDER FOR SUSPENSION,,2023-10-16,2024-12-31,,Disruption of the manufacture of the drug.,2023-10-19,2024-03-30,No
211765,02473240,Shortage,JAMP CANDESARTAN-HCT,JAMP PHARMA CORPORATION,Candesartan Cilexetil and Hydrochlorothiazide Tablets,CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE,16MG; 12.5MG,100,ORAL,Actual shortage,TABLET,,2023-11-27,2024-07-15,,Other (Please describe in comments),2023-11-29,2024-04-17,No
211768,02473259,Shortage,JAMP CANDESARTAN-HCT,JAMP PHARMA CORPORATION,Candesartan Cilexetil and Hydrochlorothiazide Tablets,HYDROCHLOROTHIAZIDE; CANDESARTAN CILEXETIL,12.5MG; 32MG,3x10,ORAL,Actual shortage,TABLET,,2023-11-27,2024-07-31,,Disruption of the manufacture of the drug.,2023-11-29,2024-04-17,No
211771,02473259,Shortage,JAMP CANDESARTAN-HCT,JAMP PHARMA CORPORATION,Candesartan Cilexetil and Hydrochlorothiazide Tablets,HYDROCHLOROTHIAZIDE; CANDESARTAN CILEXETIL,12.5MG; 32MG,100,ORAL,Actual shortage,TABLET,,2023-11-27,2024-07-31,,Disruption of the manufacture of the drug.,2023-11-29,2024-04-17,No
211774,02473267,Shortage,JAMP CANDESARTAN-HCT,JAMP PHARMA CORPORATION,Candesartan Cilexetil and Hydrochlorothiazide Tablets,HYDROCHLOROTHIAZIDE; CANDESARTAN CILEXETIL,25MG; 32MG,3x10,ORAL,Actual shortage,TABLET,,2023-11-27,2024-07-31,,Disruption of the manufacture of the drug.,2023-11-29,2024-04-17,No
211777,02473267,Shortage,JAMP CANDESARTAN-HCT,JAMP PHARMA CORPORATION,Candesartan Cilexetil and Hydrochlorothiazide Tablets,HYDROCHLOROTHIAZIDE; CANDESARTAN CILEXETIL,25MG; 32MG,100,ORAL,Actual shortage,TABLET,,2023-11-27,2024-07-31,,Disruption of the manufacture of the drug.,2023-11-29,2024-04-17,No
196738,02528436,Shortage,JAMP CEPHALEXIN SUSPENSION,JAMP PHARMA CORPORATION,Cephalexin For Oral Suspension USP,CEPHALEXIN,125MG,150 mL,ORAL,Resolved,POWDER FOR SUSPENSION,,2023-06-20,2024-02-15,2024-02-15,Disruption of the manufacture of the drug.,2023-06-27,2024-02-27,No
196741,02528444,Shortage,JAMP CEPHALEXIN SUSPENSION,JAMP PHARMA CORPORATION,Cephalexin For Oral Suspension USP,CEPHALEXIN,250MG,100 mL,ORAL,Resolved,POWDER FOR SUSPENSION,,2023-06-20,2024-02-15,2024-02-15,Disruption of the manufacture of the drug.,2023-06-27,2024-02-27,No
196744,02528444,Shortage,JAMP CEPHALEXIN SUSPENSION,JAMP PHARMA CORPORATION,Cephalexin For Oral Suspension USP,CEPHALEXIN,250MG,150 mL,ORAL,Resolved,POWDER FOR SUSPENSION,,2023-06-20,2024-02-15,2024-02-15,Disruption of the manufacture of the drug.,2023-06-27,2024-02-27,No
211783,02528207,Shortage,JAMP CLONIDINE,JAMP PHARMA CORPORATION,Clonidine Hydrochloride Tablets,CLONIDINE HYDROCHLORIDE,0.025MG,100,ORAL,Resolved,TABLET,,2023-11-27,2024-02-15,2024-01-31,Demand increase for the drug.,2023-11-29,2024-02-05,No
192205,02495139,Shortage,JAMP DESVENLAFAXINE,JAMP PHARMA CORPORATION,Desvenlafaxine Extended Release Tablets,DESVENLAFAXINE,50MG,90,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),,2023-05-10,2024-05-31,,Disruption of the manufacture of the drug.,2023-05-11,2024-03-12,No
192208,02495147,Shortage,JAMP DESVENLAFAXINE,JAMP PHARMA CORPORATION,Desvenlafaxine Extended Release Tablets,DESVENLAFAXINE,100MG,90,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),,2023-05-10,2024-05-31,,Other (Please describe in comments),2023-05-11,2024-03-12,No
189256,02472309,Shortage,JAMP DICLOFENAC TOPICAL SOLUTION,JAMP PHARMA CORPORATION,1.5% w/w diclofenac sodium solution,DICLOFENAC SODIUM,1.50%,120,TOPICAL; TOPICAL,Resolved,SOLUTION,,2023-04-11,2023-08-25,2023-08-25,Other (Please describe in comments),2023-04-11,2023-08-26,No
189263,02457539,Shortage,JAMP DORZOLAMIDE-TIMOLOL,JAMP PHARMA CORPORATION,Dorzolamide and Timolol eye drops,TIMOLOL; DORZOLAMIDE,5MG; 20MG,10,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,,2023-04-11,2023-07-14,2023-07-17,Other (Please describe in comments),2023-04-11,2023-07-18,No
183655,02457539,Shortage,JAMP DORZOLAMIDE-TIMOLOL,JAMP PHARMA CORPORATION,Dorzolamide and timolol,TIMOLOL; DORZOLAMIDE,5MG; 20MG,10mL,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,,2023-02-06,2023-03-10,2023-02-17,Demand increase for the drug.,2023-02-06,2023-02-20,No
211786,02484870,Shortage,JAMP DUTASTERIDE,JAMP PHARMA CORPORATION,Dutasteride Capsules,DUTASTERIDE,0.5MG,90,ORAL,Actual shortage,CAPSULE,,2023-11-27,2024-07-31,,Disruption of the manufacture of the drug.,2023-11-29,2024-03-12,No
207338,02493683,Shortage,JAMP ELETRIPTAN,JAMP PHARMA CORPORATION,Eletriptan Hydrobromide Tablets,ELETRIPTAN,20MG,1x6,ORAL,Actual shortage,TABLET,,2023-10-16,2024-12-31,,Disruption of the manufacture of the drug.,2023-10-19,2024-03-30,No
207344,02493691,Shortage,JAMP ELETRIPTAN,JAMP PHARMA CORPORATION,Eletriptan Hydrobromide Tablets,ELETRIPTAN,40MG,1x6,ORAL,Actual shortage,TABLET,,2023-10-16,2024-12-31,,Disruption of the manufacture of the drug.,2023-10-19,2024-03-30,No
180229,02493705,Shortage,JAMP FLECAINIDE,JAMP PHARMA CORPORATION,Flecainide Acetate Tablets,FLECAINIDE ACETATE,50MG,100,ORAL,Resolved,TABLET,,2022-12-09,2023-03-10,2023-02-17,Disruption of the manufacture of the drug.,2023-01-10,2023-02-20,No
207314,02500663,Shortage,JAMP GEFITINIB,JAMP PHARMA CORPORATION,Gefitinib Tablets,GEFITINIB,250MG,3x10,ORAL,Resolved,TABLET,,2023-10-16,2024-01-15,2024-01-31,Disruption of the manufacture of the drug.,2023-10-19,2024-02-05,No
181452,02472686,Shortage,JAMP GRANISETRON,JAMP PHARMA CORPORATION,Granisetron Hydrochloride Tablets,GRANISETRON,1MG,2x5,ORAL,Actual shortage,TABLET,,2023-01-10,2024-12-31,,Disruption of the manufacture of the drug.,2023-01-18,2024-03-30,No
183671,02495066,Shortage,JAMP IMATINIB,JAMP PHARMA CORPORATION,Imatinib mesylate,IMATINIB,100MG,12x10,ORAL,Actual shortage,TABLET,,2023-02-06,2025-12-31,,Disruption of the manufacture of the drug.,2023-02-06,2024-02-19,No
196219,02495066,Shortage,JAMP IMATINIB,JAMP PHARMA CORPORATION,Imatinib Mesylate Tablets,IMATINIB,100MG,3x10,ORAL,Resolved,TABLET,,2023-06-20,,2023-09-19,Disruption of the manufacture of the drug.,2023-06-23,2023-09-20,No
196224,02495074,Shortage,JAMP IMATINIB,JAMP PHARMA CORPORATION,Imatinib Mesylate Tablets,IMATINIB,400MG,3x10,ORAL,Resolved,TABLET,,2023-06-20,,2023-09-19,Disruption of the manufacture of the drug.,2023-06-23,2023-09-20,No
207304,02502801,Shortage,JAMP LAMIVUDINE / ZIDOVUDINE,JAMP PHARMA CORPORATION,Lamivudine and Zidovudine Tablets,LAMIVUDINE; ZIDOVUDINE,150MG; 300MG,60,ORAL,Actual shortage,TABLET,,2023-10-16,2024-09-30,,Disruption of the manufacture of the drug.,2023-10-19,2024-03-19,No
211789,02453355,Shortage,JAMP LATANOPROST,JAMP PHARMA CORPORATION,Latanoprost Ophthalmic Solution,LATANOPROST,50MCG,2.5 mL,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,,2023-11-27,2024-01-15,2024-01-31,Disruption of the manufacture of the drug.,2023-11-29,2024-02-05,No
202967,02504561,Shortage,JAMP LEVETIRACETAM TABLETS,JAMP PHARMA CORPORATION,Levetiracetam Tablets,LEVETIRACETAM,500MG,100,ORAL,Actual shortage,TABLET,,2023-08-25,2024-08-30,,Demand increase for the drug.,2023-08-25,2024-03-19,No
202970,02504588,Shortage,JAMP LEVETIRACETAM TABLETS,JAMP PHARMA CORPORATION,Levetiracetam Tablets,LEVETIRACETAM,750MG,100,ORAL,Resolved,TABLET,,2023-08-25,2024-03-15,2024-03-18,Demand increase for the drug.,2023-08-25,2024-03-19,No
180238,02380218,Shortage,JAMP METFORMIN,JAMP PHARMA CORPORATION,Metformin Hydrochloride Tablets,METFORMIN HYDROCHLORIDE,850MG,500,ORAL; ORAL,Resolved,TABLET,,2022-12-09,2023-03-24,2023-04-10,Demand increase for the drug.,2023-01-10,2023-04-11,No
189466,02380218,Shortage,JAMP METFORMIN,JAMP PHARMA CORPORATION,"Metformin Hydrochloride Tablets, USP",METFORMIN HYDROCHLORIDE,850MG,500,ORAL; ORAL,Resolved,TABLET,,2023-04-12,2023-06-10,2023-05-30,Demand increase for the drug.,2023-04-12,2023-05-31,No
180244,02417243,Shortage,JAMP OLANZAPINE FC,JAMP PHARMA CORPORATION,Olanzapine Tablets,OLANZAPINE,2.5MG,100,ORAL; ORAL,Resolved,TABLET,,2022-12-09,2023-10-31,2023-09-14,Disruption of the manufacture of the drug.,2023-01-10,2023-09-15,No
180247,02417251,Shortage,JAMP OLANZAPINE FC,JAMP PHARMA CORPORATION,Olanzapine Tablets,OLANZAPINE,5MG,100,ORAL; ORAL,Resolved,TABLET,,2022-12-09,2023-10-31,2023-10-10,Disruption of the manufacture of the drug.,2023-01-10,2023-10-18,No
180250,02417278,Shortage,JAMP OLANZAPINE FC,JAMP PHARMA CORPORATION,Olanzapine Tablets,OLANZAPINE,7.5MG,100,ORAL; ORAL,Resolved,TABLET,,2022-12-09,2023-10-31,2023-09-14,Disruption of the manufacture of the drug.,2023-01-10,2023-09-15,No
211798,02417308,Shortage,JAMP OLANZAPINE FC,JAMP PHARMA CORPORATION,Olanzapine Tablets,OLANZAPINE,20MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-11-27,2024-05-15,,Disruption of the manufacture of the drug.,2023-11-29,2024-03-11,No
192220,02406632,Shortage,JAMP OLANZAPINE ODT,JAMP PHARMA CORPORATION,Olanzapine orally disintegrating tablets,OLANZAPINE,10MG,3x10,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-05-10,2023-07-31,2023-08-02,Disruption of the manufacture of the drug.,2023-05-11,2023-08-03,No
192233,02406659,Shortage,JAMP OLANZAPINE ODT,JAMP PHARMA CORPORATION,Olanzapine orally disintegrating tablets,OLANZAPINE,20MG,3x10,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-05-10,2023-07-31,2023-08-02,Disruption of the manufacture of the drug.,2023-05-11,2023-08-03,No
183674,02461668,Shortage,JAMP OLMESARTAN,JAMP PHARMA CORPORATION,Olmesartan medoxomil,OLMESARTAN MEDOXOMIL,40MG,100,ORAL; ORAL,Resolved,TABLET,,2023-02-06,2023-03-10,2023-03-07,Demand increase for the drug.,2023-02-06,2023-03-11,No
180280,02490617,Shortage,JAMP ONDANSETRON,JAMP PHARMA CORPORATION,Ondansetron Oral Solution,ONDANSETRON,4MG,50,ORAL,Resolved,SOLUTION,,2022-12-09,2023-01-15,2023-01-05,Disruption of the manufacture of the drug.,2023-01-10,2023-01-10,No
192192,02490617,Shortage,JAMP ONDANSETRON,JAMP PHARMA CORPORATION,Ondansetron Oral Solution,ONDANSETRON,4MG,50 mL,ORAL,Resolved,SOLUTION,,2023-05-10,2023-09-15,2023-09-08,Other (Please describe in comments),2023-05-11,2023-09-11,No
189376,02497425,Shortage,JAMP OSELTAMIVIR,JAMP PHARMA CORPORATION,"Oseltamivir Phosphate Capsules, USP",OSELTAMIVIR,75MG,10,ORAL,Resolved,CAPSULE,,2023-04-12,2023-09-30,2023-09-19,Other (Please describe in comments),2023-04-12,2023-09-20,No
183744,02397307,Shortage,JAMP PIOGLITAZONE,JAMP PHARMA CORPORATION,Pioglitazone hydrochloride,PIOGLITAZONE,15MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-02-06,2023-12-15,,Disruption of the manufacture of the drug.,2023-02-06,2023-08-25,No
211801,02530333,Shortage,JAMP POSACONAZOLE,JAMP PHARMA CORPORATION,Posaconazole,POSACONAZOLE,40MG,105 mL,ORAL,Actual shortage,SUSPENSION,,2023-11-27,2024-04-15,,Disruption of the manufacture of the drug.,2023-11-29,2024-03-19,No
213590,02508362,Shortage,JAMP PYRIDOSTIGMINE BROMIDE,JAMP PHARMA CORPORATION,Pyridostigmine Bromide Tablets USP,PYRIDOSTIGMINE BROMIDE,60MG,100,ORAL,Resolved,TABLET,,2023-12-15,2024-04-30,2024-03-21,Demand increase for the drug.,2023-12-15,2024-03-29,No
180256,02390159,Shortage,JAMP QUETIAPINE FUMARATE,JAMP PHARMA CORPORATION,Quetiapine Tablets USP,QUETIAPINE,100MG,100,ORAL,Resolved,TABLET (IMMEDIATE RELEASE),,2022-12-09,2023-02-10,2023-01-27,Disruption of the manufacture of the drug.,2023-01-10,2023-01-31,No
180259,02390159,Shortage,JAMP QUETIAPINE FUMARATE,JAMP PHARMA CORPORATION,Quetiapine Tablets USP,QUETIAPINE,100MG,500,ORAL,Resolved,TABLET (IMMEDIATE RELEASE),,2022-12-09,2023-02-10,2023-02-01,Disruption of the manufacture of the drug.,2023-01-10,2023-02-03,No
192195,02390140,Shortage,JAMP QUETIAPINE FUMARATE,JAMP PHARMA CORPORATION,Quetiapine Tablets,QUETIAPINE,25MG,100,ORAL,Resolved,TABLET (IMMEDIATE RELEASE),,2023-05-10,2023-07-21,2023-08-02,Other (Please describe in comments),2023-05-11,2023-08-03,No
204044,02415291,Shortage,JAMP RABEPRAZOLE,JAMP PHARMA CORPORATION,Rabeprazole Sodium Delayed Release Tablets,RABEPRAZOLE SODIUM,20MG,500,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),,2023-09-08,2024-04-30,,Disruption of the manufacture of the drug.,2023-09-11,2024-03-11,No
204047,02415291,Shortage,JAMP RABEPRAZOLE,JAMP PHARMA CORPORATION,Rabeprazole Sodium Delayed Release Tablets,RABEPRAZOLE SODIUM,20MG,100,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),,2023-09-08,2024-04-30,,Disruption of the manufacture of the drug.,2023-09-11,2024-03-11,No
180283,02415291,Shortage,JAMP RABEPRAZOLE,JAMP PHARMA CORPORATION,Rabeprazole Sodium Delayed Release Tablets,RABEPRAZOLE SODIUM,20MG,100,ORAL,Resolved,TABLET (DELAYED-RELEASE),,2022-12-09,2023-02-10,2023-01-27,Demand increase for the drug.,2023-01-10,2023-01-31,No
211804,02415283,Shortage,JAMP RABEPRAZOLE,JAMP PHARMA CORPORATION,Rabeprazole Sodium Delayed Release Tablets,RABEPRAZOLE SODIUM,10MG,100,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),,2023-11-27,2024-05-15,,Disruption of the manufacture of the drug.,2023-11-29,2024-03-19,No
180286,02498359,Shortage,JAMP ROSUVASTATIN CALCIUM,JAMP PHARMA CORPORATION,Rosuvastatin Calcium Tablets,ROSUVASTATIN,20MG,30,ORAL,Resolved,TABLET,,2022-12-09,2023-02-10,2023-02-01,Other (Please describe in comments),2023-01-10,2023-02-03,No
180289,02498367,Shortage,JAMP ROSUVASTATIN CALCIUM,JAMP PHARMA CORPORATION,Rosuvastatin Calcium Tablets,ROSUVASTATIN,40MG,30,ORAL,Resolved,TABLET,,2022-12-09,2023-03-10,2023-02-08,Other (Please describe in comments),2023-01-10,2023-02-09,No
211810,02389959,Shortage,JAMP TELMISARTAN-HCT,JAMP PHARMA CORPORATION,Telmisartan and Hydrochlorothiazide Tablets,HYDROCHLOROTHIAZIDE; TELMISARTAN,25MG; 80MG,3x10,ORAL,Actual shortage,TABLET,,2023-11-27,2024-04-15,,Disruption of the manufacture of the drug.,2023-11-29,2024-03-30,No
211813,02389940,Shortage,JAMP TELMISARTAN-HCT,JAMP PHARMA CORPORATION,Telmisartan and Hydrochlorothiazide Tablets,HYDROCHLOROTHIAZIDE; TELMISARTAN,12.5MG; 80MG,3x10,ORAL,Actual shortage,TABLET,,2023-11-27,2024-04-15,,Disruption of the manufacture of the drug.,2023-11-29,2024-03-19,No
211816,02389940,Shortage,JAMP TELMISARTAN-HCT,JAMP PHARMA CORPORATION,Telmisartan and Hydrochlorothiazide Tablets,HYDROCHLOROTHIAZIDE; TELMISARTAN,12.5MG; 80MG,100,ORAL,Actual shortage,TABLET,,2023-11-27,2024-05-10,,Disruption of the manufacture of the drug.,2023-11-29,2024-04-15,No
192202,02496844,Shortage,JAMP TOLTERODINE,JAMP PHARMA CORPORATION,Tolterodine Tartrate Tablets,TOLTERODINE TARTRATE,2MG,100,ORAL,Resolved,TABLET,,2023-05-10,2023-09-30,2023-09-26,Disruption of the manufacture of the drug.,2023-05-11,2023-09-27,No
183705,02442817,Shortage,JAMP TRAZODONE,JAMP PHARMA CORPORATION,Trazodone hydrochloride,,100MG,100,ORAL,Resolved,TABLET,,2023-02-06,2023-09-30,2023-08-08,Disruption of the manufacture of the drug.,2023-02-06,2023-08-09,No
183720,02442825,Shortage,JAMP TRAZODONE,JAMP PHARMA CORPORATION,Trazodone hydrochloride,,150MG,100,ORAL,Resolved,TABLET,,2023-02-06,2023-09-30,2023-08-08,Disruption of the manufacture of the drug.,2023-02-06,2023-08-09,No
183725,02442809,Shortage,JAMP TRAZODONE,JAMP PHARMA CORPORATION,Trazodone hydrochloride,,50MG,500,ORAL,Resolved,TABLET,,2023-02-06,2023-09-30,2023-08-08,Disruption of the manufacture of the drug.,2023-02-06,2023-08-09,No
183760,02385031,Shortage,JAMP-ALENDRONATE,JAMP PHARMA CORPORATION,Alendronate sodium trihydrate,ALENDRONIC ACID,70MG,1x4,ORAL; ORAL,Resolved,TABLET,,2023-02-06,2025-12-31,2024-04-15,Other (Please describe in comments),2023-02-06,2024-04-17,No
181443,02433060,Shortage,JAMP-AMOXICILLIN,JAMP PHARMA CORPORATION,Amoxicillin Capsules,AMOXICILLIN,250MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-01-18,2023-03-10,2023-02-17,Demand increase for the drug.,2023-01-18,2023-02-20,No
181446,02433060,Shortage,JAMP-AMOXICILLIN,JAMP PHARMA CORPORATION,Amoxicillin Capsules,AMOXICILLIN,250MG,1000,ORAL; ORAL,Resolved,CAPSULE,,2023-01-18,2023-05-15,2023-05-01,Other (Please describe in comments),2023-01-18,2023-05-02,No
196726,02424533,Shortage,JAMP-CELECOXIB,JAMP PHARMA CORPORATION,Celecoxib Capsules,CELECOXIB,100MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-06-20,2023-09-30,2023-09-26,Disruption of the manufacture of the drug.,2023-06-27,2023-09-27,No
196729,02424533,Shortage,JAMP-CELECOXIB,JAMP PHARMA CORPORATION,Celecoxib Capsules,CELECOXIB,100MG,500,ORAL; ORAL,Resolved,CAPSULE,,2023-06-20,2023-09-30,2023-09-26,Disruption of the manufacture of the drug.,2023-06-27,2023-09-27,No
196732,02424541,Shortage,JAMP-CELECOXIB,JAMP PHARMA CORPORATION,Celecoxib Capsules,CELECOXIB,200MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-06-20,2023-11-15,2023-11-15,Disruption of the manufacture of the drug.,2023-06-27,2023-11-15,No
196735,02424541,Shortage,JAMP-CELECOXIB,JAMP PHARMA CORPORATION,Celecoxib Capsules,CELECOXIB,200MG,500,ORAL; ORAL,Resolved,CAPSULE,,2023-06-20,2023-11-15,2023-11-15,Disruption of the manufacture of the drug.,2023-06-27,2023-11-15,No
189459,02451778,Shortage,JAMP-CETIRIZINE,JAMP PHARMA CORPORATION,Cetirizine Hydrochloride Tablets,CETIRIZINE HYDROCHLORIDE,10MG,100,ORAL,Actual shortage,TABLET,,2023-04-12,2023-12-31,,Other (Please describe in comments),2023-04-12,2023-04-13,No
211780,02478595,Shortage,JAMP-CHOLESTYRAMINE,JAMP PHARMA CORPORATION,Cholestyramine for Oral Suspension,CHOLESTYRAMINE RESIN,4G,30,ORAL,Actual shortage,POWDER FOR SUSPENSION,,2023-11-27,2024-06-30,,Disruption of the manufacture of the drug.,2023-11-29,2024-02-06,Yes
207333,02458233,Shortage,JAMP-EFAVIRENZ,JAMP PHARMA CORPORATION,Efavirenz Tablets,EFAVIRENZ,600MG,30,ORAL; ORAL,Actual shortage,TABLET,,2023-10-16,2025-01-01,,Disruption of the manufacture of the drug.,2023-10-19,2024-02-06,No
192236,02423235,Shortage,JAMP-EZETIMIBE,JAMP PHARMA CORPORATION,"Ezetimibe Tablets, USP",EZETIMIBE,10MG,100,ORAL; ORAL,Resolved,TABLET,,2023-05-10,2023-08-18,2023-08-08,Other (Please describe in comments),2023-05-11,2023-08-09,No
189268,02401894,Shortage,JAMP-FLUOXETINE,JAMP PHARMA CORPORATION,Fluoxetine Capsules BP (as fluoxetine hydrochloride),FLUOXETINE,10MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-04-11,2023-05-30,2023-05-05,Other (Please describe in comments),2023-04-11,2023-05-05,No
189365,02386402,Shortage,JAMP-FLUOXETINE,JAMP PHARMA CORPORATION,Fluoxetine Capsules BP,FLUOXETINE,20MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-04-12,2023-05-30,2023-05-30,Other (Please describe in comments),2023-04-12,2023-05-31,No
180277,02361493,Shortage,JAMP-GABAPENTIN,JAMP PHARMA CORPORATION,Gabapentin Capsules,GABAPENTIN,400MG,500,ORAL; ORAL,Resolved,CAPSULE,,2022-12-09,2023-02-10,2023-01-27,Other (Please describe in comments),2023-01-10,2023-01-31,No
180232,02402289,Shortage,JAMP-GABAPENTIN TABLETS,JAMP PHARMA CORPORATION,Gabapentin Tablets,GABAPENTIN,600MG,100,ORAL; ORAL,Resolved,TABLET,,2022-12-09,2023-01-30,2023-01-27,Disruption of the manufacture of the drug.,2023-01-10,2023-01-31,No
202961,02402289,Shortage,JAMP-GABAPENTIN TABLETS,JAMP PHARMA CORPORATION,Gabapentin Tablets USP,GABAPENTIN,600MG,100,ORAL; ORAL,Resolved,TABLET,,2023-08-25,2025-12-31,2024-04-15,Other (Please describe in comments),2023-08-25,2024-04-17,No
202964,02402297,Shortage,JAMP-GABAPENTIN TABLETS,JAMP PHARMA CORPORATION,Gabapentin Tablets USP,GABAPENTIN,800MG,100,ORAL; ORAL,Resolved,TABLET,,2023-08-25,2025-12-31,2024-04-15,Other (Please describe in comments),2023-08-25,2024-04-17,No
180235,02488426,Shortage,JAMP-LACOSAMIDE,JAMP PHARMA CORPORATION,Lacosamide Tablets,LACOSAMIDE,200MG,100,ORAL,Resolved,TABLET,,2022-12-09,2023-03-10,2023-02-08,Disruption of the manufacture of the drug.,2023-01-10,2023-02-09,No
213955,02356813,Shortage,JAMP-METOPROLOL-L,JAMP PHARMA CORPORATION,Metoprolol Tartrate Tablets USP,METOPROLOL TARTRATE,25MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-12-20,2024-12-31,,Disruption of the manufacture of the drug.,2023-12-20,2024-03-12,No
213958,02356813,Shortage,JAMP-METOPROLOL-L,JAMP PHARMA CORPORATION,Metoprolol Tartrate Tablets USP,METOPROLOL TARTRATE,25MG,500,ORAL; ORAL,Actual shortage,TABLET,,2023-12-20,2024-12-31,,Disruption of the manufacture of the drug.,2023-12-20,2024-03-12,No
207295,02472120,Shortage,JAMP-MOXIFLOXACIN,JAMP PHARMA CORPORATION,Moxifloxacin Ophthalmic Solution USP,MOXIFLOXACIN,0.50%,3 mL,OPHTHALMIC; OPHTHALMIC,Actual shortage,SOLUTION,,2023-10-16,2024-10-15,,Disruption of the manufacture of the drug.,2023-10-19,2024-03-19,No
211792,02380382,Shortage,JAMP-MYCOPHENOLATE,JAMP PHARMA CORPORATION,Mycophenolate Mofetil Tablets,MYCOPHENOLATE MOFETIL,500MG,5x10,ORAL; ORAL,Resolved,TABLET,,2023-11-27,2023-12-15,2023-12-15,Disruption of the manufacture of the drug.,2023-11-29,2023-12-18,No
192217,02380382,Shortage,JAMP-MYCOPHENOLATE,JAMP PHARMA CORPORATION,"Mycophenolate Mofetil Tablets, USP",MYCOPHENOLATE MOFETIL,500MG,5x10,ORAL; ORAL,Resolved,TABLET,,2023-05-10,2023-07-31,2023-08-02,Disruption of the manufacture of the drug.,2023-05-11,2023-08-03,No
211795,02433443,Shortage,JAMP-NYSTATIN ORAL SUSPENSION USP,JAMP PHARMA CORPORATION,Nystatin Oral Suspension USP,NYSTATIN,100000UNIT,100,ORAL; ORAL,Actual shortage,SUSPENSION,,2023-11-27,2024-05-31,,Disruption of the manufacture of the drug.,2023-11-29,2024-03-11,No
189373,02433443,Shortage,JAMP-NYSTATIN ORAL SUSPENSION USP,JAMP PHARMA CORPORATION,Nystatin Oral Suspension USP,NYSTATIN,100000UNIT,500,ORAL; ORAL,Actual shortage,SUSPENSION,,2023-04-12,2024-04-15,,Other (Please describe in comments),2023-04-12,2024-03-11,No
202886,02458411,Shortage,JAMP-OLOPATADINE,JAMP PHARMA CORPORATION,Olopatadine Hydrochloride Ophthalmic Solution,OLOPATADINE,0.10%,5 mL,OPHTHALMIC; OPHTHALMIC,Actual shortage,SOLUTION,,2023-08-24,2024-12-31,,Other (Please describe in comments),2023-08-24,2024-03-30,No
183775,02368889,Shortage,JAMP-PAROXETINE,JAMP PHARMA CORPORATION,Paroxetine hydrochloride,PAROXETINE,30MG,100,ORAL; ORAL,Resolved,TABLET,,2023-02-06,2025-12-31,2024-04-15,Other (Please describe in comments),2023-02-06,2024-04-17,No
180253,02330970,Shortage,JAMP-PRAVASTATIN,JAMP PHARMA CORPORATION,Pravastatin Sodium Tablets,PRAVASTATIN SODIUM,40MG,100,ORAL; ORAL,Resolved,TABLET,,2022-12-09,2023-02-10,2023-02-01,Disruption of the manufacture of the drug.,2023-01-10,2023-02-03,No
183677,02330970,Shortage,JAMP-PRAVASTATIN,JAMP PHARMA CORPORATION,Pravastatin Sodium,PRAVASTATIN SODIUM,40MG,30,ORAL; ORAL,Resolved,TABLET,,2023-02-06,2023-04-10,2023-03-31,Demand increase for the drug.,2023-02-06,2023-04-03,No
192211,02330962,Shortage,JAMP-PRAVASTATIN,JAMP PHARMA CORPORATION,"Pravastatin Sodium Tablets, USP",PRAVASTATIN SODIUM,20MG,100,ORAL; ORAL,Resolved,TABLET,,2023-05-10,2023-09-30,2023-09-14,Other (Please describe in comments),2023-05-11,2023-09-15,No
192214,02330962,Shortage,JAMP-PRAVASTATIN,JAMP PHARMA CORPORATION,"Pravastatin Sodium Tablets, USP",PRAVASTATIN SODIUM,20MG,30,ORAL; ORAL,Resolved,TABLET,,2023-05-10,2023-09-30,2023-09-14,Other (Please describe in comments),2023-05-11,2023-09-15,No
207292,02454319,Shortage,JAMP-RISPERIDONE,JAMP PHARMA CORPORATION,Risperidone,RISPERIDONE,1MG,30 mL,ORAL; ORAL,Actual shortage,SOLUTION,,2023-10-16,2024-05-15,,Other (Please describe in comments),2023-10-19,2023-11-15,No
183778,02391279,Shortage,JAMP-ROSUVASTATIN,JAMP PHARMA CORPORATION,Rosuvastatin calcium,ROSUVASTATIN,20MG,100,ORAL; ORAL,Resolved,TABLET,,2023-02-06,2025-12-31,2024-04-15,Other (Please describe in comments),2023-02-06,2024-04-17,No
183781,02391279,Shortage,JAMP-ROSUVASTATIN,JAMP PHARMA CORPORATION,Rosuvastatin calcium,ROSUVASTATIN,20MG,500,ORAL; ORAL,Resolved,TABLET,,2023-02-06,2025-12-31,2024-04-15,Other (Please describe in comments),2023-02-06,2024-04-17,No
211807,02469669,Shortage,JAMP-SILDENAFIL R,JAMP PHARMA CORPORATION,Sildenafil Tablets,SILDENAFIL,20MG,90,ORAL,Resolved,TABLET,,2023-11-27,2024-01-31,2024-01-26,Demand increase for the drug.,2023-11-29,2024-01-27,No
180262,02424339,Shortage,JAMP-SOLIFENACIN,JAMP PHARMA CORPORATION,Solifenacin Tablets,SOLIFENACIN SUCCINATE,5MG,100,ORAL; ORAL,Resolved,TABLET,,2022-12-09,2024-01-31,2024-04-15,Disruption of the manufacture of the drug.,2023-01-10,2024-04-17,No
180265,02424339,Shortage,JAMP-SOLIFENACIN,JAMP PHARMA CORPORATION,Solifenacin Tablets,SOLIFENACIN SUCCINATE,5MG,30,ORAL; ORAL,Resolved,TABLET,,2022-12-09,2024-01-31,2024-04-15,Disruption of the manufacture of the drug.,2023-01-10,2024-04-17,No
180292,02424347,Shortage,JAMP-SOLIFENACIN,JAMP PHARMA CORPORATION,Solifenacin Tablets,SOLIFENACIN SUCCINATE,10MG,100,ORAL; ORAL,Resolved,TABLET,,2022-12-09,2024-01-31,2024-04-15,Disruption of the manufacture of the drug.,2023-01-10,2024-04-17,No
204041,02472406,Shortage,JAMP-URSODIOL,JAMP PHARMA CORPORATION,Ursodiol Tablets,URSODIOL,500MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-09-08,2024-06-30,,Disruption of the manufacture of the drug.,2023-09-11,2024-03-12,No
207298,02472392,Shortage,JAMP-URSODIOL,JAMP PHARMA CORPORATION,Ursodiol Tablets,URSODIOL,250MG,500,ORAL; ORAL,Actual shortage,TABLET,,2023-10-16,2024-06-30,,Disruption of the manufacture of the drug.,2023-10-19,2024-03-12,No
207301,02472392,Shortage,JAMP-URSODIOL,JAMP PHARMA CORPORATION,Ursodiol Tablets,URSODIOL,250MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-10-16,2024-06-30,,Disruption of the manufacture of the drug.,2023-10-19,2024-03-12,No
211819,02449110,Shortage,JAMP-VITAMIN D,JAMP PHARMA CORPORATION,Cholecalciferol Capsules,VITAMIN D3,50000UNIT,100,ORAL; ORAL,Resolved,CAPSULE,,2023-11-27,2024-01-31,2024-01-31,Disruption of the manufacture of the drug.,2023-11-29,2024-02-05,No
180271,02482525,Shortage,JAMP-ZOLEDRONIC ACID,JAMP PHARMA CORPORATION,Zoledronic Acid for Injection,ZOLEDRONIC ACID,4MG,5,INTRAVENOUS,Resolved,SOLUTION,,2022-12-09,2023-10-15,2023-10-10,Disruption of the manufacture of the drug.,2023-01-10,2023-10-18,No
183220,02333872,Shortage,JANUMET,MERCK CANADA INC,sitagliptin and metformin hydrochloride tablets,METFORMIN HYDROCHLORIDE; SITAGLIPTIN,1000MG; 50MG,60,ORAL; ORAL,Resolved,TABLET,2023-02-06,2023-02-02,2023-02-06,2023-02-06,Demand increase for the drug.,2023-02-02,2023-02-07,No
187097,02333872,Shortage,JANUMET,MERCK CANADA INC,sitagliptin and metformin hydrochloride tablets,METFORMIN HYDROCHLORIDE; SITAGLIPTIN,1000MG; 50MG,60,ORAL; ORAL,Resolved,TABLET,2023-03-15,2023-03-15,2023-03-20,2023-03-17,Demand increase for the drug.,2023-03-15,2023-03-18,No
209562,02416794,Shortage,JANUMET XR,MERCK CANADA INC,sitagliptin and metformin hydrochloride modified-release tablets,METFORMIN HYDROCHLORIDE; SITAGLIPTIN,1000MG; 50MG,60,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),2023-11-08,2023-11-08,2023-11-10,2023-11-10,Demand increase for the drug.,2023-11-08,2023-11-11,No
197795,02416794,Shortage,JANUMET XR,MERCK CANADA INC,sitagliptin and metformin hydrochloride modified-release tablets,METFORMIN HYDROCHLORIDE; SITAGLIPTIN,1000MG; 50MG,60 TAB,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),2023-08-07,2023-08-03,2023-10-27,2023-10-25,Demand increase for the drug.,2023-07-07,2023-10-26,No
179856,02303922,Shortage,JANUVIA,MERCK CANADA INC,sitagliptin tablets (as sitagliptin phosphate monohydrate),SITAGLIPTIN,100MG,30,ORAL; ORAL,Resolved,TABLET,2023-01-04,2023-01-04,2023-01-27,2023-01-25,Demand increase for the drug.,2023-01-04,2023-01-26,No
182687,02303922,Shortage,JANUVIA,MERCK CANADA INC,sitagliptin tablets (as sitagliptin phosphate monohydrate),SITAGLIPTIN,100MG,30 Tab,ORAL; ORAL,Resolved,TABLET,2023-01-30,2023-01-30,2023-02-21,2023-02-21,Demand increase for the drug.,2023-01-30,2023-02-22,No
207195,02242163,Shortage,KADIAN,BGP PHARMA ULC,MORPHINE SULFATE,MORPHINE SULFATE,10MG,100BT,ORAL; ORAL,Resolved,CAPSULE (SUSTAINED-RELEASE),2023-11-08,2023-11-13,2023-12-12,2023-12-13,Disruption of the manufacture of the drug.,2023-10-17,2023-12-19,No
205233,02184443,Shortage,KADIAN,BGP PHARMA ULC,MORPHINE SULFATE,MORPHINE SULFATE,50MG,100BT,ORAL; ORAL,Resolved,CAPSULE (SUSTAINED-RELEASE),2023-09-27,2023-09-26,2023-10-24,2023-10-20,Disruption of the manufacture of the drug.,2023-09-26,2023-10-25,No
186132,00224391,Shortage,KETALAR,ERFA CANADA 2012 INC,Ketalar,KETAMINE,10MG,20ml,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,2023-03-26,2023-03-27,2023-10-06,2023-10-06,Shortage of an inactive ingredient or component.,2023-03-03,2023-10-07,No
186135,00224405,Shortage,KETALAR,ERFA CANADA 2012 INC,ketalar,KETAMINE,50MG,10ml,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,2023-03-26,2023-03-27,,2023-07-30,Shortage of an inactive ingredient or component.,2023-03-03,2023-08-16,No
204611,02246796,Shortage,KETAMINE HYDROCHLORIDE INJECTION USP,SANDOZ CANADA INCORPORATED,KETAMINE HCL,KETAMINE,50MG,2ML 10LIVI,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-09-18,2023-12-22,2023-12-22,Requirements related to complying with good manufacturing practices.,2023-09-18,2024-01-03,No
184644,02246796,Shortage,KETAMINE HYDROCHLORIDE INJECTION USP,SANDOZ CANADA INCORPORATED,KETAMINE HCL,KETAMINE,50MG,2ML,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-02-14,2023-07-14,2023-07-17,Disruption of the manufacture of the drug.,2023-02-14,2024-01-30,No
204614,02246796,Shortage,KETAMINE HYDROCHLORIDE INJECTION USP,SANDOZ CANADA INCORPORATED,KETAMINE HCL,KETAMINE,50MG,10ML 1LIVI,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,2023-11-20,,2023-12-18,2023-11-22,Requirements related to complying with good manufacturing practices.,2023-09-18,2023-11-23,No
187803,02246796,Shortage,KETAMINE HYDROCHLORIDE INJECTION USP,SANDOZ CANADA INCORPORATED,KETAMINE HTDROCHLORIDE INJECTION USP,KETAMINE,50MG,10ML 1LIVI,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,2023-03-24,2023-03-24,2023-07-14,2023-07-17,Disruption of the manufacture of the drug.,2023-03-24,2023-07-18,No
187807,02246795,Shortage,KETAMINE HYDROCHLORIDE INJECTION USP,SANDOZ CANADA INCORPORATED,KETAMINE HCL,KETAMINE,10MG,20ML 1LIVI,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,2023-10-02,2023-10-02,2023-12-22,2023-12-22,Disruption of the manufacture of the drug.,2023-03-24,2024-01-03,No
193726,02246795,Shortage,KETAMINE HYDROCHLORIDE INJECTION USP,SANDOZ CANADA INCORPORATED,KETAMINE HCL,KETAMINE,10MG,20ML 1LIVI,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-06-05,2023-07-07,2023-07-10,Requirements related to complying with good manufacturing practices.,2023-06-05,2023-07-11,No
198735,02245821,Shortage,KETOROLAC,AA PHARMA INC,KETOROLAC,KETOROLAC TROMETHAMINE,0.50%,10ML,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,2023-07-07,,2023-10-03,2023-10-03,Disruption of the manufacture of the drug.,2023-07-14,2023-10-04,No
194899,02245821,Shortage,KETOROLAC,AA PHARMA INC,Ketorolac,KETOROLAC TROMETHAMINE,0.50%,5ML,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,2023-06-14,,2023-10-03,2023-10-03,Disruption of the manufacture of the drug.,2023-06-14,2023-10-04,No
210268,02245821,Shortage,KETOROLAC,AA PHARMA INC,KETOROLAC,KETOROLAC TROMETHAMINE,0.50%,5ML,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,2023-11-15,,2024-02-02,2024-01-29,Disruption of the manufacture of the drug.,2023-11-15,2024-01-31,No
186515,02245821,Shortage,KETOROLAC,AA PHARMA INC,Ketorolac,KETOROLAC TROMETHAMINE,0.50%,5ML,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,2023-03-23,,2023-06-16,2023-06-12,Disruption of the manufacture of the drug.,2023-03-08,2023-06-13,No
188326,02245821,Shortage,KETOROLAC,AA PHARMA INC,Ketorolac,KETOROLAC TROMETHAMINE,0.50%,10ML,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,2023-03-30,,2023-06-16,2023-06-12,Disruption of the manufacture of the drug.,2023-03-30,2023-06-13,No
200810,02390582,Shortage,KETOROLAC TROMETHAMINE INJECTION USP,PFIZER CANADA ULC,KETOROLAC TROMETHAMINE INJECTION USP,KETOROLAC TROMETHAMINE,30MG,25 x 1ml vial,INTRAMUSCULAR; INTRAMUSCULAR,Actual shortage,SOLUTION,2023-09-29,,,,Disruption of the manufacture of the drug.,2023-08-03,2023-09-30,No
194929,02244947,Shortage,"KETOROLAC TROMETHAMINE INJECTION, USP",FRESENIUS KABI CANADA LTD,"KETOROLAC TROMETHAMINE INJECTION, USP",KETOROLAC TROMETHAMINE,30MG,1 mL,INTRAMUSCULAR; INTRAMUSCULAR,Resolved,LIQUID,2023-07-01,2023-07-01,2023-07-30,2023-07-30,Disruption of the manufacture of the drug.,2023-06-14,2023-08-01,No
188465,02460548,Shortage,KEVZARA,SANOFI-AVENTIS CANADA INC,KEVZARA 200,SARILUMAB,200MG,2,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION,,2023-03-31,2023-04-10,2023-04-04,Demand increase for the drug.,2023-03-31,2023-04-04,No
181429,02472961,Shortage,KEVZARA,SANOFI-AVENTIS CANADA INC,Kevzara 150,SARILUMAB,150MG,2,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION,,2023-01-17,2023-03-15,2023-03-14,Other (Please describe in comments),2023-01-18,2023-03-15,No
189382,02472961,Shortage,KEVZARA,SANOFI-AVENTIS CANADA INC,KEVZARA 150MG,SARILUMAB,150MG,2,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION,,2023-04-12,2023-07-31,2023-08-15,Demand increase for the drug.,2023-04-12,2023-08-16,No
197753,02228602,Shortage,KINEVAC,BRACCO IMAGING CANADA,Kinevac,SINCALIDE,5MCG,Box of 10 vials (5mcg),INTRAVENOUS; INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,2023-12-15,2024-01-05,2024-06-15,,Other (Please describe in comments),2023-07-06,2024-01-12,No
212529,02513870,Shortage,KIT FOR THE PREPARATION OF TECHNETIUM (99MTC) PYROPHOSPHATE INJECTION,ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS LTD.,PYROPHOSPHATE,TETRASODIUM PYROPHOSPHATE,12MG,5 vial kit,INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,2023-11-24,2023-11-24,2024-12-31,,Disruption of the manufacture of the drug.,2023-12-05,2023-12-05,No
187969,02329794,Shortage,KIT FOR THE PREPARATION OF TECHNETIUM TC 99M SESTAMIBI INJECTION,CURIUM CANADA INC,kit for the prepration of technetium tc 99m sestamibi injection,TETRAKIS [CU,1MG,10ml vial,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION; KIT,2023-03-27,,2023-04-04,2023-04-03,Delay in shipping of the drug.,2023-03-24,2023-04-05,No
183168,02329794,Shortage,KIT FOR THE PREPARATION OF TECHNETIUM TC 99M SESTAMIBI INJECTION,CURIUM CANADA INC,kit for the prepration of technetium tc 99m sestamibi injection,TETRAKIS [CU,1MG,10ml vial,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION; KIT,2023-02-02,2022-02-02,2023-02-20,2023-02-20,Other (Please describe in comments),2023-02-02,2023-02-21,No
196380,01928783,Shortage,KOFFEX DM,TEVA CANADA LIMITED,KOFFEX DM,DEXTROMETHORPHAN HYDROBROMIDE,15MG,250ML,ORAL; ORAL,Resolved,SYRUP,,2023-06-23,2024-01-10,2023-10-03,Disruption of the manufacture of the drug.,2023-06-26,2023-10-04,No
195231,01928783,Shortage,KOFFEX DM,TEVA CANADA LIMITED,KOFFEX DM,DEXTROMETHORPHAN HYDROBROMIDE,15MG,250ML,ORAL; ORAL,Resolved,SYRUP,,2023-06-16,2023-07-30,2023-06-20,Disruption of the manufacture of the drug.,2023-06-16,2023-06-21,No
200882,01928783,Shortage,KOFFEX DM,TEVA CANADA LIMITED,KOFFEX DM,DEXTROMETHORPHAN HYDROBROMIDE,15MG,2L,ORAL; ORAL,Resolved,SYRUP,,2023-08-03,2024-01-30,2023-10-03,Disruption of the manufacture of the drug.,2023-08-03,2023-10-04,No
195640,01928791,Shortage,KOFFEX DM  (SUCROSE FREE),TEVA CANADA LIMITED,KOFFEX DM  (SUCROSE FREE),DEXTROMETHORPHAN HYDROBROMIDE,15MG,2L,ORAL; ORAL,Resolved,SYRUP,,2023-06-19,2023-07-30,2023-07-05,Disruption of the manufacture of the drug.,2023-06-19,2023-07-06,No
188188,00399736,Shortage,L-ARGININE HYDROCHLORIDE INJECTION,SANDOZ CANADA INCORPORATED,L-ARGININE HYDROCHLORIDE INJECTION,ARGININE HYDROCHLORIDE,250MG,30 ML 1LIVI,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,,2023-03-28,2024-02-16,2024-02-06,Delay in shipping of the drug.,2023-03-28,2024-02-07,No
211034,02512890,Shortage,LACOSAMIDE,SANIS HEALTH INC,LACOSAMIDE,LACOSAMIDE,150MG,60,ORAL,Resolved,TABLET,,2023-11-17,2024-01-22,2024-01-22,Disruption of the manufacture of the drug.,2023-11-22,2024-01-30,No
200437,02512882,Shortage,LACOSAMIDE,SANIS HEALTH INC,LACOSAMIDE,LACOSAMIDE,100MG,60,ORAL,Resolved,TABLET,,2023-07-31,2023-10-30,2023-10-31,Disruption of the manufacture of the drug.,2023-07-31,2023-11-06,No
180326,00039470,Shortage,LACTATED RINGER'S INJECTION,ICU MEDICAL CANADA INC,Lactated Ringer's Injection USP,SODIUM LACTATE; CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE,3.1MG; 0.2MG; 0.3MG; 6MG,1000 mL,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2023-01-23,,2023-02-13,2023-02-14,Disruption of the manufacture of the drug.,2023-01-10,2023-02-23,No
210469,02459973,Shortage,LANCORA,SERVIER CANADA INC,Ivabradine,IVABRADINE,5MG,56's,ORAL; ORAL,Resolved,TABLET,,2023-11-15,2023-11-24,2023-11-21,Delay in shipping of the drug.,2023-11-17,2023-11-22,No
207976,02459973,Shortage,LANCORA,SERVIER CANADA INC,Ivabradine,IVABRADINE,5MG,56's,ORAL; ORAL,Resolved,TABLET,,2023-10-18,2023-11-10,2023-11-02,Delay in shipping of the drug.,2023-10-24,2023-11-03,No
198933,02357690,Shortage,LANSOPRAZOLE,SANIS HEALTH INC,LANSOPRAZOLE,LANSOPRAZOLE,30MG,500,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-07-18,,2023-09-05,Disruption of the manufacture of the drug.,2023-07-18,2023-09-19,No
187015,02251930,Shortage,LANTUS,SANOFI-AVENTIS CANADA INC,LANTUS CARTRIDGES,INSULIN GLARGINE,100UNIT,5,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION,2023-03-14,,2023-03-29,2023-03-24,Other (Please describe in comments),2023-03-13,2023-03-25,No
182411,02251930,Shortage,LANTUS,SANOFI-AVENTIS CANADA INC,LANTUS CARTRIDGES,INSULIN GLARGINE,100UNIT,5,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION,,2023-01-23,2023-02-10,2023-02-07,Other (Please describe in comments),2023-01-26,2023-02-09,No
213961,02251930,Shortage,LANTUS,SANOFI-AVENTIS CANADA INC,Lantus Cartridges,INSULIN GLARGINE,100UNIT,3 ml,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION,2024-01-02,2024-01-03,2024-02-23,2024-02-22,Other (Please describe in comments),2023-12-20,2024-02-23,No
213964,02294338,Shortage,LANTUS,SANOFI-AVENTIS CANADA INC,Lantus Solostar,INSULIN GLARGINE,100UNIT,3 ml,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION,,2023-12-20,2024-02-23,2024-02-12,Other (Please describe in comments),2023-12-20,2024-02-13,No
210570,02224720,Shortage,LASIX ORAL SOLUTION,SANOFI-AVENTIS CANADA INC,LASIX,FUROSEMIDE,10MG,1,ORAL; ORAL,Resolved,SOLUTION,,2023-11-15,2023-11-30,2023-11-21,Other (Please describe in comments),2023-11-17,2023-11-23,No
184721,02224755,Shortage,LASIX SPECIAL,SANOFI-AVENTIS CANADA INC,LASIX SPECIAL,FUROSEMIDE,500MG,Bottle of 20 tablets,ORAL; ORAL,Resolved,TABLET,,2023-02-14,2023-03-31,2023-03-10,Other (Please describe in comments),2023-02-15,2023-03-16,No
193838,02489368,Shortage,LATANOPROST AND TIMOLOL OPHTHALMIC SOLUTION,HIKMA CANADA LIMITED,LATANOPROST AND TIMOLOL OPHTHALMIC SOLUTION,TIMOLOL; LATANOPROST,5MG; 50MCG,2.5mL,OPHTHALMIC,Actual shortage,SOLUTION,2023-06-26,,,,Demand increase for the drug.,2023-06-06,2023-06-27,No
197620,02351668,Shortage,LEFLUNOMIDE,SANIS HEALTH INC,LEFLUNOMIDE,LEFLUNOMIDE,10MG,30,ORAL; ORAL,Resolved,TABLET,,2023-07-05,,2023-09-22,Disruption of the manufacture of the drug.,2023-07-05,2023-09-25,No
197624,02351676,Shortage,LEFLUNOMIDE,SANIS HEALTH INC,LEFLUNOMIDE,LEFLUNOMIDE,20MG,30,ORAL; ORAL,Resolved,TABLET,,2023-07-05,2023-11-03,2023-11-03,Disruption of the manufacture of the drug.,2023-07-05,2023-11-06,No
184317,02087316,Shortage,LEUCOVORIN CALCIUM INJECTION,TEVA CANADA LIMITED,LEUCOVORIN CALCIUM INJECTION,LEUCOVORIN,10MG,1,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,2023-02-15,,2023-03-15,2023-03-22,Demand increase for the drug.,2023-02-10,2023-03-23,No
198904,02353350,Shortage,LEVETIRACETAM,SANIS HEALTH INC,LEVETIRACETAM,LEVETIRACETAM,500MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-18,,2023-09-22,Disruption of the manufacture of the drug.,2023-07-18,2023-09-25,No
198907,02353369,Shortage,LEVETIRACETAM,SANIS HEALTH INC,LEVETIRACETAM,LEVETIRACETAM,750MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-18,2023-08-25,2023-08-25,Disruption of the manufacture of the drug.,2023-07-18,2023-08-28,No
193609,02314932,Shortage,LEVOFLOXACIN IN 5% DEXTROSE INJECTION,PFIZER CANADA ULC,LEVOFLOXACIN IN 5% DEXTROSE INJECTION,LEVOFLOXACIN,5MG,24 x 50mL bag,INTRAVENOUS; INTRAVENOUS,Actual shortage,SOLUTION,,2023-09-16,2024-07-15,,Shortage of an inactive ingredient or component.,2023-06-02,2024-01-19,No
189581,02314932,Shortage,LEVOFLOXACIN IN 5% DEXTROSE INJECTION,PFIZER CANADA ULC,LEVOFLOXACIN IN 5% DEXTROSE INJECTION,LEVOFLOXACIN,5MG,24 x 150mL bag,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-06-19,,2023-11-22,Shortage of an inactive ingredient or component.,2023-04-14,2023-11-23,No
183509,02461722,Shortage,LEVOTHYROXINE SODIUM FOR INJECTION,AVIR PHARMA INC.,Levothyroxine 500mcg,LEVOTHYROXINE SODIUM,500MCG,vial,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,2023-03-01,,2023-03-03,2023-03-02,Delay in shipping of the drug.,2023-02-03,2023-03-06,No
187645,02245948,Shortage,LEVOTHYROXINE SODIUM FOR INJECTION,FRESENIUS KABI CANADA LTD,LEVOTHYROXINE SODIUM FOR INJECTION,LEVOTHYROXINE SODIUM,500MCG,10mL,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,2023-03-31,2023-03-31,2023-06-15,2023-06-16,Disruption of the manufacture of the drug.,2023-03-22,2023-07-20,No
198413,01901915,Shortage,LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP,PFIZER CANADA ULC,LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP,EPINEPHRINE; LIDOCAINE HYDROCHLORIDE,0.01MG; 20MG,25 x 20mL vial,BLOCK/INFILTRATION; BLOCK/INFILTRATION,Actual shortage,SOLUTION; SOLUTION,,2023-07-12,,,Disruption of the manufacture of the drug.,2023-07-13,2023-12-01,No
205384,02522268,Shortage,LIDOCAINE HYDROCHLORIDE INJECTION,LABORATOIRE AGUETTANT,LIDOCAINE HYDROCHLORIDE INJECTION,LIDOCAINE HYDROCHLORIDE,100MG,10 x 5 mL,INTRAVENOUS,Resolved,SOLUTION,2023-09-28,2023-10-06,2023-10-16,2023-10-13,Delay in shipping of the drug.,2023-09-28,2023-10-14,No
207616,02422018,Shortage,LIDOCAINE HYDROCHLORIDE INJECTION USP,HIKMA CANADA LIMITED,LIDOCAINE HYDROCHLORIDE INJECTION USP,LIDOCAINE HYDROCHLORIDE,10MG,20mL,BLOCK/INFILTRATION; BLOCK/INFILTRATION,Resolved,SOLUTION,2023-11-01,,2024-03-08,2024-03-05,Delay in shipping of the drug.,2023-10-20,2024-03-06,No
207619,02422018,Shortage,LIDOCAINE HYDROCHLORIDE INJECTION USP,HIKMA CANADA LIMITED,LIDOCAINE HYDROCHLORIDE INJECTION USP,LIDOCAINE HYDROCHLORIDE,10MG,50mL,BLOCK/INFILTRATION; BLOCK/INFILTRATION,Resolved,SOLUTION,2023-11-01,,2024-03-31,2024-04-08,Delay in shipping of the drug.,2023-10-20,2024-04-09,No
213834,01901982,Shortage,LIDOCAINE HYDROCHLORIDE INJECTION USP,PFIZER CANADA ULC,LIDOCAINE HYDROCHLORIDE INJECTION USP,LIDOCAINE HYDROCHLORIDE,20MG,25 x 20mL vial,BLOCK/INFILTRATION; BLOCK/INFILTRATION,Actual shortage,SOLUTION,,2024-04-09,,,Disruption of the manufacture of the drug.,2023-12-19,2024-04-10,No
200795,00436208,Shortage,LIDOCAINE HYDROCHLORIDE INJECTION USP,PFIZER CANADA ULC,LIDOCAINE HYDROCHLORIDE INJECTION USP,LIDOCAINE HYDROCHLORIDE,20MG,10 x 5ml ANSYR syringe,INTRAVENOUS; INTRAVENOUS,Actual shortage,SOLUTION,,2023-08-03,,,Disruption of the manufacture of the drug.,2023-08-03,2023-08-04,No
200813,00884154,Shortage,LIDOCAINE HYDROCHLORIDE INJECTION USP,PFIZER CANADA ULC,LIDOCAINE HYDROCHLORIDE INJECTION USP,LIDOCAINE HYDROCHLORIDE,10MG,25 x 20ml vial,BLOCK/INFILTRATION; BLOCK/INFILTRATION,Actual shortage,SOLUTION,,2024-04-01,,,Disruption of the manufacture of the drug.,2023-08-03,2024-04-10,No
180719,00436208,Shortage,LIDOCAINE HYDROCHLORIDE INJECTION USP,PFIZER CANADA ULC,LIDOCAINE HYDROCHLORIDE INJECTION USP,LIDOCAINE HYDROCHLORIDE,20MG,10x 5mL LifeShield syringe,INTRAVENOUS; INTRAVENOUS,Actual shortage,SOLUTION,,2023-02-21,,,Disruption of the manufacture of the drug.,2023-01-12,2023-08-01,No
196707,02269074,Shortage,LIPIDIL EZ,BGP PHARMA ULC,FENOFIBRATE,FENOFIBRATE,48MG,3x10 CA,ORAL; ORAL,Resolved,TABLET,2023-07-26,2023-07-24,,2023-11-06,Disruption of the manufacture of the drug.,2023-06-27,2023-11-14,No
189897,02269074,Shortage,LIPIDIL EZ,BGP PHARMA ULC,FENOFIBRATE,FENOFIBRATE,48MG,3x10,ORAL; ORAL,Avoided shortage,TABLET,2023-06-07,,2023-07-25,2023-05-01,Disruption of the manufacture of the drug.,2023-04-20,2023-05-01,No
191722,02243097,Shortage,LIPITOR,UPJOHN CANADA ULC,LIPITOR,ATORVASTATIN,80MG,30,ORAL; ORAL,Resolved,TABLET,2023-06-14,2023-06-06,2023-08-22,2023-08-15,Disruption of the manufacture of the drug.,2023-05-05,2023-10-03,No
212786,02266695,Shortage,LITHMAX,AA PHARMA INC,LITNMAX,LITHIUM CARBONATE,300MG,100 BTL,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),2023-12-07,,2024-01-22,2024-01-19,Disruption of the manufacture of the drug.,2023-12-07,2024-01-20,No
185707,02458667,Shortage,LIXIANA,SERVIER CANADA INC,ÉDOXABAN,EDOXABAN,60MG,30's,ORAL; ORAL,Resolved,TABLET,,2023-02-24,2023-03-10,2023-03-08,Delay in shipping of the drug.,2023-02-28,2023-03-09,No
202915,02458640,Shortage,LIXIANA,SERVIER CANADA INC,Edoxaban tablets,EDOXABAN,15MG,30's,ORAL; ORAL,Resolved,TABLET,,2023-08-24,2023-09-20,2023-09-08,Other (Please describe in comments),2023-08-24,2023-09-09,No
213206,00224235,Shortage,LMD 10% IN DEXTROSE 5%,PFIZER CANADA ULC,LMD 10% IN DEXTROSE 5%,DEXTROSE; DEXTRAN,5%; 10%,12 X 500ML,INTRAVENOUS; INTRAVENOUS,Actual shortage,SOLUTION,,2024-01-31,2024-06-28,,Disruption of the manufacture of the drug.,2023-12-13,2024-04-10,No
203880,00074462,Shortage,LOCACORTEN VIOFORM,PALADIN LABS INC.,Locacorten cream,FLUMETHASONE PIVALATE; CLIOQUINOL,0.02%; 3%,11 mL,TOPICAL; TOPICAL,Actual shortage,CREAM,,2023-08-21,2024-05-24,,Shortage of an active ingredient.,2023-09-07,2024-02-20,No
180700,02373955,Shortage,LODALIS,"BAUSCH HEALTH, CANADA INC.",LODALIS,COLESEVELAM HYDROCHLORIDE,625MG,180s,ORAL; ORAL,Resolved,TABLET,2023-02-14,2023-01-31,2023-03-10,2023-03-03,Other (Please describe in comments),2023-01-11,2023-03-04,No
185710,00036323,Shortage,LOMOTIL,PFIZER CANADA ULC,LOMOTIL,ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE,.025MG; 2.5MG,1 x 250's,ORAL; ORAL,Resolved,TABLET,2023-03-15,2023-03-08,2023-10-18,2023-10-16,Disruption of the manufacture of the drug.,2023-02-28,2023-10-17,No
192270,02410745,Shortage,LORAZEPAM SUBLINGUAL,AA PHARMA INC,Lorazepam Sublingual,LORAZEPAM,0.5MG,100BTL,SUBLINGUAL; SUBLINGUAL,Resolved,TABLET,2023-05-11,,2023-07-10,2023-07-14,Disruption of the manufacture of the drug.,2023-05-11,2023-07-15,No
183599,02410745,Shortage,LORAZEPAM SUBLINGUAL,AA PHARMA INC,Lorazepam Sublingual,LORAZEPAM,0.5MG,100BTL,SUBLINGUAL; SUBLINGUAL,Resolved,TABLET,2023-02-28,,2023-04-20,2023-04-14,Disruption of the manufacture of the drug.,2023-02-03,2023-04-17,No
185682,02410753,Shortage,LORAZEPAM SUBLINGUAL,AA PHARMA INC,Lorazepam SBL,LORAZEPAM,1MG,100BTL,SUBLINGUAL; SUBLINGUAL,Resolved,TABLET,2023-02-28,,2023-04-25,2023-04-25,Disruption of the manufacture of the drug.,2023-02-28,2023-05-01,No
213267,02242462,Shortage,LOSEC MUPS,CHEPLAPHARM ARZNEIMITTEL GMBH,Omeprazole,OMEPRAZOLE,20MG,50 Tablet,ORAL,Actual shortage,TABLET (DELAYED-RELEASE),,2023-12-13,2024-04-30,,Disruption of the manufacture of the drug.,2023-12-13,2024-03-27,No
198185,02378426,Shortage,LOVENOX,SANOFI-AVENTIS CANADA INC,LOVENOX,ENOXAPARIN SODIUM,60MG,10,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION,,2023-07-13,2023-07-28,2023-07-18,Other (Please describe in comments),2023-07-11,2023-07-19,No
182116,02378426,Shortage,LOVENOX,SANOFI-AVENTIS CANADA INC,Lovenox 60 mg,ENOXAPARIN SODIUM,60MG,10,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION,,2023-01-19,2023-02-10,2023-02-10,Other (Please describe in comments),2023-01-20,2023-02-11,No
185718,02242692,Shortage,LOVENOX HP,SANOFI-AVENTIS CANADA INC,LOVENOX HP 120 MG / 0.8 ML,ENOXAPARIN SODIUM,120MG,10,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION,2023-03-20,2023-04-13,2023-05-23,2023-05-16,Other (Please describe in comments),2023-02-28,2023-05-17,No
184402,02236564,Shortage,LOVENOX WITH PRESERVATIVE 300MG/3ML,SANOFI-AVENTIS CANADA INC,LOVENOX WITH PRESERVATIVE 300MG/3ML,ENOXAPARIN SODIUM,100MG,1,SUBCUTANEOUS; INTRAVENOUS; SUBCUTANEOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-02-07,2023-05-31,2023-05-11,Other (Please describe in comments),2023-02-10,2023-05-12,No
187444,02169991,Shortage,LOXAPAC IM,SANDOZ CANADA INCORPORATED,LOXAPAC IM,LOXAPINE,50MG,1ML,INTRAMUSCULAR; INTRAMUSCULAR,Resolved,LIQUID,,2023-03-20,2023-04-14,2023-04-04,Demand increase for the drug.,2023-03-20,2023-04-05,No
193299,02469170,Shortage,LUPIN-CEPHALEXIN,LUPIN PHARMA CANADA LIMITED,CEPHALEXIN,CEPHALEXIN,125MG,BO 100mL & BO 150mL,ORAL; ORAL,Resolved,POWDER FOR SUSPENSION,,2023-05-29,,2023-09-12,Demand increase for the drug.,2023-05-29,2023-09-13,No
193303,02469189,Shortage,LUPIN-CEPHALEXIN,LUPIN PHARMA CANADA LIMITED,LUPIN-CEPHALEXIN,CEPHALEXIN,250MG,BO 150mL; BO 100mL,ORAL; ORAL,Resolved,POWDER FOR SUSPENSION,,2023-05-29,,2023-09-12,Demand increase for the drug.,2023-05-29,2023-09-13,No
179775,02469170,Shortage,LUPIN-CEPHALEXIN,LUPIN PHARMA CANADA LIMITED,LUPIN-CEPHALEXIN,CEPHALEXIN,125MG,100 ml and 150 ml,ORAL; ORAL,Resolved,POWDER FOR SUSPENSION,,2023-01-03,2023-07-31,2023-01-16,Demand increase for the drug.,2023-01-04,2023-01-17,No
181400,02469189,Shortage,LUPIN-CEPHALEXIN,LUPIN PHARMA CANADA LIMITED,LUPIN-CEPHALEXIN,CEPHALEXIN,250MG,100 ML,ORAL; ORAL,Resolved,POWDER FOR SUSPENSION,,2023-01-18,2023-04-04,2023-04-05,Demand increase for the drug.,2023-01-18,2023-04-06,No
206745,02469189,Shortage,LUPIN-CEPHALEXIN,LUPIN PHARMA CANADA LIMITED,LUPIN-CEPHALEXIN,CEPHALEXIN,250MG,"100 mL, 150mL",ORAL; ORAL,Resolved,POWDER FOR SUSPENSION,,2024-01-18,2024-01-31,2024-02-05,Demand increase for the drug.,2023-10-11,2024-02-06,No
181417,02469170,Shortage,LUPIN-CEPHALEXIN,LUPIN PHARMA CANADA LIMITED,LUPIN-CEPHALEXIN,CEPHALEXIN,125MG,150 ml,ORAL; ORAL,Resolved,POWDER FOR SUSPENSION,,2023-01-03,2023-07-31,2023-04-05,Demand increase for the drug.,2023-01-18,2023-04-06,No
181214,02469189,Shortage,LUPIN-CEPHALEXIN,LUPIN PHARMA CANADA LIMITED,LUPIN-CEPHALEXIN,CEPHALEXIN,250MG,150 ML,ORAL; ORAL,Resolved,POWDER FOR SUSPENSION,,2023-02-08,2023-04-30,2023-04-05,Demand increase for the drug.,2023-01-16,2023-04-06,No
204786,02469189,Shortage,LUPIN-CEPHALEXIN,LUPIN PHARMA CANADA LIMITED,LUPIN-CEPHALEXIN,CEPHALEXIN,250MG,150mL,ORAL; ORAL,Resolved,POWDER FOR SUSPENSION,,2023-09-09,2023-10-10,2023-10-10,Demand increase for the drug.,2023-09-20,2023-10-10,No
203103,01919342,Shortage,LUVOX,BGP PHARMA ULC,FLUVOXAMINE MALEATE,FLUVOXAMINE MALEATE,50MG,2x15BL,ORAL; ORAL,Resolved,TABLET,2023-10-09,2023-10-13,2024-01-09,2024-01-09,Disruption of the manufacture of the drug.,2023-08-29,2024-01-16,No
212590,02268418,Shortage,LYRICA,BGP PHARMA ULC,pregabalin,PREGABALIN,25MG,60 caps/bottle,ORAL; ORAL,Resolved,CAPSULE,2023-12-27,2023-12-16,2024-02-20,2024-02-09,Disruption of the manufacture of the drug.,2023-12-06,2024-02-29,No
184559,02268434,Shortage,LYRICA,UPJOHN CANADA ULC,LYRICA,PREGABALIN,75MG,60,ORAL; ORAL,Resolved,CAPSULE,2023-03-09,2023-03-14,,2023-05-10,Disruption of the manufacture of the drug.,2023-02-14,2023-06-13,No
182169,02519690,Shortage,M-BETAHISTINE,MANTRA PHARMA INC,M-Betahistine,BETAHISTINE HYDROCHLORIDE,16MG,100,ORAL,Resolved,TABLET,,2023-01-16,2023-03-20,2023-03-03,Delay in shipping of the drug.,2023-01-20,2023-03-06,No
185130,02502283,Shortage,M-CLOPIDOGREL,MANTRA PHARMA INC,Clopidogrel,CLOPIDOGREL,75MG,30,ORAL,Resolved,TABLET,,2023-02-13,2023-02-28,2023-03-02,Delay in shipping of the drug.,2023-02-20,2023-03-06,No
185133,02471302,Shortage,M-VENLAFAXINE XR,MANTRA PHARMA INC,M-Venlafaxine XR,VENLAFAXINE,150MG,500,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2023-01-16,2023-11-30,2023-11-27,Delay in shipping of the drug.,2023-02-20,2023-12-04,No
182171,02471302,Shortage,M-VENLAFAXINE XR,MANTRA PHARMA INC,M-Venlafaxine xr,VENLAFAXINE,150MG,500,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2023-01-16,2023-11-30,2023-11-27,Delay in shipping of the drug.,2023-01-20,2023-12-04,No
207255,02290960,Shortage,MABCAMPATH,"SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC",Alemtuzumab,ALEMTUZUMAB,30MG,1 ml vial,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-10-18,2023-12-25,2023-12-18,Disruption of the manufacture of the drug.,2023-10-18,2023-12-19,No
184959,00392618,Shortage,MAGNESIUM SULFATE INJ 20% USP,SANDOZ CANADA INCORPORATED,MAGNESIUM,MAGNESIUM SULFATE,200MG,10ML,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-02-02,2023-07-21,2023-07-24,Disruption of the manufacture of the drug.,2023-02-16,2023-07-25,No
181990,00392618,Shortage,MAGNESIUM SULFATE INJ 20% USP,SANDOZ CANADA INCORPORATED,MAGNESIUM,MAGNESIUM SULFATE,200MG,10ML,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-01-18,2023-02-03,2023-02-02,Disruption of the manufacture of the drug.,2023-01-20,2023-02-16,No
190045,02264935,Shortage,MALARONE PEDIATRIC,GLAXOSMITHKLINE INC,atovaquone and proguanil hydrochloride tablets,PROGUANIL HYDROCHLORIDE; ATOVAQUONE,25.0MG; 62.5MG,12s,ORAL; ORAL,Resolved,TABLET,,2023-04-17,,2023-06-19,Disruption of the manufacture of the drug.,2023-04-21,2023-06-21,No
200816,00038024,Shortage,MANNITOL INJECTION USP,PFIZER CANADA ULC,MANNITOL INJECTION USP,MANNITOL,25%,25 x 50ml vial,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2024-04-15,,,2024-04-16,Disruption of the manufacture of the drug.,2023-08-03,2024-04-17,No
200395,00038016,Shortage,MANNITOL INJECTION USP,ICU MEDICAL CANADA INC,MANNITOL INJECTION USP,MANNITOL,20%,500 mL,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2023-09-22,,2023-10-20,2023-10-13,Disruption of the manufacture of the drug.,2023-07-28,2023-10-18,No
213726,02492377,Shortage,MAR-APIXABAN,MARCAN PHARMACEUTICALS INC,Apixaban,APIXABAN,5MG,500,ORAL,Resolved,TABLET,2023-12-18,2023-12-19,2024-02-28,2024-01-16,Demand increase for the drug.,2023-12-18,2024-01-17,No
213720,02379694,Shortage,MAR-CIPROFLOXACIN,MARCAN PHARMACEUTICALS INC,Ciprofloxacin,CIPROFLOXACIN,500MG,100,ORAL; ORAL,Resolved,TABLET,2023-12-18,,2024-04-30,2024-04-22,Demand increase for the drug.,2023-12-18,2024-04-23,No
214358,02446081,Shortage,MAR-DULOXETINE,MARCAN PHARMACEUTICALS INC,Duloxetine,DULOXETINE,30MG,100,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),2023-12-27,,2024-03-15,2024-03-11,Demand increase for the drug.,2023-12-27,2024-03-12,No
184738,02480107,Shortage,MAR-METHIMAZOLE,MARCAN PHARMACEUTICALS INC,MAR-Methimazole,METHIMAZOLE,5MG,100,ORAL; ORAL,Resolved,TABLET,,2023-02-16,2023-03-10,2023-03-03,Shortage of an active ingredient.,2023-02-16,2023-03-10,No
206808,02399997,Shortage,MAR-MONTELUKAST,MARCAN PHARMACEUTICALS INC,Montelukast,MONTELUKAST,10MG,30,ORAL; ORAL,Actual shortage,TABLET; TABLET,2023-10-01,2023-10-11,2024-10-31,,Disruption of the manufacture of the drug.,2023-10-11,2023-10-12,No
213723,02511673,Shortage,MAR-MYCOPHENOLIC ACID,MARCAN PHARMACEUTICALS INC,Mycophenolic Acid,MYCOPHENOLIC ACID,180MG,120,ORAL,Resolved,TABLET (ENTERIC-COATED),,2023-12-18,2024-02-28,2024-01-16,Demand increase for the drug.,2023-12-18,2024-01-17,No
206848,02305909,Shortage,MARCAINE,PFIZER CANADA ULC,MARCAINE,BUPIVACAINE HYDROCHLORIDE,250MG,10 x 20mL vial,BLOCK/INFILTRATION; BLOCK/INFILTRATION,Avoided shortage,SOLUTION; SOLUTION,2023-11-08,,,2023-10-22,Disruption of the manufacture of the drug.,2023-10-12,2023-10-23,No
189856,02241917,Shortage,MARCAINE,PFIZER CANADA ULC,MARCAINE,BUPIVACAINE HYDROCHLORIDE,150MG,10 x 20mL vial,EPIDURAL; RETROBULBAR; EPIDURAL; RETROBULBAR,Resolved,SOLUTION; SOLUTION,,2023-04-18,,2023-04-27,Disruption of the manufacture of the drug.,2023-04-19,2023-04-28,No
206248,02305909,Shortage,MARCAINE,PFIZER CANADA ULC,MARCAINE,BUPIVACAINE HYDROCHLORIDE,250MG,50mL vial,BLOCK/INFILTRATION; BLOCK/INFILTRATION,Avoided shortage,SOLUTION; SOLUTION,2023-11-16,,,2023-10-11,Disruption of the manufacture of the drug.,2023-10-04,2023-10-12,No
200041,02241915,Shortage,MARCAINE E,PFIZER CANADA ULC,MARCAINE E,EPINEPHRINE BITARTRATE; BUPIVACAINE HYDROCHLORIDE,0.182MG; 50MG,10 x 20mL vial,EPIDURAL; BLOCK/INFILTRATION; EPIDURAL; BLOCK/INFILTRATION,Resolved,SOLUTION,,2023-08-02,,2023-09-12,Disruption of the manufacture of the drug.,2023-07-26,2023-09-13,No
192966,02241916,Shortage,MARCAINE E,PFIZER CANADA ULC,MARCAINE E,EPINEPHRINE BITARTRATE; BUPIVACAINE HYDROCHLORIDE,0.182MG; 100MG,10 x 20mL vial,EPIDURAL; BLOCK/INFILTRATION; EPIDURAL; BLOCK/INFILTRATION,Resolved,SOLUTION,,2023-05-24,,2023-09-12,Disruption of the manufacture of the drug.,2023-05-24,2023-09-13,No
207832,02241915,Shortage,MARCAINE E,PFIZER CANADA ULC,MARCAINE E,EPINEPHRINE BITARTRATE; BUPIVACAINE HYDROCHLORIDE,0.182MG; 50MG,10 x 20mL vial,EPIDURAL; BLOCK/INFILTRATION; EPIDURAL; BLOCK/INFILTRATION,Actual shortage,SOLUTION,,2023-11-13,,,Disruption of the manufacture of the drug.,2023-10-23,2024-04-18,Yes
213236,02241916,Shortage,MARCAINE E,PFIZER CANADA ULC,MARCAINE E,EPINEPHRINE BITARTRATE; BUPIVACAINE HYDROCHLORIDE,0.182MG; 100MG,10 x 20mL vial,EPIDURAL; BLOCK/INFILTRATION; EPIDURAL; BLOCK/INFILTRATION,Actual shortage,SOLUTION,,2024-02-05,,,Disruption of the manufacture of the drug.,2023-12-13,2024-04-18,No
187527,02240519,Shortage,MAXALT RPD,ORGANON CANADA INC.,rizatriptan benzoate wafers,RIZATRIPTAN,10MG,12,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-03-20,2023-04-14,2023-04-04,Delay in shipping of the drug.,2023-03-20,2023-04-05,No
185520,02240518,Shortage,MAXALT RPD,ORGANON CANADA INC.,rizatriptan benzoate wafers,RIZATRIPTAN,5MG,12,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-02-23,2023-05-26,2023-05-26,Demand increase for the drug.,2023-02-23,2023-05-27,No
213920,00030988,Shortage,MEDROL 4 MG,PFIZER CANADA ULC,MEDROL 4 MG,METHYLPREDNISOLONE,4MG,1X100 BOTTLE,ORAL; ORAL,Actual shortage,TABLET,,2024-02-21,2024-05-15,,Disruption of the manufacture of the drug.,2023-12-20,2024-03-13,No
210273,02229452,Shortage,MEFENAMIC,AA PHARMA INC,MEFENAMIC,MEFENAMIC ACID,250MG,100 BTL,ORAL; ORAL,Resolved,CAPSULE,2023-11-15,,2024-01-29,2024-01-26,Disruption of the manufacture of the drug.,2023-11-15,2024-01-31,No
202753,02244366,Shortage,MEFLOQUINE,AA PHARMA INC,Mefloquine,MEFLOQUINE,250MG,8BLS,ORAL; ORAL,Resolved,TABLET,2023-08-23,,2023-09-13,2023-09-13,Disruption of the manufacture of the drug.,2023-08-23,2023-09-14,No
188323,02195917,Shortage,MEGESTROL,AA PHARMA INC,Megestrol,MEGESTROL ACETATE,40MG,100BTL,ORAL; ORAL,Resolved,TABLET,2023-04-30,,2023-08-19,2023-08-15,Disruption of the manufacture of the drug.,2023-03-30,2023-08-23,No
181343,02279924,Shortage,MENACTRA,SANOFI PASTEUR LIMITED,MENACTRA,"MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP W 135; MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP Y; MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP C; MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP A",4.0MCG; 4.0MCG; 4.0MCG; 4.0MCG,5x1,INTRAMUSCULAR; INTRAMUSCULAR,Resolved,SOLUTION,2023-01-17,2023-01-17,2023-02-01,2023-01-24,Demand increase for the drug.,2023-01-17,2023-01-25,No
191773,02047667,Shortage,MERSYNDOL WITH CODEINE,SANOFI-AVENTIS CANADA INC,MERSYNDOL,ACETAMINOPHEN; DOXYLAMINE SUCCINATE; CODEINE PHOSPHATE,325MG; 5MG; 8MG,100,ORAL; ORAL,Resolved,TABLET,2023-05-08,2023-05-08,2023-07-07,2023-07-07,Other (Please describe in comments),2023-05-05,2023-07-10,No
201038,02244931,Shortage,MESNA FOR INJECTION,FRESENIUS KABI CANADA LTD,MESNA FOR INJECTION,MESNA,100MG,10mL,INTRAVENOUS; INTRAVENOUS,Actual shortage,SOLUTION,,2023-06-30,,,Disruption of the manufacture of the drug.,2023-08-03,2024-01-09,No
209512,02247700,Shortage,METADOL,PALADIN LABS INC.,Metadol 10mg tablets,METHADONE HYDROCHLORIDE,10MG,100 Tabs,ORAL; ORAL,Resolved,TABLET,,2023-11-07,2024-02-29,2024-02-29,Other (Please describe in comments),2023-11-07,2024-03-01,No
204173,02247701,Shortage,METADOL,PALADIN LABS INC.,Metadol 25mg Tabs,METHADONE HYDROCHLORIDE,25MG,100 Tabs,ORAL; ORAL,Resolved,TABLET,,2023-08-17,2023-10-10,2023-10-02,Other (Please describe in comments),2023-09-12,2023-10-03,No
210150,02247694,Shortage,METADOL,PALADIN LABS INC.,Metadol 1mg/mL 250mL,METHADONE HYDROCHLORIDE,1MG,250 mL,ORAL; ORAL,Resolved,SOLUTION,,2023-11-07,2024-01-15,2024-01-15,Delay in shipping of the drug.,2023-11-14,2024-01-16,No
185821,02244290,Shortage,METADOL-D,PALADIN LABS INC.,Metadol-D 1L,METHADONE HYDROCHLORIDE,10MG,1L,ORAL; ORAL,Resolved,SOLUTION,2023-03-01,2023-03-01,2023-03-13,2023-03-10,Delay in shipping of the drug.,2023-03-01,2023-03-11,No
203144,02353377,Shortage,METFORMIN,SANIS HEALTH INC,METFORMIN,METFORMIN HYDROCHLORIDE,500MG,360,ORAL; ORAL,Resolved,TABLET,,2023-08-25,,2023-09-15,Disruption of the manufacture of the drug.,2023-08-29,2023-09-19,No
188139,02263912,Shortage,METHACHOLINE OMEGA,OMEGA LABORATORIES LIMITED,Methacholine Chloride Powder For Inhalation Solution 1600mg,METHACHOLINE CHLORIDE,1600MG,1 x 50mL vial / fiole,INHALATION; INHALATION,Resolved,POWDER FOR SOLUTION,,2022-06-17,,2023-05-12,Shortage of an inactive ingredient or component.,2023-03-27,2023-05-13,No
196840,02245882,Shortage,METHAZOLAMIDE,AA PHARMA INC,Methazolamide,METHAZOLAMIDE,50MG,100BTL,ORAL; ORAL,Resolved,TABLET,2023-06-29,,2026-08-31,2023-07-27,Disruption of the manufacture of the drug.,2023-06-29,2023-08-03,No
183864,02238403,Shortage,METHOPRAZINE,AA PHARMA INC,Methoprazine,METHOTRIMEPRAZINE,2MG,100BTL,ORAL; ORAL,Resolved,TABLET,,2023-02-03,2023-03-15,2023-03-15,Disruption of the manufacture of the drug.,2023-02-08,2023-03-16,No
188454,02182955,Shortage,METHOTREXATE INJECTION USP,PFIZER CANADA ULC,METHOTREXATE INJECTION USP,METHOTREXATE,25MG,1 x 2mL vial,INTRAVENOUS; INTRATHECAL; INTRAMUSCULAR; INTRA-ARTERIAL; INTRACEREBROVENTRICULAR; INTRACEREBROVENTRICULAR; INTRAVENOUS; INTRATHECAL; INTRAMUSCULAR; INTRA-ARTERIAL,Resolved,SOLUTION,,2023-06-19,,2023-07-10,Disruption of the manufacture of the drug.,2023-03-31,2023-07-11,No
191746,02491346,Shortage,METHOTREXATE SUBCUTANEOUS,ACCORD HEALTHCARE INC,METHOTREXATE SUBCUTANEOUS,METHOTREXATE,20MG,1 vial,SUBCUTANEOUS,Resolved,SOLUTION,,2023-04-28,2023-05-19,2023-05-17,Disruption of the manufacture of the drug.,2023-05-05,2023-05-18,No
197905,02491346,Shortage,METHOTREXATE SUBCUTANEOUS,ACCORD HEALTHCARE INC,METHOTREXATE (METHOTREXATE SODIUM),METHOTREXATE,20MG,1,SUBCUTANEOUS,Resolved,SOLUTION,,2023-07-07,2023-07-21,2023-07-21,Disruption of the manufacture of the drug.,2023-07-07,2023-07-22,No
181024,02491346,Shortage,METHOTREXATE SUBCUTANEOUS,ACCORD HEALTHCARE INC,Methotrexate PFS,METHOTREXATE,20MG,1,SUBCUTANEOUS,Resolved,SOLUTION,,2023-01-13,,2023-01-27,Disruption of the manufacture of the drug.,2023-01-13,2023-01-28,No
181027,02491311,Shortage,METHOTREXATE SUBCUTANEOUS,ACCORD HEALTHCARE INC,METHOTREXATE SUBCUTANEOUS,METHOTREXATE,15MG,1,SUBCUTANEOUS,Resolved,SOLUTION,,2023-01-13,2023-04-14,2023-04-13,Disruption of the manufacture of the drug.,2023-01-13,2023-04-15,No
195186,02491362,Shortage,METHOTREXATE SUBCUTANEOUS,ACCORD HEALTHCARE INC,METHOTREXATE (METHOTREXATE SODIUM),METHOTREXATE,25MG,1,SUBCUTANEOUS,Resolved,SOLUTION,,2023-06-16,2023-07-14,2023-07-14,Disruption of the manufacture of the drug.,2023-06-16,2023-07-15,No
194718,02491354,Shortage,METHOTREXATE SUBCUTANEOUS,ACCORD HEALTHCARE INC,Methotrexate,METHOTREXATE,22.5MG,1,SUBCUTANEOUS,Resolved,SOLUTION,,2023-06-09,2023-06-29,2023-06-29,Delay in shipping of the drug.,2023-06-12,2023-06-30,No
194721,02491346,Shortage,METHOTREXATE SUBCUTANEOUS,ACCORD HEALTHCARE INC,Methotrexate,METHOTREXATE,20MG,1,SUBCUTANEOUS,Resolved,SOLUTION,,2023-06-09,2023-06-23,2023-06-16,Delay in shipping of the drug.,2023-06-12,2023-06-17,No
211388,02491346,Shortage,METHOTREXATE SUBCUTANEOUS,ACCORD HEALTHCARE INC,METHOTREXATE SUBCUTANEOUS,METHOTREXATE,20MG,1,SUBCUTANEOUS,Resolved,SOLUTION,,2023-11-22,2024-01-19,2024-01-15,Disruption of the manufacture of the drug.,2023-11-24,2024-01-19,No
203459,02491346,Shortage,METHOTREXATE SUBCUTANEOUS,ACCORD HEALTHCARE INC,METHOTREXATE SUBCUTANEOUS,METHOTREXATE,20MG,1,SUBCUTANEOUS,Resolved,SOLUTION,,2023-09-01,2023-09-22,2023-10-02,Delay in shipping of the drug.,2023-09-01,2023-10-03,No
207602,02491346,Shortage,METHOTREXATE SUBCUTANEOUS,ACCORD HEALTHCARE INC,METHOTREXATE SUBCUTANEOUS,METHOTREXATE,20MG,1,SUBCUTANEOUS,Resolved,SOLUTION,,2023-10-20,2023-10-26,2023-10-25,Delay in shipping of the drug.,2023-10-20,2023-10-27,No
186504,00426830,Shortage,METHYLDOPA,AA PHARMA INC,Methyldopa,METHYLDOPA,500MG,100BTL,ORAL; ORAL,Resolved,TABLET,2023-03-09,,2023-04-24,2023-04-24,Disruption of the manufacture of the drug.,2023-03-08,2023-05-01,No
213999,00426830,Shortage,METHYLDOPA,AA PHARMA INC,METHYLDOPA,METHYLDOPA,500MG,100 BTL,ORAL; ORAL,Resolved,TABLET,2023-12-21,,2024-01-25,2024-01-19,Disruption of the manufacture of the drug.,2023-12-21,2024-01-20,No
207139,02230770,Shortage,METHYLENE BLUE INJECTION USP,OMEGA LABORATORIES LIMITED,Methylene Blue Injection USP,METHYLENE BLUE,10MG,10 x 5mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,,2023-11-06,,2024-02-12,Disruption of the manufacture of the drug.,2023-10-16,2024-02-13,No
181692,02185431,Shortage,METOCLOPRAMIDE HYDROCHLORIDE INJECTION,SANDOZ CANADA INCORPORATED,METOCLOPRAMIDE,METOCLOPRAMIDE HYDROCHLORIDE,5MG,30ML,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-01-18,2023-02-17,2023-02-14,Disruption of the manufacture of the drug.,2023-01-19,2023-02-15,No
188657,02185431,Shortage,METOCLOPRAMIDE HYDROCHLORIDE INJECTION,SANDOZ CANADA INCORPORATED,METOCLOPRAMIDE HYDROCHLORIDE INJECTION,METOCLOPRAMIDE HYDROCHLORIDE,5MG,2ML 10LIVI,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-04-04,2023-04-21,2023-04-17,Disruption of the manufacture of the drug.,2023-04-04,2023-04-18,No
183623,02243563,Shortage,METOCLOPRAMIDE OMEGA,OMEGA LABORATORIES LIMITED,Metoclopramide Hydrochloride Injection USP,METOCLOPRAMIDE HYDROCHLORIDE,5MG,10 x 2 mL vial / fiole,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-02-17,,2023-03-15,Demand increase for the drug.,2023-02-03,2023-03-16,No
202725,00649074,Shortage,METRONIDAZOLE INJECTION USP,PFIZER CANADA ULC,METRONIDAZOLE INJECTION USP,METRONIDAZOLE,5MG,24 X 100ML,INTRAVENOUS; INTRAVENOUS,Actual shortage,SOLUTION,2023-10-01,,,,Disruption of the manufacture of the drug.,2023-08-23,2023-10-02,No
212704,00870420,Shortage,"METRONIDAZOLE INJECTION, USP",BAXTER CORPORATION,Metronidazole Injection,METRONIDAZOLE,5MG,JB3401P (500 mg),INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2023-12-06,2023-12-06,2023-12-11,2023-12-11,Demand increase for the drug.,2023-12-07,2023-12-12,No
212707,00870420,Shortage,"METRONIDAZOLE INJECTION, USP",BAXTER CORPORATION,Metronidazole Injection,METRONIDAZOLE,5MG,JB3415 (500 mg),INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2023-12-06,2023-12-06,2024-02-02,2024-02-01,Demand increase for the drug.,2023-12-07,2024-02-02,No
203874,02323273,Shortage,METVIX,GALDERMA CANADA INC,methyl aminolevulinate,METHYL AMINOLEVULINATE,168MG,2 g,TOPICAL; TOPICAL,Resolved,CREAM,2023-09-11,,2023-11-25,2023-10-24,Disruption of the manufacture of the drug.,2023-09-07,2023-10-25,No
193468,02323273,Shortage,METVIX,GALDERMA CANADA INC,methyl aminolevulinate,METHYL AMINOLEVULINATE,168MG,2 g,TOPICAL; TOPICAL,Resolved,CREAM,2023-05-31,2023-05-31,2023-07-15,2023-07-07,Disruption of the manufacture of the drug.,2023-05-31,2023-07-10,No
202027,02524953,Shortage,MICAFUNGIN SODIUM FOR INJECTION,JUNO PHARMACEUTICALS CORP.,MICAFUNGIN SODIUM FOR INJECTION 50 MG/VIAL,,50MG,1 SINGLE USE VIAL (50 MG),INTRAVENOUS,Resolved,POWDER FOR SOLUTION,2023-08-16,2023-08-16,2023-09-01,2023-09-05,Other (Please describe in comments),2023-08-16,2023-09-06,No
202032,02524961,Shortage,MICAFUNGIN SODIUM FOR INJECTION,JUNO PHARMACEUTICALS CORP.,MICAFUNGIN SODIUM FOR INJECTION 100 MG/VIAL,,100MG,1 SINGLE USE VIAL (100 MG),INTRAVENOUS,Resolved,POWDER FOR SOLUTION,2023-08-16,2023-08-16,2023-09-01,2023-09-05,Other (Please describe in comments),2023-08-16,2023-09-06,No
182494,00787019,Shortage,MICRO ZN,SANDOZ CANADA INCORPORATED,MICRO ZN,ZINC,1MG,10ML,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-01-30,2023-03-31,2023-04-03,Disruption of the manufacture of the drug.,2023-01-27,2023-04-06,No
192003,02240285,Shortage,MIDAZOLAM INJECTION,SANDOZ CANADA INCORPORATED,MIDAZOLAM,MIDAZOLAM,1MG,2ML,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-05-08,2023-06-02,2023-05-22,Disruption of the manufacture of the drug.,2023-05-08,2023-05-25,No
192022,02240286,Shortage,MIDAZOLAM INJECTION,SANDOZ CANADA INCORPORATED,MIDAZOLAM,MIDAZOLAM,5MG,50ML,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Actual shortage,SOLUTION,,2023-05-08,,,Disruption of the manufacture of the drug.,2023-05-08,2023-07-04,No
195420,02240286,Shortage,MIDAZOLAM INJECTION,SANDOZ CANADA INCORPORATED,MIDAZOLAM,MIDAZOLAM,5MG,1ML 10LIVI,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-06-19,2023-07-21,2023-07-17,Disruption of the manufacture of the drug.,2023-06-19,2023-07-18,No
184251,02240286,Shortage,MIDAZOLAM INJECTION,SANDOZ CANADA INCORPORATED,MIDAZOLAM,MIDAZOLAM,5MG,1ML,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-02-08,2023-03-03,2023-02-27,Disruption of the manufacture of the drug.,2023-02-09,2023-03-06,No
181696,02240285,Shortage,MIDAZOLAM INJECTION,SANDOZ CANADA INCORPORATED,MIDAZOLAM,MIDAZOLAM,1MG,2ML,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-01-18,2023-02-17,2023-02-08,Disruption of the manufacture of the drug.,2023-01-19,2023-02-09,No
179688,02242905,Shortage,MIDAZOLAM INJECTION,FRESENIUS KABI CANADA LTD,MIDAZOLAM INJECTION,MIDAZOLAM,5MG,2 mL,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,2023-01-15,2023-01-15,2023-04-01,2023-04-01,Disruption of the manufacture of the drug.,2023-01-03,2023-04-03,No
200819,02382350,Shortage,MIDAZOLAM INJECTION USP,PFIZER CANADA ULC,MIDAZOLAM INJECTION USP,MIDAZOLAM,5MG,10 x 1ml vial,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-08-03,,2024-03-14,Disruption of the manufacture of the drug.,2023-08-03,2024-03-15,No
200822,02382342,Shortage,MIDAZOLAM INJECTION USP,PFIZER CANADA ULC,MIDAZOLAM INJECTION USP,MIDAZOLAM,1MG,10 x 2ml vial,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,2023-10-10,,,2023-10-12,Disruption of the manufacture of the drug.,2023-08-03,2023-10-13,No
180728,02382342,Shortage,MIDAZOLAM INJECTION USP,PFIZER CANADA ULC,MIDAZOLAM INJECTION USP,MIDAZOLAM,1MG,10 x 5mL vial,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-02-02,,2023-03-13,Disruption of the manufacture of the drug.,2023-01-12,2023-03-14,No
182763,02444038,Shortage,MIFEGYMISO,LINEPHARMA INTERNATIONAL LIMITED,Mifepristone/Misoprostol,MISOPROSTOL; MIFEPRISTONE,200MCG; 200MG,Combipack - 1 box with 1 tablet of mifepristone 200mg tablet + 1 box with 4 tablets of 200mcg misoprostol,ORAL; BUCCAL; ORAL; BUCCAL,Resolved,TABLET; KIT,2023-02-27,2023-02-27,2023-03-08,2023-03-08,Other (Please describe in comments),2023-01-31,2023-03-09,No
208900,02244622,Shortage,"MILRINONE LACTATE INJECTION, USP",FRESENIUS KABI CANADA LTD,"MILRINONE LACTATE INJECTION, USP",MILRINONE,1MG,20 mL,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-11-01,2024-04-22,2024-04-22,Disruption of the manufacture of the drug.,2023-11-01,2024-04-23,No
212478,02148358,Shortage,MINIMS ATROPINE SULPHATE,BAUSCH & LOMB INC,M-ATROPINE 1% 0.5ML,ATROPINE SULFATE,1%,1,OPHTHALMIC; OPHTHALMIC,Resolved,DROPS,2023-12-12,2023-12-04,2024-01-31,2024-01-30,Shortage of an inactive ingredient or component.,2023-12-04,2024-02-05,No
206343,02148447,Shortage,MINIMS PHENYLEPHRINE HYDROCHLORIDE,BAUSCH & LOMB INC,Minims - Phenylephrine HCL 2.5%,PHENYLEPHRINE HYDROCHLORIDE,2.50%,0.5mL x 20,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION; DROPS,2023-10-20,2023-10-20,2023-12-01,2023-12-04,Other (Please describe in comments),2023-10-05,2023-12-13,No
206354,02148455,Shortage,MINIMS PHENYLEPHRINE HYDROCHLORIDE,BAUSCH & LOMB INC,MINIMS PHENYLEPHRINE HYDROCHLORIDE 10%,PHENYLEPHRINE HYDROCHLORIDE,10%,0.5mL x 20,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION; DROPS,2023-10-20,2023-10-20,2023-12-01,2023-12-04,Other (Please describe in comments),2023-10-05,2023-12-13,No
212483,02148536,Shortage,MINIMS TROPICAMIDE,BAUSCH & LOMB INC,M-TROPICAMIDE 1%,TROPICAMIDE,1%,1,OPHTHALMIC; OPHTHALMIC,Resolved,DROPS,2023-12-11,,2024-01-15,2023-12-14,Delay in shipping of the drug.,2023-12-04,2024-02-05,No
188042,02475197,Shortage,MINT-DICLOFENAC,MINT PHARMACEUTICALS INC,Diclofenac,DICLOFENAC SODIUM,0.10%,5 ml bottle,OPHTHALMIC,Actual shortage,SOLUTION,,2023-03-27,2023-10-30,,Disruption of the manufacture of the drug.,2023-03-27,2023-09-27,No
188045,02475197,Shortage,MINT-DICLOFENAC,MINT PHARMACEUTICALS INC,Diclofenac,DICLOFENAC SODIUM,0.10%,10 ml bottle,OPHTHALMIC,Actual shortage,SOLUTION,,2023-03-27,2023-10-30,,Disruption of the manufacture of the drug.,2023-03-27,2023-09-27,No
199939,02438984,Shortage,MINT-DULOXETINE,MINT PHARMACEUTICALS INC,Duloxetine,DULOXETINE,30MG,100 count bottle,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-07-24,2024-01-05,2024-01-08,Disruption of the manufacture of the drug.,2023-07-24,2024-01-09,No
212474,02133326,Shortage,MIOCHOL-E,BAUSCH & LOMB INC,MIOCHOL-E SOLN 20MG/2ML,ACETYLCHOLINE CHLORIDE,20MG,1,OPHTHALMIC; OPHTHALMIC,Actual shortage,POWDER FOR SOLUTION,2023-12-10,2023-11-08,2024-05-05,,Requirements related to complying with good manufacturing practices.,2023-12-04,2024-03-06,No
197632,02370689,Shortage,MIRTAZAPINE,SANIS HEALTH INC,MIRTAZAPINE,MIRTAZAPINE,30MG,100,ORAL; ORAL,Resolved,TABLET,,2023-10-04,2024-01-26,2024-01-11,Disruption of the manufacture of the drug.,2023-07-05,2024-01-30,No
187300,02370689,Shortage,MIRTAZAPINE,SANIS HEALTH INC,MIRTAZAPINE,MIRTAZAPINE,30MG,100,ORAL; ORAL,Resolved,TABLET,,2023-02-17,2023-04-30,2023-05-03,Disruption of the manufacture of the drug.,2023-03-16,2023-05-04,No
186520,02244023,Shortage,MISOPROSTOL,AA PHARMA INC,Misoprostol,MISOPROSTOL,200MCG,100BTL,ORAL; ORAL,Resolved,TABLET,2023-03-27,,2023-05-26,2023-05-16,Disruption of the manufacture of the drug.,2023-03-08,2023-05-17,No
188329,02244022,Shortage,MISOPROSTOL,AA PHARMA INC,Misoprostol,MISOPROSTOL,100MCG,100BTL,ORAL; ORAL,Resolved,TABLET,2023-03-30,,2023-05-26,2023-05-12,Disruption of the manufacture of the drug.,2023-03-30,2023-05-13,No
192275,02232148,Shortage,MOCLOBEMIDE,AA PHARMA INC,MOCLOBEMIDE,MOCLOBEMIDE,100MG,100BTL,ORAL; ORAL,Resolved,TABLET,2023-06-02,,2023-08-31,2023-07-27,Disruption of the manufacture of the drug.,2023-05-11,2023-08-03,No
200446,02519127,Shortage,MOMETASONE,SANIS HEALTH INC,MOMETASONE,MOMETASONE FUROATE,50MCG,140,NASAL,Resolved,"SPRAY, METERED DOSE",,2023-07-31,,2023-08-18,Disruption of the manufacture of the drug.,2023-07-31,2023-08-29,No
192418,02379821,Shortage,MONTELUKAST,PRO DOC LIMITEE,MONTELUKAST,MONTELUKAST,4MG,"30,100",ORAL; ORAL,Resolved,TABLET (CHEWABLE),,2023-05-12,2023-10-06,2023-10-05,Disruption of the manufacture of the drug.,2023-05-12,2023-10-06,No
181700,02021048,Shortage,MORPHINE LP EPIDURAL,SANDOZ CANADA INCORPORATED,MORPHINE LP,MORPHINE SULFATE,1MG,5ML,EPIDURAL; SUBCUTANEOUS; INTRAVENOUS; EPIDURAL; SUBCUTANEOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-01-18,2023-03-17,2023-02-24,Disruption of the manufacture of the drug.,2023-01-19,2023-03-06,No
197750,02498278,Shortage,MORPHINE SULFATE INJECTION EPIDURAL,STERIMAX INC,MORPHINE SULFATE INJECTION EPIDURAL,MORPHINE SULFATE,0.5MG,10 X 10 ML VIALS,EPIDURAL,Resolved,SOLUTION,,2023-07-07,2023-07-31,2023-07-28,Demand increase for the drug.,2023-07-06,2023-07-29,No
185528,02498278,Shortage,MORPHINE SULFATE INJECTION EPIDURAL,STERIMAX INC,MORPHINE SULFATE INJECTION EPIDURAL,MORPHINE SULFATE,0.5MG,0.5 MG/ML  10 ML,EPIDURAL,Resolved,SOLUTION,,2023-02-20,2023-05-19,2023-05-19,Delay in shipping of the drug.,2023-02-23,2023-05-23,No
210449,02541041,Shortage,MOUNJARO,ELI LILLY CANADA INC,tirzepatide injection,,2.5MG,3 mL single-dose vial,SUBCUTANEOUS,Actual shortage,SOLUTION,,2023-11-16,2024-06-01,,Other (Please describe in comments),2023-11-17,2024-03-20,No
210452,02541068,Shortage,MOUNJARO,ELI LILLY CANADA INC,tirzepatide injection,,5MG,3 mL single-dose vial,SUBCUTANEOUS,Actual shortage,SOLUTION,2023-11-23,2023-11-23,2024-06-01,,Other (Please describe in comments),2023-11-17,2024-03-20,No
210455,02541076,Shortage,MOUNJARO,ELI LILLY CANADA INC,tirzepatide injection,,7.5MG,3 mL single-dose vial,SUBCUTANEOUS,Actual shortage,SOLUTION,,2023-11-13,2024-06-01,,Other (Please describe in comments),2023-11-17,2024-03-20,No
210458,02541084,Shortage,MOUNJARO,ELI LILLY CANADA INC,tirzepatide injection,,10MG,3 mL single-dose vial,SUBCUTANEOUS,Actual shortage,SOLUTION,2023-12-12,2023-12-04,2024-06-15,,Other (Please describe in comments),2023-11-17,2024-02-22,No
210461,02541092,Shortage,MOUNJARO,ELI LILLY CANADA INC,tirzepatide injection,,12.5MG,3 mL single-dose vial,SUBCUTANEOUS,Actual shortage,SOLUTION,2023-12-15,2023-12-15,2024-06-15,,Other (Please describe in comments),2023-11-17,2024-02-22,No
210464,02541106,Shortage,MOUNJARO,ELI LILLY CANADA INC,tirzepatide injection,,15MG,3 mL single-dose vial,SUBCUTANEOUS,Actual shortage,SOLUTION,2023-12-03,2023-12-04,2024-07-01,,Other (Please describe in comments),2023-11-17,2024-02-22,No
207114,02459132,Shortage,MOVAPO,PALADIN LABS INC.,APOMORPHINE HYDROCHLORIDE,APOMORPHINE HYDROCHLORIDE,10MG,30MG/3ML PRE-FILLED PEN,SUBCUTANEOUS; SUBCUTANEOUS,Actual shortage,SOLUTION,2023-10-01,,,,Disruption of the manufacture of the drug.,2023-10-16,2023-10-16,No
183506,02462974,Shortage,MOXIFLOXACIN,PRO DOC LIMITEE,MOXIFLOXACIN,MOXIFLOXACIN,400MG,30,ORAL; ORAL,Resolved,TABLET,,2023-02-03,2023-05-17,2023-05-17,Delay in shipping of the drug.,2023-02-03,2023-05-18,No
179934,02014238,Shortage,MS.IR,PURDUE PHARMA,Morphine Sulfate Immediate Release Tablets,MORPHINE SULFATE,20MG,60,ORAL; ORAL,Resolved,TABLET (IMMEDIATE RELEASE),2023-01-03,2023-01-03,2023-01-26,2023-01-23,Delay in shipping of the drug.,2023-01-05,2023-01-24,No
212448,00586315,Shortage,MULTI 1000,SANDOZ CANADA INCORPORATED,MULTI 1000,VITAMIN B6; NICOTINAMIDE; VITAMIN B2; VITAMIN B1; VITAMIN E; VITAMIN D; VITAMIN A; ASCORBIC ACID; D-PANTOTHENIC ACID,1.2MG; 10MG; 1MG; 4.5MG; 1UNIT; 100UNIT; 1000UNIT; 100MG; 2.6MG,10ML 10LIVI,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-12-04,2024-03-29,2024-01-16,Requirements related to complying with good manufacturing practices.,2023-12-04,2024-01-17,No
189909,02100606,Shortage,MULTI 12 INJECTION,SANDOZ CANADA INCORPORATED,MULTI 12 INJECTION,VITAMIN B12; FOLIC ACID; BIOTIN; VITAMIN E; DEXPANTHENOL; PYRIDOXINE HYDROCHLORIDE; NICOTINAMIDE; VITAMIN B2; VITAMIN B1; VITAMIN D; VITAMIN A; ASCORBIC ACID,1MCG; 80MCG; 12MCG; 2UNIT; 3MG; 0.8MG; 8MG; 0.72MG; 0.6MG; 40UNIT; 660UNIT; 20MG,5ML,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,,2023-04-20,2023-06-16,2023-05-01,Disruption of the manufacture of the drug.,2023-04-20,2023-05-03,No
189913,02100606,Shortage,MULTI 12 INJECTION,SANDOZ CANADA INCORPORATED,MULTI 12 INJECTION,VITAMIN B12; FOLIC ACID; BIOTIN; VITAMIN E; DEXPANTHENOL; PYRIDOXINE HYDROCHLORIDE; NICOTINAMIDE; VITAMIN B2; VITAMIN B1; VITAMIN D; VITAMIN A; ASCORBIC ACID,1MCG; 80MCG; 12MCG; 2UNIT; 3MG; 0.8MG; 8MG; 0.72MG; 0.6MG; 40UNIT; 660UNIT; 20MG,25ML,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,,2023-04-20,2023-05-19,2023-05-01,Disruption of the manufacture of the drug.,2023-04-20,2023-05-03,No
213568,02415380,Shortage,MYA,APOTEX INC,DROSPIRENONE / ETHINYL ESTRADIOL,ETHINYL ESTRADIOL; DROSPIRENONE,0.02MG; 3.00MG,28 BLS,ORAL,Resolved,TABLET,,2023-12-12,2023-12-22,2023-12-15,Disruption of the manufacture of the drug.,2023-12-15,2023-12-22,No
193206,02415380,Shortage,MYA,APOTEX INC,DROSPIRENONE / ETHINYL ESTRADIOL,ETHINYL ESTRADIOL; DROSPIRENONE,0.02MG; 3.00MG,28 BLS,ORAL,Resolved,TABLET,,2023-05-23,2023-06-09,2023-06-01,Disruption of the manufacture of the drug.,2023-05-26,2023-06-02,No
204996,02415380,Shortage,MYA,APOTEX INC,DROSPIRENONE / ETHINYL ESTRADIOL,ETHINYL ESTRADIOL; DROSPIRENONE,0.02MG; 3.00MG,28 BLS,ORAL,Resolved,TABLET,,2023-09-19,2023-10-13,2023-10-05,Disruption of the manufacture of the drug.,2023-09-22,2023-10-06,No
211089,02457377,Shortage,MYCOPHENOLATE MOFETIL,SANIS HEALTH INC,MYCOPHENOLATE MOFETIL,MYCOPHENOLATE MOFETIL,500MG,50,ORAL; ORAL,Resolved,TABLET,,2023-11-17,2023-12-13,2023-12-13,Shortage of an inactive ingredient or component.,2023-11-22,2023-12-26,No
207582,02479974,Shortage,MYCOPHENOLATE MOFETIL FOR INJECTION USP,STERIMAX INC,MYCOPHENOLATE MOFETIL FOR INJECTION USP,MYCOPHENOLATE MOFETIL,500MG,PACK OF 4 VIALS,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION,2023-12-15,,2024-02-01,2024-02-06,Disruption of the manufacture of the drug.,2023-10-20,2024-02-07,No
207554,02444836,Shortage,"MYCOPHENOLATE MOFETIL FOR INJECTION, USP",ACCORD HEALTHCARE INC,MYCOPHENOLATE MOFETIL HYDROCHLORIDE,MYCOPHENOLATE MOFETIL,500MG,1,INTRAVENOUS; INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,,2023-09-06,,,Disruption of the manufacture of the drug.,2023-10-19,2024-04-22,No
180241,02518538,Shortage,MYCOPHENOLIC ACID,JAMP PHARMA CORPORATION,Mycophenolic Acid Delayed-Release tablets USP,MYCOPHENOLIC ACID,180MG,120,ORAL,Resolved,TABLET (DELAYED-RELEASE),,2022-12-09,2023-02-10,2023-01-05,Demand increase for the drug.,2023-01-10,2023-01-10,No
187554,02242464,Shortage,MYLAN-ACYCLOVIR,MYLAN PHARMACEUTICALS ULC,ACYCLOVIR,ACYCLOVIR,800MG,100BT,ORAL; ORAL,Avoided shortage,TABLET,2023-04-19,,2023-04-25,2023-04-17,Disruption of the manufacture of the drug.,2023-03-20,2023-04-20,No
182969,02242784,Shortage,MYLAN-ACYCLOVIR,MYLAN PHARMACEUTICALS ULC,ACYCLOVIR,ACYCLOVIR,200MG,100BT,ORAL; ORAL,Resolved,TABLET,,2023-02-06,2023-03-14,2023-03-14,Demand increase for the drug.,2023-02-01,2023-03-20,No
213129,02398435,Shortage,MYLAN-ALMOTRIPTAN,MYLAN PHARMACEUTICALS ULC,ALMOTRIPTAN,ALMOTRIPTAN,6.25MG,6 BL,ORAL; ORAL,Resolved,TABLET,2024-02-14,2024-02-20,2024-03-26,2024-03-22,Shortage of an active ingredient.,2023-12-13,2024-03-25,No
208613,02398443,Shortage,MYLAN-ALMOTRIPTAN,MYLAN PHARMACEUTICALS ULC,ALMOTRIPTAN,ALMOTRIPTAN,12.5MG,6BL,ORAL; ORAL,Resolved,TABLET,2023-12-13,2023-12-13,2024-03-26,2024-03-20,Shortage of an active ingredient.,2023-10-30,2024-03-25,No
189338,02402165,Shortage,MYLAN-ATOVAQUONE/PROGUANIL,MYLAN PHARMACEUTICALS ULC,ATOVAQUONE/PROGUANIL,PROGUANIL HYDROCHLORIDE; ATOVAQUONE,100MG; 250MG,100BT,ORAL; ORAL,Resolved,TABLET,2023-06-07,2023-06-05,2023-08-17,2023-08-18,Disruption of the manufacture of the drug.,2023-04-12,2023-08-21,No
189891,02088401,Shortage,MYLAN-BACLOFEN,MYLAN PHARMACEUTICALS ULC,BACLOFEN,BACLOFEN,20MG,100BT,ORAL; ORAL,Resolved,TABLET,,2022-11-07,2023-08-03,2023-08-04,Disruption of the manufacture of the drug.,2023-04-20,2023-08-16,No
189894,02088398,Shortage,MYLAN-BACLOFEN,MYLAN PHARMACEUTICALS ULC,BACLOFEN,BACLOFEN,10MG,"100BT, 500BT",ORAL; ORAL,Resolved,TABLET,,2022-11-07,2023-08-03,2023-08-04,Disruption of the manufacture of the drug.,2023-04-20,2023-10-03,No
201960,02088401,Shortage,MYLAN-BACLOFEN,MYLAN PHARMACEUTICALS ULC,BACLOFEN,BACLOFEN,20MG,100 BT,ORAL; ORAL,Resolved,TABLET,2023-09-13,2023-09-18,2023-10-31,2023-10-23,Disruption of the manufacture of the drug.,2023-08-16,2023-10-25,No
203100,02172712,Shortage,MYLAN-BECLO AQ,MYLAN PHARMACEUTICALS ULC,BECLOMETHASONE DIPROPIONATE,BECLOMETHASONE DIPROPIONATE,50MCG,22s,NASAL; NASAL,Resolved,SUSPENSION; METERED-DOSE AEROSOL,2023-01-03,2023-01-03,2024-02-21,2024-02-21,Disruption of the manufacture of the drug.,2023-08-29,2024-02-29,No
186402,02241003,Shortage,MYLAN-BUDESONIDE AQ,MYLAN PHARMACEUTICALS ULC,BUDESONIDE,BUDESONIDE,64MCG,120,NASAL; NASAL,Actual shortage,"SPRAY, METERED DOSE",2022-06-05,2022-06-05,,,Disruption of the manufacture of the drug.,2023-03-07,2023-12-12,No
185423,02230648,Shortage,MYLAN-BUDESONIDE AQ,MYLAN PHARMACEUTICALS ULC,BUDESONIDE,BUDESONIDE,100MCG,165 DOSE,NASAL; NASAL,Actual shortage,"SPRAY, METERED DOSE",,2022-07-03,,,Disruption of the manufacture of the drug.,2023-02-23,2023-12-12,No
193448,02283794,Shortage,MYLAN-CILAZAPRIL,MYLAN PHARMACEUTICALS ULC,CILAZAPRIL,CILAZAPRIL,5.0MG,100BT,ORAL; ORAL,Resolved,TABLET,2023-06-07,2023-06-12,,2023-07-26,Disruption of the manufacture of the drug.,2023-05-31,2023-08-01,No
189342,02434539,Shortage,MYLAN-CINACALCET,MYLAN PHARMACEUTICALS ULC,CINACALCET,CINACALCET,30MG,30BT,ORAL; ORAL,Resolved,TABLET,2023-04-19,2023-04-19,2023-05-05,2023-04-27,Disruption of the manufacture of the drug.,2023-04-12,2023-05-01,No
183765,02434547,Shortage,MYLAN-CINACALCET,MYLAN PHARMACEUTICALS ULC,CINACALCET,CINACALCET,60MG,30BT,ORAL; ORAL,Resolved,TABLET,2023-03-08,2023-03-16,2023-04-25,2023-04-27,Disruption of the manufacture of the drug.,2023-02-06,2023-05-01,No
183768,02434555,Shortage,MYLAN-CINACALCET,MYLAN PHARMACEUTICALS ULC,CINACALCET,CINACALCET,90MG,30BT,ORAL; ORAL,Resolved,TABLET,2023-04-05,2023-04-05,2023-05-08,2023-05-05,Disruption of the manufacture of the drug.,2023-02-06,2023-05-08,No
203693,02024187,Shortage,MYLAN-CLOBETASOL CREAM,MYLAN PHARMACEUTICALS ULC,CLOBETASOL PROPIONATE,CLOBETASOL PROPIONATE,0.05%,50G,TOPICAL; TOPICAL,Resolved,CREAM,2023-10-18,2023-09-11,2023-12-12,2023-12-11,Disruption of the manufacture of the drug.,2023-09-06,2023-12-19,No
203708,02216213,Shortage,MYLAN-CLOBETASOL SCALP APPLICATION,MYLAN PHARMACEUTICALS ULC,CLOBETASOL PROPIONATE,CLOBETASOL PROPIONATE,0.05%,60ML,TOPICAL; TOPICAL,Resolved,LOTION,2023-09-13,2023-09-18,2023-11-03,2023-11-03,Disruption of the manufacture of the drug.,2023-09-06,2023-11-06,No
181324,02458934,Shortage,MYLAN-DIVALPROEX,MYLAN PHARMACEUTICALS ULC,VALPROIC ACID,VALPROIC ACID,250MG,"100BT, 500BT",ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE); TABLET (ENTERIC-COATED),,2023-01-10,2023-01-17,2023-01-16,Demand increase for the drug.,2023-01-17,2023-01-23,No
182986,02458926,Shortage,MYLAN-DIVALPROEX,MYLAN PHARMACEUTICALS ULC,MYLAN-DIVALPROEX,VALPROIC ACID,125MG,100BT,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE); TABLET (ENTERIC-COATED),,2023-02-04,2023-02-10,2023-02-10,Demand increase for the drug.,2023-02-01,2023-02-14,No
196698,02309467,Shortage,MYLAN-ESCITALOPRAM,MYLAN PHARMACEUTICALS ULC,ESCITALOPRAM,ESCITALOPRAM,10MG,100BT,ORAL; ORAL,Resolved,TABLET,2023-08-16,2023-08-16,2023-08-22,2023-08-22,Disruption of the manufacture of the drug.,2023-06-27,2023-08-29,No
187551,02469715,Shortage,MYLAN-FINGOLIMOD,MYLAN PHARMACEUTICALS ULC,FINGOLIMOD,FINGOLIMOD,0.5MG,28BL,ORAL; ORAL,Resolved,CAPSULE,2023-04-05,2023-04-02,,2023-05-01,Shortage of an active ingredient.,2023-03-20,2023-05-03,No
204098,02245293,Shortage,MYLAN-FLUCONAZOLE,MYLAN PHARMACEUTICALS ULC,FLUCONAZOLE,FLUCONAZOLE,100MG,50BT,ORAL; ORAL,Resolved,TABLET,,2023-09-13,2023-10-06,2023-09-25,Disruption of the manufacture of the drug.,2023-09-11,2023-09-26,No
209416,02339439,Shortage,MYLAN-GALANTAMINE ER,MYLAN PHARMACEUTICALS ULC,GALANTAMINE,GALANTAMINE,8MG,"30BT, 100BT",ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),2023-12-11,2023-12-18,2024-03-19,2024-03-19,Disruption of the manufacture of the drug.,2023-11-06,2024-03-25,No
198994,02339447,Shortage,MYLAN-GALANTAMINE ER,MYLAN PHARMACEUTICALS ULC,GALANTAMINE,GALANTAMINE,16MG,"30BT, 100BT",ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),2024-02-14,2024-02-12,2024-03-19,2024-03-19,Disruption of the manufacture of the drug.,2023-07-18,2024-03-25,No
191317,02339439,Shortage,MYLAN-GALANTAMINE ER,MYLAN PHARMACEUTICALS ULC,GALANTAMINE,GALANTAMINE,8MG,"30 BT, 100 BT",ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),2023-06-07,2023-05-29,2023-07-28,2023-07-28,Disruption of the manufacture of the drug.,2023-05-01,2023-08-01,No
180346,02242920,Shortage,MYLAN-HYDROXYUREA,MYLAN PHARMACEUTICALS ULC,HYDROXYUREA,HYDROXYUREA,500MG,100BT,ORAL; ORAL,Resolved,CAPSULE,2023-01-18,2023-01-19,2023-03-21,2023-03-14,Disruption of the manufacture of the drug.,2023-01-10,2023-03-20,No
196061,02242920,Shortage,MYLAN-HYDROXYUREA,MYLAN PHARMACEUTICALS ULC,HYDROXYUREA,HYDROXYUREA,500MG,100 BT,ORAL; ORAL,Resolved,CAPSULE,,2023-05-31,2023-07-21,2023-07-17,Disruption of the manufacture of the drug.,2023-06-21,2023-08-16,No
201965,02242920,Shortage,MYLAN-HYDROXYUREA,MYLAN PHARMACEUTICALS ULC,HYDROXYUREA,HYDROXYUREA,500MG,100BT,ORAL; ORAL,Resolved,CAPSULE,2023-08-30,2023-08-28,2023-10-31,2023-10-30,Disruption of the manufacture of the drug.,2023-08-16,2023-11-06,No
196701,02240067,Shortage,MYLAN-INDAPAMIDE,MYLAN PHARMACEUTICALS ULC,INDAPAMIDE,INDAPAMIDE,1.25MG,100BT,ORAL; ORAL,Resolved,TABLET,,2023-06-05,2023-11-10,2023-11-13,Disruption of the manufacture of the drug.,2023-06-27,2023-11-14,No
213761,02265516,Shortage,MYLAN-LAMOTRIGINE,MYLAN PHARMACEUTICALS ULC,LAMOTRIGINE,LAMOTRIGINE,150MG,100 BT,ORAL; ORAL,Resolved,TABLET,2023-12-19,,2023-12-28,2024-01-08,Disruption of the manufacture of the drug.,2023-12-19,2024-01-19,No
196047,02265494,Shortage,MYLAN-LAMOTRIGINE,MYLAN PHARMACEUTICALS ULC,LAMOTRIGINE,LAMOTRIGINE,25MG,100 BT,ORAL; ORAL,Resolved,TABLET,2023-06-21,2023-06-23,2023-07-05,2023-07-04,Disruption of the manufacture of the drug.,2023-06-21,2023-07-14,No
186407,02256126,Shortage,MYLAN-MIRTAZAPINE,MYLAN PHARMACEUTICALS ULC,MIRTAZAPINE,MIRTAZAPINE,45MG,100BT,ORAL; ORAL,Resolved,TABLET,2023-05-25,2023-05-25,2023-07-11,2023-07-10,Other (Please describe in comments),2023-03-07,2023-10-03,No
182205,02256118,Shortage,MYLAN-MIRTAZAPINE,MYLAN PHARMACEUTICALS ULC,MIRTAZAPINE,MIRTAZAPINE,30MG,100BT,ORAL; ORAL,Resolved,TABLET,2023-03-08,2023-03-02,2023-07-04,2023-07-04,Disruption of the manufacture of the drug.,2023-01-23,2023-07-14,No
200648,02256118,Shortage,MYLAN-MIRTAZAPINE,MYLAN PHARMACEUTICALS ULC,MIRTAZAPINE,MIRTAZAPINE,30MG,100BT,ORAL; ORAL,Avoided shortage,TABLET,2023-09-22,,,2023-07-04,Demand increase for the drug.,2023-08-01,2023-10-03,No
213764,02458608,Shortage,MYLAN-NAPROXEN/ESOMEPRAZOLE MR,MYLAN PHARMACEUTICALS ULC,NAPROXEN/ESOMEPRAZOLE,ESOMEPRAZOLE; NAPROXEN,20MG; 375MG,60 BT,ORAL; ORAL,Resolved,TABLET (IMMEDIATE AND DELAYED-RELEASE),2023-12-19,2023-12-27,2024-01-13,2024-01-11,Disruption of the manufacture of the drug.,2023-12-19,2024-01-16,No
205932,02443449,Shortage,MYLAN-NAPROXEN/ESOMEPRAZOLE MR,MYLAN PHARMACEUTICALS ULC,NAPROXEN/ESOMEPRAZOLE MR,ESOMEPRAZOLE; NAPROXEN,20MG; 500MG,60BT,ORAL; ORAL,Resolved,TABLET (IMMEDIATE AND DELAYED-RELEASE),2023-10-06,2023-11-16,2023-12-27,2024-01-05,Disruption of the manufacture of the drug.,2023-10-03,2024-01-10,No
180349,02458608,Shortage,MYLAN-NAPROXEN/ESOMEPRAZOLE MR,MYLAN PHARMACEUTICALS ULC,NAPROXEN/ESOMEPRAZOLE MR,ESOMEPRAZOLE; NAPROXEN,20MG; 375MG,60BT,ORAL; ORAL,Resolved,TABLET (IMMEDIATE AND DELAYED-RELEASE),,2023-01-09,2023-02-10,2023-02-10,Disruption of the manufacture of the drug.,2023-01-10,2023-02-14,No
191357,02443449,Shortage,MYLAN-NAPROXEN/ESOMEPRAZOLE MR,MYLAN PHARMACEUTICALS ULC,ESOMEPRAZOLE NAPROXEN,ESOMEPRAZOLE; NAPROXEN,20MG; 500MG,60BT,ORAL; ORAL,Resolved,TABLET (IMMEDIATE AND DELAYED-RELEASE),2023-06-07,2023-06-05,2023-08-22,2023-08-24,Disruption of the manufacture of the drug.,2023-05-01,2023-08-29,No
193442,02458608,Shortage,MYLAN-NAPROXEN/ESOMEPRAZOLE MR,MYLAN PHARMACEUTICALS ULC,NAPROXEN/ESOMEPRAZOLE,ESOMEPRAZOLE; NAPROXEN,20MG; 375MG,60BT,ORAL; ORAL,Resolved,TABLET (IMMEDIATE AND DELAYED-RELEASE),2023-07-05,2023-06-15,2023-08-29,2023-08-24,Disruption of the manufacture of the drug.,2023-05-31,2023-08-29,No
203214,02443449,Shortage,MYLAN-NAPROXEN/ESOMEPRAZOLE MR,MYLAN PHARMACEUTICALS ULC,NAPROXEN/ESOMEPRAZOLE MR,ESOMEPRAZOLE; NAPROXEN,20MG; 500MG,60BT,ORAL; ORAL,Resolved,TABLET (IMMEDIATE AND DELAYED-RELEASE),2023-09-04,2023-08-24,2023-09-29,2023-09-29,Shortage of an inactive ingredient or component.,2023-08-29,2023-10-03,No
184568,02443449,Shortage,MYLAN-NAPROXEN/ESOMEPRAZOLE MR,MYLAN PHARMACEUTICALS ULC,NAPROXEN/ESOMEPRAZOLE,ESOMEPRAZOLE; NAPROXEN,20MG; 500MG,60BT,ORAL; ORAL,Resolved,TABLET (IMMEDIATE AND DELAYED-RELEASE),2023-02-24,2023-02-21,2023-03-23,2023-03-24,Disruption of the manufacture of the drug.,2023-02-14,2023-03-27,No
209413,02349167,Shortage,MYLAN-NIFEDIPINE EXTENDED RELEASE,MYLAN PHARMACEUTICALS ULC,NIFEDIPINE,NIFEDIPINE,30MG,100BT,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-10-27,2023-11-13,2023-11-07,Disruption of the manufacture of the drug.,2023-11-06,2023-11-14,No
181369,02243588,Shortage,MYLAN-NITRO SUBLINGUAL SPRAY,MYLAN PHARMACEUTICALS ULC,NITROGLYCERIN,NITROGLYCERIN,0.4MG,1BT,SUBLINGUAL; SUBLINGUAL,Actual shortage,METERED-DOSE AEROSOL,,2023-01-20,,,Other (Please describe in comments),2023-01-18,2023-09-25,Yes
198991,02408570,Shortage,MYLAN-PANTOPRAZOLE T,MYLAN PHARMACEUTICALS ULC,PANTOPRAZOLE,PANTOPRAZOLE,40MG,100BT,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE),,2023-08-16,2023-08-29,2023-09-07,Demand increase for the drug.,2023-07-18,2023-10-03,No
196695,02457172,Shortage,MYLAN-PROPAFENONE,MYLAN PHARMACEUTICALS ULC,PROPAFENONE,PROPAFENONE HYDROCHLORIDE,150MG,100BT,ORAL; ORAL,Resolved,TABLET,2023-07-05,2023-07-10,2023-07-11,2023-07-14,Other (Please describe in comments),2023-06-27,2023-10-03,No
193436,02423421,Shortage,MYLAN-RIVASTIGMINE PATCH 10,MYLAN PHARMACEUTICALS ULC,RIVASTIGMINE,RIVASTIGMINE,9.5MG,30 Patches,TRANSDERMAL; TRANSDERMAL,Resolved,PATCH,,2023-05-31,2023-06-30,2023-06-29,Demand increase for the drug.,2023-05-31,2023-10-03,No
204095,02268906,Shortage,MYLAN-SUMATRIPTAN,MYLAN PHARMACEUTICALS ULC,SUMATRIPTAN,SUMATRIPTAN,25MG,6BL,ORAL; ORAL,Resolved,TABLET,2023-09-20,2023-09-20,2023-10-03,2023-10-03,Disruption of the manufacture of the drug.,2023-09-11,2023-10-11,No
204802,02410664,Shortage,MYLAN-TADALAFIL,MYLAN PHARMACEUTICALS ULC,TADALAFIL,TADALAFIL,20MG,4BL,ORAL; ORAL,Avoided shortage,TABLET,2023-12-13,,2023-12-29,2023-09-25,Disruption of the manufacture of the drug.,2023-09-20,2023-09-26,No
207187,02410664,Shortage,MYLAN-TADALAFIL,MYLAN PHARMACEUTICALS ULC,TADALAFIL,TADALAFIL,20MG,4BL,ORAL; ORAL,Resolved,TABLET,,2023-09-26,2023-12-12,2023-12-11,Disruption of the manufacture of the drug.,2023-10-17,2023-12-19,No
207184,02351560,Shortage,MYLAN-VALACYCLOVIR,MYLAN PHARMACEUTICALS ULC,VALACYCLOVIR,VALACYCLOVIR,1000MG,100BT,ORAL; ORAL,Actual shortage,TABLET,2023-11-15,2023-10-27,,,Disruption of the manufacture of the drug.,2023-10-17,2023-11-14,No
186414,02464225,Shortage,MYLAN-VARDENAFIL,MYLAN PHARMACEUTICALS ULC,VARDENAFIL,VARDENAFIL,10MG,4BL,ORAL,Avoided shortage,TABLET,2023-03-15,,2023-03-21,2023-03-14,Disruption of the manufacture of the drug.,2023-03-07,2023-03-20,No
196692,02464209,Shortage,MYLAN-VARDENAFIL,MYLAN PHARMACEUTICALS ULC,VARDENAFIL,VARDENAFIL,5MG,4BL,ORAL,Resolved,TABLET,2023-08-09,2023-08-07,2023-09-05,2023-09-01,Disruption of the manufacture of the drug.,2023-06-27,2023-09-06,No
187546,02464233,Shortage,MYLAN-VARDENAFIL,MYLAN PHARMACEUTICALS ULC,VARDENAFIL,VARDENAFIL,20MG,4BL,ORAL,Resolved,TABLET,2023-04-05,2023-04-10,2023-05-17,2023-05-15,Other (Please describe in comments),2023-03-20,2023-05-23,No
200642,02210347,Shortage,MYLAN-VERAPAMIL SR,MYLAN PHARMACEUTICALS ULC,VERAPAMIL SR,VERAPAMIL HYDROCHLORIDE,120MG,100BT,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),2023-10-03,2023-10-05,2024-02-13,2024-02-09,Disruption of the manufacture of the drug.,2023-08-01,2024-02-21,No
188108,02450496,Shortage,MYLAN-VERAPAMIL SR,MYLAN PHARMACEUTICALS ULC,VERAPAMIL SR,VERAPAMIL HYDROCHLORIDE,240MG,"100BT, 500BT",ORAL; ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),,2022-09-07,,,Disruption of the manufacture of the drug.,2023-03-27,2023-03-27,No
188111,02450488,Shortage,MYLAN-VERAPAMIL SR,MYLAN PHARMACEUTICALS ULC,VERAPAMIL SR,VERAPAMIL HYDROCHLORIDE,180MG,100BT,ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),,2022-09-07,,,Disruption of the manufacture of the drug.,2023-03-27,2024-02-22,No
181704,02148714,Shortage,NALOXONE HCL INJECTION - 1MG/ML USP,SANDOZ CANADA INCORPORATED,NALOXONE HCL,NALOXONE HYDROCHLORIDE,1MG,2ML,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-01-18,2023-03-17,2023-03-20,Demand increase for the drug.,2023-01-19,2023-03-21,No
210664,02382482,Shortage,NALOXONE HYDROCHLORIDE INJECTION USP,HIKMA CANADA LIMITED,NALOXONE HYDROCHLORIDE INJECTION USP,NALOXONE HYDROCHLORIDE,0.4MG,1mL,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Actual shortage,SOLUTION,2023-11-17,,2024-04-30,,Shortage of an active ingredient.,2023-11-17,2024-04-09,No
185677,02162423,Shortage,NAPROSYN,ATNAHS PHARMA UK LIMITED,Naprosyn Tabs,NAPROXEN,500MG,100,ORAL; ORAL,Actual shortage,TABLET (ENTERIC-COATED),,2023-01-30,2024-03-31,,Demand increase for the drug.,2023-02-28,2023-11-24,No
204887,02162423,Shortage,NAPROSYN,ATNAHS PHARMA UK LIMITED,Naproxen sodium tablets USP,NAPROXEN,500MG,100s,ORAL; ORAL,Actual shortage,TABLET (ENTERIC-COATED),,2023-09-21,2024-05-10,,Other (Please describe in comments),2023-09-21,2024-03-01,No
189849,02162415,Shortage,NAPROSYN,ATNAHS PHARMA UK LIMITED,Naproxen enteric-coated Tablets,NAPROXEN,375MG,100s,ORAL; ORAL,Resolved,TABLET (ENTERIC-COATED),,2023-04-19,,2023-05-25,Shortage of an active ingredient.,2023-04-19,2023-05-26,No
181466,02162466,Shortage,NAPROSYN,ATNAHS PHARMA UK LIMITED,Naproxen sustained release tablets,NAPROXEN,750MG,100s,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),2023-01-19,2023-01-19,,2023-05-25,Other (Please describe in comments),2023-01-19,2023-05-26,No
188744,02229415,Shortage,NAROPIN,ASPEN PHARMACARE CANADA INC.,ropivacaine HCl 5mg/mL 5x20mL SU Polyamp® Duofit®,ROPIVACAINE HYDROCHLORIDE,5MG,5 PP Polybag,EPIDURAL; BLOCK/INFILTRATION; BLOCK/INFILTRATION; EPIDURAL,Resolved,SOLUTION,2023-06-01,,2023-06-30,2023-06-01,Delay in shipping of the drug.,2023-04-04,2023-06-05,No
203931,02229418,Shortage,NAROPIN,ASPEN PHARMACARE CANADA INC.,ropivacaine HCl 10mg/mL 5x20mL SU Polyamp® Duofit®,ROPIVACAINE HYDROCHLORIDE,10MG,5 PP Polybag,EPIDURAL; EPIDURAL,Resolved,SOLUTION,2023-11-15,2023-10-17,2023-12-15,2023-11-22,Delay in shipping of the drug.,2023-09-08,2023-11-28,No
200389,02229418,Shortage,NAROPIN,ASPEN PHARMACARE CANADA INC.,ropivacaine HCl 10mg/mL 5x10mL SU Polyamp® Duofit®,ROPIVACAINE HYDROCHLORIDE,10MG,5 PP Polybag,EPIDURAL; EPIDURAL,Resolved,SOLUTION,,2023-07-27,2023-12-31,2023-11-21,Delay in shipping of the drug.,2023-07-28,2023-11-28,No
209405,02229415,Shortage,NAROPIN,ASPEN PHARMACARE CANADA INC.,ropivacaine HCl 5mg/mL 5x20mL SU Polyamp® Duofit®,ROPIVACAINE HYDROCHLORIDE,5MG,5 PP Polybag,EPIDURAL; BLOCK/INFILTRATION; BLOCK/INFILTRATION; EPIDURAL,Resolved,SOLUTION,2024-01-15,2024-01-15,2024-02-20,2024-02-13,Disruption of the manufacture of the drug.,2023-11-06,2024-02-13,No
192650,02494892,Shortage,NAT-PREGABALIN,NATCO PHARMA (CANADA) INC,Pregabalin,PREGABALIN,225MG,Bottles of 100s,ORAL,Actual shortage,CAPSULE,,2023-05-17,2025-05-16,,Other (Please describe in comments),2023-05-17,2024-02-02,No
195198,00065927,Shortage,NEO-LARYNGOBIS,TEVA CANADA LIMITED,NEO-LARYNGOBIS,BISMUTH DIPROPYLACETATE,135MG,2,RECTAL; RECTAL,Resolved,SUPPOSITORY,,2023-06-16,2023-09-30,2023-09-30,Disruption of the manufacture of the drug.,2023-06-16,2023-10-03,No
199750,02230592,Shortage,NEOSTIGMINE OMEGA,OMEGA LABORATORIES LIMITED,Neostigmine Methylsulfate Injection USP,NEOSTIGMINE METHYLSULFATE,1MG,10 x 10mL vial / fiole,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-07-21,2024-03-01,2024-02-26,Disruption of the manufacture of the drug.,2023-07-21,2024-02-27,No
200777,02230593,Shortage,NEOSTIGMINE OMEGA,OMEGA LABORATORIES LIMITED,Neostigmine Methylsulfate Injection USP,NEOSTIGMINE METHYLSULFATE,0.5MG,10 x 10mL vial /fiole,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-08-03,2024-03-28,2024-03-26,Disruption of the manufacture of the drug.,2023-08-02,2024-03-27,No
182155,02230592,Shortage,NEOSTIGMINE OMEGA,OMEGA LABORATORIES LIMITED,Neostigmine Methylsulfate Injection USP,NEOSTIGMINE METHYLSULFATE,1MG,10 x 10mL vial / fiole,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-01-20,2023-02-21,2023-02-21,Demand increase for the drug.,2023-01-20,2023-02-22,No
210095,02387166,Shortage,NEOSTIGMINE OMEGA,OMEGA LABORATORIES LIMITED,Neostigmine Methylsulfate Injection USP,NEOSTIGMINE METHYLSULFATE,2.5MG,10 x 5mL vial / fiole,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-12-22,,2024-01-23,Disruption of the manufacture of the drug.,2023-11-13,2024-01-24,No
201607,01926780,Shortage,NEULEPTIL,SEARCHLIGHT PHARMA INC,Neuleptil,PERICIAZINE,5MG,100 Caps,ORAL; ORAL,Actual shortage,CAPSULE; CAPSULE,,2021-09-25,,,Other (Please describe in comments),2023-08-11,2023-10-02,No
201610,01926772,Shortage,NEULEPTIL,SEARCHLIGHT PHARMA INC,Neuleptil,PERICIAZINE,10MG,100 caps,ORAL; ORAL,Actual shortage,CAPSULE,,2022-03-10,,,Other (Please describe in comments),2023-08-11,2023-10-02,No
187371,01926756,Shortage,NEULEPTIL,SEARCHLIGHT PHARMA INC,Neuleptil,PERICIAZINE,10MG,100ml,ORAL; ORAL,Resolved,DROPS,2023-03-01,,2023-08-15,2023-08-02,Shortage of an active ingredient.,2023-03-17,2023-08-03,No
196704,02084260,Shortage,NEURONTIN,BGP PHARMA ULC,GABAPENTIN,GABAPENTIN,100MG,100s,ORAL; ORAL,Resolved,CAPSULE,2023-07-07,2023-07-06,2023-07-19,2023-07-19,Disruption of the manufacture of the drug.,2023-06-27,2023-07-25,No
183891,02125226,Shortage,NIDAGEL,"BAUSCH HEALTH, CANADA INC.",NIDAGEL,METRONIDAZOLE,0.75%,70g,VAGINAL; VAGINAL,Resolved,GEL,2023-03-31,2023-03-20,2023-06-30,2023-06-26,Shortage of an inactive ingredient or component.,2023-02-08,2023-06-29,No
198729,00725110,Shortage,NIFEDIPINE,AA PHARMA INC,Nifedipine,NIFEDIPINE,5MG,100 BTL,ORAL; ORAL,Avoided shortage,CAPSULE,2023-07-28,,2023-08-07,2023-07-27,Disruption of the manufacture of the drug.,2023-07-14,2023-08-03,No
192073,00755907,Shortage,NIFEDIPINE,AA PHARMA INC,Nifedipine,NIFEDIPINE,10MG,100BTL,ORAL; ORAL,Resolved,CAPSULE,2023-05-12,,2023-08-07,2023-07-27,Disruption of the manufacture of the drug.,2023-05-08,2023-08-03,No
200680,02361736,Shortage,NIPRIDE,PFIZER CANADA ULC,NIPRIDE,SODIUM NITROPRUSSIDE,25MG,1x2ML,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-08-01,,2023-09-12,Disruption of the manufacture of the drug.,2023-08-02,2023-09-13,No
198722,00319511,Shortage,NITROFURANTOIN,AA PHARMA INC,Nitrofurantoin,NITROFURANTOIN,50MG,100 BTL,ORAL; ORAL,Resolved,TABLET,2023-07-14,,2023-09-06,2023-09-06,Disruption of the manufacture of the drug.,2023-07-14,2023-09-11,No
205034,00312738,Shortage,NITROFURANTOIN,AA PHARMA INC,Nitrofurantoin,NITROFURANTOIN,100MG,100 Bottle,ORAL; ORAL,Resolved,TABLET,2023-09-22,,2023-12-12,2023-12-06,Disruption of the manufacture of the drug.,2023-09-22,2023-12-07,No
209460,00778869,Shortage,NITROJECT,OMEGA LABORATORIES LIMITED,Nitroglycerin Injection USP,NITROGLYCERIN,50MG,5 x 10mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-11-06,,2023-12-13,Disruption of the manufacture of the drug.,2023-11-06,2023-12-14,No
186615,02231441,Shortage,NITROLINGUAL PUMPSPRAY,SANOFI-AVENTIS CANADA INC,NITROLINGUAL PUMPSPRAY (75 doses),NITROGLYCERIN,0.4MG,1,SUBLINGUAL; SUBLINGUAL,Resolved,METERED-DOSE PUMP,2023-03-10,2023-03-10,2024-06-30,2024-03-28,Demand increase for the drug.,2023-03-09,2024-03-29,Yes
186618,02231441,Shortage,NITROLINGUAL PUMPSPRAY,SANOFI-AVENTIS CANADA INC,NITROLINGUAL PUMPSPRAY (200 doses),NITROGLYCERIN,0.4MG,1,SUBLINGUAL; SUBLINGUAL,Actual shortage,METERED-DOSE PUMP,,2023-03-08,2024-06-30,,Demand increase for the drug.,2023-03-09,2023-12-20,Yes
191285,00037613,Shortage,NITROSTAT,BGP PHARMA ULC,NITROGLYCERIN,NITROGLYCERIN,0.3MG,100 BT,SUBLINGUAL; SUBLINGUAL,Resolved,TABLET,2023-05-17,2023-05-04,,2023-07-20,Demand increase for the drug.,2023-05-01,2023-07-25,No
201387,00037613,Shortage,NITROSTAT,BGP PHARMA ULC,NITROGLYCERIN,NITROGLYCERIN,0.3MG,1x100 BTL,SUBLINGUAL; SUBLINGUAL,Resolved,TABLET,2023-09-27,2023-09-25,2023-10-31,2023-10-20,Demand increase for the drug.,2023-08-08,2023-10-25,No
201390,00037621,Shortage,NITROSTAT,BGP PHARMA ULC,NITROGLYCERIN,NITROGLYCERIN,0.6MG,1x100 BTL,SUBLINGUAL; SUBLINGUAL,Resolved,TABLET,2023-09-12,2023-09-18,,2023-10-25,Demand increase for the drug.,2023-08-08,2023-10-30,No
189875,00037621,Shortage,NITROSTAT,BGP PHARMA ULC,NITROSTAT,NITROGLYCERIN,0.6MG,100 BT,SUBLINGUAL; SUBLINGUAL,Resolved,TABLET,2023-04-25,2023-04-21,,2023-07-20,Demand increase for the drug.,2023-04-20,2023-07-25,No
203363,02529211,Shortage,NORDITROPIN FLEXPRO,NOVO NORDISK CANADA INC,NORDITROPIN FLEXPRO,SOMATROPIN,15MG,1,SUBCUTANEOUS,Resolved,SOLUTION,2023-09-05,,2023-10-20,2023-10-23,Delay in shipping of the drug.,2023-08-31,2023-10-24,No
194906,02334879,Shortage,NORDITROPIN NORDIFLEX,NOVO NORDISK CANADA INC,Norditropin,SOMATROPIN,15MG,1,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION,2023-07-15,2023-07-07,,2023-10-23,Other (Please describe in comments),2023-06-14,2023-10-24,No
206593,02156091,Shortage,NORITATE,"BAUSCH HEALTH, CANADA INC.",NORITATE,METRONIDAZOLE,1%,45g,TOPICAL; TOPICAL,Avoided shortage,CREAM,2023-11-13,,2023-11-27,2023-10-30,Other (Please describe in comments),2023-10-06,2023-11-01,No
213952,02156091,Shortage,NORITATE,"BAUSCH HEALTH, CANADA INC.",NORITATE,METRONIDAZOLE,1%,45g,TOPICAL; TOPICAL,Resolved,CREAM,2024-01-25,2024-01-26,2024-03-16,2024-03-05,Other (Please describe in comments),2023-12-20,2024-03-06,No
195109,01934163,Shortage,NOVAMOXIN,TEVA CANADA LIMITED,NOVAMOXIN,AMOXICILLIN,250MG,150ML,ORAL; ORAL,Resolved,GRANULES FOR SUSPENSION,,2023-06-16,2023-10-31,2023-11-01,Disruption of the manufacture of the drug.,2023-06-16,2023-11-03,No
195112,00452130,Shortage,NOVAMOXIN,TEVA CANADA LIMITED,NOVAMOXIN,AMOXICILLIN,250MG,100ML,ORAL; ORAL,Resolved,GRANULES FOR SUSPENSION,,2023-06-16,2023-09-10,2023-10-10,Disruption of the manufacture of the drug.,2023-06-16,2023-10-11,No
183361,01934163,Shortage,NOVAMOXIN,TEVA CANADA LIMITED,NOVAMOXIN 250MG/5ML LS SUS,AMOXICILLIN,250MG,150ml,ORAL; ORAL,Resolved,GRANULES FOR SUSPENSION,,2023-01-30,2023-07-10,2023-07-04,Disruption of the manufacture of the drug.,2023-02-02,2023-07-05,No
195410,00406716,Shortage,NOVAMOXIN,TEVA CANADA LIMITED,NOVAMOXIN,AMOXICILLIN,500MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-06-19,2023-06-30,2023-07-04,Disruption of the manufacture of the drug.,2023-06-19,2023-07-05,No
195207,00452130,Shortage,NOVAMOXIN,TEVA CANADA LIMITED,NOVAMOXIN,AMOXICILLIN,250MG,150ML,ORAL; ORAL,Resolved,GRANULES FOR SUSPENSION,,2023-06-16,2023-09-10,2023-10-10,Disruption of the manufacture of the drug.,2023-06-16,2023-10-11,No
207503,00452130,Shortage,NOVAMOXIN,TEVA CANADA LIMITED,AMOXICILLIN SUS 250MG/5ML,AMOXICILLIN,250MG,100,ORAL; ORAL,Actual shortage,GRANULES FOR SUSPENSION,,2023-01-01,2024-03-31,,Disruption of the manufacture of the drug.,2023-10-19,2024-03-18,No
195754,01934163,Shortage,NOVAMOXIN,TEVA CANADA LIMITED,NOVAMOXIN,AMOXICILLIN,250MG,100ML,ORAL; ORAL,Resolved,GRANULES FOR SUSPENSION,,2023-06-19,2023-12-20,2023-11-01,Disruption of the manufacture of the drug.,2023-06-20,2023-11-03,No
195545,02036355,Shortage,NOVAMOXIN,TEVA CANADA LIMITED,NOVAMOXIN,AMOXICILLIN,250MG,10,ORAL; ORAL,Resolved,TABLET (CHEWABLE),,2023-06-19,2023-08-20,2023-08-17,Disruption of the manufacture of the drug.,2023-06-19,2023-08-18,No
195818,00406716,Shortage,NOVAMOXIN,TEVA CANADA LIMITED,NOVAMOXIN,AMOXICILLIN,500MG,500,ORAL; ORAL,Resolved,CAPSULE,,2023-06-19,2023-06-30,2023-07-04,Disruption of the manufacture of the drug.,2023-06-20,2023-07-05,No
199232,02482126,Shortage,NRA-DULOXETINE,NORA PHARMA INC,NRA-DULOXETINE,DULOXETINE,30MG,30's and 100's,ORAL; ORAL,Avoided shortage,CAPSULE (DELAYED RELEASE),2023-10-01,,,2023-07-28,Other (Please describe in comments),2023-07-19,2023-07-28,No
199235,02482134,Shortage,NRA-DULOXETINE,NORA PHARMA INC,NRA-DULOXETINE,DULOXETINE,60MG,30's and 100's,ORAL; ORAL,Avoided shortage,CAPSULE (DELAYED RELEASE),2024-01-01,,,2023-07-28,Other (Please describe in comments),2023-07-19,2023-07-28,No
194857,02415585,Shortage,NUCYNTA EXTENDED-RELEASE,ENDO VENTURES LTD.,TAPENTADOL,TAPENTADOL,100MG,60 tabs,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),2023-06-12,2023-06-12,2024-03-22,2024-03-25,Delay in shipping of the drug.,2023-06-13,2024-03-26,No
205952,02415607,Shortage,NUCYNTA EXTENDED-RELEASE,ENDO VENTURES LTD.,TAPENTADOL,TAPENTADOL,200MG,60 tabs,ORAL; ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),,2023-09-22,2024-04-05,,Delay in shipping of the drug.,2023-10-03,2024-03-25,No
208783,02415593,Shortage,NUCYNTA EXTENDED-RELEASE,ENDO VENTURES LTD.,TAPENTADOL,TAPENTADOL,150MG,60 tabs,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),2023-10-30,,2024-03-22,2024-03-25,Delay in shipping of the drug.,2023-10-31,2024-03-26,No
179899,02378272,Shortage,NUCYNTA IR,ENDO VENTURES LTD.,TAPENTADOL,TAPENTADOL,50MG,100 tabs,ORAL; ORAL,Resolved,TABLET (IMMEDIATE RELEASE),2023-01-05,2023-02-15,2023-02-20,2023-02-20,Delay in shipping of the drug.,2023-01-05,2023-05-02,No
196653,02253186,Shortage,NUVARING,ORGANON CANADA INC.,etonogestrel / ethinyl estradiol slow release vaginal ring,ETHINYL ESTRADIOL; ETONOGESTREL,2.6MG; 11.4MG,1,VAGINAL; VAGINAL,Resolved,RING (SLOW-RELEASE),,2023-06-22,2023-07-03,2023-06-27,Delay in shipping of the drug.,2023-06-27,2023-06-28,No
211733,02248642,Shortage,OCTREOTIDE ACETATE OMEGA,OMEGA LABORATORIES LIMITED,Octreotide Acetate Injection,OCTREOTIDE,200MCG,1 x 5 mL vial / fiole,SUBCUTANEOUS; INTRAVENOUS; SUBCUTANEOUS; INTRAVENOUS,Actual shortage,SOLUTION,,2023-12-05,2024-07-30,,Disruption of the manufacture of the drug.,2023-11-28,2024-03-05,No
200780,02248642,Shortage,OCTREOTIDE ACETATE OMEGA,OMEGA LABORATORIES LIMITED,Octreotide Acetate Injection,OCTREOTIDE,200MCG,1 x 5mL vial / fiole,SUBCUTANEOUS; INTRAVENOUS; SUBCUTANEOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-08-03,2023-11-10,2023-11-07,Demand increase for the drug.,2023-08-02,2023-11-08,No
208725,02248640,Shortage,OCTREOTIDE ACETATE OMEGA,OMEGA LABORATORIES LIMITED,Octreotide Acetate Injection 100 MCG/ML,OCTREOTIDE,100MCG,5 x 1 mL vial / fiole,SUBCUTANEOUS; INTRAVENOUS; SUBCUTANEOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-11-06,2023-11-20,2023-11-13,Demand increase for the drug.,2023-10-31,2023-11-14,No
213871,02248640,Shortage,OCTREOTIDE ACETATE OMEGA,OMEGA LABORATORIES LIMITED,"OCTREOTIDE ACETATE, 100 MCG/ML (100 MCG/1 ML), INJ",OCTREOTIDE,100MCG,5 x 1mL vial / fiole,SUBCUTANEOUS; INTRAVENOUS; SUBCUTANEOUS; INTRAVENOUS,Resolved,SOLUTION,,2024-01-03,2024-02-09,2024-02-06,Demand increase for the drug.,2023-12-19,2024-02-07,No
213107,02248639,Shortage,OCTREOTIDE ACETATE OMEGA,OMEGA LABORATORIES LIMITED,Octreotide Acetate Injection,OCTREOTIDE,50MCG,5 x 1mL vial / fiole,SUBCUTANEOUS; INTRAVENOUS; SUBCUTANEOUS; INTRAVENOUS,Resolved,SOLUTION,2024-01-04,2024-01-03,2024-01-15,2024-01-18,Demand increase for the drug.,2023-12-12,2024-01-19,No
190174,02248642,Shortage,OCTREOTIDE ACETATE OMEGA,OMEGA LABORATORIES LIMITED,Octreotide Acetate Injection,OCTREOTIDE,200MCG,1 x 5 mL vial / fiole,SUBCUTANEOUS; INTRAVENOUS; SUBCUTANEOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-04-21,2023-04-28,2023-04-25,Demand increase for the drug.,2023-04-21,2023-04-26,No
182246,02490706,Shortage,ODAN CLOBETASOL SPRAY,ODAN LABORATORIES LTD,Clobetasol Propionate Topical Solution,CLOBETASOL PROPIONATE,0.05%,59 mL,TOPICAL; TOPICAL,Resolved,SPRAY,,2023-01-24,2023-02-15,2023-02-09,Disruption of the manufacture of the drug.,2023-01-24,2023-02-10,No
186465,00626627,Shortage,ODAN-CYCLOPENTOLATE,ODAN LABORATORIES LTD,Cyclopentolate Hydrochloride Ophthalmic Solution,CYCLOPENTOLATE HYDROCHLORIDE,1%,10 mL,OPHTHALMIC,Resolved,SOLUTION,,2023-03-08,2023-07-30,2023-08-04,Demand increase for the drug.,2023-03-08,2023-09-21,No
204543,00626627,Shortage,ODAN-CYCLOPENTOLATE,ODAN LABORATORIES LTD,"Cyclopentolate Hydrochloride Ophthalmic Solution, USP",CYCLOPENTOLATE HYDROCHLORIDE,1%,10 mL,OPHTHALMIC,Resolved,SOLUTION,2023-09-18,,2023-10-09,2023-10-04,Demand increase for the drug.,2023-09-15,2023-10-05,No
205248,02231800,Shortage,ODAN-INDOMETHACIN,ODAN LABORATORIES LTD,"Indomethacin Suppositories, USP",INDOMETHACIN,100MG,Boxes of 30,RECTAL; RECTAL,Actual shortage,SUPPOSITORY,,2023-09-25,2024-09-30,,Disruption of the manufacture of the drug.,2023-09-26,2024-04-11,No
210201,00789720,Shortage,ODAN-PROCHLORPERAZINE,ODAN LABORATORIES LTD,"Prochlorperazine Suppositories, USP",PROCHLORPERAZINE,10MG,10,RECTAL; RECTAL,Actual shortage,SUPPOSITORY,,2023-09-21,2024-09-30,,Disruption of the manufacture of the drug.,2023-11-15,2024-04-11,No
184792,02473968,Shortage,ODAN-SODIUM POLYSTYRENE SULFONATE,ODAN LABORATORIES LTD,Sodium Polystyrene Sulfonate Oral/Rectal Suspension,SODIUM POLYSTYRENE SULFONATE,250MG,60 mL,RECTAL; ORAL; RECTAL; ORAL,Resolved,SUSPENSION,,2023-02-15,2023-03-30,2023-03-24,Demand increase for the drug.,2023-02-16,2023-03-27,No
188095,00622885,Shortage,ODAN-TROPICAMIDE,ODAN LABORATORIES LTD,"Tropicamide Ophthalmic Solution, USP",TROPICAMIDE,1%,10 mL,OPHTHALMIC,Resolved,SOLUTION,,2023-03-27,2023-07-31,2023-08-03,Demand increase for the drug.,2023-03-27,2023-08-04,No
198789,02372851,Shortage,OLANZAPINE,SANIS HEALTH INC,OLANZAPINE,OLANZAPINE,15MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-17,2023-09-01,2023-09-01,Disruption of the manufacture of the drug.,2023-07-17,2023-09-05,No
182306,02338653,Shortage,OLANZAPINE ODT,PRO DOC LIMITEE,OLANZAPINE ODT,OLANZAPINE,10MG,30,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-01-26,2023-02-23,2023-02-23,Delay in shipping of the drug.,2023-01-25,2023-02-24,No
211151,02343665,Shortage,OLANZAPINE ODT,SIVEM PHARMACEUTICALS ULC,Olanzapine ODT,OLANZAPINE,5MG,30,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-11-06,2024-01-29,2024-01-22,Delay in shipping of the drug.,2023-11-22,2024-01-31,No
211154,02343703,Shortage,OLANZAPINE ODT,SIVEM PHARMACEUTICALS ULC,Olanzapine ODT,OLANZAPINE,20MG,30,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-09-11,2024-02-15,2024-02-26,Delay in shipping of the drug.,2023-11-22,2024-04-01,No
196455,02210320,Shortage,OLESTYR,PHARMASCIENCE INC,OLESTYR REG,CHOLESTYRAMINE RESIN,4G,30X4g,ORAL; ORAL,Actual shortage,POWDER FOR SUSPENSION,,2023-06-26,,,Disruption of the manufacture of the drug.,2023-06-26,2024-01-30,Yes
204499,00890960,Shortage,OLESTYR,PHARMASCIENCE INC,OLESTYR,CHOLESTYRAMINE RESIN,4G,30x4g,ORAL; ORAL,Actual shortage,POWDER FOR SUSPENSION,,2023-09-15,,,Disruption of the manufacture of the drug.,2023-09-15,2024-01-30,Yes
200456,02481065,Shortage,OLMESARTAN,SANIS HEALTH INC,OLMESARTAN,OLMESARTAN MEDOXOMIL,40MG,100,ORAL,Resolved,TABLET,,2023-07-31,,2023-09-22,Disruption of the manufacture of the drug.,2023-07-31,2023-09-25,No
207885,02481065,Shortage,OLMESARTAN,SANIS HEALTH INC,OLMESARTAN,OLMESARTAN MEDOXOMIL,40MG,100,ORAL,Resolved,TABLET,,2023-10-23,2024-02-09,2024-02-12,Disruption of the manufacture of the drug.,2023-10-23,2024-02-12,No
200465,02481057,Shortage,OLMESARTAN,SANIS HEALTH INC,OLMESARTAN,OLMESARTAN MEDOXOMIL,20MG,100,ORAL,Resolved,TABLET,,2023-07-31,2023-12-29,2023-12-29,Disruption of the manufacture of the drug.,2023-07-31,2024-01-17,No
200392,02318660,Shortage,OLMETEC,ORGANON CANADA INC.,Olmesartan Medoxomil tablets,OLMESARTAN MEDOXOMIL,20MG,30,ORAL; ORAL,Resolved,TABLET,,2023-07-26,2023-08-04,2023-08-01,Delay in shipping of the drug.,2023-07-28,2023-08-02,No
212845,02416549,Shortage,OMEPRAZOLE MAGNESIUM DELAYED RELEASE TABLETS,ACCORD HEALTHCARE INC,OMEPRAZOLE,OMEPRAZOLE,20MG,100,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE),,2023-12-08,2023-12-19,2023-12-21,Delay in shipping of the drug.,2023-12-08,2023-12-22,No
188698,02172739,Shortage,OMNIPAQUE 240,GE HEALTHCARE CANADA INC,iohexol injection USP,IOHEXOL,518MG,100 mL,INTRAVASCULAR; SUBARACHNOIDAL; INTRAVASCULAR; SUBARACHNOIDAL,Resolved,SOLUTION,,2023-04-04,2023-04-13,2023-04-13,Delay in shipping of the drug.,2023-04-04,2023-04-14,No
181357,02461900,Shortage,ONCASPAR,SERVIER CANADA INC,Injection de pegaspargase,PEGASPARGASE,750UNIT,5ml,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,2023-02-20,,2024-02-29,2024-02-29,Disruption of the manufacture of the drug.,2023-01-17,2024-03-01,No
211215,02464578,Shortage,ONDANSETRON INJECTION USP,STERIMAX INC,ONDANSETRON INJECTION USP,ONDANSETRON,2MG,10 VIALS X 2 ML,INTRAVENOUS; INTRAVENOUS,Actual shortage,SOLUTION,2024-01-08,,,,Disruption of the manufacture of the drug.,2023-11-22,2024-01-09,No
181875,02464578,Shortage,ONDANSETRON INJECTION USP,STERIMAX INC,ONDANSETRON INJECTION USP,ONDANSETRON,2MG,10 X 2 ML VIALS,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-01-20,2023-03-13,2023-03-06,Delay in shipping of the drug.,2023-01-19,2023-03-07,No
202547,02279428,Shortage,ONDANSETRON INJECTION USP     -(PRESERVATIVE FREE),SANDOZ CANADA INCORPORATED,ONDANSETRON INJECTION USP,ONDANSETRON,2MG,4ML 10LIVI,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-08-21,2023-12-22,2023-12-22,Shortage of an active ingredient.,2023-08-21,2024-01-03,No
188061,02481723,Shortage,ONDANSETRON ODT,SANDOZ CANADA INCORPORATED,ONDANSETRON ODT,ONDANSETRON,4MG,10  ODT,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-03-27,2023-05-05,2023-05-08,Disruption of the manufacture of the drug.,2023-03-27,2023-05-09,No
186070,02481731,Shortage,ONDANSETRON ODT,SANDOZ CANADA INCORPORATED,ONDANSETRON,ONDANSETRON,8MG,10ODT,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-02-17,2023-07-07,2023-07-04,Shortage of an active ingredient.,2023-03-02,2023-07-05,No
212454,02481723,Shortage,ONDANSETRON ODT,SANDOZ CANADA INCORPORATED,ODANSETRON ODT,ONDANSETRON,4MG,10ODT,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-12-04,2024-01-26,2024-01-30,Disruption of the manufacture of the drug.,2023-12-04,2024-01-31,No
213256,02242502,Shortage,ONE-ALPHA,CHEPLAPHARM ARZNEIMITTEL GMBH,Alfacalcidol,ALFACALCIDOL,2MCG,0.5 ml x 10 amp.,INTRAVENOUS; INTRAVENOUS,Actual shortage,SOLUTION; LIQUID,2023-12-18,,2024-05-31,,Disruption of the manufacture of the drug.,2023-12-13,2024-01-22,No
180961,02240329,Shortage,ONE-ALPHA,CHEPLAPHARM ARZNEIMITTEL GMBH,Alfacalcidol,ALFACALCIDOL,2MCG,20 mL,ORAL; ORAL,Resolved,DROPS,2023-01-20,,2023-06-30,2023-06-12,Disruption of the manufacture of the drug.,2023-01-13,2023-06-13,No
202912,02467135,Shortage,ONIVYDE,SERVIER CANADA INC,IRINOTECAN,IRINOTECAN,4.3MG,43mg/10mL vial,INTRAVENOUS; INTRAVENOUS,Actual shortage,SUSPENSION,,2023-08-18,,,Other (Please describe in comments),2023-08-24,2023-08-24,No
191665,02467135,Shortage,ONIVYDE,SERVIER CANADA INC,IRINOTECAN,IRINOTECAN,4.3MG,43mg/10mL,INTRAVENOUS; INTRAVENOUS,Resolved,SUSPENSION,,2023-07-06,,2023-08-18,Other (Please describe in comments),2023-05-04,2023-08-22,No
197307,00701785,Shortage,OPTIMYXIN,EURO-PHARM INTERNATIONAL CANADA INC,Gramicidin and Polymyxin B Sulfate Oto-Ophthalmic Solution,GRAMICIDIN; POLYMYXIN B,0.025MG; 10000UNIT,10 mL,OTIC; OPHTHALMIC; OTIC; OPHTHALMIC,Actual shortage,DROPS,2021-12-31,2022-01-01,2025-07-01,,Other (Please describe in comments),2023-07-04,2023-07-04,No
185659,02325993,Shortage,ORAQIX,DENTSPLY CANADA LIMITED,LIDOCAINE 2.5%/ PRILOCAINE 2.5%,LIDOCAINE; PRILOCAINE,2.5%; 2.5%,20 x 1.7 g Cartridges,TOPICAL; TOPICAL,Resolved,GEL,2023-02-23,2023-02-23,2023-04-23,2023-04-25,Delay in shipping of the drug.,2023-02-28,2023-04-26,No
203938,02325993,Shortage,ORAQIX,DENTSPLY CANADA LIMITED,LIDOCAINE 2.5%/ PRILOCAINE 2.5%,LIDOCAINE; PRILOCAINE,2.5%; 2.5%,20 x 1.7 g Cartridges,TOPICAL; TOPICAL,Resolved,GEL,2023-09-05,2023-09-05,2023-11-15,2023-10-25,Delay in shipping of the drug.,2023-09-08,2023-10-26,No
180223,02495589,Shortage,OSNUVO,AVIR PHARMA INC.,Osnuvo,TERIPARATIDE,250MCG,1,SUBCUTANEOUS,Resolved,SOLUTION,2023-01-03,2023-01-03,2023-03-17,2023-03-17,Delay in shipping of the drug.,2023-01-09,2023-03-18,No
200401,02262088,Shortage,OVIDREL,"EMD SERONO, A DIVISION OF EMD INC., CANADA",Choriogonadotropin alfa,CHORIOGONADOTROPIN ALFA,250MCG,1 syringe,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION,,2023-07-28,2023-08-08,2023-08-04,Delay in shipping of the drug.,2023-07-28,2023-08-05,No
190868,02387085,Shortage,OVIMA 21,APOTEX INC,LEVONORGESTREL / ETHINYL ESTRADIOL,ETHINYL ESTRADIOL; LEVONORGESTREL,30MCG; 150MCG,21 BLS,ORAL; ORAL,Resolved,TABLET,,2023-04-24,2023-05-12,2023-05-05,Disruption of the manufacture of the drug.,2023-04-27,2023-05-06,No
185933,02387093,Shortage,OVIMA 28,APOTEX INC,LEVONORGESTREL / ETHINYL ESTRADIOL,ETHINYL ESTRADIOL; LEVONORGESTREL,30MCG; 150MCG,28 BLS,ORAL; ORAL,Resolved,TABLET,,2023-02-28,2023-03-31,2023-03-22,Disruption of the manufacture of the drug.,2023-03-02,2023-03-23,No
203427,02458403,Shortage,"OXALIPLATIN INJECTION, USP",DR REDDY'S LABORATORIES LTD,"Oxaliplatin Injection, USP 50mg/10ml",OXALIPLATIN,5MG,1 vial/carton,INTRAVENOUS,Resolved,SOLUTION,2023-09-01,,2023-11-30,2023-11-08,Other (Please describe in comments),2023-09-01,2023-11-15,No
201866,02485613,Shortage,OXERVATE,DOMPÉ FARMACEUTICI S.P.A.,CENEGERMIN,,0.00%,7 X 1 ML OXERVATE MULTIDOSE GLASS VIALS,OPHTHALMIC,Actual shortage,SOLUTION,2023-08-30,,,,Other (Please describe in comments),2023-08-15,2023-08-31,No
179931,02231934,Shortage,OXY.IR,PURDUE PHARMA,Oxycodone Hydrochloride Immediate Release Tablets,OXYCODONE HYDROCHLORIDE,5MG,60,ORAL; ORAL,Resolved,TABLET,2023-01-05,2023-01-05,2023-03-17,2023-02-17,Delay in shipping of the drug.,2023-01-05,2023-02-18,No
192385,02372797,Shortage,OXYNEO,PURDUE PHARMA,Oxycodone Hydrochloride Controlled Release Tablets,OXYCODONE HYDROCHLORIDE,20MG,60,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),2023-05-11,2023-05-11,2023-05-19,2023-05-17,Delay in shipping of the drug.,2023-05-12,2023-05-18,No
192391,02372584,Shortage,OXYNEO,PURDUE PHARMA,Oxycodone Hydrochloride Controlled Release Tablets,OXYCODONE HYDROCHLORIDE,80MG,60,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),2023-05-11,2023-05-11,2023-05-26,2023-05-19,Delay in shipping of the drug.,2023-05-12,2023-05-20,No
191123,02372568,Shortage,OXYNEO,PURDUE PHARMA,Oxycodone Hydrochloride Controlled Release Tablets,OXYCODONE HYDROCHLORIDE,40MG,60,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),2023-04-28,2023-04-28,2023-05-19,2023-05-10,Delay in shipping of the drug.,2023-04-28,2023-05-11,No
189168,02372525,Shortage,OXYNEO,PURDUE PHARMA,Oxycodone Hydrochloride Controlled Release Tablets,OXYCODONE HYDROCHLORIDE,10MG,60,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),2023-04-11,2023-04-11,2023-05-11,2023-05-08,Delay in shipping of the drug.,2023-04-11,2023-05-09,No
208495,02471477,Shortage,OZEMPIC,NOVO NORDISK CANADA INC,OZEMPIC 0.25MG/0.5MG,SEMAGLUTIDE,1.34MG,1,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION,2023-11-15,,2024-02-15,2024-02-16,Demand increase for the drug.,2023-10-30,2024-04-05,No
202216,02471469,Shortage,OZEMPIC,NOVO NORDISK CANADA INC,Ozempic,SEMAGLUTIDE,1MG,1,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION,2023-08-21,,2024-03-31,2024-01-17,Demand increase for the drug.,2023-08-17,2024-04-05,No
187390,02471469,Shortage,OZEMPIC,NOVO NORDISK CANADA INC,Ozempic,SEMAGLUTIDE,1MG,1,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION,2023-03-17,2023-03-17,2023-03-24,2023-03-24,Other (Please describe in comments),2023-03-17,2023-03-25,No
210067,02320150,Shortage,PACLITAXEL INJECTION USP,SANDOZ CANADA INCORPORATED,PACLITAXEL,PACLITAXEL,6MG,50 ML 1LIVI,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-11-13,2023-11-24,2023-11-20,Disruption of the manufacture of the drug.,2023-11-13,2023-11-21,No
207557,02391465,Shortage,PACLITAXEL INJECTION USP,ACCORD HEALTHCARE INC,PACLITAXEL,PACLITAXEL,6MG,1,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-09-14,2023-11-06,2023-11-13,Disruption of the manufacture of the drug.,2023-10-19,2023-11-14,No
202767,02244552,Shortage,PAMIDRONATE DISODIUM FOR INJECTION,PFIZER CANADA ULC,PAMIDRONATE DISODIUM FOR INJECTION,PAMIDRONATE DISODIUM,9MG,10mL vial,INTRAVENOUS; INTRAVENOUS,Actual shortage,SOLUTION,,2024-02-14,2024-05-06,,Disruption of the manufacture of the drug.,2023-08-23,2024-04-18,No
181145,02246598,Shortage,PAMIDRONATE DISODIUM FOR INJECTION,FRESENIUS KABI CANADA LTD,PAMIDRONATE DISODIUM FOR INJECTION,PAMIDRONATE DISODIUM,6MG,10mL,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-04-01,2023-05-08,2023-05-01,Disruption of the manufacture of the drug.,2023-01-16,2023-05-15,No
181148,02246599,Shortage,PAMIDRONATE DISODIUM FOR INJECTION,FRESENIUS KABI CANADA LTD,PAMIDRONATE DISODIUM FOR INJECTION,PAMIDRONATE DISODIUM,9MG,10mL,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-01-09,2023-03-31,2023-03-31,Other (Please describe in comments),2023-01-16,2023-04-03,No
189681,02249685,Shortage,PAMIDRONATE DISODIUM OMEGA 9 MG/ML,OMEGA LABORATORIES LIMITED,Pamidronate Disodium For Injection,PAMIDRONATE DISODIUM,9.0MG,10 x 1 mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2023-04-27,2023-04-27,2023-05-19,2023-05-09,Demand increase for the drug.,2023-04-14,2023-05-10,No
201273,02306727,Shortage,PANTOPRAZOLE SODIUM FOR INJECTION,SANDOZ CANADA INCORPORATED,PANTOPRAZOLE SODIUM FOR INJECTION,PANTOPRAZOLE,40MG,10LYVI V1,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION,,2023-08-07,2023-09-29,2023-10-02,Disruption of the manufacture of the drug.,2023-08-07,2023-10-03,No
213817,02306727,Shortage,PANTOPRAZOLE SODIUM FOR INJECTION,SANDOZ CANADA INCORPORATED,PANTOPRAZOLE,PANTOPRAZOLE,40MG,10LYVI,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION,,2023-12-19,2024-02-09,2024-02-09,Disruption of the manufacture of the drug.,2023-12-19,2024-02-20,No
208546,02306727,Shortage,PANTOPRAZOLE SODIUM FOR INJECTION,SANDOZ CANADA INCORPORATED,PANTOPRAZOLE SODIUM,PANTOPRAZOLE,40MG,10LYVI,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION,,2023-10-30,2023-11-24,2023-11-14,Disruption of the manufacture of the drug.,2023-10-30,2023-11-15,No
213882,00009881,Shortage,PAPAVERINE HYDROCHLORIDE INJECTION USP,SANDOZ CANADA INCORPORATED,PAPAVERINE HCL,PAPAVERINE HYDROCHLORIDE,65MG,2ML 10LIVI,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-12-19,,2024-01-05,Disruption of the manufacture of the drug.,2023-12-19,2024-01-06,No
212758,02243796,Shortage,"PARIET, ENTERIC-COATED TABLET 10MG",JANSSEN INC,PARIET 10mg,RABEPRAZOLE SODIUM,10MG,100,ORAL; ORAL,Resolved,TABLET (ENTERIC-COATED),2023-12-11,2023-12-11,2024-01-10,2024-01-11,Demand increase for the drug.,2023-12-07,2024-01-12,No
212763,02243797,Shortage,"PARIET, ENTERIC-COATED TABLET 20MG",JANSSEN INC,PARIET 20mg,RABEPRAZOLE SODIUM,20MG,100,ORAL; ORAL,Resolved,TABLET (ENTERIC-COATED),2023-12-13,2023-12-11,2024-01-10,2024-01-11,Demand increase for the drug.,2023-12-07,2024-01-12,No
202024,02316943,Shortage,PAT-GALANTAMINE ER,JANSSEN INC,PAT*-galantamine ER 8mg,GALANTAMINE,8MG,30,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),2023-08-15,2023-08-15,2023-10-13,2023-10-04,Demand increase for the drug.,2023-08-16,2023-10-05,No
204227,02316951,Shortage,PAT-GALANTAMINE ER,JANSSEN INC,PAT-GALANTAMINE ER,GALANTAMINE,16MG,30,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),2023-09-18,,2023-10-13,2023-10-04,Demand increase for the drug.,2023-09-13,2023-10-05,No
187361,02248504,Shortage,PAXIL CR,GLAXOSMITHKLINE INC,Paroxetine Tablets,PAROXETINE,25MG,30s,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-03-17,2023-04-14,2023-04-04,Disruption of the manufacture of the drug.,2023-03-17,2023-04-05,No
182602,01940481,Shortage,PAXIL TAB 20MG,GLAXOSMITHKLINE INC,Paroxetine Tablets,PAROXETINE,20MG,100's,ORAL; ORAL,Resolved,TABLET,,2023-01-27,2023-02-17,2023-02-06,Disruption of the manufacture of the drug.,2023-01-27,2023-02-08,No
196318,02484706,Shortage,PDP-AMLODIPINE,PENDOPHARM DIVISION OF PHARMASCIENCE INC,PDP-AMLODIPINE,AMLODIPINE,1MG,150 mL,ORAL; ORAL,Resolved,SOLUTION,,2023-06-23,2023-08-25,2023-08-23,Delay in shipping of the drug.,2023-06-23,2023-08-24,No
180653,02324253,Shortage,PDP-HYDROCODONE,PENDOPHARM DIVISION OF PHARMASCIENCE INC,PDP-HYDROCODONE,HYDROCODONE BITARTRATE,5MG,500mL,ORAL; ORAL,Resolved,SYRUP,,2023-01-06,2023-05-31,2023-05-15,Disruption of the manufacture of the drug.,2023-01-11,2023-05-16,No
195106,02027798,Shortage,PEDIATRIX,TEVA CANADA LIMITED,PEDIATRIX,ACETAMINOPHEN,160MG,100ML,ORAL; ORAL,Resolved,SOLUTION,,2023-06-16,2023-06-30,2023-06-26,Disruption of the manufacture of the drug.,2023-06-16,2023-06-27,No
195643,02027798,Shortage,PEDIATRIX,TEVA CANADA LIMITED,PEDIATRIX,ACETAMINOPHEN,160MG,500ML,ORAL; ORAL,Resolved,SOLUTION,,2023-06-19,2023-06-20,2023-06-26,Disruption of the manufacture of the drug.,2023-06-19,2023-06-27,No
198402,02515423,Shortage,PEMETREXED FOR INJECTION,ACCORD HEALTHCARE INC,PEMETREXED DISODIUM HEMIPENTAHYDRATE,PEMETREXED,25MG,1,INTRAVENOUS,Resolved,SOLUTION,,2023-06-01,2023-07-21,2023-07-21,Disruption of the manufacture of the drug.,2023-07-12,2023-07-22,No
185687,00642215,Shortage,PEN-VK,AA PHARMA INC,PEN-VK,PENICILLIN V POTASSIUM,300MG,100BTL,ORAL; ORAL,Resolved,TABLET,2023-02-28,,2023-05-19,2023-05-12,Disruption of the manufacture of the drug.,2023-02-28,2023-05-13,No
185690,00642215,Shortage,PEN-VK,AA PHARMA INC,PEN-VK,PENICILLIN V POTASSIUM,300MG,1000 BTL,ORAL; ORAL,Resolved,TABLET,2023-03-03,,2023-05-19,2023-05-12,Disruption of the manufacture of the drug.,2023-02-28,2023-05-13,No
212039,02183080,Shortage,PENTAMIDINE ISETIONATE FOR INJECTION BP,PFIZER CANADA ULC,PENTAMIDINE ISETIONATE FOR INJECTION BP,PENTAMIDINE ISETIONATE,300MG,300mg vial,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Actual shortage,POWDER FOR SOLUTION,,2024-02-14,2024-05-06,,Disruption of the manufacture of the drug.,2023-11-30,2024-02-15,No
213436,02240433,Shortage,PERICHLOR,PENDOPHARM DIVISION OF PHARMASCIENCE INC,PERICHLOR,CHLORHEXIDINE GLUCONATE,0.12%,475mL,BUCCAL; BUCCAL,Resolved,MOUTHWASH,,2023-12-15,2024-03-11,2024-03-14,Disruption of the manufacture of the drug.,2023-12-15,2024-03-15,No
211878,02493160,Shortage,PERICHLOR WITHOUT ALCOHOL,PENDOPHARM DIVISION OF PHARMASCIENCE INC,PERICHLOR WITHOUT ALCOHOL,CHLORHEXIDINE GLUCONATE,0.12%,475mL,BUCCAL,Actual shortage,MOUTHWASH,,2023-11-28,2024-06-17,,Disruption of the manufacture of the drug.,2023-11-30,2024-03-19,No
211058,02481650,Shortage,PERINDOPRIL ERBUMINE,SANIS HEALTH INC,PERINDOPRIL ERBUMINE,PERINDOPRIL ERBUMINE,8MG,500,ORAL; ORAL,Resolved,TABLET,,2023-11-17,2023-11-30,2023-11-30,Disruption of the manufacture of the drug.,2023-11-22,2023-12-01,No
181380,00637734,Shortage,PERSANTINE,GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE,Persantine,DIPYRIDAMOLE,5MG,5´s,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2023-02-01,,2024-02-01,2024-02-08,Disruption of the manufacture of the drug.,2023-01-18,2024-02-28,Yes
195462,00178810,Shortage,PHENOBARB,PENDOPHARM DIVISION OF PHARMASCIENCE INC,PHENOBARB,PHENOBARBITAL,60MG,500,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-07-24,2023-07-28,Demand increase for the drug.,2023-06-19,2023-07-31,No
184259,02304082,Shortage,"PHENOBARBITAL SODIUM INJECTION, USP",SANDOZ CANADA INCORPORATED,PHENOBARBITAL,PHENOBARBITAL SODIUM,30MG,1ML,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-02-08,2023-03-03,2023-03-03,Disruption of the manufacture of the drug.,2023-02-09,2023-03-04,No
184636,02243737,Shortage,PHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD,SANDOZ CANADA INCORPORATED,PHENTOLAMINE,PHENTOLAMINE MESYLATE,5MG,1ML,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-02-14,2023-02-24,2023-02-17,Disruption of the manufacture of the drug.,2023-02-14,2023-03-02,No
181836,02504545,Shortage,PHENYLEPHRINE HYDROCHLORIDE INJECTION USP,STERIMAX INC,PHENYLEPHRINE HYDROCHLORIDE INJECTION USP,PHENYLEPHRINE HYDROCHLORIDE,10MG,25 X 1 ML VIALS,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-01-20,2023-02-28,2023-02-21,Delay in shipping of the drug.,2023-01-19,2023-02-22,No
194769,01953583,Shortage,PHENYLEPHRINE HYDROCHLORIDE INJECTION USP,SANDOZ CANADA INCORPORATED,PHENYLEPHRINE HYDROCHLORIDE,PHENYLEPHRINE,10MG,5ML 10LIVI,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-06-12,2023-06-23,2023-06-19,Requirements related to complying with good manufacturing practices.,2023-06-12,2023-06-20,No
213104,02238400,Shortage,PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1%,OMEGA LABORATORIES LIMITED,Phenylephrine Hydrochloride Injection USP,PHENYLEPHRINE HYDROCHLORIDE,10MG,10 x 1mL vial / fiole,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Avoided shortage,SOLUTION,2024-01-05,,2024-02-09,2024-01-03,Demand increase for the drug.,2023-12-12,2024-01-03,No
194661,00498335,Shortage,PHENYTOIN SODIUM INJECTION USP,OMEGA LABORATORIES LIMITED,Phenytoin Sodium Injection USP,PHENYTOIN SODIUM,50MG,10 x 2 mL vial / fiole,INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-06-20,2023-10-31,2023-10-31,Disruption of the manufacture of the drug.,2023-06-09,2023-11-01,No
186267,00780626,Shortage,PHENYTOIN SODIUM INJECTION USP,SANDOZ CANADA INCORPORATED,PHENYTOIN,PHENYTOIN SODIUM,50MG,2ML,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2022-11-11,2023-03-31,2023-03-27,Disruption of the manufacture of the drug.,2023-03-06,2023-03-28,No
213140,02469677,Shortage,PINAVERIUM,AA PHARMA INC,PINAVERIUM,PINAVERIUM BROMIDE,50MG,100 BTL,ORAL; ORAL,Resolved,TABLET,2023-12-13,,2024-02-07,2024-02-01,Disruption of the manufacture of the drug.,2023-12-13,2024-02-08,No
208859,02469685,Shortage,PINAVERIUM,AA PHARMA INC,Pinaverium,PINAVERIUM BROMIDE,100MG,100 BTL,ORAL; ORAL,Resolved,TABLET,2023-11-07,,2023-12-29,2023-11-30,Disruption of the manufacture of the drug.,2023-11-01,2023-12-04,No
208864,02469677,Shortage,PINAVERIUM,AA PHARMA INC,Pinaverium,PINAVERIUM BROMIDE,50MG,100 BTL,ORAL; ORAL,Resolved,TABLET,2023-11-01,,2023-11-29,2023-11-30,Disruption of the manufacture of the drug.,2023-11-01,2023-12-04,No
207770,02521539,Shortage,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,SANDOZ CANADA INCORPORATED,PIPERACILLIN AND TAZOBACTAM,TAZOBACTAM; PIPERACILLIN,4.5G; 36G,1PSOIJ,INTRAVENOUS,Resolved,POWDER FOR SOLUTION,,2023-10-23,2023-11-17,2023-11-20,Disruption of the manufacture of the drug.,2023-10-23,2023-11-21,No
181707,02299623,Shortage,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,SANDOZ CANADA INCORPORATED,PIPERACILLIN AND TAZOBACTAM,TAZOBACTAM; PIPERACILLIN,0.25G; 2G,10PSOIJ,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION,,2023-01-18,2023-03-17,2023-03-20,Shortage of an inactive ingredient or component.,2023-01-19,2023-03-21,No
181710,02299631,Shortage,PIPERACILLIN AND TAZOBACTAM FOR INJECTION,SANDOZ CANADA INCORPORATED,PIPERACILLIN AND TAZOBACTAM,TAZOBACTAM; PIPERACILLIN,0.375G; 3G,10PSOIJ,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION,,2023-01-18,2023-03-17,2023-03-13,Shortage of an inactive ingredient or component.,2023-01-19,2023-03-14,No
193873,02238682,Shortage,PLAVIX,SANOFI-AVENTIS CANADA INC,PLAVIX,CLOPIDOGREL,75MG,28,ORAL; ORAL,Resolved,TABLET,,2023-06-06,2023-09-22,2023-09-15,Other (Please describe in comments),2023-06-08,2023-09-16,No
184405,02238682,Shortage,PLAVIX,SANOFI-AVENTIS CANADA INC,Plavix 75mg,CLOPIDOGREL,75MG,Blister of 28 Tablets,ORAL; ORAL,Resolved,TABLET,,2023-02-06,2023-03-06,2023-02-14,Other (Please describe in comments),2023-02-10,2023-02-15,No
205398,02238682,Shortage,PLAVIX,SANOFI-AVENTIS CANADA INC,PLAVIX,CLOPIDOGREL,75MG,90,ORAL; ORAL,Resolved,TABLET,,2023-09-26,2024-01-12,2023-12-11,Other (Please describe in comments),2023-09-28,2023-12-12,No
187463,01964976,Shortage,PMS DEXAMETHASONE TAB 0.5MG USP,PHARMASCIENCE INC,DEXAMETHASONE,DEXAMETHASONE,0.5MG,100,ORAL; ORAL,Resolved,TABLET,,2023-03-20,2023-04-19,2023-04-06,Disruption of the manufacture of the drug.,2023-03-20,2023-04-28,No
201559,01937235,Shortage,PMS TRAZODONE HCL TAB 100MG,PHARMASCIENCE INC,TRAZODONE,TRAZODONE HYDROCHLORIDE,100MG,100,ORAL; ORAL,Resolved,TABLET,,2023-08-10,2023-10-24,2023-10-20,Disruption of the manufacture of the drug.,2023-08-10,2023-10-24,No
187472,02237601,Shortage,PMS-ATENOLOL,PHARMASCIENCE INC,ATENOLOL,ATENOLOL,100MG,"30, 100, 500",ORAL; ORAL,Resolved,TABLET,,2023-03-20,2023-06-21,2023-06-23,Disruption of the manufacture of the drug.,2023-03-20,2023-06-26,No
187482,02246581,Shortage,PMS-ATENOLOL,PHARMASCIENCE INC,ATENOLOL,ATENOLOL,25MG,"100, 500",ORAL; ORAL,Resolved,TABLET,,2023-03-20,2023-06-12,2023-06-20,Disruption of the manufacture of the drug.,2023-03-20,2023-06-21,No
185233,02237600,Shortage,PMS-ATENOLOL,PHARMASCIENCE INC,ATENOLOL,ATENOLOL,50MG,"30,100,500",ORAL; ORAL,Resolved,TABLET,,2023-02-21,2023-06-21,2023-06-23,Disruption of the manufacture of the drug.,2023-02-21,2023-06-26,No
214319,02381028,Shortage,PMS-ATOMOXETINE,PHARMASCIENCE INC,ATOMOXETINE,ATOMOXETINE,10MG,30,ORAL; ORAL,Actual shortage,CAPSULE,,2023-12-22,2024-04-20,,Disruption of the manufacture of the drug.,2023-12-27,2024-04-12,No
214322,02381052,Shortage,PMS-ATOMOXETINE,PHARMASCIENCE INC,ATOMOXETINE,ATOMOXETINE,40MG,30 & 100,ORAL; ORAL,Resolved,CAPSULE,,2023-12-22,2024-03-26,2024-04-01,Disruption of the manufacture of the drug.,2023-12-27,2024-04-12,No
214325,02381060,Shortage,PMS-ATOMOXETINE,PHARMASCIENCE INC,ATOMOXETINE,ATOMOXETINE,60MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-12-22,2024-04-01,2024-04-02,Disruption of the manufacture of the drug.,2023-12-27,2024-04-12,No
214328,02381060,Shortage,PMS-ATOMOXETINE,PHARMASCIENCE INC,ATOMOXETINE,ATOMOXETINE,60MG,30,ORAL; ORAL,Resolved,CAPSULE,,2023-12-22,2024-04-04,2024-04-01,Disruption of the manufacture of the drug.,2023-12-27,2024-04-12,No
182160,02261642,Shortage,PMS-AZITHROMYCIN,PHARMASCIENCE INC,AZITHROMYCIN,AZITHROMYCIN,600MG,30,ORAL; ORAL,Resolved,TABLET,2023-01-23,,2023-05-22,2023-05-15,Disruption of the manufacture of the drug.,2023-01-20,2023-05-18,No
189584,02275589,Shortage,PMS-BICALUTAMIDE,PHARMASCIENCE INC,BICALUTAMIDE,BICALUTAMIDE,50MG,100,ORAL; ORAL,Resolved,TABLET,,2023-04-14,2023-06-01,2023-06-06,Disruption of the manufacture of the drug.,2023-04-14,2023-06-07,No
189587,02275589,Shortage,PMS-BICALUTAMIDE,PHARMASCIENCE INC,BICALUTAMIDE,BICALUTAMIDE,50MG,30,ORAL; ORAL,Resolved,TABLET,,2023-04-14,2023-06-12,2023-06-20,Disruption of the manufacture of the drug.,2023-04-14,2023-06-21,No
201545,02391228,Shortage,PMS-CANDESARTAN,PHARMASCIENCE INC,CANDESARTAN,CANDESARTAN CILEXETIL,32MG,30,ORAL; ORAL,Resolved,TABLET,2023-08-10,,2023-10-25,2023-09-12,Disruption of the manufacture of the drug.,2023-08-10,2023-09-18,No
189598,02391171,Shortage,PMS-CANDESARTAN,PHARMASCIENCE INC,CANDESARTAN,CANDESARTAN CILEXETIL,4MG,30,ORAL; ORAL,Resolved,TABLET,,2023-04-14,2023-08-17,2023-08-16,Disruption of the manufacture of the drug.,2023-04-14,2023-08-17,No
193024,02248437,Shortage,PMS-CIPROFLOXACIN,PHARMASCIENCE INC,CIPROFLOXACIN,CIPROFLOXACIN,250MG,100,ORAL; ORAL,Resolved,TABLET,2023-09-05,,,2023-09-18,Disruption of the manufacture of the drug.,2023-05-25,2023-09-20,No
193021,02248439,Shortage,PMS-CIPROFLOXACIN,PHARMASCIENCE INC,CIPROFLOXACIN,CIPROFLOXACIN,750MG,100,ORAL; ORAL,Resolved,TABLET,2023-08-26,,,2023-09-18,Disruption of the manufacture of the drug.,2023-05-25,2023-09-20,No
194525,02416433,Shortage,PMS-CIPROFLOXACIN XL,PHARMASCIENCE INC,CIPROFLOXACIN XL,CIPROFLOXACIN,500MG,100,ORAL; ORAL,Actual shortage,TABLET (IMMEDIATE AND EXTENDED RELEASE); TABLET (EXTENDED-RELEASE),2023-07-17,,2024-10-19,,Disruption of the manufacture of the drug.,2023-06-09,2024-03-15,No
183867,02247573,Shortage,PMS-CLARITHROMYCIN,PHARMASCIENCE INC,CLARITHROMYCIN,CLARITHROMYCIN,250MG,100,ORAL; ORAL,Resolved,TABLET,,2023-01-25,2023-05-23,2023-05-10,Disruption of the manufacture of the drug.,2023-02-08,2023-05-11,No
198008,02302616,Shortage,PMS-DICLOFENAC,PHARMASCIENCE INC,DICLOFENAC,DICLOFENAC SODIUM,25MG,100,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE),,2023-07-10,2023-12-01,2023-11-21,Disruption of the manufacture of the drug.,2023-07-10,2023-11-30,No
189595,02356783,Shortage,PMS-DICLOFENAC,PHARMASCIENCE INC,DICLOFENAC,DICLOFENAC SODIUM,1.50%,60ml,TOPICAL; TOPICAL,Resolved,SOLUTION,,2023-04-14,2023-07-20,2023-07-20,Disruption of the manufacture of the drug.,2023-04-14,2023-07-31,No
210336,02413469,Shortage,PMS-DICLOFENAC-MISOPROSTOL,PHARMASCIENCE INC,DICLOFENAC-MISOPROSTOL,MISOPROSTOL; DICLOFENAC SODIUM,200MCG; 50MG,250,ORAL; ORAL,Actual shortage,TABLET (DELAYED-RELEASE),,2023-11-10,2024-07-01,,Disruption of the manufacture of the drug.,2023-11-16,2024-04-12,No
205607,02242320,Shortage,PMS-DIGOXIN,PHARMASCIENCE INC,TOLOXIN,DIGOXIN,0.05MG,115ml,ORAL; ORAL,Resolved,SOLUTION,,2023-09-29,2023-10-17,2023-10-06,Disruption of the manufacture of the drug.,2023-10-02,2023-10-17,No
203920,02406187,Shortage,PMS-DOXYLAMINE-PYRIDOXINE,PHARMASCIENCE INC,DOXYLAMINE-PYRIDOXINE,PYRIDOXINE HYDROCHLORIDE; DOXYLAMINE SUCCINATE,10MG; 10MG,100,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE),,2023-09-09,2023-09-21,2023-09-21,Disruption of the manufacture of the drug.,2023-09-08,2023-09-25,No
210340,02406187,Shortage,PMS-DOXYLAMINE-PYRIDOXINE,PHARMASCIENCE INC,DOXYLAMINE-PYRIDOXINE,PYRIDOXINE HYDROCHLORIDE; DOXYLAMINE SUCCINATE,10MG; 10MG,100,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE),,2023-11-10,2023-11-21,2023-11-30,Disruption of the manufacture of the drug.,2023-11-16,2023-12-01,No
204505,02469251,Shortage,PMS-ESCITALOPRAM,PHARMASCIENCE INC,ESCITALOPRAM,ESCITALOPRAM,20MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-09-15,2024-06-06,,Disruption of the manufacture of the drug.,2023-09-15,2024-02-07,No
204508,02469251,Shortage,PMS-ESCITALOPRAM,PHARMASCIENCE INC,ESCITALOPRAM,ESCITALOPRAM,20MG,30,ORAL; ORAL,Actual shortage,TABLET,,2023-09-15,2024-06-06,,Disruption of the manufacture of the drug.,2023-09-15,2024-02-07,No
214331,02464640,Shortage,PMS-FLUOXETINE,PHARMASCIENCE INC,FLUOXETINE,FLUOXETINE,40MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-12-22,2024-02-14,2024-02-19,Disruption of the manufacture of the drug.,2023-12-27,2024-02-22,No
214334,02464659,Shortage,PMS-FLUOXETINE,PHARMASCIENCE INC,FLUOXETINE,FLUOXETINE,60MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-12-22,2024-02-21,2024-02-19,Disruption of the manufacture of the drug.,2023-12-27,2024-02-22,No
194536,02464640,Shortage,PMS-FLUOXETINE,PHARMASCIENCE INC,FLUOXETINE,FLUOXETINE,40MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-06-09,2023-11-30,2023-11-21,Disruption of the manufacture of the drug.,2023-06-09,2023-11-30,No
194539,02464659,Shortage,PMS-FLUOXETINE,PHARMASCIENCE INC,FLUOXETINE,FLUOXETINE,60MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-06-09,2023-11-30,2023-11-27,Disruption of the manufacture of the drug.,2023-06-09,2023-11-30,No
204502,02177579,Shortage,PMS-FLUOXETINE - CAP 10MG,PHARMASCIENCE INC,FLUOXETINE,FLUOXETINE,10MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-09-15,2023-11-16,2023-11-10,Disruption of the manufacture of the drug.,2023-09-15,2023-11-16,No
203914,02177587,Shortage,PMS-FLUOXETINE - CAP 20MG,PHARMASCIENCE INC,FLUOXETINE,FLUOXETINE,20MG,100 & 500,ORAL; ORAL,Resolved,CAPSULE,,2023-09-08,2023-11-16,2023-11-10,Disruption of the manufacture of the drug.,2023-09-08,2023-11-16,No
208562,02503115,Shortage,PMS-FLUTICASONE HFA,PHARMASCIENCE INC,FLUTICASONE HFA,FLUTICASONE PROPIONATE,50MCG,120,ORAL; INHALATION,Actual shortage,METERED-DOSE AEROSOL,,2023-10-27,,,Disruption of the manufacture of the drug.,2023-10-30,2024-04-12,No
193079,00885444,Shortage,PMS-HYDROMORPHONE TAB 1MG,PHARMASCIENCE INC,HYDROMORPHONE,HYDROMORPHONE HYDROCHLORIDE,1MG,90,ORAL; ORAL,Resolved,TABLET,,2023-05-25,2023-05-31,2023-06-23,Disruption of the manufacture of the drug.,2023-05-25,2023-06-26,No
214337,02239627,Shortage,PMS-IPRATROPIUM,PHARMASCIENCE INC,IPRATROPIUM,IPRATROPIUM BROMIDE,21MCG,30ml,NASAL; NASAL,Actual shortage,SOLUTION,,2023-12-22,2024-05-15,,Disruption of the manufacture of the drug.,2023-12-27,2024-04-12,No
196481,02239627,Shortage,PMS-IPRATROPIUM,PHARMASCIENCE INC,IPRATROPIUM,IPRATROPIUM BROMIDE,21MCG,30,NASAL; NASAL,Resolved,SOLUTION,,2023-06-26,2023-11-07,2023-10-27,Disruption of the manufacture of the drug.,2023-06-26,2023-11-10,No
201548,02317060,Shortage,PMS-IRBESARTAN,PHARMASCIENCE INC,IRBESARTAN,IRBESARTAN,75MG,100,ORAL; ORAL,Resolved,TABLET,,2023-08-10,2023-08-24,2023-08-23,Disruption of the manufacture of the drug.,2023-08-10,2023-08-28,No
188954,02328526,Shortage,PMS-IRBESARTAN-HCTZ,PHARMASCIENCE INC,IRBESARTAN-HCTZ,HYDROCHLOROTHIAZIDE; IRBESARTAN,12.5MG; 300MG,100,ORAL; ORAL,Actual shortage,TABLET,,2022-11-14,,,Disruption of the manufacture of the drug.,2023-04-06,2023-04-06,No
205611,02328534,Shortage,PMS-IRBESARTAN-HCTZ,PHARMASCIENCE INC,IRBESARTAN-HCTZ,HYDROCHLOROTHIAZIDE; IRBESARTAN,25MG; 300MG,100,ORAL; ORAL,Resolved,TABLET,,2023-09-29,2023-12-20,2023-12-15,Disruption of the manufacture of the drug.,2023-10-02,2023-12-22,No
214316,02301288,Shortage,PMS-ISMN,PHARMASCIENCE INC,ISMN,ISOSORBIDE-5-MONONITRATE,60MG,100,ORAL; ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),,2023-09-29,2024-11-20,,Disruption of the manufacture of the drug.,2023-12-27,2024-02-28,No
198000,02301288,Shortage,PMS-ISMN,PHARMASCIENCE INC,ISOSORBIDE,ISOSORBIDE-5-MONONITRATE,60MG,"100, 30",ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),2023-07-31,,2024-01-20,2023-08-10,Disruption of the manufacture of the drug.,2023-07-10,2023-08-11,No
211901,02301288,Shortage,PMS-ISMN,PHARMASCIENCE INC,ISOSORBIDE,ISOSORBIDE-5-MONONITRATE,60MG,30,ORAL; ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),,2023-11-24,2024-11-20,,Disruption of the manufacture of the drug.,2023-11-30,2024-02-28,No
196468,02246897,Shortage,PMS-LAMOTRIGINE,PHARMASCIENCE INC,LAMOTRIGINE,LAMOTRIGINE,25MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-06-26,,,Disruption of the manufacture of the drug.,2023-06-26,2023-06-27,No
196484,02246899,Shortage,PMS-LAMOTRIGINE,PHARMASCIENCE INC,LAMOTRIGINE,LAMOTRIGINE,150MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-06-26,,,Disruption of the manufacture of the drug.,2023-06-26,2023-06-27,No
186250,02296101,Shortage,PMS-LEVETIRACETAM,PHARMASCIENCE INC,LEVETIRACETAM,LEVETIRACETAM,250MG,100,ORAL,Resolved,TABLET,,2023-03-06,2023-07-03,2023-05-31,Disruption of the manufacture of the drug.,2023-03-06,2023-06-09,No
186253,02296136,Shortage,PMS-LEVETIRACETAM,PHARMASCIENCE INC,LEVETIRACETAM,LEVETIRACETAM,750MG,100,ORAL,Resolved,TABLET,,2023-03-06,2023-07-03,2023-05-31,Disruption of the manufacture of the drug.,2023-03-06,2023-06-09,No
194542,02216132,Shortage,PMS-LITHIUM CARBONATE - CAP 150MG,PHARMASCIENCE INC,LITHIUM CARBONATE,LITHIUM CARBONATE,150MG,100,ORAL; ORAL,Resolved,CAPSULE,2023-06-14,,2023-07-31,2023-07-20,Disruption of the manufacture of the drug.,2023-06-09,2023-08-07,No
207100,02216132,Shortage,PMS-LITHIUM CARBONATE - CAP 150MG,PHARMASCIENCE INC,LITHIUM CARBONATE,LITHIUM CARBONATE,150MG,100,ORAL; ORAL,Resolved,CAPSULE,2023-10-23,,2024-04-04,2024-04-05,Disruption of the manufacture of the drug.,2023-10-16,2024-04-12,No
194510,02216140,Shortage,PMS-LITHIUM CARBONATE - CAP 300MG,PHARMASCIENCE INC,LITHIUM CARBONATE,LITHIUM CARBONATE,300MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-06-09,2023-07-31,2023-07-20,Disruption of the manufacture of the drug.,2023-06-09,2023-08-07,No
207103,02216140,Shortage,PMS-LITHIUM CARBONATE - CAP 300MG,PHARMASCIENCE INC,LITHIUM CARBONATE,LITHIUM CARBONATE,300MG,100,ORAL; ORAL,Actual shortage,CAPSULE,2023-10-23,,,,Disruption of the manufacture of the drug.,2023-10-16,2024-02-02,No
183870,00728187,Shortage,PMS-LORAZEPAM,PHARMASCIENCE INC,LORAZEPAM,LORAZEPAM,0.5MG,100,ORAL; ORAL,Resolved,TABLET,,2023-02-07,2023-03-22,2023-03-20,Disruption of the manufacture of the drug.,2023-02-08,2023-03-21,No
214340,02309750,Shortage,PMS-LOSARTAN,PHARMASCIENCE INC,LOSARTAN,LOSARTAN POTASSIUM,25MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-12-22,2024-04-30,,Disruption of the manufacture of the drug.,2023-12-27,2024-03-15,No
208567,02309769,Shortage,PMS-LOSARTAN,PHARMASCIENCE INC,LOSARTAN,LOSARTAN POTASSIUM,50MG,100,ORAL; ORAL,Resolved,TABLET,,2023-10-27,2023-12-19,2023-12-18,Disruption of the manufacture of the drug.,2023-10-30,2023-12-22,No
208572,02309777,Shortage,PMS-LOSARTAN,PHARMASCIENCE INC,LOSARTAN,LOSARTAN POTASSIUM,100MG,100,ORAL; ORAL,Resolved,TABLET,,2023-10-27,2024-01-17,2024-01-12,Disruption of the manufacture of the drug.,2023-10-30,2024-01-22,No
214343,02382830,Shortage,PMS-MEMANTINE,PHARMASCIENCE INC,MEMANTINE,MEMANTINE HYDROCHLORIDE,5.0MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-12-22,2024-05-02,,Disruption of the manufacture of the drug.,2023-12-27,2024-03-15,No
193294,02248762,Shortage,PMS-MIRTAZAPINE,PHARMASCIENCE INC,MIRTAZAPINE,MIRTAZAPINE,30MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-05-29,,,Disruption of the manufacture of the drug.,2023-05-29,2023-05-30,No
189590,02354977,Shortage,PMS-MONTELUKAST,PHARMASCIENCE INC,MONTELUKAST,MONTELUKAST,4MG,30,ORAL; ORAL,Resolved,TABLET (CHEWABLE),,2023-04-14,,2023-12-26,Disruption of the manufacture of the drug.,2023-04-14,2023-12-27,No
194530,02432218,Shortage,PMS-MOXIFLOXACIN,PHARMASCIENCE INC,MOXIFLOXACIN,MOXIFLOXACIN,0.50%,3ml,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,,2023-06-09,2023-07-14,2023-07-18,Disruption of the manufacture of the drug.,2023-06-09,2023-08-07,No
214346,02455676,Shortage,PMS-NITROFURANTOIN BID,PHARMASCIENCE INC,NITROFURANTOIN,NITROFURANTOIN,100MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-12-22,2024-02-20,2024-02-21,Disruption of the manufacture of the drug.,2023-12-27,2024-02-28,No
198483,02455676,Shortage,PMS-NITROFURANTOIN BID,PHARMASCIENCE INC,NITROFURANTOIN,NITROFURANTOIN,100MG,100,ORAL; ORAL,Resolved,CAPSULE,2023-07-20,,2023-09-15,2023-09-14,Disruption of the manufacture of the drug.,2023-07-13,2023-09-15,No
198015,02303183,Shortage,PMS-OLANZAPINE,PHARMASCIENCE INC,OLANZAPINE,OLANZAPINE,15MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-10,2023-10-17,2023-10-12,Disruption of the manufacture of the drug.,2023-07-10,2023-10-16,No
185238,02303175,Shortage,PMS-OLANZAPINE,PHARMASCIENCE INC,OLANZAPINE,OLANZAPINE,10MG,100,ORAL; ORAL,Resolved,TABLET,,2023-02-21,2023-07-20,2023-07-27,Disruption of the manufacture of the drug.,2023-02-21,2023-08-07,No
194533,02461315,Shortage,PMS-OLMESARTAN,PHARMASCIENCE INC,OLMESARTAN,OLMESARTAN MEDOXOMIL,40MG,30,ORAL; ORAL,Resolved,TABLET,,2023-06-09,2023-09-30,2023-09-15,Disruption of the manufacture of the drug.,2023-06-09,2023-09-28,No
197987,02223376,Shortage,PMS-OXYBUTYNIN,PHARMASCIENCE INC,OXYBUTYNIN,OXYBUTYNIN CHLORIDE,5MG,500ml,ORAL; ORAL,Resolved,SYRUP,2023-08-01,,2023-10-02,2023-09-29,Disruption of the manufacture of the drug.,2023-07-10,2023-10-02,No
198022,02309904,Shortage,PMS-OXYCODONE CR,PHARMASCIENCE INC,OXYCODONE CR,OXYCODONE HYDROCHLORIDE,40MG,100,ORAL; ORAL,Avoided shortage,TABLET (EXTENDED-RELEASE),2023-08-21,,2023-12-19,2023-08-04,Disruption of the manufacture of the drug.,2023-07-10,2023-09-18,No
214349,02247751,Shortage,PMS-PAROXETINE,PHARMASCIENCE INC,PAROXETINE,PAROXETINE,20MG,100 & 500,ORAL; ORAL,Resolved,TABLET,,2023-12-22,2024-02-09,2024-02-01,Disruption of the manufacture of the drug.,2023-12-27,2024-02-07,No
193291,02525666,Shortage,PMS-PAZOPANIB,PHARMASCIENCE INC,PAZOPANIB,PAZOPANIB,200MG,60,ORAL,Resolved,TABLET,,2023-05-29,2023-10-15,2023-10-14,Disruption of the manufacture of the drug.,2023-05-29,2023-10-16,No
201551,02340577,Shortage,PMS-QUINAPRIL,PHARMASCIENCE INC,QUINAPRIL,QUINAPRIL,20MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-08-10,2024-07-19,,Disruption of the manufacture of the drug.,2023-08-10,2024-01-09,No
198075,02340550,Shortage,PMS-QUINAPRIL,PHARMASCIENCE INC,QUINAPRIL,QUINAPRIL,5MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-07-10,,,Disruption of the manufacture of the drug.,2023-07-10,2023-07-11,No
198078,02340569,Shortage,PMS-QUINAPRIL,PHARMASCIENCE INC,QUINAPRIL,QUINAPRIL,10MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-07-10,,,Disruption of the manufacture of the drug.,2023-07-10,2023-07-11,No
208577,02279266,Shortage,PMS-RISPERIDONE,PHARMASCIENCE INC,RISPERIDONE,RISPERIDONE,1MG,30ml,ORAL; ORAL,Resolved,SOLUTION,,2023-10-27,2024-03-11,2024-03-15,Disruption of the manufacture of the drug.,2023-10-30,2024-03-16,No
196465,02393379,Shortage,PMS-RIZATRIPTAN RDT,PHARMASCIENCE INC,RIZATRIPTAN RDT,RIZATRIPTAN,10MG,6,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-06-26,2023-09-15,2023-09-12,Disruption of the manufacture of the drug.,2023-06-26,2023-09-15,No
196459,02244840,Shortage,PMS-SERTRALINE,PHARMASCIENCE INC,SERTRALINE,SERTRALINE,100MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-06-26,2023-07-17,2023-07-20,Disruption of the manufacture of the drug.,2023-06-26,2023-08-07,No
194518,02412179,Shortage,PMS-SILDENAFIL R,PHARMASCIENCE INC,SILDENAFIL R,SILDENAFIL,20MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-09,2023-10-06,2023-10-04,Disruption of the manufacture of the drug.,2023-06-09,2023-10-05,No
201556,02517787,Shortage,PMS-SILODOSIN,PHARMASCIENCE INC,SILODOSIN,SILODOSIN,8MG,90,ORAL,Resolved,CAPSULE,,2023-08-10,2023-08-28,2023-08-23,Disruption of the manufacture of the drug.,2023-08-10,2023-08-28,No
202582,02417723,Shortage,PMS-SOLIFENACIN,PHARMASCIENCE INC,SOLIFENACIN,SOLIFENACIN SUCCINATE,5MG,30 & 100,ORAL; ORAL,Actual shortage,TABLET,,2023-08-21,2024-07-15,,Disruption of the manufacture of the drug.,2023-08-21,2023-10-16,No
202585,02417731,Shortage,PMS-SOLIFENACIN,PHARMASCIENCE INC,SOLIFENACIN,SOLIFENACIN SUCCINATE,10MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-08-21,2024-07-15,,Disruption of the manufacture of the drug.,2023-08-21,2023-10-16,No
194515,02409410,Shortage,PMS-TADALAFIL,PHARMASCIENCE INC,TADALAFIL,TADALAFIL,2.5MG,30,ORAL; ORAL,Resolved,TABLET,,2023-06-09,2023-07-24,2023-07-21,Disruption of the manufacture of the drug.,2023-06-09,2023-08-07,No
188961,02322498,Shortage,PMS-TESTOSTERONE,PHARMASCIENCE INC,TESTOSTERONE,TESTOSTERONE UNDECANOATE,40MG,100,ORAL; ORAL,Actual shortage,CAPSULE,,2023-03-06,,,Disruption of the manufacture of the drug.,2023-04-06,2023-04-06,No
214352,02312085,Shortage,PMS-TOPIRAMATE,PHARMASCIENCE INC,TOPIRAMATE,TOPIRAMATE,50MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-12-22,2024-04-30,,Disruption of the manufacture of the drug.,2023-12-27,2024-03-15,No
203917,02237339,Shortage,PMS-TRAZODONE,PHARMASCIENCE INC,TRAZODONE,TRAZODONE HYDROCHLORIDE,75MG,100,ORAL; ORAL,Resolved,TABLET,,2023-09-08,2023-11-23,2023-11-20,Disruption of the manufacture of the drug.,2023-09-08,2023-11-21,No
198027,02381230,Shortage,PMS-VALACYCLOVIR,PHARMASCIENCE INC,VALACYCLOVIR,VALACYCLOVIR,1000MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-10,2024-01-05,2023-12-20,Disruption of the manufacture of the drug.,2023-07-10,2023-12-22,No
205614,02436175,Shortage,PMS-ZOLPIDEM ODT,PHARMASCIENCE INC,ZOLPIDEM ODT,ZOLPIDEM TARTRATE,5MG,30,SUBLINGUAL; SUBLINGUAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-09-29,2023-11-25,2023-11-29,Disruption of the manufacture of the drug.,2023-10-02,2023-11-30,No
205617,02436183,Shortage,PMS-ZOLPIDEM ODT,PHARMASCIENCE INC,ZOLPIDEM ODT,ZOLPIDEM TARTRATE,10MG,30,SUBLINGUAL; SUBLINGUAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-09-29,2023-11-10,2023-11-09,Disruption of the manufacture of the drug.,2023-10-02,2023-11-10,No
202483,02181908,Shortage,POLYDERM OINTMENT USP,TARO PHARMACEUTICALS INC,POLYDERM,POLYMYXIN B SULFATE; BACITRACIN ZINC,10000UNIT; 500UNIT,30,TOPICAL; TOPICAL,Resolved,OINTMENT,,2023-06-16,2023-11-24,2023-10-27,Disruption of the manufacture of the drug.,2023-08-18,2024-01-05,No
204135,02362597,Shortage,POTASSIUM ACETATE INJECTION USP,OMEGA LABORATORIES LIMITED,Potassium Acetate Injection,POTASSIUM ACETATE,39.20%,10 x 50mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,,2023-09-25,,2023-12-01,Disruption of the manufacture of the drug.,2023-09-11,2023-12-02,No
213117,02362597,Shortage,POTASSIUM ACETATE INJECTION USP,OMEGA LABORATORIES LIMITED,Potassium Acetate Injection,POTASSIUM ACETATE,39.20%,10 x 50mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Actual shortage,LIQUID,,2023-12-19,2024-04-30,,Demand increase for the drug.,2023-12-12,2024-03-19,No
192443,02362597,Shortage,POTASSIUM ACETATE INJECTION USP,OMEGA LABORATORIES LIMITED,Potassium Acetate Injection,POTASSIUM ACETATE,39.20%,10 x 50mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,,2023-06-02,,2023-06-26,Demand increase for the drug.,2023-05-12,2023-06-27,No
209438,00402206,Shortage,POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE,OMEGA LABORATORIES LIMITED,Potassium Chloride Injection Concentrate,POTASSIUM CHLORIDE,20mEq,10 x 10mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Actual shortage,SOLUTION; SOLUTION,2023-11-13,2023-11-13,2024-06-15,,Disruption of the manufacture of the drug.,2023-11-06,2024-04-17,No
188476,00402206,Shortage,POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE,OMEGA LABORATORIES LIMITED,Potassium Chloride for Injection Concentrate,POTASSIUM CHLORIDE,20mEq,10 x 10mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION; SOLUTION,,2023-04-14,2023-06-09,2023-06-05,Demand increase for the drug.,2023-03-31,2023-06-06,No
199742,00402206,Shortage,POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE,OMEGA LABORATORIES LIMITED,Potassium Chloride For Injection Concentrate,POTASSIUM CHLORIDE,20mEq,10 x 20mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION; SOLUTION,,2023-07-21,,2023-10-24,Demand increase for the drug.,2023-07-21,2023-10-25,Yes
188487,02480034,Shortage,POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE,OMEGA LABORATORIES LIMITED,Potassium Chloride for Injection Concentrate,POTASSIUM CHLORIDE,200mEq,1 x 100mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-03-31,2023-05-31,2023-05-23,Demand increase for the drug.,2023-03-31,2023-05-24,No
180063,00402206,Shortage,POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE,OMEGA LABORATORIES LIMITED,Potassium Chloride for Injection Concentrate,POTASSIUM CHLORIDE,20mEq,10 x 10mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION; SOLUTION,,2023-01-06,,2023-01-13,Demand increase for the drug.,2023-01-06,2023-01-14,No
201621,00402206,Shortage,POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE,OMEGA LABORATORIES LIMITED,Potassium Chloride For Injection Concentrate,POTASSIUM CHLORIDE,20mEq,10 x 10mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION; SOLUTION,,2023-08-14,2024-01-15,2023-10-31,Disruption of the manufacture of the drug.,2023-08-11,2023-11-01,Yes
193268,00402206,Shortage,POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE,OMEGA LABORATORIES LIMITED,Potassium Chloride for Injection Concentrate,POTASSIUM CHLORIDE,20mEq,10 x 20mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION; SOLUTION,,2023-05-26,,2023-06-22,Demand increase for the drug.,2023-05-26,2023-06-23,No
200798,00037869,Shortage,POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP,PFIZER CANADA ULC,POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP,POTASSIUM CHLORIDE,149MG,25 x 10ml vial,INTRAVENOUS; INTRAVENOUS,Actual shortage,SOLUTION,,2023-08-03,,,Disruption of the manufacture of the drug.,2023-08-03,2023-09-05,Yes
181002,02453819,Shortage,PRALUENT,SANOFI-AVENTIS CANADA INC,PRALUENT 75 mg,ALIROCUMAB,75MG,2,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION,,2023-01-09,2023-02-15,2023-02-02,Other (Please describe in comments),2023-01-13,2023-02-03,No
181300,02453835,Shortage,PRALUENT,SANOFI-AVENTIS CANADA INC,PRALUENT 150 mg,ALIROCUMAB,150MG,2,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION,,2023-01-12,2023-02-17,2023-01-26,Other (Please describe in comments),2023-01-17,2023-01-30,No
209520,02453835,Shortage,PRALUENT,SANOFI-AVENTIS CANADA INC,PRALUENT,ALIROCUMAB,150MG,2,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION,2023-11-13,2023-11-16,2023-12-22,2023-12-22,Other (Please describe in comments),2023-11-07,2024-01-02,No
209523,02453819,Shortage,PRALUENT,SANOFI-AVENTIS CANADA INC,PRALUENT,ALIROCUMAB,75MG,2,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION,2023-11-13,,2023-12-22,2023-12-22,Other (Please describe in comments),2023-11-07,2024-01-02,No
192669,02453835,Shortage,PRALUENT,SANOFI-AVENTIS CANADA INC,PRALUENT,ALIROCUMAB,150MG,2,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION,,2023-05-12,2023-06-06,2023-05-31,Other (Please describe in comments),2023-05-17,2023-06-01,No
211037,02367602,Shortage,PRAMIPEXOLE,SANIS HEALTH INC,PRAMIPEXOLE,PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE,0.25MG,100,ORAL,Resolved,TABLET,,2023-11-17,2023-12-22,2023-12-11,Disruption of the manufacture of the drug.,2023-11-22,2023-12-26,No
203109,02405547,Shortage,PREGABALIN,SANIS HEALTH INC,PREGABLIN,PREGABALIN,50MG,500,ORAL; ORAL,Resolved,CAPSULE,,2023-08-29,2023-11-09,2023-11-09,Disruption of the manufacture of the drug.,2023-08-29,2023-11-13,No
211065,02405598,Shortage,PREGABALIN,SANIS HEALTH INC,PREGABALIN,PREGABALIN,300MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-11-17,2024-02-18,2024-02-20,Disruption of the manufacture of the drug.,2023-11-22,2024-02-21,No
211068,02405555,Shortage,PREGABALIN,SANIS HEALTH INC,PREGABALIN,PREGABALIN,75MG,500,ORAL; ORAL,Resolved,CAPSULE,,2023-11-17,2023-12-14,2023-12-07,Disruption of the manufacture of the drug.,2023-11-22,2023-12-26,No
203135,02405555,Shortage,PREGABALIN,SANIS HEALTH INC,PREGABALIN,PREGABALIN,75MG,500,ORAL; ORAL,Resolved,CAPSULE,,2023-08-25,2023-10-30,2023-10-30,Disruption of the manufacture of the drug.,2023-08-29,2023-11-06,No
202695,02405563,Shortage,PREGABALIN,SANIS HEALTH INC,PREGABALIN,PREGABALIN,150MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-08-22,2023-09-05,2023-09-05,Disruption of the manufacture of the drug.,2023-08-22,2023-09-06,No
207862,02405563,Shortage,PREGABALIN,SANIS HEALTH INC,PREGABALIN,PREGABALIN,150MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-10-23,2023-11-27,2023-11-30,Disruption of the manufacture of the drug.,2023-10-23,2023-12-01,No
207865,02405539,Shortage,PREGABALIN,SANIS HEALTH INC,PREGABALIN,PREGABALIN,25MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-10-23,2024-03-26,2024-03-08,Disruption of the manufacture of the drug.,2023-10-23,2024-03-09,No
207456,02182904,Shortage,PREGNYL,ORGANON CANADA INC.,chorionic gonadotropin for injection,CHORIONIC GONADOTROPIN,10000UNIT,10000U VIAL & 10ML SOLVENT,INTRAMUSCULAR; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION; LIQUID; KIT,,2023-10-19,2023-11-24,2023-11-22,Delay in shipping of the drug.,2023-10-19,2023-11-23,No
211906,02182904,Shortage,PREGNYL,ORGANON CANADA INC.,chorionic gonadotropin for injection,CHORIONIC GONADOTROPIN,10000UNIT,10000U VIAL & 10ML SOLVENT,INTRAMUSCULAR; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION; LIQUID; KIT,,2023-11-30,2024-04-26,2024-04-22,Delay in shipping of the drug.,2023-11-30,2024-04-23,No
186629,02043386,Shortage,PREMARIN INTRAVENOUS,PFIZER CANADA ULC,PREMARIN INTRAVENOUS,CONJUGATED ESTROGENS,25MG,1 x 5ML VIAL,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,2023-03-15,,2023-05-31,2023-06-01,Demand increase for the drug.,2023-03-10,2023-06-02,No
210157,02469405,Shortage,PREVYMIS,MERCK CANADA INC,Letermovir for injection,LETERMOVIR,20MG,1 x Vial,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2024-02-05,2024-01-31,2024-04-05,2024-03-27,Demand increase for the drug.,2023-11-14,2024-03-28,No
199221,02017776,Shortage,PRIMAQUINE,SANOFI-AVENTIS CANADA INC,PRIMAQUINE,PRIMAQUINE PHOSPHATE,26.3MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-17,2023-07-28,2023-07-20,Other (Please describe in comments),2023-07-19,2023-07-21,No
190244,02236875,Shortage,PRIMENE 10%,BAXTER CORPORATION,Amino Acid Injection 10% w/v,L-ORNITHINE DIHYDROCHLORIDE; L-PROLINE; GLYCINE; SERINE; L-ASPARTIC ACID; L-ALANINE; L-ARGININE; GLUTAMIC ACID; L-TYROSINE; TAURINE; TRYPTOPHAN; METHIONINE; L-CYSTEINE; L-THREONINE; HISTIDINE; L-PHENYLALANINE; L-ISOLEUCINE; L-VALINE; L-LYSINE; L-LEUCINE,318MG; 300MG; 400MG; 400MG; 600MG; 800MG; 840MG; 1G; 45MG; 60MG; 200MG; 240MG; 189MG; 370MG; 380MG; 420MG; 670MG; 760MG; 1.1G; 1G,250mL,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,2023-04-24,2023-04-24,2023-08-15,2023-08-15,Shortage of an inactive ingredient or component.,2023-04-24,2023-10-16,No
185638,02239208,Shortage,PRIORIX,GLAXOSMITHKLINE INC,"Combined measles, mumps and rubella vaccine, live, attenuated",WATER; RUBELLA VIRUS VACCINE LIVE ATTENUATED; MEASLES VIRUS VACCINE LIVE ATTENUATED; MUMPS VIRUS VACCINE LIVE ATTENUATED,0.5ML; 1000CCID50; 1000CCID50; 10000CCID50,10s,SUBCUTANEOUS; INTRAMUSCULAR; INTRAMUSCULAR; SUBCUTANEOUS,Resolved,POWDER FOR SOLUTION; KIT,,2023-02-22,2023-03-17,2023-03-15,Disruption of the manufacture of the drug.,2023-02-27,2023-03-16,No
195945,02321106,Shortage,PRISTIQ,PFIZER CANADA ULC,PRISTIQ,DESVENLAFAXINE,100MG,30's,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),2023-07-12,2023-07-12,2023-10-26,2023-09-22,Disruption of the manufacture of the drug.,2023-06-20,2023-09-23,No
195948,02321092,Shortage,PRISTIQ,PFIZER CANADA ULC,PRISTIQ,DESVENLAFAXINE,50MG,30's,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),2023-06-27,2023-06-27,2023-10-26,2023-10-12,Disruption of the manufacture of the drug.,2023-06-20,2023-10-13,No
212576,02317818,Shortage,PRO-CIPROFLOXACIN,PRO DOC LIMITEE,CIPROFLOXACIN,CIPROFLOXACIN,500MG,100,ORAL; ORAL,Resolved,TABLET,,2023-12-06,2024-02-15,2024-02-16,Delay in shipping of the drug.,2023-12-06,2024-02-17,No
208835,02312786,Shortage,PRO-MIRTAZAPINE,PRO DOC LIMITEE,MIRTAZAPINE,MIRTAZAPINE,30MG,100,ORAL; ORAL,Resolved,TABLET,,2023-10-30,2024-03-15,2024-03-14,Delay in shipping of the drug.,2023-11-01,2024-03-18,No
186493,02310953,Shortage,PRO-NAPROXEN EC,PRO DOC LIMITEE,NAPROXEN EC,NAPROXEN,500MG,100,ORAL; ORAL,Resolved,TABLET (ENTERIC-COATED),,2023-03-08,2023-05-03,2023-04-27,Delay in shipping of the drug.,2023-03-08,2023-05-12,No
184330,02311216,Shortage,PRO-QUININE - 200,PRO DOC LIMITEE,QUININE 200,QUININE SULFATE,200MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-02-10,2023-06-21,2023-06-21,Delay in shipping of the drug.,2023-02-10,2023-06-22,No
201280,02184486,Shortage,PROCAINAMIDE HYDROCHLORIDE INJ. USP,SANDOZ CANADA INCORPORATED,PROCAINAMIDE HYDROCHLORIDE,PROCAINAMIDE HYDROCHLORIDE,100MG,10ML 10LIVI,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-08-07,2023-10-27,2023-10-30,Demand increase for the drug.,2023-08-07,2023-10-31,No
192076,00886440,Shortage,PROCHLORAZINE,AA PHARMA INC,PROCHLORAZINE,PROCHLORPERAZINE,5MG,100BTL,ORAL; ORAL,Resolved,TABLET,2023-05-08,,2023-05-19,2023-05-19,Disruption of the manufacture of the drug.,2023-05-08,2023-05-23,No
186507,00886432,Shortage,PROCHLORAZINE,AA PHARMA INC,PROCHLORAZINE,PROCHLORPERAZINE,10MG,100BTL,ORAL; ORAL,Resolved,TABLET,2023-03-24,,2023-05-19,2023-05-19,Disruption of the manufacture of the drug.,2023-03-08,2023-05-23,No
208873,00886440,Shortage,PROCHLORAZINE,AA PHARMA INC,PROCHLORAZINE,PROCHLORPERAZINE,5MG,100 BTL,ORAL; ORAL,Resolved,TABLET,2023-11-01,,2023-12-20,2023-12-14,Disruption of the manufacture of the drug.,2023-11-01,2023-12-21,No
203121,02516187,Shortage,PROGESTERONE,SANIS HEALTH INC,PROGESTERONE,PROGESTERONE,100MG,100,ORAL,Resolved,CAPSULE,,2023-08-25,,2023-09-22,Disruption of the manufacture of the drug.,2023-08-29,2023-09-25,No
205419,02166704,Shortage,PROMETRIUM,ORGANON CANADA INC.,Progesterone capsules,PROGESTERONE,100MG,30,ORAL; ORAL,Resolved,CAPSULE,2023-12-22,2023-12-05,2024-02-14,2024-02-14,Other (Please describe in comments),2023-09-28,2024-03-22,No
201534,02089602,Shortage,PROPADERM,"BAUSCH HEALTH, CANADA INC.",PROPADERM,BECLOMETHASONE DIPROPIONATE,0.03%,45G,TOPICAL; TOPICAL,Avoided shortage,CREAM,2023-09-21,,2023-09-28,2023-09-18,Delay in shipping of the drug.,2023-08-09,2023-09-21,No
210580,02244379,Shortage,PROPOFOL INJECTION,BAXTER CORPORATION,Propofol Injection,PROPOFOL,10MG,AIN00003 (100 mL),INTRAVENOUS; INTRAVENOUS,Avoided shortage,EMULSION,2024-05-01,,,2024-04-11,Requirements related to complying with good manufacturing practices.,2023-11-17,2024-04-11,Yes
210583,02244379,Shortage,PROPOFOL INJECTION,BAXTER CORPORATION,PROPOFOL INJECTION,PROPOFOL,10MG,AIN00004 (50 mL),INTRAVENOUS; INTRAVENOUS,Resolved,EMULSION,2023-11-16,,,2024-01-10,Requirements related to complying with good manufacturing practices.,2023-11-17,2024-01-10,No
210586,02244379,Shortage,PROPOFOL INJECTION,BAXTER CORPORATION,PROPOFOL INJECTION,PROPOFOL,10MG,AIN00005 (20 mL),INTRAVENOUS; INTRAVENOUS,Avoided shortage,EMULSION,2024-06-01,,,2024-04-11,Requirements related to complying with good manufacturing practices.,2023-11-17,2024-04-11,Yes
194988,02523019,Shortage,PROPYLTHIOURACIL TABLETS,PHEBRA CANADA INC,PROPYLTHIOURACIL TABLETS,PROPYLTHIOURACIL,50MG,Bottle of 100 tablets,ORAL,Resolved,TABLET,2023-06-12,2023-06-12,2023-07-17,2023-07-13,Delay in shipping of the drug.,2023-06-16,2023-07-14,No
213216,02523019,Shortage,PROPYLTHIOURACIL TABLETS,PHEBRA CANADA INC,PROPYLTHIOURACIL TABLETS,PROPYLTHIOURACIL,50MG,Bottle of 100 tablets,ORAL,Resolved,TABLET,2023-12-13,2023-12-13,2024-02-07,2024-02-01,Delay in shipping of the drug.,2023-12-13,2024-02-02,No
204343,00559253,Shortage,PROSTIN VR STERILE SOLUTION,PFIZER CANADA ULC,PROSTIN VR STERILE SOLUTION,ALPROSTADIL,500MCG,5 x 1ML,INTRAVENOUS; INTRA-ARTERIAL; INTRAVENOUS; INTRA-ARTERIAL,Resolved,SOLUTION,,2023-09-14,,2023-12-08,Disruption of the manufacture of the drug.,2023-09-14,2023-12-09,Yes
192011,02231674,Shortage,PROTAMINE SULFATE INJECTION USP,SANDOZ CANADA INCORPORATED,PROTAMINE,PROTAMINE SULFATE,10MG,5ML,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-05-08,2023-09-01,2023-08-29,Disruption of the manufacture of the drug.,2023-05-08,2023-08-30,No
210852,02231674,Shortage,PROTAMINE SULFATE INJECTION USP,SANDOZ CANADA INCORPORATED,PROTAMINE SULFATE,PROTAMINE SULFATE,10MG,25ML 1LIVI,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-11-20,2024-02-02,2024-01-16,Disruption of the manufacture of the drug.,2023-11-20,2024-01-17,No
200334,02139537,Shortage,"PROTAMINE SULFATE INJECTION, USP",FRESENIUS KABI CANADA LTD,"PROTAMINE SULFATE INJECTION, USP",PROTAMINE SULFATE,10MG,5 mL,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2023-08-01,2023-08-01,2023-10-15,2023-08-15,Other (Please describe in comments),2023-07-27,2023-08-16,No
195655,00729973,Shortage,PROVERA 10MG TABLETS,PFIZER CANADA ULC,PROVERA,MEDROXYPROGESTERONE ACETATE,10MG,1x100 BTL,ORAL; ORAL,Resolved,TABLET,2023-06-20,,2023-07-27,2023-07-11,Demand increase for the drug.,2023-06-19,2023-07-12,No
203392,00729973,Shortage,PROVERA 10MG TABLETS,PFIZER CANADA ULC,Provera 10mg,MEDROXYPROGESTERONE ACETATE,10MG,Btl 1x100,ORAL; ORAL,Resolved,TABLET,,2023-09-01,2023-10-31,2023-10-27,Demand increase for the drug.,2023-08-31,2023-10-28,No
197202,00030937,Shortage,PROVERA 5MG TABLETS,PFIZER CANADA ULC,PROVERA 5MG,MEDROXYPROGESTERONE ACETATE,5MG,1x100 BTL,ORAL; ORAL,Resolved,TABLET,2023-07-06,2023-07-06,,2023-09-08,Demand increase for the drug.,2023-07-04,2023-09-11,No
184729,02229099,Shortage,PULMICORT NEBUAMP 0.125 MG/ML,ASTRAZENECA CANADA INC,budesonide,BUDESONIDE,0.125MG,20 ampoules,INHALATION; INHALATION,Resolved,SUSPENSION,,2023-02-15,2023-04-05,2023-04-05,Demand increase for the drug.,2023-02-16,2023-04-06,No
213767,02245215,Shortage,"PYRIDOXINE HYDROCHLORIDE INJECTION, USP",MYLAN PHARMACEUTICALS ULC,PYRIDOXINE HYDROCHLORIDE,PYRIDOXINE HYDROCHLORIDE,100MG,30 ML Vial,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Avoided shortage,SOLUTION,2024-01-10,,,2024-01-02,Disruption of the manufacture of the drug.,2023-12-19,2024-01-10,No
198410,00038172,Shortage,QUELICIN,PFIZER CANADA ULC,QUELICIN,SUCCINYLCHOLINE CHLORIDE,20MG,25 x 10mL vial,INTRAVENOUS; INTRAVENOUS,Actual shortage,SOLUTION,,2023-07-12,,,Disruption of the manufacture of the drug.,2023-07-13,2024-01-30,No
190322,02317907,Shortage,QUETIAPINE,SIVEM PHARMACEUTICALS ULC,Quetiapine,QUETIAPINE,100MG,500,ORAL; ORAL,Resolved,TABLET,,2023-02-13,2023-06-14,2023-06-14,Delay in shipping of the drug.,2023-04-26,2023-08-16,No
191760,02387794,Shortage,QUETIAPINE TABLETS,ACCORD HEALTHCARE INC,QUETIAPINE FUMARATE,QUETIAPINE,25MG,100,ORAL; ORAL,Resolved,TABLET (IMMEDIATE RELEASE); TABLET,,2023-05-05,2023-06-19,2023-06-12,Delay in shipping of the drug.,2023-05-05,2023-06-13,No
181045,02387808,Shortage,QUETIAPINE TABLETS,ACCORD HEALTHCARE INC,QUETIAPINE FUMARATE,QUETIAPINE,100MG,100,ORAL; ORAL,Resolved,TABLET (IMMEDIATE RELEASE); TABLET,,2023-01-13,,2023-03-06,Disruption of the manufacture of the drug.,2023-01-13,2023-03-07,No
208453,02387824,Shortage,QUETIAPINE TABLETS,ACCORD HEALTHCARE INC,QUETIAPINE FUMARATE,QUETIAPINE,200MG,100,ORAL; ORAL,Resolved,TABLET (IMMEDIATE RELEASE); TABLET,,2023-10-27,2023-11-23,2023-11-24,Demand increase for the drug.,2023-10-27,2023-11-25,No
201097,02387832,Shortage,QUETIAPINE TABLETS,ACCORD HEALTHCARE INC,QUETIAPINE TABLETS,QUETIAPINE,300MG,100,ORAL; ORAL,Resolved,TABLET (IMMEDIATE RELEASE); TABLET,,2023-08-03,2023-12-28,2023-12-28,Demand increase for the drug.,2023-08-04,2023-12-29,No
212202,02387794,Shortage,QUETIAPINE TABLETS,ACCORD HEALTHCARE INC,QUETIAPINE FUMARATE,QUETIAPINE,25MG,100,ORAL; ORAL,Resolved,TABLET (IMMEDIATE RELEASE); TABLET,,2023-12-01,2023-12-20,2023-12-27,Demand increase for the drug.,2023-12-01,2023-12-28,No
185592,02387824,Shortage,QUETIAPINE TABLETS,ACCORD HEALTHCARE INC,QUETIAPINE FUMARATE,QUETIAPINE,200MG,100,ORAL; ORAL,Resolved,TABLET (IMMEDIATE RELEASE); TABLET,,2023-02-24,2023-08-31,2023-08-30,Disruption of the manufacture of the drug.,2023-02-24,2023-09-01,No
207613,02387808,Shortage,QUETIAPINE TABLETS,ACCORD HEALTHCARE INC,QUETIAPINE FUMARATE,QUETIAPINE,100MG,100,ORAL; ORAL,Resolved,TABLET (IMMEDIATE RELEASE); TABLET,,2023-10-20,2023-11-23,2023-11-21,Demand increase for the drug.,2023-10-20,2023-11-22,No
186121,02242029,Shortage,QVAR,"BAUSCH HEALTH, CANADA INC.",QVAR,BECLOMETHASONE DIPROPIONATE,50MCG,n/a,INHALATION; INHALATION,Resolved,METERED-DOSE AEROSOL,2023-08-04,2023-08-04,2023-10-08,2023-10-08,Demand increase for the drug.,2023-03-03,2023-10-19,No
198918,02356538,Shortage,RABEPRAZOLE EC,SANIS HEALTH INC,RABEPRAZOLE SODIUM,RABEPRAZOLE SODIUM,20MG,500,ORAL; ORAL,Resolved,TABLET (ENTERIC-COATED),,2023-07-18,,2023-11-30,Disruption of the manufacture of the drug.,2023-07-18,2023-12-01,No
214284,02356511,Shortage,RABEPRAZOLE EC,SANIS HEALTH INC,RABEPRAZOLE SODIUM,RABEPRAZOLE SODIUM,10MG,100,ORAL; ORAL,Actual shortage,TABLET (ENTERIC-COATED),,2023-12-22,2024-04-26,,Disruption of the manufacture of the drug.,2023-12-27,2024-04-17,No
181170,02247111,Shortage,RAPAMUNE,PFIZER CANADA ULC,RAPAMUNE,SIROLIMUS,1MG,100's,ORAL; ORAL,Resolved,TABLET,,2023-01-13,2023-02-24,2023-02-07,Disruption of the manufacture of the drug.,2023-01-16,2023-02-10,No
210808,02302063,Shortage,RASILEZ,NODEN PHARMA DAC,aliskiren,ALISKIREN,150MG,28,ORAL; ORAL,Resolved,TABLET,2023-11-03,2023-11-03,2023-12-18,2023-12-27,Shortage of an active ingredient.,2023-11-20,2024-02-07,No
196602,02302071,Shortage,RASILEZ,NODEN PHARMA DAC,Rasilez,ALISKIREN,300MG,28,ORAL; ORAL,Actual shortage,TABLET,2023-08-01,2023-08-31,2024-07-15,,Shortage of an active ingredient.,2023-06-27,2023-10-03,No
197195,00870226,Shortage,RATIO-DOCUSATE SODIUM,TEVA CANADA LIMITED,RATIO-DOCUSATE SODIUM,DOCUSATE SODIUM,20MG,500ML,ORAL; ORAL,Resolved,SYRUP,,2023-07-04,2023-12-10,2023-12-10,Disruption of the manufacture of the drug.,2023-07-04,2024-02-07,No
195136,02245688,Shortage,RATIO-TOPISALIC,TEVA CANADA LIMITED,RATIO-TOPISALIC,SALICYLIC ACID; BETAMETHASONE,20MG; 0.5MG,30ML,TOPICAL; TOPICAL,Resolved,LOTION,,2023-06-16,2023-07-20,2023-06-26,Disruption of the manufacture of the drug.,2023-06-16,2023-06-27,No
184192,02245688,Shortage,RATIO-TOPISALIC,TEVA CANADA LIMITED,TOPISALIC LOTION,SALICYLIC ACID; BETAMETHASONE,20MG; 0.5MG,30ml,TOPICAL; TOPICAL,Resolved,LOTION,,2023-02-07,2023-07-20,2023-06-26,Disruption of the manufacture of the drug.,2023-02-09,2023-06-27,No
212717,02245688,Shortage,RATIO-TOPISALIC,TEVA CANADA LIMITED,TOPISALIC LOTION,SALICYLIC ACID; BETAMETHASONE,20MG; 0.5MG,30ml,TOPICAL; TOPICAL,Resolved,LOTION,,2023-12-06,2024-01-10,2024-01-10,Disruption of the manufacture of the drug.,2023-12-07,2024-01-11,No
193120,02487462,Shortage,REKOVELLE,FERRING INC,Follitropin Delta,FOLLITROPIN DELTA,12MCG,Pre-filled multidose pen with 3 needles,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION,2023-05-25,2023-05-25,2023-08-25,2023-09-13,Other (Please describe in comments),2023-05-26,2023-09-14,No
193434,02487470,Shortage,REKOVELLE,FERRING INC,Follitropin Delta,FOLLITROPIN DELTA,36MCG,36.0 μg of follitropin delta in 1.08 mL including 1 cartridge with 6 needles,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION,,2023-05-31,2023-08-04,2023-07-21,Other (Please describe in comments),2023-05-31,2023-07-22,No
193445,02487489,Shortage,REKOVELLE,FERRING INC,Follitropin Delta,FOLLITROPIN DELTA,72MCG,72.0 μg of follitropin delta in 2.16 mL including 1 cartridge with 9 needles,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION,,2023-05-31,2023-07-19,2023-07-21,Other (Please describe in comments),2023-05-31,2023-07-22,No
194835,02256304,Shortage,RELPAX,UPJOHN CANADA ULC,RELPAX,ELETRIPTAN,40MG,6,ORAL; ORAL,Resolved,TABLET,,2023-06-08,,2023-08-08,Disruption of the manufacture of the drug.,2023-06-13,2023-08-16,No
193008,02256290,Shortage,RELPAX,UPJOHN CANADA ULC,RELPAX,ELETRIPTAN,20MG,6,ORAL; ORAL,Resolved,TABLET,,2023-05-17,,2023-07-06,Demand increase for the drug.,2023-05-25,2023-07-13,No
186446,02248544,Shortage,REMERON RD,ORGANON CANADA INC.,(mirtazapine) Orally Disintegrating Tablets,MIRTAZAPINE,45MG,30,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-03-03,2023-03-17,2023-03-16,Demand increase for the drug.,2023-03-07,2023-03-17,No
208624,02017741,Shortage,RESONIUM CALCIUM,SANOFI-AVENTIS CANADA INC,Resonium Calcium,CALCIUM POLYSTYRENE SULFONATE,999MG,1,RECTAL; ORAL; RECTAL; ORAL,Resolved,POWDER FOR SOLUTION,,2023-10-26,2024-02-23,2024-02-22,Demand increase for the drug.,2023-10-30,2024-02-23,No
180339,02355655,Shortage,RESTASIS,ABBVIE CORPORATION,Restasis 0.05%,CYCLOSPORINE,0.05%,30 x 0.4 mL and 60 x 0.4 mL,OPHTHALMIC; OPHTHALMIC,Resolved,EMULSION,2023-01-10,2023-01-10,2023-01-27,2023-01-26,Demand increase for the drug.,2023-01-10,2023-01-27,No
194083,02476835,Shortage,RESTASIS MULTIDOSE,ABBVIE CORPORATION,"RESTASIS MULTIDOSE (Cyclosporine Ophthalmic  Emulsion, 0.05%w/w) 5.5 mL",CYCLOSPORINE,0.05%,10 mL bottle,OPHTHALMIC; OPHTHALMIC,Resolved,EMULSION,,2023-06-07,2023-07-28,2023-07-19,Delay in shipping of the drug.,2023-06-08,2023-07-20,No
184397,02476835,Shortage,RESTASIS MULTIDOSE,ABBVIE CORPORATION,Restasis 0.05%,CYCLOSPORINE,0.05%,5.5 mL,OPHTHALMIC; OPHTHALMIC,Resolved,EMULSION,,2023-02-10,2023-03-03,2023-03-01,Demand increase for the drug.,2023-02-10,2023-03-02,No
189931,02516926,Shortage,RETEVMO,LOXO ONCOLOGY INC,Selpercatinib capsules,,80MG,Bottle containing 60 capsules,ORAL,Resolved,CAPSULE,,2023-04-19,2023-05-23,2023-05-23,Delay in shipping of the drug.,2023-04-20,2023-05-24,No
211258,00443794,Shortage,RETIN-A,"BAUSCH HEALTH, CANADA INC.",RETIN-A,TRETINOIN,0.05%,30g,TOPICAL; TOPICAL,Resolved,CREAM,2023-12-20,2023-12-19,2024-01-31,2024-01-30,Other (Please describe in comments),2023-11-23,2024-02-01,No
211261,00443816,Shortage,RETIN-A,"BAUSCH HEALTH, CANADA INC.",RETIN-A,TRETINOIN,0.03%,30g,TOPICAL; TOPICAL,Resolved,GEL,2023-12-20,2023-12-18,2024-01-18,2024-01-16,Other (Please describe in comments),2023-11-23,2024-01-22,No
181292,02341611,Shortage,REVATIO,UPJOHN CANADA ULC,REVATIO,SILDENAFIL,0.8MG,1,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-02-06,2023-03-28,2023-02-24,Disruption of the manufacture of the drug.,2023-01-17,2023-05-05,No
190707,02213826,Shortage,REVIA,TEVA CANADA LIMITED,REVIA 50MG TABLETS 50,NALTREXONE HYDROCHLORIDE,50MG,50,ORAL; ORAL,Resolved,TABLET,,2023-04-27,2023-05-30,2023-06-08,Disruption of the manufacture of the drug.,2023-04-27,2023-06-09,No
183701,02238998,Shortage,RHO-NITRO PUMPSPRAY,SANDOZ CANADA INCORPORATED,RHO-NITRO,NITROGLYCERIN,0.4MG,200DOS LSP,SUBLINGUAL; SUBLINGUAL,Resolved,METERED-DOSE PUMP,,2023-02-06,2023-05-19,2023-05-22,Demand increase for the drug.,2023-02-06,2023-05-25,Yes
206051,02238998,Shortage,RHO-NITRO PUMPSPRAY,SANDOZ CANADA INCORPORATED,RHO-NITRO,NITROGLYCERIN,0.4MG,1DOS 200LSP,SUBLINGUAL; SUBLINGUAL,Resolved,METERED-DOSE PUMP,2023-10-04,,,2024-04-08,Demand increase for the drug.,2023-10-04,2024-04-09,No
187292,02370255,Shortage,RISEDRONATE,SANIS HEALTH INC,RISEDRONATE,RISEDRONATE SODIUM,35MG,4 & 30,ORAL; ORAL,Resolved,TABLET,,2022-08-25,,2024-02-28,Shortage of an inactive ingredient or component.,2023-03-16,2024-02-29,No
190325,02411407,Shortage,RISEDRONATE-35,SIVEM PHARMACEUTICALS ULC,Risedronate,RISEDRONATE SODIUM,35MG,4,ORAL; ORAL,Resolved,TABLET,,2023-01-23,2024-02-16,2024-02-16,Disruption of the manufacture of the drug.,2023-04-26,2024-02-17,No
190328,02411407,Shortage,RISEDRONATE-35,SIVEM PHARMACEUTICALS ULC,Risedronate,RISEDRONATE SODIUM,35MG,30,ORAL; ORAL,Resolved,TABLET,,2022-12-12,2024-02-16,2024-02-16,Disruption of the manufacture of the drug.,2023-04-26,2024-02-17,No
212593,02495643,Shortage,RIVA-PYRIDOSTIGMINE,LABORATOIRE RIVA INC.,Riva-Pyridostigmine 60mg,PYRIDOSTIGMINE BROMIDE,60MG,100,ORAL,Actual shortage,TABLET,2023-12-15,,,,Delay in shipping of the drug.,2023-12-06,2023-12-16,No
198627,02431955,Shortage,RIXUBIS,TAKEDA CANADA INC,Recombinant Coagulation Factor IX (rFIX),NONACOG GAMMA,2000UNIT,5 mL Vial,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION; KIT,2023-07-13,2023-07-13,2023-08-31,2023-08-28,Other (Please describe in comments),2023-07-13,2023-08-28,No
198631,02431947,Shortage,RIXUBIS,TAKEDA CANADA INC,Recombinant Coagulation Factor IX (rFIX),NONACOG GAMMA,1000UNIT,5 mL Vial,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION; KIT,2023-07-13,2023-07-13,2023-08-31,2023-08-28,Other (Please describe in comments),2023-07-13,2023-08-28,No
198634,02431963,Shortage,RIXUBIS,TAKEDA CANADA INC,Recombinant Coagulation Factor IX (rFIX),NONACOG GAMMA,3000UNIT,5 mL Vial,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION; KIT,2023-07-13,2023-07-13,2023-08-31,2023-08-28,Other (Please describe in comments),2023-07-13,2023-08-28,No
200440,02516756,Shortage,RIZATRIPTAN,SANIS HEALTH INC,RIZATRIPTAN,RIZATRIPTAN,10MG,12,ORAL,Resolved,TABLET,,2023-07-31,,2023-08-25,Disruption of the manufacture of the drug.,2023-07-31,2023-08-28,No
199216,01934740,Shortage,ROBITUSSIN AC,GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC,"Guaifenesin, Codeine Phosphate and Pheniramine Maleate Syrup",CODEINE PHOSPHATE; GUAIFENESIN; PHENIRAMINE MALEATE,10MG; 100MG; 7.5MG,1 L,ORAL; ORAL,Actual shortage,SYRUP,,2023-06-01,,,Other (Please describe in comments),2023-07-19,2023-08-17,No
209549,00481815,Shortage,ROCALTROL,SEARCHLIGHT PHARMA INC,Rocaltrol 0.5 mcg,CALCITRIOL,0.5MCG,100 Capsules,ORAL; ORAL,Resolved,CAPSULE,,2023-11-08,2023-12-22,2023-12-14,Delay in shipping of the drug.,2023-11-08,2023-12-29,No
209554,00481823,Shortage,ROCALTROL,SEARCHLIGHT PHARMA INC,Rocaltrol 0.25mcg,CALCITRIOL,0.25MCG,100 Capsules,ORAL; ORAL,Resolved,CAPSULE,,2023-11-08,2023-12-08,2023-12-08,Delay in shipping of the drug.,2023-11-08,2023-12-09,No
187451,02318415,Shortage,ROCURONIUM BROMIDE INJECTION,SANDOZ CANADA INCORPORATED,ROCURONIUM BROMIDE INJECTION,ROCURONIUM BROMIDE,10MG,5ML,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-03-20,2023-04-14,2023-03-22,Requirements related to complying with good manufacturing practices.,2023-03-20,2023-03-23,No
186883,00343617,Shortage,ROFACT,"BAUSCH HEALTH, CANADA INC.",Rofact,RIFAMPIN,300MG,300,ORAL; ORAL,Avoided shortage,CAPSULE,2023-03-27,,2023-04-03,2023-03-24,Other (Please describe in comments),2023-03-13,2023-03-27,No
191061,00393444,Shortage,ROFACT,"BAUSCH HEALTH, CANADA INC.",ROFACT 150MG 100 CAPS,RIFAMPIN,150MG,na,ORAL; ORAL,Avoided shortage,CAPSULE,2023-06-02,,2023-06-05,2023-05-30,Other (Please describe in comments),2023-04-28,2023-05-31,No
181154,02439409,Shortage,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP",FRESENIUS KABI CANADA LTD,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP",ROPIVACAINE HYDROCHLORIDE,10MG,10mL,EPIDURAL; EPIDURAL,Resolved,SOLUTION,,2023-01-01,2023-04-01,2023-04-01,Demand increase for the drug.,2023-01-16,2023-04-04,No
181157,02439409,Shortage,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP",FRESENIUS KABI CANADA LTD,"ROPIVACAINE HYDROCHLORIDE INJECTION, USP",ROPIVACAINE HYDROCHLORIDE,10MG,20mL,EPIDURAL; EPIDURAL,Resolved,SOLUTION,,2023-01-01,2023-11-15,2023-10-25,Disruption of the manufacture of the drug.,2023-01-16,2023-11-17,No
196099,02405644,Shortage,ROSUVASTATIN,SANIS HEALTH INC,ROSUVASTATIN,ROSUVASTATIN,20MG,500,ORAL; ORAL,Resolved,TABLET,,2023-06-22,,2023-08-01,Disruption of the manufacture of the drug.,2023-06-22,2023-08-08,No
196102,02405636,Shortage,ROSUVASTATIN,SANIS HEALTH INC,ROSUVASTATIN,ROSUVASTATIN,10MG,500,ORAL; ORAL,Resolved,TABLET,,2023-06-22,2023-09-01,2023-09-05,Disruption of the manufacture of the drug.,2023-06-22,2023-09-06,No
201860,02531186,Shortage,RYALTRIS,GLENMARK SPECIALTY SA,Olopatadine Hydrochloride and Mometasone Furoate Monohydrate Spray,MOMETASONE FUROATE,25MCG; 665MCG,240 MD 1 carton,NASAL,Resolved,"SPRAY, METERED DOSE",2023-08-15,2023-08-15,2023-11-27,2023-11-24,Disruption of the manufacture of the drug.,2023-08-15,2023-11-25,No
189885,02068036,Shortage,SABRIL,LUNDBECK PHARMACEUTICALS LLC,vigabatrin powder for oral solution,VIGABATRIN,500MG,Cartons of 50,ORAL; ORAL,Actual shortage,POWDER FOR SOLUTION,2023-06-01,2023-07-27,2024-05-15,,Disruption of the manufacture of the drug.,2023-04-20,2024-03-01,Yes
207741,02350130,Shortage,SAIZEN,"EMD SERONO, A DIVISION OF EMD INC., CANADA",somatropin for injection,SOMATROPIN,8MG,1 cartridge (12mg),SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION,2023-10-24,2023-10-24,2023-11-27,2023-11-13,Delay in shipping of the drug.,2023-10-22,2023-11-14,No
205711,00511552,Shortage,SANDOMIGRAN DS,PALADIN LABS INC.,SANDOMIGRAN DS 1mg Tabs,PIZOTIFEN,1MG,100 Tabs,ORAL; ORAL,Actual shortage,TABLET,,2023-10-02,2024-05-03,,Other (Please describe in comments),2023-10-02,2024-02-21,No
191366,02489007,Shortage,SANDOZ ADAPALENE / BENZOYL PEROXIDE,SANDOZ CANADA INCORPORATED,ADAPALENE SDZ,BENZOYL PEROXIDE; ADAPALENE,2.5%; 0.1%,70G PU,TOPICAL; TOPICAL,Resolved,GEL,,2023-05-01,2023-05-19,2023-05-22,Demand increase for the drug.,2023-05-01,2023-05-25,No
188633,02288109,Shortage,SANDOZ ALENDRONATE,SANDOZ CANADA INCORPORATED,ALENDRONATE,ALENDRONIC ACID,70MG,4TAB,ORAL; ORAL,Resolved,TABLET,,2023-04-04,2023-06-09,2023-05-22,Disruption of the manufacture of the drug.,2023-04-04,2023-05-25,No
202533,02284391,Shortage,SANDOZ AMLODIPINE,SANDOZ CANADA INCORPORATED,AMLODIPINE,AMLODIPINE,10MG,500TAB BO,ORAL; ORAL,Resolved,TABLET,,2023-08-21,2023-08-25,2023-08-28,Disruption of the manufacture of the drug.,2023-08-21,2023-08-29,No
189788,02284383,Shortage,SANDOZ AMLODIPINE,SANDOZ CANADA INCORPORATED,AMLODIPINE,AMLODIPINE,5MG,100TAB,ORAL; ORAL,Resolved,TABLET,,2023-04-17,2023-05-05,2023-05-01,Disruption of the manufacture of the drug.,2023-04-18,2023-05-03,No
191369,02284391,Shortage,SANDOZ AMLODIPINE,SANDOZ CANADA INCORPORATED,AMLODIPINE SDZ,AMLODIPINE,10MG,100TAB BO,ORAL; ORAL,Resolved,TABLET,,2023-05-01,2023-05-26,2023-05-22,Disruption of the manufacture of the drug.,2023-05-01,2023-05-25,No
198805,02284383,Shortage,SANDOZ AMLODIPINE,SANDOZ CANADA INCORPORATED,AMLODIPINE,AMLODIPINE,5MG,500TAB BO,ORAL; ORAL,Resolved,TABLET,,2023-07-17,2023-07-21,2023-07-24,Delay in shipping of the drug.,2023-07-17,2023-07-25,No
190126,02284391,Shortage,SANDOZ AMLODIPINE,SANDOZ CANADA INCORPORATED,AMLODIPINE,AMLODIPINE,10MG,500TAB BO,ORAL; ORAL,Resolved,TABLET,,2023-04-21,2023-05-19,2023-05-15,Disruption of the manufacture of the drug.,2023-04-21,2023-05-16,No
190130,02284383,Shortage,SANDOZ AMLODIPINE,SANDOZ CANADA INCORPORATED,AMLODIPINE,AMLODIPINE,5MG,500TAB,ORAL; ORAL,Resolved,TABLET,,2023-04-21,2023-04-28,2023-05-01,Disruption of the manufacture of the drug.,2023-04-21,2023-05-03,No
194746,02284383,Shortage,SANDOZ AMLODIPINE,SANDOZ CANADA INCORPORATED,AMLODIPINE,AMLODIPINE,5MG,100 TAB BO,ORAL; ORAL,Resolved,TABLET,,2023-06-12,2023-07-14,2023-07-10,Disruption of the manufacture of the drug.,2023-06-12,2023-07-11,No
205778,02330474,Shortage,SANDOZ AMLODIPINE,SANDOZ CANADA INCORPORATED,Amlodipine,AMLODIPINE,2.5MG,100TAB,ORAL; ORAL,Resolved,TABLET,,2023-10-02,2023-10-06,2023-10-10,Requirements related to complying with good manufacturing practices.,2023-10-02,2023-10-11,No
201722,02284383,Shortage,SANDOZ AMLODIPINE,SANDOZ CANADA INCORPORATED,AMLODIPINE,AMLODIPINE,5MG,100TAB BO,ORAL; ORAL,Resolved,TABLET,,2023-08-14,2023-09-08,2023-09-05,Demand increase for the drug.,2023-08-14,2023-09-06,No
201725,02284383,Shortage,SANDOZ AMLODIPINE,SANDOZ CANADA INCORPORATED,AMLODIPINE,AMLODIPINE,5MG,500TAB BO,ORAL; ORAL,Resolved,TABLET,,2023-08-14,2023-08-25,2023-08-29,Demand increase for the drug.,2023-08-14,2023-08-30,No
210829,02482584,Shortage,SANDOZ AMOXI-CLAV TABLET,SANDOZ CANADA INCORPORATED,AMOXICILLIN,CLAVULANIC ACID; AMOXICILLIN,125MG; 875MG,100FCT,ORAL; ORAL,Resolved,TABLET,,2023-11-20,2023-12-15,2023-12-11,Disruption of the manufacture of the drug.,2023-11-20,2023-12-12,No
193693,02482576,Shortage,SANDOZ AMOXI-CLAV TABLET,SANDOZ CANADA INCORPORATED,AMOXI-CLAV TABLET,CLAVULANIC ACID; AMOXICILLIN,125MG; 500MG,100FCT BO,ORAL; ORAL,Resolved,TABLET,,2023-06-05,2023-06-09,2023-06-12,Delay in shipping of the drug.,2023-06-05,2023-06-13,No
196662,02457296,Shortage,SANDOZ AMPHETAMINE XR,SANDOZ CANADA INCORPORATED,AMPHETAMINE XR,MIXED SALTS AMPHETAMINE,10MG,100PRCH,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2023-06-27,2023-08-04,2023-08-07,Other (Please describe in comments),2023-06-27,2023-08-08,No
206684,02457326,Shortage,SANDOZ AMPHETAMINE XR,SANDOZ CANADA INCORPORATED,AMPHETAMINE XR,MIXED SALTS AMPHETAMINE,20MG,100 PRCH BO,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2023-10-10,2023-10-27,2023-10-23,Demand increase for the drug.,2023-10-10,2023-10-24,No
199806,02457326,Shortage,SANDOZ AMPHETAMINE XR,SANDOZ CANADA INCORPORATED,AMPHETAMINE XR,MIXED SALTS AMPHETAMINE,20MG,100PRCH BO,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2023-07-24,2023-08-04,2023-08-07,Demand increase for the drug.,2023-07-24,2023-08-08,No
210832,02457334,Shortage,SANDOZ AMPHETAMINE XR,SANDOZ CANADA INCORPORATED,AMPHETAMINE,MIXED SALTS AMPHETAMINE,25MG,100PRCH,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2023-11-20,2023-12-22,2023-12-22,Demand increase for the drug.,2023-11-20,2024-01-03,No
205782,02457296,Shortage,SANDOZ AMPHETAMINE XR,SANDOZ CANADA INCORPORATED,amphetamine,MIXED SALTS AMPHETAMINE,10MG,100PRCH,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2023-10-02,2023-11-03,2023-11-06,Demand increase for the drug.,2023-10-02,2023-11-07,No
191993,02457334,Shortage,SANDOZ AMPHETAMINE XR,SANDOZ CANADA INCORPORATED,AMPHETAMINE XR,MIXED SALTS AMPHETAMINE,25MG,100PRCH,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2023-05-08,2023-05-19,2023-05-22,Disruption of the manufacture of the drug.,2023-05-08,2023-05-25,No
184230,02386445,Shortage,SANDOZ ATOMOXETINE,SANDOZ CANADA INCORPORATED,ATOMOXETINE,ATOMOXETINE,40MG,30HGC,ORAL; ORAL,Resolved,CAPSULE,,2023-02-03,2023-02-17,2023-02-24,Disruption of the manufacture of the drug.,2023-02-09,2023-03-03,No
197039,02386429,Shortage,SANDOZ ATOMOXETINE,SANDOZ CANADA INCORPORATED,ATOMOXETINE,ATOMOXETINE,18MG,30HGC BO,ORAL; ORAL,Resolved,CAPSULE,,2023-07-04,2023-08-04,2023-07-24,Disruption of the manufacture of the drug.,2023-07-04,2023-07-25,No
213002,02324962,Shortage,SANDOZ ATORVASTATIN,SANDOZ CANADA INCORPORATED,ATORVASTATIN,ATORVASTATIN,40MG,100FCT,ORAL; ORAL,Resolved,TABLET,,2023-12-11,2023-12-22,2023-12-22,Disruption of the manufacture of the drug.,2023-12-11,2024-01-03,No
213005,02324962,Shortage,SANDOZ ATORVASTATIN,SANDOZ CANADA INCORPORATED,ATORVASTATIN,ATORVASTATIN,40MG,500FCT,ORAL; ORAL,Resolved,TABLET,,2023-12-11,2024-02-09,2024-02-02,Disruption of the manufacture of the drug.,2023-12-11,2024-02-20,No
213794,02324954,Shortage,SANDOZ ATORVASTATIN,SANDOZ CANADA INCORPORATED,ATORVASTATIN,ATORVASTATIN,20MG,100FCT,ORAL; ORAL,Resolved,TABLET,,2023-12-19,2023-12-22,2023-12-22,Disruption of the manufacture of the drug.,2023-12-19,2024-01-03,No
213798,02324970,Shortage,SANDOZ ATORVASTATIN,SANDOZ CANADA INCORPORATED,ATORVASTATIN,ATORVASTATIN,80MG,100FCT,ORAL; ORAL,Resolved,TABLET,,2023-12-19,2024-02-02,2024-01-23,Disruption of the manufacture of the drug.,2023-12-19,2024-01-24,No
181658,02324946,Shortage,SANDOZ ATORVASTATIN,SANDOZ CANADA INCORPORATED,ATORVASTATIN,ATORVASTATIN,10MG,100FCT,ORAL; ORAL,Resolved,TABLET,,2023-01-18,2023-02-03,2023-01-31,Disruption of the manufacture of the drug.,2023-01-19,2023-02-01,No
181662,02324962,Shortage,SANDOZ ATORVASTATIN,SANDOZ CANADA INCORPORATED,ATORVASTATIN,ATORVASTATIN,40MG,100FCT,ORAL; ORAL,Resolved,TABLET,,2023-01-18,2023-02-10,2023-02-14,Disruption of the manufacture of the drug.,2023-01-19,2023-02-15,No
211127,02324946,Shortage,SANDOZ ATORVASTATIN,SANDOZ CANADA INCORPORATED,ATORVASTATIN,ATORVASTATIN,10MG,500FCT,ORAL; ORAL,Resolved,TABLET,,2023-11-22,2024-02-23,2024-02-26,Disruption of the manufacture of the drug.,2023-11-22,2024-02-27,No
193041,02332396,Shortage,SANDOZ AZITHROMYCIN,SANDOZ CANADA INCORPORATED,AZITHROMYCIN,AZITHROMYCIN,200MG,15ML,ORAL; ORAL,Resolved,POWDER FOR SUSPENSION,,2023-05-22,2023-07-14,2023-07-10,Demand increase for the drug.,2023-05-25,2023-07-11,No
181665,02332396,Shortage,SANDOZ AZITHROMYCIN,SANDOZ CANADA INCORPORATED,AZITHROMYCIN,AZITHROMYCIN,200MG,22.5ML,ORAL; ORAL,Resolved,POWDER FOR SUSPENSION,,2023-01-18,2023-01-27,2023-01-31,Demand increase for the drug.,2023-01-19,2023-02-01,No
184233,02332396,Shortage,SANDOZ AZITHROMYCIN,SANDOZ CANADA INCORPORATED,AZITHROMYCIN,AZITHROMYCIN,200MG,"22,5ML",ORAL; ORAL,Resolved,POWDER FOR SUSPENSION,,2023-02-03,2023-02-17,2023-02-17,Demand increase for the drug.,2023-02-09,2023-03-02,No
190134,02332396,Shortage,SANDOZ AZITHROMYCIN,SANDOZ CANADA INCORPORATED,AZITHROMYCIN,AZITHROMYCIN,200MG,"22,5ML",ORAL; ORAL,Resolved,POWDER FOR SUSPENSION,,2023-04-21,2023-07-14,2023-07-04,Disruption of the manufacture of the drug.,2023-04-21,2023-07-05,No
190138,02332396,Shortage,SANDOZ AZITHROMYCIN,SANDOZ CANADA INCORPORATED,AZITHROMYCIN,AZITHROMYCIN,200MG,"37,5ML",ORAL; ORAL,Resolved,POWDER FOR SUSPENSION,,2023-04-21,2023-07-21,2023-07-10,Disruption of the manufacture of the drug.,2023-04-21,2023-07-11,No
194749,02332388,Shortage,SANDOZ AZITHROMYCIN,SANDOZ CANADA INCORPORATED,AZITHROMYCIN,AZITHROMYCIN,100MG,15ML POS,ORAL; ORAL,Resolved,POWDER FOR SUSPENSION,,2023-06-12,2023-07-21,2023-07-10,Demand increase for the drug.,2023-06-12,2023-07-11,No
188637,02494035,Shortage,SANDOZ BISOPROLOL TABLETS,SANDOZ CANADA INCORPORATED,BISOPROLOL,BISOPROLOL FUMARATE,5MG,100FCT,ORAL; ORAL,Resolved,TABLET,,2023-04-03,2023-04-07,2023-04-11,Requirements related to complying with good manufacturing practices.,2023-04-04,2023-04-12,No
182538,02326957,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,4MG,100TAB,ORAL; ORAL,Resolved,TABLET,,2023-01-25,2023-02-24,2023-03-06,Disruption of the manufacture of the drug.,2023-01-27,2023-03-07,No
182541,02326965,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,8MG,500TAB,ORAL; ORAL,Resolved,TABLET,,2023-01-25,2023-03-17,2023-03-20,Disruption of the manufacture of the drug.,2023-01-27,2023-03-21,No
182547,02326973,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,16MG,30TAB,ORAL; ORAL,Resolved,TABLET,,2023-01-25,2023-02-17,2023-01-31,Disruption of the manufacture of the drug.,2023-01-27,2023-02-01,No
182805,02326957,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,4MG,30TAB,ORAL; ORAL,Resolved,TABLET,,2023-01-31,2023-04-14,2023-04-11,Disruption of the manufacture of the drug.,2023-01-31,2023-04-12,No
189217,02326973,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,16MG,30 TAB UD,ORAL; ORAL,Resolved,TABLET,,2023-04-11,2023-04-21,2023-04-17,Disruption of the manufacture of the drug.,2023-04-11,2023-04-18,No
189220,02326973,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,16MG,500 TAB BO,ORAL; ORAL,Resolved,TABLET,,2023-04-11,2023-05-05,2023-05-08,Disruption of the manufacture of the drug.,2023-04-11,2023-05-09,No
192559,02326957,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,4MG,100TAB,ORAL; ORAL,Resolved,TABLET,,2023-05-15,2023-06-16,2023-06-12,Disruption of the manufacture of the drug.,2023-05-16,2023-06-13,No
193358,02417340,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,32MG,100TAB,ORAL; ORAL,Resolved,TABLET,,2023-05-30,2023-06-02,2023-06-05,Disruption of the manufacture of the drug.,2023-05-30,2023-06-06,No
206689,02326973,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,16MG,500 TAB BO,ORAL; ORAL,Resolved,TABLET,,2023-10-10,2024-02-09,2024-01-30,Disruption of the manufacture of the drug.,2023-10-10,2024-01-31,No
191376,02417340,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,32MG,100TAB BO,ORAL; ORAL,Resolved,TABLET,,2023-05-01,2023-05-19,2023-05-22,Disruption of the manufacture of the drug.,2023-05-01,2023-05-25,No
188055,02326965,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,8MG,100 TAB,ORAL; ORAL,Resolved,TABLET,,2023-03-27,2023-04-28,2023-04-21,Disruption of the manufacture of the drug.,2023-03-27,2023-04-22,No
196784,02326957,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,4MG,30 TAB,ORAL; ORAL,Resolved,TABLET,,2023-06-28,2023-09-08,2023-08-29,Demand increase for the drug.,2023-06-28,2023-08-30,No
211122,02326973,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,16MG,30TAB,ORAL; ORAL,Resolved,TABLET,,2023-11-22,2024-01-26,2023-12-19,Disruption of the manufacture of the drug.,2023-11-22,2023-12-20,No
194760,02326973,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTAN,CANDESARTAN CILEXETIL,16MG,30TAB UD,ORAL; ORAL,Resolved,TABLET,,2023-06-12,2023-09-01,2023-08-21,Disruption of the manufacture of the drug.,2023-06-12,2023-08-22,No
188640,02326957,Shortage,SANDOZ CANDESARTAN,SANDOZ CANADA INCORPORATED,CANDESARTRAN,CANDESARTAN CILEXETIL,4MG,100TAB,ORAL; ORAL,Resolved,TABLET,,2023-04-04,2023-05-05,2023-05-01,Disruption of the manufacture of the drug.,2023-04-04,2023-05-03,No
199810,02327902,Shortage,SANDOZ CANDESARTAN PLUS,SANDOZ CANADA INCORPORATED,CANDESARTAN PLUS,HYDROCHLOROTHIAZIDE; CANDESARTAN CILEXETIL,12.5MG; 16MG,30TAB UD,ORAL; ORAL,Resolved,TABLET,,2023-07-24,2024-07-26,2024-04-03,Demand increase for the drug.,2023-07-24,2024-04-04,No
210835,02420740,Shortage,SANDOZ CANDESARTAN PLUS,SANDOZ CANADA INCORPORATED,CANDESARTAN,HYDROCHLOROTHIAZIDE; CANDESARTAN CILEXETIL,25MG; 32MG,100TAB,ORAL; ORAL,Resolved,TABLET,,2023-11-20,2024-01-19,2024-01-17,Disruption of the manufacture of the drug.,2023-11-20,2024-01-18,No
188052,02420740,Shortage,SANDOZ CANDESARTAN PLUS,SANDOZ CANADA INCORPORATED,CANDESARTAN PLUS,HYDROCHLOROTHIAZIDE; CANDESARTAN CILEXETIL,25MG; 32MG,100 TAB,ORAL; ORAL,Resolved,TABLET,,2023-03-27,2023-04-14,2023-04-11,Delay in shipping of the drug.,2023-03-27,2023-04-12,No
186277,02327902,Shortage,SANDOZ CANDESARTAN PLUS,SANDOZ CANADA INCORPORATED,CANDESARTAN PLUS,HYDROCHLOROTHIAZIDE; CANDESARTAN CILEXETIL,12.5MG; 16MG,30TAB,ORAL; ORAL,Resolved,TABLET,,2023-03-06,2023-03-31,2023-04-04,Disruption of the manufacture of the drug.,2023-03-06,2023-04-05,No
193703,02420732,Shortage,SANDOZ CANDESARTAN PLUS,SANDOZ CANADA INCORPORATED,CANDESARTAN PLUS,HYDROCHLOROTHIAZIDE; CANDESARTAN CILEXETIL,12.5MG; 32MG,100TAB BO,ORAL; ORAL,Resolved,TABLET,,2023-06-05,2024-02-23,2024-02-20,Disruption of the manufacture of the drug.,2023-06-05,2024-02-21,No
194754,02327902,Shortage,SANDOZ CANDESARTAN PLUS,SANDOZ CANADA INCORPORATED,CANDESARTAN PLUS,HYDROCHLOROTHIAZIDE; CANDESARTAN CILEXETIL,12.5MG; 16MG,100TAB BO,ORAL; ORAL,Resolved,TABLET,,2023-06-12,2023-08-18,2023-08-21,Disruption of the manufacture of the drug.,2023-06-12,2023-08-22,No
194757,02420740,Shortage,SANDOZ CANDESARTAN PLUS,SANDOZ CANADA INCORPORATED,CANDESARTAN PLUS,HYDROCHLOROTHIAZIDE; CANDESARTAN CILEXETIL,25MG; 32MG,100TAB BO,ORAL; ORAL,Resolved,TABLET,,2023-06-12,2024-01-12,2023-10-23,Disruption of the manufacture of the drug.,2023-06-12,2023-10-24,No
184619,02387131,Shortage,SANDOZ CIPROFLOXACIN,SANDOZ CANADA INCORPORATED,CIPROFLOXACIN,CIPROFLOXACIN,0.30%,5ML,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,,2023-02-14,2023-04-07,2023-04-04,Shortage of an inactive ingredient or component.,2023-02-14,2023-04-05,No
188611,02248757,Shortage,SANDOZ CIPROFLOXACIN,SANDOZ CANADA INCORPORATED,CIPROFLOXACIN,CIPROFLOXACIN,500MG,100FCT,ORAL; ORAL,Resolved,TABLET,,2023-03-31,2023-04-21,2023-04-17,Demand increase for the drug.,2023-04-04,2023-04-18,No
205785,02248757,Shortage,SANDOZ CIPROFLOXACIN,SANDOZ CANADA INCORPORATED,Ciprofloxacin,CIPROFLOXACIN,500MG,100FCT,ORAL; ORAL,Resolved,TABLET,,2023-10-02,2023-12-08,2023-10-19,Requirements related to complying with good manufacturing practices.,2023-10-02,2023-10-20,No
182808,02506882,Shortage,SANDOZ CIPROFLOXACIN / DEXAMETHASONE,SANDOZ CANADA INCORPORATED,CIPROFLOXACIN / DEXAMETHASONE,DEXAMETHASONE; CIPROFLOXACIN,0.1%; 0.3%,7.5ML,OTIC,Resolved,SUSPENSION,,2023-01-31,2023-02-24,2023-02-24,Demand increase for the drug.,2023-01-31,2023-03-06,No
186952,02506882,Shortage,SANDOZ CIPROFLOXACIN / DEXAMETHASONE,SANDOZ CANADA INCORPORATED,CIPROFLOXACIN / DEXAMETHASONE,DEXAMETHASONE; CIPROFLOXACIN,0.1%; 0.3%,7.5ML,OTIC,Resolved,SUSPENSION,,2023-03-13,2023-03-24,2023-03-27,Demand increase for the drug.,2023-03-13,2023-03-28,No
212439,02506882,Shortage,SANDOZ CIPROFLOXACIN / DEXAMETHASONE,SANDOZ CANADA INCORPORATED,CIPROFLOXACIN/DEXAMETHASONE,DEXAMETHASONE; CIPROFLOXACIN,0.1%; 0.3%,7.5ML,OTIC,Resolved,SUSPENSION,,2023-12-04,2023-12-15,2023-12-19,Demand increase for the drug.,2023-12-04,2023-12-20,No
210855,00287873,Shortage,SANDOZ COLCHICINE,SANDOZ CANADA INCORPORATED,COLCHICINE,COLCHICINE,0.6MG,100TAB,ORAL; ORAL,Resolved,TABLET,,2023-11-20,,2023-11-27,Disruption of the manufacture of the drug.,2023-11-20,2023-11-28,No
186956,02247073,Shortage,SANDOZ CYCLOSPORINE,SANDOZ CANADA INCORPORATED,CYCLOSPORINE,CYCLOSPORINE,25MG,30SGC,ORAL; ORAL,Resolved,CAPSULE,,2023-03-13,2023-05-05,2023-05-08,Disruption of the manufacture of the drug.,2023-03-13,2023-05-09,No
204722,02242821,Shortage,SANDOZ CYCLOSPORINE,SANDOZ CANADA INCORPORATED,CYCLOSPORINE,CYCLOSPORINE,100MG,30SGC,ORAL; ORAL,Resolved,CAPSULE,,2023-09-19,2023-11-03,2023-10-30,Requirements related to complying with good manufacturing practices.,2023-09-19,2023-10-31,No
197064,02237450,Shortage,SANDOZ D-FORTE,SANDOZ CANADA INCORPORATED,D-FORTE,VITAMIN D2,50000UNIT,100SGC BO,ORAL; ORAL,Resolved,CAPSULE,,2023-07-04,,2024-04-02,Disruption of the manufacture of the drug.,2023-07-04,2024-04-03,No
213801,02518732,Shortage,SANDOZ DAPAGLIFLOZIN,SANDOZ CANADA INCORPORATED,DAPAGLIFLOZIN,DAPAGLIFLOZIN,5MG,100FCT,ORAL,Resolved,TABLET,,2023-12-19,2023-12-22,2024-01-03,Disruption of the manufacture of the drug.,2023-12-19,2024-01-04,No
202538,02518740,Shortage,SANDOZ DAPAGLIFLOZIN,SANDOZ CANADA INCORPORATED,DAPAGLIFLOZIN,DAPAGLIFLOZIN,10MG,500FCT BO,ORAL,Resolved,TABLET,,2023-08-21,2023-11-17,2023-10-13,Demand increase for the drug.,2023-08-21,2023-11-13,No
203653,02518740,Shortage,SANDOZ DAPAGLIFLOZIN,SANDOZ CANADA INCORPORATED,DAPAGLIFLOZIN,DAPAGLIFLOZIN,10MG,100FCT,ORAL,Resolved,TABLET,,2023-09-05,2023-10-20,2023-10-16,Demand increase for the drug.,2023-09-05,2023-10-17,No
210838,02518740,Shortage,SANDOZ DAPAGLIFLOZIN,SANDOZ CANADA INCORPORATED,DAPAGLIFLOZIN,DAPAGLIFLOZIN,10MG,100FCT,ORAL,Resolved,TABLET,,2023-11-20,2024-01-12,2024-01-16,Disruption of the manufacture of the drug.,2023-11-20,2024-01-17,No
193710,02464470,Shortage,SANDOZ DEFERASIROX,SANDOZ CANADA INCORPORATED,DEFERASIROX,DEFERASIROX,500MG,28DT,ORAL; ORAL,Resolved,TABLET FOR SUSPENSION,,2023-06-05,2023-10-27,2023-10-23,Delay in shipping of the drug.,2023-06-05,2023-10-24,No
204727,02464462,Shortage,SANDOZ DEFERASIROX,SANDOZ CANADA INCORPORATED,DEFERASIROX,DEFERASIROX,250MG,28DT,ORAL; ORAL,Resolved,TABLET FOR SUSPENSION,,2023-09-19,2023-11-10,2023-11-13,Demand increase for the drug.,2023-09-19,2023-11-14,No
186181,02454807,Shortage,SANDOZ DICLOFENAC OPHTHA,SANDOZ CANADA INCORPORATED,DICLOFENAC,DICLOFENAC SODIUM,0.10%,5ML,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,,2023-02-24,2023-06-02,2023-06-05,Shortage of an active ingredient.,2023-03-03,2023-06-06,No
213804,02513803,Shortage,SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES,SANDOZ CANADA INCORPORATED,DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES,DIMETHYL FUMARATE,240MG,56GRC,ORAL,Actual shortage,CAPSULE (DELAYED RELEASE),,2023-12-19,,,Disruption of the manufacture of the drug.,2023-12-19,2024-02-05,No
191999,02344351,Shortage,SANDOZ DORZOLAMIDE/TIMOLOL,SANDOZ CANADA INCORPORATED,DORZOLAMIDE/TIMOLOL,TIMOLOL; DORZOLAMIDE,5MG; 20MG,10ML,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,,2023-05-08,2023-05-19,2023-05-22,Disruption of the manufacture of the drug.,2023-05-08,2023-05-25,No
186281,02439948,Shortage,SANDOZ DULOXETINE,SANDOZ CANADA INCORPORATED,DULOXETINE,DULOXETINE,30MG,30GRC,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-03-03,2023-03-10,2023-03-13,Delay in shipping of the drug.,2023-03-06,2023-03-14,No
207079,02439948,Shortage,SANDOZ DULOXETINE,SANDOZ CANADA INCORPORATED,DULOXETINE,DULOXETINE,30MG,100GRC,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-10-16,2024-03-08,2024-01-16,Requirements related to complying with good manufacturing practices.,2023-10-16,2024-01-17,No
213008,02299941,Shortage,SANDOZ ENALAPRIL,SANDOZ CANADA INCORPORATED,ENALAPRIL,ENALAPRIL SODIUM,4MG,100TAB,ORAL; ORAL,Resolved,TABLET,,2023-12-11,2024-02-16,2024-02-05,Disruption of the manufacture of the drug.,2023-12-11,2024-02-06,No
187485,02299976,Shortage,SANDOZ ENALAPRIL,SANDOZ CANADA INCORPORATED,ENALAPRIL,ENALAPRIL SODIUM,16MG,100TAB,ORAL; ORAL,Resolved,TABLET,,2023-03-20,,2023-03-27,Demand increase for the drug.,2023-03-20,2023-03-28,No
203659,02299933,Shortage,SANDOZ ENALAPRIL,SANDOZ CANADA INCORPORATED,ENALAPRIL,ENALAPRIL SODIUM,2MG,100TAB,ORAL; ORAL,Resolved,TABLET,,2023-09-09,2023-11-17,2023-10-30,Disruption of the manufacture of the drug.,2023-09-05,2023-10-31,No
184236,02299968,Shortage,SANDOZ ENALAPRIL,SANDOZ CANADA INCORPORATED,ENALAPRIL,ENALAPRIL SODIUM,8MG,100TAB,ORAL; ORAL,Resolved,TABLET,,2023-02-03,2023-03-03,2023-03-06,Delay in shipping of the drug.,2023-02-09,2023-03-07,No
193715,02299976,Shortage,SANDOZ ENALAPRIL,SANDOZ CANADA INCORPORATED,ENALAPRIL,ENALAPRIL SODIUM,16MG,100TAB BO,ORAL; ORAL,Resolved,TABLET,,2023-06-05,2023-08-04,2023-07-04,Disruption of the manufacture of the drug.,2023-06-05,2023-07-05,No
186157,02380005,Shortage,SANDOZ ENTACAPONE,SANDOZ CANADA INCORPORATED,ENTACAPONE,ENTACAPONE,200MG,100FCT,ORAL; ORAL,Resolved,TABLET,,2023-02-24,2023-04-21,2023-04-21,Requirements related to complying with good manufacturing practices.,2023-03-03,2023-04-22,No
204731,02380005,Shortage,SANDOZ ENTACAPONE,SANDOZ CANADA INCORPORATED,ENTACAPONE,ENTACAPONE,200MG,100FCT,ORAL; ORAL,Resolved,TABLET,,2023-09-19,2023-12-15,2023-12-19,Delay in shipping of the drug.,2023-09-19,2023-12-20,No
213807,02460939,Shortage,SANDOZ ESOMEPRAZOLE,SANDOZ CANADA INCORPORATED,ESOMEPRAZOLE,ESOMEPRAZOLE,40MG,500GRT,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE),,2023-12-19,2023-12-22,2023-12-22,Requirements related to complying with good manufacturing practices.,2023-12-19,2024-01-03,No
188651,02246969,Shortage,SANDOZ ESTRADIOL DERM 100,SANDOZ CANADA INCORPORATED,ESTRADIOL DERM 100,ESTRADIOL,100MCG,8TTS,TRANSDERMAL; TRANSDERMAL,Resolved,PATCH,,2023-04-04,2023-04-14,2023-04-17,Disruption of the manufacture of the drug.,2023-04-04,2023-04-18,No
184240,02246967,Shortage,SANDOZ ESTRADIOL DERM 50,SANDOZ CANADA INCORPORATED,ESTRADIOL,ESTRADIOL,50MCG,8TTS,TRANSDERMAL; TRANSDERMAL,Resolved,PATCH,,2023-02-03,2023-03-10,2023-03-13,Disruption of the manufacture of the drug.,2023-02-09,2023-03-14,No
182553,02246968,Shortage,SANDOZ ESTRADIOL DERM 75,SANDOZ CANADA INCORPORATED,ESTRADIOL,ESTRADIOL,75MCG,8TTS,TRANSDERMAL; TRANSDERMAL,Resolved,PATCH,,2023-01-25,2023-03-10,2023-02-17,Disruption of the manufacture of the drug.,2023-01-27,2023-03-02,No
196787,02492911,Shortage,SANDOZ EVEROLIMUS,SANDOZ CANADA INCORPORATED,EVEROLIMUS,EVEROLIMUS,2.5MG,30 TAB,ORAL,Resolved,TABLET,,2023-06-28,2023-08-18,2023-08-21,Disruption of the manufacture of the drug.,2023-06-28,2023-08-22,No
213011,02416778,Shortage,SANDOZ EZETIMIBE,SANDOZ CANADA INCORPORATED,EZETIMIDE,EZETIMIBE,10MG,100TAB,ORAL; ORAL,Actual shortage,TABLET,,2023-12-11,2024-10-11,,Shortage of an active ingredient.,2023-12-11,2023-12-12,No
187427,02416778,Shortage,SANDOZ EZETIMIBE,SANDOZ CANADA INCORPORATED,EZETIMIBE,EZETIMIBE,10MG,100 TAB,ORAL; ORAL,Resolved,TABLET,,2023-03-20,2023-03-24,2023-03-27,Disruption of the manufacture of the drug.,2023-03-20,2023-03-28,No
202541,02416778,Shortage,SANDOZ EZETIMIBE,SANDOZ CANADA INCORPORATED,EZETIMIBE,EZETIMIBE,10MG,100TAB BO,ORAL; ORAL,Resolved,TABLET,,2023-08-21,2023-10-27,2023-10-23,Disruption of the manufacture of the drug.,2023-08-21,2023-10-24,No
213810,02416778,Shortage,SANDOZ EZETIMIBE,SANDOZ CANADA INCORPORATED,EZETIMIBE,EZETIMIBE,10MG,30TAB,ORAL; ORAL,Resolved,TABLET,,2023-12-19,2023-12-22,2023-12-22,Disruption of the manufacture of the drug.,2023-12-19,2024-01-03,No
182812,02339471,Shortage,SANDOZ FINASTERIDE A,SANDOZ CANADA INCORPORATED,FINASTERIDE,FINASTERIDE,1MG,30FCT,ORAL; ORAL,Resolved,TABLET,,2023-01-31,2023-03-03,2023-03-06,Disruption of the manufacture of the drug.,2023-01-31,2023-03-07,No
196760,02339471,Shortage,SANDOZ FINASTERIDE A,SANDOZ CANADA INCORPORATED,FINASTERIDE A,FINASTERIDE,1MG,100FCT BO,ORAL; ORAL,Resolved,TABLET,,2023-06-28,2023-07-14,2023-06-28,Disruption of the manufacture of the drug.,2023-06-28,2023-07-04,No
210844,02339471,Shortage,SANDOZ FINASTERIDE A,SANDOZ CANADA INCORPORATED,FINASTERIDE,FINASTERIDE,1MG,30FCT,ORAL; ORAL,Resolved,TABLET,,2023-11-20,2024-01-19,2024-01-17,Demand increase for the drug.,2023-11-20,2024-01-18,No
194763,02339471,Shortage,SANDOZ FINASTERIDE A,SANDOZ CANADA INCORPORATED,FINASTERIDE A,FINASTERIDE,1MG,30FCT UD,ORAL; ORAL,Resolved,TABLET,,2023-06-12,2023-07-14,2023-07-17,Disruption of the manufacture of the drug.,2023-06-12,2023-07-18,No
182559,00432814,Shortage,SANDOZ FLUOROMETHOLONE,SANDOZ CANADA INCORPORATED,FLUOROMETHOLONE,FLUOROMETHOLONE,0.10%,5ML,OPHTHALMIC; OPHTHALMIC,Resolved,SUSPENSION,,2023-01-25,2023-03-03,2023-02-08,Disruption of the manufacture of the drug.,2023-01-27,2023-02-09,No
181566,02285673,Shortage,SANDOZ FOLIC ACID,SANDOZ CANADA INCORPORATED,FOLIC ACID,FOLIC ACID,5MG,1000TAB,ORAL; ORAL,Resolved,TABLET,,2023-01-18,,2023-06-20,Requirements related to complying with good manufacturing practices.,2023-01-19,2023-06-21,No
201250,02269619,Shortage,SANDOZ GLIMEPIRIDE,SANDOZ CANADA INCORPORATED,GLIMEPIRIDE,GLIMEPIRIDE,4MG,30TAB UD V1,ORAL; ORAL,Resolved,TABLET,,2023-08-07,2023-11-17,2023-11-20,Shortage of an active ingredient.,2023-08-07,2023-11-21,No
186959,02269619,Shortage,SANDOZ GLIMEPIRIDE,SANDOZ CANADA INCORPORATED,GLIMEPIRIDE,GLIMEPIRIDE,4MG,30TAB,ORAL; ORAL,Resolved,TABLET,,2023-03-13,2023-04-21,2023-04-17,Disruption of the manufacture of the drug.,2023-03-13,2023-04-18,No
189792,02269589,Shortage,SANDOZ GLIMEPIRIDE,SANDOZ CANADA INCORPORATED,GLIMEPIRIDE,GLIMEPIRIDE,1MG,30TAB,ORAL; ORAL,Resolved,TABLET,,2023-04-17,2023-05-05,2023-05-08,Shortage of an inactive ingredient or component.,2023-04-18,2023-05-09,No
208534,02269589,Shortage,SANDOZ GLIMEPIRIDE,SANDOZ CANADA INCORPORATED,GLIMEPIRIDE,GLIMEPIRIDE,1MG,30TAB,ORAL; ORAL,Resolved,TABLET,,2023-10-30,2023-11-24,2023-11-27,Shortage of an active ingredient.,2023-10-30,2023-11-28,No
208541,02269597,Shortage,SANDOZ GLIMEPIRIDE,SANDOZ CANADA INCORPORATED,GLIMEPIRIDE,GLIMEPIRIDE,2MG,30TAB,ORAL; ORAL,Resolved,TABLET,,2023-10-30,2023-11-24,2023-11-27,Shortage of an active ingredient.,2023-10-30,2023-11-28,No
188654,02269597,Shortage,SANDOZ GLIMEPIRIDE,SANDOZ CANADA INCORPORATED,GLIMEPIRIDE,GLIMEPIRIDE,2MG,30TAB,ORAL; ORAL,Resolved,TABLET,,2023-04-04,2023-05-05,2023-05-08,Disruption of the manufacture of the drug.,2023-04-04,2023-05-09,No
192566,02469421,Shortage,SANDOZ HYDROCORTISONE,SANDOZ CANADA INCORPORATED,HYDROCORTISONE,HYDROCORTISONE,2.50%,225G,TOPICAL; TOPICAL,Resolved,CREAM,,2023-05-15,2023-05-26,2023-05-30,Requirements related to complying with good manufacturing practices.,2023-05-16,2023-05-31,No
189232,02231799,Shortage,SANDOZ INDOMETHACIN,SANDOZ CANADA INCORPORATED,INDOMETHACIN,INDOMETHACIN,50MG,30 SUP,RECTAL; RECTAL,Resolved,SUPPOSITORY,,2023-04-11,,2023-04-18,Disruption of the manufacture of the drug.,2023-04-11,2023-04-19,No
188073,02231800,Shortage,SANDOZ INDOMETHACIN,SANDOZ CANADA INCORPORATED,INDOMETHACIN,INDOMETHACIN,100MG,30 SUP,RECTAL; RECTAL,Resolved,SUPPOSITORY,,2023-03-27,,2023-04-04,Disruption of the manufacture of the drug.,2023-03-27,2023-04-05,No
189223,02328496,Shortage,SANDOZ IRBESARTAN,SANDOZ CANADA INCORPORATED,IRBESARTAN,IRBESARTAN,300MG,100 FCT BO,ORAL; ORAL,Resolved,TABLET,,2023-04-11,2023-05-19,2023-05-15,Disruption of the manufacture of the drug.,2023-04-11,2023-05-16,No
207764,02328488,Shortage,SANDOZ IRBESARTAN,SANDOZ CANADA INCORPORATED,IRBESARTAN,IRBESARTAN,150MG,100 FCT BO,ORAL; ORAL,Resolved,TABLET,,2023-10-23,2023-11-03,2023-10-30,Requirements related to complying with good manufacturing practices.,2023-10-23,2023-10-31,No
193723,02328496,Shortage,SANDOZ IRBESARTAN,SANDOZ CANADA INCORPORATED,IRBESARTAN,IRBESARTAN,300MG,500FCT BO,ORAL; ORAL,Resolved,TABLET,,2023-06-05,2023-07-28,2023-07-17,Demand increase for the drug.,2023-06-05,2023-07-18,No
186061,02328461,Shortage,SANDOZ IRBESARTAN,SANDOZ CANADA INCORPORATED,IRBESARTAN,IRBESARTAN,75MG,100FCT,ORAL; ORAL,Resolved,TABLET,,2023-02-17,2023-06-02,2023-06-05,Disruption of the manufacture of the drug.,2023-03-02,2023-06-06,No
205797,02328461,Shortage,SANDOZ IRBESARTAN,SANDOZ CANADA INCORPORATED,Irbesartan,IRBESARTAN,75MG,100FCT,ORAL; ORAL,Resolved,TABLET,,2023-10-02,2024-02-02,2024-01-31,Disruption of the manufacture of the drug.,2023-10-02,2024-02-01,No
201264,02337436,Shortage,SANDOZ IRBESARTAN HCT,SANDOZ CANADA INCORPORATED,IRBESARTAN HCT,HYDROCHLOROTHIAZIDE; IRBESARTAN,12.5MG; 300MG,100FCT BO,ORAL; ORAL,Resolved,TABLET,,2023-08-07,2023-08-11,2023-08-14,Delay in shipping of the drug.,2023-08-07,2023-08-15,No
184632,02337444,Shortage,SANDOZ IRBESARTAN HCT,SANDOZ CANADA INCORPORATED,IRBESARTAN HCT,HYDROCHLOROTHIAZIDE; IRBESARTAN,25MG; 300MG,500FCT,ORAL; ORAL,Resolved,TABLET,,2023-02-14,2023-03-31,2023-03-27,Disruption of the manufacture of the drug.,2023-02-14,2023-03-28,No
209216,02337428,Shortage,SANDOZ IRBESARTAN HCT,SANDOZ CANADA INCORPORATED,IRBESARTAN HCT,HYDROCHLOROTHIAZIDE; IRBESARTAN,12.5MG; 150MG,100 FCT BO,ORAL; ORAL,Resolved,TABLET,,2023-11-06,2023-12-08,2023-12-11,Disruption of the manufacture of the drug.,2023-11-06,2023-12-12,No
200534,02337444,Shortage,SANDOZ IRBESARTAN HCT,SANDOZ CANADA INCORPORATED,IRBESARTAN,HYDROCHLOROTHIAZIDE; IRBESARTAN,25MG; 300MG,100 FCT BO,ORAL; ORAL,Resolved,TABLET,,2023-07-31,2024-01-12,2024-01-08,Disruption of the manufacture of the drug.,2023-07-31,2024-01-09,No
186967,02337428,Shortage,SANDOZ IRBESARTAN HCT,SANDOZ CANADA INCORPORATED,IRBESARTAN HCT,HYDROCHLOROTHIAZIDE; IRBESARTAN,12.5MG; 150MG,100FCT,ORAL; ORAL,Resolved,TABLET,,2023-03-13,2023-04-14,2023-04-17,Disruption of the manufacture of the drug.,2023-03-13,2023-04-18,No
186971,02337428,Shortage,SANDOZ IRBESARTAN HCT,SANDOZ CANADA INCORPORATED,IRBESARTAN HCT,HYDROCHLOROTHIAZIDE; IRBESARTAN,12.5MG; 150MG,500FCT,ORAL; ORAL,Resolved,TABLET,,2023-03-13,2023-05-05,2023-05-01,Disruption of the manufacture of the drug.,2023-03-13,2023-05-03,No
186285,02337436,Shortage,SANDOZ IRBESARTAN HCT,SANDOZ CANADA INCORPORATED,IRBESARTAN HCT,HYDROCHLOROTHIAZIDE; IRBESARTAN,12.5MG; 300MG,100FCT,ORAL; ORAL,Resolved,TABLET,,2023-03-06,2023-03-31,2023-03-27,Delay in shipping of the drug.,2023-03-06,2023-03-28,No
204738,02337444,Shortage,SANDOZ IRBESARTAN HCT,SANDOZ CANADA INCORPORATED,IRBESARTAN HCT,HYDROCHLOROTHIAZIDE; IRBESARTAN,25MG; 300MG,500FCT,ORAL; ORAL,Resolved,TABLET,,2023-09-19,2024-01-12,2024-01-08,Disruption of the manufacture of the drug.,2023-09-19,2024-01-09,No
212445,02337436,Shortage,SANDOZ IRBESARTAN HCT,SANDOZ CANADA INCORPORATED,IRBESARTAN HCT,HYDROCHLOROTHIAZIDE; IRBESARTAN,12.5MG; 300MG,500FCT,ORAL; ORAL,Resolved,TABLET,,2023-12-04,2024-01-19,2024-01-17,Disruption of the manufacture of the drug.,2023-12-04,2024-01-18,No
211547,02474670,Shortage,SANDOZ LACOSAMIDE,SANDOZ CANADA INCORPORATED,LACOSAMIDE,LACOSAMIDE,50MG,60FCT,ORAL; ORAL,Resolved,TABLET,,2023-11-27,2024-01-26,2024-01-16,Disruption of the manufacture of the drug.,2023-11-27,2024-01-17,No
209221,02283964,Shortage,SANDOZ LEFLUNOMIDE,SANDOZ CANADA INCORPORATED,LEFLUNOMIDE,LEFLUNOMIDE,10MG,30 FCT BO,ORAL; ORAL,Resolved,TABLET,,2023-11-06,2023-11-10,2023-11-13,Delay in shipping of the drug.,2023-11-06,2023-11-14,No
188058,02462001,Shortage,SANDOZ LEVETIRACETAM,SANDOZ CANADA INCORPORATED,LEVETIRACETAM,LEVETIRACETAM,750MG,100 FCT,ORAL; ORAL,Resolved,TABLET,,2023-03-27,2023-06-16,2023-06-19,Disruption of the manufacture of the drug.,2023-03-27,2023-06-20,No
193731,02461994,Shortage,SANDOZ LEVETIRACETAM,SANDOZ CANADA INCORPORATED,LEVETIRACETAM,LEVETIRACETAM,500MG,100FCT BO,ORAL; ORAL,Resolved,TABLET,,2023-06-05,2023-06-23,2023-06-27,Disruption of the manufacture of the drug.,2023-06-05,2023-06-28,No
205153,02298651,Shortage,SANDOZ LEVOFLOXACIN,SANDOZ CANADA INCORPORATED,LEVOFLOXACIN,LEVOFLOXACIN,750MG,50FCT,ORAL; ORAL,Actual shortage,TABLET,,2023-09-25,2024-06-07,,Disruption of the manufacture of the drug.,2023-09-25,2024-03-05,No
194766,02298643,Shortage,SANDOZ LEVOFLOXACIN,SANDOZ CANADA INCORPORATED,LEVOFLOXACIN,LEVOFLOXACIN,500MG,100FCT BO,ORAL; ORAL,Resolved,TABLET,,2023-06-12,2023-06-23,2023-06-19,Disruption of the manufacture of the drug.,2023-06-12,2023-06-20,No
201730,02302373,Shortage,SANDOZ LISINOPRIL HCT,SANDOZ CANADA INCORPORATED,LISINOPRIL HCT,HYDROCHLOROTHIAZIDE; LISINOPRIL,12.5MG; 20MG,100TAB BO,ORAL; ORAL,Resolved,TABLET,,2023-08-14,2024-03-22,2024-03-04,Requirements related to complying with good manufacturing practices.,2023-08-14,2024-03-05,No
201735,02302373,Shortage,SANDOZ LISINOPRIL HCT,SANDOZ CANADA INCORPORATED,LISINOPRIL HCT,HYDROCHLOROTHIAZIDE; LISINOPRIL,12.5MG; 20MG,30TAB UD,ORAL; ORAL,Resolved,TABLET,,2023-08-14,2024-03-01,2024-02-26,Requirements related to complying with good manufacturing practices.,2023-08-14,2024-02-27,No
191382,02313375,Shortage,SANDOZ LOSARTAN HCT,SANDOZ CANADA INCORPORATED,LOSARTAN HCT,HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM,12.5MG; 50MG,100FCT BO,ORAL; ORAL,Resolved,TABLET,,2023-05-01,2023-05-12,2023-05-08,Disruption of the manufacture of the drug.,2023-05-01,2023-05-09,No
182567,02521105,Shortage,SANDOZ LURASIDONE,SANDOZ CANADA INCORPORATED,LURASIDONE,LURASIDONE HYDROCHLORIDE,60MG,30FCT,ORAL,Resolved,TABLET,,2023-01-25,2023-02-24,2023-02-10,Demand increase for the drug.,2023-01-27,2023-03-06,No
191379,02521075,Shortage,SANDOZ LURASIDONE,SANDOZ CANADA INCORPORATED,LURASIDONE,LURASIDONE HYDROCHLORIDE,20MG,30FCT BO,ORAL,Resolved,TABLET,,2023-05-01,2023-05-12,2023-05-15,Demand increase for the drug.,2023-05-01,2023-05-16,No
190151,02521105,Shortage,SANDOZ LURASIDONE,SANDOZ CANADA INCORPORATED,LURASIDONE,LURASIDONE HYDROCHLORIDE,60MG,30FCT BO,ORAL,Resolved,TABLET,,2023-04-21,2023-05-19,2023-05-15,Demand increase for the drug.,2023-04-21,2023-05-16,No
201267,02246820,Shortage,SANDOZ METFORMIN FC,SANDOZ CANADA INCORPORATED,METFORMIN FC,METFORMIN HYDROCHLORIDE,500MG,500FCT BO,ORAL; ORAL,Resolved,TABLET,,2023-08-07,2023-08-11,2023-08-14,Disruption of the manufacture of the drug.,2023-08-07,2023-08-15,No
204121,02246820,Shortage,SANDOZ METFORMIN FC,SANDOZ CANADA INCORPORATED,METFORMIN FC,METFORMIN HYDROCHLORIDE,500MG,500FCT,ORAL; ORAL,Resolved,TABLET,,2023-09-11,2023-09-22,2023-09-25,Delay in shipping of the drug.,2023-09-11,2023-09-26,No
200539,02246820,Shortage,SANDOZ METFORMIN FC,SANDOZ CANADA INCORPORATED,METFORMIN,METFORMIN HYDROCHLORIDE,500MG,100FCT BO,ORAL; ORAL,Resolved,TABLET,,2023-07-31,2023-08-04,2023-08-07,Disruption of the manufacture of the drug.,2023-07-31,2023-08-08,No
210849,02246821,Shortage,SANDOZ METFORMIN FC,SANDOZ CANADA INCORPORATED,METFORMIN,METFORMIN HYDROCHLORIDE,850MG,500FCT,ORAL; ORAL,Resolved,TABLET,,2023-11-20,2023-12-01,2023-11-27,Disruption of the manufacture of the drug.,2023-11-20,2023-11-28,No
203185,02456257,Shortage,SANDOZ MIGLUSTAT,SANDOZ CANADA INCORPORATED,MIGLUSTAT,MIGLUSTAT,100MG,90HGC,ORAL,Resolved,CAPSULE,,2023-08-29,2023-09-01,2023-09-05,Requirements related to complying with good manufacturing practices.,2023-08-29,2023-09-06,No
188660,02456257,Shortage,SANDOZ MIGLUSTAT,SANDOZ CANADA INCORPORATED,MIGLUSTAT,MIGLUSTAT,100MG,90HGC,ORAL,Resolved,CAPSULE,,2023-04-04,2023-05-05,2023-05-08,Disruption of the manufacture of the drug.,2023-04-04,2023-05-09,No
189795,02250608,Shortage,SANDOZ MIRTAZAPINE,SANDOZ CANADA INCORPORATED,MIRTAZAPINE,MIRTAZAPINE,30MG,100FCT,ORAL; ORAL,Resolved,TABLET,,2023-04-17,2023-05-05,2023-05-01,Delay in shipping of the drug.,2023-04-18,2023-05-03,No
193045,02449811,Shortage,SANDOZ MOMETASONE,SANDOZ CANADA INCORPORATED,MOMETASONE,MOMETASONE FUROATE,50MCG,140DOS,NASAL; NASAL,Resolved,"SPRAY, METERED DOSE",,2023-05-22,2023-06-02,2023-05-30,Delay in shipping of the drug.,2023-05-25,2023-05-31,No
193735,02449811,Shortage,SANDOZ MOMETASONE,SANDOZ CANADA INCORPORATED,MOMETASONE,MOMETASONE FUROATE,50MCG,140DOS LSP,NASAL; NASAL,Resolved,"SPRAY, METERED DOSE",,2023-06-05,2023-06-16,2023-06-12,Delay in shipping of the drug.,2023-06-05,2023-06-13,No
186067,02449811,Shortage,SANDOZ MOMETASONE,SANDOZ CANADA INCORPORATED,MOMETASONE,MOMETASONE FUROATE,50MCG,140DOS,NASAL; NASAL,Resolved,"SPRAY, METERED DOSE",,2023-02-17,2023-03-17,2023-03-20,Disruption of the manufacture of the drug.,2023-03-02,2023-03-21,No
193742,02330393,Shortage,SANDOZ MONTELUKAST,SANDOZ CANADA INCORPORATED,MONTELUKAST,MONTELUKAST,5MG,100CHT BO,ORAL; ORAL,Resolved,TABLET (CHEWABLE),,2023-06-05,2023-06-09,2023-06-05,Requirements related to complying with good manufacturing practices.,2023-06-05,2023-06-06,No
184255,02244790,Shortage,SANDOZ MORPHINE SR,SANDOZ CANADA INCORPORATED,MORPHINE SR,MORPHINE SULFATE,15MG,100PRT,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-02-09,2023-02-27,2023-02-27,Disruption of the manufacture of the drug.,2023-02-09,2023-03-06,No
193049,02313855,Shortage,SANDOZ MYCOPHENOLATE MOFETIL,SANDOZ CANADA INCORPORATED,MYCOPHENOLATE,MYCOPHENOLATE MOFETIL,500MG,50FCT,ORAL; ORAL,Resolved,TABLET,,2023-05-22,2023-06-16,2023-06-19,Shortage of an active ingredient.,2023-05-25,2023-06-20,No
182816,02313855,Shortage,SANDOZ MYCOPHENOLATE MOFETIL,SANDOZ CANADA INCORPORATED,MYCOPHENOLATE MOFETIL,MYCOPHENOLATE MOFETIL,500MG,50FCT,ORAL; ORAL,Resolved,TABLET,,2023-01-31,2023-03-03,2023-02-08,Shortage of an inactive ingredient or component.,2023-01-31,2023-02-09,No
207767,02313855,Shortage,SANDOZ MYCOPHENOLATE MOFETIL,SANDOZ CANADA INCORPORATED,MYCOPHENOLATE MOFETIL,MYCOPHENOLATE MOFETIL,500MG,50 FCT,ORAL; ORAL,Resolved,TABLET,,2023-10-23,2023-11-03,2023-10-30,Disruption of the manufacture of the drug.,2023-10-23,2023-10-31,No
193387,02322323,Shortage,SANDOZ NARATRIPTAN,SANDOZ CANADA INCORPORATED,NARATRIPTAN,NARATRIPTAN,2.5MG,9FCT,ORAL; ORAL,Resolved,TABLET; TABLET,,2023-05-30,2023-06-19,2023-06-05,Requirements related to complying with good manufacturing practices.,2023-05-30,2023-06-06,No
203189,02322323,Shortage,SANDOZ NARATRIPTAN,SANDOZ CANADA INCORPORATED,NARATRIPTAN,NARATRIPTAN,2.5MG,9FCT,ORAL; ORAL,Resolved,TABLET; TABLET,,2023-08-29,2023-09-08,2023-09-11,Disruption of the manufacture of the drug.,2023-08-29,2023-09-12,No
196636,02310392,Shortage,SANDOZ OLANZAPINE,SANDOZ CANADA INCORPORATED,OLANZAPINE,OLANZAPINE,15.0MG,100FCT BO,ORAL; ORAL,Resolved,TABLET,,2023-06-27,2024-02-23,2024-02-26,Disruption of the manufacture of the drug.,2023-06-27,2024-02-27,No
182571,02310384,Shortage,SANDOZ OLANZAPINE,SANDOZ CANADA INCORPORATED,OLANZAPINE,OLANZAPINE,10.0MG,100FCT,ORAL; ORAL,Resolved,TABLET,,2023-01-25,2023-02-03,2023-02-08,Shortage of an inactive ingredient or component.,2023-01-27,2023-02-09,No
201270,02310341,Shortage,SANDOZ OLANZAPINE,SANDOZ CANADA INCORPORATED,OLANZAPINE,OLANZAPINE,2.5MG,100FCT BO,ORAL; ORAL,Resolved,TABLET,,2023-08-07,2024-02-16,2024-02-19,Shortage of an active ingredient.,2023-08-07,2024-02-19,No
205802,02310384,Shortage,SANDOZ OLANZAPINE,SANDOZ CANADA INCORPORATED,Olanzapine,OLANZAPINE,10.0MG,100FCT,ORAL; ORAL,Resolved,TABLET,,2023-10-02,2024-02-16,2024-02-19,Requirements related to complying with good manufacturing practices.,2023-10-02,2024-02-19,No
202544,02327775,Shortage,SANDOZ OLANZAPINE ODT,SANDOZ CANADA INCORPORATED,OLANZAPINE ODT,OLANZAPINE,5MG,30 UD,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-08-21,2023-10-13,2023-10-16,Shortage of an active ingredient.,2023-08-21,2023-10-17,No
199817,02327805,Shortage,SANDOZ OLANZAPINE ODT,SANDOZ CANADA INCORPORATED,OLANZAPINE ODT,OLANZAPINE,20MG,30 UD,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-07-24,2023-09-15,2023-09-19,Shortage of an active ingredient.,2023-07-24,2023-09-20,No
204741,02327791,Shortage,SANDOZ OLANZAPINE ODT,SANDOZ CANADA INCORPORATED,OLANZAPINE ODT,OLANZAPINE,15MG,30 UD,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-09-19,2023-10-13,2023-10-16,Shortage of an active ingredient.,2023-09-19,2023-10-17,No
212451,02327791,Shortage,SANDOZ OLANZAPINE ODT,SANDOZ CANADA INCORPORATED,OLANZAPINE ODT,OLANZAPINE,15MG,30UD,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-12-04,2024-01-12,2023-12-22,Shortage of an active ingredient.,2023-12-04,2024-01-03,No
205814,02296438,Shortage,SANDOZ OMEPRAZOLE,SANDOZ CANADA INCORPORATED,Omeprazole,OMEPRAZOLE,10MG,30GRC,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-10-02,,2023-10-18,Disruption of the manufacture of the drug.,2023-10-02,2023-10-19,No
210064,02243559,Shortage,SANDOZ ORPHENADRINE,SANDOZ CANADA INCORPORATED,ORPHENADRINE,ORPHENADRINE CITRATE,100MG,100 PRT BO,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-11-13,2023-12-15,2023-12-04,Disruption of the manufacture of the drug.,2023-11-13,2023-12-05,No
201744,02470411,Shortage,SANDOZ PERINDOPRIL ERBUMINE/ INDAPAMIDE LD,SANDOZ CANADA INCORPORATED,PERINDOPRIL ERBUMINE/ INDAPAMIDE LD,INDAPAMIDE; PERINDOPRIL ERBUMINE,0.625MG; 2MG,30TAB,ORAL; ORAL,Resolved,TABLET,,2023-08-14,2023-09-01,2023-09-05,Disruption of the manufacture of the drug.,2023-08-14,2023-09-06,No
195434,02496259,Shortage,SANDOZ POSACONAZOLE,SANDOZ CANADA INCORPORATED,POSACONAZOLE,POSACONAZOLE,100MG,60 GRT BO,ORAL,Resolved,TABLET (DELAYED-RELEASE),,2023-06-19,2023-07-07,2023-07-10,Disruption of the manufacture of the drug.,2023-06-19,2023-07-11,No
205805,02496259,Shortage,SANDOZ POSACONAZOLE,SANDOZ CANADA INCORPORATED,Posaconazole,POSACONAZOLE,100MG,60GRT,ORAL,Resolved,TABLET (DELAYED-RELEASE),,2023-10-02,2023-10-20,2023-10-16,Delay in shipping of the drug.,2023-10-02,2023-10-17,No
189798,01916203,Shortage,SANDOZ PREDNISOLONE,SANDOZ CANADA INCORPORATED,PREDNISOLONE,PREDNISOLONE ACETATE,1%,5ML LDP,OPHTHALMIC; OPHTHALMIC,Resolved,SUSPENSION,,2023-04-17,2023-05-19,2023-05-22,Demand increase for the drug.,2023-04-18,2023-05-25,No
192007,02390825,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,50MG,100HGC,ORAL; ORAL,Resolved,CAPSULE,,2023-05-08,2023-05-19,2023-05-15,Disruption of the manufacture of the drug.,2023-05-08,2023-05-16,No
193053,02390817,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,25MG,100HGC,ORAL; ORAL,Resolved,CAPSULE,,2023-05-22,2023-06-09,2023-06-12,Disruption of the manufacture of the drug.,2023-05-25,2023-06-13,No
189226,02390825,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,50MG,500 HGC BO,ORAL; ORAL,Resolved,CAPSULE,,2023-04-11,2023-05-12,2023-05-15,Disruption of the manufacture of the drug.,2023-04-11,2023-05-16,No
201277,02390841,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,150MG,500HGC BO,ORAL; ORAL,Resolved,CAPSULE,,2023-08-07,2023-09-15,2023-09-11,Demand increase for the drug.,2023-08-07,2023-09-12,No
186975,02390841,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,150MG,100HGC,ORAL; ORAL,Resolved,CAPSULE,,2023-03-13,2023-05-19,2023-05-15,Disruption of the manufacture of the drug.,2023-03-13,2023-05-16,No
197984,02390825,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,50MG,100HGC BO,ORAL; ORAL,Resolved,CAPSULE,,2023-07-10,2023-08-04,2023-08-07,Disruption of the manufacture of the drug.,2023-07-10,2023-08-08,No
197990,02390825,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,50MG,500HGC BO,ORAL; ORAL,Resolved,CAPSULE,,2023-07-10,2023-08-04,2023-08-07,Disruption of the manufacture of the drug.,2023-07-10,2023-08-08,No
208549,02390825,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,50MG,100HGC,ORAL; ORAL,Resolved,CAPSULE,,2023-10-30,2023-11-10,2023-11-13,Requirements related to complying with good manufacturing practices.,2023-10-30,2023-11-14,No
208556,02390825,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,50MG,500HGC,ORAL; ORAL,Resolved,CAPSULE,,2023-10-30,2023-11-10,2023-11-13,Requirements related to complying with good manufacturing practices.,2023-10-30,2023-11-14,No
186289,02390817,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,25MG,500HGC BO,ORAL; ORAL,Resolved,CAPSULE,,2023-03-06,2023-05-12,2023-05-15,Disruption of the manufacture of the drug.,2023-03-06,2023-05-16,No
186297,02390841,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,150MG,500HGC,ORAL; ORAL,Resolved,CAPSULE,,2023-03-06,2023-05-19,2023-05-15,Requirements related to complying with good manufacturing practices.,2023-03-06,2023-05-16,No
204744,02390833,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,75MG,100HGC,ORAL; ORAL,Resolved,CAPSULE,,2023-09-19,2023-10-13,2023-10-16,Disruption of the manufacture of the drug.,2023-09-19,2023-10-17,No
181713,02390817,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,25MG,500HGC,ORAL; ORAL,Resolved,CAPSULE,,2023-01-18,2023-02-10,2023-02-14,Disruption of the manufacture of the drug.,2023-01-19,2023-02-15,No
194773,02390841,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,PREGABALIN,PREGABALIN,150MG,500HGC BO,ORAL; ORAL,Resolved,CAPSULE,,2023-06-12,2023-07-14,2023-07-10,Disruption of the manufacture of the drug.,2023-06-12,2023-07-11,No
205808,02390833,Shortage,SANDOZ PREGABALIN,SANDOZ CANADA INCORPORATED,Pregabalin,PREGABALIN,75MG,500HGC,ORAL; ORAL,Resolved,CAPSULE,,2023-10-02,2023-10-20,2023-10-16,Disruption of the manufacture of the drug.,2023-10-02,2023-10-17,No
192014,02314185,Shortage,SANDOZ RABEPRAZOLE,SANDOZ CANADA INCORPORATED,RABEPRAZOLE,RABEPRAZOLE SODIUM,20MG,500GRT,ORAL; ORAL,Resolved,TABLET (ENTERIC-COATED),,2023-05-08,2023-05-26,2023-05-22,Disruption of the manufacture of the drug.,2023-05-08,2023-05-25,No
184639,02314177,Shortage,SANDOZ RABEPRAZOLE,SANDOZ CANADA INCORPORATED,RABEPRAZOLE,RABEPRAZOLE SODIUM,10MG,100GRT,ORAL; ORAL,Resolved,TABLET (ENTERIC-COATED),,2023-02-14,2023-03-03,2023-02-24,Disruption of the manufacture of the drug.,2023-02-14,2023-03-03,No
209224,02314185,Shortage,SANDOZ RABEPRAZOLE,SANDOZ CANADA INCORPORATED,RABEPRAZOLE,RABEPRAZOLE SODIUM,20MG,500 GRT BO,ORAL; ORAL,Actual shortage,TABLET (ENTERIC-COATED),,2023-11-06,2024-06-07,,Disruption of the manufacture of the drug.,2023-11-06,2024-03-11,No
207773,02314185,Shortage,SANDOZ RABEPRAZOLE,SANDOZ CANADA INCORPORATED,RABEPRAZOLE,RABEPRAZOLE SODIUM,20MG,100 GRT BO,ORAL; ORAL,Resolved,TABLET (ENTERIC-COATED),,2023-10-23,2023-12-08,2023-12-13,Disruption of the manufacture of the drug.,2023-10-23,2023-12-14,No
198817,02314177,Shortage,SANDOZ RABEPRAZOLE,SANDOZ CANADA INCORPORATED,RABEPRAZOLE,RABEPRAZOLE SODIUM,10MG,100GRT BO,ORAL; ORAL,Resolved,TABLET (ENTERIC-COATED),,2023-07-17,2023-08-11,2023-07-31,Disruption of the manufacture of the drug.,2023-07-17,2023-08-01,No
188067,02314185,Shortage,SANDOZ RABEPRAZOLE,SANDOZ CANADA INCORPORATED,RABEPRAZOLE,RABEPRAZOLE SODIUM,20MG,100 GRT,ORAL; ORAL,Resolved,TABLET (ENTERIC-COATED),,2023-03-27,2023-04-07,2023-04-11,Disruption of the manufacture of the drug.,2023-03-27,2023-04-12,No
212457,02314185,Shortage,SANDOZ RABEPRAZOLE,SANDOZ CANADA INCORPORATED,RABEPRAZOLE,RABEPRAZOLE SODIUM,20MG,30GRT,ORAL; ORAL,Resolved,TABLET (ENTERIC-COATED),,2023-12-04,2023-12-22,2023-12-19,Disruption of the manufacture of the drug.,2023-12-04,2023-12-20,No
201283,02327295,Shortage,SANDOZ RISEDRONATE,SANDOZ CANADA INCORPORATED,RISEDRONATE,RISEDRONATE SODIUM,35MG,30FCT BO,ORAL; ORAL,Resolved,TABLET,,2023-08-07,2023-09-01,2023-08-29,Disruption of the manufacture of the drug.,2023-08-07,2023-08-30,No
182578,02279819,Shortage,SANDOZ RISPERIDONE,SANDOZ CANADA INCORPORATED,RISPERIDONE,RISPERIDONE,2MG,100FCT,ORAL; ORAL,Resolved,TABLET,,2023-01-25,2023-03-17,2023-03-06,Disruption of the manufacture of the drug.,2023-01-27,2023-03-07,No
195422,02279827,Shortage,SANDOZ RISPERIDONE,SANDOZ CANADA INCORPORATED,RISPERIDONE,RISPERIDONE,3MG,250 FCT BO,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-08-04,2023-07-17,Disruption of the manufacture of the drug.,2023-06-19,2023-07-18,No
193391,02279819,Shortage,SANDOZ RISPERIDONE,SANDOZ CANADA INCORPORATED,RISPERIDONE,RISPERIDONE,2MG,500FCT,ORAL; ORAL,Resolved,TABLET,,2023-05-30,2023-06-16,2023-06-19,Disruption of the manufacture of the drug.,2023-05-30,2023-06-20,No
186981,02324571,Shortage,SANDOZ RIVASTIGMINE,SANDOZ CANADA INCORPORATED,RIVASTIGMINE,RIVASTIGMINE,3MG,100HGC,ORAL; ORAL,Resolved,CAPSULE,,2023-03-13,2023-03-31,2023-04-04,Disruption of the manufacture of the drug.,2023-03-13,2023-04-05,No
188070,02324563,Shortage,SANDOZ RIVASTIGMINE,SANDOZ CANADA INCORPORATED,RIVASTIGMINE,RIVASTIGMINE,1.5MG,56 HGC,ORAL; ORAL,Resolved,CAPSULE,,2023-03-27,2023-03-31,2023-04-04,Delay in shipping of the drug.,2023-03-27,2023-04-05,No
186300,02324563,Shortage,SANDOZ RIVASTIGMINE,SANDOZ CANADA INCORPORATED,RIVASTIGMINE,RIVASTIGMINE,1.5MG,100HGC,ORAL; ORAL,Resolved,CAPSULE,,2023-03-06,2023-03-31,2023-04-04,Delay in shipping of the drug.,2023-03-06,2023-04-05,No
190154,02426307,Shortage,SANDOZ RIVASTIGMINE PATCH 10,SANDOZ CANADA INCORPORATED,RIVASTIGMINE PATCH 10,RIVASTIGMINE,9.5MG,30TTSM,TRANSDERMAL; TRANSDERMAL,Resolved,PATCH,,2023-04-21,2023-06-09,2023-06-06,Shortage of an inactive ingredient or component.,2023-04-21,2023-06-07,No
182820,02338742,Shortage,SANDOZ ROSUVASTATIN,SANDOZ CANADA INCORPORATED,ROSUVASTATIN,ROSUVASTATIN,20MG,100FCT,ORAL; ORAL,Resolved,TABLET,,2023-01-31,2023-06-02,2023-06-05,Disruption of the manufacture of the drug.,2023-01-31,2023-06-06,No
201286,02338726,Shortage,SANDOZ ROSUVASTATIN,SANDOZ CANADA INCORPORATED,ROSUVASTATIN,ROSUVASTATIN,5MG,500FCT BO,ORAL; ORAL,Resolved,TABLET,,2023-08-07,2023-08-18,2023-08-21,Disruption of the manufacture of the drug.,2023-08-07,2023-08-22,No
206693,02338750,Shortage,SANDOZ ROSUVASTATIN,SANDOZ CANADA INCORPORATED,ROSUVASTATIN,ROSUVASTATIN,40MG,100 FCT BO,ORAL; ORAL,Resolved,TABLET,,2023-10-10,2024-02-16,2024-02-20,Disruption of the manufacture of the drug.,2023-10-10,2024-02-21,No
206697,02338726,Shortage,SANDOZ ROSUVASTATIN,SANDOZ CANADA INCORPORATED,ROSUVASTATIN,ROSUVASTATIN,5MG,100 FCT BO,ORAL; ORAL,Resolved,TABLET,,2023-10-10,2023-11-24,2023-11-27,Disruption of the manufacture of the drug.,2023-10-10,2023-11-28,No
186303,02338742,Shortage,SANDOZ ROSUVASTATIN,SANDOZ CANADA INCORPORATED,ROSUVASTATIN,ROSUVASTATIN,20MG,30FCT,ORAL; ORAL,Resolved,TABLET,,2023-03-06,2023-08-18,2023-08-07,Disruption of the manufacture of the drug.,2023-03-06,2023-08-08,No
181716,02338750,Shortage,SANDOZ ROSUVASTATIN,SANDOZ CANADA INCORPORATED,ROSUVASTATIN,ROSUVASTATIN,40MG,30FCT,ORAL; ORAL,Resolved,TABLET,,2023-01-18,2023-03-17,2023-03-13,Disruption of the manufacture of the drug.,2023-01-19,2023-03-14,No
181719,02338726,Shortage,SANDOZ ROSUVASTATIN,SANDOZ CANADA INCORPORATED,ROSUVASTATIN,ROSUVASTATIN,5MG,500FCT,ORAL; ORAL,Resolved,TABLET,,2023-01-18,2023-02-10,2023-02-14,Disruption of the manufacture of the drug.,2023-01-19,2023-02-15,No
201289,02475448,Shortage,SANDOZ SILODOSIN,SANDOZ CANADA INCORPORATED,SILODOSIN,SILODOSIN,8MG,100HGC BO,ORAL,Resolved,CAPSULE,,2023-08-07,2023-08-11,2023-08-14,Disruption of the manufacture of the drug.,2023-08-07,2023-08-15,No
198824,02475421,Shortage,SANDOZ SILODOSIN,SANDOZ CANADA INCORPORATED,SILODOSIN,SILODOSIN,4MG,30HGC BO,ORAL,Resolved,CAPSULE,,2023-07-17,2023-08-11,2023-08-14,Demand increase for the drug.,2023-07-17,2023-08-15,No
186073,02475448,Shortage,SANDOZ SILODOSIN,SANDOZ CANADA INCORPORATED,SILODOSIN,SILODOSIN,8MG,100HGC,ORAL,Resolved,CAPSULE,,2023-02-17,2023-03-17,2023-03-13,Disruption of the manufacture of the drug.,2023-03-02,2023-03-20,No
188665,02475448,Shortage,SANDOZ SILODOSIN,SANDOZ CANADA INCORPORATED,SILODOSIN,SILODOSIN,8MG,100HGC,ORAL,Resolved,CAPSULE,,2023-04-04,2023-07-14,2023-07-17,Disruption of the manufacture of the drug.,2023-04-04,2023-07-18,No
193057,02503956,Shortage,SANDOZ SITAGLIPTIN-METFORMIN,SANDOZ CANADA INCORPORATED,SITAGLIPTIN-METFORMIN,METFORMIN HYDROCHLORIDE; SITAGLIPTIN,500MG; 50MG,500FCT,ORAL,Resolved,TABLET,,2023-05-22,2023-07-07,2023-07-10,Disruption of the manufacture of the drug.,2023-05-25,2023-07-11,No
213821,02503956,Shortage,SANDOZ SITAGLIPTIN-METFORMIN,SANDOZ CANADA INCORPORATED,SITAGLIPTIN-METFORMIN,METFORMIN HYDROCHLORIDE; SITAGLIPTIN,500MG; 50MG,60FCT,ORAL,Resolved,TABLET,,2023-12-19,2024-02-02,2024-01-23,Disruption of the manufacture of the drug.,2023-12-19,2024-01-24,No
198833,02503964,Shortage,SANDOZ SITAGLIPTIN-METFORMIN,SANDOZ CANADA INCORPORATED,SITAGLIPTIN-METFORMIN,METFORMIN HYDROCHLORIDE; SITAGLIPTIN,850MG; 50MG,60FCT BO,ORAL,Resolved,TABLET,,2023-07-17,2023-08-04,2023-08-07,Shortage of an active ingredient.,2023-07-17,2023-08-08,No
198838,02503972,Shortage,SANDOZ SITAGLIPTIN-METFORMIN,SANDOZ CANADA INCORPORATED,SITAGLIPTIN-METFORMIN,METFORMIN HYDROCHLORIDE; SITAGLIPTIN,1000MG; 50MG,60FCT BO,ORAL,Resolved,TABLET,,2023-07-17,2023-08-25,2023-08-29,Shortage of an active ingredient.,2023-07-17,2023-08-30,No
203193,02503956,Shortage,SANDOZ SITAGLIPTIN-METFORMIN,SANDOZ CANADA INCORPORATED,SITAGLIPTIN-METFORMIN,METFORMIN HYDROCHLORIDE; SITAGLIPTIN,500MG; 50MG,60FCT,ORAL,Resolved,TABLET,,2023-08-29,2023-09-29,2023-09-25,Disruption of the manufacture of the drug.,2023-08-29,2023-09-26,No
205811,02503956,Shortage,SANDOZ SITAGLIPTIN-METFORMIN,SANDOZ CANADA INCORPORATED,Sitagliptin-metformin,METFORMIN HYDROCHLORIDE; SITAGLIPTIN,500MG; 50MG,500FCT,ORAL,Resolved,TABLET,,2023-10-02,,2023-10-10,Delay in shipping of the drug.,2023-10-02,2023-10-11,No
201755,02399040,Shortage,SANDOZ SOLIFENACIN,SANDOZ CANADA INCORPORATED,SOLIFENACIN,SOLIFENACIN SUCCINATE,10MG,100FCT BO,ORAL; ORAL,Resolved,TABLET,,2023-08-14,2023-10-20,2023-10-23,Disruption of the manufacture of the drug.,2023-08-14,2023-10-24,No
193060,02399040,Shortage,SANDOZ SOLIFENACIN,SANDOZ CANADA INCORPORATED,SOLIFENACIN,SOLIFENACIN SUCCINATE,10MG,30FCT,ORAL; ORAL,Resolved,TABLET,,2023-05-22,2023-08-18,2023-08-21,Disruption of the manufacture of the drug.,2023-05-25,2023-08-22,No
186985,02399040,Shortage,SANDOZ SOLIFENACIN,SANDOZ CANADA INCORPORATED,SOLIFENACIN,SOLIFENACIN SUCCINATE,10MG,100FCT,ORAL; ORAL,Resolved,TABLET,,2023-03-13,2023-03-31,2023-03-20,Disruption of the manufacture of the drug.,2023-03-13,2023-03-21,No
193395,02399032,Shortage,SANDOZ SOLIFENACIN,SANDOZ CANADA INCORPORATED,SOLIFENACIN,SOLIFENACIN SUCCINATE,5MG,100FCT,ORAL; ORAL,Resolved,TABLET,,2023-05-30,2023-10-20,2023-10-23,Disruption of the manufacture of the drug.,2023-05-30,2023-10-24,No
204748,02399032,Shortage,SANDOZ SOLIFENACIN,SANDOZ CANADA INCORPORATED,SOLIFENACIN,SOLIFENACIN SUCCINATE,5MG,30FCT,ORAL; ORAL,Resolved,TABLET,,2023-09-19,2023-10-13,2023-10-16,Disruption of the manufacture of the drug.,2023-09-19,2023-10-17,No
207776,02416816,Shortage,SANDOZ TACROLIMUS,SANDOZ CANADA INCORPORATED,TACROLIMUS,TACROLIMUS,0.5MG,100 HGC BO,ORAL; ORAL,Resolved,CAPSULE (IMMEDIATE RELEASE),,2023-10-23,2023-11-03,2023-10-30,Disruption of the manufacture of the drug.,2023-10-23,2023-10-31,No
196790,02319217,Shortage,SANDOZ TAMSULOSIN,SANDOZ CANADA INCORPORATED,TAMSULOSIN,TAMSULOSIN HYDROCHLORIDE,0.4MG,100PRCH BO,ORAL; ORAL,Resolved,CAPSULE (SUSTAINED-RELEASE),,2023-06-28,2024-04-19,2024-04-19,Disruption of the manufacture of the drug.,2023-06-28,2024-04-20,Yes
192018,02340208,Shortage,SANDOZ TAMSULOSIN CR,SANDOZ CANADA INCORPORATED,TAMSULOSIN CR,TAMSULOSIN HYDROCHLORIDE,0.4MG,500PRT,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-05-08,2023-06-16,2023-06-19,Disruption of the manufacture of the drug.,2023-05-08,2023-06-20,No
182582,02340208,Shortage,SANDOZ TAMSULOSIN CR,SANDOZ CANADA INCORPORATED,TAMSULOSIN CR,TAMSULOSIN HYDROCHLORIDE,0.4MG,100PRT,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-01-25,2023-02-24,2023-02-17,Disruption of the manufacture of the drug.,2023-01-27,2023-03-02,No
192570,02340208,Shortage,SANDOZ TAMSULOSIN CR,SANDOZ CANADA INCORPORATED,TAMSULOSIN CR,TAMSULOSIN HYDROCHLORIDE,0.4MG,100PRT,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-05-15,2023-05-26,2023-05-22,Delay in shipping of the drug.,2023-05-16,2023-05-25,No
205156,02340208,Shortage,SANDOZ TAMSULOSIN CR,SANDOZ CANADA INCORPORATED,TAMSULOSIN CR,TAMSULOSIN HYDROCHLORIDE,0.4MG,100PRT,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-09-25,2024-01-12,2024-01-17,Disruption of the manufacture of the drug.,2023-09-25,2024-01-18,No
189801,02340208,Shortage,SANDOZ TAMSULOSIN CR,SANDOZ CANADA INCORPORATED,TAMSULOSIN CR,TAMSULOSIN HYDROCHLORIDE,0.4MG,100PRT,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-04-17,2023-05-05,2023-05-01,Disruption of the manufacture of the drug.,2023-04-18,2023-05-03,No
197996,02340208,Shortage,SANDOZ TAMSULOSIN CR,SANDOZ CANADA INCORPORATED,TAMSULOSIN CR,TAMSULOSIN HYDROCHLORIDE,0.4MG,500PRT BO,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-07-10,2023-07-28,2023-07-31,Demand increase for the drug.,2023-07-10,2023-08-01,No
206701,02340208,Shortage,SANDOZ TAMSULOSIN CR,SANDOZ CANADA INCORPORATED,TAMSULOSIN CR,TAMSULOSIN HYDROCHLORIDE,0.4MG,500 PRT BO,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-10-10,2023-11-03,2023-10-30,Disruption of the manufacture of the drug.,2023-10-10,2023-10-31,No
199832,02340208,Shortage,SANDOZ TAMSULOSIN CR,SANDOZ CANADA INCORPORATED,TAMSULOSIN CR,TAMSULOSIN HYDROCHLORIDE,0.4MG,100PRT,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-07-24,2023-07-28,2023-07-31,Disruption of the manufacture of the drug.,2023-07-24,2023-08-01,No
186077,02340208,Shortage,SANDOZ TAMSULOSIN CR,SANDOZ CANADA INCORPORATED,TAMSULOSIN CR,TAMSULOSIN HYDROCHLORIDE,0.4MG,500PRT,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-02-17,2023-03-17,2023-03-20,Disruption of the manufacture of the drug.,2023-03-02,2023-03-21,No
188668,02340208,Shortage,SANDOZ TAMSULOSIN CR,SANDOZ CANADA INCORPORATED,TAMSULOSIN CR,TAMSULOSIN HYDROCHLORIDE,0.4MG,500PRT,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-04-04,2023-05-05,2023-05-01,Disruption of the manufacture of the drug.,2023-04-04,2023-05-03,No
195416,02375966,Shortage,SANDOZ TELMISARTAN,SANDOZ CANADA INCORPORATED,TELMISARTAN,TELMISARTAN,80MG,100 TAB BO,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-06-30,2023-06-27,Requirements related to complying with good manufacturing practices.,2023-06-19,2023-06-28,No
186990,02375966,Shortage,SANDOZ TELMISARTAN,SANDOZ CANADA INCORPORATED,TELMISARTAN,TELMISARTAN,80MG,100TAB,ORAL; ORAL,Resolved,TABLET,,2023-03-13,2023-03-24,2023-03-27,Delay in shipping of the drug.,2023-03-13,2023-03-28,No
208559,02375958,Shortage,SANDOZ TELMISARTAN,SANDOZ CANADA INCORPORATED,TELMISARTAN,TELMISARTAN,40MG,100TAB,ORAL; ORAL,Resolved,TABLET,,2023-10-30,2023-11-03,2023-11-06,Demand increase for the drug.,2023-10-30,2023-11-07,No
196793,02375966,Shortage,SANDOZ TELMISARTAN,SANDOZ CANADA INCORPORATED,TELMISARTAN,TELMISARTAN,80MG,500TAB BO,ORAL; ORAL,Resolved,TABLET,,2023-06-28,2023-06-30,2023-07-04,Requirements related to complying with good manufacturing practices.,2023-06-28,2023-07-05,No
181722,02375958,Shortage,SANDOZ TELMISARTAN,SANDOZ CANADA INCORPORATED,TELMISARTAN,TELMISARTAN,40MG,500TAB,ORAL; ORAL,Resolved,TABLET,,2023-01-18,2023-01-27,2023-01-31,Delay in shipping of the drug.,2023-01-19,2023-02-01,No
181726,02375966,Shortage,SANDOZ TELMISARTAN,SANDOZ CANADA INCORPORATED,TELMISARTAN,TELMISARTAN,80MG,500TAB,ORAL; ORAL,Resolved,TABLET,,2023-01-18,2023-02-17,2023-02-24,Delay in shipping of the drug.,2023-01-19,2023-03-03,No
201762,02393565,Shortage,SANDOZ TELMISARTAN HCT,SANDOZ CANADA INCORPORATED,TELMISARTAN HCT,HYDROCHLOROTHIAZIDE; TELMISARTAN,25MG; 80MG,100FCT BO,ORAL; ORAL,Resolved,TABLET,,2023-08-14,2023-09-15,2023-09-19,Delay in shipping of the drug.,2023-08-14,2023-09-20,No
206704,02393557,Shortage,SANDOZ TELMISARTAN HCT,SANDOZ CANADA INCORPORATED,TELMISARTAN HCT,HYDROCHLOROTHIAZIDE; TELMISARTAN,12.5MG; 80MG,100 FCT BO,ORAL; ORAL,Resolved,TABLET,,2023-10-10,2023-10-13,2023-10-16,Delay in shipping of the drug.,2023-10-10,2023-10-17,No
198849,02393557,Shortage,SANDOZ TELMISARTAN HCT,SANDOZ CANADA INCORPORATED,TELMISARTAN HCT,HYDROCHLOROTHIAZIDE; TELMISARTAN,12.5MG; 80MG,30FCT BO,ORAL; ORAL,Resolved,TABLET,,2023-07-17,2023-08-04,2023-08-07,Demand increase for the drug.,2023-07-17,2023-08-08,No
193737,02393557,Shortage,SANDOZ TELMISARTAN HCT,SANDOZ CANADA INCORPORATED,TELMISARTAN HCT,HYDROCHLOROTHIAZIDE; TELMISARTAN,12.5MG; 80MG,100FCT BO,ORAL; ORAL,Resolved,TABLET,,2023-06-05,2023-07-21,2023-07-24,Disruption of the manufacture of the drug.,2023-06-05,2023-07-25,No
181729,02166712,Shortage,SANDOZ TIMOLOL,SANDOZ CANADA INCORPORATED,TIMOLOL,TIMOLOL,0.25%,10ML,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,,2023-01-18,2023-04-28,2023-04-21,Disruption of the manufacture of the drug.,2023-01-19,2023-04-22,No
209227,02241755,Shortage,SANDOZ TOBRAMYCIN,SANDOZ CANADA INCORPORATED,TOBRAMYCIN,TOBRAMYCIN,0.30%,5 ML LDP,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,,2023-11-06,2023-11-17,2023-11-13,Demand increase for the drug.,2023-11-06,2023-11-14,No
198853,02241755,Shortage,SANDOZ TOBRAMYCIN,SANDOZ CANADA INCORPORATED,TOBRAMYCIN,TOBRAMYCIN,0.30%,5ML LDP V2,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,,2023-07-17,2023-07-21,2023-07-24,Demand increase for the drug.,2023-07-17,2023-07-25,No
181733,02356767,Shortage,SANDOZ VALSARTAN,SANDOZ CANADA INCORPORATED,VALSARTAN,VALSARTAN,160MG,500FCT,ORAL; ORAL,Resolved,TABLET,,2023-01-18,2023-02-10,2023-02-08,Delay in shipping of the drug.,2023-01-19,2023-02-09,No
189804,02399245,Shortage,SANDOZ VORICONAZOLE,SANDOZ CANADA INCORPORATED,VORICONAZOLE,VORICONAZOLE,50MG,30FCT,ORAL; ORAL,Resolved,TABLET,,2023-04-17,2023-06-16,2023-06-19,Disruption of the manufacture of the drug.,2023-04-18,2023-06-20,No
193399,02399253,Shortage,SANDOZ VORICONAZOLE,SANDOZ CANADA INCORPORATED,VORICONAZOLE,VORICONAZOLE,200MG,30FCT,ORAL; ORAL,Resolved,TABLET,,2023-05-30,2023-06-16,2023-06-19,Shortage of an active ingredient.,2023-05-30,2023-06-20,No
192573,02362988,Shortage,SANDOZ ZOLMITRIPTAN,SANDOZ CANADA INCORPORATED,ZOLMITRIPTAN,ZOLMITRIPTAN,2.5MG,3FCT,ORAL; ORAL,Resolved,TABLET,,2023-05-15,2023-07-28,2023-07-31,Disruption of the manufacture of the drug.,2023-05-16,2023-08-01,No
201769,02362996,Shortage,SANDOZ ZOLMITRIPTAN ODT,SANDOZ CANADA INCORPORATED,ZOLMITRIPTAN ODT,ZOLMITRIPTAN,2.5MG,6ODT UD,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-08-14,2023-09-08,2023-09-11,Disruption of the manufacture of the drug.,2023-08-14,2023-09-12,No
187457,02362996,Shortage,SANDOZ ZOLMITRIPTAN ODT,SANDOZ CANADA INCORPORATED,ZOLMITRIPTAN ODT,ZOLMITRIPTAN,2.5MG,2ODT,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-03-20,2023-09-29,2023-10-02,Disruption of the manufacture of the drug.,2023-03-20,2023-10-03,No
207076,02261847,Shortage,SANDOZ-CARBAMAZEPINE CR,SANDOZ CANADA INCORPORATED,CARBAMAZEPINE,CARBAMAZEPINE,400MG,100MRT,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-10-16,2023-12-08,2023-11-27,Disruption of the manufacture of the drug.,2023-10-16,2023-11-28,No
201774,02261944,Shortage,SANDOZ-DICLOFENAC SR,SANDOZ CANADA INCORPORATED,DICLOFENAC SR,DICLOFENAC SODIUM,100MG,100PRT BO,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-08-14,,2023-08-21,Disruption of the manufacture of the drug.,2023-08-14,2023-08-22,No
193768,02063670,Shortage,SANTYL,SMITH & NEPHEW INC,Collagenase Ointment,COLLAGENASE,250UNIT,30g,TOPICAL; TOPICAL,Actual shortage,OINTMENT,2023-07-15,2023-07-15,2024-06-30,,Disruption of the manufacture of the drug.,2023-06-05,2023-08-07,No
192381,02437899,Shortage,SAXENDA,NOVO NORDISK CANADA INC,SAXENDA,LIRAGLUTIDE,6MG,5x3M:,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION,2023-05-19,2023-05-19,2023-05-25,2023-05-25,Delay in shipping of the drug.,2023-05-12,2023-05-26,No
213933,02437899,Shortage,SAXENDA,NOVO NORDISK CANADA INC,SAXENDA® 6 MG/ML 5X3 ML,LIRAGLUTIDE,6MG,EA,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION,2023-12-20,2023-12-20,2024-01-05,2024-01-02,Demand increase for the drug.,2023-12-20,2024-01-03,No
185103,02242811,Shortage,SCOPOLAMINE HYDROBROMIDE INJECTION,OMEGA LABORATORIES LIMITED,Scopolamine Hydrobromide Injection,SCOPOLAMINE HYDROBROMIDE,0.6MG,10 x 1 mL vial / fiole,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Avoided shortage,LIQUID,2023-02-27,,2023-03-06,2023-02-24,Demand increase for the drug.,2023-02-17,2023-02-24,No
207142,02242811,Shortage,SCOPOLAMINE HYDROBROMIDE INJECTION,OMEGA LABORATORIES LIMITED,Scopolamine Hydrobromide Injection,SCOPOLAMINE HYDROBROMIDE,0.6MG,10 x 1mL vial /fiole,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-10-16,,2023-11-02,Demand increase for the drug.,2023-10-16,2023-11-03,No
184426,02242810,Shortage,SCOPOLAMINE HYDROBROMIDE INJECTION,OMEGA LABORATORIES LIMITED,Scopolamine Hydrobromide Injection,SCOPOLAMINE HYDROBROMIDE,0.4MG,10 x 1 mL vial / fiole,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-02-10,2023-03-10,2023-03-10,Demand increase for the drug.,2023-02-10,2023-03-11,No
190276,01976141,Shortage,SENSORCAINE,ASPEN PHARMACARE CANADA INC.,bupivacaine HCI 0.25% Plain 50x10mL SU Polyamp® Duofit®,BUPIVACAINE HYDROCHLORIDE,2.5MG,50 PE Polyamp,EPIDURAL; BLOCK/INFILTRATION; EPIDURAL; BLOCK/INFILTRATION,Resolved,SOLUTION,,2023-04-25,2023-07-31,2023-06-05,Delay in shipping of the drug.,2023-04-25,2023-06-06,No
203911,01976141,Shortage,SENSORCAINE,ASPEN PHARMACARE CANADA INC.,bupivacaine HCI 0.25% Plain 50x10mL SU Polyamp® Duofit®,BUPIVACAINE HYDROCHLORIDE,2.5MG,50 PE Polyamp,EPIDURAL; BLOCK/INFILTRATION; EPIDURAL; BLOCK/INFILTRATION,Resolved,SOLUTION,2023-10-23,2023-10-23,2024-04-15,2024-04-15,Disruption of the manufacture of the drug.,2023-09-08,2024-04-16,No
198622,01976141,Shortage,SENSORCAINE,ASPEN PHARMACARE CANADA INC.,bupivacaine HCI 0.25% Plain 50x10mL SU Polyamp® Duofit®,BUPIVACAINE HYDROCHLORIDE,2.5MG,50 PE Polyamp,EPIDURAL; BLOCK/INFILTRATION; EPIDURAL; BLOCK/INFILTRATION,Resolved,SOLUTION,,2023-07-01,2023-11-30,2023-09-08,Disruption of the manufacture of the drug.,2023-07-13,2023-09-09,No
209399,01976168,Shortage,SENSORCAINE,ASPEN PHARMACARE CANADA INC.,bupivacaine HCI 0.5% Plain 10x20mL SU Vial,BUPIVACAINE HYDROCHLORIDE,5MG,10 vials,EPIDURAL; BLOCK/INFILTRATION; EPIDURAL; BLOCK/INFILTRATION,Resolved,SOLUTION,2024-01-15,2024-01-16,2024-02-28,2024-02-06,Disruption of the manufacture of the drug.,2023-11-06,2024-02-07,Yes
181243,01976141,Shortage,SENSORCAINE,ASPEN PHARMACARE CANADA INC.,bupivacaine HCI 0.25% Plain 10x20mL SU Vial,BUPIVACAINE HYDROCHLORIDE,2.5MG,10 vials,EPIDURAL; BLOCK/INFILTRATION; EPIDURAL; BLOCK/INFILTRATION,Resolved,SOLUTION,2023-08-15,2023-08-14,2024-01-31,2024-01-02,Disruption of the manufacture of the drug.,2023-01-17,2024-01-04,No
188985,01976184,Shortage,SENSORCAINE WITH EPINEPHRINE,ASPEN PHARMACARE CANADA INC.,bupivacaine HCI 0.25% w/epin. 1:200M 10x20mL SU Vial,BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE,2.5MG; 5MCG,10 vials,EPIDURAL; BLOCK/INFILTRATION; EPIDURAL; BLOCK/INFILTRATION,Resolved,SOLUTION,,2023-04-06,2023-04-24,2023-04-11,Delay in shipping of the drug.,2023-04-06,2023-04-12,No
206658,01976206,Shortage,SENSORCAINE WITH EPINEPHRINE,ASPEN PHARMACARE CANADA INC.,bupivacaine HCI 0.5% w/epin. 1:200M 10x20mL SU Vial,EPINEPHRINE; BUPIVACAINE HYDROCHLORIDE,5MCG; 5MG,10 vials,EPIDURAL; BLOCK/INFILTRATION; EPIDURAL; BLOCK/INFILTRATION,Resolved,SOLUTION,2023-10-16,2023-10-16,2023-12-31,2023-12-12,Disruption of the manufacture of the drug.,2023-10-10,2023-12-13,No
203898,01976184,Shortage,SENSORCAINE WITH EPINEPHRINE,ASPEN PHARMACARE CANADA INC.,bupivacaine HCI 0.25% w/epin. 1:200M 10x20mL SU Vial,BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE,2.5MG; 5MCG,10 vials,EPIDURAL; BLOCK/INFILTRATION; EPIDURAL; BLOCK/INFILTRATION,Resolved,SOLUTION,2023-10-16,2023-10-16,2024-02-28,2024-02-06,Disruption of the manufacture of the drug.,2023-09-08,2024-02-07,Yes
191298,02243878,Shortage,SERC,BGP PHARMA ULC,BETAHISTINE HYDROCHLORIDE,BETAHISTINE HYDROCHLORIDE,16MG,4x25,ORAL; ORAL,Resolved,TABLET,2023-05-02,,2023-05-09,2023-05-05,Other (Please describe in comments),2023-05-01,2023-05-08,No
212066,02231129,Shortage,SEREVENT DISKUS (50MCG/DOSE),GLAXOSMITHKLINE INC,salmeterol xinafoate dry powder for inhalation,SALMETEROL,50MCG,1x60,INHALATION; INHALATION,Resolved,POWDER,,2023-11-27,2023-12-15,2023-12-08,Disruption of the manufacture of the drug.,2023-12-01,2023-12-09,No
200371,02231129,Shortage,SEREVENT DISKUS (50MCG/DOSE),GLAXOSMITHKLINE INC,salmeterol xinafoate dry powder for inhalation,SALMETEROL,50MCG,1x60,INHALATION; INHALATION,Resolved,POWDER,,2023-07-25,2023-08-31,2023-08-11,Disruption of the manufacture of the drug.,2023-07-28,2023-08-12,No
198926,02353539,Shortage,SERTRALINE,SANIS HEALTH INC,SERTRALINE,SERTRALINE,50MG,250,ORAL; ORAL,Resolved,CAPSULE,,2023-07-18,2023-10-11,2023-10-11,Disruption of the manufacture of the drug.,2023-07-18,2023-10-17,No
211071,02353547,Shortage,SERTRALINE,SANIS HEALTH INC,SERTRALINE,SERTRALINE,100MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-11-17,2023-11-30,2023-11-30,Disruption of the manufacture of the drug.,2023-11-22,2023-12-01,No
211074,02353539,Shortage,SERTRALINE,SANIS HEALTH INC,SERTRALINE,SERTRALINE,50MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-11-17,,2023-11-30,Disruption of the manufacture of the drug.,2023-11-22,2023-12-01,No
198792,02353520,Shortage,SERTRALINE,SANIS HEALTH INC,SERTRALINE,SERTRALINE,25MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-07-17,2023-09-01,2023-09-05,Disruption of the manufacture of the drug.,2023-07-17,2023-09-06,No
193889,02468425,Shortage,SHINGRIX,GLAXOSMITHKLINE INC,Herpes Zoster vaccine,VARICELLA-ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN,50MCG,10's,INTRAMUSCULAR; INTRAMUSCULAR,Resolved,SUSPENSION,,2023-06-14,2023-07-14,2023-07-14,Other (Please describe in comments),2023-06-08,2023-07-15,No
198785,02406160,Shortage,SILDENAFIL,SANIS HEALTH INC,SILDENAFIL,SILDENAFIL,100MG,4,ORAL; ORAL,Resolved,TABLET,,2023-07-17,,2023-09-14,Disruption of the manufacture of the drug.,2023-07-17,2023-09-19,No
211160,02386313,Shortage,SIMVASTATIN,SIVEM PHARMACEUTICALS ULC,Simvastatin,SIMVASTATIN,20MG,100,ORAL; ORAL,Resolved,TABLET,,2023-11-29,2024-02-23,2024-02-26,Delay in shipping of the drug.,2023-11-22,2024-04-01,No
211164,02386321,Shortage,SIMVASTATIN,SIVEM PHARMACEUTICALS ULC,Simvastatin,SIMVASTATIN,40MG,30,ORAL; ORAL,Resolved,TABLET,,2023-06-05,2024-02-23,2024-02-26,Delay in shipping of the drug.,2023-11-22,2024-04-01,No
211168,02386321,Shortage,SIMVASTATIN,SIVEM PHARMACEUTICALS ULC,Simvastatin,SIMVASTATIN,40MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-17,2024-02-23,2024-02-26,Delay in shipping of the drug.,2023-11-22,2024-04-01,No
185698,00024325,Shortage,SINEQUAN,AA PHARMA INC,Sinequan,DOXEPIN,10MG,100BTL,ORAL; ORAL,Resolved,CAPSULE,2023-03-13,,2023-05-02,2023-04-28,Disruption of the manufacture of the drug.,2023-02-28,2023-05-01,No
196127,02243602,Shortage,SINGULAIR,ORGANON CANADA INC.,montelukast tablets,MONTELUKAST,4MG,30,ORAL; ORAL,Resolved,TABLET (CHEWABLE),2023-07-24,2023-07-07,2023-10-06,2023-10-02,Delay in shipping of the drug.,2023-06-22,2023-10-03,No
188265,02487454,Shortage,SKYRIZI,ABBVIE CORPORATION,Risankizumab,RISANKIZUMAB,90MG,2 x 75 mg/0.83 mL Syringe,SUBCUTANEOUS; SUBCUTANEOUS,Actual shortage,SOLUTION,2023-09-01,2023-09-01,,,Other (Please describe in comments),2023-03-30,2023-09-02,No
187303,02427176,Shortage,SNS-ASA EC,SANIS HEALTH INC,ASA EC,ACETYLSALICYLIC ACID,80MG,500,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE),,2023-03-03,,2023-09-07,Disruption of the manufacture of the drug.,2023-03-16,2023-09-10,No
213101,02181746,Shortage,SODIUM ACETATE INJECTION USP,OMEGA LABORATORIES LIMITED,Sodium Acetate Injection USP,SODIUM ACETATE,328MG,10 x 50mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION; LIQUID,,2023-12-13,2024-01-12,2024-01-10,Demand increase for the drug.,2023-12-12,2024-01-11,No
193516,02139529,Shortage,"SODIUM ACETATE INJECTION, USP",FRESENIUS KABI CANADA LTD,"SODIUM ACETATE INJECTION, USP",SODIUM ACETATE,328MG,50 mL,INTRAVENOUS; INTRAVENOUS,Actual shortage,SOLUTION,2023-08-01,,,,Disruption of the manufacture of the drug.,2023-06-02,2023-08-02,No
201216,02181746,Shortage,SODIUM ACETATE-OMEGA,OMEGA LABORATORIES LIMITED,SODIUM ACETATE INJECTION,SODIUM ACETATE,328MG,10 x 50mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,,2023-08-10,2023-12-08,2023-12-06,Demand increase for the drug.,2023-08-04,2023-12-07,No
198687,02181746,Shortage,SODIUM ACETATE-OMEGA,OMEGA LABORATORIES LIMITED,SODIUM ACETATE INJECTION,SODIUM ACETATE,328MG,10 x 50mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,,2023-07-20,,2023-07-26,Demand increase for the drug.,2023-07-14,2023-07-27,No
189017,02181746,Shortage,SODIUM ACETATE-OMEGA,OMEGA LABORATORIES LIMITED,Sodium Acetate Injection USP,SODIUM ACETATE,328MG,10 x 50mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,,2023-04-06,2023-05-05,2023-05-05,Demand increase for the drug.,2023-04-06,2023-05-06,No
192437,02181746,Shortage,SODIUM ACETATE-OMEGA,OMEGA LABORATORIES LIMITED,Sodium Acetate Injection USP,SODIUM ACETATE,328MG,10 x 50mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,2023-05-25,2023-05-24,2023-07-03,2023-07-07,Demand increase for the drug.,2023-05-12,2023-07-08,No
187387,02181746,Shortage,SODIUM ACETATE-OMEGA,OMEGA LABORATORIES LIMITED,Sodium Acetate Injection USP,SODIUM ACETATE,328MG,10 x 50mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,,2023-03-23,,2023-03-29,Demand increase for the drug.,2023-03-17,2023-03-30,No
197649,00261971,Shortage,SODIUM BICARBONATE INJECTION USP,PFIZER CANADA ULC,SODIUM BICARBONATE INJECTION USP,SODIUM BICARBONATE,42MG,10 x 10mL LifeShield syringes,INTRAVENOUS; INTRAVENOUS,Actual shortage,SOLUTION,,2023-07-05,,,Disruption of the manufacture of the drug.,2023-07-05,2023-08-01,No
182109,00261998,Shortage,SODIUM BICARBONATE INJECTION USP,PFIZER CANADA ULC,SODIUM BICARBONATE INJECTION USP,SODIUM BICARBONATE,84MG,10 x 10mL LifeShield syringes,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-02-02,,2023-02-22,Disruption of the manufacture of the drug.,2023-01-20,2023-02-23,No
200801,00261998,Shortage,SODIUM BICARBONATE INJECTION USP,PFIZER CANADA ULC,SODIUM BICARBONATE INJECTION USP,SODIUM BICARBONATE,84MG,10 x 50ml LifeShield syringe,INTRAVENOUS; INTRAVENOUS,Actual shortage,SOLUTION,,2023-08-03,,,Disruption of the manufacture of the drug.,2023-08-03,2023-08-04,No
200804,00261998,Shortage,SODIUM BICARBONATE INJECTION USP,PFIZER CANADA ULC,SODIUM BICARBONATE INJECTION USP,SODIUM BICARBONATE,84MG,25 x 50ml vial,INTRAVENOUS; INTRAVENOUS,Actual shortage,SOLUTION,,2023-08-03,,,Disruption of the manufacture of the drug.,2023-08-03,2023-08-04,No
200825,00261998,Shortage,SODIUM BICARBONATE INJECTION USP,PFIZER CANADA ULC,SODIUM BICARBONATE INJECTION USP,SODIUM BICARBONATE,84MG,10 x 10ml LifeShield syringe,INTRAVENOUS; INTRAVENOUS,Actual shortage,SOLUTION,,2024-04-01,,,Disruption of the manufacture of the drug.,2023-08-03,2024-04-10,No
182958,02516225,Shortage,SODIUM BICARBONATE INJECTION USP,JAMP PHARMA CORPORATION,Sodium Bicarbonate Injection USP,SODIUM BICARBONATE,84MG,10x50mL,INTRAVENOUS,Resolved,SOLUTION,,2023-02-01,2023-03-10,2023-02-24,Demand increase for the drug.,2023-02-01,2023-02-25,No
180722,00038083,Shortage,SODIUM BICARBONATE INJECTION USP,PFIZER CANADA ULC,SODIUM BICARBONATE INJECTION USP,SODIUM BICARBONATE,75MG,10x 50mL Lifeshield syringe,INTRAVENOUS; INTRAVENOUS,Actual shortage,SOLUTION,,2023-03-13,,,Disruption of the manufacture of the drug.,2023-01-12,2023-08-01,No
186632,02486628,Shortage,"SODIUM BICARBONATE INJECTION, USP",FRESENIUS KABI CANADA LTD,"SODIUM BICARBONATE INJECTION, USP",SODIUM BICARBONATE,42MG,5 mL,INTRAVENOUS; INTRAVENOUS,Actual shortage,SOLUTION,,2024-03-08,,,Disruption of the manufacture of the drug.,2023-03-10,2024-04-05,No
197763,00060232,Shortage,SODIUM CHLORIDE 3% INJ,BAXTER CORPORATION,SODIUM CHLORIDE 3% INJ,SODIUM CHLORIDE,3G,250 mL - JB1352,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2023-07-06,2023-07-06,2023-08-14,2023-08-14,Disruption of the manufacture of the drug.,2023-07-06,2023-08-15,No
205150,00402249,Shortage,SODIUM CHLORIDE BACTERIOSTATIC INJ,OMEGA LABORATORIES LIMITED,Sodium Chloride Bacteriostatic For Injection USP,SODIUM CHLORIDE,9MG,10 x 30mL vial / fiole,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Avoided shortage,LIQUID,2023-12-12,,2023-12-15,2023-12-06,Demand increase for the drug.,2023-09-25,2023-12-05,No
194679,00402249,Shortage,SODIUM CHLORIDE BACTERIOSTATIC INJ,OMEGA LABORATORIES LIMITED,Sodium Chloride Bacteriostatic For Injection USP,SODIUM CHLORIDE,9MG,10 x 30mL vial / fiole,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-06-29,2023-07-21,2023-07-12,Demand increase for the drug.,2023-06-10,2023-07-13,No
180332,00037842,Shortage,SODIUM CHLORIDE INJECTION USP,ICU MEDICAL CANADA INC,Sodium Chloride Injection USP,SODIUM CHLORIDE,9MG,500 mL,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2023-05-15,,2023-06-05,2023-06-02,Disruption of the manufacture of the drug.,2023-01-10,2023-06-07,No
200828,00037796,Shortage,SODIUM CHLORIDE INJECTION USP,PFIZER CANADA ULC,SODIUM CHLORIDE INJECTION USP,SODIUM CHLORIDE,9MG,25 x 10ml vial,SUBCUTANEOUS; INTRAVENOUS; INTRAPERITONEAL; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAPERITONEAL; INTRAMUSCULAR,Anticipated shortage,SOLUTION,2024-06-25,,,,Disruption of the manufacture of the drug.,2023-08-03,2024-03-18,No
200831,00037796,Shortage,SODIUM CHLORIDE INJECTION USP,PFIZER CANADA ULC,SODIUM CHLORIDE INJECTION USP,SODIUM CHLORIDE,9MG,25 x 20ml vial,SUBCUTANEOUS; INTRAVENOUS; INTRAPERITONEAL; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAPERITONEAL; INTRAMUSCULAR,Avoided shortage,SOLUTION,2024-04-01,,,2024-03-06,Disruption of the manufacture of the drug.,2023-08-03,2024-03-06,No
192388,00037796,Shortage,SODIUM CHLORIDE INJECTION USP,PFIZER CANADA ULC,SODIUM CHLORIDE INJECTION USP,SODIUM CHLORIDE,9MG,25 x 10mL vial,SUBCUTANEOUS; INTRAVENOUS; INTRAPERITONEAL; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAPERITONEAL; INTRAMUSCULAR,Resolved,SOLUTION,,2023-05-12,,2023-06-28,Disruption of the manufacture of the drug.,2023-05-12,2023-06-29,No
182674,00037842,Shortage,SODIUM CHLORIDE INJECTION USP,ICU MEDICAL CANADA INC,Sodium Chloride Injection USP,SODIUM CHLORIDE,9MG,100 mL (4:1),INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-01-30,2023-02-13,2023-02-24,Disruption of the manufacture of the drug.,2023-01-30,2023-02-25,No
182677,00037842,Shortage,SODIUM CHLORIDE INJECTION USP,ICU MEDICAL CANADA INC,Sodium Chloride Injection USP,SODIUM CHLORIDE,9MG,500 mL,INTRAVENOUS; INTRAVENOUS,Avoided shortage,SOLUTION,2023-03-06,,,2023-02-23,Disruption of the manufacture of the drug.,2023-01-30,2023-02-23,No
179693,02139510,Shortage,"SODIUM CHLORIDE INJECTION, USP",FRESENIUS KABI CANADA LTD,"SODIUM CHLORIDE INJECTION, USP",SODIUM CHLORIDE,234MG,200 mL,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-01-01,2023-01-20,2023-01-20,Delay in shipping of the drug.,2023-01-03,2023-01-26,No
185509,00037826,Shortage,SODIUM CHLORIDE IRRIGATION USP,ICU MEDICAL CANADA INC,Sodium Chloride Irrigation USP,SODIUM CHLORIDE,9MG,3000 mL,IRRIGATION; INTRAPERITONEAL; INTRAPERITONEAL; IRRIGATION,Resolved,SOLUTION,2023-03-21,,2023-04-07,2023-04-13,Disruption of the manufacture of the drug.,2023-02-23,2023-04-14,No
200953,00896187,Shortage,SODIUM PHOSPHATES INJECTION USP,SANDOZ CANADA INCORPORATED,SODIUM HYDROGEN PHOSPHATE+SODIUM DIHYDROGEN PHOSPHATE,SODIUM PHOSPHATE DIBASIC; SODIUM PHOSPHATE MONOBASIC,268MG; 276MG,10ML 10LIVI,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-08-03,2023-11-03,2023-11-27,Other (Please describe in comments),2023-08-03,2023-11-28,No
209480,02428393,Shortage,SODIUM THIOSULFATE INJECTION USP,HOPE PHARMACEUTICALS LTD,Sodium Thiosulfate Injection,SODIUM THIOSULFATE,250MG,50 mL,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-11-06,2023-12-31,2024-01-08,Delay in shipping of the drug.,2023-11-07,2024-01-09,No
202983,02224623,Shortage,SOFRACORT,SANOFI-AVENTIS CANADA INC,"Framycetin sulphate, Dexamethasone and Gramicidin Ophthalmic/Otic Solution",GRAMICIDIN; DEXAMETHASONE; FRAMYCETIN SULFATE,0.05MG; 0.5MG; 5MG,8 mL bottle,OTIC; OPHTHALMIC; OTIC; OPHTHALMIC,Actual shortage,DROPS,2023-08-28,2023-08-28,,,Other (Please describe in comments),2023-08-25,2023-12-01,No
187368,02224860,Shortage,SOFRAMYCIN NASAL SPRAY,SEARCHLIGHT PHARMA INC,Soframycin,GRAMICIDIN; FRAMYCETIN SULFATE; PHENYLEPHRINE HYDROCHLORIDE,0.05MG; 12.5MG; 2.5MG,15ml,NASAL; NASAL,Resolved,SPRAY,2023-02-15,,2023-10-30,2023-10-06,Shortage of an active ingredient.,2023-03-17,2023-10-06,No
200459,02458268,Shortage,SOLIFENACIN,SANIS HEALTH INC,SOLIFENACIN,SOLIFENACIN SUCCINATE,10MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-31,2024-02-23,2024-02-12,Disruption of the manufacture of the drug.,2023-07-31,2024-02-12,No
205212,02458241,Shortage,SOLIFENACIN,SANIS HEALTH INC,SOLIFENACIN,SOLIFENACIN SUCCINATE,5MG,100,ORAL; ORAL,Resolved,TABLET,,2023-09-26,2023-11-27,2023-11-28,Disruption of the manufacture of the drug.,2023-09-26,2023-12-01,No
189497,00030600,Shortage,SOLU-CORTEF,PFIZER CANADA ULC,SOLU-CORTEF,HYDROCORTISONE,100MG,10 x 2mL vial,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,,2023-04-13,,2023-08-23,Disruption of the manufacture of the drug.,2023-04-13,2023-09-20,No
197768,00030619,Shortage,SOLU-CORTEF,PFIZER CANADA ULC,SOLU_CORTEF,HYDROCORTISONE,250MG,10x2ML,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,,2023-07-06,,2023-09-08,Disruption of the manufacture of the drug.,2023-07-06,2023-09-20,No
197771,00030627,Shortage,SOLU-CORTEF,PFIZER CANADA ULC,SOLU-CORTEF,HYDROCORTISONE,500MG,5x4ML,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,,2023-07-06,,2023-09-01,Disruption of the manufacture of the drug.,2023-07-06,2023-09-20,No
197774,00030635,Shortage,SOLU-CORTEF,PFIZER CANADA ULC,SOLU-CORTEF,HYDROCORTISONE,1G,5x8ML,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,,2023-07-06,,2023-09-08,Disruption of the manufacture of the drug.,2023-07-06,2023-09-20,No
210575,00030627,Shortage,SOLU-CORTEF,PFIZER CANADA ULC,SOLU-CORTEF,HYDROCORTISONE,500MG,5 x 4mL AOV,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,2023-12-22,,,2024-02-26,Disruption of the manufacture of the drug.,2023-11-17,2024-02-27,No
196007,00030619,Shortage,SOLU-CORTEF,PFIZER CANADA ULC,SOLU-CORTEF,HYDROCORTISONE,250MG,10 x 2 mL,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,,2023-06-20,,2023-07-03,Disruption of the manufacture of the drug.,2023-06-21,2023-07-04,No
201990,02367971,Shortage,SOLU-MEDROL,PFIZER CANADA ULC,SOLU-MEDROL,METHYLPREDNISOLONE,1G,1X8ML,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION; KIT,,2023-11-16,,2024-01-09,Disruption of the manufacture of the drug.,2023-08-16,2024-01-10,No
201998,02367955,Shortage,SOLU-MEDROL,PFIZER CANADA ULC,SOLU-MEDROL,METHYLPREDNISOLONE,125MG,10X2ML,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION; KIT,2023-10-03,,,2023-10-16,Disruption of the manufacture of the drug.,2023-08-16,2023-10-17,No
212079,02367963,Shortage,SOLU-MEDROL,PFIZER CANADA ULC,SOLU-MEDROL,METHYLPREDNISOLONE,500MG,5 X4 ML,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION; KIT,,2024-01-04,,2024-01-16,Disruption of the manufacture of the drug.,2023-12-01,2024-01-17,No
189318,02367955,Shortage,SOLU-MEDROL,PFIZER CANADA ULC,SOLU-MEDROL,METHYLPREDNISOLONE,125MG,10 x 2mL vial,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION; KIT,,2023-04-12,,2023-05-26,Disruption of the manufacture of the drug.,2023-04-12,2023-05-29,No
189321,02367947,Shortage,SOLU-MEDROL,PFIZER CANADA ULC,SOLU-MEDROL,METHYLPREDNISOLONE,40MG,10 x 1mL vial,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION; KIT,,2023-04-12,,2023-05-09,Disruption of the manufacture of the drug.,2023-04-12,2023-05-10,No
180725,02367955,Shortage,SOLU-MEDROL,PFIZER CANADA ULC,SOLU-MEDROL,METHYLPREDNISOLONE,125MG,10 x 2mL vial,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION; KIT,,2023-01-11,,2023-03-15,Disruption of the manufacture of the drug.,2023-01-12,2023-03-16,No
187129,02367963,Shortage,SOLU-MEDROL,PFIZER CANADA ULC,SOLU-MEDROL,METHYLPREDNISOLONE,500MG,5 x 4mL vial,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION; KIT,,2023-04-12,,2023-05-16,Disruption of the manufacture of the drug.,2023-03-15,2023-05-17,No
213439,00755338,Shortage,SOLYSTAT,PENDOPHARM DIVISION OF PHARMASCIENCE INC,SOLYSTAT,SODIUM POLYSTYRENE SULFONATE,1G,454g,RECTAL; ORAL; RECTAL; ORAL,Resolved,POWDER FOR SUSPENSION; POWDER,2023-12-22,2023-12-20,2024-04-01,2024-03-21,Disruption of the manufacture of the drug.,2023-12-15,2024-03-22,No
180329,00498807,Shortage,SORBITOL MANNITOL IRRIGATION,ICU MEDICAL CANADA INC,SORBITOL MANNITOL IRRIGATION,MANNITOL; SORBITOL,5.4MG; 27MG,3000 mL,IRRIGATION; IRRIGATION,Resolved,SOLUTION,,2023-01-02,2023-01-23,2023-01-30,Disruption of the manufacture of the drug.,2023-01-10,2023-01-31,No
209770,00498807,Shortage,SORBITOL MANNITOL IRRIGATION,ICU MEDICAL CANADA INC,Sorbitol Mannitol Irrigation,MANNITOL; SORBITOL,5.4MG; 27MG,3000 mL,IRRIGATION; IRRIGATION,Resolved,SOLUTION,2023-12-06,,2023-12-20,2023-12-22,Disruption of the manufacture of the drug.,2023-11-10,2023-12-27,No
198678,02203375,Shortage,STERILE LIGHT MINERAL OIL 100%,OMEGA LABORATORIES LIMITED,"MINERAL OIL, LIGHT STERILE",MINERAL OIL LIGHT,100%,10 x 30mL vial / fiole,TOPICAL; TOPICAL,Resolved,OIL,,2023-07-14,2023-11-03,2023-10-30,Disruption of the manufacture of the drug.,2023-07-14,2023-10-31,No
188484,02203375,Shortage,STERILE LIGHT MINERAL OIL 100%,OMEGA LABORATORIES LIMITED,"Mineral Oil, Light Sterile, Omega Std.",MINERAL OIL LIGHT,100%,10 x 30mL vial / fiole,TOPICAL; TOPICAL,Resolved,OIL,,2023-04-06,2023-06-23,2023-06-14,Disruption of the manufacture of the drug.,2023-03-31,2023-06-15,No
210098,02203375,Shortage,STERILE LIGHT MINERAL OIL 100%,OMEGA LABORATORIES LIMITED,"Mineral Oil, Light Sterile, Omega Std.",MINERAL OIL LIGHT,100%,10 x 30mL vial / fiole,TOPICAL; TOPICAL,Resolved,OIL,,2023-11-20,,2024-02-06,Disruption of the manufacture of the drug.,2023-11-13,2024-02-07,No
200834,02142546,Shortage,STERILE WATER FOR INJECTION USP,PFIZER CANADA ULC,STERILE WATER FOR INJECTION USP,WATER,100%,25 x 10ml vial,SUBCUTANEOUS; INTRAVENOUS; INTRAPERITONEAL; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAPERITONEAL; INTRAMUSCULAR,Actual shortage,SOLUTION,2024-04-15,,,,Disruption of the manufacture of the drug.,2023-08-03,2024-04-16,No
185338,02142546,Shortage,STERILE WATER FOR INJECTION USP,PFIZER CANADA ULC,STERILE WATER FOR INJECTION USP,WATER,100%,25 x 20mL vial,SUBCUTANEOUS; INTRAVENOUS; INTRAPERITONEAL; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAPERITONEAL; INTRAMUSCULAR,Actual shortage,SOLUTION,,2023-04-12,,,Disruption of the manufacture of the drug.,2023-02-22,2023-08-01,No
189568,00799998,Shortage,"STERILE WATER FOR IRRIGATION, USP",BAXTER CORPORATION,STERILE WATER FOR IRRIGATION,WATER,100%,500 mL - JF7113,IRRIGATION; IRRIGATION,Actual shortage,LIQUID,2023-04-14,2023-04-14,2024-05-09,,Demand increase for the drug.,2023-04-14,2024-03-28,No
182408,00799998,Shortage,"STERILE WATER FOR IRRIGATION, USP",BAXTER CORPORATION,"STERILE WATER FOR IRRIGATION, USP",WATER,100%,500mL,IRRIGATION; IRRIGATION,Resolved,LIQUID,2023-01-26,2023-01-26,2023-02-06,2023-02-06,Delay in shipping of the drug.,2023-01-26,2023-02-07,No
188299,00799998,Shortage,"STERILE WATER FOR IRRIGATION, USP",BAXTER CORPORATION,"STERILE WATER FOR IRRIGATION, USP",WATER,100%,1000 mL - JF7114,IRRIGATION; IRRIGATION,Actual shortage,LIQUID,2023-03-31,2023-03-31,2024-05-09,,Demand increase for the drug.,2023-03-30,2024-03-28,No
193892,02247228,Shortage,STIEPROX SHAMPOO,GLAXOSMITHKLINE INC,ciclopirox olamine shampoo,CICLOPIROX OLAMINE,1.50%,150ML,TOPICAL; TOPICAL,Resolved,SHAMPOO,,2023-06-09,2023-07-07,2023-07-05,Delay in shipping of the drug.,2023-06-08,2023-07-06,No
206484,02247228,Shortage,STIEPROX SHAMPOO,GLAXOSMITHKLINE INC,ciclopirox olamine shampoo,CICLOPIROX OLAMINE,1.50%,150ML,TOPICAL; TOPICAL,Resolved,SHAMPOO,,2023-10-05,2023-11-07,2023-11-07,Disruption of the manufacture of the drug.,2023-10-06,2023-11-08,No
204142,02480557,Shortage,STROMECTOL,MERCK CANADA INC,"ivermectin tablets, USP",IVERMECTIN,3MG,4tab,ORAL; ORAL,Resolved,TABLET,2023-10-02,2023-09-28,2023-10-20,2023-10-19,Demand increase for the drug.,2023-09-11,2023-10-20,No
189554,02502348,Shortage,SUBOXONE,INDIVIOR UK LIMITED,SUBOXONE SUBLINGUAL FILM 8MG/2MG 30S CA,NALOXONE; BUPRENORPHINE,2MG; 8MG,30 film strips/pack,SUBLINGUAL; BUCCAL,Resolved,"FILM, SOLUBLE",2023-04-17,,2023-05-31,2023-05-18,Demand increase for the drug.,2023-04-13,2023-05-19,No
186034,02502313,Shortage,SUBOXONE,INDIVIOR UK LIMITED,SUBOXONE SUBLINGUAL FILM 2-0.5MG CA,NALOXONE; BUPRENORPHINE,0.5MG; 2MG,30 film strips/pack,SUBLINGUAL; BUCCAL,Resolved,"FILM, SOLUBLE",2023-03-13,2023-03-21,2023-04-30,2023-04-28,Demand increase for the drug.,2023-03-02,2023-04-29,No
194776,02502321,Shortage,SUBOXONE,INDIVIOR UK LIMITED,"SUBOXONE SUBLINGUAL FILM 4MG/1MG 30S CA, 30 FILM STRIPS",NALOXONE; BUPRENORPHINE,1MG; 4MG,30 film strips/pack,SUBLINGUAL; BUCCAL,Resolved,"FILM, SOLUBLE",2023-06-14,,2023-06-30,2023-07-04,Demand increase for the drug.,2023-06-12,2023-07-05,No
189738,02422336,Shortage,SUCCINYLCHOLINE CHLORIDE INJECTION USP,HIKMA CANADA LIMITED,SUCCINYLCHOLINE CHLORIDE INJECTION USP,SUCCINYLCHOLINE CHLORIDE,20MG,10mL,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-04-17,2023-08-28,2023-09-01,Delay in shipping of the drug.,2023-04-17,2023-09-05,No
193247,02422336,Shortage,SUCCINYLCHOLINE CHLORIDE INJECTION USP,HIKMA CANADA LIMITED,SUCCINYLCHOLINE CHLORIDE INJECTION USP,SUCCINYLCHOLINE CHLORIDE,20MG,20mL,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-05-26,2024-01-31,2024-01-31,Demand increase for the drug.,2023-05-26,2024-02-01,No
205822,02422336,Shortage,SUCCINYLCHOLINE CHLORIDE INJECTION USP,HIKMA CANADA LIMITED,SUCCINYLCHOLINE CHLORIDE INJECTION USP,SUCCINYLCHOLINE CHLORIDE,20MG,10mL,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2023-10-15,,2024-01-02,2024-01-03,Demand increase for the drug.,2023-10-02,2024-01-30,No
196970,02501783,Shortage,"SUCCINYLCHOLINE CHLORIDE INJECTION, USP",DR REDDY'S LABORATORIES LTD,Succinylcholine Chloride Injection,SUCCINYLCHOLINE CHLORIDE,20MG,Vial,INTRAVENOUS,Resolved,SOLUTION,2023-08-01,,,2023-08-31,Shortage of an inactive ingredient or component.,2023-06-30,2023-09-08,No
207797,02501783,Shortage,"SUCCINYLCHOLINE CHLORIDE INJECTION, USP",DR REDDY'S LABORATORIES LTD,Succinylcholine Chloride Injection,SUCCINYLCHOLINE CHLORIDE,20MG,10 mL Multi Dose Vial,INTRAVENOUS,Resolved,SOLUTION,2023-10-27,,2023-11-30,2023-11-30,Other (Please describe in comments),2023-10-23,2024-01-30,No
193626,02100622,Shortage,SULCRATE,APTALIS PHARMA CANADA ULC,Sucralfate,SUCRALFATE,1G,100 tablets/bottle,ORAL; ORAL,Resolved,TABLET,,2023-05-25,2023-08-30,2023-08-24,Demand increase for the drug.,2023-06-02,2023-08-25,No
183596,00445282,Shortage,SULFATRIM DS,AA PHARMA INC,Sulfatrim DS,TRIMETHOPRIM; SULFAMETHOXAZOLE,160MG; 800MG,500BTL,ORAL; ORAL,Resolved,TABLET,2023-02-24,,2023-03-31,2023-03-28,Disruption of the manufacture of the drug.,2023-02-03,2023-03-30,No
210069,02262983,Shortage,SUPEUDOL,SANDOZ CANADA INCORPORATED,SUPEUDOL,OXYCODONE HYDROCHLORIDE,20MG,50 TAB BO,ORAL; ORAL,Resolved,TABLET,,2023-11-13,2023-11-17,2023-11-20,Disruption of the manufacture of the drug.,2023-11-13,2023-11-21,No
204671,00868981,Shortage,SUPRAX,ODAN LABORATORIES LTD,Cefixime tablets,CEFIXIME,400MG,7 tablets and 10 tablets,ORAL; ORAL,Resolved,TABLET,,2023-09-18,2023-11-30,2023-11-30,Demand increase for the drug.,2023-09-18,2023-12-01,No
207981,02240749,Shortage,SUPREFACT DEPOT 3 MONTHS,CHEPLAPHARM ARZNEIMITTEL GMBH,Buserelin acetate implant,BUSERELIN,9.45MG,1 applicator,SUBCUTANEOUS; SUBCUTANEOUS,Actual shortage,IMPLANT,,2023-10-24,,,Disruption of the manufacture of the drug.,2023-10-24,2023-10-25,No
206915,02016109,Shortage,SURVANTA,ABBVIE CORPORATION,SURVANTA 4 mL,BERACTANT,25MG,4 mL Vial,INTRATRACHEAL; INTRATRACHEAL,Avoided shortage,SUSPENSION,2024-02-01,,2024-06-28,2023-11-27,Disruption of the manufacture of the drug.,2023-10-12,2023-12-01,No
206918,02016109,Shortage,SURVANTA,ABBVIE CORPORATION,SURVANTA 8 mL,BERACTANT,25MG,8 mL Vial,INTRATRACHEAL; INTRATRACHEAL,Avoided shortage,SUSPENSION,2024-04-01,,2024-06-28,2023-11-27,Disruption of the manufacture of the drug.,2023-10-12,2023-12-01,No
197652,02188783,Shortage,SYNAREL,PFIZER CANADA ULC,SYNAREL,NAFARELIN,200MCG,8ML,NASAL; NASAL,Resolved,METERED-DOSE AEROSOL,2023-10-31,2023-10-27,2024-01-16,2024-01-10,Disruption of the manufacture of the drug.,2023-07-05,2024-01-11,No
187797,02456605,Shortage,SYNJARDY,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,SYNJARDY 12.5/500MG 6X10,METFORMIN HYDROCHLORIDE; EMPAGLIFLOZIN,500MG; 12.5MG,6X10,ORAL; ORAL,Resolved,TABLET,2023-03-30,2023-03-30,2023-04-10,2023-04-11,Other (Please describe in comments),2023-03-24,2023-04-12,No
187800,02456621,Shortage,SYNJARDY,BOEHRINGER INGELHEIM (CANADA) LTD LTEE,SYNJARDY 12.5/1000MG 6X10,METFORMIN HYDROCHLORIDE; EMPAGLIFLOZIN,1000MG; 12.5MG,6X10,ORAL; ORAL,Avoided shortage,TABLET,2023-03-30,,2023-03-30,2023-03-29,Other (Please describe in comments),2023-03-24,2023-03-29,No
200474,02457032,Shortage,TADALAFIL,SANIS HEALTH INC,TADALAFIL,TADALAFIL,20MG,4,ORAL,Resolved,TABLET,,2023-07-31,2023-12-11,2023-12-11,Disruption of the manufacture of the drug.,2023-07-31,2023-12-26,No
200477,02457016,Shortage,TADALAFIL,SANIS HEALTH INC,TADALAFIL,TADALAFIL,5MG,28,ORAL,Resolved,TABLET,,2023-07-31,2023-12-13,2023-12-15,Disruption of the manufacture of the drug.,2023-07-31,2023-12-26,No
211102,02427117,Shortage,TAMSULOSIN CR,SANIS HEALTH INC,TAMSULOSIN CR,TAMSULOSIN HYDROCHLORIDE,0.4MG,100,ORAL; ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),,2023-11-25,2024-08-10,,Disruption of the manufacture of the drug.,2023-11-22,2024-04-05,Yes
211157,02429667,Shortage,TAMSULOSIN CR,SIVEM PHARMACEUTICALS ULC,Tamsulosin,TAMSULOSIN HYDROCHLORIDE,0.4MG,500,ORAL; ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),,2023-11-18,,,Delay in shipping of the drug.,2023-11-22,2024-02-19,Yes
185300,02505053,Shortage,TARO-ADAPALENE/BENZOYL PEROXIDE FORTE,TARO PHARMACEUTICALS INC,ADAPALENE/BENZOYL,BENZOYL PEROXIDE; ADAPALENE,2.5%; 0.3%,70g,TOPICAL,Resolved,GEL,,2023-01-16,,2023-07-17,Disruption of the manufacture of the drug.,2023-02-22,2023-08-16,No
180499,02267993,Shortage,TARO-ATENOLOL,SUN PHARMA CANADA INC,ATENOLOL,ATENOLOL,100MG,100,ORAL; ORAL,Resolved,TABLET,,2022-12-21,2023-02-03,2023-02-03,Disruption of the manufacture of the drug.,2023-01-10,2023-02-10,No
202095,02313707,Shortage,TARO-ATORVASTATIN,SUN PHARMA CANADA INC,ATORVASTATIN,ATORVASTATIN,10MG,500,ORAL; ORAL,Actual shortage,TABLET,,2023-08-10,,,Disruption of the manufacture of the drug.,2023-08-17,2024-01-05,No
202098,02313707,Shortage,TARO-ATORVASTATIN,SUN PHARMA CANADA INC,ATORVASTATIN,ATORVASTATIN,10MG,90,ORAL; ORAL,Actual shortage,TABLET,,2023-08-10,,,Disruption of the manufacture of the drug.,2023-08-17,2024-01-05,No
202101,02313715,Shortage,TARO-ATORVASTATIN,SUN PHARMA CANADA INC,ATORVASTATIN,ATORVASTATIN,20MG,90,ORAL; ORAL,Actual shortage,TABLET,,2023-08-10,,,Disruption of the manufacture of the drug.,2023-08-17,2024-01-05,No
202104,02313715,Shortage,TARO-ATORVASTATIN,SUN PHARMA CANADA INC,ATORVASTATIN,ATORVASTATIN,20MG,500,ORAL; ORAL,Actual shortage,TABLET,,2023-08-10,,,Disruption of the manufacture of the drug.,2023-08-17,2024-01-05,No
202107,02313723,Shortage,TARO-ATORVASTATIN,SUN PHARMA CANADA INC,ATORVASTATIN,ATORVASTATIN,40MG,90,ORAL; ORAL,Actual shortage,TABLET,,2023-08-10,,,Disruption of the manufacture of the drug.,2023-08-17,2024-01-05,No
202110,02313723,Shortage,TARO-ATORVASTATIN,SUN PHARMA CANADA INC,ATORVASTATIN,ATORVASTATIN,40MG,500,ORAL; ORAL,Actual shortage,TABLET,,2023-08-10,,,Disruption of the manufacture of the drug.,2023-08-17,2024-01-05,No
202113,02313758,Shortage,TARO-ATORVASTATIN,SUN PHARMA CANADA INC,ATORVASTATIN,ATORVASTATIN,80MG,90,ORAL; ORAL,Actual shortage,TABLET,,2023-08-10,,,Disruption of the manufacture of the drug.,2023-08-17,2024-01-05,No
199111,02313758,Shortage,TARO-ATORVASTATIN,SUN PHARMA CANADA INC,ATORVASTATIN,ATORVASTATIN,80MG,500,ORAL; ORAL,Actual shortage,TABLET,,2023-07-18,,,Disruption of the manufacture of the drug.,2023-07-18,2024-01-05,No
185303,02464519,Shortage,TARO-BENZOYL PEROXIDE / CLINDAMYCIN KIT,TARO PHARMACEUTICALS INC,BENZO/CLINDA,BENZOYL PEROXIDE; CLINDAMYCIN,5%; 1%,50g,TOPICAL; TOPICAL,Resolved,GEL,,2023-02-10,,2023-11-07,Disruption of the manufacture of the drug.,2023-02-22,2024-01-05,No
202116,02475812,Shortage,TARO-BUPROPION XL,SUN PHARMA CANADA INC,BUPROPION,BUPROPION HYDROCHLORIDE,300MG,90,ORAL; ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),,2023-08-10,,,Disruption of the manufacture of the drug.,2023-08-17,2024-01-05,No
202119,02475812,Shortage,TARO-BUPROPION XL,SUN PHARMA CANADA INC,BUPROPION,BUPROPION HYDROCHLORIDE,300MG,500,ORAL; ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),,2023-08-10,,,Disruption of the manufacture of the drug.,2023-08-17,2024-01-05,No
202122,02475804,Shortage,TARO-BUPROPION XL,SUN PHARMA CANADA INC,BUPROPION,BUPROPION HYDROCHLORIDE,150MG,90,ORAL; ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),,2023-08-10,,,Disruption of the manufacture of the drug.,2023-08-17,2024-01-05,No
202125,02475804,Shortage,TARO-BUPROPION XL,SUN PHARMA CANADA INC,BUPROPION,BUPROPION HYDROCHLORIDE,150MG,500,ORAL; ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),,2023-08-10,,,Disruption of the manufacture of the drug.,2023-08-17,2024-01-05,No
181833,02485710,Shortage,TARO-CALCITRIOL,TARO PHARMACEUTICALS INC,CALCITRIOL,CALCITRIOL,0.25MCG,90,ORAL; ORAL,Resolved,CAPSULE,,2023-01-11,2023-02-03,2023-01-16,Disruption of the manufacture of the drug.,2023-01-19,2023-02-01,No
183064,02380706,Shortage,TARO-CANDESARTAN,SUN PHARMA CANADA INC,CANDESARTAN,CANDESARTAN CILEXETIL,16MG,100,ORAL; ORAL,Resolved,TABLET,,2023-01-26,2023-09-26,2023-09-22,Disruption of the manufacture of the drug.,2023-02-01,2023-09-25,No
208955,02380692,Shortage,TARO-CANDESARTAN,SUN PHARMA CANADA INC,CANDESARTAN,CANDESARTAN CILEXETIL,8MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-10-04,2024-04-19,,Disruption of the manufacture of the drug.,2023-11-02,2024-03-01,No
208958,02380706,Shortage,TARO-CANDESARTAN,SUN PHARMA CANADA INC,CANDESARTAN,CANDESARTAN CILEXETIL,16MG,100,ORAL; ORAL,Resolved,TABLET,,2023-10-25,2023-11-24,2023-11-08,Delay in shipping of the drug.,2023-11-02,2024-01-05,No
208961,02329204,Shortage,TARO-CEFPROZIL,SUN PHARMA CANADA INC,CEFPROZIL,CEFPROZIL,125MG,75,ORAL; ORAL,Resolved,POWDER FOR SUSPENSION,,2023-10-18,2023-11-24,2023-11-23,Disruption of the manufacture of the drug.,2023-11-02,2024-01-05,No
208964,02329204,Shortage,TARO-CEFPROZIL,SUN PHARMA CANADA INC,CEFPROZIL,CEFPROZIL,125MG,100,ORAL; ORAL,Resolved,POWDER FOR SUSPENSION,,2023-10-27,2023-12-22,2023-12-23,Disruption of the manufacture of the drug.,2023-11-02,2024-01-05,No
182031,02303736,Shortage,TARO-CIPROFLOX,SUN PHARMA CANADA INC,CIPROFLOX,CIPROFLOXACIN,500MG,100,ORAL; ORAL,Resolved,TABLET,,2023-01-12,2023-07-28,2023-08-11,Disruption of the manufacture of the drug.,2023-01-20,2023-08-16,No
183077,02303728,Shortage,TARO-CIPROFLOX,SUN PHARMA CANADA INC,CIPROFLOX,CIPROFLOXACIN,250MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-02-01,2024-03-15,,Disruption of the manufacture of the drug.,2023-02-01,2024-03-13,No
183082,02303744,Shortage,TARO-CIPROFLOX,SUN PHARMA CANADA INC,CIPROFLOX,CIPROFLOXACIN,750MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-02-01,2024-03-15,,Disruption of the manufacture of the drug.,2023-02-01,2024-03-13,No
185326,02266938,Shortage,TARO-CLINDAMYCIN,TARO PHARMACEUTICALS INC,CLINDAMYCIN,CLINDAMYCIN,1%,30ML,TOPICAL; TOPICAL,Resolved,SOLUTION,,2023-02-16,2023-07-21,2023-07-17,Disruption of the manufacture of the drug.,2023-02-22,2023-08-16,No
180409,02440180,Shortage,TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL,TARO PHARMACEUTICALS INC,CLINDA/BENZOYL,CLINDAMYCIN; BENZOYL PEROXIDE,1%; 5%,45,TOPICAL; TOPICAL,Resolved,GEL,,2022-12-21,2023-01-27,2023-01-18,Disruption of the manufacture of the drug.,2023-01-10,2023-02-01,No
202450,02245523,Shortage,"TARO-CLOBETASOL CREAM USP, 0.05%",TARO PHARMACEUTICALS INC,CLOBETASOL,CLOBETASOL PROPIONATE,0.05%,15,TOPICAL; TOPICAL,Resolved,CREAM,,2023-08-14,2023-09-29,2023-09-24,Disruption of the manufacture of the drug.,2023-08-18,2023-09-25,No
202453,02245523,Shortage,"TARO-CLOBETASOL CREAM USP, 0.05%",TARO PHARMACEUTICALS INC,CLOBETASOL,CLOBETASOL PROPIONATE,0.05%,50,TOPICAL; TOPICAL,Resolved,CREAM,,2023-06-08,2023-09-29,2023-09-24,Disruption of the manufacture of the drug.,2023-08-18,2023-09-25,No
185335,02245522,Shortage,"TARO-CLOBETASOL TOPICAL SOLUTION USP, 0.05%",TARO PHARMACEUTICALS INC,CLOBETASOL,CLOBETASOL PROPIONATE,0.05%,60mL,TOPICAL; TOPICAL,Resolved,SOLUTION,,2023-02-14,2023-04-28,2023-04-27,Disruption of the manufacture of the drug.,2023-02-22,2023-04-28,No
180417,02497514,Shortage,TARO-CLOMIPRAMINE,TARO PHARMACEUTICALS INC,CLOMIPRAMINE,CLOMIPRAMINE HYDROCHLORIDE,50MG,90,ORAL,Resolved,CAPSULE,,2022-12-16,2023-02-10,2023-01-30,Disruption of the manufacture of the drug.,2023-01-10,2023-02-10,No
209167,02379813,Shortage,TARO-CLOPIDOGREL,SUN PHARMA CANADA INC,CLOPIDOGREL,CLOPIDOGREL,75MG,500,ORAL; ORAL,Actual shortage,TABLET,,2023-06-30,2024-03-29,,Disruption of the manufacture of the drug.,2023-11-03,2024-01-26,No
202456,02420988,Shortage,TARO-DICLOFENAC,TARO PHARMACEUTICALS INC,DICLOFENAC,DICLOFENAC SODIUM,1.50%,60mL,TOPICAL; TOPICAL,Resolved,SOLUTION,,2023-07-10,2023-10-27,2023-10-24,Disruption of the manufacture of the drug.,2023-08-18,2023-10-25,No
208040,02471051,Shortage,TARO-DIPYRIDAMOLE/ ASA,TARO PHARMACEUTICALS INC,DIPYRIDAMOLE,ACETYLSALICYLIC ACID; DIPYRIDAMOLE,25MG; 200MG,25MG,ORAL; ORAL,Actual shortage,CAPSULE (IMMEDIATE AND EXTENDED RELEASE),,2023-05-15,,,Disruption of the manufacture of the drug.,2023-10-25,2024-01-05,No
194655,00716731,Shortage,TARO-DOCUSATE,TARO PHARMACEUTICALS INC,DOCUSATE SODIUM,DOCUSATE SODIUM,100MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-05-29,2023-11-24,2023-11-28,Delay in shipping of the drug.,2023-06-09,2024-01-05,No
194658,00716731,Shortage,TARO-DOCUSATE,TARO PHARMACEUTICALS INC,DOCUSATE SODIUM,DOCUSATE SODIUM,100MG,1000,ORAL; ORAL,Resolved,CAPSULE,,2023-05-25,2023-11-24,2023-11-28,Delay in shipping of the drug.,2023-06-09,2024-01-05,No
209170,02381516,Shortage,TARO-DONEPEZIL,SUN PHARMA CANADA INC,DONEPEZIL,DONEPEZIL HYDROCHLORIDE,10MG,100,ORAL; ORAL,Resolved,TABLET,,2023-11-01,2023-11-10,2023-11-08,Disruption of the manufacture of the drug.,2023-11-03,2024-01-05,No
209173,02352230,Shortage,TARO-ENALAPRIL,SUN PHARMA CANADA INC,ENA,ENALAPRIL SODIUM,2MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-11-01,2024-03-29,,Disruption of the manufacture of the drug.,2023-11-03,2024-01-05,No
209176,02352257,Shortage,TARO-ENALAPRIL,SUN PHARMA CANADA INC,ENALAPRIL,ENALAPRIL SODIUM,8MG,100,ORAL; ORAL,Resolved,TABLET,,2023-10-20,2023-11-10,2023-11-04,Disruption of the manufacture of the drug.,2023-11-03,2024-01-05,No
202128,02352249,Shortage,TARO-ENALAPRIL,SUN PHARMA CANADA INC,ENALAPRIL,ENALAPRIL SODIUM,4MG,100,ORAL; ORAL,Resolved,TABLET,,2023-03-20,2023-08-18,2023-08-21,Disruption of the manufacture of the drug.,2023-08-17,2023-08-30,No
202131,02352265,Shortage,TARO-ENALAPRIL,SUN PHARMA CANADA INC,ENALAPRIL,ENALAPRIL SODIUM,16MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-19,2023-11-10,2023-11-04,Disruption of the manufacture of the drug.,2023-08-17,2024-01-05,No
202134,02385481,Shortage,TARO-ESCITALOPRAM,SUN PHARMA CANADA INC,ESCITALOPRAM,ESCITALOPRAM,10MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-01,2023-10-27,2023-10-13,Disruption of the manufacture of the drug.,2023-08-17,2024-01-05,No
202459,02482983,Shortage,TARO-IMIQUIMOD PUMP,TARO PHARMACEUTICALS INC,IMIQUIMOD,IMIQUIMOD,5%,7.5,TOPICAL; TOPICAL,Resolved,CREAM,,2023-07-10,2023-11-24,2023-12-19,Disruption of the manufacture of the drug.,2023-08-18,2024-01-05,No
202473,02367157,Shortage,TARO-MOMETASONE CREAM,TARO PHARMACEUTICALS INC,MOMETASONE,MOMETASONE FUROATE,0.10%,50,TOPICAL; TOPICAL,Resolved,CREAM,,2023-07-18,2023-09-15,2023-09-18,Disruption of the manufacture of the drug.,2023-08-18,2023-09-22,No
202465,02266385,Shortage,TARO-MOMETASONE LOTION,TARO PHARMACEUTICALS INC,MOMETASONE,MOMETASONE FUROATE,0.10%,30mL,TOPICAL; TOPICAL,Resolved,LOTION,,2023-07-18,2023-09-15,2023-09-18,Disruption of the manufacture of the drug.,2023-08-18,2023-09-22,No
181893,02429209,Shortage,TARO-PEMETREXED,TARO PHARMACEUTICALS INC,PEMETREXED,PEMETREXED,500MG,20ML,INTRAVENOUS; INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,,2023-01-10,,,Disruption of the manufacture of the drug.,2023-01-19,2024-01-05,No
202476,02250896,Shortage,TARO-PHENYTOIN,TARO PHARMACEUTICALS INC,PHENYTOIN,PHENYTOIN,125MG,237mL,ORAL; ORAL,Resolved,SUSPENSION,,2023-05-25,2023-10-06,2023-09-26,Disruption of the manufacture of the drug.,2023-08-18,2023-10-25,No
180578,02392801,Shortage,TARO-PREGABALIN,SUN PHARMA CANADA INC,PREGABALIN,PREGABALIN,25MG,100,ORAL; ORAL,Actual shortage,CAPSULE,,2023-01-04,2024-03-23,,Disruption of the manufacture of the drug.,2023-01-10,2024-03-01,No
180581,02392828,Shortage,TARO-PREGABALIN,SUN PHARMA CANADA INC,PREGABALIN,PREGABALIN,50MG,500,ORAL; ORAL,Resolved,CAPSULE,,2022-12-20,2023-02-03,2023-02-04,Disruption of the manufacture of the drug.,2023-01-10,2023-02-10,No
180584,02392836,Shortage,TARO-PREGABALIN,SUN PHARMA CANADA INC,PREGABALIN,PREGABALIN,75MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-01-06,2023-02-03,2023-02-04,Disruption of the manufacture of the drug.,2023-01-10,2023-02-10,No
180589,02392844,Shortage,TARO-PREGABALIN,SUN PHARMA CANADA INC,PREGABALIN,PREGABALIN,150MG,100,ORAL; ORAL,Resolved,CAPSULE,,2022-12-14,2023-02-03,2023-02-04,Disruption of the manufacture of the drug.,2023-01-10,2023-02-10,No
202869,02392828,Shortage,TARO-PREGABALIN,SUN PHARMA CANADA INC,PREGABALIN,PREGABALIN,50MG,500,ORAL; ORAL,Actual shortage,CAPSULE,,2023-08-10,2024-03-23,,Disruption of the manufacture of the drug.,2023-08-24,2024-03-01,No
202872,02392836,Shortage,TARO-PREGABALIN,SUN PHARMA CANADA INC,PREGABALIN,PREGABALIN,75MG,500,ORAL; ORAL,Resolved,CAPSULE,,2023-08-10,2023-11-17,2023-11-17,Disruption of the manufacture of the drug.,2023-08-24,2024-01-05,No
199131,02392828,Shortage,TARO-PREGABALIN,SUN PHARMA CANADA INC,PREGABALIN,PREGABALIN,50MG,100,ORAL; ORAL,Actual shortage,CAPSULE,,2023-05-04,2024-03-23,,Disruption of the manufacture of the drug.,2023-07-18,2024-03-01,No
208108,02392844,Shortage,TARO-PREGABALIN,SUN PHARMA CANADA INC,PREGABALIN,PREGABALIN,150MG,500,ORAL; ORAL,Avoided shortage,CAPSULE,2023-11-01,,2023-11-17,2023-01-26,Disruption of the manufacture of the drug.,2023-10-25,2024-01-05,No
199134,02310538,Shortage,TARO-RAMIPRIL,SUN PHARMA CANADA INC,RAMIPRIL,RAMIPRIL,5MG,500,ORAL; ORAL,Resolved,CAPSULE,,2023-06-20,2023-09-29,2023-09-21,Disruption of the manufacture of the drug.,2023-07-18,2023-10-25,No
180604,02449439,Shortage,TARO-RAMIPRIL HCTZ,SUN PHARMA CANADA INC,RAMIPRIL,HYDROCHLOROTHIAZIDE; RAMIPRIL,12.5MG; 2.5MG,100,ORAL; ORAL,Resolved,TABLET,,2022-12-16,2023-02-24,2023-02-24,Disruption of the manufacture of the drug.,2023-01-10,2023-02-28,No
180609,02449463,Shortage,TARO-RAMIPRIL HCTZ,SUN PHARMA CANADA INC,RAMIPRIL,HYDROCHLOROTHIAZIDE; RAMIPRIL,25MG; 5MG,100,ORAL; ORAL,Resolved,TABLET,,2022-12-30,2023-02-24,2023-02-24,Disruption of the manufacture of the drug.,2023-01-10,2023-02-28,No
199137,02449447,Shortage,TARO-RAMIPRIL HCTZ,SUN PHARMA CANADA INC,RAMIPRIL,HYDROCHLOROTHIAZIDE; RAMIPRIL,12.5MG; 5MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-18,2024-02-16,2024-02-23,Disruption of the manufacture of the drug.,2023-07-18,2024-03-01,No
199140,02449471,Shortage,TARO-RAMIPRIL HCTZ,SUN PHARMA CANADA INC,RAMIPRIL,HYDROCHLOROTHIAZIDE; RAMIPRIL,25MG; 10MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2024-02-16,2024-02-23,Disruption of the manufacture of the drug.,2023-07-18,2024-03-01,No
199143,02328305,Shortage,TARO-RISPERIDONE,SUN PHARMA CANADA INC,RISPERIDONE,RISPERIDONE,0.25MG,100,ORAL; ORAL,Resolved,TABLET,,2023-01-01,2023-10-15,2023-09-15,Disruption of the manufacture of the drug.,2023-07-18,2023-09-22,No
199146,02328313,Shortage,TARO-RISPERIDONE,SUN PHARMA CANADA INC,RISPERIDONE,RISPERIDONE,0.5MG,100,ORAL; ORAL,Resolved,TABLET,,2023-05-12,2023-09-15,2023-09-15,Disruption of the manufacture of the drug.,2023-07-18,2023-09-22,No
202875,02382644,Shortage,TARO-ROSUVASTATIN,SUN PHARMA CANADA INC,ROSUVASTATIN,ROSUVASTATIN,5MG,100,ORAL; ORAL,Resolved,TABLET,,2023-08-10,2023-11-10,2024-01-02,Disruption of the manufacture of the drug.,2023-08-24,2024-01-05,No
202878,02382644,Shortage,TARO-ROSUVASTATIN,SUN PHARMA CANADA INC,ROSUVASTATIN,ROSUVASTATIN,5MG,500,ORAL; ORAL,Resolved,TABLET,,2023-08-10,2023-11-10,2024-01-02,Disruption of the manufacture of the drug.,2023-08-24,2024-01-05,No
202881,02382652,Shortage,TARO-ROSUVASTATIN,SUN PHARMA CANADA INC,ROSUVASTATIN,ROSUVASTATIN,10MG,100,ORAL; ORAL,Resolved,TABLET,,2023-08-10,2023-11-10,2024-01-02,Disruption of the manufacture of the drug.,2023-08-24,2024-01-05,No
202884,02382652,Shortage,TARO-ROSUVASTATIN,SUN PHARMA CANADA INC,ROSUVASTATIN,ROSUVASTATIN,10MG,500,ORAL; ORAL,Resolved,TABLET,,2023-08-10,2023-11-10,2024-01-02,Disruption of the manufacture of the drug.,2023-08-24,2024-01-05,No
180612,02382660,Shortage,TARO-ROSUVASTATIN,SUN PHARMA CANADA INC,ROSUVASTATIN,ROSUVASTATIN,20MG,100,ORAL; ORAL,Resolved,TABLET,,2022-12-20,2023-01-27,2023-01-27,Disruption of the manufacture of the drug.,2023-01-10,2023-02-01,No
202889,02382660,Shortage,TARO-ROSUVASTATIN,SUN PHARMA CANADA INC,ROSUVASTATIN,ROSUVASTATIN,20MG,100,ORAL; ORAL,Resolved,TABLET,,2023-08-10,2023-11-10,2024-01-02,Disruption of the manufacture of the drug.,2023-08-24,2024-01-05,No
202893,02382660,Shortage,TARO-ROSUVASTATIN,SUN PHARMA CANADA INC,ROSUVASTATIN,ROSUVASTATIN,20MG,500,ORAL; ORAL,Resolved,TABLET,,2023-08-10,2023-11-27,2024-01-02,Disruption of the manufacture of the drug.,2023-08-24,2024-01-05,No
202896,02382679,Shortage,TARO-ROSUVASTATIN,SUN PHARMA CANADA INC,ROSUVASTATIN,ROSUVASTATIN,40MG,100,ORAL; ORAL,Resolved,TABLET,,2023-08-10,2024-02-02,2024-02-08,Disruption of the manufacture of the drug.,2023-08-24,2024-02-09,No
202899,02382679,Shortage,TARO-ROSUVASTATIN,SUN PHARMA CANADA INC,ROSUVASTATIN,ROSUVASTATIN,40MG,500,ORAL; ORAL,Resolved,TABLET,,2023-08-10,2024-02-02,2024-02-02,Disruption of the manufacture of the drug.,2023-08-24,2024-02-08,No
208126,02382660,Shortage,TARO-ROSUVASTATIN,SUN PHARMA CANADA INC,ros,ROSUVASTATIN,20MG,500,ORAL; ORAL,Resolved,TABLET,,2023-07-07,2023-11-10,2024-01-02,Disruption of the manufacture of the drug.,2023-10-26,2024-01-05,No
202932,02437988,Shortage,TARO-SOLIFENACIN,SUN PHARMA CANADA INC,SOLIFENACIN,SOLIFENACIN SUCCINATE,5MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-08-10,,,Disruption of the manufacture of the drug.,2023-08-25,2024-01-05,No
202935,02437996,Shortage,TARO-SOLIFENACIN,SUN PHARMA CANADA INC,SOLIFENACIN,SOLIFENACIN SUCCINATE,10MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-08-10,,,Disruption of the manufacture of the drug.,2023-08-25,2024-01-05,No
180463,02450437,Shortage,TARO-TRAMADOL ER,TARO PHARMACEUTICALS INC,TRAMADOL,TRAMADOL HYDROCHLORIDE,200MG,100,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2022-12-29,2023-02-24,2023-02-24,Disruption of the manufacture of the drug.,2023-01-10,2023-02-28,No
205186,02242682,Shortage,TARO-WARFARIN,TARO PHARMACEUTICALS INC,WARFARIN,WARFARIN SODIUM,2.5MG,250,ORAL; ORAL,Resolved,TABLET,,2023-07-20,2023-11-24,2023-09-27,Disruption of the manufacture of the drug.,2023-09-25,2024-01-05,No
182004,02242680,Shortage,TARO-WARFARIN,TARO PHARMACEUTICALS INC,WARFARIN,WARFARIN SODIUM,1MG,100,ORAL; ORAL,Resolved,TABLET,,2023-01-12,2023-02-10,2023-02-03,Disruption of the manufacture of the drug.,2023-01-20,2023-02-10,No
211177,02390345,Shortage,TELMISARTAN,SIVEM PHARMACEUTICALS ULC,Telmisartan,TELMISARTAN,40MG,30,ORAL; ORAL,Actual shortage,TABLET,,2023-06-28,2024-04-15,,Delay in shipping of the drug.,2023-11-22,2023-11-22,No
211180,02390345,Shortage,TELMISARTAN,SIVEM PHARMACEUTICALS ULC,Telmisartan,TELMISARTAN,40MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-08-14,2024-04-15,,Delay in shipping of the drug.,2023-11-22,2023-11-22,No
183176,02390310,Shortage,TELMISARTAN HCTZ,SIVEM PHARMACEUTICALS ULC,Telmisartan HCTZ,HYDROCHLOROTHIAZIDE; TELMISARTAN,25MG; 80MG,30,ORAL; ORAL,Resolved,TABLET,,2023-01-23,2024-01-04,2024-02-02,Delay in shipping of the drug.,2023-02-02,2024-02-03,No
183206,02390310,Shortage,TELMISARTAN HCTZ,SIVEM PHARMACEUTICALS ULC,Telmisartan HCTZ,HYDROCHLOROTHIAZIDE; TELMISARTAN,25MG; 80MG,100,ORAL; ORAL,Resolved,TABLET,,2023-02-28,2024-01-04,2024-02-02,Delay in shipping of the drug.,2023-02-02,2024-02-03,No
211171,02390302,Shortage,TELMISARTAN HCTZ,SIVEM PHARMACEUTICALS ULC,Telmisartan HCTZ,HYDROCHLOROTHIAZIDE; TELMISARTAN,12.5MG; 80MG,30,ORAL; ORAL,Resolved,TABLET,,2023-05-15,2024-02-02,2024-02-02,Other (Please describe in comments),2023-11-22,2024-02-03,No
211174,02390302,Shortage,TELMISARTAN HCTZ,SIVEM PHARMACEUTICALS ULC,Telmisartan HCTZ,HYDROCHLOROTHIAZIDE; TELMISARTAN,12.5MG; 80MG,100,ORAL; ORAL,Resolved,TABLET,,2023-05-15,2024-02-02,2024-02-02,Other (Please describe in comments),2023-11-22,2024-02-03,No
202904,02241096,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,250MG,5CAP,ORAL; ORAL,Resolved,CAPSULE,2023-10-27,2023-10-24,2024-02-19,2024-02-16,Delay in shipping of the drug.,2023-08-24,2024-02-17,No
212123,02312794,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,140MG,5CAP,ORAL; ORAL,Avoided shortage,CAPSULE,2024-02-05,,2024-02-12,2024-01-23,Delay in shipping of the drug.,2023-12-01,2024-01-23,No
192163,02241094,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,20MG,5CAP,ORAL; ORAL,Resolved,CAPSULE,,2023-05-10,2023-06-09,2023-05-26,Delay in shipping of the drug.,2023-05-10,2023-05-27,No
209354,02241093,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,5MG,5CAP,ORAL; ORAL,Resolved,CAPSULE,2023-12-04,2023-11-21,2024-01-29,2024-01-24,Delay in shipping of the drug.,2023-11-06,2024-01-25,No
209360,02241094,Shortage,TEMODAL,MERCK CANADA INC,temozolomide capsules,TEMOZOLOMIDE,20MG,5CAP,ORAL; ORAL,Resolved,CAPSULE,2023-11-27,2023-11-23,2024-01-29,2024-01-12,Demand increase for the drug.,2023-11-06,2024-01-13,No
187735,00875996,Shortage,TEMPRA DOUBLE STRENGTH CHILDREN'S SYRUP,PALADIN LABS INC.,ACETAMINOPHEN,ACETAMINOPHEN,160MG,100mL,ORAL; ORAL,Actual shortage,SYRUP,2022-03-17,2022-03-17,,,Disruption of the manufacture of the drug.,2023-03-23,2023-03-23,No
201887,02039532,Shortage,TENORMIN,SEARCHLIGHT PHARMA INC,TENORMIN,ATENOLOL,50MG,30 tabs,ORAL; ORAL,Resolved,TABLET,2023-07-01,2023-07-15,2024-02-28,2024-01-31,Requirements related to complying with good manufacturing practices.,2023-08-15,2024-02-01,No
192723,02039532,Shortage,TENORMIN,SEARCHLIGHT PHARMA INC,Tenormin,ATENOLOL,50MG,30 tabs,ORAL; ORAL,Resolved,TABLET,2023-05-05,2023-05-05,,2023-07-31,Requirements related to complying with good manufacturing practices.,2023-05-18,2023-08-01,No
192726,02039540,Shortage,TENORMIN,SEARCHLIGHT PHARMA INC,Tenormin,ATENOLOL,100MG,30 tabs,ORAL; ORAL,Resolved,TABLET,2023-05-05,2023-05-05,2024-02-28,2024-01-31,Requirements related to complying with good manufacturing practices.,2023-05-18,2024-02-01,No
195072,02416662,Shortage,TEVA-ABACAVIR/LAMIVUDINE,TEVA CANADA LIMITED,TEVA-ABACAVIR/LAMIVUDINE,LAMIVUDINE; ABACAVIR,300MG; 600MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-16,2023-08-20,2023-07-17,Disruption of the manufacture of the drug.,2023-06-16,2023-08-17,No
195900,02416662,Shortage,TEVA-ABACAVIR/LAMIVUDINE,TEVA CANADA LIMITED,TEVA-ABACAVIR/LAMIVUDINE,LAMIVUDINE; ABACAVIR,300MG; 600MG,300MG,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-08-30,2023-08-17,Disruption of the manufacture of the drug.,2023-06-20,2023-08-18,No
194180,02416662,Shortage,TEVA-ABACAVIR/LAMIVUDINE,TEVA CANADA LIMITED,TEVA-ABACAVIR/LAMIVUDINE,LAMIVUDINE; ABACAVIR,300MG; 600MG,"100, 30",ORAL; ORAL,Resolved,TABLET,,2023-06-08,2023-08-20,2023-07-04,Disruption of the manufacture of the drug.,2023-06-08,2023-07-05,No
190743,02204533,Shortage,TEVA-ACEBUTOLOL,TEVA CANADA LIMITED,TEVA-ACEBUTOLOL 400MG TABLETS 100,ACEBUTOLOL,400MG,100,ORAL; ORAL,Resolved,TABLET,,2023-04-27,2023-10-31,2023-11-01,Disruption of the manufacture of the drug.,2023-04-27,2023-11-03,No
190764,02204517,Shortage,TEVA-ACEBUTOLOL,TEVA CANADA LIMITED,TEVA-ACEBUTOLOL 100MG TABLETS 100,ACEBUTOLOL,100MG,100,ORAL; ORAL,Resolved,TABLET,,2023-04-27,2023-10-20,2023-10-25,Disruption of the manufacture of the drug.,2023-04-27,2023-10-26,No
195142,02204533,Shortage,TEVA-ACEBUTOLOL,TEVA CANADA LIMITED,TEVA-ACEBUTOLOL,ACEBUTOLOL,400MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-16,2023-07-30,2023-07-04,Disruption of the manufacture of the drug.,2023-06-16,2023-07-05,No
195237,02204517,Shortage,TEVA-ACEBUTOLOL,TEVA CANADA LIMITED,TEVA-ACEBUTOLOL,ACEBUTOLOL,100MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-16,2023-07-30,2023-07-05,Disruption of the manufacture of the drug.,2023-06-16,2023-07-06,No
207524,02261715,Shortage,TEVA-ALENDRONATE,TEVA CANADA LIMITED,ALENDRONATE 70MG TAB,ALENDRONIC ACID,70MG,50's & PP 4's,ORAL; ORAL,Resolved,TABLET,,2023-09-06,2023-12-10,2023-12-06,Disruption of the manufacture of the drug.,2023-10-19,2023-12-07,No
180894,02434849,Shortage,TEVA-ALMOTRIPTAN,TEVA CANADA LIMITED,ALMOTRIPTAN 12.5MG TABS,ALMOTRIPTAN,12.5MG,PP6,ORAL; ORAL,Resolved,TABLET,,2023-01-10,2023-06-30,2023-06-20,Disruption of the manufacture of the drug.,2023-01-12,2023-06-21,No
180897,01913492,Shortage,TEVA-ALPRAZOLAM,TEVA CANADA LIMITED,ALPRAZOLAM 0.5MG TAB,ALPRAZOLAM,0.5MG,"1,001,000",ORAL; ORAL,Resolved,TABLET,,2023-01-10,2023-03-10,2023-04-27,Disruption of the manufacture of the drug.,2023-01-12,2023-04-28,No
195594,02439263,Shortage,TEVA-AMPHETAMINE XR,TEVA CANADA LIMITED,TEVA-AMPHETAMINE XR,MIXED SALTS AMPHETAMINE,20MG,100,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2023-06-19,2023-06-30,2023-07-04,Disruption of the manufacture of the drug.,2023-06-19,2023-07-05,No
190755,02439255,Shortage,TEVA-AMPHETAMINE XR,TEVA CANADA LIMITED,TEVA-AMPHETAMINE XR 15MG CAPSULES 100,MIXED SALTS AMPHETAMINE,15MG,100,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2023-04-27,2023-08-10,2023-08-17,Disruption of the manufacture of the drug.,2023-04-27,2023-08-18,No
195876,02439247,Shortage,TEVA-AMPHETAMINE XR,TEVA CANADA LIMITED,TEVA-AMPHETAMINE XR,MIXED SALTS AMPHETAMINE,10MG,100,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2023-06-19,2023-07-20,2023-07-05,Disruption of the manufacture of the drug.,2023-06-20,2023-07-06,No
190758,02439263,Shortage,TEVA-AMPHETAMINE XR,TEVA CANADA LIMITED,TEVA-AMPHETAMINE XR 20MG CAPSULES 100,MIXED SALTS AMPHETAMINE,20MG,100,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2023-04-27,2023-07-30,2023-07-27,Disruption of the manufacture of the drug.,2023-04-27,2023-07-28,No
195891,02439239,Shortage,TEVA-AMPHETAMINE XR,TEVA CANADA LIMITED,TEVA-AMPHETAMINE XR,MIXED SALTS AMPHETAMINE,5MG,100,ORAL; ORAL,Avoided shortage,CAPSULE (EXTENDED RELEASE),,2023-06-19,2023-07-20,2022-07-05,Disruption of the manufacture of the drug.,2023-06-20,2023-07-05,No
195130,02439255,Shortage,TEVA-AMPHETAMINE XR,TEVA CANADA LIMITED,TEVA-AMPHETAMINE XR,MIXED SALTS AMPHETAMINE,15MG,100,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2023-06-16,2023-06-30,2023-07-05,Disruption of the manufacture of the drug.,2023-06-16,2023-07-06,No
195139,02439298,Shortage,TEVA-AMPHETAMINE XR,TEVA CANADA LIMITED,TEVA-AMPHETAMINE XR,MIXED SALTS AMPHETAMINE,30MG,100,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2023-06-16,2023-07-20,2023-07-04,Disruption of the manufacture of the drug.,2023-06-16,2023-07-05,No
183419,02439298,Shortage,TEVA-AMPHETAMINE XR,TEVA CANADA LIMITED,AMPHETAMINE XR 30MG CAPS,MIXED SALTS AMPHETAMINE,30MG,100,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2023-01-30,2023-08-30,2023-09-06,Disruption of the manufacture of the drug.,2023-02-02,2023-09-07,No
184219,02439239,Shortage,TEVA-AMPHETAMINE XR,TEVA CANADA LIMITED,AMPHETAMINE XR 5MG CAPS,MIXED SALTS AMPHETAMINE,5MG,100,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2023-02-07,2023-07-30,2023-07-27,Disruption of the manufacture of the drug.,2023-02-09,2023-07-28,No
184222,02439271,Shortage,TEVA-AMPHETAMINE XR,TEVA CANADA LIMITED,AMPHETAMINE XR 25MG CAPS,MIXED SALTS AMPHETAMINE,25MG,100,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2023-02-07,2023-11-30,2023-11-29,Disruption of the manufacture of the drug.,2023-02-09,2023-11-30,No
195778,02439271,Shortage,TEVA-AMPHETAMINE XR,TEVA CANADA LIMITED,TEVA-AMPHETAMINE XR,MIXED SALTS AMPHETAMINE,25MG,100,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2023-06-19,2023-07-20,2023-07-04,Disruption of the manufacture of the drug.,2023-06-20,2023-07-05,No
207494,00020885,Shortage,TEVA-AMPICILLIN,TEVA CANADA LIMITED,AMPICILLIN 500MG CAPS,AMPICILLIN,500MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-09-27,2023-11-10,2023-11-08,Disruption of the manufacture of the drug.,2023-10-19,2023-11-09,No
195882,02171791,Shortage,TEVA-ATENOLOL,TEVA CANADA LIMITED,TEVA-ATENOLOL,ATENOLOL,50MG,500,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-08-20,2023-07-04,Disruption of the manufacture of the drug.,2023-06-20,2023-07-05,No
190773,02171805,Shortage,TEVA-ATENOLOL,TEVA CANADA LIMITED,TEVA-ATENOLOL 100MG FC TABLETS 100,ATENOLOL,100MG,100,ORAL; ORAL,Resolved,TABLET,,2023-04-27,2023-09-20,2023-09-20,Disruption of the manufacture of the drug.,2023-04-27,2023-10-04,No
180900,02171791,Shortage,TEVA-ATENOLOL,TEVA CANADA LIMITED,TEVA-ATENOLOL 50MG FC TAB,ATENOLOL,50MG,100,ORAL; ORAL,Resolved,TABLET,,2023-01-10,2023-10-10,2023-10-04,Disruption of the manufacture of the drug.,2023-01-12,2023-10-05,No
195751,02171805,Shortage,TEVA-ATENOLOL,TEVA CANADA LIMITED,TEVA-ATENOLOL,ATENOLOL,100MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-08-30,2023-07-04,Disruption of the manufacture of the drug.,2023-06-20,2023-07-05,No
195772,02171791,Shortage,TEVA-ATENOLOL,TEVA CANADA LIMITED,TEVA-ATENOLOL,ATENOLOL,50MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-08-20,2023-07-04,Disruption of the manufacture of the drug.,2023-06-20,2023-07-05,No
209669,02314541,Shortage,TEVA-ATOMOXETINE,TEVA CANADA LIMITED,TEVA-ATOMOXETINE 10MG CAPS,ATOMOXETINE,10MG,UD 30,ORAL; ORAL,Resolved,CAPSULE,,2023-11-08,2023-12-10,2023-12-13,Disruption of the manufacture of the drug.,2023-11-09,2023-12-14,No
211982,02310899,Shortage,TEVA-ATORVASTATIN,TEVA CANADA LIMITED,ATORVASTATIN 10 MG FC TAB,ATORVASTATIN,10MG,90,ORAL; ORAL,Resolved,TABLET,,2023-11-29,2024-01-20,2024-01-10,Disruption of the manufacture of the drug.,2023-11-30,2024-01-11,No
211988,02310910,Shortage,TEVA-ATORVASTATIN,TEVA CANADA LIMITED,ATORVASTATIN 40MG FC TAB,ATORVASTATIN,40MG,PP 30's,ORAL; ORAL,Resolved,TABLET,,2023-11-29,2023-12-20,2023-12-06,Disruption of the manufacture of the drug.,2023-11-30,2023-12-07,No
211992,02310910,Shortage,TEVA-ATORVASTATIN,TEVA CANADA LIMITED,ATORVASTATIN 40MG FC TAB,ATORVASTATIN,40MG,90,ORAL; ORAL,Resolved,TABLET,,2023-11-29,2024-01-10,2024-01-10,Disruption of the manufacture of the drug.,2023-11-30,2024-01-11,No
213371,02310929,Shortage,TEVA-ATORVASTATIN,TEVA CANADA LIMITED,ATORVASTATIN 80MG FC TAB,ATORVASTATIN,80MG,90,ORAL; ORAL,Resolved,TABLET,,2023-12-13,2024-01-31,2024-01-30,Disruption of the manufacture of the drug.,2023-12-14,2024-02-01,No
210428,02310902,Shortage,TEVA-ATORVASTATIN,TEVA CANADA LIMITED,ATORVASTATIN 20MG FC TAB,ATORVASTATIN,20MG,90,ORAL; ORAL,Resolved,TABLET,,2023-11-15,2023-12-10,2023-12-13,Disruption of the manufacture of the drug.,2023-11-16,2023-12-14,No
195606,02236819,Shortage,TEVA-AZATHIOPRINE,TEVA CANADA LIMITED,TEVA-AZATHIOPRINE,AZATHIOPRINE,50MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-07-10,2023-07-11,Disruption of the manufacture of the drug.,2023-06-19,2023-07-12,No
190782,02236819,Shortage,TEVA-AZATHIOPRINE,TEVA CANADA LIMITED,TEVA-AZATHIOPRINE 50MG TABLET 100,AZATHIOPRINE,50MG,100,ORAL; ORAL,Resolved,TABLET,,2023-04-27,2023-07-20,2023-07-20,Disruption of the manufacture of the drug.,2023-04-27,2023-07-21,No
208254,02280183,Shortage,TEVA-BETAHISTINE,TEVA CANADA LIMITED,BETAHISTINE 8MG TAB,BETAHISTINE HYDROCHLORIDE,8MG,100,ORAL; ORAL,Resolved,TABLET,,2023-10-11,2023-11-20,2023-11-20,Disruption of the manufacture of the drug.,2023-10-26,2023-11-23,No
208257,02280205,Shortage,TEVA-BETAHISTINE,TEVA CANADA LIMITED,TEVA-BETAHISTINE 24MG TAB,BETAHISTINE HYDROCHLORIDE,24MG,100,ORAL; ORAL,Resolved,TABLET,,2023-10-18,2023-11-10,2023-11-01,Disruption of the manufacture of the drug.,2023-10-26,2023-11-03,No
184198,02280191,Shortage,TEVA-BETAHISTINE,TEVA CANADA LIMITED,BETAHISTINE 16MG TAB,BETAHISTINE HYDROCHLORIDE,16MG,PP 100,ORAL; ORAL,Resolved,TABLET,,2023-02-07,2023-05-20,2023-06-08,Disruption of the manufacture of the drug.,2023-02-09,2023-06-09,No
184201,02280205,Shortage,TEVA-BETAHISTINE,TEVA CANADA LIMITED,BETAHISTINE 24MG TAB,BETAHISTINE HYDROCHLORIDE,24MG,PP 100,ORAL; ORAL,Resolved,TABLET,,2023-02-07,2023-06-30,2023-07-05,Disruption of the manufacture of the drug.,2023-02-09,2023-07-06,No
195512,02280205,Shortage,TEVA-BETAHISTINE,TEVA CANADA LIMITED,TEVA-BETAHISTINE,BETAHISTINE HYDROCHLORIDE,24MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-06-20,2023-06-20,Disruption of the manufacture of the drug.,2023-06-19,2023-06-21,No
196403,02427419,Shortage,TEVA-BETAMETHASONE/ CALCIPOTRIOL,TEVA CANADA LIMITED,TEVA-BETAMETHASONE/ CALCIPOTRIOL,CALCIPOTRIOL; BETAMETHASONE,50MCG; 0.5MG,120G,TOPICAL,Resolved,OINTMENT,,2023-06-23,2023-07-10,2023-07-05,Disruption of the manufacture of the drug.,2023-06-26,2023-07-06,No
195478,02465957,Shortage,TEVA-BUDESONIDE,TEVA CANADA LIMITED,TEVA-BUDESONIDE,BUDESONIDE,0.5MG,20,INHALATION; INHALATION,Actual shortage,SUSPENSION,,2023-06-19,2024-05-10,,Disruption of the manufacture of the drug.,2023-06-19,2024-03-28,No
195815,02465949,Shortage,TEVA-BUDESONIDE,TEVA CANADA LIMITED,TEVA-BUDESONIDE,BUDESONIDE,0.125MG,2,INHALATION; INHALATION,Resolved,SUSPENSION,,2023-06-19,2023-07-20,2023-07-05,Disruption of the manufacture of the drug.,2023-06-20,2023-07-06,No
209145,02465949,Shortage,TEVA-BUDESONIDE,TEVA CANADA LIMITED,TEVA-BUDESONIDE INH 0.125MG/ML,BUDESONIDE,0.125MG,2 pk,INHALATION; INHALATION,Resolved,SUSPENSION,,2023-11-01,2024-02-29,2024-01-18,Disruption of the manufacture of the drug.,2023-11-03,2024-01-19,No
209672,02439662,Shortage,TEVA-BUPROPION XL,TEVA CANADA LIMITED,02439662,BUPROPION HYDROCHLORIDE,300MG,500,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-11-01,2023-12-20,2023-12-06,Disruption of the manufacture of the drug.,2023-11-09,2023-12-07,No
190728,02439662,Shortage,TEVA-BUPROPION XL,TEVA CANADA LIMITED,TEVA-BUPROPION XL 300MG SR TABLETS 500,BUPROPION HYDROCHLORIDE,300MG,500,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-04-27,2023-05-30,2023-06-08,Disruption of the manufacture of the drug.,2023-04-27,2023-06-09,No
211985,02366312,Shortage,TEVA-CANDESARTAN,TEVA CANADA LIMITED,CANDESARTAN 8MG TAB,CANDESARTAN CILEXETIL,8MG,100,ORAL; ORAL,Resolved,TABLET,,2023-11-29,2024-01-20,2024-01-10,Disruption of the manufacture of the drug.,2023-11-30,2024-01-11,No
195115,02366320,Shortage,TEVA-CANDESARTAN,TEVA CANADA LIMITED,TEVA-CANDESARTAN,CANDESARTAN CILEXETIL,16MG,PP 30,ORAL; ORAL,Resolved,TABLET,,2023-06-16,2023-07-30,2023-07-27,Disruption of the manufacture of the drug.,2023-06-16,2023-07-28,No
181599,02366320,Shortage,TEVA-CANDESARTAN,TEVA CANADA LIMITED,CANDESARTAN 32MG TABS,CANDESARTAN CILEXETIL,16MG,100,ORAL; ORAL,Resolved,TABLET,,2023-01-18,2023-07-30,2023-06-08,Disruption of the manufacture of the drug.,2023-01-19,2023-06-09,No
181605,02366339,Shortage,TEVA-CANDESARTAN,TEVA CANADA LIMITED,CANDESARTAN 32MG TABS,CANDESARTAN CILEXETIL,32MG,30UD,ORAL; ORAL,Resolved,TABLET,,2023-01-18,2023-02-20,2023-04-27,Disruption of the manufacture of the drug.,2023-01-19,2023-04-28,No
194154,02366339,Shortage,TEVA-CANDESARTAN,TEVA CANADA LIMITED,TEVA-CANDESARTAN,CANDESARTAN CILEXETIL,32MG,30,ORAL; ORAL,Resolved,TABLET,,2023-06-08,2023-10-20,2023-10-18,Disruption of the manufacture of the drug.,2023-06-08,2023-10-19,No
183413,02366320,Shortage,TEVA-CANDESARTAN,TEVA CANADA LIMITED,CANDESARTAN 16MG TABS,CANDESARTAN CILEXETIL,16MG,PP30,ORAL; ORAL,Resolved,TABLET,,2023-01-30,2023-04-30,2023-06-08,Disruption of the manufacture of the drug.,2023-02-02,2023-06-09,No
195557,02366339,Shortage,TEVA-CANDESARTAN,TEVA CANADA LIMITED,TEVA-CANDESARTAN,CANDESARTAN CILEXETIL,32MG,30,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-07-30,2023-07-04,Disruption of the manufacture of the drug.,2023-06-19,2023-07-05,No
206425,02395568,Shortage,TEVA-CANDESARTAN/HCTZ,TEVA CANADA LIMITED,CANDESARTAN/HCTZ 32/12.5MG,HYDROCHLOROTHIAZIDE; CANDESARTAN CILEXETIL,12.5MG; 32MG,PP,ORAL; ORAL,Resolved,TABLET,,2023-05-24,2024-03-31,2024-04-03,Disruption of the manufacture of the drug.,2023-10-05,2024-04-05,No
211973,00782718,Shortage,TEVA-CARBAMAZEPINE,TEVA CANADA LIMITED,CARBAMAZEPINE 200MG TAB,CARBAMAZEPINE,200MG,500,ORAL; ORAL,Resolved,TABLET,,2023-11-29,2024-02-20,2024-02-14,Disruption of the manufacture of the drug.,2023-11-30,2024-02-15,No
183380,00782718,Shortage,TEVA-CARBAMAZEPINE,TEVA CANADA LIMITED,CARBAMAZEPINE 200MG TAB,CARBAMAZEPINE,200MG,100,ORAL; ORAL,Resolved,TABLET,,2023-01-30,2023-03-20,2023-04-27,Disruption of the manufacture of the drug.,2023-02-02,2023-04-28,No
196406,02235134,Shortage,TEVA-CEFADROXIL,TEVA CANADA LIMITED,TEVA-CEFADROXIL,CEFADROXIL,500MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-06-23,2024-01-31,2024-01-10,Disruption of the manufacture of the drug.,2023-06-26,2024-01-11,No
190716,02235134,Shortage,TEVA-CEFADROXIL,TEVA CANADA LIMITED,TEVA-CEFADROXIL 500MG CAPSULES 100,CEFADROXIL,500MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-04-27,2023-05-30,2023-06-08,Disruption of the manufacture of the drug.,2023-04-27,2023-06-09,No
195885,00342114,Shortage,TEVA-CEPHALEXIN,TEVA CANADA LIMITED,TEVA-CEPHALEXIN,CEPHALEXIN,500MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-06-19,2023-07-30,2023-07-04,Disruption of the manufacture of the drug.,2023-06-20,2023-07-05,No
195894,00342084,Shortage,TEVA-CEPHALEXIN,TEVA CANADA LIMITED,TEVA-CEPHALEXIN,CEPHALEXIN,250MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-06-19,2023-07-20,2023-07-05,Disruption of the manufacture of the drug.,2023-06-20,2023-07-06,No
209136,00583413,Shortage,TEVA-CEPHALEXIN,TEVA CANADA LIMITED,TEVA-CEPHALEXIN 250MG TAB,CEPHALEXIN,250MG,100,ORAL; ORAL,Resolved,TABLET,,2023-11-01,2024-06-20,2024-04-17,Disruption of the manufacture of the drug.,2023-11-03,2024-04-18,No
211316,00342106,Shortage,TEVA-CEPHALEXIN 125,TEVA CANADA LIMITED,CEPHALEXIN SUSP 125MG/5ML,CEPHALEXIN,125MG,150ml,ORAL; ORAL,Resolved,POWDER FOR SUSPENSION,,2023-11-22,2024-03-31,2024-03-26,Disruption of the manufacture of the drug.,2023-11-23,2024-03-28,No
195228,00342106,Shortage,TEVA-CEPHALEXIN 125,TEVA CANADA LIMITED,TEVA-CEPHALEXIN 125,CEPHALEXIN,125MG,150ML,ORAL; ORAL,Resolved,POWDER FOR SUSPENSION,,2023-06-16,2023-08-20,2023-07-27,Disruption of the manufacture of the drug.,2023-06-16,2023-07-28,No
197282,00342106,Shortage,TEVA-CEPHALEXIN 125,TEVA CANADA LIMITED,TEVA-CEPHALEXIN 125,CEPHALEXIN,125MG,100ML,ORAL; ORAL,Resolved,POWDER FOR SUSPENSION,,2023-07-04,2023-09-10,2023-09-30,Disruption of the manufacture of the drug.,2023-07-04,2023-10-03,No
197743,00342092,Shortage,TEVA-CEPHALEXIN 250,TEVA CANADA LIMITED,TEVA-CEPHALEXIN 250,CEPHALEXIN,250MG,150ML,ORAL; ORAL,Resolved,POWDER FOR SUSPENSION,,2023-07-06,2023-08-10,2023-07-27,Disruption of the manufacture of the drug.,2023-07-06,2023-07-28,No
207500,00342092,Shortage,TEVA-CEPHALEXIN 250,TEVA CANADA LIMITED,CEPHALEXIN SUSP 250MG/5ML,CEPHALEXIN,250MG,100ml,ORAL; ORAL,Resolved,POWDER FOR SUSPENSION,,2023-10-11,2024-02-20,2024-02-14,Disruption of the manufacture of the drug.,2023-10-19,2024-02-15,No
200864,00342092,Shortage,TEVA-CEPHALEXIN 250,TEVA CANADA LIMITED,TEVA-CEPHALEXIN 250,CEPHALEXIN,250MG,150ML,ORAL; ORAL,Actual shortage,POWDER FOR SUSPENSION,,2023-08-03,2024-04-30,,Disruption of the manufacture of the drug.,2023-08-03,2024-04-18,No
195554,00342092,Shortage,TEVA-CEPHALEXIN 250,TEVA CANADA LIMITED,TEVA-CEPHALEXIN 250,CEPHALEXIN,250MG,150ML,ORAL; ORAL,Resolved,POWDER FOR SUSPENSION,,2023-06-19,2023-07-10,2023-06-26,Disruption of the manufacture of the drug.,2023-06-19,2023-06-27,No
190761,00232823,Shortage,TEVA-CHLORPROMAZINE,TEVA CANADA LIMITED,TEVA-CHLORPROMAZINE 25MG TABS 500,CHLORPROMAZINE,25.0MG,500,ORAL; ORAL,Resolved,TABLET,,2023-04-27,2023-06-20,2023-06-08,Disruption of the manufacture of the drug.,2023-04-27,2023-06-09,No
202490,02238334,Shortage,TEVA-CLOBAZAM,TEVA CANADA LIMITED,TEVA-CLOBAZAM,CLOBAZAM,10MG,PP 30,ORAL; ORAL,Resolved,TABLET,,2023-08-18,2023-09-20,2023-09-20,Disruption of the manufacture of the drug.,2023-08-18,2023-10-04,No
195867,01910272,Shortage,TEVA-CLOBETASOL,TEVA CANADA LIMITED,TEVA-CLOBETASOL,CLOBETASOL PROPIONATE,0.05%,50G,TOPICAL; TOPICAL,Resolved,CREAM,,2023-06-19,2023-10-20,2023-07-04,Disruption of the manufacture of the drug.,2023-06-20,2023-07-05,No
194080,01910272,Shortage,TEVA-CLOBETASOL,TEVA CANADA LIMITED,TEVA-CLOBETASOL,CLOBETASOL PROPIONATE,0.05%,50G,TOPICAL; TOPICAL,Resolved,CREAM,,2023-06-08,2023-09-10,2023-09-10,Disruption of the manufacture of the drug.,2023-06-08,2023-10-04,No
181611,01910272,Shortage,TEVA-CLOBETASOL,TEVA CANADA LIMITED,TEVA-CLOBETASOL 0.05% CREAM,CLOBETASOL PROPIONATE,0.05%,50g,TOPICAL; TOPICAL,Resolved,CREAM,,2023-01-18,2023-02-28,2023-01-24,Disruption of the manufacture of the drug.,2023-01-19,2023-01-26,No
199313,01910272,Shortage,TEVA-CLOBETASOL,TEVA CANADA LIMITED,TEVA-CLOBETASOL,CLOBETASOL PROPIONATE,0.05%,15g,TOPICAL; TOPICAL,Resolved,CREAM,,2023-07-20,2023-08-30,2023-08-30,Disruption of the manufacture of the drug.,2023-07-20,2023-10-04,No
195888,02046148,Shortage,TEVA-CLONIDINE,TEVA CANADA LIMITED,TEVA-CLONIDINE,CLONIDINE HYDROCHLORIDE,0.2MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-07-31,2023-07-04,Disruption of the manufacture of the drug.,2023-06-20,2023-07-05,No
183364,02046121,Shortage,TEVA-CLONIDINE,TEVA CANADA LIMITED,CLONIDINE 0.1MG TAB,CLONIDINE HYDROCHLORIDE,0.1MG,100,ORAL; ORAL,Resolved,TABLET,,2023-01-30,2023-03-10,2023-04-27,Disruption of the manufacture of the drug.,2023-02-02,2023-04-28,No
206416,02304163,Shortage,TEVA-CLONIDINE,TEVA CANADA LIMITED,CLONIDINE 0.025MG TAB,CLONIDINE HYDROCHLORIDE,0.025MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-08-02,2024-04-30,,Disruption of the manufacture of the drug.,2023-10-05,2023-10-05,No
184946,02046148,Shortage,TEVA-CLONIDINE,TEVA CANADA LIMITED,CLONIDINE 0.2MG TAB,CLONIDINE HYDROCHLORIDE,0.2MG,100,ORAL; ORAL,Resolved,TABLET,,2023-02-14,2023-09-20,2023-09-30,Disruption of the manufacture of the drug.,2023-02-16,2023-10-04,No
190752,02293161,Shortage,TEVA-CLOPIDOGREL,TEVA CANADA LIMITED,TEVA-CLOPIDOGREL 75MG TABLETS 100,CLOPIDOGREL,75MG,"100,30",ORAL; ORAL,Resolved,TABLET,,2023-04-27,2023-07-20,2023-07-04,Disruption of the manufacture of the drug.,2023-04-27,2023-07-05,No
195803,02293161,Shortage,TEVA-CLOPIDOGREL,TEVA CANADA LIMITED,TEVA-CLOPIDOGREL,CLOPIDOGREL,75MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-10-20,2023-10-05,Disruption of the manufacture of the drug.,2023-06-20,2023-10-06,No
195566,02293161,Shortage,TEVA-CLOPIDOGREL,TEVA CANADA LIMITED,TEVA-CLOPIDOGREL,CLOPIDOGREL,75MG,500,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-10-10,2023-10-05,Disruption of the manufacture of the drug.,2023-06-19,2023-10-06,No
212720,02388065,Shortage,TEVA-CLOPIDOGREL,TEVA CANADA LIMITED,CLOPIDOGREL 300MG TAB,CLOPIDOGREL,300MG,PP30,ORAL; ORAL,Actual shortage,TABLET,,2023-12-06,2024-06-30,,Disruption of the manufacture of the drug.,2023-12-07,2024-04-18,No
195824,02293161,Shortage,TEVA-CLOPIDOGREL,TEVA CANADA LIMITED,TEVA-CLOPIDOGREL,CLOPIDOGREL,75MG,30,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-10-20,2023-10-05,Disruption of the manufacture of the drug.,2023-06-20,2023-10-06,No
194054,00337757,Shortage,TEVA-CLOXACILLIN,TEVA CANADA LIMITED,TEVA-CLOXACILLIN,CLOXACILLIN,125MG,100,ORAL; ORAL,Resolved,GRANULES FOR SOLUTION,,2023-06-08,2023-08-10,2023-07-04,Disruption of the manufacture of the drug.,2023-06-08,2023-07-05,No
198587,00337773,Shortage,TEVA-CLOXACILLIN,TEVA CANADA LIMITED,TEVA-CLOXACILLIN,CLOXACILLIN,500MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-07-13,2023-08-20,2023-08-30,Disruption of the manufacture of the drug.,2023-07-13,2023-10-03,No
195518,00337757,Shortage,TEVA-CLOXACILLIN,TEVA CANADA LIMITED,TEVA-CLOXACILLIN,CLOXACILLIN,125MG,100ML,ORAL; ORAL,Resolved,GRANULES FOR SOLUTION,,2023-06-19,2023-09-20,2023-09-30,Disruption of the manufacture of the drug.,2023-06-19,2023-10-03,No
190701,00593435,Shortage,TEVA-CODEINE,TEVA CANADA LIMITED,TEVA-CODEINE 15MG TABLETS 100,CODEINE PHOSPHATE,15MG,100,ORAL; ORAL,Resolved,TABLET,,2023-04-27,2023-05-30,2023-06-08,Disruption of the manufacture of the drug.,2023-04-27,2023-06-09,No
212714,02053403,Shortage,TEVA-COTRIDIN EXPECTORANT,TEVA CANADA LIMITED,TEVA-COTRIDIN EXPECTORANT SYRUP,CODEINE PHOSPHATE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE,10MG; 100MG; 30MG; 2MG,500ml,ORAL; ORAL,Actual shortage,SYRUP,,2023-12-06,2024-03-10,,Disruption of the manufacture of the drug.,2023-12-07,2024-02-22,No
184931,02462486,Shortage,TEVA-CYCLOSPORINE,TEVA CANADA LIMITED,CYCLOSPORINE 0.05% OPH SOLN,CYCLOSPORINE,0.05%,0.4ml,OPHTHALMIC; OPHTHALMIC,Resolved,EMULSION,,2023-02-14,2023-07-30,2023-08-03,Disruption of the manufacture of the drug.,2023-02-16,2023-08-04,No
195563,02462486,Shortage,TEVA-CYCLOSPORINE,TEVA CANADA LIMITED,TEVA-CYCLOSPORINE,CYCLOSPORINE,0.05%,0.4ML,OPHTHALMIC; OPHTHALMIC,Resolved,EMULSION,,2023-06-19,2023-08-30,2023-07-04,Disruption of the manufacture of the drug.,2023-06-19,2023-07-05,No
212730,02462486,Shortage,TEVA-CYCLOSPORINE,TEVA CANADA LIMITED,CYCLOSPORINE 0.05% OPH SOLN,CYCLOSPORINE,0.05%,0.4ml,OPHTHALMIC; OPHTHALMIC,Resolved,EMULSION,,2023-12-06,2024-03-20,2024-03-20,Disruption of the manufacture of the drug.,2023-12-07,2024-03-21,No
210431,02462486,Shortage,TEVA-CYCLOSPORINE,TEVA CANADA LIMITED,CYCLOSPORINE 0.05% OPH SOLN,CYCLOSPORINE,0.05%,4ml,OPHTHALMIC; OPHTHALMIC,Resolved,EMULSION,,2023-11-15,2024-02-20,2023-11-20,Disruption of the manufacture of the drug.,2023-11-16,2023-11-23,No
194128,02309556,Shortage,TEVA-CYPROTERONE / ETHINYL ESTRADIOL,TEVA CANADA LIMITED,TEVA-CYPROTERONE / ETHINYL ESTRADIOL,ETHINYL ESTRADIOL; CYPROTERONE ACETATE,0.035MG; 2MG,21,ORAL; ORAL,Resolved,TABLET,,2023-06-08,2023-06-20,2023-06-20,Disruption of the manufacture of the drug.,2023-06-08,2023-06-21,No
199199,02429330,Shortage,TEVA-DILTIAZEM XC,TEVA CANADA LIMITED,TEVA-DILTIAZEM XC,DILTIAZEM HYDROCHLORIDE,240MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-07-19,2023-12-10,2023-12-13,Disruption of the manufacture of the drug.,2023-07-19,2023-12-14,No
199717,02429349,Shortage,TEVA-DILTIAZEM XC,TEVA CANADA LIMITED,TEVA-DILTIAZEM XC,DILTIAZEM HYDROCHLORIDE,300MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-07-21,2024-01-10,2024-01-10,Disruption of the manufacture of the drug.,2023-07-21,2024-01-11,No
206904,02429322,Shortage,TEVA-DILTIAZEM XC,TEVA CANADA LIMITED,DILTIAZEM XC 180MG TAB,DILTIAZEM HYDROCHLORIDE,180MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-08-30,2023-12-10,2023-12-06,Disruption of the manufacture of the drug.,2023-10-12,2023-12-07,No
184919,02429322,Shortage,TEVA-DILTIAZEM XC,TEVA CANADA LIMITED,DILTIAZEM XC 180MG TAB,DILTIAZEM HYDROCHLORIDE,180MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-02-14,2023-03-20,2023-04-27,Disruption of the manufacture of the drug.,2023-02-16,2023-04-28,No
184922,02429330,Shortage,TEVA-DILTIAZEM XC,TEVA CANADA LIMITED,DILTIAZEM XC 240MG TAB,DILTIAZEM HYDROCHLORIDE,240MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-02-14,2023-03-20,2023-04-27,Disruption of the manufacture of the drug.,2023-02-16,2023-04-28,No
184925,02429349,Shortage,TEVA-DILTIAZEM XC,TEVA CANADA LIMITED,DILTIAZEM XC 300MG TAB,DILTIAZEM HYDROCHLORIDE,300MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-02-14,2023-03-20,2023-04-27,Disruption of the manufacture of the drug.,2023-02-16,2023-04-28,No
194191,02429357,Shortage,TEVA-DILTIAZEM XC,TEVA CANADA LIMITED,TEVA-DILTIAZEM XC,DILTIAZEM HYDROCHLORIDE,360MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-06-08,2023-12-20,2023-12-21,Disruption of the manufacture of the drug.,2023-06-08,2024-01-08,No
195763,02429357,Shortage,TEVA-DILTIAZEM XC,TEVA CANADA LIMITED,TEVA-DILTIAZEM XC,DILTIAZEM HYDROCHLORIDE,360MG,100,ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-06-19,2023-07-30,2023-07-04,Disruption of the manufacture of the drug.,2023-06-20,2023-07-05,No
184183,01912070,Shortage,TEVA-DOMPERIDONE,TEVA CANADA LIMITED,DOMPERIDONE 10MG TAB,DOMPERIDONE,10MG,500,ORAL; ORAL,Resolved,TABLET,,2023-02-07,2023-05-20,2023-06-08,Disruption of the manufacture of the drug.,2023-02-09,2023-06-09,No
207506,01912070,Shortage,TEVA-DOMPERIDONE,TEVA CANADA LIMITED,DOMPERIDONE 10MG TAB,DOMPERIDONE,10MG,500,ORAL; ORAL,Resolved,TABLET,,2023-05-17,2023-11-30,2023-11-29,Disruption of the manufacture of the drug.,2023-10-19,2023-11-30,No
202249,02242730,Shortage,TEVA-DOXAZOSIN,TEVA CANADA LIMITED,TEVA-DOXAZOSIN,DOXAZOSIN,4MG,100,ORAL; ORAL,Resolved,TABLET,,2023-08-17,2023-09-10,2023-09-10,Disruption of the manufacture of the drug.,2023-08-17,2023-10-04,No
183367,02242729,Shortage,TEVA-DOXAZOSIN,TEVA CANADA LIMITED,DOXAZOSIN 2MG TAB,DOXAZOSIN,2MG,100,ORAL; ORAL,Resolved,TABLET,,2023-01-30,2023-04-10,2023-04-27,Disruption of the manufacture of the drug.,2023-02-02,2023-04-28,No
180903,02242730,Shortage,TEVA-DOXAZOSIN,TEVA CANADA LIMITED,DOXAZOSIN 4MG TAB,DOXAZOSIN,4MG,100,ORAL; ORAL,Resolved,TABLET,,2023-01-10,2023-02-28,2023-02-14,Disruption of the manufacture of the drug.,2023-01-12,2023-02-16,No
206431,02456753,Shortage,TEVA-DULOXETINE,TEVA CANADA LIMITED,TEVA-DULOXETINE HCL 30MG CAPS,DULOXETINE,30MG,100,ORAL; ORAL,Actual shortage,CAPSULE (DELAYED RELEASE),,2023-09-09,2024-02-29,,Disruption of the manufacture of the drug.,2023-10-05,2024-01-25,No
198391,02456761,Shortage,TEVA-DULOXETINE,TEVA CANADA LIMITED,TEVA-DULOXETINE,DULOXETINE,60MG,PP30,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-07-12,2023-12-10,2023-11-20,Disruption of the manufacture of the drug.,2023-07-12,2023-11-23,No
195164,02408287,Shortage,TEVA-DUTASTERIDE,TEVA CANADA LIMITED,TEVA-DUTASTERIDE,DUTASTERIDE,0.5MG,30,ORAL; ORAL,Resolved,CAPSULE,,2023-06-16,2023-07-10,2023-07-04,Disruption of the manufacture of the drug.,2023-06-16,2023-07-05,No
184216,02408287,Shortage,TEVA-DUTASTERIDE,TEVA CANADA LIMITED,DUTASTERIDE 0.5MG CAP,DUTASTERIDE,0.5MG,100,ORAL; ORAL,Actual shortage,CAPSULE,,2023-02-08,2024-04-30,,Disruption of the manufacture of the drug.,2023-02-09,2024-04-11,No
207548,02408287,Shortage,TEVA-DUTASTERIDE,TEVA CANADA LIMITED,DUTASTERIDE 0.5MG CAPS,DUTASTERIDE,0.5MG,pp 30,ORAL; ORAL,Resolved,CAPSULE,,2023-07-05,2024-04-20,2024-04-09,Disruption of the manufacture of the drug.,2023-10-19,2024-04-11,No
195775,02408287,Shortage,TEVA-DUTASTERIDE,TEVA CANADA LIMITED,TEVA-DUTASTERIDE,DUTASTERIDE,0.5MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-06-19,2023-07-30,2023-07-04,Disruption of the manufacture of the drug.,2023-06-20,2023-07-05,No
195600,00535427,Shortage,TEVA-ECTOSONE,TEVA CANADA LIMITED,TEVA-ECTOSONE,BETAMETHASONE,0.05%,450G,TOPICAL; TOPICAL,Resolved,CREAM,,2023-06-19,2023-09-30,2023-07-04,Disruption of the manufacture of the drug.,2023-06-19,2023-07-05,No
194068,00535427,Shortage,TEVA-ECTOSONE,TEVA CANADA LIMITED,TEVA-ECTOSONE,BETAMETHASONE,0.05%,450G,TOPICAL; TOPICAL,Resolved,CREAM,,2023-06-08,2023-12-10,2023-11-15,Disruption of the manufacture of the drug.,2023-06-08,2023-11-16,No
194074,00653209,Shortage,TEVA-ECTOSONE,TEVA CANADA LIMITED,TEVA-ECTOSONE,BETAMETHASONE,0.05%,60ML,TOPICAL; TOPICAL,Resolved,LOTION,,2023-06-08,2024-05-20,2024-03-06,Disruption of the manufacture of the drug.,2023-06-08,2024-03-07,No
195634,00750050,Shortage,TEVA-ECTOSONE,TEVA CANADA LIMITED,TEVA-ECTOSONE,BETAMETHASONE,0.10%,60ML,TOPICAL; TOPICAL,Resolved,LOTION,,2023-06-19,2024-03-10,2024-03-10,Disruption of the manufacture of the drug.,2023-06-19,2024-03-18,No
195189,00653209,Shortage,TEVA-ECTOSONE,TEVA CANADA LIMITED,TEVA-ECTOSONE,BETAMETHASONE,0.05%,60ML,TOPICAL; TOPICAL,Resolved,LOTION,,2023-06-16,2023-11-20,2023-07-04,Disruption of the manufacture of the drug.,2023-06-16,2023-07-05,No
195795,00535435,Shortage,TEVA-ECTOSONE,TEVA CANADA LIMITED,TEVA-ECTOSONE,BETAMETHASONE,0.10%,450G,TOPICAL; TOPICAL,Resolved,CREAM,,2023-06-19,2023-07-20,2023-07-04,Disruption of the manufacture of the drug.,2023-06-20,2023-07-05,No
190689,00750050,Shortage,TEVA-ECTOSONE,TEVA CANADA LIMITED,TEVA-ECTOSONE 0.1% REGULAR LOTION 60ML,BETAMETHASONE,0.10%,60ml,TOPICAL; TOPICAL,Resolved,LOTION,,2023-04-27,2023-07-20,2023-07-04,Other (Please describe in comments),2023-04-27,2023-07-05,No
195858,02389762,Shortage,TEVA-EFAVIRENZ,TEVA CANADA LIMITED,TEVA-EFAVIRENZ,EFAVIRENZ,600MG,30,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-06-30,2023-07-05,Disruption of the manufacture of the drug.,2023-06-20,2023-07-06,No
190767,02389762,Shortage,TEVA-EFAVIRENZ,TEVA CANADA LIMITED,TEVA-EFAVIRENZ 600MG TABLETS 30,EFAVIRENZ,600MG,30,ORAL; ORAL,Resolved,TABLET,,2023-04-27,2023-07-10,2023-07-05,Disruption of the manufacture of the drug.,2023-04-27,2023-07-06,No
199190,02375559,Shortage,TEVA-ENTACAPONE,TEVA CANADA LIMITED,TEVA-ENTACAPONE,ENTACAPONE,200MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-19,2023-08-20,2023-08-03,Disruption of the manufacture of the drug.,2023-07-19,2023-08-04,No
195133,02318180,Shortage,TEVA-ESCITALOPRAM,TEVA CANADA LIMITED,TEVA-ESCITALOPRAM,ESCITALOPRAM,10MG,30,ORAL; ORAL,Resolved,TABLET,,2023-06-16,2023-06-20,2023-06-26,Disruption of the manufacture of the drug.,2023-06-16,2023-06-27,No
194141,02318180,Shortage,TEVA-ESCITALOPRAM,TEVA CANADA LIMITED,TEVA-ESCITALOPRAM,ESCITALOPRAM,10MG,30,ORAL; ORAL,Resolved,TABLET,,2023-06-08,2023-07-10,2023-06-26,Disruption of the manufacture of the drug.,2023-06-08,2023-06-27,No
180906,02318202,Shortage,TEVA-ESCITALOPRAM,TEVA CANADA LIMITED,ESCITALOPRAM 20MG TABS,ESCITALOPRAM,20MG,PP30,ORAL; ORAL,Resolved,TABLET,,2023-01-10,2023-04-10,2023-04-27,Disruption of the manufacture of the drug.,2023-01-12,2023-04-28,No
195052,02423863,Shortage,TEVA-ESOMEPRAZOLE,TEVA CANADA LIMITED,TEVA-ESOMEPRAZOLE,ESOMEPRAZOLE,40MG,100,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE),,2023-06-16,2024-04-10,2024-01-18,Disruption of the manufacture of the drug.,2023-06-16,2024-01-19,No
183416,02408473,Shortage,TEVA-EXEMESTANE,TEVA CANADA LIMITED,EXEMESTANE 25MG TAB,EXEMESTANE,25MG,PP30,ORAL; ORAL,Resolved,TABLET,,2023-01-30,2023-03-20,2023-04-27,Disruption of the manufacture of the drug.,2023-02-02,2023-04-28,No
194175,02408473,Shortage,TEVA-EXEMESTANE,TEVA CANADA LIMITED,TEVA-EXEMESTANE,EXEMESTANE,25MG,30,ORAL; ORAL,Resolved,TABLET,,2023-06-08,2023-08-20,2023-07-12,Disruption of the manufacture of the drug.,2023-06-08,2023-10-04,No
195569,02408473,Shortage,TEVA-EXEMESTANE,TEVA CANADA LIMITED,TEVA-EXEMESTANE,EXEMESTANE,25MG,30,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-07-20,2023-07-04,Disruption of the manufacture of the drug.,2023-06-19,2023-07-05,No
209125,02354101,Shortage,TEVA-EZETIMIBE,TEVA CANADA LIMITED,TEVA-EZETIMIBE 10MG TAB,EZETIMIBE,10MG,100 & 500,ORAL; ORAL,Resolved,TABLET,,2023-11-01,2024-06-20,2024-01-24,Disruption of the manufacture of the drug.,2023-11-03,2024-01-25,No
209130,02354101,Shortage,TEVA-EZETIMIBE,TEVA CANADA LIMITED,TEVA-EZETIMIBE 10MG TABLETS,EZETIMIBE,10MG,500,ORAL; ORAL,Resolved,TABLET,,2023-11-01,2024-01-10,2023-11-20,Disruption of the manufacture of the drug.,2023-11-03,2023-11-23,No
209133,02354101,Shortage,TEVA-EZETIMIBE,TEVA CANADA LIMITED,TEVA-EZETIMIBE 10MG TAB,EZETIMIBE,10MG,PP30,ORAL; ORAL,Resolved,TABLET,,2023-11-01,2024-03-20,2024-01-24,Disruption of the manufacture of the drug.,2023-11-03,2024-01-25,No
206434,02466198,Shortage,TEVA-FEBUXOSTAT,TEVA CANADA LIMITED,FEBUXOSTAT 80MG FC TABS,FEBUXOSTAT,80MG,100,ORAL; ORAL,Resolved,TABLET,,2023-01-01,2024-02-10,2024-02-07,Disruption of the manufacture of the drug.,2023-10-05,2024-02-08,No
202265,02282968,Shortage,TEVA-FENTANYL,TEVA CANADA LIMITED,TEVA-FENTANYL,FENTANYL,50MCG,5,TRANSDERMAL; TRANSDERMAL,Resolved,PATCH,,2023-08-17,2023-09-20,2023-09-20,Disruption of the manufacture of the drug.,2023-08-17,2023-10-04,No
180909,02311925,Shortage,TEVA-FENTANYL,TEVA CANADA LIMITED,FENTANYL TDS 12 MCG/H PATCH,FENTANYL,12MCG,5,TRANSDERMAL; TRANSDERMAL,Resolved,PATCH,,2023-01-10,2023-05-20,2023-06-08,Disruption of the manufacture of the drug.,2023-01-12,2023-06-09,No
184210,02348500,Shortage,TEVA-FINASTERIDE,TEVA CANADA LIMITED,FINASTERIDE 5MG TAB,FINASTERIDE,5MG,100,ORAL; ORAL,Resolved,TABLET,,2023-02-10,2023-04-10,2023-04-27,Disruption of the manufacture of the drug.,2023-02-09,2023-04-28,No
198394,02469561,Shortage,TEVA-FINGOLIMOD,TEVA CANADA LIMITED,TEVA-FINGOLIMOD,FINGOLIMOD,0.5MG,30,ORAL; ORAL,Actual shortage,CAPSULE,,2023-07-12,,,Disruption of the manufacture of the drug.,2023-07-12,2024-02-01,No
184928,02453738,Shortage,TEVA-FLUTICASONE,TEVA CANADA LIMITED,FLUTICASONE 50MCG SPRAY,FLUTICASONE PROPIONATE,50MCG,120,NASAL; NASAL,Resolved,METERED-DOSE PUMP,,2023-02-14,2023-03-20,2023-04-27,Disruption of the manufacture of the drug.,2023-02-16,2023-04-28,No
195429,02299232,Shortage,TEVA-FLUVASTATIN,TEVA CANADA LIMITED,TEVA-FLUVASTATIN,FLUVASTATIN,40MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-06-19,2023-07-10,2023-07-04,Disruption of the manufacture of the drug.,2023-06-19,2023-07-05,No
209111,02299224,Shortage,TEVA-FLUVASTATIN,TEVA CANADA LIMITED,TEVA-FLUVASTATIN 20MG CAPS,FLUVASTATIN,20MG,100,ORAL; ORAL,Actual shortage,CAPSULE,,2023-11-01,2024-04-30,,Disruption of the manufacture of the drug.,2023-11-03,2024-04-22,No
197539,02247803,Shortage,TEVA-FOSINOPRIL,TEVA CANADA LIMITED,TEVA-FOSINOPRIL,FOSINOPRIL SODIUM,20MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-05,2023-07-30,2023-07-20,Disruption of the manufacture of the drug.,2023-07-05,2023-07-21,No
194077,00765953,Shortage,TEVA-FUROSEMIDE,TEVA CANADA LIMITED,TEVA-FUROSEMIDE,FUROSEMIDE,80MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-08,2023-06-20,2023-06-20,Disruption of the manufacture of the drug.,2023-06-08,2023-06-21,No
184174,00337749,Shortage,TEVA-FUROSEMIDE,TEVA CANADA LIMITED,FUROSEMIDE 40MG TAB,FUROSEMIDE,40MG,100,ORAL; ORAL,Resolved,TABLET,,2023-02-07,2023-06-20,2023-06-08,Disruption of the manufacture of the drug.,2023-02-09,2023-06-09,No
199284,00337730,Shortage,TEVA-FUROSEMIDE,TEVA CANADA LIMITED,TEVA-FUROSEMIDE,FUROSEMIDE,20MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-20,2023-08-20,2023-08-30,Disruption of the manufacture of the drug.,2023-07-20,2023-10-03,No
195459,00337730,Shortage,TEVA-FUROSEMIDE,TEVA CANADA LIMITED,TEVA-FUROSEMIDE,FUROSEMIDE,20MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-07-10,2023-07-11,Disruption of the manufacture of the drug.,2023-06-19,2023-07-12,No
207497,00337730,Shortage,TEVA-FUROSEMIDE,TEVA CANADA LIMITED,FUROSEMIDE 20MG TAB,FUROSEMIDE,20MG,1000,ORAL; ORAL,Resolved,TABLET,,2023-01-01,2024-01-19,2024-01-10,Disruption of the manufacture of the drug.,2023-10-19,2024-01-11,No
200240,02244514,Shortage,TEVA-GABAPENTIN,TEVA CANADA LIMITED,TEVA-GABAPENTIN,GABAPENTIN,300MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-07-27,2023-10-10,2023-10-10,Disruption of the manufacture of the drug.,2023-07-27,2023-10-12,No
196427,02244514,Shortage,TEVA-GABAPENTIN,TEVA CANADA LIMITED,TEVA-GABAPENTIN,GABAPENTIN,300MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-06-23,2023-06-30,2023-07-05,Disruption of the manufacture of the drug.,2023-06-26,2023-07-06,No
181617,02244515,Shortage,TEVA-GABAPENTIN,TEVA CANADA LIMITED,TEVA-GLYBURIDE 5MG TAB,GABAPENTIN,400MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-01-18,2023-04-10,2023-04-27,Disruption of the manufacture of the drug.,2023-01-19,2023-04-28,No
184189,02244515,Shortage,TEVA-GABAPENTIN,TEVA CANADA LIMITED,GABAPENTIN 400MG CAPS,GABAPENTIN,400MG,500,ORAL; ORAL,Resolved,CAPSULE,,2023-02-07,2023-04-10,2023-04-27,Disruption of the manufacture of the drug.,2023-02-09,2023-04-28,No
183422,02244513,Shortage,TEVA-GABAPENTIN,TEVA CANADA LIMITED,GABAPENTIN 100MG CAPS,GABAPENTIN,100MG,"100,500",ORAL; ORAL,Resolved,CAPSULE,,2023-01-30,2023-03-10,2023-02-07,Disruption of the manufacture of the drug.,2023-02-02,2023-02-09,No
199053,02248457,Shortage,TEVA-GABAPENTIN,TEVA CANADA LIMITED,TEVA-GABAPENTIN,GABAPENTIN,600MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-18,2023-08-20,2023-08-17,Disruption of the manufacture of the drug.,2023-07-18,2023-08-18,No
200910,02244513,Shortage,TEVA-GABAPENTIN,TEVA CANADA LIMITED,TEVA-GABAPENTIN,GABAPENTIN,100MG,500,ORAL; ORAL,Resolved,CAPSULE,,2023-08-03,2023-08-30,2023-08-30,Disruption of the manufacture of the drug.,2023-08-03,2023-10-04,No
198960,02142074,Shortage,TEVA-GEMFIBROZIL,TEVA CANADA LIMITED,TEVA-GEMFIBROZIL,GEMFIBROZIL,600MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-18,2023-08-20,2023-08-17,Disruption of the manufacture of the drug.,2023-07-18,2023-08-18,No
195618,02216221,Shortage,TEVA-IPRATROPIUM STERINEBS,TEVA CANADA LIMITED,TEVA-IPRATROPIUM STERINEBS,IPRATROPIUM BROMIDE,250MCG,20ML,INHALATION; INHALATION,Resolved,SOLUTION,,2023-06-19,2023-07-10,2023-06-26,Disruption of the manufacture of the drug.,2023-06-19,2023-06-27,No
198292,02216221,Shortage,TEVA-IPRATROPIUM STERINEBS,TEVA CANADA LIMITED,TEVA-IPRATROPIUM STERINEBS,IPRATROPIUM BROMIDE,250MCG,10x2M,INHALATION; INHALATION,Actual shortage,SOLUTION,,2023-07-11,2024-02-20,,Disruption of the manufacture of the drug.,2023-07-11,2023-12-07,No
207512,02216221,Shortage,TEVA-IPRATROPIUM STERINEBS,TEVA CANADA LIMITED,IPRATROPIUM 250MCG/ML UDV,IPRATROPIUM BROMIDE,250MCG,20 x 1ml,INHALATION; INHALATION,Actual shortage,SOLUTION,,2023-10-11,2024-07-31,,Disruption of the manufacture of the drug.,2023-10-19,2024-03-28,No
190674,02216221,Shortage,TEVA-IPRATROPIUM STERINEBS,TEVA CANADA LIMITED,TEVA-IPRATROPIUM 250MCG/ML UDV 20 X 1ML,IPRATROPIUM BROMIDE,250MCG,20,INHALATION; INHALATION,Resolved,SOLUTION,,2023-04-27,2023-06-30,2023-06-26,Disruption of the manufacture of the drug.,2023-04-27,2023-06-27,No
195588,02316390,Shortage,TEVA-IRBESARTAN,TEVA CANADA LIMITED,TEVA-IRBESARTAN,IRBESARTAN,75MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-07-20,2023-07-04,Disruption of the manufacture of the drug.,2023-06-19,2023-07-05,No
195609,02316412,Shortage,TEVA-IRBESARTAN,TEVA CANADA LIMITED,TEVA-IRBESARTAN,IRBESARTAN,300MG,100,ORAL; ORAL,Resolved,TABLET; TABLET,,2023-06-19,2023-10-20,2023-07-04,Disruption of the manufacture of the drug.,2023-06-19,2023-07-05,No
206422,02316404,Shortage,TEVA-IRBESARTAN,TEVA CANADA LIMITED,IRBESARTAN 150MG TAB,IRBESARTAN,150MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-05,2023-10-31,2023-11-01,Disruption of the manufacture of the drug.,2023-10-05,2023-11-03,No
194135,02316390,Shortage,TEVA-IRBESARTAN,TEVA CANADA LIMITED,TEVA-IRBESARTAN,IRBESARTAN,75MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-08,2023-11-10,2023-11-01,Disruption of the manufacture of the drug.,2023-06-08,2023-11-03,No
194138,02316412,Shortage,TEVA-IRBESARTAN,TEVA CANADA LIMITED,TEVA-IRBESARTAN,IRBESARTAN,300MG,100,ORAL; ORAL,Resolved,TABLET; TABLET,,2023-06-08,2024-04-20,2024-04-09,Disruption of the manufacture of the drug.,2023-06-08,2024-04-11,No
209122,02330539,Shortage,TEVA-IRBESARTAN HCTZ,TEVA CANADA LIMITED,TEVA-IRBESARTAN/HCTZ 300/25MG TABS,IRBESARTAN; HYDROCHLOROTHIAZIDE,300MG; 25MG,100,ORAL; ORAL,Resolved,TABLET,,2023-11-01,2024-03-10,2024-03-06,Disruption of the manufacture of the drug.,2023-11-03,2024-03-07,No
195446,02472929,Shortage,TEVA-LACOSAMIDE,TEVA CANADA LIMITED,TEVA-LACOSAMIDE,LACOSAMIDE,150MG,60,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-07-10,2023-06-26,Disruption of the manufacture of the drug.,2023-06-19,2023-06-27,No
194194,02472929,Shortage,TEVA-LACOSAMIDE,TEVA CANADA LIMITED,TEVA-LACOSAMIDE,LACOSAMIDE,150MG,60,ORAL; ORAL,Resolved,TABLET,,2023-06-08,2023-12-30,2023-06-26,Disruption of the manufacture of the drug.,2023-06-08,2023-06-27,No
183401,02331551,Shortage,TEVA-LACTULOSE,TEVA CANADA LIMITED,LACTULOSE 667MG/ML SACH 15ML,LACTULOSE,667MG,20,ORAL; ORAL,Resolved,SOLUTION,,2023-01-30,2023-03-31,2023-04-27,Disruption of the manufacture of the drug.,2023-02-02,2023-04-28,No
195766,02331551,Shortage,TEVA-LACTULOSE,TEVA CANADA LIMITED,TEVA-LACTULOSE,LACTULOSE,667MG,20,ORAL; ORAL,Resolved,SOLUTION,,2023-06-19,2023-09-30,2023-09-30,Disruption of the manufacture of the drug.,2023-06-20,2023-10-03,No
195879,02280523,Shortage,TEVA-LANSOPRAZOLE,TEVA CANADA LIMITED,TEVA-LANSOPRAZOLE,LANSOPRAZOLE,30MG,100,ORAL; ORAL,Actual shortage,CAPSULE (DELAYED RELEASE),,2023-06-19,,,Disruption of the manufacture of the drug.,2023-06-20,2024-03-18,No
195649,02280523,Shortage,TEVA-LANSOPRAZOLE,TEVA CANADA LIMITED,TEVA-LANSOPRAZOLE,LANSOPRAZOLE,30MG,500,ORAL; ORAL,Actual shortage,CAPSULE (DELAYED RELEASE),,2023-06-19,,,Disruption of the manufacture of the drug.,2023-06-19,2024-03-18,No
195036,02280515,Shortage,TEVA-LANSOPRAZOLE,TEVA CANADA LIMITED,TEVA-LANSOPRAZOLE,LANSOPRAZOLE,15MG,100,ORAL; ORAL,Resolved,CAPSULE (DELAYED RELEASE),,2023-06-16,2023-06-30,2023-07-05,Disruption of the manufacture of the drug.,2023-06-16,2023-07-06,No
195864,02261278,Shortage,TEVA-LEFLUNOMIDE,TEVA CANADA LIMITED,TEVA-LEFLUNOMIDE,LEFLUNOMIDE,20MG,30,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-08-30,2023-07-04,Disruption of the manufacture of the drug.,2023-06-20,2023-07-05,No
200249,02261278,Shortage,TEVA-LEFLUNOMIDE,TEVA CANADA LIMITED,TEVA-LEFLUNOMIDE,LEFLUNOMIDE,20MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-27,2023-10-20,2023-10-25,Disruption of the manufacture of the drug.,2023-07-27,2023-10-26,No
190710,02261278,Shortage,TEVA-LEFLUNOMIDE,TEVA CANADA LIMITED,TEVA-LEFLUNOMIDE 20MG TABLETS 30,LEFLUNOMIDE,20MG,30,ORAL; ORAL,Resolved,TABLET,,2023-04-27,2023-10-20,2023-10-25,Disruption of the manufacture of the drug.,2023-04-27,2023-10-26,No
206374,00621463,Shortage,TEVA-LENOLTEC NO. 4,TEVA CANADA LIMITED,LENOLTEC NO.4 TAB,CODEINE PHOSPHATE; ACETAMINOPHEN,60MG; 300MG,100,ORAL; ORAL,Resolved,TABLET,,2023-04-19,2024-01-10,2024-01-18,Disruption of the manufacture of the drug.,2023-10-05,2024-01-19,No
183404,02343657,Shortage,TEVA-LETROZOLE,TEVA CANADA LIMITED,LETROZOLE 2.5MG TAB,LETROZOLE,2.5MG,pp 30,ORAL; ORAL,Resolved,TABLET,,2023-01-30,2023-10-30,2023-10-05,Disruption of the manufacture of the drug.,2023-02-02,2023-10-06,No
195833,02343657,Shortage,TEVA-LETROZOLE,TEVA CANADA LIMITED,TEVA-LETROZOLE,LETROZOLE,2.5MG,30,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-08-30,2023-07-05,Disruption of the manufacture of the drug.,2023-06-20,2023-07-06,No
195591,02274191,Shortage,TEVA-LEVETIRACETAM,TEVA CANADA LIMITED,TEVA-LEVETIRACETAM,LEVETIRACETAM,500MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-08-10,2023-07-04,Disruption of the manufacture of the drug.,2023-06-19,2023-07-05,No
194103,02274191,Shortage,TEVA-LEVETIRACETAM,TEVA CANADA LIMITED,TEVA-LEVETIRACETAM,LEVETIRACETAM,500MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-08,2023-08-30,2023-08-17,Disruption of the manufacture of the drug.,2023-06-08,2023-08-18,No
194106,02274205,Shortage,TEVA-LEVETIRACETAM,TEVA CANADA LIMITED,TEVA-LEVETIRACETAM,LEVETIRACETAM,750MG,500,ORAL; ORAL,Resolved,TABLET,,2023-06-23,2023-08-20,2023-08-20,Disruption of the manufacture of the drug.,2023-06-08,2023-10-04,No
195484,02274205,Shortage,TEVA-LEVETIRACETAM,TEVA CANADA LIMITED,TEVA-LEVETIRACETAM,LEVETIRACETAM,750MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-09-20,2023-09-21,Disruption of the manufacture of the drug.,2023-06-19,2023-10-04,No
190692,02285126,Shortage,TEVA-LISINOPRIL (TYPE Z),TEVA CANADA LIMITED,TEVA-LISINOPRIL Z 10MG TABLETS 100,LISINOPRIL,10MG,100,ORAL; ORAL,Resolved,TABLET,,2023-04-27,2023-05-20,2023-06-08,Disruption of the manufacture of the drug.,2023-04-27,2023-06-09,No
195597,02301776,Shortage,TEVA-LISINOPRIL/HCTZ (TYPE Z),TEVA CANADA LIMITED,TEVA-LISINOPRIL/HCTZ (TYPE Z),HYDROCHLOROTHIAZIDE; LISINOPRIL,12.5MG; 20MG,10,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-07-10,2023-07-13,Disruption of the manufacture of the drug.,2023-06-19,2023-07-14,No
202278,02301784,Shortage,TEVA-LISINOPRIL/HCTZ (TYPE Z),TEVA CANADA LIMITED,TEVA-LISINOPRIL/HCTZ (TYPE Z),HYDROCHLOROTHIAZIDE; LISINOPRIL,25MG; 20MG,100,ORAL; ORAL,Resolved,TABLET,,2023-08-17,2023-08-30,2023-08-30,Disruption of the manufacture of the drug.,2023-08-17,2023-10-04,No
195124,02301784,Shortage,TEVA-LISINOPRIL/HCTZ (TYPE Z),TEVA CANADA LIMITED,TEVA-LISINOPRIL/HCTZ (TYPE Z),HYDROCHLOROTHIAZIDE; LISINOPRIL,25MG; 20MG,30,ORAL; ORAL,Resolved,TABLET,,2023-06-16,2023-07-30,2023-06-26,Disruption of the manufacture of the drug.,2023-06-16,2023-06-27,No
194119,02301776,Shortage,TEVA-LISINOPRIL/HCTZ (TYPE Z),TEVA CANADA LIMITED,TEVA-LISINOPRIL/HCTZ (TYPE Z),HYDROCHLOROTHIAZIDE; LISINOPRIL,12.5MG; 20MG,"30, 10",ORAL; ORAL,Resolved,TABLET,,2023-06-08,2023-07-30,2023-07-05,Disruption of the manufacture of the drug.,2023-06-08,2023-07-06,No
194122,02301784,Shortage,TEVA-LISINOPRIL/HCTZ (TYPE Z),TEVA CANADA LIMITED,TEVA-LISINOPRIL/HCTZ (TYPE Z),HYDROCHLOROTHIAZIDE; LISINOPRIL,25MG; 20MG,"30, 100",ORAL; ORAL,Resolved,TABLET,,2023-06-08,2023-07-30,2023-06-26,Disruption of the manufacture of the drug.,2023-06-08,2023-06-27,No
183398,02301784,Shortage,TEVA-LISINOPRIL/HCTZ (TYPE Z),TEVA CANADA LIMITED,LISINOPRIL/HCTZ Z 20/25MG TAB,HYDROCHLOROTHIAZIDE; LISINOPRIL,25MG; 20MG,100,ORAL; ORAL,Resolved,TABLET,,2023-01-30,2023-03-10,2023-02-14,Disruption of the manufacture of the drug.,2023-02-02,2023-02-16,No
195204,02301784,Shortage,TEVA-LISINOPRIL/HCTZ (TYPE Z),TEVA CANADA LIMITED,TEVA-LISINOPRIL/HCTZ (TYPE Z),HYDROCHLOROTHIAZIDE; LISINOPRIL,25MG; 20MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-16,2023-06-20,2023-06-26,Disruption of the manufacture of the drug.,2023-06-16,2023-06-27,No
199103,02301768,Shortage,TEVA-LISINOPRIL/HCTZ (TYPE Z),TEVA CANADA LIMITED,TEVA-LISINOPRIL/HCTZ (TYPE Z),HYDROCHLOROTHIAZIDE; LISINOPRIL,12.5MG; 10MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-18,2023-08-30,2023-08-31,Disruption of the manufacture of the drug.,2023-07-18,2023-10-03,No
195033,02301776,Shortage,TEVA-LISINOPRIL/HCTZ (TYPE Z),TEVA CANADA LIMITED,TEVA-LISINOPRIL/HCTZ (TYPE Z),HYDROCHLOROTHIAZIDE; LISINOPRIL,12.5MG; 20MG,30,ORAL; ORAL,Resolved,TABLET,,2023-06-16,2023-08-10,2023-08-03,Disruption of the manufacture of the drug.,2023-06-16,2023-08-04,No
197104,02301784,Shortage,TEVA-LISINOPRIL/HCTZ (TYPE Z),TEVA CANADA LIMITED,TEVA-LISINOPRIL/HCTZ (TYPE Z),HYDROCHLOROTHIAZIDE; LISINOPRIL,25MG; 20MG,PP 30,ORAL; ORAL,Resolved,TABLET,,2023-07-04,2023-08-20,2023-08-03,Disruption of the manufacture of the drug.,2023-07-04,2023-08-04,No
198957,02132591,Shortage,TEVA-LOPERAMIDE,TEVA CANADA LIMITED,TEVA-LOPERAMIDE,LOPERAMIDE HYDROCHLORIDE,2MG,500,ORAL; ORAL,Resolved,TABLET,,2023-07-18,2023-07-30,2023-07-20,Disruption of the manufacture of the drug.,2023-07-18,2023-07-21,No
198312,02258315,Shortage,TEVA-MELOXICAM,TEVA CANADA LIMITED,TEVA-MELOXICAM,MELOXICAM,7.5MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-11,2023-09-20,2023-09-20,Disruption of the manufacture of the drug.,2023-07-11,2023-10-04,No
209675,02257734,Shortage,TEVA-METFORMIN,TEVA CANADA LIMITED,ACT-METFORMIN 850MG FC TAB,METFORMIN HYDROCHLORIDE,850MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-03-29,2024-03-31,,Disruption of the manufacture of the drug.,2023-11-09,2024-02-07,No
206389,02257734,Shortage,TEVA-METFORMIN,TEVA CANADA LIMITED,METFORMIN 850MG FC TAB,METFORMIN HYDROCHLORIDE,850MG,500,ORAL; ORAL,Actual shortage,TABLET,,2023-03-29,2024-04-10,,Disruption of the manufacture of the drug.,2023-10-05,2024-02-08,No
207521,02257726,Shortage,TEVA-METFORMIN,TEVA CANADA LIMITED,METFORMIN 500MG FC TAB,METFORMIN HYDROCHLORIDE,500MG,500,ORAL; ORAL,Resolved,TABLET,,2023-09-30,2023-12-10,2023-12-06,Disruption of the manufacture of the drug.,2023-10-19,2023-12-07,No
195615,00842648,Shortage,TEVA-METOPROLOL,TEVA CANADA LIMITED,TEVA-METOPROLOL,METOPROLOL TARTRATE,50MG,500,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-08-10,2023-07-04,Disruption of the manufacture of the drug.,2023-06-19,2023-07-05,No
206377,00842656,Shortage,TEVA-METOPROLOL,TEVA CANADA LIMITED,METOPROLOL 100MG UNCOAT TABS,METOPROLOL TARTRATE,100MG,100,ORAL; ORAL,Resolved,TABLET,,2023-09-27,2023-11-30,2023-11-15,Disruption of the manufacture of the drug.,2023-10-05,2023-11-16,No
183383,00842648,Shortage,TEVA-METOPROLOL,TEVA CANADA LIMITED,METOPROLOL 50MG UNCOAT TAB,METOPROLOL TARTRATE,50MG,500,ORAL; ORAL,Resolved,TABLET,,2023-01-30,2023-08-20,2023-08-17,Disruption of the manufacture of the drug.,2023-02-02,2023-08-18,No
194091,02230359,Shortage,TEVA-MEXILETINE,TEVA CANADA LIMITED,TEVA-MEXILETINE,MEXILETINE HYDROCHLORIDE,100MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-06-08,2023-08-30,2023-07-04,Disruption of the manufacture of the drug.,2023-06-08,2023-07-05,No
206895,02230360,Shortage,TEVA-MEXILETINE,TEVA CANADA LIMITED,MEXILETINE HCL 200MG CAPS,MEXILETINE HYDROCHLORIDE,200MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-10-04,2023-10-31,2023-11-01,Disruption of the manufacture of the drug.,2023-10-12,2023-11-03,No
184186,02230360,Shortage,TEVA-MEXILETINE,TEVA CANADA LIMITED,MEXILETINE HCL 200MG CAP,MEXILETINE HYDROCHLORIDE,200MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-02-07,2023-05-10,2023-06-08,Disruption of the manufacture of the drug.,2023-02-09,2023-06-09,No
195542,02230359,Shortage,TEVA-MEXILETINE,TEVA CANADA LIMITED,TEVA-MEXILETINE,MEXILETINE HYDROCHLORIDE,100MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-06-19,2023-10-31,2023-11-01,Disruption of the manufacture of the drug.,2023-06-19,2023-11-03,No
211979,02259354,Shortage,TEVA-MIRTAZAPINE,TEVA CANADA LIMITED,MIRTAZAPINE 30MG TAB,MIRTAZAPINE,30MG,100,ORAL; ORAL,Resolved,TABLET,,2023-11-29,2024-01-20,2024-01-18,Disruption of the manufacture of the drug.,2023-11-30,2024-01-19,No
194100,02259354,Shortage,TEVA-MIRTAZAPINE,TEVA CANADA LIMITED,TEVA-MIRTAZAPINE,MIRTAZAPINE,30MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-08,2023-08-20,2023-08-31,Disruption of the manufacture of the drug.,2023-06-08,2023-10-03,No
206407,02259354,Shortage,TEVA-MIRTAZAPINE,TEVA CANADA LIMITED,MIRTAZAPINE 30MG TABS,MIRTAZAPINE,30MG,pp 30,ORAL; ORAL,Actual shortage,TABLET,,2023-10-04,2024-06-10,,Disruption of the manufacture of the drug.,2023-10-05,2023-11-09,No
195509,02259354,Shortage,TEVA-MIRTAZAPINE,TEVA CANADA LIMITED,TEVA-MIRTAZAPINE,MIRTAZAPINE,30MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-08-20,2023-07-05,Disruption of the manufacture of the drug.,2023-06-19,2023-07-06,No
195472,02248130,Shortage,TEVA-MOMETASONE,TEVA CANADA LIMITED,TEVA-MOMETASONE,MOMETASONE FUROATE,0.10%,15G,TOPICAL; TOPICAL,Resolved,OINTMENT,,2023-06-19,2023-07-30,2023-07-04,Disruption of the manufacture of the drug.,2023-06-19,2023-07-05,No
197169,02302772,Shortage,TEVA-MORPHINE SR,TEVA CANADA LIMITED,TEVA-MORPHINE SR,MORPHINE SULFATE,30MG,50,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-07-04,2023-07-30,2023-08-03,Disruption of the manufacture of the drug.,2023-07-04,2023-08-04,No
194125,02302764,Shortage,TEVA-MORPHINE SR,TEVA CANADA LIMITED,TEVA-MORPHINE SR,MORPHINE SULFATE,15MG,50,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-06-08,2023-06-30,2023-06-26,Disruption of the manufacture of the drug.,2023-06-08,2023-06-27,No
195210,02302764,Shortage,TEVA-MORPHINE SR,TEVA CANADA LIMITED,TEVA-MORPHINE SR,MORPHINE SULFATE,15MG,50,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-06-16,2023-06-30,2023-06-20,Disruption of the manufacture of the drug.,2023-06-16,2023-06-21,No
195847,02375702,Shortage,TEVA-MOXIFLOXACIN,TEVA CANADA LIMITED,TEVA-MOXIFLOXACIN,MOXIFLOXACIN,400MG,30,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-09-30,2023-07-05,Disruption of the manufacture of the drug.,2023-06-20,2023-07-06,No
194157,02375702,Shortage,TEVA-MOXIFLOXACIN,TEVA CANADA LIMITED,TEVA-MOXIFLOXACIN,MOXIFLOXACIN,400MG,30,ORAL; ORAL,Actual shortage,TABLET,,2023-06-08,,,Disruption of the manufacture of the drug.,2023-06-08,2024-04-11,No
195870,02364883,Shortage,TEVA-MYCOPHENOLATE,TEVA CANADA LIMITED,TEVA-MYCOPHENOLATE,MYCOPHENOLATE MOFETIL,250MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-06-19,2023-07-20,2023-07-04,Disruption of the manufacture of the drug.,2023-06-20,2023-07-05,No
197172,02348675,Shortage,TEVA-MYCOPHENOLATE,TEVA CANADA LIMITED,TEVA-MYCOPHENOLATE,MYCOPHENOLATE MOFETIL,500MG,50,ORAL; ORAL,Resolved,TABLET,,2023-07-04,2023-08-30,2023-08-30,Disruption of the manufacture of the drug.,2023-07-04,2023-10-04,No
207536,02348675,Shortage,TEVA-MYCOPHENOLATE,TEVA CANADA LIMITED,MYCOPHENOLATE 500MG TABS,MYCOPHENOLATE MOFETIL,500MG,UD 50's,ORAL; ORAL,Resolved,TABLET,,2023-10-04,2024-02-29,2024-02-21,Disruption of the manufacture of the drug.,2023-10-19,2024-02-22,No
207539,02364883,Shortage,TEVA-MYCOPHENOLATE,TEVA CANADA LIMITED,MYCOPHENOLATE 250MG CAPS,MYCOPHENOLATE MOFETIL,250MG,UD 100,ORAL; ORAL,Resolved,CAPSULE,,2023-05-10,2024-04-20,2023-12-06,Disruption of the manufacture of the drug.,2023-10-19,2023-12-07,No
211970,00565350,Shortage,TEVA-NAPROXEN,TEVA CANADA LIMITED,NAPROXEN 250MG TAB,NAPROXEN,250MG,100,ORAL; ORAL,Resolved,TABLET,,2023-11-29,2023-12-20,2023-12-21,Disruption of the manufacture of the drug.,2023-11-30,2024-01-08,No
200203,00589861,Shortage,TEVA-NAPROXEN,TEVA CANADA LIMITED,TEVA-NAPROXEN,NAPROXEN,500MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-27,2023-08-10,2023-08-17,Disruption of the manufacture of the drug.,2023-07-27,2023-08-18,No
211319,00589861,Shortage,TEVA-NAPROXEN,TEVA CANADA LIMITED,NAPROXEN 500MG TAB,NAPROXEN,500MG,100,ORAL; ORAL,Resolved,TABLET,,2023-11-22,2023-12-31,2024-01-10,Disruption of the manufacture of the drug.,2023-11-23,2024-01-11,No
199306,00589861,Shortage,TEVA-NAPROXEN,TEVA CANADA LIMITED,TEVA-NAPROXEN,NAPROXEN,500MG,500,ORAL; ORAL,Resolved,TABLET,,2023-07-20,2023-07-30,2023-07-27,Disruption of the manufacture of the drug.,2023-07-20,2023-07-28,No
209661,00627097,Shortage,TEVA-NAPROXEN,TEVA CANADA LIMITED,NAPROXEN 375MG TAB,NAPROXEN,375MG,100,ORAL; ORAL,Resolved,TABLET,,2023-11-08,2023-12-20,2024-01-10,Disruption of the manufacture of the drug.,2023-11-09,2024-01-11,No
190740,02243312,Shortage,TEVA-NAPROXEN EC,TEVA CANADA LIMITED,TEVA-NAPROXEN-EC 250MG TABLETS 100,NAPROXEN,250MG,100,ORAL; ORAL,Resolved,TABLET (ENTERIC-COATED),,2023-04-27,2023-06-10,2023-06-08,Disruption of the manufacture of the drug.,2023-04-27,2023-06-09,No
194094,02243314,Shortage,TEVA-NAPROXEN EC,TEVA CANADA LIMITED,TEVA-NAPROXEN EC,NAPROXEN,500MG,100,ORAL; ORAL,Resolved,TABLET (ENTERIC-COATED),,2023-06-08,2023-08-10,2023-06-20,Disruption of the manufacture of the drug.,2023-06-08,2023-06-21,No
206392,02243314,Shortage,TEVA-NAPROXEN EC,TEVA CANADA LIMITED,NAPROXEN-EC 500MG TAB,NAPROXEN,500MG,100,ORAL; ORAL,Resolved,TABLET (ENTERIC-COATED),,2023-09-27,2023-12-10,2023-12-13,Disruption of the manufacture of the drug.,2023-10-05,2023-12-14,No
197052,02243314,Shortage,TEVA-NAPROXEN EC,TEVA CANADA LIMITED,TEVA-NAPROXEN EC,NAPROXEN,500MG,100,ORAL; ORAL,Resolved,TABLET (ENTERIC-COATED),,2023-07-04,2023-07-04,2023-07-13,Disruption of the manufacture of the drug.,2023-07-04,2023-07-14,No
207509,02026600,Shortage,TEVA-NAPROXEN SODIUM DS,TEVA CANADA LIMITED,NAPROXEN SODIUM DS 550MG TABS,NAPROXEN SODIUM,550MG,100,ORAL; ORAL,Resolved,TABLET,,2023-10-11,2023-11-20,2023-11-08,Disruption of the manufacture of the drug.,2023-10-19,2023-11-09,No
194131,02314304,Shortage,TEVA-NARATRIPTAN,TEVA CANADA LIMITED,TEVA-NARATRIPTAN,NARATRIPTAN,2.5MG,8,ORAL; ORAL,Resolved,TABLET,,2023-06-08,2023-08-30,2023-08-17,Disruption of the manufacture of the drug.,2023-06-08,2023-08-18,No
184207,02314304,Shortage,TEVA-NARATRIPTAN,TEVA CANADA LIMITED,NARATRIPTAN 2.5MG TABS,NARATRIPTAN,2.5MG,PP 8,ORAL; ORAL,Resolved,TABLET,,2023-02-07,2023-03-10,2023-02-14,Disruption of the manufacture of the drug.,2023-02-09,2023-02-16,No
195487,02314304,Shortage,TEVA-NARATRIPTAN,TEVA CANADA LIMITED,TEVA-NARATRIPTAN,NARATRIPTAN,2.5MG,8,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-07-31,2023-07-05,Disruption of the manufacture of the drug.,2023-06-19,2023-07-06,No
199387,02314290,Shortage,TEVA-NARATRIPTAN,TEVA CANADA LIMITED,TEVA-NARATRIPTAN,NARATRIPTAN,1MG,PP 8,ORAL,Resolved,TABLET,,2023-07-20,2023-08-30,2023-08-31,Disruption of the manufacture of the drug.,2023-07-20,2023-10-04,No
202246,02231015,Shortage,TEVA-NITROFURANTOIN,TEVA CANADA LIMITED,TEVA-NITROFURANTOIN,NITROFURANTOIN,50MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-08-17,2023-08-20,2023-08-31,Disruption of the manufacture of the drug.,2023-08-17,2023-10-03,No
206380,02231016,Shortage,TEVA-NITROFURANTOIN,TEVA CANADA LIMITED,NITROFURANTOIN 100MG CAPS,NITROFURANTOIN,100MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-01-01,2023-11-30,2023-11-29,Disruption of the manufacture of the drug.,2023-10-05,2023-11-30,No
184916,02231016,Shortage,TEVA-NITROFURANTOIN,TEVA CANADA LIMITED,TEVA-NITROFURANTOIN 100MG CAPS,NITROFURANTOIN,100MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-02-14,2023-03-20,2023-04-27,Disruption of the manufacture of the drug.,2023-02-16,2023-04-28,No
199026,02231016,Shortage,TEVA-NITROFURANTOIN,TEVA CANADA LIMITED,TEVA-NITROFURANTOIN,NITROFURANTOIN,100MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-07-18,2023-08-30,2023-08-17,Disruption of the manufacture of the drug.,2023-07-18,2023-08-18,No
207515,02231015,Shortage,TEVA-NITROFURANTOIN,TEVA CANADA LIMITED,NITROFURANTOIN 50MG CAPS,NITROFURANTOIN,50MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-09-09,2023-12-10,2023-11-29,Disruption of the manufacture of the drug.,2023-10-19,2023-11-30,No
211976,02194201,Shortage,TEVA-NYSTATIN,TEVA CANADA LIMITED,TEVA-NYSTATIN 100MU/ML DROPS,NYSTATIN,100000UNIT,100ml,ORAL; ORAL,Resolved,SUSPENSION,,2023-11-29,2024-01-10,2024-01-10,Disruption of the manufacture of the drug.,2023-11-30,2024-01-11,No
200231,02194201,Shortage,TEVA-NYSTATIN,TEVA CANADA LIMITED,TEVA-NYSTATIN,NYSTATIN,100000UNIT,100ML,ORAL; ORAL,Resolved,SUSPENSION,,2023-07-27,2023-08-20,2023-08-03,Disruption of the manufacture of the drug.,2023-07-27,2023-08-04,No
195501,02194201,Shortage,TEVA-NYSTATIN,TEVA CANADA LIMITED,TEVA-NYSTATIN,NYSTATIN,100000UNIT,100ML,ORAL; ORAL,Resolved,SUSPENSION,,2023-06-19,2023-07-20,2023-07-13,Disruption of the manufacture of the drug.,2023-06-19,2023-07-14,No
202239,02194201,Shortage,TEVA-NYSTATIN,TEVA CANADA LIMITED,TEVA-NYSTATIN,NYSTATIN,100000UNIT,1L,ORAL; ORAL,Resolved,SUSPENSION,,2023-08-17,2023-12-20,2023-12-13,Disruption of the manufacture of the drug.,2023-08-17,2023-12-14,No
210434,02276747,Shortage,TEVA-OLANZAPINE,TEVA CANADA LIMITED,OLANZAPINE 10MG TAB,OLANZAPINE,10MG,100,ORAL; ORAL,Resolved,TABLET,,2023-11-15,2023-12-10,2023-12-13,Disruption of the manufacture of the drug.,2023-11-16,2023-12-14,No
194109,02276712,Shortage,TEVA-OLANZAPINE,TEVA CANADA LIMITED,TEVA-OLANZAPINE,OLANZAPINE,2.5MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-08,2023-07-20,2023-07-20,Disruption of the manufacture of the drug.,2023-06-08,2023-07-21,No
183389,02276720,Shortage,TEVA-OLANZAPINE,TEVA CANADA LIMITED,OLANZAPINE 5MG TAB,OLANZAPINE,5MG,100,ORAL; ORAL,Resolved,TABLET,,2023-01-30,2023-03-20,2023-04-27,Disruption of the manufacture of the drug.,2023-02-02,2023-04-28,No
183410,02359707,Shortage,TEVA-OLANZAPINE,TEVA CANADA LIMITED,OLANZAPINE 20MG TAB,OLANZAPINE,20MG,100,ORAL; ORAL,Resolved,TABLET,,2023-01-30,2023-03-10,2023-04-27,Disruption of the manufacture of the drug.,2023-02-02,2023-04-28,No
195216,02276712,Shortage,TEVA-OLANZAPINE,TEVA CANADA LIMITED,TEVA-OLANZAPINE,OLANZAPINE,2.5MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-16,2023-07-20,2023-07-04,Disruption of the manufacture of the drug.,2023-06-16,2023-07-05,No
207527,02276755,Shortage,TEVA-OLANZAPINE,TEVA CANADA LIMITED,OLANZAPINE 15MG TAB,OLANZAPINE,15MG,100,ORAL; ORAL,Resolved,TABLET,,2023-10-11,2023-12-10,2023-12-13,Disruption of the manufacture of the drug.,2023-10-19,2023-12-14,No
198319,02276720,Shortage,TEVA-OLANZAPINE,TEVA CANADA LIMITED,TEVA-OLANZAPINE,OLANZAPINE,5MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-11,2023-07-30,2023-07-20,Disruption of the manufacture of the drug.,2023-07-11,2023-07-21,No
199365,02276747,Shortage,TEVA-OLANZAPINE,TEVA CANADA LIMITED,TEVA-OLANZAPINE,OLANZAPINE,10MG,100,ORAL; ORAL,Avoided shortage,TABLET,,2023-07-20,2023-08-20,2023-07-17,Disruption of the manufacture of the drug.,2023-07-20,2023-08-17,No
190695,02276755,Shortage,TEVA-OLANZAPINE,TEVA CANADA LIMITED,TEVA-OLANZAPINE 15MG TABLETS 100,OLANZAPINE,15MG,100,ORAL; ORAL,Resolved,TABLET,,2023-04-27,2023-06-10,2023-06-20,Disruption of the manufacture of the drug.,2023-04-27,2023-06-21,No
195830,02276755,Shortage,TEVA-OLANZAPINE,TEVA CANADA LIMITED,TEVA-OLANZAPINE,OLANZAPINE,15MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-06-20,2023-06-20,Disruption of the manufacture of the drug.,2023-06-20,2023-06-21,No
194116,02295415,Shortage,TEVA-OMEPRAZOLE,TEVA CANADA LIMITED,TEVA-OMEPRAZOLE,OMEPRAZOLE,20MG,100,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE),,2023-06-08,2023-08-10,2023-08-17,Disruption of the manufacture of the drug.,2023-06-08,2023-08-18,No
195177,02295415,Shortage,TEVA-OMEPRAZOLE,TEVA CANADA LIMITED,TEVA-OMEPRAZOLE,OMEPRAZOLE,20MG,100,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE),,2023-06-16,2023-07-30,2023-07-04,Disruption of the manufacture of the drug.,2023-06-16,2023-07-05,No
206371,00608165,Shortage,TEVA-OXYCOCET,TEVA CANADA LIMITED,OXYCOCET TAB,ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE,325MG; 5MG,UD 100,ORAL; ORAL,Resolved,TABLET,,2023-08-09,2024-01-20,2023-12-06,Disruption of the manufacture of the drug.,2023-10-05,2023-12-07,No
183377,00608165,Shortage,TEVA-OXYCOCET,TEVA CANADA LIMITED,OXYCOCET TABS 5MG/325MG,ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE,325MG; 5MG,500,ORAL; ORAL,Resolved,TABLET,,2023-01-30,2023-05-30,2023-06-08,Disruption of the manufacture of the drug.,2023-02-02,2023-06-09,No
197507,00608165,Shortage,TEVA-OXYCOCET,TEVA CANADA LIMITED,TEVA-OXYCOCET,ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE,325MG; 5MG,500,ORAL; ORAL,Resolved,TABLET,,2023-07-05,2023-07-30,2023-07-20,Disruption of the manufacture of the drug.,2023-07-05,2023-07-21,No
195222,00608165,Shortage,TEVA-OXYCOCET,TEVA CANADA LIMITED,TEVA-OXYCOCET,ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE,325MG; 5MG,500,ORAL; ORAL,Resolved,TABLET,,2023-06-16,2023-06-20,2023-06-26,Disruption of the manufacture of the drug.,2023-06-16,2023-06-27,No
200873,00608165,Shortage,TEVA-OXYCOCET,TEVA CANADA LIMITED,TEVA-OXYCOCET,ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE,325MG; 5MG,500,ORAL; ORAL,Resolved,TABLET,,2023-08-03,2023-08-20,2023-08-17,Disruption of the manufacture of the drug.,2023-08-03,2023-08-18,No
198602,00608165,Shortage,TEVA-OXYCOCET,TEVA CANADA LIMITED,TEVA-OXYCOCET,ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE,325MG; 5MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-13,2023-08-20,2023-09-01,Disruption of the manufacture of the drug.,2023-07-13,2023-10-04,No
195839,00608165,Shortage,TEVA-OXYCOCET,TEVA CANADA LIMITED,TEVA-OXYCOCET,ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE,325MG; 5MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-08-20,2023-07-11,Disruption of the manufacture of the drug.,2023-06-20,2023-07-12,No
209666,02285487,Shortage,TEVA-PANTOPRAZOLE,TEVA CANADA LIMITED,TEVA-PANTOPRAZOLE 40MG 100 TAB,PANTOPRAZOLE,40MG,100 & 500,ORAL; ORAL,Actual shortage,TABLET (DELAYED-RELEASE),,2023-11-08,,,Disruption of the manufacture of the drug.,2023-11-09,2024-02-08,No
190770,02440628,Shortage,TEVA-PANTOPRAZOLE MAGNESIUM,TEVA CANADA LIMITED,TEVA-PANTOPRAZOLE MAG 40MG TABS 100,PANTOPRAZOLE,40MG,100,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE),,2023-04-27,2023-12-20,2023-12-13,Disruption of the manufacture of the drug.,2023-04-27,2023-12-14,No
195800,02440628,Shortage,TEVA-PANTOPRAZOLE MAGNESIUM,TEVA CANADA LIMITED,TEVA-PANTOPRAZOLE MAGNESIUM,PANTOPRAZOLE,40MG,100,ORAL; ORAL,Resolved,TABLET (DELAYED-RELEASE),,2023-06-19,2023-08-20,2023-07-04,Disruption of the manufacture of the drug.,2023-06-20,2023-07-05,No
183371,00021288,Shortage,TEVA-PHENIRAM,TEVA CANADA LIMITED,PHENIRAM 4MG TAB,CHLORPHENIRAMINE MALEATE,4MG,100,ORAL; ORAL,Resolved,TABLET,,2023-01-30,2023-05-20,2023-06-08,Disruption of the manufacture of the drug.,2023-02-02,2023-06-09,No
190737,00869023,Shortage,TEVA-PINDOLOL,TEVA CANADA LIMITED,TEVA-PINDOLOL 15MG TABLETS 100,PINDOLOL,15MG,100,ORAL; ORAL,Resolved,TABLET,,2023-04-27,2023-07-10,2023-07-04,Disruption of the manufacture of the drug.,2023-04-27,2023-07-05,No
195533,00869023,Shortage,TEVA-PINDOLOL,TEVA CANADA LIMITED,TEVA-PINDOLOL,PINDOLOL,15MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-07-10,2023-07-11,Disruption of the manufacture of the drug.,2023-06-19,2023-07-12,No
195903,00695696,Shortage,TEVA-PIROXICAM,TEVA CANADA LIMITED,TEVA-PIROXICAM,PIROXICAM,20MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-06-19,2023-09-20,2023-07-04,Disruption of the manufacture of the drug.,2023-06-20,2023-07-05,No
207435,00695696,Shortage,TEVA-PIROXICAM,TEVA CANADA LIMITED,TEVA-PIROXICAM 20MG CAPS,PIROXICAM,20MG,100,ORAL; ORAL,Resolved,CAPSULE,,2022-03-03,2024-02-20,2024-02-14,Disruption of the manufacture of the drug.,2023-10-19,2024-02-15,No
206395,02247010,Shortage,TEVA-PRAVASTATIN,TEVA CANADA LIMITED,PRAVASTATIN 40MG TABS,PRAVASTATIN SODIUM,40MG,PP 30,ORAL; ORAL,Resolved,TABLET,,2023-10-04,2024-01-10,2024-01-10,Disruption of the manufacture of the drug.,2023-10-05,2024-01-11,No
195861,00700401,Shortage,TEVA-PREDNISOLONE,TEVA CANADA LIMITED,TEVA-PREDNISOLONE,PREDNISOLONE ACETATE,1%,10ML,OPHTHALMIC; OPHTHALMIC,Resolved,SUSPENSION,,2023-06-19,2023-06-20,2023-06-26,Disruption of the manufacture of the drug.,2023-06-20,2023-06-27,No
196448,00232378,Shortage,TEVA-PREDNISONE,TEVA CANADA LIMITED,TEVA-PREDNISONE,PREDNISONE,50MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-23,2023-07-30,2023-07-20,Disruption of the manufacture of the drug.,2023-06-26,2023-07-21,No
213365,00021695,Shortage,TEVA-PREDNISONE,TEVA CANADA LIMITED,PREDNISONE 5MG TAB,PREDNISONE,5MG,1000,ORAL; ORAL,Resolved,TABLET,,2023-12-13,2024-02-20,2024-02-14,Disruption of the manufacture of the drug.,2023-12-14,2024-02-15,No
195627,02439913,Shortage,TEVA-PROGESTERONE,TEVA CANADA LIMITED,TEVA-PROGESTERONE,PROGESTERONE,100MG,30,ORAL; ORAL,Actual shortage,CAPSULE,,2023-06-19,2024-07-30,,Disruption of the manufacture of the drug.,2023-06-19,2023-07-21,No
195153,02439913,Shortage,TEVA-PROGESTERONE,TEVA CANADA LIMITED,TEVA-PROGESTERONE,PROGESTERONE,100MG,100,ORAL; ORAL,Actual shortage,CAPSULE,,2023-06-16,2024-07-30,,Disruption of the manufacture of the drug.,2023-06-16,2023-07-21,No
190704,02439913,Shortage,TEVA-PROGESTERONE,TEVA CANADA LIMITED,TEVA-PROGESTERONE 100MG CAPS P/PACK 30,PROGESTERONE,100MG,30,ORAL; ORAL,Resolved,CAPSULE,,2023-04-27,2023-07-30,2023-06-29,Disruption of the manufacture of the drug.,2023-04-27,2023-06-30,No
194057,00496502,Shortage,TEVA-PROPRANOLOL,TEVA CANADA LIMITED,TEVA-PROPRANOLOL,PROPRANOLOL HYDROCHLORIDE,80MG,500,ORAL; ORAL,Resolved,TABLET,,2023-06-08,2023-07-10,2023-07-05,Disruption of the manufacture of the drug.,2023-06-08,2023-07-06,No
194061,00496502,Shortage,TEVA-PROPRANOLOL,TEVA CANADA LIMITED,TEVA-PROPRANOLOL,PROPRANOLOL HYDROCHLORIDE,80MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-08,2023-07-20,2023-07-20,Disruption of the manufacture of the drug.,2023-06-08,2023-07-21,No
195612,00496499,Shortage,TEVA-PROPRANOLOL,TEVA CANADA LIMITED,TEVA-PROPRANOLOL,PROPRANOLOL HYDROCHLORIDE,40MG,1000,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-07-10,2023-07-04,Disruption of the manufacture of the drug.,2023-06-19,2023-07-05,No
184177,00496480,Shortage,TEVA-PROPRANOLOL,TEVA CANADA LIMITED,PROPRANOLOL 10MG TAB,PROPRANOLOL HYDROCHLORIDE,10MG,1000,ORAL; ORAL,Resolved,TABLET,,2023-02-07,2023-07-30,2023-07-11,Disruption of the manufacture of the drug.,2023-02-09,2023-07-12,No
184180,00496499,Shortage,TEVA-PROPRANOLOL,TEVA CANADA LIMITED,PROPRANOLOL 40MG TAB,PROPRANOLOL HYDROCHLORIDE,40MG,100,ORAL; ORAL,Resolved,TABLET,,2023-02-07,2023-07-10,2023-07-11,Disruption of the manufacture of the drug.,2023-02-09,2023-07-12,No
184949,00740675,Shortage,TEVA-PROPRANOLOL,TEVA CANADA LIMITED,PROPRANOLOL 20MG TAB,PROPRANOLOL HYDROCHLORIDE,20MG,100,ORAL; ORAL,Resolved,TABLET,,2023-02-14,2023-07-10,2023-07-05,Disruption of the manufacture of the drug.,2023-02-16,2023-07-06,No
181623,00496502,Shortage,TEVA-PROPRANOLOL,TEVA CANADA LIMITED,TEVA-PROPRANOLOL 80MG TAB,PROPRANOLOL HYDROCHLORIDE,80MG,"100,500",ORAL; ORAL,Resolved,TABLET,,2023-01-18,2023-03-20,2023-04-27,Disruption of the manufacture of the drug.,2023-01-19,2023-04-28,No
195213,00496480,Shortage,TEVA-PROPRANOLOL,TEVA CANADA LIMITED,TEVA-PROPRANOLOL,PROPRANOLOL HYDROCHLORIDE,10MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-16,2023-07-10,2023-07-05,Disruption of the manufacture of the drug.,2023-06-16,2023-07-06,No
195234,00496480,Shortage,TEVA-PROPRANOLOL,TEVA CANADA LIMITED,TEVA-PROPRANOLOL,PROPRANOLOL HYDROCHLORIDE,10MG,1000,ORAL; ORAL,Resolved,TABLET,,2023-06-16,2023-07-30,2023-07-04,Disruption of the manufacture of the drug.,2023-06-16,2023-07-05,No
195240,00740675,Shortage,TEVA-PROPRANOLOL,TEVA CANADA LIMITED,TEVA-PROPRANOLOL,PROPRANOLOL HYDROCHLORIDE,20MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-16,2023-06-30,2023-07-05,Disruption of the manufacture of the drug.,2023-06-16,2023-07-06,No
195498,00496502,Shortage,TEVA-PROPRANOLOL,TEVA CANADA LIMITED,TEVA-PROPRANOLOL,PROPRANOLOL HYDROCHLORIDE,80MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-07-10,2023-07-04,Disruption of the manufacture of the drug.,2023-06-19,2023-07-05,No
195760,00496502,Shortage,TEVA-PROPRANOLOL,TEVA CANADA LIMITED,TEVA-PROPRANOLOL,PROPRANOLOL HYDROCHLORIDE,80MG,500,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-07-10,2023-07-04,Disruption of the manufacture of the drug.,2023-06-20,2023-07-05,No
195809,00740675,Shortage,TEVA-PROPRANOLOL,TEVA CANADA LIMITED,TEVA-PROPRANOLOL,PROPRANOLOL HYDROCHLORIDE,20MG,500,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-07-10,2023-07-05,Disruption of the manufacture of the drug.,2023-06-20,2023-07-06,No
195821,00496499,Shortage,TEVA-PROPRANOLOL,TEVA CANADA LIMITED,TEVA-PROPRANOLOL,PROPRANOLOL HYDROCHLORIDE,40MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-07-10,2023-07-04,Disruption of the manufacture of the drug.,2023-06-20,2023-07-05,No
195118,02395452,Shortage,TEVA-QUETIAPINE XR,TEVA CANADA LIMITED,TEVA-QUETIAPINE XR,QUETIAPINE,150MG,60,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-06-16,2023-07-10,2023-07-04,Disruption of the manufacture of the drug.,2023-06-16,2023-07-05,No
194163,02395452,Shortage,TEVA-QUETIAPINE XR,TEVA CANADA LIMITED,TEVA-QUETIAPINE XR,QUETIAPINE,150MG,60,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-06-08,2023-07-10,2023-07-11,Disruption of the manufacture of the drug.,2023-06-08,2023-07-12,No
199554,02395444,Shortage,TEVA-QUETIAPINE XR,TEVA CANADA LIMITED,TEVA-QUETIAPINE XR,QUETIAPINE,50MG,60,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-07-21,2023-08-20,2023-08-17,Disruption of the manufacture of the drug.,2023-07-21,2023-08-18,No
194097,02247945,Shortage,TEVA-RAMIPRIL,TEVA CANADA LIMITED,TEVA-RAMIPRIL,RAMIPRIL,2.5MG,30,ORAL; ORAL,Resolved,CAPSULE,,2023-06-08,2023-06-30,2023-06-26,Disruption of the manufacture of the drug.,2023-06-08,2023-06-27,No
195201,02247945,Shortage,TEVA-RAMIPRIL,TEVA CANADA LIMITED,TEVA-RAMIPRIL,RAMIPRIL,2.5MG,30,ORAL; ORAL,Resolved,CAPSULE,,2023-06-16,2023-06-20,2023-06-26,Disruption of the manufacture of the drug.,2023-06-16,2023-06-27,No
190686,02247946,Shortage,TEVA-RAMIPRIL,TEVA CANADA LIMITED,TEVA-RAMIPRIL 5MG CAPSULES P/PACK 30,RAMIPRIL,5MG,30,ORAL; ORAL,Resolved,CAPSULE,,2023-04-27,2023-08-20,2023-06-20,Disruption of the manufacture of the drug.,2023-04-27,2023-06-21,No
206428,02396688,Shortage,TEVA-RIZATRIPTAN ODT,TEVA CANADA LIMITED,RIZATRIPTAN OD 10MG TABS,RIZATRIPTAN,10MG,PP 6,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-05-10,2023-11-10,2023-11-08,Disruption of the manufacture of the drug.,2023-10-05,2023-11-09,No
184213,02396688,Shortage,TEVA-RIZATRIPTAN ODT,TEVA CANADA LIMITED,RIZATRIPTAN OD 10MG TAB,RIZATRIPTAN,10MG,pp 6,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-02-07,2023-03-10,2023-04-27,Disruption of the manufacture of the drug.,2023-02-09,2023-04-28,No
196471,02316846,Shortage,TEVA-ROPINIROLE,TEVA CANADA LIMITED,TEVA-ROPINIROLE,ROPINIROLE,0.25MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-23,2023-08-20,2023-08-17,Disruption of the manufacture of the drug.,2023-06-26,2023-08-18,No
210437,02354624,Shortage,TEVA-ROSUVASTATIN,TEVA CANADA LIMITED,ROSUVASTATIN 20MG TAB,ROSUVASTATIN,20MG,100,ORAL; ORAL,Resolved,TABLET,,2023-11-15,2023-12-31,2023-12-13,Disruption of the manufacture of the drug.,2023-11-16,2023-12-14,No
195103,02354632,Shortage,TEVA-ROSUVASTATIN,TEVA CANADA LIMITED,TEVA-ROSUVASTATIN,ROSUVASTATIN,40MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-16,2023-09-10,2023-09-30,Disruption of the manufacture of the drug.,2023-06-16,2023-10-03,No
195621,02354632,Shortage,TEVA-ROSUVASTATIN,TEVA CANADA LIMITED,TEVA-ROSUVASTATIN,ROSUVASTATIN,40MG,500,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-08-20,2023-08-03,Disruption of the manufacture of the drug.,2023-06-19,2023-08-04,No
200290,02354616,Shortage,TEVA-ROSUVASTATIN,TEVA CANADA LIMITED,TEVA-ROSUVASTATIN,ROSUVASTATIN,10MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-27,2024-01-31,2024-01-18,Disruption of the manufacture of the drug.,2023-07-27,2024-01-19,No
194148,02354624,Shortage,TEVA-ROSUVASTATIN,TEVA CANADA LIMITED,TEVA-ROSUVASTATIN,ROSUVASTATIN,20MG,500,ORAL; ORAL,Resolved,TABLET,,2023-06-08,2023-08-10,2023-08-17,Disruption of the manufacture of the drug.,2023-06-08,2023-08-18,No
194151,02354632,Shortage,TEVA-ROSUVASTATIN,TEVA CANADA LIMITED,TEVA-ROSUVASTATIN,ROSUVASTATIN,40MG,"500, 100",ORAL; ORAL,Resolved,TABLET,,2023-06-08,2023-09-20,2023-07-04,Disruption of the manufacture of the drug.,2023-06-08,2023-07-05,No
195443,02354624,Shortage,TEVA-ROSUVASTATIN,TEVA CANADA LIMITED,TEVA-ROSUVASTATIN,ROSUVASTATIN,20MG,PP3,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-10-20,2023-07-20,Disruption of the manufacture of the drug.,2023-06-19,2023-07-21,No
211322,02354624,Shortage,TEVA-ROSUVASTATIN,TEVA CANADA LIMITED,ROSUVASTATIN 20MG TAB,ROSUVASTATIN,20MG,500,ORAL; ORAL,Resolved,TABLET,,2023-11-22,2023-12-31,2023-12-13,Disruption of the manufacture of the drug.,2023-11-23,2023-12-14,No
196476,02354624,Shortage,TEVA-ROSUVASTATIN,TEVA CANADA LIMITED,TEVA-ROSUVASTATIN,ROSUVASTATIN,20MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-23,2023-08-10,2023-08-17,Disruption of the manufacture of the drug.,2023-06-26,2023-08-18,No
183425,02354632,Shortage,TEVA-ROSUVASTATIN,TEVA CANADA LIMITED,ROSUVASTATIN 40MG TAB,ROSUVASTATIN,40MG,500,ORAL; ORAL,Resolved,TABLET,,2023-01-30,2023-02-28,2023-02-07,Disruption of the manufacture of the drug.,2023-02-02,2023-02-09,No
199398,02354616,Shortage,TEVA-ROSUVASTATIN,TEVA CANADA LIMITED,TEVA-ROSUVASTATIN,ROSUVASTATIN,10MG,500,ORAL; ORAL,Resolved,TABLET,,2023-07-20,2024-01-31,2024-01-18,Disruption of the manufacture of the drug.,2023-07-20,2024-01-19,No
190746,02240481,Shortage,TEVA-SERTRALINE,TEVA CANADA LIMITED,TEVA-SERTRALINE 100MG CAPSULES 100,SERTRALINE,100MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-04-27,2023-07-20,2023-07-13,Disruption of the manufacture of the drug.,2023-04-27,2023-07-14,No
197218,02240485,Shortage,TEVA-SERTRALINE,TEVA CANADA LIMITED,TEVA-SERTRALINE,SERTRALINE,25MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-07-04,2023-08-30,2023-08-17,Disruption of the manufacture of the drug.,2023-07-04,2023-08-18,No
195449,02240481,Shortage,TEVA-SERTRALINE,TEVA CANADA LIMITED,TEVA-SERTRALINE,SERTRALINE,100MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-06-19,2023-07-20,2023-07-04,Disruption of the manufacture of the drug.,2023-06-19,2023-07-05,No
206419,02308746,Shortage,TEVA-SILDENAFIL,TEVA CANADA LIMITED,SILDENAFIL 50MG TAB,SILDENAFIL,50MG,PP 4,ORAL; ORAL,Resolved,TABLET,,2023-07-19,2023-12-10,2023-12-06,Disruption of the manufacture of the drug.,2023-10-05,2023-12-07,No
201207,02319500,Shortage,TEVA-SILDENAFIL R,TEVA CANADA LIMITED,TEVA-SILDENAFIL R,SILDENAFIL,20MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-08-04,,,Disruption of the manufacture of the drug.,2023-08-04,2024-01-18,No
202252,02250144,Shortage,TEVA-SIMVASTATIN,TEVA CANADA LIMITED,TEVA-SIMVASTATIN,SIMVASTATIN,5MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-08-17,2024-05-31,,Disruption of the manufacture of the drug.,2023-08-17,2024-04-05,No
206401,02250152,Shortage,TEVA-SIMVASTATIN,TEVA CANADA LIMITED,SIMVASTATIN 10MG TABS,SIMVASTATIN,10MG,PP 30,ORAL; ORAL,Actual shortage,TABLET,,2023-09-09,2024-05-31,,Disruption of the manufacture of the drug.,2023-10-05,2024-04-05,No
207518,02250179,Shortage,TEVA-SIMVASTATIN,TEVA CANADA LIMITED,SIMVASTATIN 40MG TABS,SIMVASTATIN,40MG,PP 30,ORAL; ORAL,Actual shortage,TABLET,,2023-10-10,2024-05-31,,Disruption of the manufacture of the drug.,2023-10-19,2024-04-05,No
198303,02250144,Shortage,TEVA-SIMVASTATIN,TEVA CANADA LIMITED,TEVA-SIMVASTATIN,SIMVASTATIN,5MG,PP30,ORAL; ORAL,Actual shortage,TABLET,,2023-07-11,2024-05-31,,Disruption of the manufacture of the drug.,2023-07-11,2024-04-05,No
198306,02250160,Shortage,TEVA-SIMVASTATIN,TEVA CANADA LIMITED,TEVA-SIMVASTATIN,SIMVASTATIN,20MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-07-11,2024-05-31,,Disruption of the manufacture of the drug.,2023-07-11,2024-04-05,No
198309,02250160,Shortage,TEVA-SIMVASTATIN,TEVA CANADA LIMITED,TEVA-SIMVASTATIN,SIMVASTATIN,20MG,pp30,ORAL; ORAL,Actual shortage,TABLET,,2023-07-11,2024-05-31,,Disruption of the manufacture of the drug.,2023-07-11,2024-04-05,No
195243,02250179,Shortage,TEVA-SIMVASTATIN,TEVA CANADA LIMITED,TEVA-SIMVASTATIN,SIMVASTATIN,40MG,30,ORAL; ORAL,Resolved,TABLET,,2023-06-16,2023-06-30,2023-06-20,Disruption of the manufacture of the drug.,2023-06-16,2023-06-21,No
180912,02250179,Shortage,TEVA-SIMVASTATIN,TEVA CANADA LIMITED,OMEPRAZOLE 20MG TAB,SIMVASTATIN,40MG,100,ORAL; ORAL,Resolved,TABLET,,2023-01-10,2023-06-30,2023-07-11,Disruption of the manufacture of the drug.,2023-01-12,2023-07-12,No
180915,02250187,Shortage,TEVA-SIMVASTATIN,TEVA CANADA LIMITED,TEVA-SIMVASTATIN 80MG TAB,SIMVASTATIN,80MG,100,ORAL; ORAL,Resolved,TABLET,,2023-01-10,2023-06-10,2023-06-20,Disruption of the manufacture of the drug.,2023-01-12,2023-06-21,No
195652,02397900,Shortage,TEVA-SOLIFENACIN,TEVA CANADA LIMITED,TEVA-SOLIFENACIN,SOLIFENACIN SUCCINATE,5MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-06-19,2024-06-30,,Disruption of the manufacture of the drug.,2023-06-19,2023-11-03,No
194167,02397919,Shortage,TEVA-SOLIFENACIN,TEVA CANADA LIMITED,TEVA-SOLIFENACIN,SOLIFENACIN SUCCINATE,10MG,"100, 30",ORAL; ORAL,Resolved,TABLET,,2023-06-08,2023-09-30,2023-07-04,Disruption of the manufacture of the drug.,2023-06-08,2023-07-05,No
195456,02397919,Shortage,TEVA-SOLIFENACIN,TEVA CANADA LIMITED,TEVA-SOLIFENACIN,SOLIFENACIN SUCCINATE,10MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-06-19,2024-06-30,,Disruption of the manufacture of the drug.,2023-06-19,2023-11-03,No
195481,02397919,Shortage,TEVA-SOLIFENACIN,TEVA CANADA LIMITED,TEVA-SOLIFENACIN,SOLIFENACIN SUCCINATE,10MG,30,ORAL; ORAL,Actual shortage,TABLET,,2023-06-19,2024-06-30,,Disruption of the manufacture of the drug.,2023-06-19,2023-11-03,No
195506,02397900,Shortage,TEVA-SOLIFENACIN,TEVA CANADA LIMITED,TEVA-SOLIFENACIN,SOLIFENACIN SUCCINATE,5MG,30,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-09-30,2023-07-04,Disruption of the manufacture of the drug.,2023-06-19,2023-07-05,No
194071,00613223,Shortage,TEVA-SPIRONOLACTONE,TEVA CANADA LIMITED,TEVA-SPIRONOLACTONE,SPIRONOLACTONE,100MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-08,2023-06-30,2023-07-04,Disruption of the manufacture of the drug.,2023-06-08,2023-07-05,No
195225,00613223,Shortage,TEVA-SPIRONOLACTONE,TEVA CANADA LIMITED,TEVA-SPIRONOLACTONE,SPIRONOLACTONE,100MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-16,2023-09-20,2023-07-11,Disruption of the manufacture of the drug.,2023-06-16,2023-07-12,No
208251,00657182,Shortage,TEVA-SPIRONOLACTONE/HCTZ,TEVA CANADA LIMITED,TEVA-SPIRONOLACTONE HCTZ 50/50MG TAB,HYDROCHLOROTHIAZIDE; SPIRONOLACTONE,50MG; 50MG,100,ORAL; ORAL,Resolved,TABLET,,2023-09-27,2023-11-10,2023-11-08,Disruption of the manufacture of the drug.,2023-10-26,2023-11-09,No
200210,02045702,Shortage,TEVA-SUCRALFATE,TEVA CANADA LIMITED,TEVA-SUCRALFATE,SUCRALFATE,1G,500,ORAL; ORAL,Resolved,TABLET,,2023-07-27,2023-07-30,2023-08-03,Disruption of the manufacture of the drug.,2023-07-27,2023-08-04,No
184934,02045702,Shortage,TEVA-SUCRALFATE,TEVA CANADA LIMITED,SUCRALFATE 1GM TAB,SUCRALFATE,1G,500,ORAL; ORAL,Resolved,TABLET,,2023-02-14,2023-05-30,2023-06-08,Disruption of the manufacture of the drug.,2023-02-16,2023-06-09,No
213368,02045702,Shortage,TEVA-SUCRALFATE,TEVA CANADA LIMITED,SUCRALFATE 1GM TAB,SUCRALFATE,1G,500,ORAL; ORAL,Actual shortage,TABLET,,2023-12-13,2024-02-29,,Disruption of the manufacture of the drug.,2023-12-14,2024-02-22,No
195039,02045702,Shortage,TEVA-SUCRALFATE,TEVA CANADA LIMITED,TEVA-SUCRALFATE,SUCRALFATE,1G,500,ORAL; ORAL,Resolved,TABLET,,2023-06-16,2023-07-20,2023-07-20,Disruption of the manufacture of the drug.,2023-06-16,2023-07-21,No
195055,02045702,Shortage,TEVA-SUCRALFATE,TEVA CANADA LIMITED,TEVA-SUCRALFATE,SUCRALFATE,1G,100,ORAL; ORAL,Resolved,TABLET,,2023-06-16,2023-09-10,2023-09-10,Disruption of the manufacture of the drug.,2023-06-16,2023-10-04,No
202228,02045702,Shortage,TEVA-SUCRALFATE,TEVA CANADA LIMITED,TEVA-SUCRALFATE,SUCRALFATE,1G,500,ORAL; ORAL,Resolved,TABLET,,2023-08-17,2023-09-10,2023-09-10,Disruption of the manufacture of the drug.,2023-08-17,2023-10-04,No
184943,02440164,Shortage,TEVA-TADALAFIL,TEVA CANADA LIMITED,TADALAFIL 10MG TAB,TADALAFIL,10MG,4 p pak,ORAL; ORAL,Resolved,TABLET,,2023-02-14,2023-04-10,2023-04-27,Disruption of the manufacture of the drug.,2023-02-16,2023-04-28,No
207551,02440172,Shortage,TEVA-TADALAFIL,TEVA CANADA LIMITED,TADALAFIL 20MG TA,TADALAFIL,20MG,100,ORAL; ORAL,Resolved,TABLET,,2023-10-11,2024-05-31,2024-03-20,Disruption of the manufacture of the drug.,2023-10-19,2024-03-21,No
212725,02440172,Shortage,TEVA-TADALAFIL,TEVA CANADA LIMITED,TADALAFIL 20MG TAB,TADALAFIL,20MG,PP4,ORAL; ORAL,Resolved,TABLET,,2023-12-06,2024-03-20,2024-04-17,Disruption of the manufacture of the drug.,2023-12-07,2024-04-18,No
195078,02368242,Shortage,TEVA-TAMSULOSIN CR,TEVA CANADA LIMITED,TEVA-TAMSULOSIN CR,TAMSULOSIN HYDROCHLORIDE,0.4MG,100,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-06-16,2023-10-20,2023-10-05,Disruption of the manufacture of the drug.,2023-06-16,2023-10-06,No
190785,02368242,Shortage,TEVA-TAMSULOSIN CR,TEVA CANADA LIMITED,TEVA-TAMSULOSIN 0.4MG CR TABS P/PACK 30,TAMSULOSIN HYDROCHLORIDE,0.4MG,30,ORAL; ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),,2023-04-27,2024-05-20,,Disruption of the manufacture of the drug.,2023-04-27,2024-03-07,Yes
195827,02368242,Shortage,TEVA-TAMSULOSIN CR,TEVA CANADA LIMITED,TEVA-TAMSULOSIN CR,TAMSULOSIN HYDROCHLORIDE,0.4MG,30,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-06-19,2023-12-30,2023-07-04,Disruption of the manufacture of the drug.,2023-06-20,2023-07-05,No
209148,02368242,Shortage,TEVA-TAMSULOSIN CR,TEVA CANADA LIMITED,TEVA-TAMSULOSIN 0.4MG CR TAB,TAMSULOSIN HYDROCHLORIDE,0.4MG,100,ORAL; ORAL,Actual shortage,TABLET (EXTENDED-RELEASE),,2023-11-01,2024-05-20,,Disruption of the manufacture of the drug.,2023-11-03,2024-04-11,Yes
195850,00608211,Shortage,TEVA-TECNAL,TEVA CANADA LIMITED,TEVA-TECNAL,ACETYLSALICYLIC ACID; CAFFEINE; BUTALBITAL,330MG; 40MG; 50MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-07-31,2023-07-05,Disruption of the manufacture of the drug.,2023-06-20,2023-07-06,No
195603,02320185,Shortage,TEVA-TELMISARTAN,TEVA CANADA LIMITED,TEVA-TELMISARTAN,TELMISARTAN,80MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-07-20,2023-07-11,Disruption of the manufacture of the drug.,2023-06-19,2023-07-12,No
190749,02320185,Shortage,TEVA-TELMISARTAN,TEVA CANADA LIMITED,TEVA-TELMISARTAN 80MG TABLETS 500,TELMISARTAN,80MG,500,ORAL; ORAL,Resolved,TABLET,,2023-04-27,2023-07-10,2023-07-11,Disruption of the manufacture of the drug.,2023-04-27,2023-07-12,No
195873,02320185,Shortage,TEVA-TELMISARTAN,TEVA CANADA LIMITED,TEVA-TELMISARTAN,TELMISARTAN,80MG,500,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-07-20,2023-07-04,Disruption of the manufacture of the drug.,2023-06-20,2023-07-05,No
206898,02320185,Shortage,TEVA-TELMISARTAN,TEVA CANADA LIMITED,TELMISARTAN 80MG TABS,TELMISARTAN,80MG,PP 30's,ORAL; ORAL,Actual shortage,TABLET,,2023-08-09,2024-05-10,,Disruption of the manufacture of the drug.,2023-10-12,2024-04-05,No
184171,02320177,Shortage,TEVA-TELMISARTAN,TEVA CANADA LIMITED,TELMISARTAN 40MG TAB,TELMISARTAN,40MG,"100, PP 30",ORAL; ORAL,Resolved,TABLET,,2023-02-07,2023-03-10,2023-04-27,Disruption of the manufacture of the drug.,2023-02-09,2023-04-28,No
207530,02320177,Shortage,TEVA-TELMISARTAN,TEVA CANADA LIMITED,TELMISARTAN 40MG TABS,TELMISARTAN,40MG,pp 30,ORAL; ORAL,Actual shortage,TABLET,,2023-10-18,2024-05-10,,Disruption of the manufacture of the drug.,2023-10-19,2024-04-05,No
199393,02320177,Shortage,TEVA-TELMISARTAN,TEVA CANADA LIMITED,TEVA-TELMISARTAN,TELMISARTAN,40MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-07-20,2024-04-20,,Disruption of the manufacture of the drug.,2023-07-20,2024-04-18,No
196362,02330288,Shortage,TEVA-TELMISARTAN HCTZ,TEVA CANADA LIMITED,TEVA-TELMISARTAN HCTZ,HYDROCHLOROTHIAZIDE; TELMISARTAN,12.5MG; 80MG,P/P,ORAL; ORAL,Resolved,TABLET,,2023-06-23,2023-12-20,2023-12-21,Disruption of the manufacture of the drug.,2023-06-26,2024-01-08,No
195897,02330288,Shortage,TEVA-TELMISARTAN HCTZ,TEVA CANADA LIMITED,TEVA-TELMISARTAN HCTZ,HYDROCHLOROTHIAZIDE; TELMISARTAN,12.5MG; 80MG,10,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-08-30,2023-07-04,Disruption of the manufacture of the drug.,2023-06-20,2023-07-05,No
195757,02330288,Shortage,TEVA-TELMISARTAN HCTZ,TEVA CANADA LIMITED,TEVA-TELMISARTAN HCTZ,HYDROCHLOROTHIAZIDE; TELMISARTAN,12.5MG; 80MG,50,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-08-30,2023-07-04,Disruption of the manufacture of the drug.,2023-06-20,2023-07-05,No
195539,02330288,Shortage,TEVA-TELMISARTAN HCTZ,TEVA CANADA LIMITED,TEVA-TELMISARTAN HCTZ,HYDROCHLOROTHIAZIDE; TELMISARTAN,12.5MG; 80MG,10,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-12-20,2023-12-21,Disruption of the manufacture of the drug.,2023-06-19,2024-01-08,No
190677,02330288,Shortage,TEVA-TELMISARTAN HCTZ,TEVA CANADA LIMITED,TEVA-TELMISARTAN/HCTZ 80/12.5MG TAB,HYDROCHLOROTHIAZIDE; TELMISARTAN,12.5MG; 80MG,50,ORAL; ORAL,Resolved,TABLET,,2023-04-27,2023-12-20,2023-12-21,Disruption of the manufacture of the drug.,2023-04-27,2024-01-08,No
206901,02395312,Shortage,TEVA-TEMOZOLOMIDE,TEVA CANADA LIMITED,TEMOZOLOMIDE 250MG CAPS,TEMOZOLOMIDE,250MG,5,ORAL; ORAL,Actual shortage,CAPSULE,,2023-08-09,2024-09-20,,Disruption of the manufacture of the drug.,2023-10-12,2024-02-07,No
202295,02395282,Shortage,TEVA-TEMOZOLOMIDE,TEVA CANADA LIMITED,TEVA-TEMOZOLOMIDE,TEMOZOLOMIDE,100MG,5,ORAL; ORAL,Actual shortage,CAPSULE,,2023-08-17,2024-09-20,,Disruption of the manufacture of the drug.,2023-08-17,2024-02-07,No
184940,02395274,Shortage,TEVA-TEMOZOLOMIDE,TEVA CANADA LIMITED,TEMOZOLOMIDE 20MG CAPS,TEMOZOLOMIDE,20MG,5,ORAL; ORAL,Resolved,CAPSULE,,2023-02-14,2023-03-31,2023-04-27,Disruption of the manufacture of the drug.,2023-02-16,2023-04-28,No
181628,02395312,Shortage,TEVA-TEMOZOLOMIDE,TEVA CANADA LIMITED,TEVA-TEMOZOLOMIDE 250MG CAPS,TEMOZOLOMIDE,250MG,5,ORAL; ORAL,Resolved,CAPSULE,,2023-01-18,2023-03-31,2023-04-27,Disruption of the manufacture of the drug.,2023-01-19,2023-04-28,No
207542,02395274,Shortage,TEVA-TEMOZOLOMIDE,TEVA CANADA LIMITED,TEMOZOLOMIDE 20MG CAPS,TEMOZOLOMIDE,20MG,5,ORAL; ORAL,Actual shortage,CAPSULE,,2023-10-18,2024-09-20,,Disruption of the manufacture of the drug.,2023-10-19,2024-02-07,No
199360,02179679,Shortage,TEVA-TIAPROFENIC ACID,TEVA CANADA LIMITED,TEVA-TIAPROFENIC ACID,TIAPROFENIC ACID,200MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-20,2023-10-10,2023-10-04,Disruption of the manufacture of the drug.,2023-07-20,2023-10-05,No
194160,02389622,Shortage,TEVA-TOBRAMYCIN,TEVA CANADA LIMITED,TEVA-TOBRAMYCIN,TOBRAMYCIN,60MG,56,INHALATION; INHALATION,Resolved,SOLUTION,,2023-06-08,2023-07-30,2023-06-20,Disruption of the manufacture of the drug.,2023-06-08,2023-06-21,No
206410,02299593,Shortage,TEVA-TOLTERODINE,TEVA CANADA LIMITED,TOLTERODINE 1MG TAB,TOLTERODINE TARTRATE,1MG,60,ORAL; ORAL,Actual shortage,TABLET,,2023-10-04,,,Disruption of the manufacture of the drug.,2023-10-05,2024-01-08,No
206413,02299607,Shortage,TEVA-TOLTERODINE,TEVA CANADA LIMITED,TOLTERODINE 2MG TAB,TOLTERODINE TARTRATE,2MG,60,ORAL,Actual shortage,TABLET,,2023-10-04,,,Disruption of the manufacture of the drug.,2023-10-05,2024-01-08,No
195844,02412209,Shortage,TEVA-TOLTERODINE LA,TEVA CANADA LIMITED,TEVA-TOLTERODINE LA,TOLTERODINE TARTRATE,4MG,100,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2023-06-19,2023-06-30,2023-06-26,Disruption of the manufacture of the drug.,2023-06-20,2023-06-27,No
195515,02412209,Shortage,TEVA-TOLTERODINE LA,TEVA CANADA LIMITED,TEVA-TOLTERODINE LA,TOLTERODINE TARTRATE,4MG,30,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2023-06-19,2023-06-30,2023-06-26,Disruption of the manufacture of the drug.,2023-06-19,2023-06-27,No
190713,02412209,Shortage,TEVA-TOLTERODINE LA,TEVA CANADA LIMITED,TEVA-TOLTERODINE 4MG ER CAPSULES 30,TOLTERODINE TARTRATE,4MG,30,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2023-04-27,2023-06-20,2023-06-26,Disruption of the manufacture of the drug.,2023-04-27,2023-06-27,No
194088,01927914,Shortage,TEVA-TOPILENE,TEVA CANADA LIMITED,TEVA-TOPILENE,BETAMETHASONE,0.05%,60ML,TOPICAL; TOPICAL,Resolved,LOTION,,2023-06-08,2023-07-30,2023-07-14,Disruption of the manufacture of the drug.,2023-06-08,2023-07-15,No
195579,01927914,Shortage,TEVA-TOPILENE,TEVA CANADA LIMITED,TEVA-TOPILENE,BETAMETHASONE,0.05%,60ML,TOPICAL; TOPICAL,Resolved,LOTION,,2023-06-19,2023-07-30,2023-07-04,Disruption of the manufacture of the drug.,2023-06-19,2023-07-05,No
206398,02248862,Shortage,TEVA-TOPIRAMATE,TEVA CANADA LIMITED,TOPIRAMATE 200MG TAB,TOPIRAMATE,200MG,60,ORAL; ORAL,Resolved,TABLET,,2023-10-04,2024-01-30,2024-01-24,Disruption of the manufacture of the drug.,2023-10-05,2024-01-25,No
199345,02248861,Shortage,TEVA-TOPIRAMATE,TEVA CANADA LIMITED,TEVA-TOPIRAMATE,TOPIRAMATE,100MG,60,ORAL; ORAL,Resolved,TABLET,,2023-07-20,2023-09-20,2023-09-30,Disruption of the manufacture of the drug.,2023-07-20,2023-10-04,No
209116,00804991,Shortage,TEVA-TOPISONE,TEVA CANADA LIMITED,TEVA-TOPISONE 0.05% CREAM,BETAMETHASONE,0.05%,50g,TOPICAL; TOPICAL,Resolved,CREAM,,2023-11-01,2024-01-10,2023-12-13,Disruption of the manufacture of the drug.,2023-11-03,2023-12-14,No
209119,00809187,Shortage,TEVA-TOPISONE,TEVA CANADA LIMITED,TEVA-TOPISONE 0.05% LOTION,BETAMETHASONE,0.05%,75ml,TOPICAL; TOPICAL,Resolved,LOTION,,2023-11-01,2023-12-20,2023-12-13,Disruption of the manufacture of the drug.,2023-11-03,2023-12-14,No
183407,02347180,Shortage,TEVA-TRAMADOL/ACETAMINOPHEN,TEVA CANADA LIMITED,TRAMADOL/ACET 37.5/325MG TAB,TRAMADOL HYDROCHLORIDE; ACETAMINOPHEN,37.5MG; 325MG,PP6,ORAL; ORAL,Resolved,TABLET,,2023-01-30,2023-06-20,2023-06-08,Disruption of the manufacture of the drug.,2023-02-02,2023-06-09,No
200223,02144271,Shortage,TEVA-TRAZODONE,TEVA CANADA LIMITED,TEVA-TRAZODONE,TRAZODONE HYDROCHLORIDE,100MG,500,ORAL; ORAL,Resolved,TABLET,,2023-07-27,2023-11-10,2023-10-05,Disruption of the manufacture of the drug.,2023-07-27,2023-10-06,No
200226,02144298,Shortage,TEVA-TRAZODONE,TEVA CANADA LIMITED,TEVA-TRAZODONE,TRAZODONE HYDROCHLORIDE,150MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-27,2023-12-10,2023-12-13,Disruption of the manufacture of the drug.,2023-07-27,2023-12-14,No
195624,02144271,Shortage,TEVA-TRAZODONE,TEVA CANADA LIMITED,TEVA-TRAZODONE,TRAZODONE HYDROCHLORIDE,100MG,500,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-06-30,2023-06-26,Disruption of the manufacture of the drug.,2023-06-19,2023-06-27,No
195637,02144271,Shortage,TEVA-TRAZODONE,TEVA CANADA LIMITED,TEVA-TRAZODONE,TRAZODONE HYDROCHLORIDE,100MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-19,2023-06-30,2023-06-26,Disruption of the manufacture of the drug.,2023-06-19,2023-06-27,No
199015,02144271,Shortage,TEVA-TRAZODONE,TEVA CANADA LIMITED,TEVA-TRAZODONE,TRAZODONE HYDROCHLORIDE,100MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-18,2023-11-10,2023-10-05,Disruption of the manufacture of the drug.,2023-07-18,2023-10-06,No
198280,02144263,Shortage,TEVA-TRAZODONE,TEVA CANADA LIMITED,TEVA-TRAZODONE,TRAZODONE HYDROCHLORIDE,50MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-11,2024-01-20,2023-12-13,Disruption of the manufacture of the drug.,2023-07-11,2023-12-14,No
198283,02144263,Shortage,TEVA-TRAZODONE,TEVA CANADA LIMITED,TEVA-TRAZODONE,TRAZODONE HYDROCHLORIDE,50MG,500,ORAL; ORAL,Resolved,TABLET,,2023-07-11,2024-01-20,2023-12-13,Disruption of the manufacture of the drug.,2023-07-11,2023-12-14,No
209139,02144271,Shortage,TEVA-TRAZODONE,TEVA CANADA LIMITED,TEVA-TRAZODONE 100MG FC TAB,TRAZODONE HYDROCHLORIDE,100MG,100,ORAL; ORAL,Resolved,TABLET,,2023-11-01,2024-02-28,2023-12-13,Disruption of the manufacture of the drug.,2023-11-03,2023-12-14,No
209142,02144271,Shortage,TEVA-TRAZODONE,TEVA CANADA LIMITED,TEVA-TRAZODONE 100MG FC TAB,TRAZODONE HYDROCHLORIDE,100MG,500,ORAL; ORAL,Resolved,TABLET,,2023-11-01,2023-12-20,2023-12-13,Disruption of the manufacture of the drug.,2023-11-03,2023-12-14,No
183374,00550507,Shortage,TEVA-TRIACOMB,TEVA CANADA LIMITED,TEVA-TRIACOMB CREAM,GRAMICIDIN; NEOMYCIN; NYSTATIN; TRIAMCINOLONE ACETONIDE,0.25MG; 2.5MG; 100000UNIT; 1MG,15g,TOPICAL; TOPICAL,Resolved,CREAM,,2023-01-30,2023-07-30,2023-07-13,Disruption of the manufacture of the drug.,2023-02-02,2023-07-14,No
195192,00550507,Shortage,TEVA-TRIACOMB,TEVA CANADA LIMITED,TEVA-TRIACOMB,GRAMICIDIN; NEOMYCIN; NYSTATIN; TRIAMCINOLONE ACETONIDE,0.25MG; 2.5MG; 100000UNIT; 1MG,30G,TOPICAL; TOPICAL,Resolved,CREAM,,2023-06-16,2023-07-30,2023-07-05,Disruption of the manufacture of the drug.,2023-06-16,2023-07-06,No
195812,00550507,Shortage,TEVA-TRIACOMB,TEVA CANADA LIMITED,TEVA-TRIACOMB,GRAMICIDIN; NEOMYCIN; NYSTATIN; TRIAMCINOLONE ACETONIDE,0.25MG; 2.5MG; 100000UNIT; 1MG,15G,TOPICAL; TOPICAL,Resolved,CREAM,,2023-06-19,2023-07-30,2023-07-05,Disruption of the manufacture of the drug.,2023-06-20,2023-07-06,No
202200,00532657,Shortage,TEVA-TRIAMTERENE/HCTZ,TEVA CANADA LIMITED,TEVA-TRIAMTERENE/HCTZ,HYDROCHLOROTHIAZIDE; TRIAMTERENE,25MG; 50MG,100,ORAL; ORAL,Resolved,TABLET,,2023-08-17,2023-10-10,2023-10-11,Disruption of the manufacture of the drug.,2023-08-17,2023-10-12,No
206383,02240333,Shortage,TEVA-TRYPTOPHAN,TEVA CANADA LIMITED,TRYPTOPHAN 500MG TAB,TRYPTOPHAN,500MG,100,ORAL; ORAL,Resolved,TABLET,,2023-08-09,2024-03-10,2024-03-06,Disruption of the manufacture of the drug.,2023-10-05,2024-03-18,No
210440,02413825,Shortage,TEVA-VALGANCICLOVIR,TEVA CANADA LIMITED,VALGANCICLOVIR HCL 450MG TAB,VALGANCICLOVIR,450MG,60,ORAL; ORAL,Resolved,TABLET,,2023-11-15,2024-03-31,2024-03-26,Disruption of the manufacture of the drug.,2023-11-16,2024-03-28,No
190683,02413825,Shortage,TEVA-VALGANCICLOVIR,TEVA CANADA LIMITED,TEVA-VALGANCICLOVIR HCL 450MG TABS 60,VALGANCICLOVIR,450MG,60,ORAL; ORAL,Resolved,TABLET,,2023-04-27,2023-06-30,2023-06-20,Disruption of the manufacture of the drug.,2023-04-27,2023-06-21,No
204769,02413825,Shortage,TEVA-VALGANCICLOVIR,TEVA CANADA LIMITED,VALGANCICLOVIR HCL,VALGANCICLOVIR,450MG,60,ORAL; ORAL,Resolved,TABLET,,2023-03-01,2023-10-20,2023-10-25,Disruption of the manufacture of the drug.,2023-09-19,2023-10-26,No
200307,02396874,Shortage,TEVA-VORICONAZOLE,TEVA CANADA LIMITED,TEVA-VORICONAZOLE,VORICONAZOLE,200MG,30,ORAL; ORAL,Actual shortage,TABLET,,2023-07-27,2024-07-10,,Disruption of the manufacture of the drug.,2023-07-27,2024-04-18,No
207545,02396866,Shortage,TEVA-VORICONAZOLE,TEVA CANADA LIMITED,VORICONAZOLE 50MG TAB,VORICONAZOLE,50MG,30's,ORAL; ORAL,Actual shortage,TABLET,,2023-10-11,2024-06-20,,Disruption of the manufacture of the drug.,2023-10-19,2024-03-28,No
206386,02242481,Shortage,TEVA-ZOPICLONE,TEVA CANADA LIMITED,ZOPICLONE 7.5MG TAB,ZOPICLONE,7.5MG,500,ORAL; ORAL,Resolved,TABLET,,2023-01-01,2023-11-10,2023-10-18,Disruption of the manufacture of the drug.,2023-10-05,2023-10-19,No
183386,02246534,Shortage,TEVA-ZOPICLONE,TEVA CANADA LIMITED,ZOPICLONE 5MG TAB,ZOPICLONE,5MG,100,ORAL; ORAL,Actual shortage,TABLET,,2023-01-30,,,Disruption of the manufacture of the drug.,2023-02-02,2024-02-01,No
195195,02246534,Shortage,TEVA-ZOPICLONE,TEVA CANADA LIMITED,TEVA-ZOPICLONE,ZOPICLONE,5MG,100,ORAL; ORAL,Resolved,TABLET,,2023-06-16,2024-01-31,2023-07-04,Disruption of the manufacture of the drug.,2023-06-16,2023-07-05,No
196179,02193221,Shortage,THIAMIJECT INJECTION  - LIQ IM IV 100MG/ML,OMEGA LABORATORIES LIMITED,THIAMINE HYDROCHLORIDE INJECTION 100MG/ML,THIAMINE HYDROCHLORIDE,100MG,5 x 10mL vial / fiole,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-06-29,,2023-11-06,Demand increase for the drug.,2023-06-22,2023-11-07,No
192873,02193221,Shortage,THIAMIJECT INJECTION  - LIQ IM IV 100MG/ML,OMEGA LABORATORIES LIMITED,THIAMINE HYDROCHLORIDE INJECTION 100MG/ML,THIAMINE HYDROCHLORIDE,100MG,5 x 10mL vial / fiole,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-05-26,,2023-06-15,Demand increase for the drug.,2023-05-19,2023-06-16,No
213098,02193221,Shortage,THIAMIJECT INJECTION  - LIQ IM IV 100MG/ML,OMEGA LABORATORIES LIMITED,Thiamine Hydrochloride Injection USP,THIAMINE HYDROCHLORIDE,100MG,5 x 10mL vial / fiole,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Actual shortage,LIQUID,,2023-12-19,2024-06-03,,Disruption of the manufacture of the drug.,2023-12-12,2024-04-03,Yes
182152,02193221,Shortage,THIAMIJECT INJECTION  - LIQ IM IV 100MG/ML,OMEGA LABORATORIES LIMITED,THIAMINE HYDROCHLORIDE INJECTION 100MG/ML,THIAMINE HYDROCHLORIDE,100MG,5 x 10mL vial / fiole,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,2023-01-30,2023-01-27,2023-02-23,2023-02-23,Demand increase for the drug.,2023-01-20,2023-02-24,No
210082,02193221,Shortage,THIAMIJECT INJECTION  - LIQ IM IV 100MG/ML,OMEGA LABORATORIES LIMITED,Thiamine Hydrochloride Injection USP,THIAMINE HYDROCHLORIDE,100MG,5 x 10mL vial / fiole,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-11-13,2023-11-24,2023-11-17,Demand increase for the drug.,2023-11-13,2023-11-18,No
186796,02193221,Shortage,THIAMIJECT INJECTION  - LIQ IM IV 100MG/ML,OMEGA LABORATORIES LIMITED,THIAMINE HYDROCHLORIDE INJECTION 100MG/ML,THIAMINE HYDROCHLORIDE,100MG,5 x 10mL vial / fiole,INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Resolved,LIQUID,,2023-03-14,2023-05-12,2023-05-12,Demand increase for the drug.,2023-03-10,2023-05-13,No
191764,02246016,Shortage,THYROGEN,"SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC",THYROGEN,THYROTROPIN ALFA,0.9MG,2,INTRAMUSCULAR; INTRAMUSCULAR,Actual shortage,POWDER FOR SOLUTION,,2023-05-03,,,Other (Please describe in comments),2023-05-05,2023-12-18,Yes
187119,02246016,Shortage,THYROGEN,"SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC",THYROGEN,THYROTROPIN ALFA,0.9MG,2,INTRAMUSCULAR; INTRAMUSCULAR,Resolved,POWDER FOR SOLUTION,,2023-03-14,2023-04-21,2023-04-21,Other (Please describe in comments),2023-03-15,2023-04-24,No
213825,02242276,Shortage,TIMOLOL MALEATE-EX,SANDOZ CANADA INCORPORATED,TIMOLOL,TIMOLOL,0.50%,5ML,OPHTHALMIC; OPHTHALMIC,Actual shortage,SOLUTION (EXTENDED RELEASE),,2023-12-19,2024-06-14,,Disruption of the manufacture of the drug.,2023-12-19,2024-04-16,No
186993,02242275,Shortage,TIMOLOL MALEATE-EX,SANDOZ CANADA INCORPORATED,TIMOLOL MALEATE-EX,TIMOLOL,0.25%,5ML EGEL,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION (EXTENDED RELEASE),,2023-03-13,2023-05-12,2023-05-15,Disruption of the manufacture of the drug.,2023-03-13,2023-05-16,No
192953,02239630,Shortage,TOBI,BGP PHARMA ULC,TOBRAMYCIN,TOBRAMYCIN,300MG,56 AMPULES,INHALATION; INHALATION,Actual shortage,SOLUTION,2023-06-01,2023-05-31,2024-04-30,,Demand increase for the drug.,2023-05-24,2024-04-16,No
193492,02502372,Shortage,TOBRAMYCIN INJECTION USP,STERIMAX INC,TOBRAMYCIN INJECTION USP,TOBRAMYCIN,40MG,25 VIALS,INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-05-29,2023-06-16,2023-06-19,Delay in shipping of the drug.,2023-06-01,2023-06-20,No
210280,02229566,Shortage,TOMUDEX,PFIZER CANADA ULC,TOMUDEX,RALTITREXED,2MG,1 X 2MG,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION,,2023-11-16,,2024-01-31,Disruption of the manufacture of the drug.,2023-11-16,2024-02-01,No
211209,02498650,Shortage,TOMVI,STERIMAX INC,ETOMIDATE INJECTION USP,,2MG,10 VIALS,INTRAVENOUS,Avoided shortage,SOLUTION,2024-01-31,,2024-01-31,2024-01-24,Delay in shipping of the drug.,2023-11-22,2024-01-24,No
211244,02221918,Shortage,TOPICORT,"BAUSCH HEALTH, CANADA INC.",TOPICORT,DESOXIMETASONE,0.05%,20G,TOPICAL; TOPICAL,Resolved,CREAM,2024-01-26,2024-01-26,2024-02-23,2024-02-19,Other (Please describe in comments),2023-11-23,2024-02-22,No
211247,02221934,Shortage,TOPICORT,"BAUSCH HEALTH, CANADA INC.",TOPICORT,DESOXIMETASONE,0.25%,60g,TOPICAL; TOPICAL,Resolved,OINTMENT,2023-12-08,,2024-01-14,2023-12-11,Other (Please describe in comments),2023-11-23,2023-12-15,No
211250,02221918,Shortage,TOPICORT,"BAUSCH HEALTH, CANADA INC.",TOPICORT,DESOXIMETASONE,0.05%,20g,TOPICAL; TOPICAL,Resolved,CREAM,,2023-11-21,2023-11-30,2023-12-04,Other (Please describe in comments),2023-11-23,2023-12-06,No
202719,02221918,Shortage,TOPICORT,"BAUSCH HEALTH, CANADA INC.",TOPICORT,DESOXIMETASONE,0.05%,60g,TOPICAL; TOPICAL,Resolved,CREAM,2023-10-20,,2023-10-20,2023-10-20,Other (Please describe in comments),2023-08-23,2023-10-26,No
181005,02441829,Shortage,TOUJEO SOLOSTAR,SANOFI-AVENTIS CANADA INC,TOUJEO SOLOSTAR (450 IU),INSULIN GLARGINE,300UNIT,5,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION,,2023-01-09,2023-01-30,2023-01-18,Other (Please describe in comments),2023-01-13,2023-01-19,No
184409,02441829,Shortage,TOUJEO SOLOSTAR,SANOFI-AVENTIS CANADA INC,TOUJEO SOLOSTAR (450 IU),INSULIN GLARGINE,300UNIT,3,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,SOLUTION,,2023-02-06,2023-03-07,2023-03-07,Other (Please describe in comments),2023-02-10,2023-03-08,No
200837,00590215,Shortage,TPN ELECTROLYTES,PFIZER CANADA ULC,TPN ELECTROLYTES,SODIUM CHLORIDE; SODIUM ACETATE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; CALCIUM CHLORIDE,16.05MG; 121MG; 25.4MG; 74.55MG; 16.55MG,25 x 20ml vial,INTRAVENOUS; INTRAVENOUS,Avoided shortage,SOLUTION,2024-03-01,,,2024-02-15,Disruption of the manufacture of the drug.,2023-08-03,2024-02-15,No
209473,02392763,Shortage,TRANEXAMIC ACID INJECTION,OMEGA LABORATORIES LIMITED,Tranexamic Acid Injection,TRANEXAMIC ACID,100MG,10 x 5mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-11-20,,2023-12-13,Disruption of the manufacture of the drug.,2023-11-06,2023-12-14,No
183628,02392763,Shortage,TRANEXAMIC ACID INJECTION,OMEGA LABORATORIES LIMITED,Tranexamic Acid Injection,TRANEXAMIC ACID,100MG,10 x 10mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-02-17,,2023-03-16,Demand increase for the drug.,2023-02-03,2023-03-17,No
196188,02392763,Shortage,TRANEXAMIC ACID INJECTION,OMEGA LABORATORIES LIMITED,Tranexamic Acid Injection,TRANEXAMIC ACID,100MG,10 x 10mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-06-29,2023-08-31,2023-08-23,Demand increase for the drug.,2023-06-22,2023-08-24,No
184432,02392763,Shortage,TRANEXAMIC ACID INJECTION,OMEGA LABORATORIES LIMITED,Tranexamic Acid Injection,TRANEXAMIC ACID,100MG,1 x 50mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-02-17,2023-04-17,2023-04-17,Demand increase for the drug.,2023-02-10,2023-04-18,No
194673,02392763,Shortage,TRANEXAMIC ACID INJECTION,OMEGA LABORATORIES LIMITED,Tranexamic Acid Injection,TRANEXAMIC ACID,100MG,1 x 50mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-06-29,2023-08-31,2023-08-21,Demand increase for the drug.,2023-06-10,2023-08-22,No
180133,02392763,Shortage,TRANEXAMIC ACID INJECTION,OMEGA LABORATORIES LIMITED,Tranexamic Acid Injection,TRANEXAMIC ACID,100MG,1 x 50mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Avoided shortage,SOLUTION,2023-01-25,,2023-01-31,2023-01-24,Demand increase for the drug.,2023-01-06,2023-01-24,No
205772,02392763,Shortage,TRANEXAMIC ACID INJECTION,OMEGA LABORATORIES LIMITED,Tranexamic Acid Injection,TRANEXAMIC ACID,100MG,10 x 10mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-10-30,,2023-12-13,Disruption of the manufacture of the drug.,2023-10-02,2023-12-14,No
205775,02392763,Shortage,TRANEXAMIC ACID INJECTION,OMEGA LABORATORIES LIMITED,Tranexamic Acid Injection,TRANEXAMIC ACID,100MG,1 x 50mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-11-06,,2024-02-20,Disruption of the manufacture of the drug.,2023-10-02,2024-02-21,No
205159,02246365,Shortage,TRANEXAMIC ACID INJECTION BP,SANDOZ CANADA INCORPORATED,TRANEXAMIC,TRANEXAMIC ACID,100MG,10ML,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-09-25,2023-10-27,2023-10-23,Disruption of the manufacture of the drug.,2023-09-25,2023-10-24,No
184263,02246365,Shortage,TRANEXAMIC ACID INJECTION BP,SANDOZ CANADA INCORPORATED,TRANEXAMIC ACID INJECTION BP,TRANEXAMIC ACID,100MG,10ML,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-02-08,2023-02-24,2023-03-03,Disruption of the manufacture of the drug.,2023-02-09,2023-03-04,No
207906,02348772,Shortage,TRAZODONE,SANIS HEALTH INC,TRAZODONE,TRAZODONE HYDROCHLORIDE,50MG,100,ORAL; ORAL,Resolved,TABLET,,2023-10-23,2023-11-15,2023-11-15,Disruption of the manufacture of the drug.,2023-10-23,2023-12-01,No
203118,02348799,Shortage,TRAZODONE,SANIS HEALTH INC,TRAZODONE,TRAZODONE HYDROCHLORIDE,150MG,100,ORAL; ORAL,Resolved,TABLET,,2023-08-25,,2023-09-08,Disruption of the manufacture of the drug.,2023-08-29,2023-09-10,No
211117,02348799,Shortage,TRAZODONE,SANIS HEALTH INC,tr,TRAZODONE HYDROCHLORIDE,150MG,100,ORAL; ORAL,Resolved,TABLET,,2023-11-17,2023-12-22,2023-12-11,Disruption of the manufacture of the drug.,2023-11-22,2023-12-26,No
200429,02348772,Shortage,TRAZODONE,SANIS HEALTH INC,TRAZODONE,TRAZODONE HYDROCHLORIDE,50MG,100,ORAL; ORAL,Resolved,TABLET,,2023-07-31,2023-09-03,2023-09-05,Disruption of the manufacture of the drug.,2023-07-31,2023-09-06,No
188979,02508087,Shortage,TRI-CIRA 21,APOTEX INC,NORGESTIMATE / ETHINYL ESTRADIOL,ETHINYL ESTRADIOL; NORGESTIMATE; ETHINYL ESTRADIOL; NORGESTIMATE; ETHINYL ESTRADIOL; NORGESTIMATE,0.035MG; 0.25MG; 0.035MG; 0.215MG; 0.035MG; 0.18MG,21 BLS,ORAL,Resolved,TABLET,,2023-04-04,2023-08-08,2023-08-11,Disruption of the manufacture of the drug.,2023-04-06,2023-08-12,No
187715,02508095,Shortage,TRI-CIRA 28,APOTEX INC,NORGESTIMATE / ETHINYL ESTRADIOL,ETHINYL ESTRADIOL; NORGESTIMATE; ETHINYL ESTRADIOL; NORGESTIMATE; ETHINYL ESTRADIOL; NORGESTIMATE,0.035MG; 0.25MG; 0.035MG; 0.215MG; 0.035MG; 0.18MG,28 BLS,ORAL,Resolved,TABLET,,2023-03-21,2023-08-08,2023-08-11,Disruption of the manufacture of the drug.,2023-03-23,2023-08-12,No
190062,00326836,Shortage,TRIFLUOPERAZINE,AA PHARMA INC,TRIFLUOPERAZINE,TRIFLUOPERAZINE,10MG,100BTL,ORAL; ORAL,Actual shortage,TABLET,2023-08-30,,,,Disruption of the manufacture of the drug.,2023-04-21,2023-08-31,No
200930,00595942,Shortage,TRIFLUOPERAZINE,AA PHARMA INC,Trifluoperazine,TRIFLUOPERAZINE,20MG,100 BTL,ORAL; ORAL,Actual shortage,TABLET,2023-08-31,,,,Disruption of the manufacture of the drug.,2023-08-03,2023-09-01,No
183589,02245663,Shortage,TRIMEBUTINE,AA PHARMA INC,Trimebutine,TRIMEBUTINE MALEATE,100MG,100BTL,ORAL; ORAL,Resolved,TABLET,,2023-02-03,2023-04-14,2023-04-14,Disruption of the manufacture of the drug.,2023-02-03,2023-04-17,No
198716,02245663,Shortage,TRIMEBUTINE,AA PHARMA INC,Trimebutine,TRIMEBUTINE MALEATE,100MG,100 BTL,ORAL; ORAL,Resolved,TABLET,2023-07-17,,2026-08-07,2023-08-09,Disruption of the manufacture of the drug.,2023-07-14,2023-08-14,No
185693,02243116,Shortage,TRIMETHOPRIM TABLETS,AA PHARMA INC,Trimethoprim,TRIMETHOPRIM,100MG,100BTL,ORAL; ORAL,Resolved,TABLET,2023-02-28,,2023-04-10,2023-03-29,Disruption of the manufacture of the drug.,2023-02-28,2023-03-30,No
206939,00740810,Shortage,TRIMIPRAMINE,AA PHARMA INC,Trimipramine,TRIMIPRAMINE,50MG,100 BTL,ORAL; ORAL,Resolved,TABLET,2023-10-12,,2023-12-06,2023-12-04,Disruption of the manufacture of the drug.,2023-10-13,2023-12-05,No
211678,02230733,Shortage,TRINIPATCH 0.4,PALADIN LABS INC.,Trinipatch 0.4 mg,NITROGLYCERIN,0.4MG,30 patches and 100 patches,TRANSDERMAL; TRANSDERMAL,Resolved,PATCH,,2023-11-28,2024-03-01,2024-02-07,Other (Please describe in comments),2023-11-28,2024-02-08,No
197812,02470632,Shortage,TRISPAN,MEDEXUS INC,TRIAMCINOLONE HEXACETONIDE INJECTABLE SUSPENSION,TRIAMCINOLONE HEXACETONIDE,20MG,1 ml ampoule - 10 ampoules/pack,INTRASYNOVIAL; PERIARTICULAR; INTRA-ARTICULAR; PERIARTICULAR; INTRASYNOVIAL; INTRA-ARTICULAR,Actual shortage,SUSPENSION,2023-09-01,,,,Other (Please describe in comments),2023-07-07,2024-04-16,No
206237,00511234,Shortage,TROMBOJECT 1%,OMEGA LABORATORIES LIMITED,Sodium Tetradecyl Sulfate Injection,SODIUM TETRADECYL SULFATE,10MG,10 x 2mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-06-01,,2023-10-27,Disruption of the manufacture of the drug.,2023-10-04,2023-10-28,No
206240,00511226,Shortage,TROMBOJECT 3%,OMEGA LABORATORIES LIMITED,Sodium Tetradecyl Sulfate Injection,SODIUM TETRADECYL SULFATE,30MG,10 x 2mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Actual shortage,SOLUTION,,2023-01-01,,,Disruption of the manufacture of the drug.,2023-10-04,2024-01-16,No
206243,00511226,Shortage,TROMBOJECT 3%,OMEGA LABORATORIES LIMITED,Sodium Tetradecyl Sulfate Injection,SODIUM TETRADECYL SULFATE,30MG,5 x 5mL vial / fiole,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-10-01,,2024-02-07,Disruption of the manufacture of the drug.,2023-10-04,2024-02-08,No
211401,02448599,Shortage,TRULICITY,ELI LILLY CANADA INC,dulaglutide,DULAGLUTIDE,0.75MG,4 x 0.5 mL single-use prefilled pen,SUBCUTANEOUS; SUBCUTANEOUS,Actual shortage,SOLUTION,2023-11-30,2023-11-30,2024-05-31,,Demand increase for the drug.,2023-11-24,2024-03-20,No
211404,02448602,Shortage,TRULICITY,ELI LILLY CANADA INC,dulaglutide,DULAGLUTIDE,1.5MG,4 x 0.5 mL single-use prefilled pen,SUBCUTANEOUS; SUBCUTANEOUS,Actual shortage,SOLUTION,2024-01-04,2024-01-04,2024-05-31,,Demand increase for the drug.,2023-11-24,2024-03-20,No
187945,02216205,Shortage,TRUSOPT,ELVIUM LIFE SCIENCES,Dorzolamide Hydrochloride Ophthalmic Solution,DORZOLAMIDE,2%,5ml,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,2023-03-24,2023-03-24,2023-05-12,2023-05-08,Delay in shipping of the drug.,2023-03-24,2023-05-09,No
186004,02130955,Shortage,TYPHIM VI,SANOFI PASTEUR LIMITED,TYPHIM Vi,SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE,25MCG,1 x 0.5 mL,INTRAMUSCULAR; INTRAMUSCULAR,Resolved,SOLUTION,2023-03-10,2023-03-06,2023-10-31,2023-08-29,Demand increase for the drug.,2023-03-02,2023-08-30,No
206722,02441608,Shortage,ULTRA-TECHNEKOW V4,CURIUM CANADA INC,Technetium Tc 99m generator (Sodium Pertechnetate Tc 99m Injection),SODIUM PERTECHNETATE TC-99M,19CI,1-19 curies,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2023-10-10,2023-10-12,2023-10-12,2023-10-14,Shortage of an active ingredient.,2023-10-10,2023-10-16,No
188852,02441608,Shortage,ULTRA-TECHNEKOW V4,CURIUM CANADA INC,Sodium Pertechnetate Tc 99m Injection,SODIUM PERTECHNETATE TC-99M,19CI,1-19 curies,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2023-06-11,,2023-06-14,2023-06-15,Shortage of an active ingredient.,2023-04-05,2023-06-19,No
208033,02061597,Shortage,UNISOM SLEEPGELS EXTRA STRENGTH,PALADIN LABS INC.,Diphenhydramine,DIPHENHYDRAMINE HYDROCHLORIDE,50MG,20 capsules,ORAL; ORAL,Actual shortage,CAPSULE,,2023-10-25,2024-03-31,,Delay in shipping of the drug.,2023-10-25,2024-02-02,No
206032,01914022,Shortage,UROCIT-K,MISSION PHARMACAL COMPANY,Potassium Citrate Extended Release Tablets,POTASSIUM CITRATE,540MG,100-ct,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),2023-10-03,2023-10-03,2024-02-29,2024-02-02,Delay in shipping of the drug.,2023-10-03,2024-02-05,No
206035,02353997,Shortage,UROCIT-K,MISSION PHARMACAL COMPANY,Potassium Citrate Extended Release Tablets,POTASSIUM CITRATE,1080MG,100-ct,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),2023-10-03,2023-10-03,2024-02-29,2024-02-02,Delay in shipping of the drug.,2023-10-03,2024-02-05,No
214355,02241411,Shortage,UROMITEXAN,BAXTER CORPORATION,Mesna Injection,MESNA,100MG,"100 mg/mL, 10 mL, 15 units/case (2639B2010)",ORAL; INTRAVENOUS; ORAL; INTRAVENOUS,Resolved,SOLUTION,2023-12-22,2023-12-22,2024-02-23,2024-02-20,Demand increase for the drug.,2023-12-27,2024-02-21,No
203947,02371839,Shortage,UROMITEXAN,BAXTER CORPORATION,Mesna Injection,MESNA,100MG,1 gram (2639B3923),INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,2023-09-08,2023-09-08,2023-09-22,2023-09-26,Demand increase for the drug.,2023-09-08,2023-09-27,No
207872,02519585,Shortage,VALACYCLOVIR,SANIS HEALTH INC,VALACYCLOVIR,VALACYCLOVIR,1000MG,100,ORAL,Resolved,TABLET,,2023-10-23,2023-11-27,2023-11-27,Disruption of the manufacture of the drug.,2023-10-23,2023-12-01,No
207875,02454645,Shortage,VALACYCLOVIR,SANIS HEALTH INC,VALACYCLOVIR,VALACYCLOVIR,500MG,100,ORAL; ORAL,Resolved,TABLET,,2023-10-23,2023-11-27,2023-11-30,Disruption of the manufacture of the drug.,2023-10-23,2023-12-01,No
191490,02245777,Shortage,VALCYTE,CHEPLAPHARM ARZNEIMITTEL GMBH,Valganciclovir Tablets,VALGANCICLOVIR,450MG,bottles of 60,ORAL; ORAL,Resolved,TABLET,,2023-05-02,2023-07-31,2023-05-24,Disruption of the manufacture of the drug.,2023-05-02,2023-05-25,No
191497,02306085,Shortage,VALCYTE,CHEPLAPHARM ARZNEIMITTEL GMBH,Valganciclovir Powder for Oral Solution,VALGANCICLOVIR,50MG,5 g valganciclovir / bottle,ORAL; ORAL,Resolved,POWDER FOR SOLUTION,,2023-05-02,2023-11-30,2023-11-02,Disruption of the manufacture of the drug.,2023-05-02,2023-11-05,No
205325,02245777,Shortage,VALCYTE,CHEPLAPHARM ARZNEIMITTEL GMBH,Valganciclovir Tablets,VALGANCICLOVIR,450MG,bottles of 60,ORAL; ORAL,Resolved,TABLET,2023-09-28,,2023-11-30,2023-11-02,Disruption of the manufacture of the drug.,2023-09-27,2023-11-05,No
191332,02394634,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",SANDOZ CANADA INCORPORATED,VANCOMYCIN HCL,VANCOMYCIN,1G,10LYVI,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION,,2023-05-01,2023-05-19,2023-05-08,Disruption of the manufacture of the drug.,2023-05-01,2023-05-09,No
203663,02394626,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",SANDOZ CANADA INCORPORATED,VANCOMYCIN,VANCOMYCIN,500MG,10LYVI,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION,,2023-09-05,2024-04-05,2024-04-08,Disruption of the manufacture of the drug.,2023-09-05,2024-04-09,No
181151,02241807,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",FRESENIUS KABI CANADA LTD,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",VANCOMYCIN,10G,100mL,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION,,2023-01-01,2023-03-31,2023-03-31,Other (Please describe in comments),2023-01-16,2023-04-03,No
181736,02394642,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",SANDOZ CANADA INCORPORATED,VANCOMYCIN,VANCOMYCIN,5G,1LYVI,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION,,2023-01-18,2023-02-17,2023-02-17,Disruption of the manufacture of the drug.,2023-01-19,2023-03-02,No
207085,02394634,Shortage,"VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",SANDOZ CANADA INCORPORATED,VANCOMYCIN,VANCOMYCIN,1G,10LYVI,INTRAVENOUS; INTRAVENOUS,Actual shortage,POWDER FOR SOLUTION,,2023-10-16,2024-05-03,,Disruption of the manufacture of the drug.,2023-10-16,2024-03-11,No
195572,02246081,Shortage,VARIVAX III,MERCK CANADA INC,"varicella virus vaccine, live, attenuated [Oka/Merck]) Lyophilized powder for injection",VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED,1350UNIT,1x vial,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,POWDER FOR SOLUTION,2023-06-19,2023-06-21,2023-07-14,2023-07-13,Delay in shipping of the drug.,2023-06-19,2023-07-14,No
206439,00670928,Shortage,VASOTEC,ORGANON CANADA INC.,enalapril tablets,ENALAPRIL SODIUM,16MG,28,ORAL; ORAL,Avoided shortage,TABLET,2023-12-04,,2024-01-12,2023-11-29,Delay in shipping of the drug.,2023-10-05,2023-11-29,No
206442,00708879,Shortage,VASOTEC,ORGANON CANADA INC.,enalapril tablets,ENALAPRIL SODIUM,4MG,28,ORAL; ORAL,Resolved,TABLET,2023-10-23,2023-10-18,2023-12-01,2023-11-03,Delay in shipping of the drug.,2023-10-05,2023-11-04,No
180268,02516535,Shortage,VENLAFAXINE XR,JAMP PHARMA CORPORATION,Venlafaxine Hydrochloride Extended-Release Capsules,VENLAFAXINE,37.5MG,500,ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2022-12-09,2023-09-30,2023-09-30,Other (Please describe in comments),2023-01-10,2023-10-01,No
183708,02516535,Shortage,VENLAFAXINE XR,JAMP PHARMA CORPORATION,Venlafaxine Hydrochloride,VENLAFAXINE,37.5MG,100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),,2023-02-06,2024-06-30,,Disruption of the manufacture of the drug.,2023-02-06,2024-03-30,No
183728,02516535,Shortage,VENLAFAXINE XR,JAMP PHARMA CORPORATION,Venlafaxine Hydrochloride,VENLAFAXINE,37.5MG,500,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),,2023-02-06,2024-06-30,,Disruption of the manufacture of the drug.,2023-02-06,2024-03-30,No
183733,02516543,Shortage,VENLAFAXINE XR,JAMP PHARMA CORPORATION,Venlafaxine Hydrochloride,VENLAFAXINE,75MG,500,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),,2023-02-06,2024-06-30,,Disruption of the manufacture of the drug.,2023-02-06,2024-03-30,No
183736,02516543,Shortage,VENLAFAXINE XR,JAMP PHARMA CORPORATION,Venlafaxine Hydrochloride,VENLAFAXINE,75MG,100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),,2023-02-06,2024-06-30,,Disruption of the manufacture of the drug.,2023-02-06,2024-03-30,No
189379,02516551,Shortage,VENLAFAXINE XR,JAMP PHARMA CORPORATION,Venlafaxine Hydrochloride Extended-Release Capsules,VENLAFAXINE,150MG,500,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),,2023-04-12,2024-06-30,,Other (Please describe in comments),2023-04-12,2024-03-30,No
205261,02516551,Shortage,VENLAFAXINE XR,JAMP PHARMA CORPORATION,Venlafaxine Hydrochloride Extended-Release Capsules,VENLAFAXINE,150MG,100,ORAL,Actual shortage,CAPSULE (EXTENDED RELEASE),,2023-09-29,2024-06-30,,Disruption of the manufacture of the drug.,2023-09-26,2024-03-30,No
200434,02354713,Shortage,VENLAFAXINE XR,SANIS HEALTH INC,VENLAFAXINE XR,VENLAFAXINE,37.5MG,100,ORAL; ORAL,Resolved,CAPSULE (EXTENDED RELEASE),,2023-07-31,,2023-09-29,Disruption of the manufacture of the drug.,2023-07-31,2023-10-01,No
208287,02241497,Shortage,VENTOLIN HFA,GLAXOSMITHKLINE INC,"salbutamol pressurised inhalation, suspension",SALBUTAMOL,100MCG,1x200,INHALATION; INHALATION,Resolved,METERED-DOSE AEROSOL,,2023-10-26,2024-02-01,2024-02-01,Disruption of the manufacture of the drug.,2023-10-26,2024-02-02,No
186176,02166739,Shortage,VERAPAMIL HYDROCHLORIDE INJECTION USP,SANDOZ CANADA INCORPORATED,VERAPAMIL HCL,VERAPAMIL HYDROCHLORIDE,2.5MG,2ML,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,,2023-02-24,2023-04-21,2023-04-21,Disruption of the manufacture of the drug.,2023-03-03,2023-04-22,No
209230,02166739,Shortage,VERAPAMIL HYDROCHLORIDE INJECTION USP,SANDOZ CANADA INCORPORATED,VERAPAMIL HCL,VERAPAMIL HYDROCHLORIDE,2.5MG,2 ML 10 LIVI,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,,2023-11-06,2023-12-22,2023-12-22,Disruption of the manufacture of the drug.,2023-11-06,2024-01-03,No
198005,02166739,Shortage,VERAPAMIL HYDROCHLORIDE INJECTION USP,SANDOZ CANADA INCORPORATED,VERAPAMIL HYDROCHLORIDE,VERAPAMIL HYDROCHLORIDE,2.5MG,2ML 10LIVI,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,,2023-07-10,2023-07-28,2023-07-31,Disruption of the manufacture of the drug.,2023-07-10,2023-08-01,No
208998,02277263,Shortage,VESICARE,ASTELLAS PHARMA CANADA INC,Vesicare,SOLIFENACIN SUCCINATE,5MG,"1 bottle, 30 tablets",ORAL; ORAL,Resolved,TABLET,2023-11-03,2023-11-03,2023-11-10,2023-11-10,Demand increase for the drug.,2023-11-03,2023-11-11,No
208279,02277271,Shortage,VESICARE,ASTELLAS PHARMA CANADA INC,Vesicare,SOLIFENACIN SUCCINATE,10MG,"1 Bottle, 30 Tablets",ORAL; ORAL,Resolved,TABLET,2023-11-06,2023-11-03,2023-11-10,2023-11-10,Demand increase for the drug.,2023-10-26,2023-11-11,No
184244,02279991,Shortage,VFEND,PFIZER CANADA ULC,VFEND,VORICONAZOLE,200MG,70mL BTL,ORAL; ORAL,Resolved,POWDER FOR SUSPENSION,,2023-02-09,,2023-03-27,Disruption of the manufacture of the drug.,2023-02-09,2023-03-28,No
201791,02451557,Shortage,VIACORAM,SERVIER CANADA INC,Perindopril arginine/amlodipine,AMLODIPINE; PERINDOPRIL ARGININE,10MG; 14MG,30's,ORAL; ORAL,Resolved,TABLET,2023-08-18,,2024-01-03,2023-12-05,Delay in shipping of the drug.,2023-08-14,2023-12-06,No
192838,02451530,Shortage,VIACORAM,SERVIER CANADA INC,Perindopril arginine/amlodipine,AMLODIPINE; PERINDOPRIL ARGININE,2.5MG; 3.5MG,30's,ORAL; ORAL,Resolved,TABLET,,2023-05-18,2023-05-26,2023-05-26,Delay in shipping of the drug.,2023-05-19,2023-05-27,No
198226,02451557,Shortage,VIACORAM,SERVIER CANADA INC,Perindopril arginine/amlodipine,AMLODIPINE; PERINDOPRIL ARGININE,10MG; 14MG,30,ORAL; ORAL,Resolved,TABLET,,2023-07-07,,2023-07-27,Delay in shipping of the drug.,2023-07-11,2023-07-28,No
204772,02451549,Shortage,VIACORAM,SERVIER CANADA INC,Perindopril arginine/amlodipine,PERINDOPRIL ARGININE; AMLODIPINE,7MG; 5MG,30,ORAL; ORAL,Resolved,TABLET,,2023-09-13,2023-11-21,2023-11-21,Delay in shipping of the drug.,2023-09-19,2023-11-22,No
182999,00717002,Shortage,VIADERM KC CRM,TARO PHARMACEUTICALS INC,VIADERM KC,NYSTATIN; GRAMICIDIN; NEOMYCIN; TRIAMCINOLONE ACETONIDE,100000UNIT; 0.25MG; 2.5MG; 1MG,60,TOPICAL; TOPICAL,Resolved,CREAM,,2023-01-26,2023-02-24,2023-02-14,Disruption of the manufacture of the drug.,2023-02-01,2023-02-28,No
182001,00717002,Shortage,VIADERM KC CRM,TARO PHARMACEUTICALS INC,VIADERM KC,NYSTATIN; GRAMICIDIN; NEOMYCIN; TRIAMCINOLONE ACETONIDE,100000UNIT; 0.25MG; 2.5MG; 1MG,30,TOPICAL; TOPICAL,Resolved,CREAM,,2023-01-11,2023-02-24,2023-02-14,Disruption of the manufacture of the drug.,2023-01-20,2023-02-28,No
204062,02443732,Shortage,VIIBRYD,ABBVIE CORPORATION,VIIBRYD 20MG TAB 30,VILAZODONE HYDROCHLORIDE,20MG,30 tablets/bottle,ORAL; ORAL,Resolved,TABLET,,2023-09-11,2023-09-29,2023-09-28,Delay in shipping of the drug.,2023-09-11,2023-09-29,No
212766,02443724,Shortage,VIIBRYD,ABBVIE CORPORATION,Vilazodone HCI,VILAZODONE HYDROCHLORIDE,10MG,30 tablets/bottle,ORAL; ORAL,Resolved,TABLET,2023-12-07,2023-12-07,2024-01-19,2024-01-15,Delay in shipping of the drug.,2023-12-07,2024-01-16,No
212769,02443732,Shortage,VIIBRYD,ABBVIE CORPORATION,vilazodone HCI,VILAZODONE HYDROCHLORIDE,20MG,30 tablets/bottle,ORAL; ORAL,Resolved,TABLET,,2023-12-07,2024-01-19,2023-12-07,Delay in shipping of the drug.,2023-12-07,2023-12-08,No
192501,02443724,Shortage,VIIBRYD,ABBVIE CORPORATION,Viibrid 10 mg Tablet,VILAZODONE HYDROCHLORIDE,10MG,30 tablets/bottle,ORAL; ORAL,Resolved,TABLET,,2023-05-15,2023-06-09,2023-06-08,Delay in shipping of the drug.,2023-05-15,2023-06-09,No
199446,02183056,Shortage,VINBLASTINE SULFATE INJECTION,PFIZER CANADA ULC,VINBLASTINE SULFATE INJECTION,VINBLASTINE SULFATE,1MG,10mL vial,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-08-01,,2023-09-06,Disruption of the manufacture of the drug.,2023-07-21,2023-09-07,No
189937,02183013,Shortage,VINCRISTINE SULFATE INJECTION USP,PFIZER CANADA ULC,VINCRISTINE SULFATE INJECTION USP,VINCRISTINE SULFATE,1MG,2mL vial,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-06-02,,2023-10-18,Disruption of the manufacture of the drug.,2023-04-20,2023-10-19,No
191469,02241933,Shortage,VIOKACE,NESTLE ENTERPRISES S.A.,Pancrelipase,AMYLASE; PROTEASE; LIPASE,113400UNIT; 112500UNIT; 20880UNIT,100 tablet bottles,ORAL; ORAL,Resolved,TABLET,2023-05-03,2023-05-04,,2023-08-02,Shortage of an active ingredient.,2023-05-02,2023-08-03,No
193926,02170140,Shortage,VIRAZOLE,"BAUSCH HEALTH, CANADA INC.",VIRAZOLE,RIBAVIRIN,6G,n/a,INHALATION; INHALATION,Resolved,POWDER FOR SOLUTION; AEROSOL,2023-06-20,2023-06-20,2023-10-31,2023-10-30,Demand increase for the drug.,2023-06-08,2023-11-01,No
213468,02170140,Shortage,VIRAZOLE,"BAUSCH HEALTH, CANADA INC.",VIRAZOLE,RIBAVIRIN,6G,4's,INHALATION; INHALATION,Resolved,POWDER FOR SOLUTION; AEROSOL,,2023-12-07,2024-01-23,2024-01-22,Demand increase for the drug.,2023-12-15,2024-01-29,No
199253,02279525,Shortage,VISIONBLUE,DUTCH OPHTHALMIC RESEARCH CENTER INTERNATIONAL BV,Visionblue,TRYPAN BLUE,0.06%,10 syringe/box,INTRAOCULAR; INTRAOCULAR,Resolved,SOLUTION; DROPS,,2023-07-03,2023-08-07,2023-08-08,Other (Please describe in comments),2023-07-20,2023-08-09,No
189229,02429063,Shortage,VISTITAN,SANDOZ CANADA INCORPORATED,VISTITAN,BIMATOPROST,0.03%,5ML LDP,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,,2023-04-11,2023-04-28,2023-04-21,Disruption of the manufacture of the drug.,2023-04-11,2023-04-22,No
186307,00521515,Shortage,VITAMIN B12,SANDOZ CANADA INCORPORATED,VITAMIN B12,VITAMIN B12,1000MCG,10ML,SUBCUTANEOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-03-06,2023-03-31,2023-04-04,Disruption of the manufacture of the drug.,2023-03-06,2023-04-05,No
184576,02245214,Shortage,VITAMIN C,MYLAN PHARMACEUTICALS ULC,ASCORBIC ACID,ASCORBIC ACID,500MG,50ML 1VL,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,,2023-02-10,2023-02-28,2023-02-15,Demand increase for the drug.,2023-02-14,2023-03-02,No
207192,02245214,Shortage,VITAMIN C,MYLAN PHARMACEUTICALS ULC,ASCORBIC ACID,ASCORBIC ACID,500MG,50ML 1VL,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Actual shortage,SOLUTION,,2023-10-13,2024-05-06,,Demand increase for the drug.,2023-10-17,2024-03-25,No
189880,02245214,Shortage,VITAMIN C,MYLAN PHARMACEUTICALS ULC,ASCORBIC ACID,ASCORBIC ACID,500MG,50ML 1VL,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Resolved,SOLUTION,2023-06-14,2023-05-23,,2023-07-17,Demand increase for the drug.,2023-04-20,2023-07-18,No
182486,00804312,Shortage,VITAMIN K1 INJ 10MG/ML USP,SANDOZ CANADA INCORPORATED,VITAMIN K1,VITAMIN K1,10MG,1ML,SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR,Resolved,EMULSION,,2023-01-30,2023-05-26,2023-05-02,Disruption of the manufacture of the drug.,2023-01-27,2023-05-30,No
191158,02490323,Shortage,VITRAKVI,BAYER INC,LAROTRECTINIB,LAROTRECTINIB,100MG,56's,ORAL,Resolved,CAPSULE,,2023-04-28,2023-05-05,2023-05-02,Delay in shipping of the drug.,2023-04-28,2023-05-03,No
189904,02490315,Shortage,VITRAKVI,BAYER INC,LAROTRECTINIB,LAROTRECTINIB,25MG,56's,ORAL,Resolved,CAPSULE,2023-04-24,2023-04-25,2023-06-16,2023-06-09,Demand increase for the drug.,2023-04-20,2023-06-10,No
205330,01940414,Shortage,VOLTAREN OPHTHA,NOVARTIS PHARMACEUTICALS CANADA INC,VOLTAREN SOLN. 5ML,DICLOFENAC SODIUM,0.10%,5ML,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,2023-09-27,2023-09-27,2024-02-09,2024-02-02,Delay in shipping of the drug.,2023-09-27,2024-02-03,No
192835,01940414,Shortage,VOLTAREN OPHTHA,NOVARTIS PHARMACEUTICALS CANADA INC,VOLTAREN 5ML,DICLOFENAC SODIUM,0.10%,5ML,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,2023-05-24,2023-05-26,2023-09-25,2023-09-25,Disruption of the manufacture of the drug.,2023-05-19,2023-09-27,No
201890,02486822,Shortage,VPI-BENZTROPINE,VPI PHARMACEUTICALS INC,BENZTROPINE MESYLATE,BENZTROPINE MESYLATE,2MG,"Vials of 2 ml, boxes of 10",INTRAVENOUS; INTRAMUSCULAR; INTRAVENOUS; INTRAMUSCULAR,Actual shortage,SOLUTION,,2023-03-30,,,Disruption of the manufacture of the drug.,2023-08-15,2023-10-11,No
185609,02490250,Shortage,VYVANSE,TAKEDA CANADA INC,Lisdexamfetamine dimesylate chewable tablets,LISDEXAMFETAMINE DIMESYLATE,40MG,Bottles of 100's,ORAL; ORAL,Resolved,TABLET (CHEWABLE),2023-02-24,2023-02-24,2023-03-17,2023-03-06,Delay in shipping of the drug.,2023-02-25,2023-03-07,No
203355,02439603,Shortage,VYVANSE,TAKEDA CANADA INC,Lisdexamfetamine dimesylate capsules,LISDEXAMFETAMINE DIMESYLATE,10MG,Bottles of 100's,ORAL; ORAL,Resolved,CAPSULE,2023-08-30,2023-08-30,2023-09-20,2023-09-13,Demand increase for the drug.,2023-08-31,2023-09-14,No
196238,02347156,Shortage,VYVANSE,TAKEDA CANADA INC,Lisdexamfetamine dimesylate capsules,LISDEXAMFETAMINE DIMESYLATE,20MG,Bottles of 100's,ORAL; ORAL,Resolved,CAPSULE,2023-06-23,2023-06-23,2023-10-20,2023-10-06,Delay in shipping of the drug.,2023-06-23,2023-10-07,No
188217,02510162,Shortage,XARELTO,BAYER INC,RIVAROXABAN,RIVAROXABAN,51.7MG,100 ML,ORAL,Resolved,GRANULES FOR SUSPENSION,2023-04-10,2023-04-25,2023-06-09,2023-06-02,Delay in shipping of the drug.,2023-03-29,2023-06-05,No
212621,02316986,Shortage,XARELTO,BAYER INC,RIVAROXABAN,RIVAROXABAN,10MG,50's,ORAL; ORAL,Resolved,TABLET,2023-12-15,2023-12-15,2024-01-05,2023-12-21,Delay in shipping of the drug.,2023-12-07,2023-12-22,No
182739,02378604,Shortage,XARELTO,BAYER INC,RIVAROXABAN,RIVAROXABAN,15MG,90's,ORAL; ORAL,Resolved,TABLET,,2023-01-31,2023-02-10,2023-02-07,Delay in shipping of the drug.,2023-01-31,2023-02-08,No
194785,02316986,Shortage,XARELTO,BAYER INC,RIVAROXABAN,RIVAROXABAN,10MG,50's,ORAL; ORAL,Resolved,TABLET,,2023-06-12,2023-06-19,2023-06-13,Delay in shipping of the drug.,2023-06-12,2023-06-14,No
196859,02510162,Shortage,XARELTO,BAYER INC,Rivaroxaban,RIVAROXABAN,51.7MG,100 mL bottle,ORAL,Avoided shortage,GRANULES FOR SUSPENSION,2023-11-20,,2023-11-24,2023-11-16,Shortage of an inactive ingredient or component.,2023-06-29,2023-11-17,No
196862,02510170,Shortage,XARELTO,BAYER INC,Rivaroxaban,RIVAROXABAN,103.4MG,250 mL bottle,ORAL,Resolved,GRANULES FOR SUSPENSION,2023-09-22,2023-09-22,2023-11-17,2023-11-16,Shortage of an inactive ingredient or component.,2023-06-29,2023-11-17,No
196992,02245565,Shortage,XATRAL,SANOFI-AVENTIS CANADA INC,Alfuzosin Hydrochloride,ALFUZOSIN HYDROCHLORIDE,10MG,100,ORAL; ORAL,Resolved,TABLET (EXTENDED-RELEASE),,2023-06-30,2023-07-31,2023-07-20,Other (Please describe in comments),2023-06-30,2023-07-28,No
183894,02404044,Shortage,XERESE,"BAUSCH HEALTH, CANADA INC.",XERESE,HYDROCORTISONE; ACYCLOVIR,1%; 5%,5g,TOPICAL; TOPICAL,Avoided shortage,CREAM,2023-04-21,,2023-06-13,2023-04-07,Shortage of an inactive ingredient or component.,2023-02-08,2023-04-11,No
211221,02260565,Shortage,XOLAIR,NOVARTIS PHARMACEUTICALS CANADA INC,XOLAIR 150MG/5ML VIALS 1 X 1,OMALIZUMAB,150MG,1 x 5mL,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,POWDER FOR SOLUTION,2024-01-31,2024-01-25,2024-03-31,2024-04-09,Delay in shipping of the drug.,2023-11-22,2024-04-10,No
181249,02302411,Shortage,XYLOCAINE 1%,ASPEN PHARMACARE CANADA INC.,lidocaine HCI 1% Plain 10x50mL MD Vial,LIDOCAINE HYDROCHLORIDE,10MG,10 vials,BLOCK/INFILTRATION; BLOCK/INFILTRATION,Resolved,SOLUTION,2023-07-15,2023-07-20,2023-11-30,2023-11-06,Disruption of the manufacture of the drug.,2023-01-17,2023-11-07,No
188990,02302411,Shortage,XYLOCAINE 1%,ASPEN PHARMACARE CANADA INC.,lidocaine HCI 1% Plain 10x20mL MD Vial,LIDOCAINE HYDROCHLORIDE,10MG,10 vials,BLOCK/INFILTRATION; BLOCK/INFILTRATION,Avoided shortage,SOLUTION,2023-12-01,,2024-01-01,2023-05-02,Delay in shipping of the drug.,2023-04-06,2023-05-02,No
206661,02302411,Shortage,XYLOCAINE 1%,ASPEN PHARMACARE CANADA INC.,lidocaine HCI 1% Plain 10x20mL MD Vial,LIDOCAINE HYDROCHLORIDE,10MG,10 vials,BLOCK/INFILTRATION; BLOCK/INFILTRATION,Resolved,SOLUTION,2023-11-01,2023-11-01,2024-01-31,2024-01-25,Disruption of the manufacture of the drug.,2023-10-10,2024-02-05,No
183697,02302411,Shortage,XYLOCAINE 1%,ASPEN PHARMACARE CANADA INC.,Xylocaine® 1% Plain 10x20mL MD Vial,LIDOCAINE HYDROCHLORIDE,10MG,10 vials,BLOCK/INFILTRATION; BLOCK/INFILTRATION,Avoided shortage,SOLUTION,2023-10-01,,2023-10-31,2023-05-02,Delay in shipping of the drug.,2023-02-06,2023-05-02,No
197712,00001791,Shortage,XYLOCAINE 1% W EPINEPHRINE 1:100000,ASPEN PHARMACARE CANADA INC.,lidocaine HCI 1% w/epin. 1:100M 10x20mL MD Vial,EPINEPHRINE; LIDOCAINE HYDROCHLORIDE,0.01MG; 10MG,10 vials,BLOCK/INFILTRATION; BLOCK/INFILTRATION,Resolved,SOLUTION,2023-09-22,2023-09-22,2023-11-30,2023-11-06,Disruption of the manufacture of the drug.,2023-07-06,2023-11-07,No
183689,00001791,Shortage,XYLOCAINE 1% W EPINEPHRINE 1:100000,ASPEN PHARMACARE CANADA INC.,Xylocaine® 1% w/epin. 1:100M 10x20mL MD Vial,EPINEPHRINE; LIDOCAINE HYDROCHLORIDE,0.01MG; 10MG,10 vials,BLOCK/INFILTRATION; BLOCK/INFILTRATION,Avoided shortage,SOLUTION,2023-07-15,,2023-09-30,2023-03-07,Disruption of the manufacture of the drug.,2023-02-06,2023-03-07,No
209382,00001791,Shortage,XYLOCAINE 1% W EPINEPHRINE 1:100000,ASPEN PHARMACARE CANADA INC.,lidocaine HCI 1% w/epin. 1:100M 10x20mL MD Vial,EPINEPHRINE; LIDOCAINE HYDROCHLORIDE,0.01MG; 10MG,10 vials,BLOCK/INFILTRATION; BLOCK/INFILTRATION,Avoided shortage,SOLUTION,2024-01-01,,2024-01-31,2023-12-08,Disruption of the manufacture of the drug.,2023-11-06,2023-12-12,No
188732,00001805,Shortage,XYLOCAINE 1% W EPINEPHRINE 1:200000,ASPEN PHARMACARE CANADA INC.,lidocaine HCI 1% w/epin. 1:200M 10x20mL MD Vial,EPINEPHRINE; LIDOCAINE HYDROCHLORIDE,5MCG; 10MG,10 vials,BLOCK/INFILTRATION; BLOCK/INFILTRATION,Resolved,SOLUTION,2023-04-28,2023-05-01,2023-07-31,2023-06-23,Disruption of the manufacture of the drug.,2023-04-04,2023-07-06,No
188735,00001805,Shortage,XYLOCAINE 1% W EPINEPHRINE 1:200000,ASPEN PHARMACARE CANADA INC.,lidocaine HCI 1% w/epin. 1:200M 10x20mL MD Vial,EPINEPHRINE; LIDOCAINE HYDROCHLORIDE,5MCG; 10MG,10 vials,BLOCK/INFILTRATION; BLOCK/INFILTRATION,Avoided shortage,SOLUTION,2023-10-01,,2023-11-30,2023-05-02,Disruption of the manufacture of the drug.,2023-04-04,2023-05-02,No
200029,00001805,Shortage,XYLOCAINE 1% W EPINEPHRINE 1:200000,ASPEN PHARMACARE CANADA INC.,lidocaine HCI 1% w/epin. 1:200M 10x20mL MD Vial,EPINEPHRINE; LIDOCAINE HYDROCHLORIDE,5MCG; 10MG,10 vials,BLOCK/INFILTRATION; BLOCK/INFILTRATION,Resolved,SOLUTION,2023-08-25,2023-08-16,2024-01-01,2024-01-01,Disruption of the manufacture of the drug.,2023-07-26,2024-01-04,No
197732,02302438,Shortage,XYLOCAINE 2%,ASPEN PHARMACARE CANADA INC.,lidocaine HCI 2% Plain 10x50mL MD Vial,LIDOCAINE HYDROCHLORIDE,20MG,10 vials,BLOCK/INFILTRATION; BLOCK/INFILTRATION,Avoided shortage,SOLUTION,2023-08-20,,2023-08-20,2023-08-17,Disruption of the manufacture of the drug.,2023-07-06,2023-09-06,No
209393,02302438,Shortage,XYLOCAINE 2%,ASPEN PHARMACARE CANADA INC.,lidocaine HCI 2% Plain 10x50mL MD Vial,LIDOCAINE HYDROCHLORIDE,20MG,10 vials,BLOCK/INFILTRATION; BLOCK/INFILTRATION,Resolved,SOLUTION,2024-01-15,2024-01-16,2024-02-28,2024-01-31,Disruption of the manufacture of the drug.,2023-11-06,2024-02-05,No
209396,02302438,Shortage,XYLOCAINE 2%,ASPEN PHARMACARE CANADA INC.,lidocaine HCI 2% Plain 10x20mL MD Vial,LIDOCAINE HYDROCHLORIDE,20MG,10 vials,BLOCK/INFILTRATION; BLOCK/INFILTRATION,Resolved,SOLUTION,2023-12-22,,2024-01-31,2024-01-03,Disruption of the manufacture of the drug.,2023-11-06,2024-01-04,No
181246,02302438,Shortage,XYLOCAINE 2%,ASPEN PHARMACARE CANADA INC.,lidocaine HCI 2% Plain 10x20mL MD Vial,LIDOCAINE HYDROCHLORIDE,20MG,10 vials,BLOCK/INFILTRATION; BLOCK/INFILTRATION,Resolved,SOLUTION,2023-08-01,2023-08-01,2023-08-31,2023-08-28,Delay in shipping of the drug.,2023-01-17,2023-09-06,No
188726,00284106,Shortage,XYLOCAINE 2% W EPINEPHRINE 1:200000,ASPEN PHARMACARE CANADA INC.,lidocaine HCI 2% w/epin. 1:200M 10x20mL SU Vial,EPINEPHRINE; LIDOCAINE HYDROCHLORIDE,5MCG; 20MG,10 vials,EPIDURAL; EPIDURAL,Avoided shortage,SOLUTION,2023-06-15,,2023-06-30,2023-06-05,Delay in shipping of the drug.,2023-04-04,2023-06-05,No
188729,00284106,Shortage,XYLOCAINE 2% W EPINEPHRINE 1:200000,ASPEN PHARMACARE CANADA INC.,lidocaine HCI 2% w/epin. 1:200M 10x20mL SU Vial,EPINEPHRINE; LIDOCAINE HYDROCHLORIDE,5MCG; 20MG,10 vials,EPIDURAL; EPIDURAL,Avoided shortage,SOLUTION,2023-10-01,,2023-10-31,2023-05-02,Delay in shipping of the drug.,2023-04-04,2023-05-02,No
200026,00284106,Shortage,XYLOCAINE 2% W EPINEPHRINE 1:200000,ASPEN PHARMACARE CANADA INC.,lidocaine HCI 2% w/epin. 1:200M 10x20mL SU Vial,EPINEPHRINE; LIDOCAINE HYDROCHLORIDE,5MCG; 20MG,10 vials,EPIDURAL; EPIDURAL,Avoided shortage,SOLUTION,2023-10-01,,2023-12-22,2023-09-08,Disruption of the manufacture of the drug.,2023-07-26,2023-09-08,No
203734,00284106,Shortage,XYLOCAINE 2% W EPINEPHRINE 1:200000,ASPEN PHARMACARE CANADA INC.,lidocaine HCI 2% w/epin. 1:200M 10x20mL SU Vial,EPINEPHRINE; LIDOCAINE HYDROCHLORIDE,5MCG; 20MG,10 vials,EPIDURAL; EPIDURAL,Resolved,SOLUTION,,2023-09-05,2024-02-28,2024-02-06,Disruption of the manufacture of the drug.,2023-09-06,2024-02-07,No
188723,02373130,Shortage,XYLOCAINE 2% WITH EPINEPHRINE 1:200000,ASPEN PHARMACARE CANADA INC.,lidocaine HCI 2% w/epin. 1:200M 10x20mL MD Vial,EPINEPHRINE; LIDOCAINE HYDROCHLORIDE,0.005MG; 20MG,10 vials,BLOCK/INFILTRATION; BLOCK/INFILTRATION,Avoided shortage,SOLUTION,2023-09-01,,2023-10-31,2023-05-02,Disruption of the manufacture of the drug.,2023-04-04,2023-05-02,No
183684,02373130,Shortage,XYLOCAINE 2% WITH EPINEPHRINE 1:200000,ASPEN PHARMACARE CANADA INC.,lidocaine HCI 2% w/epin. 1:200M 10x20mL MD Vial,EPINEPHRINE; LIDOCAINE HYDROCHLORIDE,0.005MG; 20MG,10 vials,BLOCK/INFILTRATION; BLOCK/INFILTRATION,Resolved,SOLUTION,2023-08-15,2023-08-04,2024-01-01,2024-01-03,Disruption of the manufacture of the drug.,2023-02-06,2024-01-04,No
186439,00001694,Shortage,XYLOCAINE JELLY 2%,ASPEN PHARMACARE CANADA INC.,lidocaine HCI 2% Jelly 30mL Aluminum Tube,LIDOCAINE HYDROCHLORIDE,20MG,1 Tube,TOPICAL; TOPICAL,Avoided shortage,GEL,2023-11-01,,2023-12-31,2023-05-01,Disruption of the manufacture of the drug.,2023-03-07,2023-05-01,No
197729,02003767,Shortage,XYLOCAINE SPRAY,ASPEN PHARMACARE CANADA INC.,lidocaine Endotracheal Spray 10mg 50mL Bottle,LIDOCAINE,10MG,1 Bottle,TOPICAL; ORAL; ORAL,Resolved,"SPRAY, METERED DOSE; SOLUTION",2023-07-10,2023-07-10,2023-12-31,2023-12-19,Disruption of the manufacture of the drug.,2023-07-06,2023-12-20,No
202308,02321157,Shortage,YAZ,BAYER INC,Drospirenone and Ethinyl Estradiol,ETHINYL ESTRADIOL; DROSPIRENONE,0.02MG; 3MG,28's,ORAL; ORAL,Avoided shortage,TABLET,2023-08-25,,2023-08-28,2023-08-21,Delay in shipping of the drug.,2023-08-17,2023-08-21,No
198397,02379384,Shortage,YERVOY,BRISTOL-MYERS SQUIBB CANADA,Ipilimumab,IPILIMUMAB,5MG,1x40ml,INTRAVENOUS; INTRAVENOUS,Resolved,LIQUID,2023-07-12,2023-07-12,,2023-08-21,Disruption of the manufacture of the drug.,2023-07-12,2023-08-22,No
192079,00428833,Shortage,YF-VAX,SANOFI PASTEUR LIMITED,YF-VAX,YELLOW FEVER VACCINE,109648PFU,5,SUBCUTANEOUS; SUBCUTANEOUS,Resolved,POWDER FOR SOLUTION,2023-05-15,,2023-06-14,2023-05-16,Other (Please describe in comments),2023-05-08,2023-05-17,No
195081,02410788,Shortage,ZAMINE 21,APOTEX INC,DROSPIRENONE / ETHINYL ESTRADIOL,ETHINYL ESTRADIOL; DROSPIRENONE,0.03MG; 3MG,21 BLS,ORAL,Resolved,TABLET,,2023-06-13,2023-07-28,2023-07-26,Disruption of the manufacture of the drug.,2023-06-16,2023-07-27,No
210668,02410788,Shortage,ZAMINE 21,APOTEX INC,DROSPIRENONE / ETHINYL ESTRADIOL,ETHINYL ESTRADIOL; DROSPIRENONE,0.03MG; 3MG,21 BLS,ORAL,Resolved,TABLET,,2023-11-14,2024-01-05,2023-12-21,Disruption of the manufacture of the drug.,2023-11-17,2023-12-22,No
211487,02410796,Shortage,ZAMINE 28,APOTEX INC,DROSPIRENONE / ETHINYL ESTRADIOL,ETHINYL ESTRADIOL; DROSPIRENONE,0.03MG; 3MG,28 BLS,ORAL,Resolved,TABLET,,2023-11-21,2024-01-05,2023-12-21,Disruption of the manufacture of the drug.,2023-11-24,2023-12-22,No
203831,02410796,Shortage,ZAMINE 28,APOTEX INC,DROSPIRENONE / ETHINYL ESTRADIOL,ETHINYL ESTRADIOL; DROSPIRENONE,0.03MG; 3MG,28 BLS,ORAL,Resolved,TABLET,,2023-09-05,2023-09-29,2023-09-15,Disruption of the manufacture of the drug.,2023-09-07,2023-09-28,No
210026,00022799,Shortage,ZARONTIN,SEARCHLIGHT PHARMA INC,Zarontin,ETHOSUXIMIDE,250MG,100 caps,ORAL; ORAL,Avoided shortage,CAPSULE,2023-12-15,,2024-02-01,2023-12-01,Delay in shipping of the drug.,2023-11-13,2023-12-01,No
191769,00888400,Shortage,ZAROXOLYN,SANOFI-AVENTIS CANADA INC,ZAROXOLYN,METOLAZONE,2.5MG,100,ORAL; ORAL,Resolved,TABLET,,2023-05-04,2023-05-31,2023-05-09,Other (Please describe in comments),2023-05-05,2023-05-10,No
200374,02489783,Shortage,ZEJULA,GLAXOSMITHKLINE INC,niraparib capsules,NIRAPARIB,100MG,84,ORAL; ORAL,Resolved,CAPSULE,,2023-07-31,,2023-09-25,Other (Please describe in comments),2023-07-28,2023-09-28,No
201950,02298619,Shortage,ZELDOX,UPJOHN CANADA ULC,ZELDOX,ZIPRASIDONE,60MG,60,ORAL; ORAL,Resolved,CAPSULE,2023-08-21,,2023-10-10,2023-09-18,Disruption of the manufacture of the drug.,2023-08-16,2023-10-17,No
191725,02298627,Shortage,ZELDOX,UPJOHN CANADA ULC,ZELDOX,ZIPRASIDONE,80MG,60,ORAL; ORAL,Resolved,CAPSULE,2023-05-12,2023-05-08,,2023-08-08,Disruption of the manufacture of the drug.,2023-05-05,2023-08-16,No
193011,02298597,Shortage,ZELDOX,UPJOHN CANADA ULC,ZELDOX,ZIPRASIDONE,20MG,60,ORAL; ORAL,Resolved,CAPSULE,2023-07-06,2023-07-05,2023-08-15,2023-08-15,Disruption of the manufacture of the drug.,2023-05-25,2023-08-16,No
204548,02103729,Shortage,ZESTORETIC,SEARCHLIGHT PHARMA INC,ZESTORETIC,LISINOPRIL; HYDROCHLOROTHIAZIDE,10MG; 12.5MG,100 Tablets,ORAL; ORAL,Resolved,TABLET,2023-09-04,2023-09-04,2023-09-04,2023-09-04,Shortage of an inactive ingredient or component.,2023-09-15,2023-09-20,No
202917,02103729,Shortage,ZESTORETIC,SEARCHLIGHT PHARMA INC,Zestoretic 10/12.5,LISINOPRIL; HYDROCHLOROTHIAZIDE,10MG; 12.5MG,100 tablets,ORAL; ORAL,Actual shortage,TABLET,2023-09-02,2023-09-02,2024-12-31,,Other (Please describe in comments),2023-08-24,2023-12-05,No
195535,02103729,Shortage,ZESTORETIC,SEARCHLIGHT PHARMA INC,ZESTORETIC,HYDROCHLOROTHIAZIDE; LISINOPRIL,12.5MG; 10MG,100 tablets,ORAL; ORAL,Resolved,TABLET,2023-06-19,2023-06-20,2023-07-12,2023-07-12,Delay in shipping of the drug.,2023-06-19,2023-07-13,No
211672,02045737,Shortage,ZESTORETIC,SEARCHLIGHT PHARMA INC,ZESTORETIC,HYDROCHLOROTHIAZIDE; LISINOPRIL,12.5MG; 20MG,100 Tablets,ORAL; ORAL,Resolved,TABLET,2024-01-01,,2024-01-22,2024-01-22,Shortage of an inactive ingredient or component.,2023-11-28,2024-01-23,No
211675,02045729,Shortage,ZESTORETIC,SEARCHLIGHT PHARMA INC,ZESTORITIC,HYDROCHLOROTHIAZIDE; LISINOPRIL,25MG; 20MG,100 Tablets,ORAL; ORAL,Actual shortage,TABLET,2023-12-15,,2024-12-31,,Shortage of an inactive ingredient or component.,2023-11-28,2023-12-16,No
200688,02045737,Shortage,ZESTORETIC,SEARCHLIGHT PHARMA INC,zestoretic,HYDROCHLOROTHIAZIDE; LISINOPRIL,12.5MG; 20MG,100 tablets,ORAL; ORAL,Resolved,TABLET,2023-08-02,,2023-08-02,2023-08-02,Requirements related to complying with good manufacturing practices.,2023-08-02,2023-08-03,No
185721,02153432,Shortage,ZINECARD,PFIZER CANADA ULC,ZINECARD,DEXRAZOXANE,250MG,25mL vial,INTRAVENOUS; INTRAVENOUS,Resolved,POWDER FOR SOLUTION,,2023-02-28,,2023-10-04,Disruption of the manufacture of the drug.,2023-02-28,2023-10-31,No
188567,02212021,Shortage,ZITHROMAX,PFIZER CANADA ULC,ZITHROMAX,AZITHROMYCIN,250MG,1 x 6 BLST,ORAL; ORAL,Resolved,TABLET,,2023-04-03,,2023-06-27,Disruption of the manufacture of the drug.,2023-04-03,2023-06-28,No
194985,00884340,Shortage,ZOCOR,ORGANON CANADA INC.,simvastatin tablets,SIMVASTATIN,20MG,28,ORAL; ORAL,Resolved,TABLET,,2023-06-15,2023-07-21,2023-07-19,Requirements related to complying with good manufacturing practices.,2023-06-16,2023-07-20,No
181739,02401606,Shortage,ZOLEDRONIC ACID - Z,SANDOZ CANADA INCORPORATED,ZOLEDRONIC ACID,ZOLEDRONIC ACID,4MG,5ML,INTRAVENOUS; INTRAVENOUS,Resolved,SOLUTION,,2023-01-18,2023-01-27,2023-01-31,Demand increase for the drug.,2023-01-19,2023-02-01,No
198939,02442671,Shortage,ZOLMITRIPTAN ODT,SANIS HEALTH INC,ZOLMITRIPTAN ODT,ZOLMITRIPTAN,2.5MG,6,ORAL; ORAL,Resolved,TABLET (ORALLY DISINTEGRATING),,2023-07-18,2023-10-27,2023-10-13,Disruption of the manufacture of the drug.,2023-07-18,2023-10-23,No
181295,02132702,Shortage,ZOLOFT,UPJOHN CANADA ULC,ZOLOFT,SERTRALINE,25MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-02-06,2023-02-28,2023-03-16,Disruption of the manufacture of the drug.,2023-01-17,2023-03-20,No
191713,01962817,Shortage,ZOLOFT,UPJOHN CANADA ULC,ZOLOFT,SERTRALINE,50MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-04-11,2023-07-25,2023-07-24,Disruption of the manufacture of the drug.,2023-05-05,2023-08-03,No
184552,02132702,Shortage,ZOLOFT,UPJOHN CANADA ULC,ZOLFT,SERTRALINE,25MG,100,ORAL; ORAL,Resolved,CAPSULE,,2023-02-07,2023-03-14,2023-03-16,Disruption of the manufacture of the drug.,2023-02-14,2023-03-20,No
191728,01962817,Shortage,ZOLOFT,UPJOHN CANADA ULC,ZOLOFT,SERTRALINE,50MG,250,ORAL; ORAL,Resolved,CAPSULE,2023-05-08,,2023-07-25,2023-07-24,Disruption of the manufacture of the drug.,2023-05-05,2023-08-03,No
193014,02132702,Shortage,ZOLOFT,UPJOHN CANADA ULC,ZOLOFT,SERTRALINE,25MG,100,ORAL; ORAL,Resolved,CAPSULE,2023-06-05,2023-06-12,2023-07-25,2023-07-24,Disruption of the manufacture of the drug.,2023-05-25,2023-08-03,No
196208,00886157,Shortage,ZOVIRAX,GLAXOSMITHKLINE INC,Acyclovir Oral Suspension,ACYCLOVIR,200MG,475ML,ORAL; ORAL,Actual shortage,SUSPENSION,,2023-06-22,,,Shortage of an active ingredient.,2023-06-23,2024-04-01,No
210159,02257270,Shortage,ZYMAR,ABBVIE CORPORATION,Zymar 0.3% 5 mL,GATIFLOXACIN,0.30%,5mL  bottle,OPHTHALMIC; OPHTHALMIC,Resolved,SOLUTION,2023-11-08,2023-11-08,2023-12-06,2023-12-06,Disruption of the manufacture of the drug.,2023-11-14,2023-12-07,No
